data_2ho9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ho9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -134.84 165.87 24.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.872 2.069 . . . . 0.0 109.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.52 146.03 47.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.981 1.313 . . . . 0.0 107.485 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -141.75 138.24 32.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.477 0.711 . . . . 0.0 110.163 -168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.5 tp -78.71 132.63 37.07 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.267 2.0 m -117.91 146.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 119.24 0.927 . . . . 0.0 108.617 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -141.0 164.99 28.79 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.208 1.003 . . . . 0.0 110.537 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 m -121.01 146.02 47.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.78 134.04 14.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.8 -92.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.771 1.177 . . . . 0.0 110.363 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -151.28 37.84 0.62 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.06 1.344 . . . . 0.0 109.493 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -140.04 154.4 47.08 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.386 1.474 . . . . 0.0 108.433 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.93 155.46 31.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.799 1.285 . . . . 0.0 109.983 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -143.68 158.55 43.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.418 1.887 . . . . 0.0 107.901 -169.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.25 154.86 20.78 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.084 1.326 . . . . 0.0 110.024 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.1 mt -139.89 135.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.41 124.18 15.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.799 0.727 . . . . 0.0 109.177 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.69 -34.09 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.463 0.705 . . . . 0.0 112.631 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 mt -68.18 -24.36 64.96 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.853 0.751 . . . . 0.0 112.131 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.88 -14.51 50.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.953 0.797 . . . . 0.0 111.555 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.71 128.1 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -87.43 -55.7 3.68 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.432 1.093 . . . . 0.0 108.464 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -167.24 -178.06 3.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.866 1.266 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.91 142.69 43.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -167.77 2.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.448 1.499 . . . . 0.0 107.885 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.99 160.45 21.26 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -75.74 -0.96 22.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -5.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -168.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 34.19 1.39 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.343 1.429 . . . . 0.0 113.576 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.44 140.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.4 m -129.77 91.53 3.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 28.8 tpt180 -68.18 112.5 5.14 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.23 157.11 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.3 72.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -139.23 22.91 2.57 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.525 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -63.05 156.71 66.44 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -59.77 142.02 97.91 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.68 68.01 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.365 -0.835 . . . . 0.0 112.78 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -52.27 -40.56 61.9 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.541 0.609 . . . . 0.0 110.239 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.18 94.99 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -50.01 -33.12 17.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.286 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.62 177.01 31.3 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.9 153.92 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -140.63 163.42 32.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.732 1.151 . . . . 0.0 108.794 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -89.28 113.31 24.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.043 0.937 . . . . 0.0 110.75 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.48 171.66 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.4 mtp-105 -72.61 64.61 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.273 1.397 . . . . 0.0 112.81 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.96 -9.83 2.29 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 127.076 2.274 . . . . 0.0 113.24 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.34 -164.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 119.231 1.516 . . . . 0.0 108.536 -169.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.9 tp -127.81 157.04 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.174 1.79 . . . . 0.0 108.525 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p -151.38 141.99 14.93 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.44 138.36 42.17 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.183 1.922 . . . . 0.0 109.991 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.86 137.45 56.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.68 1.192 . . . . 0.0 108.319 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.99 139.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -97.89 120.69 38.72 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.303 0.641 . . . . 0.0 109.651 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -68.29 -18.87 64.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.175 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.21 -37.17 86.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.862 1.665 . . . . 0.0 110.455 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.26 -48.02 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -73.98 -27.4 60.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.324 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.31 11.44 2.56 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.948 1.249 . . . . 0.0 113.335 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m 60.63 34.1 20.2 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.606 -1.309 . . . . 0.0 112.926 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -50.85 155.2 1.22 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.645 0.778 . . . . 0.0 112.503 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 t -59.16 -64.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.786 1.234 . . . . 0.0 113.192 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -157.23 63.19 0.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.775 0.797 . . . . 0.0 111.457 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.54 135.55 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -158.39 158.52 34.38 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.482 1.513 . . . . 0.0 108.427 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.01 48.43 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.85 1.66 . . . . 0.0 112.767 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.1 -16.08 0.11 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.961 2.904 . . . . 0.0 109.987 169.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.69 -8.11 9.97 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.486 1.914 . . . . 0.0 111.562 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.48 35.14 1.84 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.687 1.595 . . . . 0.0 109.775 -169.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -100.08 -11.56 20.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -168.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.28 157.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.08 133.06 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.3 mt -107.67 133.76 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.27 137.92 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.8 mt -136.0 154.68 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.726 1.611 . . . . 0.0 107.549 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.47 149.64 42.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.32 176.02 8.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -11.67 -65.71 0.01 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 128.096 2.76 . . . . 0.0 116.24 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -137.95 26.63 2.72 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 111.638 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -151.4 164.63 36.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.778 -1.201 . . . . 0.0 111.952 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.17 144.12 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 0.0 109.015 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -157.64 -178.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.618 1.567 . . . . 0.0 107.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.62 -179.69 41.02 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.538 -1.352 . . . . 0.0 110.526 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.9 pt -141.91 144.21 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.108 0.963 . . . . 0.0 108.915 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 m -79.44 141.87 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.134 1.374 . . . . 0.0 108.46 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.98 163.21 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.256 1.822 . . . . 0.0 110.275 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -80.11 -46.7 16.01 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.954 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.56 161.94 31.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.71 116.49 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -41.57 34.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.573 0.749 . . . . 0.0 111.601 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -170.16 -174.82 1.83 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.65 123.45 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.6 mt -140.27 171.52 14.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.626 1.171 . . . . 0.0 109.994 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 m -125.6 139.38 53.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.091 0.556 . . . . 0.0 110.131 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.78 159.46 42.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.6 1.16 . . . . 0.0 109.366 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -122.38 155.18 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.117 2.167 . . . . 0.0 106.941 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -27.74 63.66 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.121 -0.987 . . . . 0.0 112.498 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.21 -33.64 73.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.634 1.173 . . . . 0.0 111.234 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -78.0 -42.31 33.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 109.617 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.5 mt -85.41 68.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.287 1.435 . . . . 0.0 109.11 -170.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -113.75 -60.53 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.367 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -179.1 1.74 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.034 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.19 32.52 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.774 1.63 . . . . 0.0 108.874 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.1 51.29 3.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.613 2.876 . . . . 0.0 110.709 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.83 27.89 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.832 2.053 . . . . 0.0 114.103 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -65.4 176.64 1.34 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 110.46 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.73 32.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.457 1.903 . . . . 0.0 113.685 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 m -66.93 167.09 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.188 0.995 . . . . 0.0 109.914 169.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -63.82 -16.1 60.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 0.0 113.391 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.44 108.61 4.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.562 1.145 . . . . 0.0 111.01 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 m -67.53 155.47 39.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.052 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -66.07 -34.07 77.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.611 1.164 . . . . 0.0 112.543 -171.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.16 -17.45 62.54 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.601 -1.312 . . . . 0.0 113.241 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.77 26.13 5.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.785 0.834 . . . . 0.0 109.939 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.54 140.02 54.83 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -70.28 -176.5 1.21 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.597 1.959 . . . . 0.0 110.66 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.02 178.89 16.39 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 169.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.1 mt -134.64 150.72 50.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.46 171.1 34.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.65 157.21 25.76 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.209 1.004 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.8 79.12 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.99 -50.96 2.72 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.7 2.095 . . . . 0.0 112.869 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.31 -30.53 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.223 2.209 . . . . 0.0 111.023 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -66.55 164.75 15.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.139 0.976 . . . . 0.0 108.886 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.7 mtp -139.17 150.74 45.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.764 1.226 . . . . 0.0 108.072 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.4 mt -138.53 137.92 37.52 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.678 1.191 . . . . 0.0 107.908 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 98.8 mt -86.89 113.29 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.03 109.23 15.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.24 128.92 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -75.24 51.61 0.55 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.77 1.228 . . . . 0.0 110.859 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 tp -57.23 -40.67 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.998 -1.064 . . . . 0.0 111.979 -169.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.94 -10.61 40.64 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.39 0.65 6.99 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.765 169.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.84 -69.07 0.25 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.838 1.199 . . . . 0.0 109.924 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.94 -33.25 74.31 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.89 -46.22 78.41 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.747 -0.595 . . . . 0.0 110.647 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -77.2 -22.46 52.32 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.282 0.633 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.44 -15.0 19.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.186 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.24 -48.08 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.495 1.498 . . . . 0.0 111.737 -169.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.9 ptp -60.86 -27.72 68.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.028 0.931 . . . . 0.0 113.007 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.62 -34.99 12.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.59 1.156 . . . . 0.0 111.282 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.78 -62.17 2.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.224 1.41 . . . . 0.0 109.004 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -26.68 66.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -169.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.466 0.361 0 C-N-CA 123.896 0.878 . . . . 0.0 112.643 -177.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.629 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.47 168.02 20.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.997 2.119 . . . . 0.0 110.291 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -121.54 147.39 45.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.85 137.28 31.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 109.416 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.4 tp -77.75 136.58 38.17 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 167.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.252 1.6 m -124.92 148.54 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 119.657 1.117 . . . . 0.0 109.078 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -140.64 150.17 43.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.677 1.191 . . . . 0.0 109.665 -172.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.3 m -91.09 146.71 23.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp -134.69 90.23 2.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.6 -71.53 0.37 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.815 1.674 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.56 28.85 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.504 1.522 . . . . 0.0 111.047 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.45 161.49 36.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.779 1.632 . . . . 0.0 107.939 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -122.99 151.07 42.19 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.516 1.15 . . . . 0.0 109.76 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -142.15 158.57 43.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.961 2.105 . . . . 0.0 107.437 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.87 161.27 24.52 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.43 1.014 . . . . 0.0 111.237 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.41 135.14 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -48.42 116.7 1.67 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 109.302 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.96 -33.34 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.332 0.653 . . . . 0.0 111.441 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.95 -22.94 67.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.591 0.756 . . . . 0.0 112.588 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -82.62 -19.93 37.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.99 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.65 142.15 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 119.194 0.907 . . . . 0.0 108.771 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.79 -53.92 2.66 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.401 1.081 . . . . 0.0 108.567 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.91 -176.5 4.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.569 1.147 . . . . 0.0 109.821 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.7 149.15 31.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -151.85 -157.9 0.85 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.379 1.872 . . . . 0.0 107.786 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.53 151.58 18.95 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 120.116 1.326 . . . . 0.0 112.691 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -77.02 91.23 3.62 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.122 1.369 . . . . 0.0 107.468 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -149.03 -18.11 0.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 51.91 1.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.094 0.861 . . . . 0.0 111.005 -169.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.45 152.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 O-C-N 120.674 -1.266 . . . . 0.0 110.463 169.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -133.56 131.03 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -128.26 133.74 48.85 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -168.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 mm -79.38 159.93 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.52 63.08 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.84 28.32 0.37 Allowed 'General case' 0 C--N 1.341 0.226 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -169.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.53 154.65 78.83 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.309 169.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -63.13 136.21 54.95 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.096 1.864 . . . . 0.0 107.671 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.83 -28.15 47.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -52.57 -46.08 66.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.663 0.665 . . . . 0.0 110.282 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.4 94.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -51.32 -47.44 62.64 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.96 -129.16 1.52 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 165.99 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.802 1.241 . . . . 0.0 107.866 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.5 t -145.54 173.33 12.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -82.89 160.95 22.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 120.796 -1.19 . . . . 0.0 111.608 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -121.89 168.97 11.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 167.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.36 58.43 0.26 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.641 1.576 . . . . 0.0 111.942 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.72 -13.95 1.18 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 127.111 2.291 . . . . 0.0 113.563 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.444 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.63 -161.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.762 1.781 . . . . 0.0 109.036 -169.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.444 ' H ' HG11 ' A' ' 64' ' ' VAL . 4.2 tp -119.28 158.77 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.924 1.689 . . . . 0.0 108.928 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.59 137.81 12.54 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 109.617 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.62 144.14 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.953 1.769 . . . . 0.0 109.469 169.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.3 136.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.39 150.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -123.83 128.76 49.98 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.76 -15.63 63.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.431 -0.319 . . . . 0.0 110.942 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -58.54 -21.35 52.19 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.879 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mt -127.91 23.16 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.351 2.26 . . . . 0.0 108.534 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -139.36 -27.88 0.79 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.724 -1.235 . . . . 0.0 112.352 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.24 15.57 4.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.962 0.905 . . . . 0.0 111.229 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m 51.16 47.45 24.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.738 1.615 . . . . 0.0 111.476 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -53.74 166.7 0.3 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.727 1.211 . . . . 0.0 111.4 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -60.99 169.66 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.81 0.844 . . . . 0.0 109.609 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.53 71.38 0.95 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 128.73 2.812 . . . . 0.0 110.691 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.5 m -38.81 153.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 128.627 2.771 . . . . 0.0 114.09 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.52 161.49 42.18 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.308 1.443 . . . . 0.0 108.518 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -72.11 49.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.869 1.668 . . . . 0.0 111.212 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.23 -19.67 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.808 2.843 . . . . 0.0 110.152 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.82 -15.31 3.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.779 1.232 . . . . 0.0 112.324 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -145.4 47.75 1.28 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.804 1.241 . . . . 0.0 108.322 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.3 p -78.15 -4.81 49.39 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.358 2.663 . . . . 0.0 117.644 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.11 153.85 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 121.463 1.938 . . . . 0.0 109.091 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.22 122.23 62.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.086 1.754 . . . . 0.0 107.233 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.4 mt -93.57 140.6 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.0 133.71 60.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.77 165.74 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.047 1.739 . . . . 0.0 108.953 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.13 153.39 51.85 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.295 1.038 . . . . 0.0 110.007 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -133.79 85.6 2.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.88 -67.7 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.781 1.658 . . . . 0.0 113.72 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -136.15 3.19 2.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.863 1.665 . . . . 0.0 112.338 -171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.71 169.25 16.45 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 110.066 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.871 1.269 . . . . 0.0 108.992 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -157.49 171.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.447 1.499 . . . . 0.0 107.194 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.07 171.59 32.06 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -138.46 143.7 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.877 0.871 . . . . 0.0 108.79 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.83 134.44 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 108.943 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.36 170.5 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 125.581 1.552 . . . . 0.0 109.914 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.41 -41.87 72.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.53 158.83 10.99 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.74 130.73 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.17 -42.64 7.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.266 1.026 . . . . 0.0 111.358 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -168.18 -175.57 2.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 109.877 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.04 127.27 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 169.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -137.36 165.31 26.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.429 1.092 . . . . 0.0 109.524 -169.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 m -124.41 130.56 52.7 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.33 162.52 33.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.927 . . . . 0.0 108.962 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -138.15 159.93 40.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.908 1.283 . . . . 0.0 108.538 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.18 -23.4 8.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.18 -34.43 74.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.04 -1.038 . . . . 0.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -85.29 -38.68 18.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.177 1.391 . . . . 0.0 110.554 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.54 102.67 13.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.6 mtm105 -140.15 -56.93 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.948 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.53 168.68 14.17 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.712 1.608 . . . . 0.0 111.354 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.03 154.71 29.27 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.31 1.444 . . . . 0.0 108.957 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.26 146.57 71.31 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.739 2.293 . . . . 0.0 110.91 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.06 18.99 0.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.577 1.151 . . . . 0.0 110.757 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -73.65 170.29 15.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 111.121 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.97 65.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.701 1.6 . . . . 0.0 110.584 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.47 175.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.455 1.502 . . . . 0.0 109.66 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.92 11.53 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.413 1.885 . . . . 0.0 114.942 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.7 158.04 18.92 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.285 1.434 . . . . 0.0 110.227 -173.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -142.42 148.08 37.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 110.969 -171.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -55.77 -29.45 59.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.144 1.777 . . . . 0.0 114.406 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.68 -22.58 65.28 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.71 25.66 1.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.542 1.064 . . . . 0.0 112.517 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.62 18.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p 64.86 -170.99 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.429 1.492 . . . . 0.0 112.151 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.65 28.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 106.584 -2.606 . . . . 0.0 106.584 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.66 153.74 39.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.465 1.633 . . . . 0.0 109.491 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.97 173.2 35.22 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.11 157.8 16.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.266 1.026 . . . . 0.0 111.202 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.07 72.48 1.38 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.187 1.795 . . . . 0.0 107.143 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.8 -46.36 2.03 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.385 1.945 . . . . 0.0 113.724 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -36.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.19 2.196 . . . . 0.0 110.403 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -73.55 166.09 23.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.655 0.741 . . . . 0.0 110.031 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.5 mtp -141.03 148.4 40.19 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.4 153.94 36.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.689 0.796 . . . . 0.0 110.459 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 79.5 mt -104.89 109.97 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.349 1.459 . . . . 0.0 107.178 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.31 108.13 15.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.035 1.334 . . . . 0.0 107.736 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.3 131.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.547 1.139 . . . . 0.0 108.138 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -78.74 60.54 2.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.61 0.719 . . . . 0.0 109.643 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 tp -54.42 -39.01 42.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 C-N-CA 124.764 1.226 . . . . 0.0 111.147 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.45 -13.16 60.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.747 0.703 . . . . 0.0 112.568 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -111.81 -7.72 14.18 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.872 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.42 -77.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.641 1.11 . . . . 0.0 110.742 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.49 -20.1 65.41 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.33 -0.856 . . . . 0.0 110.443 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.49 -37.43 75.52 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.097 -1.002 . . . . 0.0 110.664 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 m -85.82 -30.14 23.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.695 0.798 . . . . 0.0 111.242 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -90.96 -9.44 46.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.938 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -49.31 -47.96 46.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.763 1.619 . . . . 0.0 111.792 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -63.42 -44.7 93.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.717 0.407 . . . . 0.0 109.956 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.49 82.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.325 0.65 . . . . 0.0 111.368 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.24 -58.62 7.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.718 1.207 . . . . 0.0 109.321 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.86 62.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.432 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 112.917 174.809 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -69.89 163.84 25.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.081 0.553 . . . . 0.0 109.609 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -124.91 143.28 50.94 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.539 1.536 . . . . 0.0 107.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -142.3 136.79 30.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.648 0.779 . . . . 0.0 110.501 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.6 tp -77.88 135.97 37.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 167.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.28 152.88 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.736 1.153 . . . . 0.0 109.57 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -140.38 151.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 109.56 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -93.38 146.53 23.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -156.0 134.95 11.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 169.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -98.52 0.53 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.31 36.71 0.67 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.348 1.459 . . . . 0.0 108.776 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.02 161.0 39.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.156 1.782 . . . . 0.0 107.852 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -120.1 156.4 31.09 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.117 1.437 . . . . 0.0 110.457 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -138.11 147.73 44.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.943 2.097 . . . . 0.0 106.457 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.48 156.64 15.97 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.49 134.9 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -49.52 115.5 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.034 0.934 . . . . 0.0 109.111 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.54 -33.1 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.702 . . . . 0.0 111.712 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.84 -24.8 67.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.687 0.795 . . . . 0.0 112.606 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -83.16 -17.73 41.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.682 0.674 . . . . 0.0 111.763 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.8 145.25 13.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.632 1.106 . . . . 0.0 109.087 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -123.05 -47.16 2.05 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.073 0.949 . . . . 0.0 111.346 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -162.84 172.41 15.2 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.609 0.764 . . . . 0.0 109.487 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.25 144.54 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 106.595 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -148.05 176.53 10.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.619 1.567 . . . . 0.0 108.04 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.33 168.92 44.97 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -83.49 -164.42 0.9 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 110.032 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 60.3 38.33 19.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.275 1.83 . . . . 0.0 112.859 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -141.14 26.76 1.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.635 1.574 . . . . 0.0 109.767 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 102.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 120.97 -1.082 . . . . 0.0 108.424 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -61.95 -44.51 96.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.518 . . . . 0.0 110.46 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 56.53 -176.52 0.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.828 2.051 . . . . 0.0 112.515 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mm -133.55 160.23 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.88 -23.12 67.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.74 27.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 148.26 57.71 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 122.765 0.426 . . . . 0.0 110.947 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.31 152.68 66.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.21 2.607 . . . . 0.0 110.041 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.33 73.81 0.98 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.599 1.19 . . . . 0.0 110.528 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -162.72 -52.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 130.12 3.368 . . . . 0.0 103.696 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.3 mt -75.42 92.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -51.01 -41.4 59.77 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.912 0.885 . . . . 0.0 108.9 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.85 -156.04 19.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 m -124.1 151.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -136.34 148.26 47.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -80.62 92.34 5.95 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.404 1.081 . . . . 0.0 109.895 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.58 171.65 4.88 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -67.14 63.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.182 1.793 . . . . 0.0 113.155 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.21 -8.63 3.8 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.968 2.223 . . . . 0.0 113.507 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -152.83 -165.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 119.104 1.452 . . . . 0.0 108.342 -169.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 64' ' ' VAL . 5.4 tp -121.62 157.88 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.546 1.938 . . . . 0.0 107.709 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.72 138.79 12.71 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.896 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.38 145.29 64.84 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.181 1.92 . . . . 0.0 110.049 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -129.05 138.31 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.82 164.34 11.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -132.14 126.98 34.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.0 -21.99 64.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.122 1.369 . . . . 0.0 111.665 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -37.67 80.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.274 1.397 . . . . 0.0 110.101 169.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.85 -57.0 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -66.64 -28.78 68.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.861 0.864 . . . . 0.0 113.199 -169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -135.11 5.93 3.32 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.3 m 53.14 41.87 32.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.183 0.901 . . . . 0.0 111.687 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -52.6 146.3 10.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.1 t -44.92 -61.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 112.742 -169.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -175.21 86.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.79 1.636 . . . . 0.0 108.657 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.7 144.1 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.84 163.92 31.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 109.493 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.55 42.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.722 2.409 . . . . 0.0 112.889 172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.05 -12.87 0.16 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.161 2.184 . . . . 0.0 111.318 170.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.71 -5.94 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.335 1.454 . . . . 0.0 111.735 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.41 44.24 1.52 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.452 -1.405 . . . . 0.0 108.762 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 p -99.38 -2.97 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.344 1.858 . . . . 0.0 114.297 -169.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.6 t -128.06 154.79 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.16 130.68 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.129 1.771 . . . . 0.0 106.341 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.2 mt -102.7 138.22 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.17 133.76 54.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.3 mt -133.53 163.69 28.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.607 1.563 . . . . 0.0 107.922 -170.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.84 146.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.853 1.261 . . . . 0.0 107.674 171.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.7 157.34 43.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.52 -112.44 2.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.82 27.04 5.79 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.511 1.524 . . . . 0.0 110.383 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -141.14 171.27 14.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.401 1.081 . . . . 0.0 110.835 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.76 154.27 38.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.229 1.011 . . . . 0.0 110.704 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.6 p -161.28 176.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.324 1.85 . . . . 0.0 106.878 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.24 -179.87 37.98 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 120.548 -1.345 . . . . 0.0 111.785 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 pt -142.46 155.97 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.519 1.528 . . . . 0.0 108.579 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.2 143.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.55 171.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.411 1.884 . . . . 0.0 110.086 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.59 -42.51 42.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.776 0.716 . . . . 0.0 109.973 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.63 153.42 9.69 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 173.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.57 123.99 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.9 -52.86 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.313 0.645 . . . . 0.0 110.373 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -173.23 -177.17 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.941 1.697 . . . . 0.0 108.093 -169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -117.26 132.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.8 mt -135.09 174.42 10.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.762 1.625 . . . . 0.0 108.665 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -132.4 141.72 48.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.213 0.605 . . . . 0.0 109.587 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.7 134.97 27.52 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 51.8 p -76.77 163.76 26.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.321 0.581 . . . . 0.0 110.712 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.99 10.01 0.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.377 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.99 -40.46 5.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.418 2.287 . . . . 0.0 108.851 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -61.13 -47.43 86.31 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.1 mt -67.21 119.6 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -151.3 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.15 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -177.58 2.66 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.247 1.964 . . . . 0.0 111.257 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.36 153.64 29.56 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.377 1.471 . . . . 0.0 108.707 169.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.14 51.05 3.52 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.603 3.535 . . . . 0.0 110.65 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 7.7 1.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.634 1.573 . . . . 0.0 114.847 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -146.1 160.07 42.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.3 32.95 14.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.738 2.015 . . . . 0.0 114.367 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.21 166.13 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.599 1.56 . . . . 0.0 108.697 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -5.36 34.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 113.747 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.22 156.8 11.69 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.989 1.716 . . . . 0.0 111.632 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 m -133.45 151.14 51.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.362 0.665 . . . . 0.0 112.103 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -57.32 -23.95 52.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.399 1.88 . . . . 0.0 114.49 -169.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -66.25 -32.22 73.51 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.817 0.735 . . . . 0.0 111.414 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.25 29.41 1.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.772 0.829 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.4 p 62.31 -163.35 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.238 1.415 . . . . 0.0 111.434 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -149.18 177.94 27.05 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 171.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -139.89 142.28 36.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.57 172.94 31.69 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.7 157.16 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.24 0.543 . . . . 0.0 111.83 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.53 68.01 1.38 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.539 2.336 . . . . 0.0 106.699 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.04 -48.18 2.7 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.471 1.986 . . . . 0.0 113.584 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -145.89 -32.2 0.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.429 1.892 . . . . 0.0 110.933 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -70.23 151.35 45.45 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.3 mtp -139.22 143.34 38.01 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.92 120.19 22.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.54 114.34 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.82 99.54 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.1 t -59.91 122.52 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 108.24 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -80.25 60.59 3.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.502 0.667 . . . . 0.0 110.371 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.69 -37.17 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.068 1.347 . . . . 0.0 111.578 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.37 -27.93 69.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.276 0.489 . . . . 0.0 111.554 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -97.01 -28.28 14.23 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 116.772 -1.585 . . . . 0.0 112.218 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -47.35 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.461 1.504 . . . . 0.0 112.451 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.65 -35.01 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -58.58 -34.11 70.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 112.535 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 m -99.4 -14.3 19.21 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.357 1.063 . . . . 0.0 111.473 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.7 -2.69 56.91 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.143 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -52.84 -42.98 65.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.208 1.367 . . . . 0.0 112.051 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -66.8 -24.08 66.13 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.202 1.401 . . . . 0.0 112.368 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.68 -31.21 13.92 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.415 1.486 . . . . 0.0 111.002 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.81 -62.81 1.59 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.738 1.215 . . . . 0.0 109.167 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -67.84 -29.73 68.95 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.891 -169.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 124.085 0.954 . . . . 0.0 112.81 177.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -145.59 155.74 43.24 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.469 1.908 . . . . 0.0 109.266 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -103.29 147.45 27.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.88 135.45 29.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.451 1.1 . . . . 0.0 109.154 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.43 132.74 37.43 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 167.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.93 149.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 119.719 1.145 . . . . 0.0 108.764 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.46 148.3 37.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.917 0.887 . . . . 0.0 110.039 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 m -89.4 146.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -150.41 133.29 15.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.61 -93.16 0.04 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.73 37.25 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.51 163.81 34.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.746 1.218 . . . . 0.0 108.755 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.29 151.13 36.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 123.026 1.393 . . . . 0.0 110.753 173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -138.5 158.02 45.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.457 2.303 . . . . 0.0 107.139 -171.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.82 158.81 23.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.107 0.86 . . . . 0.0 111.007 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -48.79 118.23 2.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.09 0.956 . . . . 0.0 108.696 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.42 -33.49 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.123 0.569 . . . . 0.0 111.754 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.91 -23.62 67.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.532 0.733 . . . . 0.0 112.701 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -80.97 -21.27 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.756 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.79 141.89 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.309 0.958 . . . . 0.0 108.452 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -118.07 -46.61 2.61 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.554 1.142 . . . . 0.0 110.278 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -162.47 172.09 16.07 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.622 1.169 . . . . 0.0 108.66 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -135.46 141.21 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -145.15 177.51 8.74 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.312 1.445 . . . . 0.0 107.672 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.28 162.45 18.99 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -56.61 136.79 54.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -153.96 -52.21 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.0 58.7 0.79 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.307 0.643 . . . . 0.0 110.773 -169.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.25 110.69 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.4 m -62.82 -38.03 89.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.29 1.436 . . . . 0.0 110.545 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 30.57 19.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.496 1.518 . . . . 0.0 112.599 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.0 mm 43.08 -95.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 127.675 2.39 . . . . 0.0 110.096 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.15 -44.3 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.912 1.285 . . . . 0.0 109.562 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.06 32.41 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.422 0.689 . . . . 0.0 112.13 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.88 143.56 60.63 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.702 1.201 . . . . 0.0 110.516 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.43 159.36 50.76 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 111.084 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.77 65.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.041 0.936 . . . . 0.0 112.1 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -71.63 4.07 3.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.26 -36.74 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.685 1.194 . . . . 0.0 110.737 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.251 63.2 mttt 50.9 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.566 2.346 . . . . 0.0 110.338 -167.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.77 -176.16 40.62 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 121.88 2.127 . . . . 0.0 113.102 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.11 156.51 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 122.071 -0.664 . . . . 0.0 110.625 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 t -134.47 160.49 37.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.913 1.285 . . . . 0.0 108.716 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -77.99 142.11 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.45 174.88 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.21 1.404 . . . . 0.0 108.159 168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 -35.78 -30.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.43 21.53 0.28 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.129 0.877 . . . . 0.0 113.183 169.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -152.45 -165.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.0 1.32 . . . . 0.0 108.108 -170.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 ' H ' HG11 ' A' ' 64' ' ' VAL . 4.1 tp -130.79 157.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.716 1.606 . . . . 0.0 108.979 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.26 139.62 13.01 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.53 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 131.29 27.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.36 2.04 . . . . 0.0 109.429 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.63 128.46 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.57 165.07 20.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -121.37 128.88 52.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.702 0.801 . . . . 0.0 109.522 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.93 -10.38 58.37 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.58 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.02 -21.41 61.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.078 1.308 . . . . 0.0 110.06 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.84 18.29 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 126.036 1.734 . . . . 0.0 108.788 -171.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.52 -32.41 0.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 117.936 -1.03 . . . . 0.0 112.047 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -132.21 5.38 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.534 1.061 . . . . 0.0 112.428 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 m 51.52 36.25 16.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.37 1.468 . . . . 0.0 111.468 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -59.28 147.94 33.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -22.36 -61.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.041 3.337 . . . . 0.0 115.419 -169.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -157.39 27.58 0.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.766 0.826 . . . . 0.0 111.702 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.7 140.87 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.111 -0.993 . . . . 0.0 109.886 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -171.62 178.07 3.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.014 2.925 . . . . 0.0 104.943 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -65.7 60.58 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.716 2.406 . . . . 0.0 110.821 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -160.38 -30.43 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.558 2.743 . . . . 0.0 109.904 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 86' ' ' THR . 25.7 t0 -78.7 40.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.602 1.161 . . . . 0.0 111.855 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.99 -15.85 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.913 3.685 . . . . 0.0 114.997 -173.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 84' ' ' ASP 0.282 14.8 p 31.19 72.36 0.07 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.122 3.369 . . . . 0.0 117.307 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.1 155.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.7 119.65 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.368 -1.457 . . . . 0.0 107.772 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.65 139.38 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.33 134.76 52.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.6 mt -132.54 163.44 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 108.381 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 155.36 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.402 1.081 . . . . 0.0 108.959 173.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mp -131.22 -179.9 5.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -20.83 -61.84 0.02 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.694 2.568 . . . . 0.0 116.18 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -137.51 24.4 2.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.031 0.933 . . . . 0.0 111.923 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -150.67 165.37 33.61 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.772 -1.205 . . . . 0.0 111.262 -169.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.69 151.42 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.533 1.133 . . . . 0.0 109.214 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.32 166.86 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.997 1.319 . . . . 0.0 107.912 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.57 176.58 34.66 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.148 -0.97 . . . . 0.0 112.044 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.9 pt -146.03 152.11 14.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.66 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -82.95 144.45 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.628 1.171 . . . . 0.0 110.052 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.5 164.59 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.716 1.606 . . . . 0.0 109.119 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.81 -42.28 58.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.349 -0.844 . . . . 0.0 108.825 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.33 156.05 11.95 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.81 126.3 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -76.8 -55.53 5.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -176.61 176.99 1.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.644 1.978 . . . . 0.0 107.58 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -100.08 139.24 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.6 mt -140.12 172.13 13.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.551 . . . . 0.0 107.573 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.8 m -130.77 143.61 50.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.764 0.711 . . . . 0.0 110.344 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.17 171.09 14.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.025 1.33 . . . . 0.0 109.409 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -134.66 160.49 37.96 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.806 1.643 . . . . 0.0 108.467 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.33 1.93 3.4 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.42 -45.75 12.4 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.507 1.523 . . . . 0.0 107.721 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -67.44 -41.75 84.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.207 1.003 . . . . 0.0 109.928 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -82.42 112.52 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -142.45 -57.62 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.619 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.52 175.67 4.92 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.14 1.893 . . . . 0.0 111.683 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.44 156.94 33.77 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.614 1.565 . . . . 0.0 108.471 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.55 50.95 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.904 3.069 . . . . 0.0 111.071 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.56 26.26 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.585 1.954 . . . . 0.0 113.37 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -68.73 175.88 3.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.651 1.98 . . . . 0.0 111.381 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 67.85 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.631 1.572 . . . . 0.0 110.753 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.48 -179.21 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.898 1.679 . . . . 0.0 109.245 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -6.96 11.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -69.89 155.54 40.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.023 0.929 . . . . 0.0 110.635 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.4 m -139.29 157.73 45.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.843 1.257 . . . . 0.0 109.131 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 p -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.987 1.315 . . . . 0.0 113.131 -171.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.32 -36.37 83.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 111.103 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -129.13 33.05 4.63 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.576 1.55 . . . . 0.0 108.801 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 127.51 32.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 146' ' ' ASN . 81.8 p -74.92 -171.92 1.47 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.828 1.651 . . . . 0.0 110.134 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.07 172.86 22.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.319 -2.313 . . . . 0.0 107.319 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.33 151.67 37.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.101 1.451 . . . . 0.0 109.539 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.02 177.72 27.06 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.27 0.938 . . . . 0.0 111.163 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.82 159.08 36.86 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.41 0.684 . . . . 0.0 111.903 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.77 59.8 1.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.624 2.369 . . . . 0.0 107.241 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.57 -45.25 2.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.345 1.926 . . . . 0.0 113.93 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -140.17 -38.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.491 2.316 . . . . 0.0 109.678 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -73.76 153.2 40.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 89.1 mtp -141.72 140.52 33.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -133.43 137.54 45.8 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.82 110.48 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.79 112.37 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.85 136.16 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.455 ' H ' HG23 ' A' ' 132' ' ' THR . 45.1 t-20 -78.85 61.96 3.21 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 109.822 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 tp -54.81 -38.38 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.997 1.319 . . . . 0.0 111.126 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.0 -15.6 59.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -111.12 -9.35 14.37 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.333 -1.318 . . . . 0.0 111.556 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.74 -80.8 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.136 -169.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.76 -30.81 70.37 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.029 -1.044 . . . . 0.0 109.442 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.4 -21.86 62.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.3 m -115.17 -12.19 11.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.804 0.842 . . . . 0.0 112.078 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.42 -15.32 19.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.512 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.51 -40.49 78.8 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.891 1.678 . . . . 0.0 111.953 -169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.0 ptp -63.23 -31.82 73.07 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.42 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.53 25.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.75 1.22 . . . . 0.0 111.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.79 -55.64 9.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.69 -28.36 68.57 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.068 -0.395 . . . . 0.0 111.731 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 124.649 1.179 . . . . 0.0 112.807 176.569 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -68.87 161.74 28.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 168.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.4 142.6 49.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -141.64 134.55 28.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 109.564 -169.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.19 133.22 35.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 151.34 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 119.531 1.06 . . . . 0.0 109.15 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.99 153.23 46.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.77 1.228 . . . . 0.0 109.407 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -96.65 146.46 24.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 tp -149.61 132.71 16.28 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.79 -104.74 0.69 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.23 37.39 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.664 1.585 . . . . 0.0 108.912 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.24 159.95 41.06 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.825 2.05 . . . . 0.0 107.594 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.82 160.85 20.69 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 110.281 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -142.68 152.57 42.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.932 2.093 . . . . 0.0 106.809 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.23 154.85 21.39 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mt -139.5 134.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.18 117.17 2.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 109.157 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -54.42 -35.56 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.895 0.878 . . . . 0.0 111.558 -170.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.93 -24.98 68.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.717 0.807 . . . . 0.0 112.508 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -80.65 -23.53 39.6 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.483 0.583 . . . . 0.0 111.464 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.71 132.96 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.409 HE22 ' CD1' ' A' ' 61' ' ' LEU . 42.3 tt0 -90.09 -59.07 2.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.33 -179.42 7.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.435 1.094 . . . . 0.0 109.825 -172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.61 143.13 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -147.78 173.88 12.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.403 1.081 . . . . 0.0 108.483 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.64 157.8 33.09 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -77.26 106.71 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 108.654 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -157.76 163.53 38.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.736 1.214 . . . . 0.0 109.569 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.88 34.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.904 2.481 . . . . 0.0 114.484 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.17 143.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.709 0.766 . . . . 0.0 109.396 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -136.03 93.09 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.524 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 30.5 tpt180 -71.21 118.96 14.66 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -70.02 157.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -23.5 67.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -172.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.89 23.91 0.51 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.524 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -60.22 156.99 35.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 122.935 0.494 . . . . 0.0 110.906 171.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -59.18 145.69 96.94 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 N-CA-C 107.995 -1.579 . . . . 0.0 107.995 169.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.67 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.728 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.12 -38.27 67.96 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.994 0.816 . . . . 0.0 110.675 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.5 mt -75.57 90.7 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -58.31 -26.41 63.01 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.02 -158.96 32.09 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.24 153.69 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -134.67 165.15 25.92 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.244 0.929 . . . . 0.0 108.985 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -71.23 99.4 1.9 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.535 1.534 . . . . 0.0 110.857 -173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' CD1' HE22 ' A' ' 37' ' ' GLN 0.25 0.5 OUTLIER -77.9 64.3 3.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 107.677 169.645 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 45.55 34.35 1.64 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.061 2.944 . . . . 0.0 114.145 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.79 -20.9 4.52 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.982 1.277 . . . . 0.0 112.136 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.66 -163.21 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 172.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 tp -138.27 147.14 25.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 121.156 -0.965 . . . . 0.0 111.979 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.59 135.99 18.48 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.89 147.95 75.56 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.998 1.799 . . . . 0.0 110.157 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 tp -126.61 131.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.59 155.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -140.48 143.08 35.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.22 1.009 . . . . 0.0 109.27 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.48 -16.74 62.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.943 1.297 . . . . 0.0 110.566 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -61.81 -20.19 63.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.093 1.315 . . . . 0.0 111.144 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.4 mt -115.89 -48.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.96 -25.36 67.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.811 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -135.0 -6.39 2.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.589 1.086 . . . . 0.0 113.116 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.5 m 55.92 46.02 22.84 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.086 -1.009 . . . . 0.0 111.716 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -47.04 142.88 3.33 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.34 -65.04 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.722 1.609 . . . . 0.0 112.65 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -162.28 79.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.161 0.985 . . . . 0.0 109.697 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.52 144.79 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -164.63 171.56 14.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.683 1.593 . . . . 0.0 107.462 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -70.17 48.32 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.736 2.014 . . . . 0.0 110.921 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.69 -12.91 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.741 3.216 . . . . 0.0 110.737 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.16 -3.26 1.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.428 1.491 . . . . 0.0 111.988 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -146.56 40.05 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.224 1.409 . . . . 0.0 109.095 -169.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 p -96.21 -11.6 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.293 1.837 . . . . 0.0 114.041 -169.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.68 155.67 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.0 t -130.08 135.7 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.185 1.794 . . . . 0.0 106.231 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.61 124.61 65.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.29 134.31 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.7 mt -133.09 162.01 32.87 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.102 1.361 . . . . 0.0 108.822 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.35 153.9 41.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.5 136.55 18.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.6 -94.97 0.08 OUTLIER Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -169.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -139.91 22.33 2.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.054 1.742 . . . . 0.0 110.76 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -134.52 163.31 30.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.113 -0.992 . . . . 0.0 110.106 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.23 152.27 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 110.393 -170.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.94 177.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 126.224 1.809 . . . . 0.0 106.711 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.8 33.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.4 154.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.895 0.878 . . . . 0.0 109.082 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.96 144.61 13.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.83 170.96 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.737 1.615 . . . . 0.0 110.049 -168.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -76.72 -42.93 39.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.971 -0.456 . . . . 0.0 110.353 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.97 153.79 9.16 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.9 129.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 m -77.03 -57.83 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.405 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -176.62 175.33 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 107.796 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.5 140.09 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.28 176.34 8.8 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.994 1.718 . . . . 0.0 108.16 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 m -131.63 139.63 49.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.199 0.6 . . . . 0.0 109.566 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.53 165.72 26.79 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.238 1.415 . . . . 0.0 108.4 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.7 m -137.58 158.8 43.6 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 107.811 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.18 -13.01 2.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.8 -40.71 92.17 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.81 1.186 . . . . 0.0 110.129 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -82.72 -39.08 22.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.533 1.533 . . . . 0.0 109.692 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.77 85.83 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.411 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 44.6 mtm180 -140.88 -53.69 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 116.608 -1.663 . . . . 0.0 112.725 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.1 Cg_endo -65.01 175.93 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 121.699 1.643 . . . . 0.0 111.167 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.65 158.23 32.21 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.939 1.296 . . . . 0.0 109.157 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.02 60.7 7.94 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.778 2.986 . . . . 0.0 110.994 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.35 33.52 0.06 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.378 1.871 . . . . 0.0 112.495 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.2 178.3 4.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.52 1.528 . . . . 0.0 110.74 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.55 0.93 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.203 1.401 . . . . 0.0 110.568 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.71 159.16 39.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.799 1.639 . . . . 0.0 109.039 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -58.52 -25.05 61.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.881 0.872 . . . . 0.0 112.2 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.96 -26.92 68.51 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.796 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -76.11 75.46 2.96 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 124.319 2.009 . . . . 0.0 111.292 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 t -155.52 177.57 11.22 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 129.502 3.121 . . . . 0.0 103.776 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.6 -7.55 0.99 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 126.472 1.909 . . . . 0.0 115.963 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -73.21 -5.35 38.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.737 1.153 . . . . 0.0 110.438 168.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -46.59 135.52 8.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.108 2.163 . . . . 0.0 114.459 -169.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.6 p -77.02 -165.7 0.6 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.878 2.871 . . . . 0.0 110.355 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.23 -179.72 16.84 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.464 1.983 . . . . 0.0 108.544 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mt -133.62 150.64 51.6 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.932 1.693 . . . . 0.0 106.948 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.33 171.85 32.87 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.09 158.06 43.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.089 0.956 . . . . 0.0 110.927 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 mt -144.89 69.37 1.25 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.231 1.812 . . . . 0.0 107.605 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.87 -49.56 2.85 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.337 1.922 . . . . 0.0 113.1 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -145.45 -31.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.379 1.872 . . . . 0.0 110.953 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -69.64 153.13 43.87 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.3 mtp -142.8 146.67 34.44 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.31 147.62 25.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.368 0.667 . . . . 0.0 109.879 -175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -93.02 112.42 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.53 107.77 10.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.91 122.8 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -79.41 53.79 1.6 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.371 0.668 . . . . 0.0 110.683 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 tp -54.09 -37.39 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.52 1.128 . . . . 0.0 111.123 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -65.49 -6.45 10.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.867 1.267 . . . . 0.0 112.782 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -124.49 -28.9 3.55 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 0.0 111.608 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.2 tp -45.49 -64.5 0.71 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.875 1.67 . . . . 0.0 111.841 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.28 -46.34 56.24 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.95 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -65.09 -21.4 66.8 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.256 0.935 . . . . 0.0 113.064 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.7 m -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.68 1.127 . . . . 0.0 111.506 170.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.87 -15.01 46.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.881 0.872 . . . . 0.0 112.182 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -49.6 -44.64 47.32 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 125.754 1.622 . . . . 0.0 113.555 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -64.1 -40.78 96.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.552 0.614 . . . . 0.0 111.432 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.36 -37.86 65.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.342 0.657 . . . . 0.0 110.545 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.4 tt -59.67 -56.61 19.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.259 1.424 . . . . 0.0 109.742 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -26.24 61.9 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 122.807 0.443 . . . . 0.0 111.384 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 CA--C 1.54 0.58 0 C-N-CA 123.09 0.556 . . . . 0.0 112.416 171.024 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.16 160.14 24.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -116.43 144.76 43.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.84 136.79 30.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.624 0.77 . . . . 0.0 110.03 -169.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.8 tp -77.57 134.55 38.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 102.849 -3.019 . . . . 0.0 102.849 167.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.25 149.88 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.655 1.116 . . . . 0.0 108.781 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.92 151.81 44.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.225 1.01 . . . . 0.0 110.15 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -95.49 143.72 26.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -139.38 94.4 2.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.044 1.338 . . . . 0.0 107.517 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.47 -74.52 0.71 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.279 1.419 . . . . 0.0 111.456 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.69 29.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.067 1.347 . . . . 0.0 110.603 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.14 160.87 38.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.31 1.444 . . . . 0.0 108.111 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.18 151.64 45.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.808 1.289 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.9 155.76 47.03 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.634 1.974 . . . . 0.0 107.729 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.57 157.91 22.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -142.61 134.48 25.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -50.07 119.07 3.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.464 0.706 . . . . 0.0 109.378 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -54.8 -34.65 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.871 0.868 . . . . 0.0 111.285 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.65 -22.15 66.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.554 0.742 . . . . 0.0 112.735 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.66 -21.09 32.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.07 0.85 . . . . 0.0 111.688 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.09 140.72 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.84 -42.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.496 1.119 . . . . 0.0 110.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -161.53 171.02 18.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.383 1.073 . . . . 0.0 108.815 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.1 147.59 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -150.17 173.99 13.3 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.56 163.67 26.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -60.27 136.76 58.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.0 -55.14 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.96 84.25 1.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -169.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.14 119.02 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 m -78.64 93.2 4.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -78.1 88.73 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.79 137.46 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.2 -17.93 60.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -137.11 37.92 2.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.68 1.192 . . . . 0.0 111.017 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 53' ' ' ALA . 27.1 p -60.82 166.48 4.53 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 121.804 -0.56 . . . . 0.0 111.897 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.6 20.21 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 123.227 2.618 . . . . 0.0 111.358 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' THR . . . 59.1 -39.91 0.07 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 131.319 3.848 . . . . 0.0 116.938 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -52.97 -44.18 66.95 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 120.326 1.421 . . . . 0.0 108.509 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.99 110.29 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -67.79 -34.91 77.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.58 -153.52 21.19 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -117.71 162.4 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.45 150.41 34.55 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.287 -1.508 . . . . 0.0 110.117 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.05 135.22 46.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.226 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.37 97.44 5.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.512 1.125 . . . . 0.0 109.434 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 57.17 17.28 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 113.334 172.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.41 6.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.002 1.287 . . . . 0.0 113.007 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.34 -172.05 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.93 1.292 . . . . 0.0 108.295 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.15 155.01 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.834 1.253 . . . . 0.0 110.393 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.39 141.97 15.21 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.626 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.08 140.15 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.097 1.865 . . . . 0.0 109.27 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 tp -126.18 135.15 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.18 148.76 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.806 2.042 . . . . 0.0 106.028 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -125.78 128.56 47.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.06 -18.93 65.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.986 0.914 . . . . 0.0 111.346 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -58.88 -25.53 63.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.815 -1.178 . . . . 0.0 110.531 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.36 -30.8 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.516 1.526 . . . . 0.0 110.085 -169.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -92.77 -22.03 19.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.21 0.914 . . . . 0.0 113.004 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -132.83 3.1 3.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.278 0.944 . . . . 0.0 111.807 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 m 51.39 41.7 28.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.86 1.264 . . . . 0.0 111.402 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -57.41 170.96 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.715 0.806 . . . . 0.0 111.175 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 m -58.13 169.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.02 0.914 . . . . 0.0 109.416 168.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.28 62.51 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.468 2.307 . . . . 0.0 111.349 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -45.42 150.93 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.287 2.235 . . . . 0.0 111.759 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -152.11 165.15 35.66 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.249 1.42 . . . . 0.0 108.449 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -74.6 53.18 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 0.0 110.597 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -151.46 -21.96 0.2 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.245 3.418 . . . . 0.0 109.708 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.79 7.52 2.75 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.538 1.535 . . . . 0.0 111.659 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -154.69 40.52 0.45 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.137 2.175 . . . . 0.0 108.567 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 p -88.96 7.14 36.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.586 1.954 . . . . 0.0 115.362 -168.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.49 157.43 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.4 136.19 55.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.67 134.32 48.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.7 mt -133.82 164.22 27.74 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 108.007 -171.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.97 154.09 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.313 0.645 . . . . 0.0 110.113 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mp -136.51 80.81 1.84 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.4 -68.95 2.34 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.676 -0.64 . . . . 0.0 113.214 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -137.01 0.6 2.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.402 1.881 . . . . 0.0 111.833 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.92 165.55 22.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.502 1.121 . . . . 0.0 109.103 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.39 150.45 32.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.019 0.927 . . . . 0.0 109.18 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.91 165.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.02 32.15 Favored Glycine 0 N--CA 1.451 -0.364 0 O-C-N 121.118 -0.989 . . . . 0.0 111.683 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.29 164.56 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 109.847 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 m -111.37 132.13 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.153 1.781 . . . . 0.0 108.183 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.89 164.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.97 1.308 . . . . 0.0 109.611 -168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.3 -41.67 73.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.13 158.94 20.93 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.32 123.12 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -48.3 15.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.921 0.888 . . . . 0.0 109.682 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -173.44 -174.54 1.02 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 108.02 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.73 128.76 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.56 173.22 11.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.217 1.407 . . . . 0.0 108.923 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.3 m -130.92 139.05 50.03 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.3 161.12 38.65 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 m -132.9 157.21 45.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.09 1.756 . . . . 0.0 108.238 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -17.36 24.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.86 -36.33 80.09 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.24 -40.46 19.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.606 1.562 . . . . 0.0 110.434 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.05 103.67 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -140.54 -55.84 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 116.936 -1.507 . . . . 0.0 111.423 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.48 173.2 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.97 157.51 30.74 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.0 1.72 . . . . 0.0 108.89 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.41 143.66 48.36 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.817 1.678 . . . . 0.0 109.457 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.14 22.75 0.65 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.035 1.334 . . . . 0.0 110.335 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.63 176.85 5.83 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.275 1.43 . . . . 0.0 111.442 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.23 66.48 0.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.739 1.615 . . . . 0.0 110.603 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.45 172.83 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.846 1.658 . . . . 0.0 109.433 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -15.63 61.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.283 1.433 . . . . 0.0 113.724 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.82 144.41 54.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.937 . . . . 0.0 110.206 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.8 m -138.32 162.26 34.82 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.28 1.032 . . . . 0.0 109.791 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -57.45 -27.52 62.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 114.338 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -74.69 -24.09 58.72 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.623 -0.673 . . . . 0.0 111.895 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -127.2 -3.35 6.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.087 0.955 . . . . 0.0 112.73 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.08 161.47 5.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.614 0.643 . . . . 0.0 110.76 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.2 p -113.69 -166.54 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.8 1.64 . . . . 0.0 110.407 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.4 168.69 23.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.6 154.61 39.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.913 1.857 . . . . 0.0 111.0 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.3 173.38 40.27 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.092 0.377 . . . . 0.0 112.853 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.15 157.26 17.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.927 0.891 . . . . 0.0 111.13 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.06 85.06 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.16 -55.0 2.3 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.751 2.119 . . . . 0.0 112.862 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -150.34 -28.12 0.23 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.199 2.199 . . . . 0.0 111.524 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -69.12 163.3 25.12 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.754 0.707 . . . . 0.0 109.529 171.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.99 134.59 47.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.83 134.82 51.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.06 107.11 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.04 109.99 13.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.51 130.55 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.857 1.263 . . . . 0.0 108.434 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -74.87 57.03 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.442 1.897 . . . . 0.0 109.867 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -46.71 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.825 1.65 . . . . 0.0 111.268 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -66.86 -10.0 43.65 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.6 -14.93 16.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.471 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.6 tp -55.5 -78.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.812 1.245 . . . . 0.0 111.325 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.6 tp -77.32 -20.47 54.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.99 0.813 . . . . 0.0 111.257 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.07 -39.96 79.83 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.259 -0.9 . . . . 0.0 111.661 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 -19.92 17.29 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.024 -0.512 . . . . 0.0 112.058 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.98 -10.52 57.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.763 1.165 . . . . 0.0 112.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.73 -44.34 58.23 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 121.303 1.865 . . . . 0.0 112.028 -171.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.9 mtm -65.23 -46.09 82.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.29 0.636 . . . . 0.0 110.311 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.45 74.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.53 0.732 . . . . 0.0 111.787 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.58 -64.17 1.04 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.61 -31.46 72.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -169.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 175.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -69.67 167.08 17.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 110.143 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.93 146.15 50.73 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.604 1.561 . . . . 0.0 107.417 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -142.15 140.32 32.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.612 0.765 . . . . 0.0 110.289 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.5 tp -80.39 134.45 36.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.36 148.29 27.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 109.123 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.14 153.68 45.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.509 1.124 . . . . 0.0 110.123 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -95.52 149.39 21.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.46 128.41 7.35 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.31 -89.51 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.71 34.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.352 1.461 . . . . 0.0 109.145 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -143.44 158.89 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.829 1.651 . . . . 0.0 107.871 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 155.55 28.05 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 123.251 1.5 . . . . 0.0 110.299 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -142.23 160.97 39.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.913 2.085 . . . . 0.0 107.338 -171.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.8 164.12 26.45 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.784 0.707 . . . . 0.0 111.729 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -144.68 136.15 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -49.26 118.8 2.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.15 0.98 . . . . 0.0 109.343 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.21 -33.83 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.814 0.846 . . . . 0.0 111.566 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.73 -23.39 67.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.434 0.694 . . . . 0.0 112.604 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -81.01 -19.13 44.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.272 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.54 142.24 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.267 1.394 . . . . 0.0 109.162 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -125.57 -39.84 2.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.121 1.369 . . . . 0.0 110.781 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -167.04 171.24 11.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.663 1.585 . . . . 0.0 107.754 175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.19 140.81 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -149.95 176.67 10.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 108.564 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.63 173.89 44.19 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -59.11 -31.06 68.59 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.83 -0.806 . . . . 0.0 112.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.0 t0 34.22 -90.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 129.33 3.052 . . . . 0.0 116.588 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 66.53 1.34 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 113.405 -169.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.57 133.9 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 m -70.88 -42.18 70.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.579 1.152 . . . . 0.0 111.593 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.03 89.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.75 2.02 . . . . 0.0 109.33 -169.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.9 150.87 6.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.77 66.73 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.71 20.85 0.61 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -172.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.71 148.39 47.24 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.41 121.46 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 N-CA-C 105.639 -2.485 . . . . 0.0 105.639 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.84 -33.03 0.69 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -168.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.09 -38.24 37.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.023 0.829 . . . . 0.0 110.976 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.8 mt -93.39 105.2 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.8 -57.45 12.64 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.43 -173.19 36.19 Favored Glycine 0 C--O 1.227 -0.315 0 O-C-N 121.021 -1.049 . . . . 0.0 111.73 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -83.6 153.82 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -138.09 160.66 38.81 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.94 108.36 19.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.522 -0.736 . . . . 0.0 111.556 -172.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.2 72.67 3.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.66 -0.65 . . . . 0.0 110.685 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 49.89 28.78 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.684 1.594 . . . . 0.0 114.422 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.93 -20.61 2.15 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.371 0.986 . . . . 0.0 113.063 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -169.25 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.829 1.252 . . . . 0.0 107.806 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.72 148.63 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.766 -1.209 . . . . 0.0 110.08 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 p -148.87 134.56 9.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.93 138.9 45.7 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.314 2.676 . . . . 0.0 110.685 170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.84 135.32 63.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.386 1.089 . . . . 0.0 109.12 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.87 162.87 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.556 2.342 . . . . 0.0 105.188 169.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -139.79 145.05 37.71 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 120.652 -1.28 . . . . 0.0 109.409 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.11 -21.66 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.647 1.179 . . . . 0.0 112.917 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -70.34 -11.13 60.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.707 1.594 . . . . 0.0 112.213 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.16 20.92 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 0.0 109.034 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -141.55 -23.7 0.72 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.657 1.183 . . . . 0.0 111.449 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -139.39 12.16 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.561 1.144 . . . . 0.0 111.991 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.0 m 54.26 38.95 30.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.488 1.515 . . . . 0.0 112.427 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 156.2 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -40.85 -67.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.657 2.383 . . . . 0.0 113.268 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -169.77 97.63 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.832 1.653 . . . . 0.0 109.13 -169.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.28 143.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.176 0.99 . . . . 0.0 109.593 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.25 158.23 35.75 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.109 1.364 . . . . 0.0 108.767 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -69.46 42.48 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.932 2.093 . . . . 0.0 113.143 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.86 -12.02 0.16 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.159 2.183 . . . . 0.0 110.671 169.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -125.51 -5.53 7.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.558 1.543 . . . . 0.0 111.98 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.98 38.83 2.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.271 1.428 . . . . 0.0 108.972 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -102.15 -4.73 25.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.561 . . . . 0.0 114.376 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.34 155.36 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.5 t -133.33 137.14 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.57 124.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.64 140.22 17.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -135.76 162.65 32.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.992 1.717 . . . . 0.0 107.843 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.05 148.86 39.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.178 1.391 . . . . 0.0 108.027 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.44 151.1 29.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.53 -102.54 0.11 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -139.62 34.07 2.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.498 1.519 . . . . 0.0 109.809 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.1 167.76 21.32 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.779 1.632 . . . . 0.0 109.297 -171.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.04 151.19 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 124.157 0.983 . . . . 0.0 109.547 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.67 176.78 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.854 1.661 . . . . 0.0 107.204 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.61 179.48 41.51 Favored Glycine 0 N--CA 1.448 -0.537 0 O-C-N 120.685 -1.259 . . . . 0.0 111.427 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.4 pt -141.65 158.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.587 1.155 . . . . 0.0 109.542 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.09 145.11 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.8 172.4 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.634 1.574 . . . . 0.0 110.606 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.22 -43.51 51.35 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.98 -0.45 . . . . 0.0 109.831 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.46 155.68 10.57 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 129.0 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -41.36 10.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.427 0.691 . . . . 0.0 111.802 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.4 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.2 t0 -167.57 -175.67 2.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 110.727 -168.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -135.84 125.28 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.18 166.53 24.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 110.191 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 m -125.37 141.24 52.18 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.201 0.6 . . . . 0.0 110.42 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.1 139.04 30.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.438 1.095 . . . . 0.0 108.398 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 p -82.95 153.31 25.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.18 -16.73 35.46 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.5 -42.04 75.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.003 1.321 . . . . 0.0 110.037 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -58.67 -39.58 81.05 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.749 0.819 . . . . 0.0 109.359 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.1 mt -77.77 0.63 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 126.314 1.846 . . . . 0.0 112.151 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -53.59 -53.57 55.57 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.167 -1.583 . . . . 0.0 114.344 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.39 175.71 9.68 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.346 2.03 . . . . 0.0 112.396 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.5 163.32 24.56 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.244 1.418 . . . . 0.0 109.313 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.4 -50.0 9.35 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.762 2.308 . . . . 0.0 113.018 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 51.24 20.15 0.87 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.912 2.085 . . . . 0.0 114.219 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -73.93 160.09 31.87 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 110.033 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.92 32.51 0.14 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.867 1.667 . . . . 0.0 112.8 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.27 -175.21 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.927 1.291 . . . . 0.0 109.952 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -11.23 21.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.885 1.274 . . . . 0.0 113.92 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.74 156.29 33.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.446 1.499 . . . . 0.0 110.459 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.1 m -137.13 156.45 48.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.044 0.938 . . . . 0.0 109.752 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 p -64.89 -24.12 67.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.957 1.303 . . . . 0.0 113.426 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.02 -34.24 73.03 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -127.18 30.74 5.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.261 1.424 . . . . 0.0 109.06 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 131.15 49.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.466 1.106 . . . . 0.0 108.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.8 p -69.78 -177.92 1.39 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.68 1.592 . . . . 0.0 110.491 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -125.53 179.14 16.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 169.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.32 157.59 43.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.253 1.527 . . . . 0.0 108.808 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.13 172.6 34.03 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.11 20.84 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.14 0.576 . . . . 0.0 109.778 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.1 82.56 1.76 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.77 2.66 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.582 2.039 . . . . 0.0 112.995 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.68 -31.25 0.09 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.033 2.133 . . . . 0.0 111.103 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.4 HH22 ' HB2' ' A' ' 107' ' ' ASP . 59.0 mtp180 -68.94 162.99 25.49 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.0 mtp -139.8 144.94 37.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.18 126.13 29.3 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.8 mt -81.47 111.62 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.53 111.08 22.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.1 t -67.41 131.09 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 108.329 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -75.79 62.22 1.51 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.225 1.01 . . . . 0.0 109.734 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -43.98 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.895 1.678 . . . . 0.0 110.33 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.23 -18.41 63.5 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 112.814 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -111.16 -10.74 14.3 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.956 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.0 -67.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.005 1.275 . . . . 0.0 110.08 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.67 -39.89 84.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.071 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -55.42 -48.51 74.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 0.0 110.717 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 m -82.15 -16.29 50.32 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 112.779 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.08 3.28 33.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.984 1.265 . . . . 0.0 112.783 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.26 -42.06 97.98 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.501 -1.374 . . . . 0.0 110.615 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.1 ptp -62.08 -28.97 69.99 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.719 -0.613 . . . . 0.0 112.004 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.86 32.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.0 tp -56.95 -53.62 55.99 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.97 -14.62 61.93 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.436 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 120.381 1.446 . . . . 0.0 111.849 175.919 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -66.02 146.79 54.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.18 145.6 33.97 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -142.01 138.38 31.81 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.171 0.989 . . . . 0.0 110.175 -169.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -84.19 137.47 33.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 167.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.256 1.5 m -125.7 146.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 119.439 1.018 . . . . 0.0 108.525 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -143.23 153.79 43.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.085 1.354 . . . . 0.0 110.393 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 m -95.17 143.8 26.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.81 103.98 4.78 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.49 -78.49 0.25 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.331 1.443 . . . . 0.0 111.781 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.26 30.19 0.55 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.608 1.163 . . . . 0.0 111.032 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.77 161.04 39.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.577 1.151 . . . . 0.0 108.568 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -115.65 149.39 38.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.97 1.367 . . . . 0.0 109.817 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -139.3 165.65 26.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 107.403 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.41 169.06 28.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 119.15 0.886 . . . . 0.0 113.534 170.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 mt -144.01 137.73 24.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.06 118.65 3.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.881 0.872 . . . . 0.0 109.015 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -53.64 -32.81 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.708 0.803 . . . . 0.0 111.747 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.53 -24.49 67.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.04 0.836 . . . . 0.0 112.72 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.32 -21.36 39.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.278 0.945 . . . . 0.0 111.113 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.09 138.41 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -113.25 -46.18 3.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.559 1.144 . . . . 0.0 109.46 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -162.65 177.32 9.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.869 1.268 . . . . 0.0 108.803 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -139.41 143.27 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 172.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -134.29 -104.88 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 0.0 110.764 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 154.65 11.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -169.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -68.42 125.72 27.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -156.84 -48.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -150.9 50.66 0.86 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.04 0.936 . . . . 0.0 109.894 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.74 112.07 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 m -95.31 89.17 5.37 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.69 144.85 56.69 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.4 mm -84.39 28.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.236 1.014 . . . . 0.0 109.071 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 65.37 -31.4 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.127 2.571 . . . . 0.0 115.144 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.63 24.52 0.78 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.531 1.532 . . . . 0.0 112.924 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.28 144.88 97.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 110.232 169.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.69 142.34 14.26 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.752 2.968 . . . . 0.0 111.11 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.52 69.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.735 0.414 . . . . 0.0 110.59 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -65.75 0.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 0.0 114.191 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.04 -35.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 124.804 1.242 . . . . 0.0 110.996 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 mttm 57.17 -75.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.344 1.858 . . . . 0.0 110.795 -168.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.1 -123.93 1.13 Allowed Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 121.247 1.84 . . . . 0.0 110.99 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.13 169.47 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -143.53 158.79 43.38 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 120.838 -1.164 . . . . 0.0 108.383 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -72.9 137.86 45.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 110.013 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.39 173.64 7.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.21 65.44 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.38 1.072 . . . . 0.0 112.933 -169.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.23 -8.69 4.74 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.241 2.353 . . . . 0.0 113.106 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -152.94 -165.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 119.189 1.494 . . . . 0.0 109.417 -169.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -125.59 159.35 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.589 1.956 . . . . 0.0 108.035 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.45 133.49 10.05 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.3 130.72 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.653 1.568 . . . . 0.0 108.428 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.17 134.83 55.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -126.35 144.22 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.02 109.5 20.85 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.64 -17.21 45.86 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.923 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.0 -37.89 21.65 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.969 1.258 . . . . 0.0 111.005 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.34 -38.59 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -69.65 -12.91 62.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.755 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -122.59 -3.96 8.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.001 1.273 . . . . 0.0 113.547 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m 49.61 47.05 23.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.826 1.251 . . . . 0.0 111.796 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -177.71 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.649 0.737 . . . . 0.0 110.926 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.16 170.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.69 1.196 . . . . 0.0 110.997 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.53 63.3 5.77 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 110.541 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.73 164.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.611 1.164 . . . . 0.0 111.508 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -154.36 172.77 17.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.872 1.669 . . . . 0.0 108.58 -172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -70.89 54.92 0.17 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.001 1.381 . . . . 0.0 111.111 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.404 ' H ' ' H ' ' A' ' 84' ' ' ASP . 42.1 t30 -154.66 -19.27 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 131.085 3.754 . . . . 0.0 109.288 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 83' ' ' ASN . 27.6 t70 -141.0 16.92 2.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.803 2.041 . . . . 0.0 110.822 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -159.79 42.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.407 3.083 . . . . 0.0 106.929 -173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.7 p -99.18 6.78 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -168.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.5 t -126.36 151.4 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.349 1.431 . . . . 0.0 108.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.43 141.99 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.48 128.12 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.52 135.37 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.1 mt -134.54 162.26 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.64 1.576 . . . . 0.0 109.046 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.69 145.64 33.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 107.676 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.64 151.56 20.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.29 -94.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.742 1.163 . . . . 0.0 112.728 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.03 21.14 3.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.189 1.796 . . . . 0.0 110.975 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -145.43 173.79 11.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.011 -1.055 . . . . 0.0 112.824 -169.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.73 142.42 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.767 2.027 . . . . 0.0 106.234 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.07 178.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 125.563 1.545 . . . . 0.0 106.859 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.78 179.0 41.39 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.97 146.65 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.1 144.22 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.25 166.67 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.845 2.058 . . . . 0.0 107.602 -173.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.22 -44.92 71.07 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.241 -0.912 . . . . 0.0 109.893 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.94 162.1 24.46 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 m -74.87 127.48 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.71 -43.53 13.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.254 1.021 . . . . 0.0 110.166 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -171.0 176.74 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 110.762 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.97 131.72 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.841 2.057 . . . . 0.0 106.971 169.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.86 -178.49 5.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.337 1.055 . . . . 0.0 109.863 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 m -130.17 151.88 50.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.948 0.795 . . . . 0.0 112.069 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.46 163.93 31.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.61 1.564 . . . . 0.0 109.914 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.7 p -114.22 167.44 10.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.687 1.195 . . . . 0.0 111.522 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.31 -9.66 35.08 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.939 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.85 -52.02 11.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.04 -36.4 83.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.379 1.072 . . . . 0.0 111.493 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.7 mt -103.56 106.57 20.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -145.82 -53.07 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.205 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.79 176.64 3.46 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.879 1.719 . . . . 0.0 111.733 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.17 160.63 32.96 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.56 1.944 . . . . 0.0 107.775 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.01 -45.47 5.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.733 1.622 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 45.58 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 131.693 3.997 . . . . 0.0 119.932 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -153.59 160.31 42.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.437 1.471 . . . . 0.0 109.338 -173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.25 35.41 16.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.838 1.655 . . . . 0.0 112.647 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.89 156.57 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.901 1.681 . . . . 0.0 107.913 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -12.46 61.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.978 1.311 . . . . 0.0 113.015 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -54.79 162.52 1.21 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.171 2.988 . . . . 0.0 113.596 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m -135.6 151.24 50.07 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.963 0.905 . . . . 0.0 111.969 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.89 -29.21 27.01 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.877 2.471 . . . . 0.0 114.389 -169.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -62.07 -32.3 72.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -147.47 31.19 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.259 1.023 . . . . 0.0 110.61 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 18.49 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.4 p 64.01 -175.27 0.16 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.936 1.694 . . . . 0.0 112.176 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.72 177.52 20.11 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 106.396 -2.681 . . . . 0.0 106.396 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.65 158.67 44.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.677 1.238 . . . . 0.0 109.268 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.06 177.46 32.29 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.98 152.96 33.49 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.817 0.847 . . . . 0.0 109.652 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.79 82.59 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.147 1.379 . . . . 0.0 107.405 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.23 -48.44 2.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.586 2.041 . . . . 0.0 113.56 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -156.43 -35.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.29 2.236 . . . . 0.0 110.353 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -71.09 165.97 22.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.848 0.832 . . . . 0.0 110.142 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.7 mtp -136.95 147.97 46.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -137.9 129.95 28.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.5 mt -85.38 114.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.82 112.62 24.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.85 133.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.317 1.047 . . . . 0.0 108.36 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.88 61.38 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.36 -39.83 45.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.701 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.0 -13.34 45.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.021 0.828 . . . . 0.0 112.729 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -111.16 -12.59 14.12 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 117.039 -1.458 . . . . 0.0 112.649 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -54.66 -73.26 0.05 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.801 1.24 . . . . 0.0 111.088 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.9 -23.98 28.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.801 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -58.56 -28.64 65.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 111.491 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.0 m -96.17 -39.83 9.5 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.77 0.713 . . . . 0.0 110.883 173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.88 -10.81 59.62 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.769 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -49.78 -47.83 50.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 121.613 2.006 . . . . 0.0 112.035 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -67.06 -43.87 81.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.099 0.56 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.74 -31.2 71.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.548 0.739 . . . . 0.0 111.964 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.45 -60.57 2.19 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.98 -28.06 69.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.978 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 111.989 175.782 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -75.85 165.13 25.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.815 1.246 . . . . 0.0 108.482 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -133.12 143.42 49.26 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -139.36 141.09 37.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.779 0.432 . . . . 0.0 110.424 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -82.33 128.86 34.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.38 147.31 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.329 0.968 . . . . 0.0 108.889 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.74 153.73 42.74 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.249 1.02 . . . . 0.0 109.898 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -92.73 146.92 23.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.23 125.74 14.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -88.7 0.16 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -154.26 34.76 0.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.331 1.452 . . . . 0.0 109.796 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.64 158.2 43.9 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 107.602 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.62 156.21 34.75 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.022 1.391 . . . . 0.0 111.887 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -144.92 161.25 39.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.021 2.528 . . . . 0.0 107.127 -171.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.96 25.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.364 0.983 . . . . 0.0 111.035 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.46 137.92 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -47.38 115.86 1.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.585 1.154 . . . . 0.0 110.213 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.09 -33.79 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.104 0.962 . . . . 0.0 111.753 -169.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.54 -25.73 68.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.672 0.789 . . . . 0.0 112.66 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -79.26 -20.18 48.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.868 0.758 . . . . 0.0 111.883 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.14 128.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 118.902 0.774 . . . . 0.0 109.027 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -86.99 -60.28 2.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -163.65 -176.74 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.274 1.43 . . . . 0.0 109.012 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.29 145.95 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' A' ' 41' ' ' GLY . 1.3 tmm_? -144.0 173.84 11.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.561 1.944 . . . . 0.0 106.278 -177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 40' ' ' ARG . . . -101.73 172.1 22.49 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.133 -0.98 . . . . 0.0 111.172 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -67.88 120.97 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 168.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.44 -48.98 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -150.92 86.42 1.37 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.887 0.875 . . . . 0.0 109.01 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.15 161.21 2.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.77 130.82 17.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -134.99 129.67 34.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.367 0.985 . . . . 0.0 108.982 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.19 137.44 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -8.96 25.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -130.43 34.0 4.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.081 1.752 . . . . 0.0 109.829 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 149.45 84.55 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.141 0.576 . . . . 0.0 111.192 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.84 26.18 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.835 3.69 . . . . 0.0 112.026 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.87 -37.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.918 2.887 . . . . 0.0 115.821 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -56.17 -44.13 79.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.711 1.142 . . . . 0.0 109.565 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.25 88.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -60.14 -26.68 66.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.133 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.02 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.435 1.017 . . . . 0.0 111.019 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 151.12 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 t -134.33 151.09 51.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.986 0.812 . . . . 0.0 109.369 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -66.08 107.64 1.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.404 1.082 . . . . 0.0 109.173 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.51 64.81 3.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 49.81 30.22 3.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.467 1.507 . . . . 0.0 113.209 169.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.49 -25.46 1.08 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.856 1.217 . . . . 0.0 113.387 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.46 -165.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 107.877 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 tp -130.32 147.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.451 1.478 . . . . 0.0 110.624 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.55 138.73 15.63 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.5 143.78 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.404 2.069 . . . . 0.0 110.596 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -127.84 135.55 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.2 167.04 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -129.08 116.52 19.4 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 mt -66.82 -17.29 64.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.358 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -54.75 -42.33 71.52 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.835 1.198 . . . . 0.0 110.333 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.36 -44.19 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -60.89 -23.75 65.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.42 -3.54 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.043 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.9 m 49.55 48.64 21.13 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.031 1.287 . . . . 0.0 110.57 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.31 -171.22 0.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 110.864 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.78 164.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.36 1.064 . . . . 0.0 110.225 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -84.06 62.89 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.273 1.829 . . . . 0.0 110.575 -169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 m -53.25 158.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.714 0.806 . . . . 0.0 111.036 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -144.03 178.03 8.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.237 1.415 . . . . 0.0 108.643 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.65 64.18 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.123 1.769 . . . . 0.0 109.484 169.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.36 -35.73 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 131.563 3.945 . . . . 0.0 108.456 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -145.98 30.7 1.05 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.641 1.976 . . . . 0.0 110.072 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -154.97 28.81 0.42 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.268 3.027 . . . . 0.0 107.666 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 p -106.51 12.17 29.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.538 1.935 . . . . 0.0 115.95 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.77 154.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.33 113.79 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -82.21 141.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 137.02 47.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.0 mt -135.82 154.85 51.06 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.531 1.532 . . . . 0.0 109.112 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 139.67 37.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.97 155.25 35.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.28 -100.49 0.04 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.2 0.905 . . . . 0.0 111.656 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -136.57 27.7 3.05 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.613 1.965 . . . . 0.0 109.958 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -146.97 171.04 15.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.2 144.79 34.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 125.363 1.465 . . . . 0.0 107.456 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.48 -176.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.78 176.54 41.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 pt -140.33 144.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.191 0.519 . . . . 0.0 110.343 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.51 142.9 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.944 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.44 166.05 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.654 1.982 . . . . 0.0 108.021 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.53 -41.48 65.79 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.94 151.81 8.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.29 128.98 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -36.5 10.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.203 0.601 . . . . 0.0 111.772 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.3 t0 -169.09 -178.4 3.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.593 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.1 t -137.48 122.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 103.984 -2.598 . . . . 0.0 103.984 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -141.16 150.25 42.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.456 0.702 . . . . 0.0 110.718 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 p -94.86 135.68 36.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.418 0.687 . . . . 0.0 109.639 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mp -138.18 143.31 40.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 67.5 p -100.4 164.8 11.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.55 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.91 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -104.89 -36.2 7.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.772 1.629 . . . . 0.0 110.052 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.41 -45.92 82.04 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.49 112.75 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -148.19 -62.86 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.802 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.18 -178.08 3.03 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.105 1.87 . . . . 0.0 111.539 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.32 155.55 39.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.564 1.946 . . . . 0.0 108.097 169.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.23 59.43 7.39 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.111 3.207 . . . . 0.0 111.107 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.63 29.18 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.077 1.751 . . . . 0.0 112.863 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.11 -174.46 1.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.746 1.618 . . . . 0.0 110.401 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 28.75 0.06 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.269 1.428 . . . . 0.0 113.468 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.72 161.37 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.828 1.651 . . . . 0.0 109.475 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -44.57 95.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -62.88 166.01 6.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 m -134.19 175.2 9.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.2 1.4 . . . . 0.0 110.64 -169.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -56.15 -27.71 55.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.88 -30.2 56.11 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.337 0.972 . . . . 0.0 111.157 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -110.97 -9.55 14.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.093 0.957 . . . . 0.0 112.505 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.7 160.91 5.15 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.559 0.744 . . . . 0.0 112.132 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 146' ' ' ASN . 38.8 p -114.15 166.31 11.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.392 1.877 . . . . 0.0 108.757 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.86 176.53 45.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.59 145.78 39.0 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.3 174.72 37.07 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.04 39.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.018 0.927 . . . . 0.0 110.184 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.25 82.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.33 -51.9 2.57 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.623 2.059 . . . . 0.0 112.98 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -157.35 -31.4 0.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.147 2.179 . . . . 0.0 111.076 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.443 HH22 ' HB2' ' A' ' 107' ' ' ASP . 66.0 mtp180 -68.79 162.21 26.82 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.6 mtp -138.87 144.15 39.06 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.25 128.09 35.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.55 120.72 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.51 102.9 15.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.44 120.74 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.068 1.347 . . . . 0.0 108.956 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 132' ' ' THR . 40.4 t30 -75.99 60.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.133 1.773 . . . . 0.0 110.121 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.45 -35.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.089 1.356 . . . . 0.0 111.24 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -68.7 -5.94 23.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -134.26 18.8 3.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.068 1.347 . . . . 0.0 110.667 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.1 tp -79.2 -88.28 0.06 Allowed 'General case' 0 C--N 1.341 0.222 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.0 tp -68.95 -31.51 70.44 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.543 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.74 -22.58 47.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -124.33 -3.66 7.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.405 1.082 . . . . 0.0 112.072 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -122.21 2.15 9.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 113.023 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.62 -34.35 67.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.293 1.406 . . . . 0.0 111.38 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -61.14 -45.92 92.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.0 109.932 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.06 73.72 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.212 0.605 . . . . 0.0 111.443 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.3 -56.68 10.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.329 0.652 . . . . 0.0 109.707 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.35 -30.4 71.23 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.063 -0.398 . . . . 0.0 111.08 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.469 0.501 0 C-N-CA 123.644 0.778 . . . . 0.0 112.855 175.073 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.37 165.99 22.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.766 1.227 . . . . 0.0 108.357 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.45 143.91 46.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -142.09 137.96 31.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.396 0.679 . . . . 0.0 109.815 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -83.27 134.6 34.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.42 151.71 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 119.212 0.914 . . . . 0.0 109.135 -173.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -140.46 150.97 44.46 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.643 1.177 . . . . 0.0 109.26 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -91.71 148.54 22.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 tp -144.63 109.46 5.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.06 -87.71 0.23 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.413 1.006 . . . . 0.0 111.326 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.23 32.46 0.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.245 1.418 . . . . 0.0 109.589 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.22 159.07 43.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.957 1.703 . . . . 0.0 107.794 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.76 153.74 37.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.918 1.342 . . . . 0.0 109.874 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -138.58 150.79 46.68 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.76 2.024 . . . . 0.0 106.867 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.93 157.3 19.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.8 134.25 42.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -48.66 116.67 1.7 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.394 1.078 . . . . 0.0 108.785 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.4 -34.75 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.513 0.725 . . . . 0.0 111.766 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.29 -24.53 67.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.795 0.838 . . . . 0.0 112.586 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -79.17 -24.0 43.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.48 0.582 . . . . 0.0 111.41 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -67.3 140.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -104.57 -59.57 1.72 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.118 0.967 . . . . 0.0 108.952 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.27 178.3 9.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.842 0.857 . . . . 0.0 110.222 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.58 146.69 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 41' ' ' GLY . 20.6 ttp180 -148.51 176.5 10.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.389 1.475 . . . . 0.0 108.279 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 40' ' ' ARG . . . -91.95 166.23 29.81 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.554 -0.716 . . . . 0.0 111.361 174.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -166.13 0.23 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.523 1.529 . . . . 0.0 112.28 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 67.34 27.89 8.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.455 1.902 . . . . 0.0 112.934 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 31.82 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.39 1.076 . . . . 0.0 109.72 174.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -75.74 116.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -60.85 -47.41 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 109.16 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 54.29 175.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.05 2.54 . . . . 0.0 113.106 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.52 155.86 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.55 -25.5 60.04 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -149.96 23.74 0.85 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.96 142.72 98.19 Favored Pre-proline 0 C--O 1.239 0.53 0 CA-C-O 119.019 -0.515 . . . . 0.0 109.743 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.41 148.67 92.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.953 2.435 . . . . 0.0 110.039 174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.15 -24.87 67.84 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -61.17 -55.94 26.42 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.191 0.905 . . . . 0.0 109.702 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.4 -37.0 48.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 C-N-CA 125.228 1.411 . . . . 0.0 109.993 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 58.54 -79.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.328 1.851 . . . . 0.0 107.768 -168.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.48 -132.61 2.19 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 121.358 1.89 . . . . 0.0 110.759 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.91 160.6 39.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.304 1.042 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -133.41 147.99 51.77 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -77.95 108.99 11.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.41 76.94 7.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.477 0.655 . . . . 0.0 109.854 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 49.88 29.04 3.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.023 1.329 . . . . 0.0 114.358 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.48 -19.43 2.81 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.671 1.129 . . . . 0.0 113.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.54 -169.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.842 1.321 . . . . 0.0 108.187 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.07 149.51 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.205 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.58 141.08 14.42 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.758 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.46 132.33 33.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.877 1.718 . . . . 0.0 109.682 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.61 119.21 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.46 154.04 9.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 125.589 1.556 . . . . 0.0 110.269 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -92.65 111.4 22.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.358 1.063 . . . . 0.0 110.545 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.71 -37.75 76.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -43.6 92.87 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.378 0.99 . . . . 0.0 109.484 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.8 -36.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.14 -31.16 67.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.208 0.913 . . . . 0.0 113.427 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -116.58 9.5 14.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.923 0.783 . . . . 0.0 112.376 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.6 m 47.92 41.74 15.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.279 1.032 . . . . 0.0 111.002 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -179.84 7.48 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.636 1.175 . . . . 0.0 109.51 -172.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.79 -84.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -173.57 106.04 0.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.034 1.334 . . . . 0.0 108.792 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.01 129.69 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.389 1.075 . . . . 0.0 108.266 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.78 149.38 26.41 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.693 0.797 . . . . 0.0 108.92 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.6 36.9 0.07 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.252 2.221 . . . . 0.0 112.758 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.48 -9.86 0.16 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.476 2.31 . . . . 0.0 111.005 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.48 -4.69 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.061 1.344 . . . . 0.0 111.866 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.66 24.11 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -172.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -80.95 9.75 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 117.826 2.528 . . . . 0.0 117.826 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.6 160.49 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 120.276 1.398 . . . . 0.0 107.902 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.68 127.47 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.88 142.59 15.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.91 134.16 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.59 163.84 29.19 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.008 1.723 . . . . 0.0 109.183 -169.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 148.37 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.449 1.499 . . . . 0.0 107.651 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.4 152.31 25.68 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.51 -90.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.049 1.309 . . . . 0.0 113.508 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.78 23.81 2.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.221 1.809 . . . . 0.0 110.699 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -149.46 173.41 13.61 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.732 -1.23 . . . . 0.0 111.57 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.95 151.95 36.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 125.078 1.351 . . . . 0.0 108.654 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.85 172.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 125.008 1.323 . . . . 0.0 107.6 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.24 177.21 40.03 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.07 142.89 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.56 140.16 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.68 168.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.125 1.77 . . . . 0.0 109.01 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.64 -43.47 72.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.824 1.193 . . . . 0.0 109.978 171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.64 153.67 8.97 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.33 121.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -46.62 12.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.498 0.719 . . . . 0.0 111.15 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -169.29 179.5 3.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.143 0.977 . . . . 0.0 109.767 -168.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.98 136.3 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.86 1.664 . . . . 0.0 107.026 169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -142.58 174.4 10.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.814 1.245 . . . . 0.0 109.16 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.5 m -131.84 137.79 48.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -141.25 155.15 46.05 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.932 0.893 . . . . 0.0 109.277 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -126.99 158.37 37.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.871 1.668 . . . . 0.0 108.365 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.28 42.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -65.97 -41.64 90.93 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.187 -0.946 . . . . 0.0 109.787 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.95 -40.07 40.67 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.348 1.459 . . . . 0.0 110.462 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -91.37 99.17 9.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -139.6 -53.35 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.144 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 170.96 9.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.425 1.544 . . . . 0.0 111.623 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.18 30.25 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.261 1.424 . . . . 0.0 108.667 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -80.72 50.47 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.797 2.998 . . . . 0.0 110.371 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 16.76 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.272 1.429 . . . . 0.0 113.921 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -146.92 152.97 39.55 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.886 2.074 . . . . 0.0 108.134 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.62 42.36 23.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.176 1.39 . . . . 0.0 112.773 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 166.08 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.738 1.615 . . . . 0.0 108.744 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -35.66 10.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.011 0.525 . . . . 0.0 111.583 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.41 171.77 2.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.655 1.182 . . . . 0.0 112.971 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.9 m -121.6 168.53 11.65 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.043 1.337 . . . . 0.0 110.441 -170.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 p -52.93 -21.98 5.02 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.858 2.463 . . . . 0.0 115.829 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -85.79 -34.42 21.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.825 0.85 . . . . 0.0 110.892 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -91.88 -14.36 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.225 0.61 . . . . 0.0 110.208 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.47 136.87 43.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.797 2.439 . . . . 0.0 111.207 -172.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.1 p -80.59 -170.3 2.54 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.45 2.3 . . . . 0.0 110.918 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.06 172.06 22.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 106.402 -2.679 . . . . 0.0 106.402 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 154.54 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.624 1.712 . . . . 0.0 110.289 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.44 175.03 31.99 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.81 157.04 19.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.811 0.844 . . . . 0.0 110.168 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.73 82.29 1.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.43 -51.39 2.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.489 1.995 . . . . 0.0 113.11 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.38 -31.9 0.09 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.058 2.143 . . . . 0.0 110.97 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -69.09 161.01 29.96 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 170.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -137.94 140.43 40.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.22 130.94 45.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.9 104.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.35 110.89 9.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.08 129.83 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -78.92 54.8 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.496 1.118 . . . . 0.0 109.669 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 tp -56.01 -35.82 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.449 1.5 . . . . 0.0 111.762 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -67.54 -19.73 65.32 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.558 . . . . 0.0 112.375 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -105.81 -22.52 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 117.47 -1.252 . . . . 0.0 111.866 171.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -48.42 -75.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 111.562 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.6 tp -78.51 -25.46 45.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.177 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.66 -27.05 67.53 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.759 1.163 . . . . 0.0 112.911 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.7 m -115.23 -8.03 12.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.684 1.193 . . . . 0.0 111.888 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -97.69 -7.25 31.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.984 1.266 . . . . 0.0 111.429 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -54.5 -46.31 73.44 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.999 1.727 . . . . 0.0 110.236 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 ptp -59.14 -25.81 64.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.271 1.028 . . . . 0.0 112.932 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.92 -26.0 16.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.049 1.739 . . . . 0.0 112.046 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.68 -56.8 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.05 0.94 . . . . 0.0 108.655 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.802 -0.561 . . . . 0.0 112.125 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.567 1.547 . . . . 0.0 112.112 172.694 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -65.89 148.07 52.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -109.88 145.64 36.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -142.13 140.02 32.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.196 0.998 . . . . 0.0 110.736 -169.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.12 136.18 34.55 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 167.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.46 149.86 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.91 1.232 . . . . 0.0 109.223 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -141.17 152.09 44.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.244 1.018 . . . . 0.0 110.176 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.9 m -91.53 146.88 23.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 170.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -145.3 121.14 10.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.52 -98.62 0.21 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -141.67 37.09 1.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.211 1.404 . . . . 0.0 109.633 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.67 160.11 40.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.836 1.654 . . . . 0.0 107.92 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.3 152.54 44.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.093 1.425 . . . . 0.0 110.361 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.32 154.97 48.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.711 2.005 . . . . 0.0 107.459 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.32 159.13 21.31 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.904 1.24 . . . . 0.0 110.113 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mt -142.22 133.69 25.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -45.75 113.96 0.69 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 109.082 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -53.05 -39.0 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.49 -16.84 64.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.225 0.92 . . . . 0.0 112.941 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -74.2 -24.74 59.4 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.753 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -64.78 140.89 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -120.37 -42.0 2.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.479 1.112 . . . . 0.0 110.511 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 169.54 24.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.585 1.154 . . . . 0.0 108.386 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.6 142.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -149.11 174.4 12.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.928 0.891 . . . . 0.0 108.633 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.04 25.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.66 126.04 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.37 159.0 2.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.754 . . . . 0.0 108.2 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.57 43.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.935 2.894 . . . . 0.0 116.18 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 t -74.22 107.97 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -76.12 95.01 3.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.38 142.75 50.33 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.7 8.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.691 0.796 . . . . 0.0 110.099 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.26 -4.8 0.26 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.349 2.26 . . . . 0.0 115.511 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.99 14.75 1.34 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.054 1.342 . . . . 0.0 112.449 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.0 144.4 75.7 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.259 1.024 . . . . 0.0 109.95 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.36 157.56 53.83 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.917 2.411 . . . . 0.0 109.274 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.53 -33.8 64.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.748 0.819 . . . . 0.0 112.728 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.91 -49.08 63.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.851 0.75 . . . . 0.0 110.549 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.54 -37.69 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.804 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? 48.58 -82.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.834 2.454 . . . . 0.0 111.352 -169.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.87 14.06 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 120.726 1.603 . . . . 0.0 112.713 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.73 156.79 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -140.07 157.03 46.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.924 1.238 . . . . 0.0 109.622 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -78.62 101.84 7.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.911 1.284 . . . . 0.0 110.98 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.75 70.71 2.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 109.931 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 50.81 27.7 3.24 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.7 1.6 . . . . 0.0 114.227 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.6 -17.85 2.03 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.391 0.996 . . . . 0.0 113.263 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -171.45 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.723 1.261 . . . . 0.0 107.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -132.18 150.4 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 120.768 -1.207 . . . . 0.0 110.202 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.87 141.5 14.97 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.676 -1.154 . . . . 0.0 109.289 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.1 131.08 24.28 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.884 1.723 . . . . 0.0 108.585 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.69 123.83 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.13 147.89 12.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.452 2.301 . . . . 0.0 107.117 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.84 118.56 37.1 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.747 0.819 . . . . 0.0 109.562 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.28 -20.39 66.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.055 0.942 . . . . 0.0 113.195 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -56.02 -39.8 72.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.425 1.466 . . . . 0.0 109.434 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.33 12.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 109.763 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -131.83 -27.44 1.88 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.859 -1.151 . . . . 0.0 112.079 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.55 6.3 3.23 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.746 1.157 . . . . 0.0 113.718 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m 59.18 23.39 11.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -61.12 149.37 37.48 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.48 0.712 . . . . 0.0 111.674 -169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 m -24.25 -75.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 129.054 2.942 . . . . 0.0 117.506 -169.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -164.93 67.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.362 1.065 . . . . 0.0 109.758 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -50.84 140.57 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.21 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -160.52 165.62 30.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.677 1.191 . . . . 0.0 109.009 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -73.99 43.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.281 2.232 . . . . 0.0 111.157 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -159.22 -19.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.85 3.26 . . . . 0.0 110.028 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -135.75 6.54 3.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.638 1.575 . . . . 0.0 111.501 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -154.8 37.27 0.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.434 1.893 . . . . 0.0 109.05 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p -94.87 11.57 31.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.32 1.848 . . . . 0.0 115.751 -168.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.64 160.37 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.44 135.05 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -171.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.6 mt -115.89 127.03 73.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.73 134.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 mt -129.79 164.03 24.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.411 1.484 . . . . 0.0 108.209 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.01 157.3 44.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.867 0.867 . . . . 0.0 108.696 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.29 -178.05 4.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.18 97.35 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.896 1.236 . . . . 0.0 113.136 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 63.16 22.48 13.41 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.541 1.936 . . . . 0.0 115.282 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -147.2 161.94 39.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.79 1.632 . . . . 0.0 111.016 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.5 m -135.54 151.45 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 123.799 0.84 . . . . 0.0 110.396 -170.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.55 174.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.235 1.814 . . . . 0.0 106.673 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.45 176.55 40.33 Favored Glycine 0 N--CA 1.448 -0.541 0 O-C-N 120.201 -1.562 . . . . 0.0 110.28 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.46 149.4 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.827 0.851 . . . . 0.0 109.559 -169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 m -94.32 136.1 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.836 1.254 . . . . 0.0 108.86 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.02 166.02 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.608 1.563 . . . . 0.0 109.363 -169.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.52 -43.0 67.27 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.07 154.0 10.73 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.45 123.41 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -49.38 12.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.867 0.467 . . . . 0.0 110.79 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.56 179.73 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.67 1.188 . . . . 0.0 109.618 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.45 127.92 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 pp -156.17 177.68 11.16 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.837 1.255 . . . . 0.0 109.753 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -129.86 148.82 51.77 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.866 0.757 . . . . 0.0 112.179 -169.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mp -139.96 145.89 38.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.175 1.39 . . . . 0.0 108.698 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -94.02 172.2 8.37 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 111.543 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.1 21.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.406 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.11 -39.36 12.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.704 1.202 . . . . 0.0 109.143 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -69.02 -41.6 77.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.821 0.848 . . . . 0.0 110.703 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -86.43 117.58 31.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -143.23 -64.32 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.562 0 CA-C-O 116.838 -1.554 . . . . 0.0 111.818 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.93 -175.1 1.97 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.243 1.962 . . . . 0.0 111.501 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.22 31.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.221 1.808 . . . . 0.0 107.978 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.69 149.63 61.3 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.203 1.935 . . . . 0.0 110.546 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.57 24.96 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.709 1.204 . . . . 0.0 110.549 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -76.82 34.67 0.15 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.191 1.796 . . . . 0.0 114.038 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.77 32.28 5.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.891 2.076 . . . . 0.0 113.608 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.67 -178.86 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.401 1.08 . . . . 0.0 109.755 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -8.63 8.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.483 1.513 . . . . 0.0 113.974 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.05 151.23 40.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.102 1.361 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -135.25 160.28 38.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.422 1.089 . . . . 0.0 108.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 p -62.07 -10.47 10.2 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -22.46 12.06 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.306 1.042 . . . . 0.0 111.365 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -84.8 -9.8 57.81 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.941 -0.475 . . . . 0.0 110.341 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.93 120.26 2.95 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.197 2.199 . . . . 0.0 112.327 -169.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.1 p -75.91 -166.18 0.55 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.428 2.691 . . . . 0.0 111.431 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.74 175.18 20.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.48 143.59 39.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.32 170.14 31.56 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.7 154.49 29.45 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.22 1.008 . . . . 0.0 109.595 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.39 71.79 1.36 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.72 -38.64 1.27 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.894 2.188 . . . . 0.0 113.723 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.6 -34.92 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.99 2.116 . . . . 0.0 110.13 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -71.54 166.08 22.54 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -139.59 145.42 38.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -132.01 126.31 33.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.9 mt -79.7 110.88 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.07 105.64 11.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.15 120.89 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.52 60.33 2.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.305 0.574 . . . . 0.0 110.131 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -53.17 -37.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.615 1.166 . . . . 0.0 111.018 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.35 -23.52 66.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.187 0.995 . . . . 0.0 112.312 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -110.56 -20.41 12.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 117.337 -1.316 . . . . 0.0 111.841 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.21 -61.67 2.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.782 1.173 . . . . 0.0 109.885 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.04 -48.37 63.05 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.82 -40.07 75.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.32 0.509 . . . . 0.0 111.83 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.2 m -80.89 -29.55 35.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.187 0.449 . . . . 0.0 111.568 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.01 -9.31 57.02 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.477 0.711 . . . . 0.0 111.125 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.99 -49.05 66.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.895 1.225 . . . . 0.0 112.089 -169.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.6 ptp -66.02 -31.41 72.28 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.868 -0.52 . . . . 0.0 112.056 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.2 59.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.339 1.056 . . . . 0.0 110.35 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.95 -49.24 78.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.089 1.356 . . . . 0.0 109.041 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.1 -24.61 63.09 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 123.796 0.839 . . . . 0.0 111.977 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.535 0.382 0 CA-C-N 119.281 0.946 . . . . 0.0 112.35 178.826 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -75.52 170.17 16.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.737 0.815 . . . . 0.0 110.168 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.34 145.19 51.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.0 136.26 35.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.382 0.673 . . . . 0.0 110.136 -169.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.5 tp -78.44 133.94 37.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 167.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.28 148.14 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 119.324 0.965 . . . . 0.0 108.54 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.15 153.16 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.957 0.903 . . . . 0.0 110.125 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -93.55 145.92 24.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' CD1' HD22 ' A' ' 85' ' ' ASN . 56.4 tp -136.77 96.76 3.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.624 . . . . 0.0 107.5 173.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.48 -76.03 0.52 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.169 1.366 . . . . 0.0 111.907 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.08 30.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.285 1.434 . . . . 0.0 110.494 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.36 160.54 39.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 108.145 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -127.93 151.6 48.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.045 1.403 . . . . 0.0 110.824 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -137.33 156.84 47.76 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.878 2.071 . . . . 0.0 108.045 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.73 153.92 19.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.848 1.213 . . . . 0.0 110.419 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -136.63 130.99 47.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -48.65 120.36 3.71 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.94 -31.89 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.336 0.654 . . . . 0.0 111.595 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.99 -23.58 67.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.502 -0.749 . . . . 0.0 112.689 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -77.64 -22.91 49.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.928 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.94 140.2 20.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.637 1.108 . . . . 0.0 108.369 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 -40.67 2.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.522 1.129 . . . . 0.0 110.431 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -166.19 177.47 6.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.559 . . . . 0.0 107.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.86 135.6 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -120.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -170.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.85 164.07 32.77 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.732 1.634 . . . . 0.0 109.266 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -61.8 139.48 58.34 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -147.96 -65.31 0.25 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.465 0.306 . . . . 0.0 111.195 -174.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.48 72.84 0.55 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.491 1.116 . . . . 0.0 108.606 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.83 113.97 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 m -73.46 85.66 1.52 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -65.92 104.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 mm -69.82 148.04 11.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.85 -23.57 67.41 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -170.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.29 31.86 0.38 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 160.04 60.89 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.922 -1.111 . . . . 0.0 109.206 169.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -61.1 145.83 98.38 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.957 1.772 . . . . 0.0 108.176 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.72 -31.47 64.55 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -56.62 -41.91 77.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.227 0.467 . . . . 0.0 111.174 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.0 mt -92.23 89.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -51.7 -47.74 63.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.022 169.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.28 -177.04 28.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.977 1.262 . . . . 0.0 111.853 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 159.93 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 118.051 0.925 . . . . 0.0 109.788 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 t -141.24 158.56 43.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.519 1.054 . . . . 0.0 109.559 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -79.82 129.92 34.88 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.436 1.095 . . . . 0.0 110.233 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.19 84.42 2.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.902 1.281 . . . . 0.0 107.894 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 53.12 34.85 18.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.624 1.17 . . . . 0.0 113.425 169.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.1 -5.26 25.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.502 1.049 . . . . 0.0 112.974 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.72 177.49 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.153 1.781 . . . . 0.0 106.495 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -134.43 156.33 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 120.555 -1.341 . . . . 0.0 109.721 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -154.18 141.4 13.49 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.352 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.11 130.07 19.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.137 1.891 . . . . 0.0 108.747 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -106.85 135.88 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 108.422 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.61 139.35 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -96.26 104.49 16.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.312 1.045 . . . . 0.0 109.094 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -29.76 70.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.328 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -38.57 83.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.5 -36.82 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -71.72 -22.16 61.67 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.37 11.22 9.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.884 1.22 . . . . 0.0 112.842 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m 55.34 25.07 7.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.556 1.542 . . . . 0.0 113.023 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -68.77 161.62 28.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.878 0.871 . . . . 0.0 111.211 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.01 165.95 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 0.0 111.293 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.4 t70 45.05 68.14 0.61 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.106 2.962 . . . . 0.0 114.073 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.09 62.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.911 1.284 . . . . 0.0 109.5 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -143.54 164.67 29.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.61 1.164 . . . . 0.0 110.99 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -81.71 66.76 7.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 169.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.32 -60.16 0.27 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.076 1.351 . . . . 0.0 109.721 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.69 -38.86 73.73 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.014 0.825 . . . . 0.0 111.476 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.479 HD22 ' CD1' ' A' ' 24' ' ' LEU . 7.2 m120 -91.86 -79.31 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -169.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.7 p 60.67 -3.56 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.929 2.092 . . . . 0.0 116.073 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.68 144.97 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 120.468 1.485 . . . . 0.0 107.211 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -120.58 139.49 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.37 133.25 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.57 134.87 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.35 163.01 30.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.755 1.622 . . . . 0.0 108.839 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.28 145.03 35.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.006 1.723 . . . . 0.0 107.547 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -159.44 142.4 14.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.49 -85.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.567 1.556 . . . . 0.0 113.047 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -143.48 16.58 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.013 -170.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.2 177.98 9.41 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.153 -0.967 . . . . 0.0 112.089 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.97 157.41 38.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 110.027 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -160.39 169.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 126.205 1.802 . . . . 0.0 107.218 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.94 168.88 30.68 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.5 pt -140.72 147.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 123.966 0.906 . . . . 0.0 108.76 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.26 139.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.988 0.915 . . . . 0.0 109.16 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.86 156.68 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 108.736 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.26 -39.4 89.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.204 0.911 . . . . 0.0 110.578 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.96 162.56 20.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.62 117.97 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -49.26 42.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.194 0.597 . . . . 0.0 110.565 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -172.44 -174.82 1.26 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.292 1.437 . . . . 0.0 108.526 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.18 131.07 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.88 146.21 40.88 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.116 0.966 . . . . 0.0 109.604 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 p -84.8 144.43 28.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 109.568 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.08 138.48 29.92 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 p -77.57 153.86 32.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.19 -10.01 37.39 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.562 -0.711 . . . . 0.0 111.756 172.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.08 -30.78 70.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.687 1.195 . . . . 0.0 110.23 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -68.07 -41.45 81.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.908 0.776 . . . . 0.0 110.124 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.87 89.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.249 1.82 . . . . 0.0 109.315 -169.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -142.79 -60.24 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-O 116.809 -1.567 . . . . 0.0 112.846 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.13 176.8 4.24 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.944 1.762 . . . . 0.0 111.491 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.1 154.01 30.36 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.892 1.277 . . . . 0.0 109.38 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -80.6 50.04 3.42 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.417 3.411 . . . . 0.0 110.646 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.54 21.09 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.114 1.766 . . . . 0.0 114.621 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -142.81 146.96 34.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.973 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.32 6.95 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.08 2.152 . . . . 0.0 115.039 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.03 165.82 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.921 1.288 . . . . 0.0 109.457 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -0.38 13.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.739 1.216 . . . . 0.0 113.996 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.3 150.77 21.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.326 0.966 . . . . 0.0 110.59 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.6 m -136.67 147.71 46.98 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -57.13 -3.18 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.346 2.258 . . . . 0.0 116.015 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.91 -38.17 23.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.797 1.239 . . . . 0.0 110.575 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -132.16 1.74 3.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.71 1.604 . . . . 0.0 111.608 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.22 132.09 12.74 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.741 2.416 . . . . 0.0 109.963 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.1 p -80.93 -169.39 2.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.774 2.83 . . . . 0.0 111.875 -170.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.98 179.27 16.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.19 149.32 44.28 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 108.206 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.72 169.69 29.89 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 169.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.53 158.84 43.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.176 0.99 . . . . 0.0 110.644 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.5 mt -146.0 67.05 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.366 1.866 . . . . 0.0 107.483 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.34 2.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.168 1.842 . . . . 0.0 113.333 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.54 -32.82 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.695 1.998 . . . . 0.0 110.625 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -69.35 153.36 43.72 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -141.89 142.4 33.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -133.34 124.18 26.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.39 109.56 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.65 116.8 18.48 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.18 141.63 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.49 0.586 . . . . 0.0 109.92 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.43 57.25 3.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.805 0.812 . . . . 0.0 109.021 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.34 -38.69 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.428 1.491 . . . . 0.0 112.732 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -67.71 -7.06 23.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.807 0.843 . . . . 0.0 113.204 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -133.1 23.48 4.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.231 1.412 . . . . 0.0 110.232 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.41 -90.96 0.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -32.34 71.89 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.17 -20.55 54.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -117.63 4.21 12.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.064 0.945 . . . . 0.0 112.22 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -113.47 -9.65 13.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.651 1.18 . . . . 0.0 111.35 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.43 -39.28 83.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.117 1.326 . . . . 0.0 111.452 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.5 ptp -59.07 -23.73 62.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 112.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.43 -29.04 12.98 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.801 1.64 . . . . 0.0 111.484 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.9 -62.19 2.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.424 1.09 . . . . 0.0 109.438 170.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -18.26 60.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.09 -168.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 169.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -134.95 165.81 24.47 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.635 1.974 . . . . 0.0 110.412 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -111.16 147.78 34.17 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.34 137.49 32.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.186 0.994 . . . . 0.0 108.927 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.7 tp -78.64 137.04 37.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.01 147.99 30.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 119.579 1.082 . . . . 0.0 108.824 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -143.12 156.48 44.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.313 1.045 . . . . 0.0 110.168 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.5 m -95.8 145.3 25.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -159.95 129.99 5.43 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 125.791 1.636 . . . . 0.0 106.904 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 39.78 87.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.323 0.963 . . . . 0.0 113.509 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.5 37.43 19.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.144 1.778 . . . . 0.0 111.751 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.46 162.1 37.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.716 2.006 . . . . 0.0 107.058 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -118.39 152.73 35.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.819 1.295 . . . . 0.0 110.496 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -138.99 161.65 36.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.016 2.126 . . . . 0.0 107.72 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.75 164.11 27.15 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.407 0.527 . . . . 0.0 112.398 169.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.2 mt -143.65 138.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -46.41 119.08 2.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.426 1.091 . . . . 0.0 109.261 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.44 -32.47 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.481 0.712 . . . . 0.0 111.865 -170.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.98 -21.11 66.79 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.468 -0.77 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -23.47 60.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.261 0.937 . . . . 0.0 111.786 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.43 143.02 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 119.021 0.828 . . . . 0.0 109.377 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -106.67 -59.53 1.79 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.563 1.145 . . . . 0.0 108.41 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.65 177.57 10.35 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 109.774 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.32 147.67 32.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -149.8 164.74 34.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.974 2.11 . . . . 0.0 106.805 -170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.75 168.46 51.2 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.04 -1.037 . . . . 0.0 110.817 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -74.16 109.6 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -162.81 154.57 18.08 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.411 1.484 . . . . 0.0 107.783 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 26.99 56.75 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.066 2.546 . . . . 0.0 115.119 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.45 97.47 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 167.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -50.94 -41.07 58.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.522 1.129 . . . . 0.0 110.461 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 52.99 -179.81 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.402 1.881 . . . . 0.0 111.763 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -132.7 159.48 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.16 68.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.12 36.0 0.43 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.869 0.868 . . . . 0.0 112.688 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 145.31 49.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.312 -0.868 . . . . 0.0 111.219 173.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.22 161.69 29.51 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.563 2.842 . . . . 0.0 111.316 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.1 50.22 0.47 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.172 1.789 . . . . 0.0 113.352 -170.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -157.46 -46.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.228 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.3 mt -49.19 -42.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.275 1.03 . . . . 0.0 110.745 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.4 tttp 57.41 -81.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.888 2.075 . . . . 0.0 108.97 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.35 -160.11 10.07 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 120.705 1.593 . . . . 0.0 114.469 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.89 153.78 27.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.7 t -139.22 150.38 45.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.925 0.784 . . . . 0.0 110.48 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -79.21 89.86 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.869 1.668 . . . . 0.0 110.715 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.75 90.1 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.019 0.528 . . . . 0.0 110.107 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 49.62 29.36 3.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.691 1.196 . . . . 0.0 114.004 168.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.71 -3.67 14.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.683 1.135 . . . . 0.0 114.098 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.16 -174.39 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.839 1.656 . . . . 0.0 107.445 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.62 151.39 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.535 -1.353 . . . . 0.0 110.587 -172.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.27 143.38 16.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.532 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.44 129.47 21.47 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.748 1.632 . . . . 0.0 108.323 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.62 114.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.93 172.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.402 2.281 . . . . 0.0 106.232 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -138.45 124.75 20.42 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.611 -1.306 . . . . 0.0 108.749 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -62.45 -27.97 69.48 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.376 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.92 -39.11 53.87 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.189 0.904 . . . . 0.0 111.032 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.12 -41.63 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -81.65 -7.65 59.62 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.448 -0.782 . . . . 0.0 112.874 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.85 -12.66 14.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.285 0.948 . . . . 0.0 113.13 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m 53.46 35.18 19.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.532 1.06 . . . . 0.0 111.82 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.46 162.53 15.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.524 -0.735 . . . . 0.0 110.578 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -37.82 -92.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 128.258 2.623 . . . . 0.0 115.865 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -163.87 84.01 0.45 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.789 1.236 . . . . 0.0 108.997 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -51.16 139.02 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.086 0.954 . . . . 0.0 110.523 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.27 167.95 26.4 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.688 1.595 . . . . 0.0 108.51 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -70.25 50.78 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.355 1.462 . . . . 0.0 111.92 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -159.58 -16.09 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.758 3.223 . . . . 0.0 110.557 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -141.3 3.4 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.771 1.628 . . . . 0.0 111.692 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -150.21 37.13 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.434 -1.416 . . . . 0.0 109.662 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.8 p -96.14 0.14 50.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.662 1.585 . . . . 0.0 114.494 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.2 t -134.49 159.76 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.591 1.157 . . . . 0.0 108.153 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.84 131.1 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 107.051 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.63 137.62 28.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.08 135.41 53.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -136.32 166.8 22.61 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.659 1.183 . . . . 0.0 109.854 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.3 131.91 28.86 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.73 124.47 23.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -168.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.87 -81.91 0.12 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.909 0.766 . . . . 0.0 112.564 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.42 13.92 1.09 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.223 1.809 . . . . 0.0 110.669 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -143.5 174.43 10.77 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.466 1.106 . . . . 0.0 110.246 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.71 155.52 26.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.859 0.864 . . . . 0.0 109.592 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.18 175.27 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 126.189 1.796 . . . . 0.0 107.01 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.65 178.47 41.03 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.29 146.93 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.47 146.41 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -149.78 168.17 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 126.433 1.893 . . . . 0.0 108.893 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.79 -42.09 64.29 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.811 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.85 154.93 9.64 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.97 124.34 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 172.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -40.85 13.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.1 0.56 . . . . 0.0 111.056 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB2' HH22 ' A' ' 140' ' ' ARG . 5.8 t0 -168.04 -177.24 3.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.865 0.466 . . . . 0.0 110.882 -168.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.19 124.14 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.4 mt -140.91 171.8 13.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.703 1.201 . . . . 0.0 109.815 -168.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.4 m -126.45 134.31 50.99 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.682 0.674 . . . . 0.0 110.699 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.23 160.35 39.68 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.125 0.97 . . . . 0.0 110.194 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -145.18 161.32 39.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.23 1.412 . . . . 0.0 109.297 -168.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.22 -25.26 13.45 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.7 -38.15 86.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.073 -1.017 . . . . 0.0 109.669 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -83.07 -37.92 23.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 110.969 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.58 108.93 22.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -58.67 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.075 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 173.29 9.21 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.11 1.873 . . . . 0.0 112.052 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.07 162.27 27.07 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.215 1.806 . . . . 0.0 108.335 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.46 -54.98 2.42 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.991 2.461 . . . . 0.0 112.723 -175.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 53.37 -21.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 130.392 3.477 . . . . 0.0 117.969 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -144.49 159.93 41.94 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.305 1.442 . . . . 0.0 109.582 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.6 36.07 13.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.523 1.529 . . . . 0.0 112.758 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.39 155.75 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 108.121 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -35.39 76.57 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.562 0.745 . . . . 0.0 111.304 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.4 170.44 4.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.981 1.713 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.9 m -140.83 178.98 6.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.368 2.267 . . . . 0.0 107.276 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 -27.87 2.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.571 2.349 . . . . 0.0 114.227 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.83 -18.94 62.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.422 1.489 . . . . 0.0 112.344 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.17 23.3 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.33 1.852 . . . . 0.0 109.762 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.92 115.05 27.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.482 1.513 . . . . 0.0 111.604 -169.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.8 p -72.27 -179.1 2.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.048 2.539 . . . . 0.0 111.216 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.84 172.93 15.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.943 -2.463 . . . . 0.0 106.943 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.25 157.64 43.52 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.329 1.565 . . . . 0.0 110.329 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.07 179.57 38.21 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.22 157.44 23.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.24 1.016 . . . . 0.0 111.071 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.18 81.3 1.67 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.61 2.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.6 2.047 . . . . 0.0 113.012 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.01 -32.02 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 111.043 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.406 HH22 ' HB2' ' A' ' 107' ' ' ASP . 62.1 mtp180 -69.49 162.56 27.22 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.7 mtp -139.49 145.96 39.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.24 130.15 36.72 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.9 mt -84.07 100.94 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.45 118.03 20.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.54 137.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -72.92 52.75 0.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.479 1.112 . . . . 0.0 110.077 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.83 -40.56 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.505 1.522 . . . . 0.0 114.784 -168.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.97 -20.91 51.79 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.669 -1.27 . . . . 0.0 111.432 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -41.96 21.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.7 tp -50.6 -45.0 57.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 110.184 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.29 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.714 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -75.93 -56.23 4.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -54.46 -46.24 73.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 110.425 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -74.33 -20.57 60.06 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.135 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.44 -47.02 80.65 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 122.122 2.237 . . . . 0.0 110.102 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.0 mtm -65.19 -45.95 82.72 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.85 96.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.074 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.3 -60.42 3.88 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.949 1.299 . . . . 0.0 109.548 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -27.98 68.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.992 -169.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 123.317 0.647 . . . . 0.0 112.676 174.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -135.3 166.97 21.89 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.167 1.787 . . . . 0.0 110.655 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -117.79 148.52 41.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.78 135.45 29.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.918 0.887 . . . . 0.0 109.296 -169.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.9 tp -77.21 134.66 38.56 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 168.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -121.57 149.21 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.778 1.172 . . . . 0.0 109.127 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.65 150.86 44.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.477 1.111 . . . . 0.0 109.696 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -91.43 147.46 23.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 tp -140.73 101.41 4.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.37 -76.26 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.512 1.53 . . . . 0.0 112.026 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.17 31.13 0.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.428 1.491 . . . . 0.0 110.657 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.77 160.54 39.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.941 1.696 . . . . 0.0 107.952 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -119.89 153.57 35.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.191 1.472 . . . . 0.0 110.846 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -140.51 159.43 42.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.532 2.333 . . . . 0.0 107.274 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.55 164.26 26.34 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 118.669 0.668 . . . . 0.0 111.989 170.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 mt -142.29 135.85 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -49.0 115.81 1.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.664 1.186 . . . . 0.0 108.983 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.37 -34.12 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.438 0.695 . . . . 0.0 111.697 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.63 -24.92 67.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.759 0.824 . . . . 0.0 112.668 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -84.83 -18.64 34.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.813 0.733 . . . . 0.0 112.061 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.87 136.8 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -100.44 -56.44 2.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 108.912 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -162.31 -179.18 6.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.526 1.13 . . . . 0.0 109.75 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -136.2 147.09 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -145.28 169.38 18.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.154 1.382 . . . . 0.0 108.297 -172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.66 148.85 19.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -82.03 100.69 9.88 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.81 1.244 . . . . 0.0 107.922 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.3 165.99 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.6 1.96 . . . . 0.0 106.587 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . 0.299 1.0 OUTLIER 42.91 30.02 0.22 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.582 2.753 . . . . 0.0 117.498 171.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.01 127.92 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 112.691 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 45.34 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.67 2.388 . . . . 0.0 110.689 -169.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.0 mm -57.37 153.43 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -18.37 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.43 23.27 0.72 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.53 155.57 67.64 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.519 0.728 . . . . 0.0 110.079 169.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -61.98 161.17 26.83 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.387 2.058 . . . . 0.0 109.01 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.52 80.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.674 -172.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -59.89 -41.08 90.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.195 0.907 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 mt -71.81 82.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -53.18 -30.61 38.39 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.629 1.172 . . . . 0.0 109.455 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.98 -151.5 22.45 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.85 154.92 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -136.01 145.96 46.64 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.99 92.89 5.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.45 175.62 1.31 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -69.54 59.49 0.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.87 1.668 . . . . 0.0 113.249 -169.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.86 -6.89 3.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.168 2.318 . . . . 0.0 113.389 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.427 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER -153.71 -165.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.375 1.588 . . . . 0.0 108.458 -169.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' H ' HG11 ' A' ' 64' ' ' VAL . 4.6 tp -121.1 158.75 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.094 1.758 . . . . 0.0 108.403 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.82 142.39 15.43 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.817 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.15 147.18 59.78 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.408 2.072 . . . . 0.0 110.745 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -131.32 148.16 32.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.721 0.808 . . . . 0.0 109.04 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.84 137.31 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -95.7 124.74 39.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.78 -18.83 64.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.361 0.664 . . . . 0.0 111.98 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -60.23 -31.44 70.19 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.839 -1.163 . . . . 0.0 109.624 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.64 -47.83 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -71.79 -33.08 68.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.859 -1.067 . . . . 0.0 113.581 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -121.55 3.05 10.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.816 1.189 . . . . 0.0 112.552 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.3 m 58.67 29.59 18.78 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.986 0.812 . . . . 0.0 111.317 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -57.06 142.03 43.72 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.726 0.81 . . . . 0.0 110.41 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.22 140.47 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 122.092 0.949 . . . . 0.0 111.946 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 24.68 60.55 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 130.734 3.614 . . . . 0.0 115.557 168.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.5 146.92 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -160.33 162.27 33.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.678 0.791 . . . . 0.0 109.251 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.77 40.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.872 2.469 . . . . 0.0 111.562 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -155.28 -25.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.837 2.455 . . . . 0.0 110.978 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -135.32 9.32 3.45 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 111.491 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.12 36.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.602 1.961 . . . . 0.0 108.478 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 p -73.41 4.88 4.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.81 165.23 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.986 1.721 . . . . 0.0 108.948 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -141.06 140.8 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.283 1.833 . . . . 0.0 106.236 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.0 134.87 56.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.62 134.13 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.46 161.62 34.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.469 1.508 . . . . 0.0 108.316 -169.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.56 148.65 39.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.38 127.34 29.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 52.35 -99.1 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 CA-C-N 118.609 0.641 . . . . 0.0 111.791 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.64 20.94 5.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.347 1.459 . . . . 0.0 111.863 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.72 166.32 22.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.479 1.112 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.89 153.03 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.525 1.13 . . . . 0.0 109.883 -171.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -160.28 176.51 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.819 1.648 . . . . 0.0 107.05 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 176.82 38.97 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 120.538 -1.351 . . . . 0.0 111.025 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.2 pt -141.79 154.1 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 124.396 1.078 . . . . 0.0 109.032 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.05 137.2 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.321 1.048 . . . . 0.0 108.304 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.25 168.09 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.15 1.38 . . . . 0.0 110.38 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.28 -40.99 64.14 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.856 -1.153 . . . . 0.0 110.619 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.31 154.53 9.52 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.83 128.23 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.47 -43.29 9.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.236 0.615 . . . . 0.0 111.321 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -168.36 -174.32 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.739 0.816 . . . . 0.0 109.874 -168.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.0 t -134.19 129.61 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -138.21 169.75 17.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.867 1.267 . . . . 0.0 109.309 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -129.24 134.93 48.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.446 0.566 . . . . 0.0 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.19 160.25 41.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.815 1.246 . . . . 0.0 109.579 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -144.06 172.7 12.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.81 2.044 . . . . 0.0 107.347 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.6 0.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -78.1 -45.42 23.46 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 120.182 1.355 . . . . 0.0 108.669 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -84.31 -32.68 24.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.111 1.364 . . . . 0.0 111.656 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.93 121.67 50.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -147.96 -54.86 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.604 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.28 -178.78 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.114 1.876 . . . . 0.0 111.981 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.27 32.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.694 1.598 . . . . 0.0 109.36 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.01 58.09 6.78 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.052 3.168 . . . . 0.0 111.704 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 30.07 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.297 1.439 . . . . 0.0 112.456 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.91 30.26 0.11 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.236 2.215 . . . . 0.0 113.865 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.47 31.81 4.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.882 2.073 . . . . 0.0 113.456 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 m -78.33 175.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -57.05 -17.38 9.96 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.05 -29.34 49.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.564 0.746 . . . . 0.0 112.921 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.1 m -70.91 78.02 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.731 1.612 . . . . 0.0 111.003 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.2 p -140.21 -102.01 0.15 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.374 1.069 . . . . 0.0 112.279 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 131' ' ' LEU . 13.3 pt-20 -142.31 -36.18 0.41 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 127.333 2.253 . . . . 0.0 109.895 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -78.92 15.49 1.08 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -50.8 137.6 20.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.806 2.042 . . . . 0.0 109.896 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.8 p -81.91 -168.86 2.09 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.823 2.049 . . . . 0.0 109.877 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.52 177.03 18.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 171.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -140.54 140.72 35.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.725 1.21 . . . . 0.0 107.783 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.73 173.97 30.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.84 155.11 50.83 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.69 0.796 . . . . 0.0 110.8 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.2 mt -142.31 78.11 1.61 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.002 1.721 . . . . 0.0 107.38 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.94 -51.48 3.15 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.43 1.967 . . . . 0.0 112.833 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.02 -30.56 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.278 1.831 . . . . 0.0 111.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -69.79 153.51 43.23 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 171.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.94 140.72 40.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.36 115.2 15.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.7 mt -75.61 107.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.67 111.44 21.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.17 126.28 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -76.43 56.89 1.13 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.674 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.66 -35.0 48.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.035 1.334 . . . . 0.0 111.51 -170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.77 -18.43 64.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.301 0.64 . . . . 0.0 112.348 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.99 -15.59 14.32 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 116.917 -1.516 . . . . 0.0 112.003 170.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.25 -63.91 1.03 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.932 1.696 . . . . 0.0 110.668 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.37 -39.55 81.72 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -60.1 -43.81 95.3 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.663 1.12 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -73.38 -16.22 61.35 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.902 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -115.58 -0.29 13.08 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.702 -1.142 . . . . 0.0 113.43 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -49.72 -53.1 26.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.022 1.737 . . . . 0.0 111.819 -173.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.62 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.551 1.069 . . . . 0.0 111.167 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.4 tp -59.77 -53.04 62.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.727 1.211 . . . . 0.0 108.46 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.07 -11.88 61.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 118.127 -0.94 . . . . 0.0 112.389 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 120.028 1.286 . . . . 0.0 110.965 173.682 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.08 138.85 58.58 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.34 143.81 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.67 139.56 33.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.997 0.919 . . . . 0.0 109.346 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 tp -83.37 130.24 35.04 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.2 152.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 109.317 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.27 153.59 45.3 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.544 1.138 . . . . 0.0 109.596 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -93.4 144.78 25.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -133.03 88.28 2.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.695 1.598 . . . . 0.0 106.742 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.75 -70.15 0.4 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.935 1.731 . . . . 0.0 112.755 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -151.24 27.73 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.37 1.468 . . . . 0.0 111.223 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.75 161.71 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.579 1.552 . . . . 0.0 108.154 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.82 150.2 46.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.464 1.126 . . . . 0.0 109.663 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -141.16 155.19 46.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.409 1.884 . . . . 0.0 107.507 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.97 158.68 22.99 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.425 1.012 . . . . 0.0 110.584 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.58 140.62 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -49.89 117.26 2.2 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.83 0.852 . . . . 0.0 109.993 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.75 -30.56 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.457 0.703 . . . . 0.0 111.569 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 mt -66.43 -4.88 9.16 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -109.88 -13.52 14.43 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 112.878 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.51 142.17 17.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 119.548 1.067 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -103.68 -57.71 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.22 -179.37 6.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.7 1.2 . . . . 0.0 109.295 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.57 149.51 31.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -143.59 174.32 10.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.28 1.432 . . . . 0.0 107.743 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.0 161.59 26.9 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 169.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.19 129.19 39.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.78 -43.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.7 41.19 0.77 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.61 135.86 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -123.43 92.33 3.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.17 111.66 5.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.2 -45.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.207 -170.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 144.73 -62.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.461 3.504 . . . . 0.0 108.696 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.82 18.47 22.08 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.673 1.189 . . . . 0.0 112.544 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.53 155.77 2.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.74 1.616 . . . . 0.0 110.003 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.24 146.65 49.0 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.726 1.617 . . . . 0.0 108.641 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -33.0 74.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.581 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -53.63 -42.5 67.84 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.976 0.807 . . . . 0.0 109.959 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.9 87.17 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -49.77 -32.09 13.04 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.317 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.62 -162.32 35.74 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.49 145.15 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -136.55 161.03 37.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 119.801 1.182 . . . . 0.0 109.178 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -80.31 108.94 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.759 0.823 . . . . 0.0 110.125 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.72 171.81 14.09 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.62 55.19 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.76 1.624 . . . . 0.0 112.831 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.01 -11.76 1.24 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.392 2.425 . . . . 0.0 113.743 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.56 -159.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 119.87 1.835 . . . . 0.0 108.828 -169.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.443 ' H ' HG11 ' A' ' 64' ' ' VAL . 5.2 tp -121.36 155.35 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.839 1.655 . . . . 0.0 109.12 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.89 139.94 15.16 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.404 1.081 . . . . 0.0 109.314 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 141.26 47.22 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.228 1.952 . . . . 0.0 109.774 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -126.09 138.03 55.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.491 1.117 . . . . 0.0 108.602 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.12 130.44 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.11 119.47 25.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.55 -18.98 64.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.135 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -33.99 70.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 121.007 1.73 . . . . 0.0 110.278 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.03 0.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.51 1.124 . . . . 0.0 109.065 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -116.29 -30.6 5.89 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.757 -1.214 . . . . 0.0 111.616 172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -136.78 0.06 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 m 54.06 50.53 16.43 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.137 1.335 . . . . 0.0 111.941 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -54.94 169.28 0.23 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.469 1.108 . . . . 0.0 112.85 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.48 -66.46 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.391 1.477 . . . . 0.0 112.108 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.24 98.14 0.35 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 0.0 109.255 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.21 139.95 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.6 137.11 15.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.964 0.905 . . . . 0.0 109.351 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -73.23 34.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.118 2.167 . . . . 0.0 113.049 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -13.37 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.182 2.193 . . . . 0.0 110.636 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.01 8.63 4.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.628 1.171 . . . . 0.0 111.827 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.59 35.97 0.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.048 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -100.31 16.77 23.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -168.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.15 157.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.009 1.277 . . . . 0.0 107.68 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.43 111.65 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 mt -84.05 143.08 12.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.02 131.7 72.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.8 mt -134.18 166.15 23.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.957 1.703 . . . . 0.0 108.272 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.63 156.05 49.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.499 0.72 . . . . 0.0 109.845 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.54 96.93 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.51 -73.22 0.77 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.511 0.596 . . . . 0.0 113.752 174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -143.31 7.14 1.54 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.951 2.1 . . . . 0.0 111.879 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -137.73 161.99 35.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.77 1.628 . . . . 0.0 108.288 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.79 151.18 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.07 170.93 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.988 1.715 . . . . 0.0 106.92 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.83 176.96 37.4 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 120.77 -1.206 . . . . 0.0 111.233 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -145.68 144.97 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.106 0.962 . . . . 0.0 109.147 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 m -89.51 133.71 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.025 0.93 . . . . 0.0 109.119 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.08 169.59 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.34 1.456 . . . . 0.0 109.83 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.84 -43.85 67.67 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 170.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.05 156.15 11.3 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 m -71.93 123.84 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -53.97 6.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 109.857 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -174.48 177.31 2.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.015 1.726 . . . . 0.0 108.533 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.46 133.38 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.158 1.783 . . . . 0.0 107.481 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.87 178.26 10.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.936 1.294 . . . . 0.0 109.397 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 m -129.94 150.55 51.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.303 0.501 . . . . 0.0 111.91 -171.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -140.49 141.7 35.34 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.413 1.485 . . . . 0.0 107.227 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.8 p -76.95 162.71 27.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.356 0.598 . . . . 0.0 109.993 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.21 7.24 1.34 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.814 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -101.9 -37.32 8.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.719 2.008 . . . . 0.0 109.131 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.53 -41.26 98.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 106.891 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -144.23 -70.99 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.463 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.41 -174.35 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.4 2.067 . . . . 0.0 111.314 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.91 55.6 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.657 1.583 . . . . 0.0 108.929 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -82.58 38.45 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 124.133 3.222 . . . . 0.0 111.053 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.18 21.0 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.381 1.472 . . . . 0.0 114.135 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -137.52 144.74 42.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.674 1.19 . . . . 0.0 110.314 -171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.11 35.94 14.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.506 1.922 . . . . 0.0 114.479 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.24 176.84 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.42 1.488 . . . . 0.0 109.074 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -9.9 50.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 113.495 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.42 153.38 43.03 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.845 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -144.97 165.86 26.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.59 1.156 . . . . 0.0 109.318 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.7 p -56.14 -28.72 59.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.169 1.388 . . . . 0.0 113.119 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.88 -29.09 67.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.572 0.749 . . . . 0.0 112.148 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -123.67 -1.12 8.51 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.226 1.011 . . . . 0.0 112.892 -168.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.27 0.9 OUTLIER -61.71 164.87 5.64 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.378 1.085 . . . . 0.0 112.937 -171.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.8 p -122.05 -159.47 0.82 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.142 1.777 . . . . 0.0 109.346 -168.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.83 23.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 168.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.53 153.62 40.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.363 1.582 . . . . 0.0 109.577 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.19 172.68 39.24 Favored Glycine 0 C--N 1.333 0.377 0 O-C-N 123.09 0.244 . . . . 0.0 113.55 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.61 153.15 17.86 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.942 0.897 . . . . 0.0 110.967 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.75 79.79 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.64 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.611 2.053 . . . . 0.0 113.31 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -156.71 -33.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.504 2.322 . . . . 0.0 110.582 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -68.92 166.41 17.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.64 0.776 . . . . 0.0 110.493 172.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.8 mmm -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 169.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.66 151.08 46.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.2 mt -110.09 120.27 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.88 104.19 16.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.64 129.89 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 126.011 1.724 . . . . 0.0 108.133 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -62.96 -28.36 70.03 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . 0.315 8.2 tp 46.31 -48.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 131.421 3.888 . . . . 0.0 116.503 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -62.62 -17.26 59.94 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.278 1.854 . . . . 0.0 113.961 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -101.93 -10.34 19.89 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 116.575 -1.679 . . . . 0.0 112.502 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.55 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.533 1.515 . . . . 0.0 111.455 -169.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.24 -29.57 64.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.613 -0.68 . . . . 0.0 110.388 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.38 -36.16 70.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.682 0.674 . . . . 0.0 111.649 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 m -91.77 -27.7 17.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.081 0.553 . . . . 0.0 111.485 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.98 -15.37 38.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.133 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.4 -36.11 77.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.196 1.816 . . . . 0.0 112.498 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -63.62 -45.78 88.71 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.744 -0.597 . . . . 0.0 109.537 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.15 87.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.122 0.569 . . . . 0.0 111.089 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.23 -64.43 0.82 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.131 1.372 . . . . 0.0 108.311 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.62 -31.26 70.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -168.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.371 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -67.8 138.06 55.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -106.02 144.16 33.14 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.96 140.21 32.67 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.03 0.932 . . . . 0.0 110.594 -169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.08 137.04 35.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 167.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.04 151.11 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 119.782 1.174 . . . . 0.0 109.066 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -139.45 150.04 44.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.466 1.106 . . . . 0.0 109.556 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -89.71 147.02 24.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.33 106.36 4.96 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.71 -80.37 0.24 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.653 1.121 . . . . 0.0 111.756 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -153.71 32.34 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.684 1.593 . . . . 0.0 110.158 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.58 162.06 36.86 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.462 1.905 . . . . 0.0 107.707 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.58 154.96 38.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.823 1.297 . . . . 0.0 111.042 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -140.86 156.28 46.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.182 2.193 . . . . 0.0 107.593 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.22 157.03 22.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.543 1.068 . . . . 0.0 111.31 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 136.34 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.97 123.56 13.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.22 -35.04 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.604 0.762 . . . . 0.0 112.822 -169.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.8 -18.71 60.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.984 1.266 . . . . 0.0 112.681 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.45 -23.32 50.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.731 0.696 . . . . 0.0 110.55 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.61 136.96 23.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -43.9 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.268 1.027 . . . . 0.0 110.26 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -159.81 170.99 20.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.0 . . . . 0.0 109.064 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.75 142.09 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -147.62 178.59 8.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.506 1.122 . . . . 0.0 108.252 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.21 165.43 15.07 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.94 128.75 38.76 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.59 -45.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -148.35 65.72 1.08 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.876 1.27 . . . . 0.0 108.907 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 37.4 t -85.07 112.13 21.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -75.88 81.98 2.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -60.77 133.7 56.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.16 151.83 8.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -30.38 66.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.81 28.34 0.85 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.96 156.83 9.25 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.458 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.52 132.93 32.65 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 84.98 0.68 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 122.755 1.264 . . . . 0.0 111.076 -170.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -167.8 -46.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.012 4.525 . . . . 0.0 102.889 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -78.37 97.06 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.116 1.766 . . . . 0.0 108.775 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -58.68 -36.03 73.53 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.58 -147.37 9.79 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.88 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 m -122.38 165.41 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.0 t -145.34 159.83 42.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.347 -1.471 . . . . 0.0 109.124 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -81.26 96.01 7.14 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.114 0.966 . . . . 0.0 111.275 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.15 164.06 13.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -74.06 58.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.493 1.042 . . . . 0.0 113.18 -169.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.39 -15.78 0.57 Allowed Glycine 0 CA--C 1.536 1.384 0 C-N-CA 127.3 2.381 . . . . 0.0 112.945 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.21 -158.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 119.302 1.551 . . . . 0.0 108.653 -169.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 tp -125.19 153.6 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.269 1.828 . . . . 0.0 108.276 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.7 139.23 14.58 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.426 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.79 146.05 82.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.33 2.02 . . . . 0.0 111.368 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 tp -130.48 132.37 64.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 124.157 0.983 . . . . 0.0 108.965 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.72 153.46 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.4 1.88 . . . . 0.0 106.629 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -131.1 128.66 40.62 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.08 -19.09 62.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.674 1.59 . . . . 0.0 111.056 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -57.32 -27.52 62.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.635 1.107 . . . . 0.0 111.568 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.82 -46.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.64 -27.74 68.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.745 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.96 1.84 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.041 1.291 . . . . 0.0 112.317 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.9 m 55.08 44.51 27.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.177 0.991 . . . . 0.0 112.091 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . 0.289 0.0 OUTLIER -54.45 148.76 11.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.114 -0.366 . . . . 0.0 111.363 176.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -37.91 -60.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 128.39 2.676 . . . . 0.0 114.337 -169.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -174.38 88.4 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.057 1.743 . . . . 0.0 108.968 -169.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.16 154.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.461 0.648 . . . . 0.0 110.882 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 83' ' ' ASN . 20.7 t0 -158.45 161.2 37.43 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.19 38.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.267 1.827 . . . . 0.0 111.375 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 81' ' ' ASP . 69.3 m-80 -151.69 -7.98 0.22 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.948 2.899 . . . . 0.0 110.282 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.34 -23.09 4.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.749 1.22 . . . . 0.0 112.664 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 34.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.666 0.787 . . . . 0.0 109.436 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 p -82.52 -13.37 56.76 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.94 153.02 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.752 1.614 . . . . 0.0 107.653 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.4 t -120.53 137.88 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 126.159 1.783 . . . . 0.0 106.326 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.77 134.66 58.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.42 136.27 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -133.38 153.56 51.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.905 1.682 . . . . 0.0 108.384 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.84 144.96 43.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.46 158.76 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 40.27 -98.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.158 1.361 . . . . 0.0 112.919 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -136.19 30.53 2.99 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.077 1.751 . . . . 0.0 110.52 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.51 178.55 8.72 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.965 -1.085 . . . . 0.0 112.256 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 p -136.82 146.32 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.473 1.509 . . . . 0.0 107.991 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.18 -178.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.636 1.574 . . . . 0.0 107.774 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.66 177.14 41.0 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 120.639 -1.288 . . . . 0.0 111.008 169.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 pt -140.22 163.21 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.11 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 m -106.82 142.1 20.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.131 0.972 . . . . 0.0 108.93 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.33 168.15 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.528 1.531 . . . . 0.0 110.019 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.42 -43.83 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.885 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.32 156.11 12.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.63 127.66 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.6 -41.88 9.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.901 0.48 . . . . 0.0 111.717 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -167.15 178.72 5.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.26 0.624 . . . . 0.0 110.576 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.4 t -136.3 125.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 pp -158.12 178.3 10.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.743 1.217 . . . . 0.0 109.677 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -129.78 150.08 51.24 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.444 0.565 . . . . 0.0 111.995 -171.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -143.32 169.31 17.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.782 1.633 . . . . 0.0 109.043 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -129.02 168.55 15.88 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.642 1.577 . . . . 0.0 109.566 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.32 -13.14 48.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.72 -33.83 75.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.603 1.092 . . . . 0.0 109.575 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -87.75 -39.6 14.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.585 1.154 . . . . 0.0 110.682 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.9 mt -91.58 101.86 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.913 0.885 . . . . 0.0 108.672 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 -143.3 -57.64 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 CA-C-O 116.624 -1.655 . . . . 0.0 113.372 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.98 175.87 3.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.951 1.767 . . . . 0.0 111.499 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.06 150.6 26.11 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.714 1.206 . . . . 0.0 109.227 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.89 44.25 1.68 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.93 3.753 . . . . 0.0 110.986 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.44 19.65 0.08 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.838 1.655 . . . . 0.0 114.053 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.5 155.85 42.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.335 1.454 . . . . 0.0 110.605 -169.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.66 33.29 10.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.525 1.93 . . . . 0.0 114.413 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.12 169.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.779 1.632 . . . . 0.0 108.858 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.98 -76.58 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.811 1.245 . . . . 0.0 109.534 172.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tp 49.71 -167.23 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.626 2.371 . . . . 0.0 113.626 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 p -155.51 145.54 21.58 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 120.976 -1.078 . . . . 0.0 110.401 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -64.41 -21.43 66.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.746 1.219 . . . . 0.0 113.91 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.69 -22.46 21.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.461 0.573 . . . . 0.0 110.464 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.31 7.82 11.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.169 0.988 . . . . 0.0 111.898 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -63.22 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.9 p 62.51 -170.91 0.17 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.5 1.92 . . . . 0.0 113.834 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -143.66 176.08 23.25 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 169.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.11 143.22 38.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.44 161.97 32.07 Favored Glycine 0 CA--C 1.519 0.321 0 O-C-N 123.61 0.569 . . . . 0.0 112.442 170.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.16 153.85 17.46 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 110.313 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.75 85.05 1.87 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.41 -52.79 2.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.622 2.058 . . . . 0.0 112.804 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.52 -30.31 0.1 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.034 2.134 . . . . 0.0 111.215 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -67.67 161.67 25.35 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.809 0.844 . . . . 0.0 108.993 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 76.8 mmm -127.44 140.53 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.34 135.21 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.31 106.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.72 111.18 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.2 m -65.93 143.05 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.84 59.29 4.75 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.8 0.727 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.51 -52.62 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.68 2.392 . . . . 0.0 113.511 -168.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.08 11.44 1.82 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.696 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -135.76 20.51 3.3 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.579 1.552 . . . . 0.0 110.499 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.05 -98.33 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.86 -29.03 65.04 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.606 -1.309 . . . . 0.0 109.92 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -62.27 -15.72 49.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.4 m -124.93 5.54 8.01 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 112.029 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -122.79 2.58 9.46 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.016 0.927 . . . . 0.0 112.952 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.75 -38.99 90.02 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 119.796 -1.815 . . . . 0.0 112.312 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -62.43 -36.1 81.34 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.285 0.634 . . . . 0.0 110.566 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.21 -38.13 66.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.771 0.829 . . . . 0.0 111.08 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.27 -61.9 2.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.829 1.252 . . . . 0.0 109.126 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.64 -29.6 69.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.441 -168.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.309 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.422 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -136.89 164.0 29.35 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.531 1.932 . . . . 0.0 110.414 -169.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -110.87 149.84 30.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -141.97 134.62 28.36 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.065 0.946 . . . . 0.0 109.33 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.4 tp -74.94 139.05 42.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.82 146.54 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.691 1.132 . . . . 0.0 108.795 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -140.81 150.19 43.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.413 1.085 . . . . 0.0 110.261 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -91.02 142.6 27.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -133.24 90.92 2.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.14 -71.71 0.31 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.18 1.848 . . . . 0.0 112.222 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.62 28.66 0.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.215 1.406 . . . . 0.0 111.164 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.72 162.41 34.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.611 1.564 . . . . 0.0 108.053 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.58 150.76 45.58 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.598 1.189 . . . . 0.0 110.098 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -140.49 156.86 46.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.97 2.108 . . . . 0.0 107.506 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.9 158.1 22.72 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.589 1.09 . . . . 0.0 111.463 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 mt -144.89 133.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -48.12 115.88 1.34 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.896 1.278 . . . . 0.0 109.584 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -53.94 -39.27 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -168.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.63 -17.14 64.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.319 0.963 . . . . 0.0 112.784 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -74.2 -24.26 59.33 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.537 0.608 . . . . 0.0 110.588 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.29 138.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 119.463 1.028 . . . . 0.0 108.723 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -102.15 -57.44 2.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.858 0.863 . . . . 0.0 109.293 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -160.69 174.62 13.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.581 1.152 . . . . 0.0 108.768 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.47 139.01 46.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -141.76 179.31 6.92 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.742 1.617 . . . . 0.0 107.856 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.92 161.5 14.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -56.44 131.18 47.74 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -155.14 -46.96 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.61 81.5 1.29 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.048 0.939 . . . . 0.0 109.525 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 115.67 32.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 90.32 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 173.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 118.87 10.95 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mm -81.95 -38.46 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.7 13.66 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.851 2.06 . . . . 0.0 114.798 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.93 13.91 2.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.525 2.33 . . . . 0.0 110.233 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.66 170.79 7.35 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 130.024 3.33 . . . . 0.0 110.333 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.94 -38.53 37.6 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.968 1.779 . . . . 0.0 112.134 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 139.42 170.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.657 4.383 . . . . 0.0 106.885 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 68.12 -53.72 0.52 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 128.137 2.575 . . . . 0.0 109.346 -169.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -72.75 82.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.326 2.25 . . . . 0.0 110.209 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -56.07 -36.59 68.28 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 109.725 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.48 -173.38 36.99 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.024 -1.56 . . . . 0.0 115.112 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.77 119.43 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -89.66 146.84 24.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.757 1.623 . . . . 0.0 110.033 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -62.02 101.58 0.22 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -78.79 64.89 3.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.161 1.384 . . . . 0.0 107.834 169.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 43.35 36.96 1.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.443 2.297 . . . . 0.0 112.72 170.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.44 -23.39 4.05 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.013 1.292 . . . . 0.0 112.981 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -160.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.327 1.851 . . . . 0.0 106.692 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.86 146.77 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.878 1.217 . . . . 0.0 112.398 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.12 132.5 13.64 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.049 0.94 . . . . 0.0 108.685 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.55 142.01 69.48 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 CA-C-N 121.249 1.482 . . . . 0.0 110.207 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -128.16 132.62 68.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 152.95 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.555 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -103.88 119.91 39.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.172 1.389 . . . . 0.0 107.945 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.93 -7.18 49.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.319 -0.848 . . . . 0.0 113.01 -170.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ttt85 -69.56 -38.15 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 121.338 1.881 . . . . 0.0 108.202 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.88 -17.73 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 0.0 110.497 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -122.46 -29.11 4.15 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.777 1.172 . . . . 0.0 113.698 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -131.72 15.32 4.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.787 1.176 . . . . 0.0 112.72 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 m 58.93 28.97 18.3 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.53 1.132 . . . . 0.0 113.113 171.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -48.51 140.92 7.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.383 0.673 . . . . 0.0 109.246 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.07 -54.15 27.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 125.301 1.44 . . . . 0.0 111.377 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -165.43 82.58 0.34 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.593 1.157 . . . . 0.0 108.423 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.3 114.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -153.21 148.98 27.51 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.368 1.067 . . . . 0.0 109.085 -175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.81 45.82 0.73 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.683 1.593 . . . . 0.0 111.944 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.82 -17.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.397 2.279 . . . . 0.0 111.284 169.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.93 -3.31 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.698 1.199 . . . . 0.0 112.178 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.58 38.03 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -85.3 -7.55 58.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.516 2.327 . . . . 0.0 117.177 -168.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.39 152.72 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 120.693 1.588 . . . . 0.0 107.911 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.17 111.99 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -87.52 142.78 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.82 134.65 63.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 mt -134.32 160.23 38.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 108.817 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 152.16 46.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.491 1.517 . . . . 0.0 107.479 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.8 130.69 13.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.89 -83.2 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.211 1.386 . . . . 0.0 113.162 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -142.19 12.48 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.337 1.855 . . . . 0.0 111.704 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -143.98 166.8 23.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.403 1.081 . . . . 0.0 110.315 -169.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.62 151.88 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.737 1.215 . . . . 0.0 109.836 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.02 177.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.057 1.743 . . . . 0.0 106.939 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.31 173.93 39.52 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 120.494 -1.379 . . . . 0.0 110.628 170.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.3 pt -142.81 145.3 23.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 108.792 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.46 135.75 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.767 0.827 . . . . 0.0 109.047 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.84 169.79 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.872 1.269 . . . . 0.0 110.091 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 -42.04 65.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.81 160.36 19.11 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.34 135.83 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.61 -42.19 6.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.95 0.9 . . . . 0.0 111.161 -173.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -168.94 -177.37 2.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.72 125.91 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -140.26 173.94 11.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.091 1.356 . . . . 0.0 109.382 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 m -129.18 138.71 51.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.153 0.888 . . . . 0.0 110.797 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -145.86 163.53 34.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.9 1.28 . . . . 0.0 110.229 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 m -141.76 174.07 10.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.382 2.273 . . . . 0.0 107.133 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.04 1.59 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.72 -51.01 8.62 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.859 -1.151 . . . . 0.0 108.04 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -70.85 -43.12 69.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.613 1.165 . . . . 0.0 110.157 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.43 116.29 33.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -142.19 -66.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 116.395 -1.765 . . . . 0.0 110.8 -171.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.8 -175.69 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.105 1.87 . . . . 0.0 111.099 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.7 154.41 31.47 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.902 1.681 . . . . 0.0 107.715 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.51 42.21 1.29 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.839 3.026 . . . . 0.0 110.987 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.17 -19.7 3.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -140.74 34.6 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.936 0.894 . . . . 0.0 110.669 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.13 19.57 2.79 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 172.36 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.592 1.957 . . . . 0.0 108.788 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 2.82 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.368 1.867 . . . . 0.0 113.75 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.14 164.6 15.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.211 2.204 . . . . 0.0 112.685 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.4 m -137.12 159.28 42.36 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.554 1.542 . . . . 0.0 108.924 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 p -61.35 -20.45 63.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.535 . . . . 0.0 113.434 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -70.09 -36.18 74.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.3 13.12 19.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.431 1.092 . . . . 0.0 109.68 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 121.43 9.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.37 1.068 . . . . 0.0 110.862 -169.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.44 HG21 ' H ' ' A' ' 146' ' ' ASN . 58.6 p -81.24 -162.22 0.48 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.991 2.517 . . . . 0.0 110.518 -175.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.53 174.86 21.08 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.88 141.96 44.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.05 177.71 32.14 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.37 156.04 47.98 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.379 1.071 . . . . 0.0 109.711 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.5 mt -141.78 77.87 1.61 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.706 1.603 . . . . 0.0 107.272 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.31 -52.28 3.38 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.512 2.005 . . . . 0.0 112.624 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.64 -29.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.398 1.879 . . . . 0.0 111.637 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -69.38 157.13 37.65 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mtp -136.0 153.69 51.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.095 170.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -145.51 135.86 24.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.4 mt -97.67 118.43 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.83 105.53 17.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.68 120.37 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.626 1.17 . . . . 0.0 107.918 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.44 ' H ' HG21 ' A' ' 132' ' ' THR . 27.2 t30 -75.62 66.2 1.93 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.966 0.889 . . . . 0.0 109.902 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tp -57.6 -35.89 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.567 1.147 . . . . 0.0 110.801 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.62 -18.84 65.62 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -114.15 -2.74 13.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.971 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.74 -75.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.971 1.308 . . . . 0.0 109.652 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.02 -28.53 63.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.887 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.39 -34.42 61.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.056 0.942 . . . . 0.0 111.83 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -103.77 -19.62 14.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.78 0.832 . . . . 0.0 111.73 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.55 -18.8 32.33 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.421 -0.799 . . . . 0.0 111.796 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.5 -35.82 76.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.94 1.245 . . . . 0.0 111.968 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.7 mtm -63.82 -41.1 97.93 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 109.952 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.84 -43.16 72.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.916 0.487 . . . . 0.0 110.459 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.63 -58.93 5.21 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.718 1.207 . . . . 0.0 109.647 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -18.37 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 170.415 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.721 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -56.97 135.28 56.16 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -110.44 144.91 38.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -140.6 139.95 35.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.692 0.797 . . . . 0.0 109.554 -169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.33 134.01 35.25 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 168.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.61 148.79 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 119.274 0.943 . . . . 0.0 109.164 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -144.21 150.1 37.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.54 1.136 . . . . 0.0 109.506 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -86.71 148.0 25.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -143.42 111.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.495 1.518 . . . . 0.0 106.92 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -84.77 0.19 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.308 0.956 . . . . 0.0 111.398 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.21 32.17 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.114 1.366 . . . . 0.0 110.377 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -144.08 161.05 39.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.149 1.379 . . . . 0.0 108.236 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -118.58 150.4 39.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.648 1.213 . . . . 0.0 109.256 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.91 158.3 44.3 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.897 2.079 . . . . 0.0 107.142 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.28 24.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.856 0.741 . . . . 0.0 111.551 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mt -140.21 137.33 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.62 124.2 14.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.44 0.564 . . . . 0.0 109.708 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.99 -33.61 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.61 0.764 . . . . 0.0 112.5 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.46 -23.6 65.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.965 0.802 . . . . 0.0 111.961 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.79 -21.95 40.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.626 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.92 137.75 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.53 -43.23 2.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.759 1.223 . . . . 0.0 109.246 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -160.98 172.94 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 108.289 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.4 138.45 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -145.81 168.38 20.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.195 1.398 . . . . 0.0 107.552 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.06 164.7 27.5 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -70.1 3.88 2.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.088 1.355 . . . . 0.0 114.37 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -22.18 3.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.148 1.779 . . . . 0.0 115.714 -169.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.31 49.11 1.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.546 1.067 . . . . 0.0 112.64 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.95 110.79 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 90.45 5.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 27.0 tpt180 -67.87 110.67 3.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 mm -71.24 156.39 7.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.79 -24.58 65.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.7 p30 -145.98 22.63 1.39 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.494 1.117 . . . . 0.0 113.927 -169.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.445 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -64.03 153.74 84.05 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.28 151.33 83.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.852 1.701 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.46 75.67 4.01 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 122.097 0.951 . . . . 0.0 109.977 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -163.88 -46.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 130.613 3.565 . . . . 0.0 103.919 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.92 90.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 108.027 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -52.99 -27.83 21.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.158 0.983 . . . . 0.0 110.516 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.13 -168.69 40.54 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.905 1.229 . . . . 0.0 112.106 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.97 114.76 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -85.5 135.57 33.78 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.763 1.625 . . . . 0.0 109.049 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.39 91.48 3.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.46 174.04 2.38 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 169.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -68.86 52.59 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.417 2.287 . . . . 0.0 113.597 -169.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.34 -8.58 1.89 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.361 2.41 . . . . 0.0 113.512 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.451 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.96 -164.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 119.565 1.683 . . . . 0.0 108.848 -169.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.451 ' H ' HG11 ' A' ' 64' ' ' VAL . 5.5 tp -122.74 156.14 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.466 1.906 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.98 135.42 9.44 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.437 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.82 140.01 59.55 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 121.274 1.491 . . . . 0.0 110.451 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.96 130.87 73.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.25 158.64 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -121.57 121.51 37.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.97 -22.37 66.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HG3' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.29 -24.03 67.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.862 1.665 . . . . 0.0 111.785 170.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.34 -48.6 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.97 -18.25 65.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -132.13 -3.92 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.509 1.504 . . . . 0.0 112.636 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.5 m 50.08 37.41 14.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.29 1.036 . . . . 0.0 111.595 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -66.45 100.57 0.66 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.991 1.317 . . . . 0.0 109.439 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 t 39.15 -115.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 126.809 2.044 . . . . 0.0 108.733 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -158.0 100.07 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.25 1.42 . . . . 0.0 107.253 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.407 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 20.2 m -68.42 176.95 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 111.225 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 83' ' ' ASN . 21.1 t0 -149.24 169.67 20.24 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.678 1.591 . . . . 0.0 108.917 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.36 43.3 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.638 1.975 . . . . 0.0 111.646 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 81' ' ' ASP . 59.0 m-80 -152.89 -6.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.649 3.179 . . . . 0.0 109.978 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.12 12.53 1.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.766 1.626 . . . . 0.0 111.3 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.72 25.47 0.57 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.108 2.563 . . . . 0.0 108.648 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.5 p -97.66 -2.43 41.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.4 t -110.67 160.45 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.6 t -138.29 132.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.0 mt -104.8 129.27 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.33 141.6 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -134.24 160.52 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.604 1.562 . . . . 0.0 108.852 -169.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.76 146.74 38.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.515 1.126 . . . . 0.0 108.196 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -159.6 143.82 14.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.22 5.28 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 119.414 1.006 . . . . 0.0 114.581 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 56.86 35.25 26.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.3 1.44 . . . . 0.0 113.628 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.94 173.91 11.04 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.696 1.598 . . . . 0.0 109.151 169.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.21 152.47 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.705 0.802 . . . . 0.0 110.576 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.89 -175.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 106.355 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.04 -179.1 42.75 Favored Glycine 0 N--CA 1.448 -0.527 0 O-C-N 120.495 -1.378 . . . . 0.0 109.67 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 pt -141.94 144.49 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.844 0.457 . . . . 0.0 110.532 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.86 145.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 169.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.82 167.72 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.589 1.956 . . . . 0.0 108.547 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.02 -45.48 63.86 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.667 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.48 151.9 8.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.4 142.43 16.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 m -124.16 -26.96 3.91 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -168.71 178.74 4.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.653 1.115 . . . . 0.0 110.475 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.17 120.88 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.86 167.23 22.59 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.12 0.968 . . . . 0.0 110.291 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -128.07 138.15 52.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.77 0.428 . . . . 0.0 110.722 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.92 165.9 26.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 107.552 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.76 161.29 29.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -18.25 53.95 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.463 -0.773 . . . . 0.0 112.953 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.66 -36.74 83.27 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.986 -1.071 . . . . 0.0 110.45 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -76.69 -42.25 42.33 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.061 0.945 . . . . 0.0 109.848 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.78 88.91 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.203 1.001 . . . . 0.0 108.58 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -139.53 -55.32 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.981 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.55 175.27 4.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.716 1.611 . . . . 0.0 111.315 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.93 157.3 30.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.848 1.259 . . . . 0.0 109.723 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.36 59.83 6.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.354 3.369 . . . . 0.0 110.048 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.39 1.4 11.79 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -148.16 160.35 43.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.369 0.986 . . . . 0.0 110.948 -172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.25 34.87 21.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.034 2.133 . . . . 0.0 114.24 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.0 161.98 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.135 1.374 . . . . 0.0 109.006 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -10.09 58.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.089 1.356 . . . . 0.0 113.426 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.2 tp -52.75 125.78 17.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.68 1.592 . . . . 0.0 113.806 -169.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -63.78 148.53 49.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 111.026 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.2 p -76.92 -16.07 59.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.982 0.913 . . . . 0.0 113.109 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -94.45 -43.07 8.53 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -80.59 7.3 10.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.76 1.224 . . . . 0.0 110.699 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.85 118.34 5.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p -69.96 -177.27 1.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.782 2.433 . . . . 0.0 110.838 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -123.39 179.17 16.21 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 mt -136.45 147.56 47.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.673 1.589 . . . . 0.0 106.878 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.35 171.26 34.62 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.17 154.19 31.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.118 0.967 . . . . 0.0 109.972 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.06 81.71 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.411 1.485 . . . . 0.0 107.052 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 -47.94 2.0 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.662 2.077 . . . . 0.0 113.672 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.53 -36.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.3 2.24 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -71.51 167.19 20.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.759 0.79 . . . . 0.0 110.056 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.0 mtp -135.13 154.79 51.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -136.75 138.22 40.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.7 mt -87.86 113.74 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.88 107.46 14.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.36 120.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.211 1.404 . . . . 0.0 107.909 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -76.72 63.89 2.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.705 0.764 . . . . 0.0 110.27 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.58 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.396 1.478 . . . . 0.0 111.321 -172.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.49 -4.19 14.16 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -126.94 22.97 6.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.558 1.143 . . . . 0.0 110.839 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 -95.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.57 -35.62 81.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.985 -1.072 . . . . 0.0 110.112 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.16 -30.51 49.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.141 0.977 . . . . 0.0 113.051 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.5 m -114.7 -1.97 13.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.21 -9.14 11.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.771 -1.109 . . . . 0.0 113.195 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -52.66 -42.95 65.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.901 1.682 . . . . 0.0 112.168 -172.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.3 ptp -59.65 -27.56 66.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.02 1.328 . . . . 0.0 113.338 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.83 -33.48 12.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.093 1.357 . . . . 0.0 111.242 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.95 -60.12 4.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.488 1.115 . . . . 0.0 109.318 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -29.06 68.14 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.522 -169.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 124.344 1.058 . . . . 0.0 112.725 179.068 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -65.22 151.0 47.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.252 1.421 . . . . 0.0 108.247 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.1 143.53 44.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -142.39 136.89 30.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.504 0.722 . . . . 0.0 110.272 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.74 135.87 36.62 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 167.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.16 149.49 31.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 109.098 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -146.11 151.97 38.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.255 1.022 . . . . 0.0 110.242 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.5 m -86.93 146.39 26.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.438 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -137.23 103.23 5.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.95 -86.86 0.17 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.958 0.789 . . . . 0.0 111.575 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.02 31.02 0.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.239 1.416 . . . . 0.0 110.376 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.66 159.2 42.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.711 1.605 . . . . 0.0 107.566 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -122.71 149.65 43.79 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.206 1.479 . . . . 0.0 110.785 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -137.92 161.56 36.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 107.621 -169.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.64 163.95 26.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.845 0.748 . . . . 0.0 112.145 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mt -142.75 138.04 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -48.04 114.59 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.169 . . . . 0.0 109.357 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -54.84 -34.12 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.968 0.907 . . . . 0.0 111.594 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.75 -23.87 67.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.717 0.807 . . . . 0.0 112.618 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -82.64 -19.0 39.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.948 0.794 . . . . 0.0 112.069 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.29 125.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -80.83 -57.58 3.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.02 -178.29 5.53 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.625 1.57 . . . . 0.0 108.537 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.34 141.71 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -143.4 -155.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.925 1.29 . . . . 0.0 108.186 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.15 161.84 26.41 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.33 136.09 57.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -160.3 -51.82 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.45 0.7 . . . . 0.0 110.27 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -157.63 73.06 0.69 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.173 1.389 . . . . 0.0 107.926 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.42 103.44 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 168.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.46 84.9 4.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 29.3 tpt180 -70.06 118.13 12.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.97 -24.06 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 118.222 0.464 . . . . 0.0 110.287 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.11 20.92 3.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.002 1.721 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -142.47 41.08 1.6 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.777 2.831 . . . . 0.0 105.127 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.478 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -148.88 151.18 34.42 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 109.096 -168.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.16 156.33 55.89 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.132 1.888 . . . . 0.0 108.846 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.64 -25.55 64.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -53.43 -50.33 65.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.427 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.7 mt -77.17 82.03 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -60.8 -27.39 67.99 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.562 -0.711 . . . . 0.0 110.069 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -166.45 34.81 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.903 0.774 . . . . 0.0 111.302 169.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.92 121.2 66.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -99.93 131.17 46.06 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.742 1.217 . . . . 0.0 110.739 -168.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -63.24 136.33 57.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.0 102.45 4.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 169.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.31 34.38 14.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.393 1.077 . . . . 0.0 113.139 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 9.39 55.56 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.035 0.826 . . . . 0.0 113.432 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 65' ' ' ILE . 1.6 t -131.8 -176.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 127.0 2.12 . . . . 0.0 106.816 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 64' ' ' VAL . 3.9 tp -136.82 159.07 37.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.831 1.253 . . . . 0.0 109.939 -173.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.18 140.47 13.75 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.09 132.21 23.9 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 N-CA-C 106.833 -2.026 . . . . 0.0 106.833 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -111.87 140.14 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.54 172.21 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -132.51 117.8 18.46 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.93 -24.86 67.65 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.363 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -66.46 -25.53 66.77 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 120.075 1.307 . . . . 0.0 111.687 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.7 mm -71.43 -50.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 120.053 1.297 . . . . 0.0 107.545 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -64.91 -16.93 63.87 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.94 1.81 9.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.653 1.181 . . . . 0.0 112.542 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m 47.59 38.15 7.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.579 1.152 . . . . 0.0 111.505 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.21 29.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.502 1.121 . . . . 0.0 110.681 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t 33.62 -109.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.6 2.36 . . . . 0.0 112.178 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -172.02 111.58 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.031 2.132 . . . . 0.0 105.888 -172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -56.31 160.41 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.963 0.905 . . . . 0.0 111.462 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -153.28 149.88 28.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.219 1.008 . . . . 0.0 108.305 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.18 38.21 0.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.643 1.977 . . . . 0.0 113.163 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.14 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.099 2.16 . . . . 0.0 110.747 169.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.11 6.72 5.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.854 1.262 . . . . 0.0 111.658 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.34 28.86 0.4 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.705 -1.247 . . . . 0.0 110.343 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 p -94.05 15.17 17.66 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -167.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.84 150.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.417 1.462 . . . . 0.0 107.144 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 m -119.61 135.1 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 119.691 1.132 . . . . 0.0 109.963 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -98.94 128.7 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.84 133.42 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -133.65 166.43 22.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.505 1.522 . . . . 0.0 109.617 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -139.93 154.83 47.33 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.89 0.876 . . . . 0.0 109.439 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -137.09 83.74 2.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.82 -68.66 1.9 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.057 0.837 . . . . 0.0 112.91 169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.04 2.25 2.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.804 1.642 . . . . 0.0 112.42 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 166.27 21.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.631 1.105 . . . . 0.0 110.189 174.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.81 154.5 34.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.697 1.199 . . . . 0.0 108.842 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.33 169.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.86 175.41 30.63 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 120.82 -1.175 . . . . 0.0 110.164 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 pt -135.48 140.85 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.17 135.7 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.486 0.714 . . . . 0.0 109.084 170.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 m -141.65 166.17 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.039 1.735 . . . . 0.0 108.862 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.17 -43.97 69.72 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.233 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.23 10.63 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.18 127.6 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.2 -53.69 7.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.226 0.61 . . . . 0.0 109.673 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -175.26 -176.63 0.95 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.003 1.721 . . . . 0.0 108.166 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.9 132.35 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -134.63 175.96 9.06 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.787 1.635 . . . . 0.0 108.192 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 m -133.33 143.66 49.14 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.53 141.34 33.57 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 158.9 15.56 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.445 1.098 . . . . 0.0 108.308 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.64 26.37 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.7 -31.13 63.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.937 1.295 . . . . 0.0 111.065 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.79 -39.65 30.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.375 1.47 . . . . 0.0 110.482 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.75 113.81 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.6 ttp-105 -155.2 -56.96 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 116.708 -1.615 . . . . 0.0 112.312 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.82 178.22 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.701 1.601 . . . . 0.0 111.567 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.81 156.01 29.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.43 1.492 . . . . 0.0 109.567 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.38 59.71 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.684 3.589 . . . . 0.0 111.574 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.66 31.29 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.149 1.779 . . . . 0.0 112.906 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.51 171.28 9.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.164 1.386 . . . . 0.0 110.418 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.22 30.74 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.767 1.627 . . . . 0.0 113.38 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.77 177.43 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.42 1.488 . . . . 0.0 110.119 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -9.13 15.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.425 1.49 . . . . 0.0 113.789 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.57 142.34 55.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.0 m -143.46 163.36 33.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 110.114 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -53.98 -31.54 51.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.884 1.673 . . . . 0.0 115.222 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -69.63 -26.07 64.24 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.455 1.025 . . . . 0.0 112.808 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.2 9.9 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.276 0.631 . . . . 0.0 112.597 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.11 154.73 12.35 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 118.382 0.537 . . . . 0.0 110.126 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.8 p -107.34 172.73 6.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.342 1.457 . . . . 0.0 109.335 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.39 -179.62 29.74 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.0 145.19 32.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 168.78 32.65 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.55 154.69 25.56 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.696 0.799 . . . . 0.0 109.517 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.31 80.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -174.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.42 -57.2 2.01 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.924 2.202 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -148.96 -24.91 0.3 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.315 2.246 . . . . 0.0 111.939 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -71.72 165.8 23.29 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.9 mtp -141.46 142.2 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -133.77 123.54 25.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 mt -77.42 112.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 170.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.52 108.36 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.02 128.35 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.792 1.637 . . . . 0.0 108.098 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -79.17 60.0 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.687 1.195 . . . . 0.0 110.191 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 149' ' ' LYS . 8.6 tp -59.84 168.67 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.821 0.848 . . . . 0.0 108.866 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.67 -18.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.136 1.775 . . . . 0.0 113.009 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' ILE . 18.0 mmmt -109.67 -33.56 6.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.09 -1.433 . . . . 0.0 111.38 169.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -48.65 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.528 1.531 . . . . 0.0 112.205 -170.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 tp -71.36 -25.96 62.6 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.176 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -56.78 -29.4 62.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.253 0.933 . . . . 0.0 112.136 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -114.82 -3.34 12.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.234 1.414 . . . . 0.0 111.678 -173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.08 2.35 19.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.534 1.534 . . . . 0.0 111.739 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.54 -44.86 77.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.444 1.098 . . . . 0.0 111.343 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.11 -37.79 88.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.003 0.921 . . . . 0.0 111.082 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 -37.25 72.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.644 0.778 . . . . 0.0 111.273 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.77 -55.1 33.71 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.06 -28.84 69.36 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.645 0.778 . . . . 0.0 112.118 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 123.675 0.79 . . . . 0.0 112.478 -177.78 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -80.76 153.1 27.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.512 1.525 . . . . 0.0 108.724 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.02 142.52 49.73 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -142.65 143.01 32.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.348 0.659 . . . . 0.0 111.608 -169.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -83.79 133.56 34.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 167.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.98 152.08 25.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 119.875 1.216 . . . . 0.0 109.514 -174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -146.55 153.76 40.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.379 1.072 . . . . 0.0 110.46 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.6 m -90.07 147.15 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.2 tp -144.97 105.59 4.12 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.512 1.525 . . . . 0.0 107.468 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.54 -77.68 0.61 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.146 1.355 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -153.45 22.97 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.061 1.344 . . . . 0.0 112.084 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.48 160.33 40.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.175 1.39 . . . . 0.0 108.555 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -120.17 150.35 40.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.911 1.339 . . . . 0.0 110.449 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -140.12 159.49 42.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.564 1.946 . . . . 0.0 108.029 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.18 160.31 23.88 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.487 1.041 . . . . 0.0 111.092 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -140.62 139.2 35.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -50.07 115.51 1.44 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.946 0.899 . . . . 0.0 109.667 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -54.13 -33.99 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.373 1.069 . . . . 0.0 112.212 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.5 -24.97 68.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.805 0.842 . . . . 0.0 112.988 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -79.85 -18.53 50.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.024 0.829 . . . . 0.0 112.22 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.93 139.75 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.385 0.674 . . . . 0.0 109.235 -175.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -103.17 -57.96 1.95 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.451 1.1 . . . . 0.0 108.722 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.02 178.73 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.484 1.114 . . . . 0.0 109.556 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.43 144.15 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -147.66 168.71 21.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.472 1.909 . . . . 0.0 107.146 -169.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.46 -178.0 52.12 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.089 -1.007 . . . . 0.0 111.411 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -124.08 93.39 3.91 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.511 1.525 . . . . 0.0 106.942 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.49 -43.76 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.549 1.139 . . . . 0.0 109.678 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -74.07 29.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.456 1.902 . . . . 0.0 114.13 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.63 157.49 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.041 0.936 . . . . 0.0 110.878 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.7 m -141.93 148.72 39.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.381 2.672 . . . . 0.0 104.576 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -146.63 142.97 28.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.324 1.42 . . . . 0.0 109.642 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -64.76 140.53 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.11 -26.33 26.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -169.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -139.29 37.83 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.767 1.627 . . . . 0.0 112.422 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -55.72 152.49 18.91 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.71 147.59 81.62 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 N-CA-C 106.163 -2.283 . . . . 0.0 106.163 167.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.35 32.48 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -61.24 -39.47 90.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.247 0.931 . . . . 0.0 110.806 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.37 80.93 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -60.73 -14.07 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.09 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.5 -141.25 9.12 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 120.579 1.536 . . . . 0.0 114.158 168.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 166.19 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 128.374 2.669 . . . . 0.0 105.144 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 t -147.96 151.23 35.45 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.507 -1.371 . . . . 0.0 110.33 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.46 112.8 15.87 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.488 0.715 . . . . 0.0 110.78 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.38 91.74 8.27 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.59 21.67 0.93 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.089 1.756 . . . . 0.0 115.417 169.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.7 5.55 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.515 1.052 . . . . 0.0 114.079 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.81 -172.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.75 1.62 . . . . 0.0 107.55 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tp -129.41 152.59 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 120.132 1.333 . . . . 0.0 110.844 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.61 142.55 18.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.32 151.74 84.22 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.691 1.594 . . . . 0.0 111.777 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tp -125.55 134.96 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.89 142.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -103.53 113.01 26.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.47 -170.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.52 -27.09 65.87 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.112 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -55.12 -46.22 75.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.019 0.827 . . . . 0.0 109.753 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.86 -38.78 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -64.73 -28.35 69.53 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.442 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.31 2.23 10.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.666 0.786 . . . . 0.0 112.725 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m 50.34 48.25 22.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.433 1.093 . . . . 0.0 111.551 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -174.99 0.3 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 111.148 175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.21 173.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.878 1.271 . . . . 0.0 110.949 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -80.78 65.61 5.99 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.589 2.356 . . . . 0.0 110.073 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 m -51.0 157.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.906 1.282 . . . . 0.0 112.744 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -151.53 176.11 11.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.9 1.68 . . . . 0.0 110.548 -171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -67.96 49.85 0.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.366 2.267 . . . . 0.0 110.686 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -149.72 -30.48 0.23 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.338 2.655 . . . . 0.0 109.986 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -141.9 19.22 2.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.127 1.371 . . . . 0.0 111.832 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -142.82 16.75 1.96 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.799 2.039 . . . . 0.0 110.484 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -73.56 3.29 6.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.631 2.772 . . . . 0.0 116.309 -168.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.04 157.45 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 119.781 1.173 . . . . 0.0 108.043 -175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.3 t -132.81 133.62 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.059 2.144 . . . . 0.0 107.632 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -99.99 134.14 40.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.293 -2.855 . . . . 0.0 103.293 168.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.91 134.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.5 mt -134.44 167.47 20.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.572 1.549 . . . . 0.0 108.703 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.04 153.4 42.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.08 141.95 20.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 170.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.36 0.02 OUTLIER Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.063 1.315 . . . . 0.0 112.148 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -146.29 9.12 1.08 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.832 1.653 . . . . 0.0 111.521 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 164.28 24.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.773 -1.204 . . . . 0.0 110.68 -173.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.46 149.73 26.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.195 1.398 . . . . 0.0 108.567 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.12 162.24 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.28 167.08 24.83 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.62 135.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.18 144.31 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -148.13 165.83 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.547 1.939 . . . . 0.0 108.315 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.37 -42.78 74.73 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.248 -0.908 . . . . 0.0 110.03 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.93 157.97 11.59 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.26 122.19 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.79 -48.43 18.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.254 0.622 . . . . 0.0 111.039 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.94 -179.78 2.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.724 1.21 . . . . 0.0 109.692 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.3 t -127.48 126.86 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.88 178.07 10.68 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.892 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.1 m -130.44 148.73 52.28 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.166 0.587 . . . . 0.0 111.053 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -143.07 143.19 31.76 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.9 p -82.84 164.92 20.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.352 0.596 . . . . 0.0 111.37 174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 14.61 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.719 1.208 . . . . 0.0 113.376 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.25 -38.49 3.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.228 1.811 . . . . 0.0 109.512 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.66 -39.5 88.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.97 121.91 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.66 1.984 . . . . 0.0 106.988 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -150.83 -56.33 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 117.088 -1.434 . . . . 0.0 110.61 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.78 178.35 2.33 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.889 2.392 . . . . 0.0 112.704 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.05 33.48 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.254 1.421 . . . . 0.0 109.415 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -80.98 50.42 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.086 3.191 . . . . 0.0 110.441 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.5 21.21 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.521 1.529 . . . . 0.0 114.424 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -148.86 152.39 36.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.844 1.658 . . . . 0.0 109.377 -169.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.31 40.14 17.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.734 . . . . 0.0 114.008 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.2 157.94 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.861 1.265 . . . . 0.0 109.396 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -15.69 61.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.194 1.397 . . . . 0.0 112.376 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 155.85 1.0 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.378 2.271 . . . . 0.0 112.22 176.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.5 m -130.38 156.21 45.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 110.261 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -60.05 -35.28 74.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -76.98 -15.56 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.123 1.329 . . . . 0.0 112.75 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -126.39 25.4 6.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.94 138.93 57.71 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.1 p -75.41 -174.45 2.43 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.32 1.848 . . . . 0.0 109.989 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.46 175.48 20.17 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.39 155.78 42.28 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.041 1.421 . . . . 0.0 109.506 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.38 179.82 29.43 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 123.696 0.665 . . . . 0.0 111.958 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.86 158.48 39.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -169.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.51 60.14 1.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.107 2.163 . . . . 0.0 107.463 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.25 2.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.22 1.867 . . . . 0.0 113.199 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.87 -32.35 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.73 2.012 . . . . 0.0 110.39 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -68.92 154.56 41.82 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.7 mtp -143.77 143.71 31.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.895 1.678 . . . . 0.0 106.496 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -137.01 140.48 42.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 92.4 mt -96.34 112.42 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.49 110.22 19.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.52 130.43 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.511 1.124 . . . . 0.0 108.277 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -79.98 60.61 3.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.022 1.329 . . . . 0.0 109.408 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.99 -37.14 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.514 1.126 . . . . 0.0 111.78 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.15 -26.78 68.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.374 0.534 . . . . 0.0 112.409 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -106.54 -17.47 14.24 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.856 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -50.35 -73.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.495 1.498 . . . . 0.0 110.858 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.3 tp -74.37 -26.51 60.16 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.31 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -63.56 -31.12 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.849 1.204 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -84.1 -27.59 28.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.872 0.869 . . . . 0.0 111.559 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.31 6.42 20.48 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -51.21 -48.9 61.92 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.991 1.316 . . . . 0.0 111.074 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -28.27 69.97 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.512 0.725 . . . . 0.0 112.554 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.08 -42.67 23.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.666 0.786 . . . . 0.0 110.593 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.43 -46.05 91.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.997 0.817 . . . . 0.0 109.547 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.93 -12.96 61.18 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.143 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 120.038 1.29 . . . . 0.0 111.507 177.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.45 165.93 11.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.239 1.016 . . . . 0.0 111.234 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.63 -59.1 0.51 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -145.51 159.16 43.52 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.545 1.538 . . . . 0.0 108.26 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m 52.42 39.27 27.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.894 1.278 . . . . 0.0 112.5 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -77.69 43.86 0.43 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.343 1.057 . . . . 0.0 111.353 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.1 m -60.01 -23.64 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.859 1.264 . . . . 0.0 112.533 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m 55.44 80.39 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.621 1.568 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.89 -20.95 25.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.833 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.4 tp 50.74 52.46 14.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.498 2.319 . . . . 0.0 110.485 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.56 -24.26 2.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.197 0.999 . . . . 0.0 112.851 -173.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -155.19 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.099 0.952 . . . . 0.0 112.411 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.11 159.91 84.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.521 1.929 . . . . 0.0 109.637 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.92 -28.18 85.95 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.802 2.335 . . . . 0.0 113.172 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m 48.85 41.81 19.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.53 1.532 . . . . 0.0 114.155 169.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.16 105.52 0.45 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 171.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -134.84 165.87 24.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.872 2.069 . . . . 0.0 109.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.52 146.03 47.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.981 1.313 . . . . 0.0 107.485 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -141.75 138.24 32.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.477 0.711 . . . . 0.0 110.163 -168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.5 tp -78.71 132.63 37.07 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.267 2.0 m -117.91 146.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 119.24 0.927 . . . . 0.0 108.617 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -141.0 164.99 28.79 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.208 1.003 . . . . 0.0 110.537 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 m -121.01 146.02 47.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.78 134.04 14.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.8 -92.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.771 1.177 . . . . 0.0 110.363 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -151.28 37.84 0.62 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.06 1.344 . . . . 0.0 109.493 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -140.04 154.4 47.08 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.386 1.474 . . . . 0.0 108.433 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.93 155.46 31.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.799 1.285 . . . . 0.0 109.983 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -143.68 158.55 43.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.418 1.887 . . . . 0.0 107.901 -169.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.25 154.86 20.78 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.084 1.326 . . . . 0.0 110.024 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.1 mt -139.89 135.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.41 124.18 15.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.799 0.727 . . . . 0.0 109.177 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.69 -34.09 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.463 0.705 . . . . 0.0 112.631 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 mt -68.18 -24.36 64.96 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.853 0.751 . . . . 0.0 112.131 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.88 -14.51 50.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.953 0.797 . . . . 0.0 111.555 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.71 128.1 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -87.43 -55.7 3.68 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.432 1.093 . . . . 0.0 108.464 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -167.24 -178.06 3.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.866 1.266 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.91 142.69 43.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -167.77 2.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.448 1.499 . . . . 0.0 107.885 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.99 160.45 21.26 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -75.74 -0.96 22.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -5.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -168.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 34.19 1.39 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.343 1.429 . . . . 0.0 113.576 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.44 140.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.4 m -129.77 91.53 3.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 28.8 tpt180 -68.18 112.5 5.14 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.23 157.11 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.3 72.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -139.23 22.91 2.57 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.525 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -63.05 156.71 66.44 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -59.77 142.02 97.91 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.68 68.01 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.365 -0.835 . . . . 0.0 112.78 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -52.27 -40.56 61.9 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.541 0.609 . . . . 0.0 110.239 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.18 94.99 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -50.01 -33.12 17.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.286 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.62 177.01 31.3 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.9 153.92 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -140.63 163.42 32.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.732 1.151 . . . . 0.0 108.794 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -89.28 113.31 24.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.043 0.937 . . . . 0.0 110.75 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.48 171.66 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.4 mtp-105 -72.61 64.61 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.273 1.397 . . . . 0.0 112.81 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.96 -9.83 2.29 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 127.076 2.274 . . . . 0.0 113.24 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.34 -164.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 119.231 1.516 . . . . 0.0 108.536 -169.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.9 tp -127.81 157.04 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.174 1.79 . . . . 0.0 108.525 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p -151.38 141.99 14.93 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.44 138.36 42.17 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.183 1.922 . . . . 0.0 109.991 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.86 137.45 56.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.68 1.192 . . . . 0.0 108.319 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.99 139.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -97.89 120.69 38.72 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.303 0.641 . . . . 0.0 109.651 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -68.29 -18.87 64.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.175 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.21 -37.17 86.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.862 1.665 . . . . 0.0 110.455 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.26 -48.02 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -73.98 -27.4 60.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.324 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.31 11.44 2.56 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.948 1.249 . . . . 0.0 113.335 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m 60.63 34.1 20.2 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.606 -1.309 . . . . 0.0 112.926 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -50.85 155.2 1.22 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.645 0.778 . . . . 0.0 112.503 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 t -59.16 -64.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.786 1.234 . . . . 0.0 113.192 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -157.23 63.19 0.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.775 0.797 . . . . 0.0 111.457 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.54 135.55 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -158.39 158.52 34.38 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.482 1.513 . . . . 0.0 108.427 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.01 48.43 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.85 1.66 . . . . 0.0 112.767 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.1 -16.08 0.11 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.961 2.904 . . . . 0.0 109.987 169.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.69 -8.11 9.97 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.486 1.914 . . . . 0.0 111.562 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.48 35.14 1.84 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.687 1.595 . . . . 0.0 109.775 -169.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -100.08 -11.56 20.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -168.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.28 157.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.08 133.06 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.3 mt -107.67 133.76 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.27 137.92 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.8 mt -136.0 154.68 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.726 1.611 . . . . 0.0 107.549 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.47 149.64 42.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.32 176.02 8.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -11.67 -65.71 0.01 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 128.096 2.76 . . . . 0.0 116.24 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -137.95 26.63 2.72 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 111.638 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -151.4 164.63 36.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.778 -1.201 . . . . 0.0 111.952 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.17 144.12 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 0.0 109.015 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -157.64 -178.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.618 1.567 . . . . 0.0 107.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.62 -179.69 41.02 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.538 -1.352 . . . . 0.0 110.526 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.9 pt -141.91 144.21 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.108 0.963 . . . . 0.0 108.915 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 m -79.44 141.87 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.134 1.374 . . . . 0.0 108.46 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.98 163.21 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.256 1.822 . . . . 0.0 110.275 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -80.11 -46.7 16.01 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.954 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.56 161.94 31.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.71 116.49 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -41.57 34.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.573 0.749 . . . . 0.0 111.601 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -170.16 -174.82 1.83 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.65 123.45 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.6 mt -140.27 171.52 14.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.626 1.171 . . . . 0.0 109.994 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 m -125.6 139.38 53.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.091 0.556 . . . . 0.0 110.131 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.78 159.46 42.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.6 1.16 . . . . 0.0 109.366 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -122.38 155.18 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.117 2.167 . . . . 0.0 106.941 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -27.74 63.66 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.121 -0.987 . . . . 0.0 112.498 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.21 -33.64 73.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.634 1.173 . . . . 0.0 111.234 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -78.0 -42.31 33.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 109.617 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.5 mt -85.41 68.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.287 1.435 . . . . 0.0 109.11 -170.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -113.75 -60.53 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.367 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -179.1 1.74 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.034 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.19 32.52 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.774 1.63 . . . . 0.0 108.874 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.1 51.29 3.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.613 2.876 . . . . 0.0 110.709 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.83 27.89 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.832 2.053 . . . . 0.0 114.103 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -65.4 176.64 1.34 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 110.46 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.73 32.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.457 1.903 . . . . 0.0 113.685 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 m -66.93 167.09 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.188 0.995 . . . . 0.0 109.914 169.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -63.82 -16.1 60.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 0.0 113.391 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.44 108.61 4.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.562 1.145 . . . . 0.0 111.01 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 m -67.53 155.47 39.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.052 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -66.07 -34.07 77.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.611 1.164 . . . . 0.0 112.543 -171.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.16 -17.45 62.54 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.601 -1.312 . . . . 0.0 113.241 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.77 26.13 5.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.785 0.834 . . . . 0.0 109.939 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.54 140.02 54.83 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -70.28 -176.5 1.21 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.597 1.959 . . . . 0.0 110.66 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.02 178.89 16.39 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 169.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.1 mt -134.64 150.72 50.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.46 171.1 34.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.65 157.21 25.76 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.209 1.004 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.8 79.12 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.99 -50.96 2.72 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.7 2.095 . . . . 0.0 112.869 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.31 -30.53 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.223 2.209 . . . . 0.0 111.023 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -66.55 164.75 15.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.139 0.976 . . . . 0.0 108.886 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.7 mtp -139.17 150.74 45.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.764 1.226 . . . . 0.0 108.072 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.4 mt -138.53 137.92 37.52 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.678 1.191 . . . . 0.0 107.908 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 98.8 mt -86.89 113.29 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.03 109.23 15.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.24 128.92 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -75.24 51.61 0.55 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.77 1.228 . . . . 0.0 110.859 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 tp -57.23 -40.67 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.998 -1.064 . . . . 0.0 111.979 -169.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.94 -10.61 40.64 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.39 0.65 6.99 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.765 169.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.84 -69.07 0.25 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.838 1.199 . . . . 0.0 109.924 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.94 -33.25 74.31 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.89 -46.22 78.41 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.747 -0.595 . . . . 0.0 110.647 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -77.2 -22.46 52.32 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.282 0.633 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.44 -15.0 19.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.186 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.24 -48.08 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.495 1.498 . . . . 0.0 111.737 -169.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.9 ptp -60.86 -27.72 68.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.028 0.931 . . . . 0.0 113.007 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.62 -34.99 12.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.59 1.156 . . . . 0.0 111.282 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.78 -62.17 2.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.224 1.41 . . . . 0.0 109.004 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -26.68 66.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -169.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -54.58 -28.38 45.71 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.896 0.878 . . . . 0.0 112.643 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.8 m -136.07 23.37 3.28 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.964 0.905 . . . . 0.0 111.52 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.36 8.68 1.6 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.11 7.92 1.49 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.513 1.052 . . . . 0.0 113.282 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.2 m 72.63 -34.71 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.063 2.545 . . . . 0.0 113.298 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -66.53 -6.64 15.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.081 1.353 . . . . 0.0 111.784 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.25 3.42 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.025 2.13 . . . . 0.0 111.273 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.583 -0.723 . . . . 0.0 109.156 172.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -66.65 -25.9 66.8 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.405 1.082 . . . . 0.0 112.249 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.95 -171.69 40.79 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ttt -60.74 -39.79 89.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.448 0.624 . . . . 0.0 110.604 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p 53.09 18.27 1.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.565 1.946 . . . . 0.0 114.517 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -148.82 36.34 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.67 1.588 . . . . 0.0 109.147 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.83 129.36 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 108.612 -174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -61.2 -41.9 97.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.397 0.679 . . . . 0.0 110.009 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -80.49 72.07 7.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -139.07 69.3 1.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 171.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.46 -12.73 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.705 1.602 . . . . 0.0 112.45 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.26 26.07 1.67 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.966 1.706 . . . . 0.0 109.166 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -122.74 135.56 25.85 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.581 1.552 . . . . 0.0 108.865 -169.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.57 -20.05 20.92 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.545 2.163 . . . . 0.0 113.116 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m 56.66 178.11 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.559 1.544 . . . . 0.0 113.775 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.34 120.22 21.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.47 168.02 20.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.997 2.119 . . . . 0.0 110.291 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -121.54 147.39 45.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.85 137.28 31.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 109.416 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.4 tp -77.75 136.58 38.17 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 167.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.252 1.6 m -124.92 148.54 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 119.657 1.117 . . . . 0.0 109.078 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -140.64 150.17 43.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.677 1.191 . . . . 0.0 109.665 -172.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.3 m -91.09 146.71 23.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp -134.69 90.23 2.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.6 -71.53 0.37 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.815 1.674 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.56 28.85 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.504 1.522 . . . . 0.0 111.047 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.45 161.49 36.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.779 1.632 . . . . 0.0 107.939 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -122.99 151.07 42.19 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.516 1.15 . . . . 0.0 109.76 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -142.15 158.57 43.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.961 2.105 . . . . 0.0 107.437 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.87 161.27 24.52 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.43 1.014 . . . . 0.0 111.237 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.41 135.14 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -48.42 116.7 1.67 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 109.302 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.96 -33.34 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.332 0.653 . . . . 0.0 111.441 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.95 -22.94 67.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.591 0.756 . . . . 0.0 112.588 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -82.62 -19.93 37.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.99 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.65 142.15 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 119.194 0.907 . . . . 0.0 108.771 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.79 -53.92 2.66 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.401 1.081 . . . . 0.0 108.567 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.91 -176.5 4.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.569 1.147 . . . . 0.0 109.821 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.7 149.15 31.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -151.85 -157.9 0.85 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.379 1.872 . . . . 0.0 107.786 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.53 151.58 18.95 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 120.116 1.326 . . . . 0.0 112.691 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -77.02 91.23 3.62 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.122 1.369 . . . . 0.0 107.468 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -149.03 -18.11 0.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 51.91 1.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.094 0.861 . . . . 0.0 111.005 -169.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.45 152.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 O-C-N 120.674 -1.266 . . . . 0.0 110.463 169.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -133.56 131.03 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -128.26 133.74 48.85 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -168.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 mm -79.38 159.93 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.52 63.08 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.84 28.32 0.37 Allowed 'General case' 0 C--N 1.341 0.226 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -169.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.53 154.65 78.83 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.309 169.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -63.13 136.21 54.95 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.096 1.864 . . . . 0.0 107.671 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.83 -28.15 47.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -52.57 -46.08 66.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.663 0.665 . . . . 0.0 110.282 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.4 94.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -51.32 -47.44 62.64 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.96 -129.16 1.52 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 165.99 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.802 1.241 . . . . 0.0 107.866 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.5 t -145.54 173.33 12.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -82.89 160.95 22.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 120.796 -1.19 . . . . 0.0 111.608 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -121.89 168.97 11.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 167.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.36 58.43 0.26 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.641 1.576 . . . . 0.0 111.942 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.72 -13.95 1.18 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 127.111 2.291 . . . . 0.0 113.563 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.444 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.63 -161.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.762 1.781 . . . . 0.0 109.036 -169.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.444 ' H ' HG11 ' A' ' 64' ' ' VAL . 4.2 tp -119.28 158.77 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.924 1.689 . . . . 0.0 108.928 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.59 137.81 12.54 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 109.617 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.62 144.14 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.953 1.769 . . . . 0.0 109.469 169.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.3 136.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.39 150.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -123.83 128.76 49.98 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.76 -15.63 63.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.431 -0.319 . . . . 0.0 110.942 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -58.54 -21.35 52.19 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.879 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mt -127.91 23.16 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.351 2.26 . . . . 0.0 108.534 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -139.36 -27.88 0.79 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.724 -1.235 . . . . 0.0 112.352 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.24 15.57 4.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.962 0.905 . . . . 0.0 111.229 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m 51.16 47.45 24.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.738 1.615 . . . . 0.0 111.476 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -53.74 166.7 0.3 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.727 1.211 . . . . 0.0 111.4 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -60.99 169.66 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.81 0.844 . . . . 0.0 109.609 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.53 71.38 0.95 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 128.73 2.812 . . . . 0.0 110.691 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.5 m -38.81 153.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 128.627 2.771 . . . . 0.0 114.09 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.52 161.49 42.18 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.308 1.443 . . . . 0.0 108.518 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -72.11 49.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.869 1.668 . . . . 0.0 111.212 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.23 -19.67 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.808 2.843 . . . . 0.0 110.152 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.82 -15.31 3.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.779 1.232 . . . . 0.0 112.324 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -145.4 47.75 1.28 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.804 1.241 . . . . 0.0 108.322 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.3 p -78.15 -4.81 49.39 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.358 2.663 . . . . 0.0 117.644 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.11 153.85 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 121.463 1.938 . . . . 0.0 109.091 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.22 122.23 62.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.086 1.754 . . . . 0.0 107.233 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.4 mt -93.57 140.6 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.0 133.71 60.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.77 165.74 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.047 1.739 . . . . 0.0 108.953 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.13 153.39 51.85 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.295 1.038 . . . . 0.0 110.007 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -133.79 85.6 2.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.88 -67.7 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.781 1.658 . . . . 0.0 113.72 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -136.15 3.19 2.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.863 1.665 . . . . 0.0 112.338 -171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.71 169.25 16.45 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 110.066 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.871 1.269 . . . . 0.0 108.992 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -157.49 171.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.447 1.499 . . . . 0.0 107.194 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.07 171.59 32.06 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -138.46 143.7 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.877 0.871 . . . . 0.0 108.79 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.83 134.44 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 108.943 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.36 170.5 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 125.581 1.552 . . . . 0.0 109.914 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.41 -41.87 72.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.53 158.83 10.99 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.74 130.73 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.17 -42.64 7.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.266 1.026 . . . . 0.0 111.358 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -168.18 -175.57 2.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 109.877 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.04 127.27 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 169.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -137.36 165.31 26.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.429 1.092 . . . . 0.0 109.524 -169.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 m -124.41 130.56 52.7 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.33 162.52 33.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.927 . . . . 0.0 108.962 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -138.15 159.93 40.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.908 1.283 . . . . 0.0 108.538 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.18 -23.4 8.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.18 -34.43 74.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.04 -1.038 . . . . 0.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -85.29 -38.68 18.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.177 1.391 . . . . 0.0 110.554 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.54 102.67 13.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.6 mtm105 -140.15 -56.93 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.948 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.53 168.68 14.17 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.712 1.608 . . . . 0.0 111.354 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.03 154.71 29.27 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.31 1.444 . . . . 0.0 108.957 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.26 146.57 71.31 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.739 2.293 . . . . 0.0 110.91 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.06 18.99 0.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.577 1.151 . . . . 0.0 110.757 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -73.65 170.29 15.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 111.121 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.97 65.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.701 1.6 . . . . 0.0 110.584 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.47 175.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.455 1.502 . . . . 0.0 109.66 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.92 11.53 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.413 1.885 . . . . 0.0 114.942 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.7 158.04 18.92 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.285 1.434 . . . . 0.0 110.227 -173.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -142.42 148.08 37.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 110.969 -171.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -55.77 -29.45 59.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.144 1.777 . . . . 0.0 114.406 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.68 -22.58 65.28 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.71 25.66 1.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.542 1.064 . . . . 0.0 112.517 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.62 18.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p 64.86 -170.99 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.429 1.492 . . . . 0.0 112.151 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.65 28.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 106.584 -2.606 . . . . 0.0 106.584 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.66 153.74 39.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.465 1.633 . . . . 0.0 109.491 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.97 173.2 35.22 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.11 157.8 16.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.266 1.026 . . . . 0.0 111.202 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.07 72.48 1.38 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.187 1.795 . . . . 0.0 107.143 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.8 -46.36 2.03 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.385 1.945 . . . . 0.0 113.724 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -36.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.19 2.196 . . . . 0.0 110.403 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -73.55 166.09 23.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.655 0.741 . . . . 0.0 110.031 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.5 mtp -141.03 148.4 40.19 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.4 153.94 36.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.689 0.796 . . . . 0.0 110.459 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 79.5 mt -104.89 109.97 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.349 1.459 . . . . 0.0 107.178 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.31 108.13 15.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.035 1.334 . . . . 0.0 107.736 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.3 131.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.547 1.139 . . . . 0.0 108.138 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -78.74 60.54 2.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.61 0.719 . . . . 0.0 109.643 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 tp -54.42 -39.01 42.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 C-N-CA 124.764 1.226 . . . . 0.0 111.147 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.45 -13.16 60.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.747 0.703 . . . . 0.0 112.568 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -111.81 -7.72 14.18 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.872 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.42 -77.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.641 1.11 . . . . 0.0 110.742 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.49 -20.1 65.41 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.33 -0.856 . . . . 0.0 110.443 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.49 -37.43 75.52 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.097 -1.002 . . . . 0.0 110.664 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 m -85.82 -30.14 23.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.695 0.798 . . . . 0.0 111.242 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -90.96 -9.44 46.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.938 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -49.31 -47.96 46.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.763 1.619 . . . . 0.0 111.792 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -63.42 -44.7 93.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.717 0.407 . . . . 0.0 109.956 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.49 82.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.325 0.65 . . . . 0.0 111.368 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.24 -58.62 7.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.718 1.207 . . . . 0.0 109.321 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.86 62.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.432 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.58 -20.88 5.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 112.917 174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 26.7 m -123.05 -46.54 2.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -84.64 -2.26 57.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.62 82.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 110.672 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.2 p 173.22 -22.78 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.397 1.879 . . . . 0.0 111.428 -169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.98 -34.5 76.27 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.06 0.944 . . . . 0.0 111.497 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.27 -45.31 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.104 0.962 . . . . 0.0 110.609 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.754 174.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttm . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.5 p -75.45 148.18 39.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.55 -157.99 27.4 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.1 mtt -59.22 -17.66 29.92 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.517 0.658 . . . . 0.0 111.953 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -60.69 -12.28 9.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.348 2.259 . . . . 0.0 113.669 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -62.27 0.91 0.38 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.907 1.683 . . . . 0.0 115.0 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.4 t -53.25 -30.14 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.561 -1.337 . . . . 0.0 111.231 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -58.98 -23.17 61.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.839 1.256 . . . . 0.0 113.46 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -138.53 33.86 2.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.258 1.423 . . . . 0.0 108.889 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -3.62 0.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.47 170.1 16.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.701 2.8 . . . . 0.0 104.258 -169.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 52.63 40.77 30.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.372 0.606 . . . . 0.0 109.594 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.09 150.18 75.34 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.712 1.605 . . . . 0.0 107.86 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.53 172.33 16.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.38 2.053 . . . . 0.0 111.536 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.9 m -53.04 143.55 17.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.833 1.653 . . . . 0.0 111.906 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.46 97.2 1.93 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 125.979 1.752 . . . . 0.0 108.862 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -69.89 163.84 25.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.081 0.553 . . . . 0.0 109.609 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -124.91 143.28 50.94 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.539 1.536 . . . . 0.0 107.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -142.3 136.79 30.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.648 0.779 . . . . 0.0 110.501 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.6 tp -77.88 135.97 37.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 167.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.28 152.88 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.736 1.153 . . . . 0.0 109.57 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -140.38 151.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 109.56 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -93.38 146.53 23.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -156.0 134.95 11.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 169.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -98.52 0.53 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.31 36.71 0.67 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.348 1.459 . . . . 0.0 108.776 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.02 161.0 39.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.156 1.782 . . . . 0.0 107.852 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -120.1 156.4 31.09 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.117 1.437 . . . . 0.0 110.457 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -138.11 147.73 44.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.943 2.097 . . . . 0.0 106.457 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.48 156.64 15.97 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.49 134.9 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -49.52 115.5 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.034 0.934 . . . . 0.0 109.111 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.54 -33.1 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.702 . . . . 0.0 111.712 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.84 -24.8 67.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.687 0.795 . . . . 0.0 112.606 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -83.16 -17.73 41.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.682 0.674 . . . . 0.0 111.763 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.8 145.25 13.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.632 1.106 . . . . 0.0 109.087 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -123.05 -47.16 2.05 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.073 0.949 . . . . 0.0 111.346 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -162.84 172.41 15.2 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.609 0.764 . . . . 0.0 109.487 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.25 144.54 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 106.595 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -148.05 176.53 10.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.619 1.567 . . . . 0.0 108.04 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.33 168.92 44.97 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -83.49 -164.42 0.9 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 110.032 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 60.3 38.33 19.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.275 1.83 . . . . 0.0 112.859 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -141.14 26.76 1.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.635 1.574 . . . . 0.0 109.767 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 102.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 120.97 -1.082 . . . . 0.0 108.424 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -61.95 -44.51 96.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.518 . . . . 0.0 110.46 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 56.53 -176.52 0.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.828 2.051 . . . . 0.0 112.515 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mm -133.55 160.23 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.88 -23.12 67.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.74 27.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 148.26 57.71 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 122.765 0.426 . . . . 0.0 110.947 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.31 152.68 66.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.21 2.607 . . . . 0.0 110.041 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.33 73.81 0.98 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.599 1.19 . . . . 0.0 110.528 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -162.72 -52.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 130.12 3.368 . . . . 0.0 103.696 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.3 mt -75.42 92.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -51.01 -41.4 59.77 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.912 0.885 . . . . 0.0 108.9 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.85 -156.04 19.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 m -124.1 151.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -136.34 148.26 47.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -80.62 92.34 5.95 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.404 1.081 . . . . 0.0 109.895 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.58 171.65 4.88 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -67.14 63.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.182 1.793 . . . . 0.0 113.155 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.21 -8.63 3.8 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.968 2.223 . . . . 0.0 113.507 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -152.83 -165.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 119.104 1.452 . . . . 0.0 108.342 -169.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 64' ' ' VAL . 5.4 tp -121.62 157.88 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.546 1.938 . . . . 0.0 107.709 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.72 138.79 12.71 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.896 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.38 145.29 64.84 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.181 1.92 . . . . 0.0 110.049 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -129.05 138.31 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.82 164.34 11.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -132.14 126.98 34.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.0 -21.99 64.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.122 1.369 . . . . 0.0 111.665 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -37.67 80.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.274 1.397 . . . . 0.0 110.101 169.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.85 -57.0 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -66.64 -28.78 68.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.861 0.864 . . . . 0.0 113.199 -169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -135.11 5.93 3.32 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.3 m 53.14 41.87 32.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.183 0.901 . . . . 0.0 111.687 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -52.6 146.3 10.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.1 t -44.92 -61.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 112.742 -169.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -175.21 86.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.79 1.636 . . . . 0.0 108.657 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.7 144.1 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.84 163.92 31.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 109.493 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.55 42.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.722 2.409 . . . . 0.0 112.889 172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.05 -12.87 0.16 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.161 2.184 . . . . 0.0 111.318 170.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.71 -5.94 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.335 1.454 . . . . 0.0 111.735 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.41 44.24 1.52 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.452 -1.405 . . . . 0.0 108.762 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 p -99.38 -2.97 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.344 1.858 . . . . 0.0 114.297 -169.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.6 t -128.06 154.79 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.16 130.68 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.129 1.771 . . . . 0.0 106.341 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.2 mt -102.7 138.22 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.17 133.76 54.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.3 mt -133.53 163.69 28.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.607 1.563 . . . . 0.0 107.922 -170.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.84 146.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.853 1.261 . . . . 0.0 107.674 171.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.7 157.34 43.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.52 -112.44 2.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.82 27.04 5.79 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.511 1.524 . . . . 0.0 110.383 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -141.14 171.27 14.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.401 1.081 . . . . 0.0 110.835 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.76 154.27 38.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.229 1.011 . . . . 0.0 110.704 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.6 p -161.28 176.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.324 1.85 . . . . 0.0 106.878 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.24 -179.87 37.98 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 120.548 -1.345 . . . . 0.0 111.785 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 pt -142.46 155.97 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.519 1.528 . . . . 0.0 108.579 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.2 143.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.55 171.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.411 1.884 . . . . 0.0 110.086 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.59 -42.51 42.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.776 0.716 . . . . 0.0 109.973 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.63 153.42 9.69 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 173.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.57 123.99 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.9 -52.86 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.313 0.645 . . . . 0.0 110.373 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -173.23 -177.17 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.941 1.697 . . . . 0.0 108.093 -169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -117.26 132.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.8 mt -135.09 174.42 10.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.762 1.625 . . . . 0.0 108.665 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -132.4 141.72 48.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.213 0.605 . . . . 0.0 109.587 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.7 134.97 27.52 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 51.8 p -76.77 163.76 26.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.321 0.581 . . . . 0.0 110.712 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.99 10.01 0.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.377 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.99 -40.46 5.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.418 2.287 . . . . 0.0 108.851 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -61.13 -47.43 86.31 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.1 mt -67.21 119.6 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -151.3 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.15 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -177.58 2.66 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.247 1.964 . . . . 0.0 111.257 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.36 153.64 29.56 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.377 1.471 . . . . 0.0 108.707 169.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.14 51.05 3.52 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.603 3.535 . . . . 0.0 110.65 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 7.7 1.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.634 1.573 . . . . 0.0 114.847 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -146.1 160.07 42.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.3 32.95 14.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.738 2.015 . . . . 0.0 114.367 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.21 166.13 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.599 1.56 . . . . 0.0 108.697 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -5.36 34.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 113.747 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.22 156.8 11.69 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.989 1.716 . . . . 0.0 111.632 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 m -133.45 151.14 51.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.362 0.665 . . . . 0.0 112.103 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -57.32 -23.95 52.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.399 1.88 . . . . 0.0 114.49 -169.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -66.25 -32.22 73.51 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.817 0.735 . . . . 0.0 111.414 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.25 29.41 1.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.772 0.829 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.4 p 62.31 -163.35 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.238 1.415 . . . . 0.0 111.434 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -149.18 177.94 27.05 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 171.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -139.89 142.28 36.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.57 172.94 31.69 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.7 157.16 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.24 0.543 . . . . 0.0 111.83 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.53 68.01 1.38 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.539 2.336 . . . . 0.0 106.699 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.04 -48.18 2.7 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.471 1.986 . . . . 0.0 113.584 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -145.89 -32.2 0.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.429 1.892 . . . . 0.0 110.933 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -70.23 151.35 45.45 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.3 mtp -139.22 143.34 38.01 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.92 120.19 22.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.54 114.34 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.82 99.54 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.1 t -59.91 122.52 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 108.24 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -80.25 60.59 3.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.502 0.667 . . . . 0.0 110.371 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.69 -37.17 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.068 1.347 . . . . 0.0 111.578 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.37 -27.93 69.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.276 0.489 . . . . 0.0 111.554 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -97.01 -28.28 14.23 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 116.772 -1.585 . . . . 0.0 112.218 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -47.35 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.461 1.504 . . . . 0.0 112.451 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.65 -35.01 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -58.58 -34.11 70.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 112.535 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 m -99.4 -14.3 19.21 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.357 1.063 . . . . 0.0 111.473 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.7 -2.69 56.91 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.143 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -52.84 -42.98 65.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.208 1.367 . . . . 0.0 112.051 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -66.8 -24.08 66.13 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.202 1.401 . . . . 0.0 112.368 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.68 -31.21 13.92 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.415 1.486 . . . . 0.0 111.002 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.81 -62.81 1.59 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.738 1.215 . . . . 0.0 109.167 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -67.84 -29.73 68.95 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.891 -169.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.07 -25.19 29.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.085 0.954 . . . . 0.0 112.81 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.5 m -133.18 15.18 4.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.418 1.087 . . . . 0.0 112.254 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.45 12.99 0.83 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.28 6.91 1.48 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.431 1.014 . . . . 0.0 112.967 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 72.53 -34.23 0.29 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.135 2.574 . . . . 0.0 113.398 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.65 -7.22 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.877 1.271 . . . . 0.0 111.895 169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -121.51 2.47 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.676 1.99 . . . . 0.0 111.478 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.81 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m -60.15 -36.34 77.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.35 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.59 -177.66 46.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -150.25 156.41 41.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.578 1.151 . . . . 0.0 108.803 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -76.87 -0.41 24.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.274 1.029 . . . . 0.0 112.558 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -55.22 -25.3 32.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.531 1.132 . . . . 0.0 113.866 -171.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.14 -16.14 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.217 1.407 . . . . 0.0 113.478 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.3 m -59.97 -19.95 54.94 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.618 1.567 . . . . 0.0 112.507 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.08 148.29 6.38 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.368 0.986 . . . . 0.0 111.531 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.32 -43.26 99.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.47 0.308 . . . . 0.0 110.572 -172.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.94 -58.86 0.06 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 m -164.25 124.79 2.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -145.4 164.26 27.41 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.708 1.603 . . . . 0.0 107.506 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.29 152.65 78.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.289 1.993 . . . . 0.0 111.154 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m 44.89 38.97 3.23 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.604 1.561 . . . . 0.0 114.25 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.83 119.72 18.06 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 170.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -145.59 155.74 43.24 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.469 1.908 . . . . 0.0 109.266 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -103.29 147.45 27.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.88 135.45 29.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.451 1.1 . . . . 0.0 109.154 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.43 132.74 37.43 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 167.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.93 149.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 119.719 1.145 . . . . 0.0 108.764 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.46 148.3 37.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.917 0.887 . . . . 0.0 110.039 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 m -89.4 146.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -150.41 133.29 15.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.61 -93.16 0.04 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.73 37.25 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.51 163.81 34.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.746 1.218 . . . . 0.0 108.755 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.29 151.13 36.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 123.026 1.393 . . . . 0.0 110.753 173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -138.5 158.02 45.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.457 2.303 . . . . 0.0 107.139 -171.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.82 158.81 23.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.107 0.86 . . . . 0.0 111.007 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -48.79 118.23 2.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.09 0.956 . . . . 0.0 108.696 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.42 -33.49 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.123 0.569 . . . . 0.0 111.754 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.91 -23.62 67.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.532 0.733 . . . . 0.0 112.701 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -80.97 -21.27 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.756 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.79 141.89 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.309 0.958 . . . . 0.0 108.452 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -118.07 -46.61 2.61 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.554 1.142 . . . . 0.0 110.278 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -162.47 172.09 16.07 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.622 1.169 . . . . 0.0 108.66 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -135.46 141.21 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -145.15 177.51 8.74 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.312 1.445 . . . . 0.0 107.672 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.28 162.45 18.99 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -56.61 136.79 54.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -153.96 -52.21 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.0 58.7 0.79 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.307 0.643 . . . . 0.0 110.773 -169.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.25 110.69 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.4 m -62.82 -38.03 89.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.29 1.436 . . . . 0.0 110.545 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 30.57 19.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.496 1.518 . . . . 0.0 112.599 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.0 mm 43.08 -95.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 127.675 2.39 . . . . 0.0 110.096 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.15 -44.3 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.912 1.285 . . . . 0.0 109.562 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.06 32.41 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.422 0.689 . . . . 0.0 112.13 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.88 143.56 60.63 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.702 1.201 . . . . 0.0 110.516 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.43 159.36 50.76 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 111.084 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.77 65.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.041 0.936 . . . . 0.0 112.1 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -71.63 4.07 3.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.26 -36.74 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.685 1.194 . . . . 0.0 110.737 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.251 63.2 mttt 50.9 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.566 2.346 . . . . 0.0 110.338 -167.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.77 -176.16 40.62 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 121.88 2.127 . . . . 0.0 113.102 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.11 156.51 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 122.071 -0.664 . . . . 0.0 110.625 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 t -134.47 160.49 37.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.913 1.285 . . . . 0.0 108.716 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -77.99 142.11 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.45 174.88 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.21 1.404 . . . . 0.0 108.159 168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 -35.78 -30.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.43 21.53 0.28 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.129 0.877 . . . . 0.0 113.183 169.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -152.45 -165.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.0 1.32 . . . . 0.0 108.108 -170.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 ' H ' HG11 ' A' ' 64' ' ' VAL . 4.1 tp -130.79 157.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.716 1.606 . . . . 0.0 108.979 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.26 139.62 13.01 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.53 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 131.29 27.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.36 2.04 . . . . 0.0 109.429 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.63 128.46 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.57 165.07 20.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -121.37 128.88 52.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.702 0.801 . . . . 0.0 109.522 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.93 -10.38 58.37 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.58 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.02 -21.41 61.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.078 1.308 . . . . 0.0 110.06 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.84 18.29 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 126.036 1.734 . . . . 0.0 108.788 -171.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.52 -32.41 0.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 117.936 -1.03 . . . . 0.0 112.047 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -132.21 5.38 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.534 1.061 . . . . 0.0 112.428 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 m 51.52 36.25 16.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.37 1.468 . . . . 0.0 111.468 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -59.28 147.94 33.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -22.36 -61.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.041 3.337 . . . . 0.0 115.419 -169.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -157.39 27.58 0.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.766 0.826 . . . . 0.0 111.702 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.7 140.87 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.111 -0.993 . . . . 0.0 109.886 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -171.62 178.07 3.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.014 2.925 . . . . 0.0 104.943 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -65.7 60.58 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.716 2.406 . . . . 0.0 110.821 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -160.38 -30.43 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.558 2.743 . . . . 0.0 109.904 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 86' ' ' THR . 25.7 t0 -78.7 40.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.602 1.161 . . . . 0.0 111.855 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.99 -15.85 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.913 3.685 . . . . 0.0 114.997 -173.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 84' ' ' ASP 0.282 14.8 p 31.19 72.36 0.07 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.122 3.369 . . . . 0.0 117.307 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.1 155.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.7 119.65 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.368 -1.457 . . . . 0.0 107.772 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.65 139.38 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.33 134.76 52.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.6 mt -132.54 163.44 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 108.381 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 155.36 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.402 1.081 . . . . 0.0 108.959 173.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mp -131.22 -179.9 5.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -20.83 -61.84 0.02 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.694 2.568 . . . . 0.0 116.18 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -137.51 24.4 2.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.031 0.933 . . . . 0.0 111.923 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -150.67 165.37 33.61 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.772 -1.205 . . . . 0.0 111.262 -169.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.69 151.42 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.533 1.133 . . . . 0.0 109.214 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.32 166.86 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.997 1.319 . . . . 0.0 107.912 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.57 176.58 34.66 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.148 -0.97 . . . . 0.0 112.044 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.9 pt -146.03 152.11 14.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.66 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -82.95 144.45 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.628 1.171 . . . . 0.0 110.052 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.5 164.59 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.716 1.606 . . . . 0.0 109.119 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.81 -42.28 58.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.349 -0.844 . . . . 0.0 108.825 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.33 156.05 11.95 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.81 126.3 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -76.8 -55.53 5.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -176.61 176.99 1.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.644 1.978 . . . . 0.0 107.58 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -100.08 139.24 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.6 mt -140.12 172.13 13.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.551 . . . . 0.0 107.573 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.8 m -130.77 143.61 50.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.764 0.711 . . . . 0.0 110.344 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.17 171.09 14.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.025 1.33 . . . . 0.0 109.409 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -134.66 160.49 37.96 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.806 1.643 . . . . 0.0 108.467 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.33 1.93 3.4 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.42 -45.75 12.4 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.507 1.523 . . . . 0.0 107.721 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -67.44 -41.75 84.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.207 1.003 . . . . 0.0 109.928 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -82.42 112.52 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -142.45 -57.62 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.619 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.52 175.67 4.92 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.14 1.893 . . . . 0.0 111.683 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.44 156.94 33.77 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.614 1.565 . . . . 0.0 108.471 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.55 50.95 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.904 3.069 . . . . 0.0 111.071 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.56 26.26 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.585 1.954 . . . . 0.0 113.37 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -68.73 175.88 3.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.651 1.98 . . . . 0.0 111.381 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 67.85 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.631 1.572 . . . . 0.0 110.753 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.48 -179.21 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.898 1.679 . . . . 0.0 109.245 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -6.96 11.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -69.89 155.54 40.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.023 0.929 . . . . 0.0 110.635 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.4 m -139.29 157.73 45.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.843 1.257 . . . . 0.0 109.131 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 p -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.987 1.315 . . . . 0.0 113.131 -171.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.32 -36.37 83.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 111.103 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -129.13 33.05 4.63 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.576 1.55 . . . . 0.0 108.801 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 127.51 32.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 146' ' ' ASN . 81.8 p -74.92 -171.92 1.47 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.828 1.651 . . . . 0.0 110.134 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.07 172.86 22.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.319 -2.313 . . . . 0.0 107.319 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.33 151.67 37.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.101 1.451 . . . . 0.0 109.539 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.02 177.72 27.06 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.27 0.938 . . . . 0.0 111.163 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.82 159.08 36.86 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.41 0.684 . . . . 0.0 111.903 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.77 59.8 1.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.624 2.369 . . . . 0.0 107.241 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.57 -45.25 2.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.345 1.926 . . . . 0.0 113.93 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -140.17 -38.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.491 2.316 . . . . 0.0 109.678 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -73.76 153.2 40.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 89.1 mtp -141.72 140.52 33.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -133.43 137.54 45.8 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.82 110.48 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.79 112.37 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.85 136.16 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.455 ' H ' HG23 ' A' ' 132' ' ' THR . 45.1 t-20 -78.85 61.96 3.21 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 109.822 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 tp -54.81 -38.38 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.997 1.319 . . . . 0.0 111.126 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.0 -15.6 59.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -111.12 -9.35 14.37 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.333 -1.318 . . . . 0.0 111.556 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.74 -80.8 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.136 -169.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.76 -30.81 70.37 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.029 -1.044 . . . . 0.0 109.442 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.4 -21.86 62.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.3 m -115.17 -12.19 11.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.804 0.842 . . . . 0.0 112.078 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.42 -15.32 19.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.512 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.51 -40.49 78.8 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.891 1.678 . . . . 0.0 111.953 -169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.0 ptp -63.23 -31.82 73.07 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.42 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.53 25.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.75 1.22 . . . . 0.0 111.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.79 -55.64 9.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.69 -28.36 68.57 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.068 -0.395 . . . . 0.0 111.731 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.63 -28.71 9.35 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.649 1.179 . . . . 0.0 112.807 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.9 m -134.12 19.62 3.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.661 1.185 . . . . 0.0 111.812 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.61 15.53 1.11 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.006 0.922 . . . . 0.0 112.579 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.32 12.73 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.353 1.061 . . . . 0.0 111.84 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 15.2 m 62.31 17.81 9.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.392 1.877 . . . . 0.0 112.649 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.24 -40.92 58.55 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.599 -0.688 . . . . 0.0 109.808 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.9 -28.34 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.704 0.801 . . . . 0.0 111.156 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.819 -179.711 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 121.015 0.436 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -60.39 177.61 0.26 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.876 1.671 . . . . 0.0 111.912 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.1 15.95 1.24 Allowed Glycine 0 CA--C 1.54 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 113.484 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 ptm -153.09 160.45 42.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.054 2.542 . . . . 0.0 106.51 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -74.97 72.12 2.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.168 1.387 . . . . 0.0 110.723 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -76.48 60.64 1.63 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.36 121.33 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 130.22 43.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.53 0.732 . . . . 0.0 110.199 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -159.58 128.98 5.32 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.316 1.047 . . . . 0.0 108.282 169.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.72 99.68 4.4 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.46 -11.45 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.447 1.099 . . . . 0.0 111.994 171.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -154.77 41.7 0.46 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.559 1.544 . . . . 0.0 108.546 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.48 148.71 44.65 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.2 1.4 . . . . 0.0 109.625 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.79 1.15 8.42 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.03 3.154 . . . . 0.0 113.474 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m 54.0 53.05 11.75 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.502 1.521 . . . . 0.0 113.645 173.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.66 75.23 1.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.309 0.481 . . . . 0.0 114.282 169.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -68.87 161.74 28.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 168.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.4 142.6 49.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -141.64 134.55 28.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 109.564 -169.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.19 133.22 35.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 151.34 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 119.531 1.06 . . . . 0.0 109.15 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.99 153.23 46.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.77 1.228 . . . . 0.0 109.407 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -96.65 146.46 24.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 tp -149.61 132.71 16.28 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.79 -104.74 0.69 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.23 37.39 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.664 1.585 . . . . 0.0 108.912 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.24 159.95 41.06 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.825 2.05 . . . . 0.0 107.594 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.82 160.85 20.69 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 110.281 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -142.68 152.57 42.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.932 2.093 . . . . 0.0 106.809 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.23 154.85 21.39 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mt -139.5 134.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.18 117.17 2.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 109.157 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -54.42 -35.56 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.895 0.878 . . . . 0.0 111.558 -170.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.93 -24.98 68.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.717 0.807 . . . . 0.0 112.508 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -80.65 -23.53 39.6 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.483 0.583 . . . . 0.0 111.464 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.71 132.96 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.409 HE22 ' CD1' ' A' ' 61' ' ' LEU . 42.3 tt0 -90.09 -59.07 2.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.33 -179.42 7.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.435 1.094 . . . . 0.0 109.825 -172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.61 143.13 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -147.78 173.88 12.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.403 1.081 . . . . 0.0 108.483 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.64 157.8 33.09 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -77.26 106.71 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 108.654 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -157.76 163.53 38.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.736 1.214 . . . . 0.0 109.569 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.88 34.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.904 2.481 . . . . 0.0 114.484 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.17 143.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.709 0.766 . . . . 0.0 109.396 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -136.03 93.09 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.524 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 30.5 tpt180 -71.21 118.96 14.66 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -70.02 157.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -23.5 67.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -172.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.89 23.91 0.51 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.524 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -60.22 156.99 35.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 122.935 0.494 . . . . 0.0 110.906 171.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -59.18 145.69 96.94 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 N-CA-C 107.995 -1.579 . . . . 0.0 107.995 169.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.67 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.728 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.12 -38.27 67.96 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.994 0.816 . . . . 0.0 110.675 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.5 mt -75.57 90.7 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -58.31 -26.41 63.01 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.02 -158.96 32.09 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.24 153.69 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -134.67 165.15 25.92 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.244 0.929 . . . . 0.0 108.985 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -71.23 99.4 1.9 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.535 1.534 . . . . 0.0 110.857 -173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' CD1' HE22 ' A' ' 37' ' ' GLN 0.25 0.5 OUTLIER -77.9 64.3 3.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 107.677 169.645 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 45.55 34.35 1.64 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.061 2.944 . . . . 0.0 114.145 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.79 -20.9 4.52 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.982 1.277 . . . . 0.0 112.136 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.66 -163.21 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 172.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 tp -138.27 147.14 25.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 121.156 -0.965 . . . . 0.0 111.979 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.59 135.99 18.48 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.89 147.95 75.56 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.998 1.799 . . . . 0.0 110.157 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 tp -126.61 131.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.59 155.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -140.48 143.08 35.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.22 1.009 . . . . 0.0 109.27 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.48 -16.74 62.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.943 1.297 . . . . 0.0 110.566 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -61.81 -20.19 63.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.093 1.315 . . . . 0.0 111.144 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.4 mt -115.89 -48.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.96 -25.36 67.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.811 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -135.0 -6.39 2.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.589 1.086 . . . . 0.0 113.116 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.5 m 55.92 46.02 22.84 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.086 -1.009 . . . . 0.0 111.716 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -47.04 142.88 3.33 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.34 -65.04 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.722 1.609 . . . . 0.0 112.65 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -162.28 79.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.161 0.985 . . . . 0.0 109.697 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.52 144.79 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -164.63 171.56 14.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.683 1.593 . . . . 0.0 107.462 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -70.17 48.32 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.736 2.014 . . . . 0.0 110.921 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.69 -12.91 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.741 3.216 . . . . 0.0 110.737 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.16 -3.26 1.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.428 1.491 . . . . 0.0 111.988 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -146.56 40.05 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.224 1.409 . . . . 0.0 109.095 -169.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 p -96.21 -11.6 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.293 1.837 . . . . 0.0 114.041 -169.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.68 155.67 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.0 t -130.08 135.7 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.185 1.794 . . . . 0.0 106.231 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.61 124.61 65.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.29 134.31 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.7 mt -133.09 162.01 32.87 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.102 1.361 . . . . 0.0 108.822 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.35 153.9 41.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.5 136.55 18.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.6 -94.97 0.08 OUTLIER Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -169.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -139.91 22.33 2.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.054 1.742 . . . . 0.0 110.76 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -134.52 163.31 30.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.113 -0.992 . . . . 0.0 110.106 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.23 152.27 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 110.393 -170.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.94 177.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 126.224 1.809 . . . . 0.0 106.711 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.8 33.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.4 154.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.895 0.878 . . . . 0.0 109.082 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.96 144.61 13.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.83 170.96 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.737 1.615 . . . . 0.0 110.049 -168.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -76.72 -42.93 39.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.971 -0.456 . . . . 0.0 110.353 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.97 153.79 9.16 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.9 129.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 m -77.03 -57.83 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.405 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -176.62 175.33 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 107.796 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.5 140.09 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.28 176.34 8.8 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.994 1.718 . . . . 0.0 108.16 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 m -131.63 139.63 49.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.199 0.6 . . . . 0.0 109.566 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.53 165.72 26.79 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.238 1.415 . . . . 0.0 108.4 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.7 m -137.58 158.8 43.6 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 107.811 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.18 -13.01 2.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.8 -40.71 92.17 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.81 1.186 . . . . 0.0 110.129 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -82.72 -39.08 22.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.533 1.533 . . . . 0.0 109.692 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.77 85.83 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.411 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 44.6 mtm180 -140.88 -53.69 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 116.608 -1.663 . . . . 0.0 112.725 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.1 Cg_endo -65.01 175.93 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 121.699 1.643 . . . . 0.0 111.167 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.65 158.23 32.21 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.939 1.296 . . . . 0.0 109.157 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.02 60.7 7.94 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.778 2.986 . . . . 0.0 110.994 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.35 33.52 0.06 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.378 1.871 . . . . 0.0 112.495 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.2 178.3 4.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.52 1.528 . . . . 0.0 110.74 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.55 0.93 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.203 1.401 . . . . 0.0 110.568 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.71 159.16 39.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.799 1.639 . . . . 0.0 109.039 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -58.52 -25.05 61.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.881 0.872 . . . . 0.0 112.2 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.96 -26.92 68.51 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.796 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -76.11 75.46 2.96 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 124.319 2.009 . . . . 0.0 111.292 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 t -155.52 177.57 11.22 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 129.502 3.121 . . . . 0.0 103.776 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.6 -7.55 0.99 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 126.472 1.909 . . . . 0.0 115.963 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -73.21 -5.35 38.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.737 1.153 . . . . 0.0 110.438 168.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -46.59 135.52 8.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.108 2.163 . . . . 0.0 114.459 -169.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.6 p -77.02 -165.7 0.6 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.878 2.871 . . . . 0.0 110.355 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.23 -179.72 16.84 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.464 1.983 . . . . 0.0 108.544 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mt -133.62 150.64 51.6 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.932 1.693 . . . . 0.0 106.948 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.33 171.85 32.87 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.09 158.06 43.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.089 0.956 . . . . 0.0 110.927 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 mt -144.89 69.37 1.25 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.231 1.812 . . . . 0.0 107.605 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.87 -49.56 2.85 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.337 1.922 . . . . 0.0 113.1 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -145.45 -31.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.379 1.872 . . . . 0.0 110.953 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -69.64 153.13 43.87 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.3 mtp -142.8 146.67 34.44 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.31 147.62 25.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.368 0.667 . . . . 0.0 109.879 -175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -93.02 112.42 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.53 107.77 10.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.91 122.8 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -79.41 53.79 1.6 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.371 0.668 . . . . 0.0 110.683 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 tp -54.09 -37.39 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.52 1.128 . . . . 0.0 111.123 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -65.49 -6.45 10.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.867 1.267 . . . . 0.0 112.782 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -124.49 -28.9 3.55 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 0.0 111.608 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.2 tp -45.49 -64.5 0.71 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.875 1.67 . . . . 0.0 111.841 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.28 -46.34 56.24 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.95 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -65.09 -21.4 66.8 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.256 0.935 . . . . 0.0 113.064 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.7 m -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.68 1.127 . . . . 0.0 111.506 170.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.87 -15.01 46.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.881 0.872 . . . . 0.0 112.182 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -49.6 -44.64 47.32 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 125.754 1.622 . . . . 0.0 113.555 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -64.1 -40.78 96.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.552 0.614 . . . . 0.0 111.432 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.36 -37.86 65.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.342 0.657 . . . . 0.0 110.545 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.4 tt -59.67 -56.61 19.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.259 1.424 . . . . 0.0 109.742 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -26.24 61.9 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 122.807 0.443 . . . . 0.0 111.384 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -55.67 -18.57 8.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.09 0.556 . . . . 0.0 112.416 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.8 m -131.35 19.39 4.83 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.537 1.535 . . . . 0.0 111.551 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.04 46.97 0.61 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.475 1.51 . . . . 0.0 108.524 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.18 15.78 2.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 112.81 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.4 m 64.34 41.92 5.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 108.776 -169.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -147.73 -78.08 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.489 1.115 . . . . 0.0 108.804 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.83 -34.64 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.297 0.639 . . . . 0.0 110.444 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 129.926 3.29 . . . . 0.0 104.69 169.739 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.771 0.319 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -66.89 165.04 16.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.955 0.902 . . . . 0.0 110.958 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.1 -127.51 0.92 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.3 mmt -59.84 -15.14 18.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.828 0.814 . . . . 0.0 112.393 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -57.02 -25.73 59.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.262 1.425 . . . . 0.0 112.163 169.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.31 71.85 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.311 1.044 . . . . 0.0 108.437 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.18 -8.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.23 153.06 38.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.096 1.316 . . . . 0.0 109.187 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.3 tptt 54.18 35.46 22.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.285 1.434 . . . . 0.0 111.306 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.85 -10.42 59.54 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.713 -0.617 . . . . 0.0 111.712 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.66 -170.82 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.831 2.452 . . . . 0.0 106.142 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -70.23 42.91 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.448 1.899 . . . . 0.0 112.842 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.67 154.25 66.91 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.116 1.366 . . . . 0.0 110.251 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.12 145.28 54.59 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.733 2.288 . . . . 0.0 112.27 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -127.59 31.06 5.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.289 1.036 . . . . 0.0 112.132 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.17 55.72 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.118 0.866 . . . . 0.0 111.03 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.16 160.14 24.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -116.43 144.76 43.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.84 136.79 30.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.624 0.77 . . . . 0.0 110.03 -169.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.8 tp -77.57 134.55 38.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 102.849 -3.019 . . . . 0.0 102.849 167.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.25 149.88 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.655 1.116 . . . . 0.0 108.781 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.92 151.81 44.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.225 1.01 . . . . 0.0 110.15 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -95.49 143.72 26.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -139.38 94.4 2.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.044 1.338 . . . . 0.0 107.517 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.47 -74.52 0.71 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.279 1.419 . . . . 0.0 111.456 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.69 29.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.067 1.347 . . . . 0.0 110.603 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.14 160.87 38.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.31 1.444 . . . . 0.0 108.111 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.18 151.64 45.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.808 1.289 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.9 155.76 47.03 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.634 1.974 . . . . 0.0 107.729 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.57 157.91 22.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -142.61 134.48 25.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -50.07 119.07 3.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.464 0.706 . . . . 0.0 109.378 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -54.8 -34.65 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.871 0.868 . . . . 0.0 111.285 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.65 -22.15 66.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.554 0.742 . . . . 0.0 112.735 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.66 -21.09 32.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.07 0.85 . . . . 0.0 111.688 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.09 140.72 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.84 -42.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.496 1.119 . . . . 0.0 110.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -161.53 171.02 18.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.383 1.073 . . . . 0.0 108.815 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.1 147.59 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -150.17 173.99 13.3 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.56 163.67 26.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -60.27 136.76 58.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.0 -55.14 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.96 84.25 1.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -169.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.14 119.02 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 m -78.64 93.2 4.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -78.1 88.73 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.79 137.46 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.2 -17.93 60.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -137.11 37.92 2.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.68 1.192 . . . . 0.0 111.017 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 53' ' ' ALA . 27.1 p -60.82 166.48 4.53 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 121.804 -0.56 . . . . 0.0 111.897 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.6 20.21 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 123.227 2.618 . . . . 0.0 111.358 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' THR . . . 59.1 -39.91 0.07 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 131.319 3.848 . . . . 0.0 116.938 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -52.97 -44.18 66.95 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 120.326 1.421 . . . . 0.0 108.509 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.99 110.29 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -67.79 -34.91 77.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.58 -153.52 21.19 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -117.71 162.4 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.45 150.41 34.55 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.287 -1.508 . . . . 0.0 110.117 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.05 135.22 46.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.226 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.37 97.44 5.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.512 1.125 . . . . 0.0 109.434 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 57.17 17.28 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 113.334 172.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.41 6.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.002 1.287 . . . . 0.0 113.007 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.34 -172.05 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.93 1.292 . . . . 0.0 108.295 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.15 155.01 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.834 1.253 . . . . 0.0 110.393 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.39 141.97 15.21 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.626 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.08 140.15 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.097 1.865 . . . . 0.0 109.27 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 tp -126.18 135.15 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.18 148.76 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.806 2.042 . . . . 0.0 106.028 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -125.78 128.56 47.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.06 -18.93 65.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.986 0.914 . . . . 0.0 111.346 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -58.88 -25.53 63.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.815 -1.178 . . . . 0.0 110.531 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.36 -30.8 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.516 1.526 . . . . 0.0 110.085 -169.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -92.77 -22.03 19.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.21 0.914 . . . . 0.0 113.004 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -132.83 3.1 3.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.278 0.944 . . . . 0.0 111.807 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 m 51.39 41.7 28.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.86 1.264 . . . . 0.0 111.402 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -57.41 170.96 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.715 0.806 . . . . 0.0 111.175 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 m -58.13 169.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.02 0.914 . . . . 0.0 109.416 168.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.28 62.51 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.468 2.307 . . . . 0.0 111.349 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -45.42 150.93 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.287 2.235 . . . . 0.0 111.759 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -152.11 165.15 35.66 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.249 1.42 . . . . 0.0 108.449 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -74.6 53.18 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 0.0 110.597 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -151.46 -21.96 0.2 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.245 3.418 . . . . 0.0 109.708 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.79 7.52 2.75 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.538 1.535 . . . . 0.0 111.659 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -154.69 40.52 0.45 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.137 2.175 . . . . 0.0 108.567 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 p -88.96 7.14 36.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.586 1.954 . . . . 0.0 115.362 -168.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.49 157.43 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.4 136.19 55.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.67 134.32 48.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.7 mt -133.82 164.22 27.74 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 108.007 -171.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.97 154.09 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.313 0.645 . . . . 0.0 110.113 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mp -136.51 80.81 1.84 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.4 -68.95 2.34 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.676 -0.64 . . . . 0.0 113.214 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -137.01 0.6 2.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.402 1.881 . . . . 0.0 111.833 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.92 165.55 22.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.502 1.121 . . . . 0.0 109.103 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.39 150.45 32.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.019 0.927 . . . . 0.0 109.18 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.91 165.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.02 32.15 Favored Glycine 0 N--CA 1.451 -0.364 0 O-C-N 121.118 -0.989 . . . . 0.0 111.683 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.29 164.56 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 109.847 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 m -111.37 132.13 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.153 1.781 . . . . 0.0 108.183 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.89 164.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.97 1.308 . . . . 0.0 109.611 -168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.3 -41.67 73.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.13 158.94 20.93 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.32 123.12 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -48.3 15.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.921 0.888 . . . . 0.0 109.682 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -173.44 -174.54 1.02 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 108.02 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.73 128.76 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.56 173.22 11.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.217 1.407 . . . . 0.0 108.923 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.3 m -130.92 139.05 50.03 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.3 161.12 38.65 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 m -132.9 157.21 45.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.09 1.756 . . . . 0.0 108.238 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -17.36 24.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.86 -36.33 80.09 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.24 -40.46 19.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.606 1.562 . . . . 0.0 110.434 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.05 103.67 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -140.54 -55.84 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 116.936 -1.507 . . . . 0.0 111.423 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.48 173.2 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.97 157.51 30.74 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.0 1.72 . . . . 0.0 108.89 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.41 143.66 48.36 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.817 1.678 . . . . 0.0 109.457 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.14 22.75 0.65 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.035 1.334 . . . . 0.0 110.335 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.63 176.85 5.83 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.275 1.43 . . . . 0.0 111.442 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.23 66.48 0.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.739 1.615 . . . . 0.0 110.603 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.45 172.83 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.846 1.658 . . . . 0.0 109.433 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -15.63 61.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.283 1.433 . . . . 0.0 113.724 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.82 144.41 54.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.937 . . . . 0.0 110.206 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.8 m -138.32 162.26 34.82 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.28 1.032 . . . . 0.0 109.791 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -57.45 -27.52 62.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 114.338 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -74.69 -24.09 58.72 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.623 -0.673 . . . . 0.0 111.895 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -127.2 -3.35 6.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.087 0.955 . . . . 0.0 112.73 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.08 161.47 5.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.614 0.643 . . . . 0.0 110.76 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.2 p -113.69 -166.54 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.8 1.64 . . . . 0.0 110.407 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.4 168.69 23.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.6 154.61 39.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.913 1.857 . . . . 0.0 111.0 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.3 173.38 40.27 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.092 0.377 . . . . 0.0 112.853 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.15 157.26 17.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.927 0.891 . . . . 0.0 111.13 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.06 85.06 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.16 -55.0 2.3 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.751 2.119 . . . . 0.0 112.862 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -150.34 -28.12 0.23 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.199 2.199 . . . . 0.0 111.524 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -69.12 163.3 25.12 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.754 0.707 . . . . 0.0 109.529 171.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.99 134.59 47.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.83 134.82 51.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.06 107.11 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.04 109.99 13.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.51 130.55 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.857 1.263 . . . . 0.0 108.434 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -74.87 57.03 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.442 1.897 . . . . 0.0 109.867 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -46.71 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.825 1.65 . . . . 0.0 111.268 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -66.86 -10.0 43.65 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.6 -14.93 16.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.471 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.6 tp -55.5 -78.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.812 1.245 . . . . 0.0 111.325 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.6 tp -77.32 -20.47 54.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.99 0.813 . . . . 0.0 111.257 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.07 -39.96 79.83 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.259 -0.9 . . . . 0.0 111.661 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 -19.92 17.29 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.024 -0.512 . . . . 0.0 112.058 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.98 -10.52 57.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.763 1.165 . . . . 0.0 112.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.73 -44.34 58.23 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 121.303 1.865 . . . . 0.0 112.028 -171.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.9 mtm -65.23 -46.09 82.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.29 0.636 . . . . 0.0 110.311 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.45 74.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.53 0.732 . . . . 0.0 111.787 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.58 -64.17 1.04 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.61 -31.46 72.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -169.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -55.21 -23.1 20.39 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.2 m -137.13 19.82 2.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.96 1.304 . . . . 0.0 111.892 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -152.74 13.03 0.53 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.92 12.21 0.56 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.523 1.129 . . . . 0.0 112.955 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.0 m 74.37 -34.79 0.28 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.134 2.574 . . . . 0.0 113.173 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.51 -11.99 48.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.734 1.213 . . . . 0.0 111.935 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.23 6.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.372 1.869 . . . . 0.0 111.419 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.399 178.174 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.1 m -144.77 146.36 32.1 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.62 -21.07 1.84 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.651 0.643 . . . . 0.0 112.749 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -61.07 162.42 7.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.133 0.973 . . . . 0.0 110.518 170.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -57.28 -17.04 10.09 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.44 1.496 . . . . 0.0 114.318 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -46.74 -33.46 4.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.876 1.271 . . . . 0.0 112.884 171.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -58.28 -19.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -135.24 23.76 3.5 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.2 1.4 . . . . 0.0 109.322 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -152.23 57.89 0.83 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.87 -35.92 75.82 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.526 0.731 . . . . 0.0 109.407 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.74 -66.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.05 1.34 . . . . 0.0 108.544 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -172.73 47.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.649 1.18 . . . . 0.0 110.616 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.08 140.57 31.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.754 1.222 . . . . 0.0 110.73 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.45 168.11 25.2 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.666 2.244 . . . . 0.0 111.753 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -55.33 147.58 16.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.669 1.587 . . . . 0.0 111.825 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.35 94.72 1.43 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.854 1.693 . . . . 0.0 109.151 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -69.67 167.08 17.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 110.143 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.93 146.15 50.73 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.604 1.561 . . . . 0.0 107.417 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -142.15 140.32 32.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.612 0.765 . . . . 0.0 110.289 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.5 tp -80.39 134.45 36.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.36 148.29 27.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 109.123 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.14 153.68 45.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.509 1.124 . . . . 0.0 110.123 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -95.52 149.39 21.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.46 128.41 7.35 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.31 -89.51 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.71 34.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.352 1.461 . . . . 0.0 109.145 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -143.44 158.89 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.829 1.651 . . . . 0.0 107.871 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 155.55 28.05 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 123.251 1.5 . . . . 0.0 110.299 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -142.23 160.97 39.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.913 2.085 . . . . 0.0 107.338 -171.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.8 164.12 26.45 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.784 0.707 . . . . 0.0 111.729 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -144.68 136.15 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -49.26 118.8 2.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.15 0.98 . . . . 0.0 109.343 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.21 -33.83 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.814 0.846 . . . . 0.0 111.566 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.73 -23.39 67.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.434 0.694 . . . . 0.0 112.604 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -81.01 -19.13 44.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.272 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.54 142.24 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.267 1.394 . . . . 0.0 109.162 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -125.57 -39.84 2.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.121 1.369 . . . . 0.0 110.781 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -167.04 171.24 11.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.663 1.585 . . . . 0.0 107.754 175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.19 140.81 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -149.95 176.67 10.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 108.564 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.63 173.89 44.19 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -59.11 -31.06 68.59 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.83 -0.806 . . . . 0.0 112.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.0 t0 34.22 -90.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 129.33 3.052 . . . . 0.0 116.588 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 66.53 1.34 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 113.405 -169.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.57 133.9 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 m -70.88 -42.18 70.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.579 1.152 . . . . 0.0 111.593 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.03 89.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.75 2.02 . . . . 0.0 109.33 -169.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.9 150.87 6.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.77 66.73 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.71 20.85 0.61 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -172.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.71 148.39 47.24 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.41 121.46 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 N-CA-C 105.639 -2.485 . . . . 0.0 105.639 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.84 -33.03 0.69 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -168.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.09 -38.24 37.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.023 0.829 . . . . 0.0 110.976 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.8 mt -93.39 105.2 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.8 -57.45 12.64 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.43 -173.19 36.19 Favored Glycine 0 C--O 1.227 -0.315 0 O-C-N 121.021 -1.049 . . . . 0.0 111.73 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -83.6 153.82 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -138.09 160.66 38.81 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.94 108.36 19.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.522 -0.736 . . . . 0.0 111.556 -172.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.2 72.67 3.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.66 -0.65 . . . . 0.0 110.685 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 49.89 28.78 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.684 1.594 . . . . 0.0 114.422 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.93 -20.61 2.15 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.371 0.986 . . . . 0.0 113.063 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -169.25 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.829 1.252 . . . . 0.0 107.806 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.72 148.63 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.766 -1.209 . . . . 0.0 110.08 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 p -148.87 134.56 9.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.93 138.9 45.7 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.314 2.676 . . . . 0.0 110.685 170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.84 135.32 63.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.386 1.089 . . . . 0.0 109.12 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.87 162.87 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.556 2.342 . . . . 0.0 105.188 169.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -139.79 145.05 37.71 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 120.652 -1.28 . . . . 0.0 109.409 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.11 -21.66 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.647 1.179 . . . . 0.0 112.917 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -70.34 -11.13 60.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.707 1.594 . . . . 0.0 112.213 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.16 20.92 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 0.0 109.034 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -141.55 -23.7 0.72 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.657 1.183 . . . . 0.0 111.449 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -139.39 12.16 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.561 1.144 . . . . 0.0 111.991 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.0 m 54.26 38.95 30.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.488 1.515 . . . . 0.0 112.427 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 156.2 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -40.85 -67.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.657 2.383 . . . . 0.0 113.268 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -169.77 97.63 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.832 1.653 . . . . 0.0 109.13 -169.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.28 143.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.176 0.99 . . . . 0.0 109.593 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.25 158.23 35.75 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.109 1.364 . . . . 0.0 108.767 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -69.46 42.48 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.932 2.093 . . . . 0.0 113.143 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.86 -12.02 0.16 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.159 2.183 . . . . 0.0 110.671 169.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -125.51 -5.53 7.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.558 1.543 . . . . 0.0 111.98 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.98 38.83 2.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.271 1.428 . . . . 0.0 108.972 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -102.15 -4.73 25.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.561 . . . . 0.0 114.376 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.34 155.36 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.5 t -133.33 137.14 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.57 124.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.64 140.22 17.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -135.76 162.65 32.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.992 1.717 . . . . 0.0 107.843 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.05 148.86 39.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.178 1.391 . . . . 0.0 108.027 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.44 151.1 29.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.53 -102.54 0.11 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -139.62 34.07 2.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.498 1.519 . . . . 0.0 109.809 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.1 167.76 21.32 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.779 1.632 . . . . 0.0 109.297 -171.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.04 151.19 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 124.157 0.983 . . . . 0.0 109.547 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.67 176.78 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.854 1.661 . . . . 0.0 107.204 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.61 179.48 41.51 Favored Glycine 0 N--CA 1.448 -0.537 0 O-C-N 120.685 -1.259 . . . . 0.0 111.427 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.4 pt -141.65 158.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.587 1.155 . . . . 0.0 109.542 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.09 145.11 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.8 172.4 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.634 1.574 . . . . 0.0 110.606 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.22 -43.51 51.35 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.98 -0.45 . . . . 0.0 109.831 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.46 155.68 10.57 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 129.0 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -41.36 10.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.427 0.691 . . . . 0.0 111.802 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.2 t0 -167.57 -175.67 2.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 110.727 -168.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -135.84 125.28 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.18 166.53 24.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 110.191 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 m -125.37 141.24 52.18 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.201 0.6 . . . . 0.0 110.42 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.1 139.04 30.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.438 1.095 . . . . 0.0 108.398 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 p -82.95 153.31 25.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.18 -16.73 35.46 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.5 -42.04 75.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.003 1.321 . . . . 0.0 110.037 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -58.67 -39.58 81.05 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.749 0.819 . . . . 0.0 109.359 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.1 mt -77.77 0.63 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 126.314 1.846 . . . . 0.0 112.151 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -53.59 -53.57 55.57 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.167 -1.583 . . . . 0.0 114.344 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.39 175.71 9.68 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.346 2.03 . . . . 0.0 112.396 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.5 163.32 24.56 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.244 1.418 . . . . 0.0 109.313 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.4 -50.0 9.35 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.762 2.308 . . . . 0.0 113.018 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 51.24 20.15 0.87 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.912 2.085 . . . . 0.0 114.219 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -73.93 160.09 31.87 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 110.033 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.92 32.51 0.14 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.867 1.667 . . . . 0.0 112.8 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.27 -175.21 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.927 1.291 . . . . 0.0 109.952 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -11.23 21.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.885 1.274 . . . . 0.0 113.92 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.74 156.29 33.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.446 1.499 . . . . 0.0 110.459 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.1 m -137.13 156.45 48.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.044 0.938 . . . . 0.0 109.752 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 p -64.89 -24.12 67.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.957 1.303 . . . . 0.0 113.426 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.02 -34.24 73.03 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -127.18 30.74 5.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.261 1.424 . . . . 0.0 109.06 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 131.15 49.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.466 1.106 . . . . 0.0 108.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.8 p -69.78 -177.92 1.39 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.68 1.592 . . . . 0.0 110.491 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -125.53 179.14 16.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 169.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.32 157.59 43.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.253 1.527 . . . . 0.0 108.808 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.13 172.6 34.03 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.11 20.84 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.14 0.576 . . . . 0.0 109.778 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.1 82.56 1.76 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.77 2.66 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.582 2.039 . . . . 0.0 112.995 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.68 -31.25 0.09 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.033 2.133 . . . . 0.0 111.103 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.4 HH22 ' HB2' ' A' ' 107' ' ' ASP . 59.0 mtp180 -68.94 162.99 25.49 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.0 mtp -139.8 144.94 37.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.18 126.13 29.3 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.8 mt -81.47 111.62 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.53 111.08 22.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.1 t -67.41 131.09 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 108.329 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -75.79 62.22 1.51 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.225 1.01 . . . . 0.0 109.734 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -43.98 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.895 1.678 . . . . 0.0 110.33 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.23 -18.41 63.5 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 112.814 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -111.16 -10.74 14.3 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.956 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.0 -67.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.005 1.275 . . . . 0.0 110.08 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.67 -39.89 84.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.071 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -55.42 -48.51 74.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 0.0 110.717 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 m -82.15 -16.29 50.32 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 112.779 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.08 3.28 33.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.984 1.265 . . . . 0.0 112.783 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.26 -42.06 97.98 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.501 -1.374 . . . . 0.0 110.615 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.1 ptp -62.08 -28.97 69.99 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.719 -0.613 . . . . 0.0 112.004 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.86 32.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.0 tp -56.95 -53.62 55.99 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.97 -14.62 61.93 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.436 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -55.51 -25.84 39.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.381 1.446 . . . . 0.0 111.849 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 m -123.16 -34.33 3.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.698 1.199 . . . . 0.0 111.535 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' A' ' 164' ' ' SER . . . -82.71 4.98 22.84 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.52 12.56 0.33 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.47 1.032 . . . . 0.0 111.456 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 162' ' ' ALA . 9.8 m 70.44 14.89 7.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.531 2.332 . . . . 0.0 111.784 -169.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.89 -28.76 49.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.5 0.72 . . . . 0.0 111.09 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -136.02 -42.92 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.128 0.971 . . . . 0.0 110.166 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.85 173.743 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -59.13 -39.43 82.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.828 1.251 . . . . 0.0 113.2 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.92 9.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.215 1.388 . . . . 0.0 110.032 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.3 ptm -59.42 -25.61 64.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 p -63.02 -25.33 68.33 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.727 1.211 . . . . 0.0 112.031 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -78.43 87.39 4.44 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.5 m -57.23 -19.79 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 0.0 112.625 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.5 m 67.46 -50.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.022 2.529 . . . . 0.0 113.243 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -152.89 -57.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.4 1.08 . . . . 0.0 109.052 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.1 tp 45.65 50.84 10.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.189 1.796 . . . . 0.0 111.864 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.05 -20.02 2.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.193 0.997 . . . . 0.0 112.633 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -142.75 38.34 1.48 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.651 1.58 . . . . 0.0 108.258 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.37 156.94 74.9 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 0.0 108.938 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.37 136.96 57.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.435 2.09 . . . . 0.0 111.824 -173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.6 m -122.81 31.65 5.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.77 1.228 . . . . 0.0 110.65 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.39 52.69 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.997 1.284 . . . . 0.0 110.523 171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -66.02 146.79 54.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.18 145.6 33.97 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -142.01 138.38 31.81 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.171 0.989 . . . . 0.0 110.175 -169.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -84.19 137.47 33.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 167.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.256 1.5 m -125.7 146.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 119.439 1.018 . . . . 0.0 108.525 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -143.23 153.79 43.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.085 1.354 . . . . 0.0 110.393 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 m -95.17 143.8 26.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.81 103.98 4.78 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.49 -78.49 0.25 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.331 1.443 . . . . 0.0 111.781 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.26 30.19 0.55 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.608 1.163 . . . . 0.0 111.032 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.77 161.04 39.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.577 1.151 . . . . 0.0 108.568 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -115.65 149.39 38.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.97 1.367 . . . . 0.0 109.817 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -139.3 165.65 26.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 107.403 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.41 169.06 28.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 119.15 0.886 . . . . 0.0 113.534 170.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 mt -144.01 137.73 24.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.06 118.65 3.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.881 0.872 . . . . 0.0 109.015 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -53.64 -32.81 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.708 0.803 . . . . 0.0 111.747 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.53 -24.49 67.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.04 0.836 . . . . 0.0 112.72 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.32 -21.36 39.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.278 0.945 . . . . 0.0 111.113 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.09 138.41 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -113.25 -46.18 3.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.559 1.144 . . . . 0.0 109.46 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -162.65 177.32 9.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.869 1.268 . . . . 0.0 108.803 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -139.41 143.27 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 172.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -134.29 -104.88 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 0.0 110.764 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 154.65 11.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -169.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -68.42 125.72 27.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -156.84 -48.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -150.9 50.66 0.86 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.04 0.936 . . . . 0.0 109.894 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.74 112.07 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 m -95.31 89.17 5.37 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.69 144.85 56.69 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.4 mm -84.39 28.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.236 1.014 . . . . 0.0 109.071 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 65.37 -31.4 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.127 2.571 . . . . 0.0 115.144 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.63 24.52 0.78 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.531 1.532 . . . . 0.0 112.924 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.28 144.88 97.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 110.232 169.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.69 142.34 14.26 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.752 2.968 . . . . 0.0 111.11 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.52 69.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.735 0.414 . . . . 0.0 110.59 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -65.75 0.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 0.0 114.191 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.04 -35.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 124.804 1.242 . . . . 0.0 110.996 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 mttm 57.17 -75.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.344 1.858 . . . . 0.0 110.795 -168.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.1 -123.93 1.13 Allowed Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 121.247 1.84 . . . . 0.0 110.99 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.13 169.47 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -143.53 158.79 43.38 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 120.838 -1.164 . . . . 0.0 108.383 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -72.9 137.86 45.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 110.013 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.39 173.64 7.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.21 65.44 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.38 1.072 . . . . 0.0 112.933 -169.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.23 -8.69 4.74 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.241 2.353 . . . . 0.0 113.106 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -152.94 -165.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 119.189 1.494 . . . . 0.0 109.417 -169.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -125.59 159.35 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.589 1.956 . . . . 0.0 108.035 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.45 133.49 10.05 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.3 130.72 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.653 1.568 . . . . 0.0 108.428 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.17 134.83 55.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -126.35 144.22 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.02 109.5 20.85 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.64 -17.21 45.86 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.923 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.0 -37.89 21.65 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.969 1.258 . . . . 0.0 111.005 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.34 -38.59 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -69.65 -12.91 62.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.755 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -122.59 -3.96 8.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.001 1.273 . . . . 0.0 113.547 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m 49.61 47.05 23.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.826 1.251 . . . . 0.0 111.796 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -177.71 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.649 0.737 . . . . 0.0 110.926 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.16 170.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.69 1.196 . . . . 0.0 110.997 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.53 63.3 5.77 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 110.541 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.73 164.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.611 1.164 . . . . 0.0 111.508 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -154.36 172.77 17.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.872 1.669 . . . . 0.0 108.58 -172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -70.89 54.92 0.17 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.001 1.381 . . . . 0.0 111.111 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.404 ' H ' ' H ' ' A' ' 84' ' ' ASP . 42.1 t30 -154.66 -19.27 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 131.085 3.754 . . . . 0.0 109.288 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 83' ' ' ASN . 27.6 t70 -141.0 16.92 2.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.803 2.041 . . . . 0.0 110.822 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -159.79 42.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.407 3.083 . . . . 0.0 106.929 -173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.7 p -99.18 6.78 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -168.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.5 t -126.36 151.4 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.349 1.431 . . . . 0.0 108.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.43 141.99 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.48 128.12 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.52 135.37 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.1 mt -134.54 162.26 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.64 1.576 . . . . 0.0 109.046 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.69 145.64 33.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 107.676 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.64 151.56 20.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.29 -94.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.742 1.163 . . . . 0.0 112.728 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.03 21.14 3.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.189 1.796 . . . . 0.0 110.975 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -145.43 173.79 11.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.011 -1.055 . . . . 0.0 112.824 -169.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.73 142.42 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.767 2.027 . . . . 0.0 106.234 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.07 178.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 125.563 1.545 . . . . 0.0 106.859 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.78 179.0 41.39 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.97 146.65 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.1 144.22 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.25 166.67 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.845 2.058 . . . . 0.0 107.602 -173.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.22 -44.92 71.07 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.241 -0.912 . . . . 0.0 109.893 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.94 162.1 24.46 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 m -74.87 127.48 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.71 -43.53 13.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.254 1.021 . . . . 0.0 110.166 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -171.0 176.74 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 110.762 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.97 131.72 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.841 2.057 . . . . 0.0 106.971 169.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.86 -178.49 5.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.337 1.055 . . . . 0.0 109.863 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 m -130.17 151.88 50.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.948 0.795 . . . . 0.0 112.069 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.46 163.93 31.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.61 1.564 . . . . 0.0 109.914 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.7 p -114.22 167.44 10.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.687 1.195 . . . . 0.0 111.522 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.31 -9.66 35.08 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.939 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.85 -52.02 11.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.04 -36.4 83.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.379 1.072 . . . . 0.0 111.493 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.7 mt -103.56 106.57 20.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -145.82 -53.07 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.205 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.79 176.64 3.46 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.879 1.719 . . . . 0.0 111.733 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.17 160.63 32.96 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.56 1.944 . . . . 0.0 107.775 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.01 -45.47 5.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.733 1.622 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 45.58 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 131.693 3.997 . . . . 0.0 119.932 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -153.59 160.31 42.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.437 1.471 . . . . 0.0 109.338 -173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.25 35.41 16.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.838 1.655 . . . . 0.0 112.647 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.89 156.57 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.901 1.681 . . . . 0.0 107.913 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -12.46 61.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.978 1.311 . . . . 0.0 113.015 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -54.79 162.52 1.21 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.171 2.988 . . . . 0.0 113.596 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m -135.6 151.24 50.07 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.963 0.905 . . . . 0.0 111.969 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.89 -29.21 27.01 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.877 2.471 . . . . 0.0 114.389 -169.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -62.07 -32.3 72.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -147.47 31.19 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.259 1.023 . . . . 0.0 110.61 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 18.49 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.4 p 64.01 -175.27 0.16 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.936 1.694 . . . . 0.0 112.176 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.72 177.52 20.11 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 106.396 -2.681 . . . . 0.0 106.396 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.65 158.67 44.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.677 1.238 . . . . 0.0 109.268 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.06 177.46 32.29 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.98 152.96 33.49 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.817 0.847 . . . . 0.0 109.652 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.79 82.59 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.147 1.379 . . . . 0.0 107.405 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.23 -48.44 2.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.586 2.041 . . . . 0.0 113.56 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -156.43 -35.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.29 2.236 . . . . 0.0 110.353 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -71.09 165.97 22.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.848 0.832 . . . . 0.0 110.142 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.7 mtp -136.95 147.97 46.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -137.9 129.95 28.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.5 mt -85.38 114.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.82 112.62 24.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.85 133.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.317 1.047 . . . . 0.0 108.36 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.88 61.38 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.36 -39.83 45.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.701 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.0 -13.34 45.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.021 0.828 . . . . 0.0 112.729 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -111.16 -12.59 14.12 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 117.039 -1.458 . . . . 0.0 112.649 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -54.66 -73.26 0.05 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.801 1.24 . . . . 0.0 111.088 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.9 -23.98 28.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.801 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -58.56 -28.64 65.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 111.491 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.0 m -96.17 -39.83 9.5 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.77 0.713 . . . . 0.0 110.883 173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.88 -10.81 59.62 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.769 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -49.78 -47.83 50.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 121.613 2.006 . . . . 0.0 112.035 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -67.06 -43.87 81.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.099 0.56 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.74 -31.2 71.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.548 0.739 . . . . 0.0 111.964 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.45 -60.57 2.19 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.98 -28.06 69.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.978 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.58 -37.32 7.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 111.989 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 73.7 m -137.42 32.15 2.57 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.275 1.03 . . . . 0.0 111.081 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.53 25.68 1.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.763 1.225 . . . . 0.0 110.739 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.27 -0.26 9.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.149 0.98 . . . . 0.0 113.154 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.0 m 68.97 -32.74 0.23 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.659 2.383 . . . . 0.0 112.873 -171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.62 -28.25 69.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.718 1.207 . . . . 0.0 110.573 169.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.67 -22.64 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.945 1.298 . . . . 0.0 112.429 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.955 0.902 . . . . 0.0 111.194 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.3 p -67.2 -19.97 65.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.695 1.198 . . . . 0.0 112.723 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.69 -179.22 39.75 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.8 mtm -143.34 170.21 16.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.811 1.244 . . . . 0.0 109.153 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.259 16.7 p 49.59 39.76 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.594 1.957 . . . . 0.0 112.626 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -73.96 62.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.078 1.351 . . . . 0.0 109.159 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -57.73 142.3 13.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.429 1.092 . . . . 0.0 110.707 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -72.38 139.27 47.76 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 169.11 9.17 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.619 -0.676 . . . . 0.0 110.076 172.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 85.56 2.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.52 -18.21 0.54 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.133 0.973 . . . . 0.0 113.473 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -151.09 41.76 0.75 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.85 1.66 . . . . 0.0 108.027 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -133.8 159.09 73.81 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.478 1.911 . . . . 0.0 109.592 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.93 -163.06 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.436 2.757 . . . . 0.0 109.353 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -45.12 134.11 6.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.417 1.487 . . . . 0.0 111.096 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.18 95.84 0.73 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -75.85 165.13 25.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.815 1.246 . . . . 0.0 108.482 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -133.12 143.42 49.26 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -139.36 141.09 37.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.779 0.432 . . . . 0.0 110.424 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -82.33 128.86 34.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.38 147.31 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.329 0.968 . . . . 0.0 108.889 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.74 153.73 42.74 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.249 1.02 . . . . 0.0 109.898 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -92.73 146.92 23.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.23 125.74 14.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -88.7 0.16 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -154.26 34.76 0.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.331 1.452 . . . . 0.0 109.796 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.64 158.2 43.9 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 107.602 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.62 156.21 34.75 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.022 1.391 . . . . 0.0 111.887 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -144.92 161.25 39.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.021 2.528 . . . . 0.0 107.127 -171.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.96 25.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.364 0.983 . . . . 0.0 111.035 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mt -137.46 137.92 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -47.38 115.86 1.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.585 1.154 . . . . 0.0 110.213 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.09 -33.79 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.104 0.962 . . . . 0.0 111.753 -169.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.54 -25.73 68.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.672 0.789 . . . . 0.0 112.66 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -79.26 -20.18 48.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.868 0.758 . . . . 0.0 111.883 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.14 128.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 118.902 0.774 . . . . 0.0 109.027 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -86.99 -60.28 2.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -163.65 -176.74 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.274 1.43 . . . . 0.0 109.012 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.29 145.95 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' A' ' 41' ' ' GLY . 1.3 tmm_? -144.0 173.84 11.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.561 1.944 . . . . 0.0 106.278 -177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 40' ' ' ARG . . . -101.73 172.1 22.49 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.133 -0.98 . . . . 0.0 111.172 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -67.88 120.97 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 168.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.44 -48.98 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -150.92 86.42 1.37 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.887 0.875 . . . . 0.0 109.01 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.15 161.21 2.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.77 130.82 17.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -134.99 129.67 34.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.367 0.985 . . . . 0.0 108.982 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.19 137.44 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -8.96 25.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -130.43 34.0 4.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.081 1.752 . . . . 0.0 109.829 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 149.45 84.55 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.141 0.576 . . . . 0.0 111.192 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.84 26.18 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.835 3.69 . . . . 0.0 112.026 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.87 -37.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.918 2.887 . . . . 0.0 115.821 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -56.17 -44.13 79.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.711 1.142 . . . . 0.0 109.565 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.25 88.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -60.14 -26.68 66.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.133 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.02 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.435 1.017 . . . . 0.0 111.019 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 151.12 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 t -134.33 151.09 51.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.986 0.812 . . . . 0.0 109.369 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -66.08 107.64 1.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.404 1.082 . . . . 0.0 109.173 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.51 64.81 3.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 49.81 30.22 3.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.467 1.507 . . . . 0.0 113.209 169.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.49 -25.46 1.08 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.856 1.217 . . . . 0.0 113.387 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.46 -165.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 107.877 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 tp -130.32 147.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.451 1.478 . . . . 0.0 110.624 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.55 138.73 15.63 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.5 143.78 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.404 2.069 . . . . 0.0 110.596 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -127.84 135.55 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.2 167.04 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -129.08 116.52 19.4 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 mt -66.82 -17.29 64.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.358 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -54.75 -42.33 71.52 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.835 1.198 . . . . 0.0 110.333 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.36 -44.19 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -60.89 -23.75 65.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.42 -3.54 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.043 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.9 m 49.55 48.64 21.13 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.031 1.287 . . . . 0.0 110.57 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.31 -171.22 0.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 110.864 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.78 164.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.36 1.064 . . . . 0.0 110.225 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -84.06 62.89 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.273 1.829 . . . . 0.0 110.575 -169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 m -53.25 158.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.714 0.806 . . . . 0.0 111.036 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -144.03 178.03 8.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.237 1.415 . . . . 0.0 108.643 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.65 64.18 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.123 1.769 . . . . 0.0 109.484 169.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.36 -35.73 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 131.563 3.945 . . . . 0.0 108.456 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -145.98 30.7 1.05 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.641 1.976 . . . . 0.0 110.072 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -154.97 28.81 0.42 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.268 3.027 . . . . 0.0 107.666 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 p -106.51 12.17 29.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.538 1.935 . . . . 0.0 115.95 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.77 154.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.33 113.79 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -82.21 141.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 137.02 47.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.0 mt -135.82 154.85 51.06 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.531 1.532 . . . . 0.0 109.112 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 139.67 37.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.97 155.25 35.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.28 -100.49 0.04 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.2 0.905 . . . . 0.0 111.656 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -136.57 27.7 3.05 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.613 1.965 . . . . 0.0 109.958 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -146.97 171.04 15.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.2 144.79 34.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 125.363 1.465 . . . . 0.0 107.456 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.48 -176.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.78 176.54 41.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 pt -140.33 144.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.191 0.519 . . . . 0.0 110.343 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.51 142.9 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.944 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.44 166.05 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.654 1.982 . . . . 0.0 108.021 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.53 -41.48 65.79 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.94 151.81 8.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.29 128.98 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -36.5 10.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.203 0.601 . . . . 0.0 111.772 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.3 t0 -169.09 -178.4 3.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.593 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.1 t -137.48 122.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 103.984 -2.598 . . . . 0.0 103.984 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -141.16 150.25 42.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.456 0.702 . . . . 0.0 110.718 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 p -94.86 135.68 36.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.418 0.687 . . . . 0.0 109.639 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mp -138.18 143.31 40.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 67.5 p -100.4 164.8 11.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.55 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.91 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -104.89 -36.2 7.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.772 1.629 . . . . 0.0 110.052 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.41 -45.92 82.04 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.49 112.75 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -148.19 -62.86 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.802 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.18 -178.08 3.03 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.105 1.87 . . . . 0.0 111.539 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.32 155.55 39.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.564 1.946 . . . . 0.0 108.097 169.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.23 59.43 7.39 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.111 3.207 . . . . 0.0 111.107 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.63 29.18 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.077 1.751 . . . . 0.0 112.863 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.11 -174.46 1.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.746 1.618 . . . . 0.0 110.401 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 28.75 0.06 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.269 1.428 . . . . 0.0 113.468 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.72 161.37 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.828 1.651 . . . . 0.0 109.475 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -44.57 95.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -62.88 166.01 6.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 m -134.19 175.2 9.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.2 1.4 . . . . 0.0 110.64 -169.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -56.15 -27.71 55.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.88 -30.2 56.11 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.337 0.972 . . . . 0.0 111.157 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -110.97 -9.55 14.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.093 0.957 . . . . 0.0 112.505 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.7 160.91 5.15 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.559 0.744 . . . . 0.0 112.132 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 146' ' ' ASN . 38.8 p -114.15 166.31 11.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.392 1.877 . . . . 0.0 108.757 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.86 176.53 45.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.59 145.78 39.0 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.3 174.72 37.07 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.04 39.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.018 0.927 . . . . 0.0 110.184 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.25 82.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.33 -51.9 2.57 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.623 2.059 . . . . 0.0 112.98 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -157.35 -31.4 0.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.147 2.179 . . . . 0.0 111.076 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.443 HH22 ' HB2' ' A' ' 107' ' ' ASP . 66.0 mtp180 -68.79 162.21 26.82 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.6 mtp -138.87 144.15 39.06 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.25 128.09 35.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.55 120.72 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.51 102.9 15.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.44 120.74 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.068 1.347 . . . . 0.0 108.956 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 132' ' ' THR . 40.4 t30 -75.99 60.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.133 1.773 . . . . 0.0 110.121 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.45 -35.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.089 1.356 . . . . 0.0 111.24 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -68.7 -5.94 23.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -134.26 18.8 3.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.068 1.347 . . . . 0.0 110.667 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.1 tp -79.2 -88.28 0.06 Allowed 'General case' 0 C--N 1.341 0.222 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.0 tp -68.95 -31.51 70.44 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.543 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.74 -22.58 47.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -124.33 -3.66 7.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.405 1.082 . . . . 0.0 112.072 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -122.21 2.15 9.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 113.023 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.62 -34.35 67.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.293 1.406 . . . . 0.0 111.38 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -61.14 -45.92 92.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.0 109.932 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.06 73.72 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.212 0.605 . . . . 0.0 111.443 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.3 -56.68 10.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.329 0.652 . . . . 0.0 109.707 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.35 -30.4 71.23 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.063 -0.398 . . . . 0.0 111.08 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -19.9 7.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.644 0.778 . . . . 0.0 112.855 175.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.9 m -130.57 14.63 5.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.878 1.271 . . . . 0.0 112.204 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -151.17 11.04 0.62 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 13.29 1.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.489 1.116 . . . . 0.0 111.888 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.7 m 68.09 7.88 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.171 2.188 . . . . 0.0 112.58 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.38 -20.63 60.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.357 1.063 . . . . 0.0 111.578 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.78 -0.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.239 1.015 . . . . 0.0 111.248 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 O-C-N 121.378 -0.826 . . . . 0.0 109.113 169.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -39.03 93.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.51 1.124 . . . . 0.0 111.051 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.84 -171.7 43.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.31 -8.95 57.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.231 0.516 . . . . 0.0 111.785 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -139.07 165.55 26.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.521 1.928 . . . . 0.0 106.828 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.3 t30 52.85 65.34 1.54 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 111.452 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.29 23.25 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.946 1.698 . . . . 0.0 110.263 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -139.33 162.12 35.78 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.469 1.107 . . . . 0.0 109.308 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -141.97 161.21 38.56 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.192 1.397 . . . . 0.0 109.213 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.79 -60.4 3.9 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.087 0.555 . . . . 0.0 109.677 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.72 -46.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.345 1.858 . . . . 0.0 109.586 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -143.2 42.28 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 111.322 -169.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.21 155.21 57.75 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 146.54 95.01 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.108 1.872 . . . . 0.0 113.256 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -63.24 170.51 2.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.427 1.891 . . . . 0.0 111.968 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.2 102.68 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.114 1.34 . . . . 0.0 111.35 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.37 165.99 22.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.766 1.227 . . . . 0.0 108.357 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.45 143.91 46.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -142.09 137.96 31.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.396 0.679 . . . . 0.0 109.815 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -83.27 134.6 34.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.42 151.71 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 119.212 0.914 . . . . 0.0 109.135 -173.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -140.46 150.97 44.46 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.643 1.177 . . . . 0.0 109.26 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -91.71 148.54 22.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 tp -144.63 109.46 5.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.06 -87.71 0.23 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.413 1.006 . . . . 0.0 111.326 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.23 32.46 0.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.245 1.418 . . . . 0.0 109.589 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.22 159.07 43.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.957 1.703 . . . . 0.0 107.794 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.76 153.74 37.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.918 1.342 . . . . 0.0 109.874 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -138.58 150.79 46.68 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.76 2.024 . . . . 0.0 106.867 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.93 157.3 19.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.8 134.25 42.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -48.66 116.67 1.7 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.394 1.078 . . . . 0.0 108.785 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.4 -34.75 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.513 0.725 . . . . 0.0 111.766 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.29 -24.53 67.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.795 0.838 . . . . 0.0 112.586 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -79.17 -24.0 43.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.48 0.582 . . . . 0.0 111.41 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -67.3 140.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -104.57 -59.57 1.72 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.118 0.967 . . . . 0.0 108.952 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.27 178.3 9.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.842 0.857 . . . . 0.0 110.222 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.58 146.69 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 41' ' ' GLY . 20.6 ttp180 -148.51 176.5 10.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.389 1.475 . . . . 0.0 108.279 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 40' ' ' ARG . . . -91.95 166.23 29.81 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.554 -0.716 . . . . 0.0 111.361 174.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -166.13 0.23 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.523 1.529 . . . . 0.0 112.28 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 67.34 27.89 8.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.455 1.902 . . . . 0.0 112.934 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 31.82 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.39 1.076 . . . . 0.0 109.72 174.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -75.74 116.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -60.85 -47.41 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 109.16 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 54.29 175.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.05 2.54 . . . . 0.0 113.106 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.52 155.86 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.55 -25.5 60.04 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -149.96 23.74 0.85 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.96 142.72 98.19 Favored Pre-proline 0 C--O 1.239 0.53 0 CA-C-O 119.019 -0.515 . . . . 0.0 109.743 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.41 148.67 92.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.953 2.435 . . . . 0.0 110.039 174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.15 -24.87 67.84 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -61.17 -55.94 26.42 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.191 0.905 . . . . 0.0 109.702 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -56.4 -37.0 48.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 C-N-CA 125.228 1.411 . . . . 0.0 109.993 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 58.54 -79.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.328 1.851 . . . . 0.0 107.768 -168.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.48 -132.61 2.19 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 121.358 1.89 . . . . 0.0 110.759 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.91 160.6 39.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.304 1.042 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -133.41 147.99 51.77 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -77.95 108.99 11.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.41 76.94 7.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.477 0.655 . . . . 0.0 109.854 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 49.88 29.04 3.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.023 1.329 . . . . 0.0 114.358 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.48 -19.43 2.81 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.671 1.129 . . . . 0.0 113.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.54 -169.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.842 1.321 . . . . 0.0 108.187 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.07 149.51 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.205 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.58 141.08 14.42 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.758 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.46 132.33 33.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.877 1.718 . . . . 0.0 109.682 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.61 119.21 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.46 154.04 9.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 125.589 1.556 . . . . 0.0 110.269 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -92.65 111.4 22.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.358 1.063 . . . . 0.0 110.545 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.71 -37.75 76.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -43.6 92.87 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.378 0.99 . . . . 0.0 109.484 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.8 -36.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.14 -31.16 67.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.208 0.913 . . . . 0.0 113.427 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -116.58 9.5 14.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.923 0.783 . . . . 0.0 112.376 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.6 m 47.92 41.74 15.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.279 1.032 . . . . 0.0 111.002 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -179.84 7.48 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.636 1.175 . . . . 0.0 109.51 -172.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.79 -84.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -173.57 106.04 0.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.034 1.334 . . . . 0.0 108.792 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.01 129.69 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.389 1.075 . . . . 0.0 108.266 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.78 149.38 26.41 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.693 0.797 . . . . 0.0 108.92 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.6 36.9 0.07 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.252 2.221 . . . . 0.0 112.758 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.48 -9.86 0.16 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.476 2.31 . . . . 0.0 111.005 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.48 -4.69 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.061 1.344 . . . . 0.0 111.866 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.66 24.11 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -172.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -80.95 9.75 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 117.826 2.528 . . . . 0.0 117.826 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.6 160.49 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 120.276 1.398 . . . . 0.0 107.902 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.68 127.47 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.88 142.59 15.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.91 134.16 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.59 163.84 29.19 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.008 1.723 . . . . 0.0 109.183 -169.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 148.37 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.449 1.499 . . . . 0.0 107.651 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.4 152.31 25.68 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.51 -90.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.049 1.309 . . . . 0.0 113.508 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.78 23.81 2.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.221 1.809 . . . . 0.0 110.699 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -149.46 173.41 13.61 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.732 -1.23 . . . . 0.0 111.57 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.95 151.95 36.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 125.078 1.351 . . . . 0.0 108.654 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.85 172.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 125.008 1.323 . . . . 0.0 107.6 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.24 177.21 40.03 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.07 142.89 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.56 140.16 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.68 168.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.125 1.77 . . . . 0.0 109.01 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.64 -43.47 72.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.824 1.193 . . . . 0.0 109.978 171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.64 153.67 8.97 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.33 121.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -46.62 12.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.498 0.719 . . . . 0.0 111.15 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -169.29 179.5 3.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.143 0.977 . . . . 0.0 109.767 -168.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.98 136.3 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.86 1.664 . . . . 0.0 107.026 169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -142.58 174.4 10.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.814 1.245 . . . . 0.0 109.16 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.5 m -131.84 137.79 48.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -141.25 155.15 46.05 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.932 0.893 . . . . 0.0 109.277 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -126.99 158.37 37.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.871 1.668 . . . . 0.0 108.365 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.28 42.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -65.97 -41.64 90.93 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.187 -0.946 . . . . 0.0 109.787 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.95 -40.07 40.67 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.348 1.459 . . . . 0.0 110.462 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -91.37 99.17 9.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -139.6 -53.35 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.144 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 170.96 9.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.425 1.544 . . . . 0.0 111.623 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.18 30.25 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.261 1.424 . . . . 0.0 108.667 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -80.72 50.47 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.797 2.998 . . . . 0.0 110.371 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 16.76 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.272 1.429 . . . . 0.0 113.921 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -146.92 152.97 39.55 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.886 2.074 . . . . 0.0 108.134 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.62 42.36 23.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.176 1.39 . . . . 0.0 112.773 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 166.08 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.738 1.615 . . . . 0.0 108.744 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -35.66 10.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.011 0.525 . . . . 0.0 111.583 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.41 171.77 2.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.655 1.182 . . . . 0.0 112.971 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.9 m -121.6 168.53 11.65 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.043 1.337 . . . . 0.0 110.441 -170.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 p -52.93 -21.98 5.02 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.858 2.463 . . . . 0.0 115.829 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -85.79 -34.42 21.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.825 0.85 . . . . 0.0 110.892 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -91.88 -14.36 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.225 0.61 . . . . 0.0 110.208 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.47 136.87 43.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.797 2.439 . . . . 0.0 111.207 -172.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.1 p -80.59 -170.3 2.54 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.45 2.3 . . . . 0.0 110.918 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.06 172.06 22.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 106.402 -2.679 . . . . 0.0 106.402 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 154.54 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.624 1.712 . . . . 0.0 110.289 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.44 175.03 31.99 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.81 157.04 19.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.811 0.844 . . . . 0.0 110.168 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.73 82.29 1.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.43 -51.39 2.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.489 1.995 . . . . 0.0 113.11 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.38 -31.9 0.09 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.058 2.143 . . . . 0.0 110.97 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -69.09 161.01 29.96 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 170.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -137.94 140.43 40.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.22 130.94 45.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.9 104.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.35 110.89 9.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.08 129.83 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -78.92 54.8 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.496 1.118 . . . . 0.0 109.669 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 tp -56.01 -35.82 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.449 1.5 . . . . 0.0 111.762 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -67.54 -19.73 65.32 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.558 . . . . 0.0 112.375 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -105.81 -22.52 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 117.47 -1.252 . . . . 0.0 111.866 171.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -48.42 -75.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 111.562 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.6 tp -78.51 -25.46 45.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.177 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.66 -27.05 67.53 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.759 1.163 . . . . 0.0 112.911 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.7 m -115.23 -8.03 12.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.684 1.193 . . . . 0.0 111.888 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -97.69 -7.25 31.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.984 1.266 . . . . 0.0 111.429 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -54.5 -46.31 73.44 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.999 1.727 . . . . 0.0 110.236 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 ptp -59.14 -25.81 64.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.271 1.028 . . . . 0.0 112.932 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.92 -26.0 16.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.049 1.739 . . . . 0.0 112.046 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.68 -56.8 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.05 0.94 . . . . 0.0 108.655 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.802 -0.561 . . . . 0.0 112.125 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -45.87 -42.15 12.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.567 1.547 . . . . 0.0 112.112 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 65.7 m -133.12 28.07 4.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.426 1.091 . . . . 0.0 110.892 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -141.29 31.49 1.73 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.338 1.455 . . . . 0.0 109.486 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.28 -4.53 22.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.456 1.103 . . . . 0.0 112.978 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.5 m 68.35 -24.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.18 2.192 . . . . 0.0 113.005 -171.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.16 -33.43 74.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.118 0.967 . . . . 0.0 110.15 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.44 -23.06 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 112.554 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 123.822 0.849 . . . . 0.0 110.477 -175.242 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p -130.55 6.97 4.83 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.842 1.257 . . . . 0.0 111.756 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.87 53.1 2.91 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.431 1.491 . . . . 0.0 112.744 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.69 -175.98 0.59 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.766 1.626 . . . . 0.0 110.233 174.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -62.0 -21.12 64.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.775 -1.203 . . . . 0.0 112.752 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -67.66 -10.92 56.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.685 0.794 . . . . 0.0 112.075 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t 67.38 -45.38 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 130.335 3.454 . . . . 0.0 112.079 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 m 45.1 -107.62 0.13 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.388 1.475 . . . . 0.0 109.637 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -156.95 167.06 31.6 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.37 2.268 . . . . 0.0 106.261 169.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.09 -50.45 72.74 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.523 1.129 . . . . 0.0 111.677 -170.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.39 -169.2 3.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -70.66 38.77 0.05 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.572 1.549 . . . . 0.0 113.316 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -59.24 150.19 64.43 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 125.462 1.505 . . . . 0.0 108.779 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 162.51 36.34 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.719 2.28 . . . . 0.0 114.221 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -127.5 28.77 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.715 1.206 . . . . 0.0 111.603 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.01 65.18 0.02 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.578 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -65.89 148.07 52.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -109.88 145.64 36.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -142.13 140.02 32.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.196 0.998 . . . . 0.0 110.736 -169.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.12 136.18 34.55 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 167.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.46 149.86 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.91 1.232 . . . . 0.0 109.223 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -141.17 152.09 44.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.244 1.018 . . . . 0.0 110.176 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.9 m -91.53 146.88 23.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 170.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -145.3 121.14 10.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.52 -98.62 0.21 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -141.67 37.09 1.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.211 1.404 . . . . 0.0 109.633 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.67 160.11 40.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.836 1.654 . . . . 0.0 107.92 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.3 152.54 44.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.093 1.425 . . . . 0.0 110.361 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.32 154.97 48.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.711 2.005 . . . . 0.0 107.459 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.32 159.13 21.31 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.904 1.24 . . . . 0.0 110.113 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mt -142.22 133.69 25.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -45.75 113.96 0.69 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 109.082 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -53.05 -39.0 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.49 -16.84 64.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.225 0.92 . . . . 0.0 112.941 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -74.2 -24.74 59.4 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.753 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -64.78 140.89 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -120.37 -42.0 2.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.479 1.112 . . . . 0.0 110.511 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 169.54 24.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.585 1.154 . . . . 0.0 108.386 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.6 142.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -149.11 174.4 12.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.928 0.891 . . . . 0.0 108.633 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.04 25.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.66 126.04 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.37 159.0 2.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.754 . . . . 0.0 108.2 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.57 43.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.935 2.894 . . . . 0.0 116.18 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 t -74.22 107.97 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -76.12 95.01 3.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.38 142.75 50.33 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.7 8.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.691 0.796 . . . . 0.0 110.099 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.26 -4.8 0.26 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.349 2.26 . . . . 0.0 115.511 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.99 14.75 1.34 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.054 1.342 . . . . 0.0 112.449 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.0 144.4 75.7 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.259 1.024 . . . . 0.0 109.95 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.36 157.56 53.83 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.917 2.411 . . . . 0.0 109.274 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.53 -33.8 64.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.748 0.819 . . . . 0.0 112.728 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.91 -49.08 63.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.851 0.75 . . . . 0.0 110.549 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.54 -37.69 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.804 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? 48.58 -82.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.834 2.454 . . . . 0.0 111.352 -169.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.87 14.06 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 120.726 1.603 . . . . 0.0 112.713 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.73 156.79 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -140.07 157.03 46.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.924 1.238 . . . . 0.0 109.622 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -78.62 101.84 7.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.911 1.284 . . . . 0.0 110.98 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.75 70.71 2.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 109.931 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 50.81 27.7 3.24 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.7 1.6 . . . . 0.0 114.227 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.6 -17.85 2.03 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.391 0.996 . . . . 0.0 113.263 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -171.45 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.723 1.261 . . . . 0.0 107.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -132.18 150.4 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 120.768 -1.207 . . . . 0.0 110.202 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.87 141.5 14.97 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.676 -1.154 . . . . 0.0 109.289 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.1 131.08 24.28 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.884 1.723 . . . . 0.0 108.585 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.69 123.83 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.13 147.89 12.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.452 2.301 . . . . 0.0 107.117 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.84 118.56 37.1 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.747 0.819 . . . . 0.0 109.562 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.28 -20.39 66.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.055 0.942 . . . . 0.0 113.195 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -56.02 -39.8 72.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.425 1.466 . . . . 0.0 109.434 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.33 12.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 109.763 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -131.83 -27.44 1.88 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.859 -1.151 . . . . 0.0 112.079 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.55 6.3 3.23 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.746 1.157 . . . . 0.0 113.718 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m 59.18 23.39 11.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -61.12 149.37 37.48 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.48 0.712 . . . . 0.0 111.674 -169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 m -24.25 -75.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 129.054 2.942 . . . . 0.0 117.506 -169.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -164.93 67.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.362 1.065 . . . . 0.0 109.758 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -50.84 140.57 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.21 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -160.52 165.62 30.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.677 1.191 . . . . 0.0 109.009 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -73.99 43.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.281 2.232 . . . . 0.0 111.157 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -159.22 -19.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.85 3.26 . . . . 0.0 110.028 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -135.75 6.54 3.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.638 1.575 . . . . 0.0 111.501 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -154.8 37.27 0.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.434 1.893 . . . . 0.0 109.05 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p -94.87 11.57 31.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.32 1.848 . . . . 0.0 115.751 -168.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.64 160.37 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.44 135.05 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -171.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.6 mt -115.89 127.03 73.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.73 134.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 mt -129.79 164.03 24.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.411 1.484 . . . . 0.0 108.209 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.01 157.3 44.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.867 0.867 . . . . 0.0 108.696 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.29 -178.05 4.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.18 97.35 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.896 1.236 . . . . 0.0 113.136 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 63.16 22.48 13.41 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.541 1.936 . . . . 0.0 115.282 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -147.2 161.94 39.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.79 1.632 . . . . 0.0 111.016 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.5 m -135.54 151.45 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 123.799 0.84 . . . . 0.0 110.396 -170.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.55 174.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.235 1.814 . . . . 0.0 106.673 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.45 176.55 40.33 Favored Glycine 0 N--CA 1.448 -0.541 0 O-C-N 120.201 -1.562 . . . . 0.0 110.28 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.46 149.4 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.827 0.851 . . . . 0.0 109.559 -169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 m -94.32 136.1 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.836 1.254 . . . . 0.0 108.86 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.02 166.02 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.608 1.563 . . . . 0.0 109.363 -169.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.52 -43.0 67.27 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.07 154.0 10.73 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.45 123.41 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -49.38 12.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.867 0.467 . . . . 0.0 110.79 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.56 179.73 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.67 1.188 . . . . 0.0 109.618 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.45 127.92 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 pp -156.17 177.68 11.16 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.837 1.255 . . . . 0.0 109.753 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -129.86 148.82 51.77 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.866 0.757 . . . . 0.0 112.179 -169.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mp -139.96 145.89 38.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.175 1.39 . . . . 0.0 108.698 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -94.02 172.2 8.37 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 111.543 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.1 21.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.406 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.11 -39.36 12.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.704 1.202 . . . . 0.0 109.143 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -69.02 -41.6 77.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.821 0.848 . . . . 0.0 110.703 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -86.43 117.58 31.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -143.23 -64.32 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.562 0 CA-C-O 116.838 -1.554 . . . . 0.0 111.818 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.93 -175.1 1.97 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.243 1.962 . . . . 0.0 111.501 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.22 31.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.221 1.808 . . . . 0.0 107.978 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.69 149.63 61.3 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.203 1.935 . . . . 0.0 110.546 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.57 24.96 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.709 1.204 . . . . 0.0 110.549 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -76.82 34.67 0.15 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.191 1.796 . . . . 0.0 114.038 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.77 32.28 5.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.891 2.076 . . . . 0.0 113.608 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.67 -178.86 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.401 1.08 . . . . 0.0 109.755 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -8.63 8.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.483 1.513 . . . . 0.0 113.974 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.05 151.23 40.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.102 1.361 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -135.25 160.28 38.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.422 1.089 . . . . 0.0 108.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 p -62.07 -10.47 10.2 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -22.46 12.06 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.306 1.042 . . . . 0.0 111.365 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -84.8 -9.8 57.81 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.941 -0.475 . . . . 0.0 110.341 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.93 120.26 2.95 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.197 2.199 . . . . 0.0 112.327 -169.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.1 p -75.91 -166.18 0.55 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.428 2.691 . . . . 0.0 111.431 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.74 175.18 20.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.48 143.59 39.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.32 170.14 31.56 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.7 154.49 29.45 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.22 1.008 . . . . 0.0 109.595 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.39 71.79 1.36 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.72 -38.64 1.27 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.894 2.188 . . . . 0.0 113.723 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.6 -34.92 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.99 2.116 . . . . 0.0 110.13 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -71.54 166.08 22.54 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -139.59 145.42 38.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -132.01 126.31 33.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.9 mt -79.7 110.88 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.07 105.64 11.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.15 120.89 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.52 60.33 2.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.305 0.574 . . . . 0.0 110.131 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -53.17 -37.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.615 1.166 . . . . 0.0 111.018 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.35 -23.52 66.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.187 0.995 . . . . 0.0 112.312 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -110.56 -20.41 12.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 117.337 -1.316 . . . . 0.0 111.841 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.21 -61.67 2.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.782 1.173 . . . . 0.0 109.885 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.04 -48.37 63.05 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.82 -40.07 75.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.32 0.509 . . . . 0.0 111.83 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.2 m -80.89 -29.55 35.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.187 0.449 . . . . 0.0 111.568 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.01 -9.31 57.02 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.477 0.711 . . . . 0.0 111.125 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.99 -49.05 66.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.895 1.225 . . . . 0.0 112.089 -169.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.6 ptp -66.02 -31.41 72.28 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.868 -0.52 . . . . 0.0 112.056 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.2 59.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.339 1.056 . . . . 0.0 110.35 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.95 -49.24 78.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.089 1.356 . . . . 0.0 109.041 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.1 -24.61 63.09 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 123.796 0.839 . . . . 0.0 111.977 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.21 -22.06 64.42 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.281 0.946 . . . . 0.0 112.35 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.6 m -130.91 23.6 4.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 111.428 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.75 48.84 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.384 1.474 . . . . 0.0 108.476 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.71 14.74 1.22 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.172 1.389 . . . . 0.0 112.87 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.6 m 64.01 41.93 6.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.412 1.485 . . . . 0.0 108.882 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.08 -77.31 0.16 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.424 1.09 . . . . 0.0 109.117 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -65.66 -35.18 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.384 0 C-N-CA 129.59 3.156 . . . . 0.0 104.738 169.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 18.45 2.94 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.438 1.095 . . . . 0.0 110.297 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.54 -53.8 4.29 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 125.122 1.344 . . . . 0.0 111.2 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.7 mtm -58.11 -27.37 63.65 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.278 1.431 . . . . 0.0 111.42 174.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -70.94 -28.37 64.44 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.712 . . . . 0.0 112.443 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -87.62 16.05 6.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.853 1.261 . . . . 0.0 113.505 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.35 165.04 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 110.577 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.17 137.94 12.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.786 1.234 . . . . 0.0 109.661 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -122.68 109.32 14.12 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -169.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.26 -5.78 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.533 1.133 . . . . 0.0 112.667 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.17 20.7 2.79 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.628 1.571 . . . . 0.0 110.115 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 51.67 36.5 17.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.223 1.409 . . . . 0.0 111.669 -172.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.36 134.94 88.5 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 123.796 0.838 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.77 -42.07 5.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.563 2.175 . . . . 0.0 112.881 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.4 m -167.98 158.71 10.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 127.208 2.203 . . . . 0.0 106.951 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 88.48 0.29 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -75.52 170.17 16.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.737 0.815 . . . . 0.0 110.168 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.34 145.19 51.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.0 136.26 35.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.382 0.673 . . . . 0.0 110.136 -169.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.5 tp -78.44 133.94 37.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 167.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.28 148.14 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 119.324 0.965 . . . . 0.0 108.54 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.15 153.16 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.957 0.903 . . . . 0.0 110.125 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -93.55 145.92 24.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' CD1' HD22 ' A' ' 85' ' ' ASN . 56.4 tp -136.77 96.76 3.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.624 . . . . 0.0 107.5 173.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.48 -76.03 0.52 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.169 1.366 . . . . 0.0 111.907 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.08 30.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.285 1.434 . . . . 0.0 110.494 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.36 160.54 39.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 108.145 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -127.93 151.6 48.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.045 1.403 . . . . 0.0 110.824 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -137.33 156.84 47.76 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.878 2.071 . . . . 0.0 108.045 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.73 153.92 19.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.848 1.213 . . . . 0.0 110.419 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -136.63 130.99 47.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -48.65 120.36 3.71 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.94 -31.89 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.336 0.654 . . . . 0.0 111.595 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.99 -23.58 67.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.502 -0.749 . . . . 0.0 112.689 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -77.64 -22.91 49.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.928 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.94 140.2 20.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.637 1.108 . . . . 0.0 108.369 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 -40.67 2.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.522 1.129 . . . . 0.0 110.431 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -166.19 177.47 6.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.559 . . . . 0.0 107.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.86 135.6 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -120.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -170.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.85 164.07 32.77 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.732 1.634 . . . . 0.0 109.266 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -61.8 139.48 58.34 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -147.96 -65.31 0.25 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.465 0.306 . . . . 0.0 111.195 -174.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.48 72.84 0.55 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.491 1.116 . . . . 0.0 108.606 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.83 113.97 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 m -73.46 85.66 1.52 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -65.92 104.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 mm -69.82 148.04 11.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.85 -23.57 67.41 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -170.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.29 31.86 0.38 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 160.04 60.89 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.922 -1.111 . . . . 0.0 109.206 169.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -61.1 145.83 98.38 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.957 1.772 . . . . 0.0 108.176 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.72 -31.47 64.55 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -56.62 -41.91 77.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.227 0.467 . . . . 0.0 111.174 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.0 mt -92.23 89.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -51.7 -47.74 63.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.022 169.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.28 -177.04 28.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.977 1.262 . . . . 0.0 111.853 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 159.93 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 118.051 0.925 . . . . 0.0 109.788 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 t -141.24 158.56 43.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.519 1.054 . . . . 0.0 109.559 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -79.82 129.92 34.88 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.436 1.095 . . . . 0.0 110.233 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.19 84.42 2.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.902 1.281 . . . . 0.0 107.894 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 53.12 34.85 18.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.624 1.17 . . . . 0.0 113.425 169.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.1 -5.26 25.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.502 1.049 . . . . 0.0 112.974 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.72 177.49 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.153 1.781 . . . . 0.0 106.495 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -134.43 156.33 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 120.555 -1.341 . . . . 0.0 109.721 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -154.18 141.4 13.49 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.352 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.11 130.07 19.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.137 1.891 . . . . 0.0 108.747 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -106.85 135.88 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 108.422 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.61 139.35 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -96.26 104.49 16.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.312 1.045 . . . . 0.0 109.094 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -29.76 70.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.328 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -38.57 83.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.5 -36.82 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -71.72 -22.16 61.67 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.37 11.22 9.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.884 1.22 . . . . 0.0 112.842 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m 55.34 25.07 7.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.556 1.542 . . . . 0.0 113.023 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -68.77 161.62 28.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.878 0.871 . . . . 0.0 111.211 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.01 165.95 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 0.0 111.293 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.4 t70 45.05 68.14 0.61 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.106 2.962 . . . . 0.0 114.073 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.09 62.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.911 1.284 . . . . 0.0 109.5 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -143.54 164.67 29.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.61 1.164 . . . . 0.0 110.99 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -81.71 66.76 7.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 169.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.32 -60.16 0.27 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.076 1.351 . . . . 0.0 109.721 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.69 -38.86 73.73 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.014 0.825 . . . . 0.0 111.476 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.479 HD22 ' CD1' ' A' ' 24' ' ' LEU . 7.2 m120 -91.86 -79.31 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -169.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.7 p 60.67 -3.56 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.929 2.092 . . . . 0.0 116.073 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.68 144.97 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 120.468 1.485 . . . . 0.0 107.211 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -120.58 139.49 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.37 133.25 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.57 134.87 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.35 163.01 30.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.755 1.622 . . . . 0.0 108.839 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.28 145.03 35.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.006 1.723 . . . . 0.0 107.547 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -159.44 142.4 14.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.49 -85.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.567 1.556 . . . . 0.0 113.047 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -143.48 16.58 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.013 -170.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.2 177.98 9.41 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.153 -0.967 . . . . 0.0 112.089 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.97 157.41 38.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 110.027 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -160.39 169.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 126.205 1.802 . . . . 0.0 107.218 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.94 168.88 30.68 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.5 pt -140.72 147.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 123.966 0.906 . . . . 0.0 108.76 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.26 139.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.988 0.915 . . . . 0.0 109.16 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.86 156.68 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 108.736 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.26 -39.4 89.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.204 0.911 . . . . 0.0 110.578 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.96 162.56 20.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.62 117.97 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -49.26 42.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.194 0.597 . . . . 0.0 110.565 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -172.44 -174.82 1.26 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.292 1.437 . . . . 0.0 108.526 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.18 131.07 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.88 146.21 40.88 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.116 0.966 . . . . 0.0 109.604 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 p -84.8 144.43 28.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 109.568 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.08 138.48 29.92 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 p -77.57 153.86 32.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.19 -10.01 37.39 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.562 -0.711 . . . . 0.0 111.756 172.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.08 -30.78 70.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.687 1.195 . . . . 0.0 110.23 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -68.07 -41.45 81.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.908 0.776 . . . . 0.0 110.124 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.87 89.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.249 1.82 . . . . 0.0 109.315 -169.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -142.79 -60.24 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-O 116.809 -1.567 . . . . 0.0 112.846 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.13 176.8 4.24 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.944 1.762 . . . . 0.0 111.491 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.1 154.01 30.36 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.892 1.277 . . . . 0.0 109.38 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -80.6 50.04 3.42 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.417 3.411 . . . . 0.0 110.646 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.54 21.09 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.114 1.766 . . . . 0.0 114.621 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -142.81 146.96 34.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.973 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.32 6.95 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.08 2.152 . . . . 0.0 115.039 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.03 165.82 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.921 1.288 . . . . 0.0 109.457 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -0.38 13.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.739 1.216 . . . . 0.0 113.996 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.3 150.77 21.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.326 0.966 . . . . 0.0 110.59 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.6 m -136.67 147.71 46.98 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -57.13 -3.18 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.346 2.258 . . . . 0.0 116.015 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.91 -38.17 23.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.797 1.239 . . . . 0.0 110.575 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -132.16 1.74 3.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.71 1.604 . . . . 0.0 111.608 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.22 132.09 12.74 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.741 2.416 . . . . 0.0 109.963 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.1 p -80.93 -169.39 2.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.774 2.83 . . . . 0.0 111.875 -170.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.98 179.27 16.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.19 149.32 44.28 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 108.206 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.72 169.69 29.89 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 169.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.53 158.84 43.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.176 0.99 . . . . 0.0 110.644 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.5 mt -146.0 67.05 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.366 1.866 . . . . 0.0 107.483 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.34 2.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.168 1.842 . . . . 0.0 113.333 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.54 -32.82 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.695 1.998 . . . . 0.0 110.625 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -69.35 153.36 43.72 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -141.89 142.4 33.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -133.34 124.18 26.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.39 109.56 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.65 116.8 18.48 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.18 141.63 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.49 0.586 . . . . 0.0 109.92 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.43 57.25 3.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.805 0.812 . . . . 0.0 109.021 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.34 -38.69 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.428 1.491 . . . . 0.0 112.732 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -67.71 -7.06 23.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.807 0.843 . . . . 0.0 113.204 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -133.1 23.48 4.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.231 1.412 . . . . 0.0 110.232 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.41 -90.96 0.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -32.34 71.89 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.17 -20.55 54.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -117.63 4.21 12.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.064 0.945 . . . . 0.0 112.22 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -113.47 -9.65 13.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.651 1.18 . . . . 0.0 111.35 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.43 -39.28 83.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.117 1.326 . . . . 0.0 111.452 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.5 ptp -59.07 -23.73 62.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 112.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.43 -29.04 12.98 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.801 1.64 . . . . 0.0 111.484 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.9 -62.19 2.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.424 1.09 . . . . 0.0 109.438 170.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -18.26 60.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.09 -168.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -52.89 -22.1 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 169.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.3 m -124.82 -41.28 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.338 1.055 . . . . 0.0 111.415 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 164' ' ' SER . . . -81.93 -4.33 56.36 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.35 18.33 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.17 1.35 . . . . 0.0 111.833 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 162' ' ' ALA . 8.5 m 69.9 16.3 7.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.768 2.027 . . . . 0.0 111.723 -169.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.66 -32.54 71.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.726 0.81 . . . . 0.0 109.81 169.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -132.06 -41.33 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.651 1.58 . . . . 0.0 109.631 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.694 175.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.6 p -77.33 -34.11 55.38 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.59 -0.694 . . . . 0.0 110.307 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 119.15 -43.06 1.64 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.994 -2.043 . . . . 0.0 107.994 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.49 -28.85 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.065 -0.668 . . . . 0.0 110.445 170.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -54.13 -17.34 2.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.55 1.54 . . . . 0.0 114.012 171.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -66.95 -22.42 65.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.147 0.885 . . . . 0.0 113.219 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.1 167.86 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.207 0.912 . . . . 0.0 111.421 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.5 167.61 10.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -141.64 81.46 1.77 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.69 -13.1 0.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.774 1.629 . . . . 0.0 112.141 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.02 27.95 1.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.196 2.198 . . . . 0.0 108.493 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -141.47 159.84 59.12 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.477 1.911 . . . . 0.0 109.033 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 132.59 31.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.723 2.282 . . . . 0.0 112.016 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 m -62.62 161.55 12.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.132 1.373 . . . . 0.0 111.591 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.67 111.56 4.01 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 169.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -134.95 165.81 24.47 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.635 1.974 . . . . 0.0 110.412 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -111.16 147.78 34.17 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.34 137.49 32.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.186 0.994 . . . . 0.0 108.927 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.7 tp -78.64 137.04 37.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.01 147.99 30.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 119.579 1.082 . . . . 0.0 108.824 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -143.12 156.48 44.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.313 1.045 . . . . 0.0 110.168 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.5 m -95.8 145.3 25.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -159.95 129.99 5.43 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 125.791 1.636 . . . . 0.0 106.904 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 39.78 87.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.323 0.963 . . . . 0.0 113.509 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.5 37.43 19.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.144 1.778 . . . . 0.0 111.751 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.46 162.1 37.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.716 2.006 . . . . 0.0 107.058 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -118.39 152.73 35.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.819 1.295 . . . . 0.0 110.496 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -138.99 161.65 36.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.016 2.126 . . . . 0.0 107.72 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.75 164.11 27.15 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.407 0.527 . . . . 0.0 112.398 169.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.2 mt -143.65 138.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -46.41 119.08 2.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.426 1.091 . . . . 0.0 109.261 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.44 -32.47 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.481 0.712 . . . . 0.0 111.865 -170.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.98 -21.11 66.79 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.468 -0.77 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -23.47 60.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.261 0.937 . . . . 0.0 111.786 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.43 143.02 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 119.021 0.828 . . . . 0.0 109.377 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -106.67 -59.53 1.79 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.563 1.145 . . . . 0.0 108.41 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.65 177.57 10.35 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 109.774 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.32 147.67 32.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -149.8 164.74 34.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.974 2.11 . . . . 0.0 106.805 -170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.75 168.46 51.2 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.04 -1.037 . . . . 0.0 110.817 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -74.16 109.6 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -162.81 154.57 18.08 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.411 1.484 . . . . 0.0 107.783 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 26.99 56.75 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.066 2.546 . . . . 0.0 115.119 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.45 97.47 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 167.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -50.94 -41.07 58.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.522 1.129 . . . . 0.0 110.461 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 52.99 -179.81 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.402 1.881 . . . . 0.0 111.763 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -132.7 159.48 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.16 68.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.12 36.0 0.43 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.869 0.868 . . . . 0.0 112.688 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 145.31 49.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.312 -0.868 . . . . 0.0 111.219 173.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.22 161.69 29.51 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.563 2.842 . . . . 0.0 111.316 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.1 50.22 0.47 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.172 1.789 . . . . 0.0 113.352 -170.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -157.46 -46.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.228 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.3 mt -49.19 -42.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.275 1.03 . . . . 0.0 110.745 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.4 tttp 57.41 -81.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.888 2.075 . . . . 0.0 108.97 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.35 -160.11 10.07 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 120.705 1.593 . . . . 0.0 114.469 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.89 153.78 27.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.7 t -139.22 150.38 45.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.925 0.784 . . . . 0.0 110.48 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -79.21 89.86 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.869 1.668 . . . . 0.0 110.715 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.75 90.1 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.019 0.528 . . . . 0.0 110.107 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 49.62 29.36 3.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.691 1.196 . . . . 0.0 114.004 168.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.71 -3.67 14.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.683 1.135 . . . . 0.0 114.098 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.16 -174.39 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.839 1.656 . . . . 0.0 107.445 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.62 151.39 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.535 -1.353 . . . . 0.0 110.587 -172.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.27 143.38 16.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.532 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.44 129.47 21.47 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.748 1.632 . . . . 0.0 108.323 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.62 114.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.93 172.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.402 2.281 . . . . 0.0 106.232 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -138.45 124.75 20.42 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.611 -1.306 . . . . 0.0 108.749 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -62.45 -27.97 69.48 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.376 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.92 -39.11 53.87 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.189 0.904 . . . . 0.0 111.032 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.12 -41.63 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -81.65 -7.65 59.62 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.448 -0.782 . . . . 0.0 112.874 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.85 -12.66 14.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.285 0.948 . . . . 0.0 113.13 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m 53.46 35.18 19.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.532 1.06 . . . . 0.0 111.82 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.46 162.53 15.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.524 -0.735 . . . . 0.0 110.578 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -37.82 -92.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 128.258 2.623 . . . . 0.0 115.865 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -163.87 84.01 0.45 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.789 1.236 . . . . 0.0 108.997 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -51.16 139.02 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.086 0.954 . . . . 0.0 110.523 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.27 167.95 26.4 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.688 1.595 . . . . 0.0 108.51 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -70.25 50.78 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.355 1.462 . . . . 0.0 111.92 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -159.58 -16.09 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.758 3.223 . . . . 0.0 110.557 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -141.3 3.4 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.771 1.628 . . . . 0.0 111.692 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -150.21 37.13 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.434 -1.416 . . . . 0.0 109.662 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.8 p -96.14 0.14 50.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.662 1.585 . . . . 0.0 114.494 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.2 t -134.49 159.76 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.591 1.157 . . . . 0.0 108.153 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.84 131.1 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 107.051 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.63 137.62 28.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.08 135.41 53.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -136.32 166.8 22.61 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.659 1.183 . . . . 0.0 109.854 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.3 131.91 28.86 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -135.73 124.47 23.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -168.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.87 -81.91 0.12 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.909 0.766 . . . . 0.0 112.564 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.42 13.92 1.09 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.223 1.809 . . . . 0.0 110.669 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -143.5 174.43 10.77 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.466 1.106 . . . . 0.0 110.246 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.71 155.52 26.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.859 0.864 . . . . 0.0 109.592 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.18 175.27 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 126.189 1.796 . . . . 0.0 107.01 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.65 178.47 41.03 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.29 146.93 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.47 146.41 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -149.78 168.17 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 126.433 1.893 . . . . 0.0 108.893 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.79 -42.09 64.29 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.811 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.85 154.93 9.64 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.97 124.34 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 172.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -40.85 13.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.1 0.56 . . . . 0.0 111.056 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB2' HH22 ' A' ' 140' ' ' ARG . 5.8 t0 -168.04 -177.24 3.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.865 0.466 . . . . 0.0 110.882 -168.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.19 124.14 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.4 mt -140.91 171.8 13.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.703 1.201 . . . . 0.0 109.815 -168.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.4 m -126.45 134.31 50.99 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.682 0.674 . . . . 0.0 110.699 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.23 160.35 39.68 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.125 0.97 . . . . 0.0 110.194 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -145.18 161.32 39.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.23 1.412 . . . . 0.0 109.297 -168.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.22 -25.26 13.45 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.7 -38.15 86.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.073 -1.017 . . . . 0.0 109.669 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -83.07 -37.92 23.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 110.969 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.58 108.93 22.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -58.67 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.075 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.67 173.29 9.21 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.11 1.873 . . . . 0.0 112.052 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.07 162.27 27.07 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.215 1.806 . . . . 0.0 108.335 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.46 -54.98 2.42 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.991 2.461 . . . . 0.0 112.723 -175.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 53.37 -21.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 130.392 3.477 . . . . 0.0 117.969 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -144.49 159.93 41.94 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.305 1.442 . . . . 0.0 109.582 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.6 36.07 13.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.523 1.529 . . . . 0.0 112.758 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.39 155.75 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 108.121 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -35.39 76.57 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.562 0.745 . . . . 0.0 111.304 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.4 170.44 4.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.981 1.713 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.9 m -140.83 178.98 6.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.368 2.267 . . . . 0.0 107.276 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 -27.87 2.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.571 2.349 . . . . 0.0 114.227 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.83 -18.94 62.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.422 1.489 . . . . 0.0 112.344 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.17 23.3 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.33 1.852 . . . . 0.0 109.762 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.92 115.05 27.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.482 1.513 . . . . 0.0 111.604 -169.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.8 p -72.27 -179.1 2.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.048 2.539 . . . . 0.0 111.216 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.84 172.93 15.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.943 -2.463 . . . . 0.0 106.943 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.25 157.64 43.52 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.329 1.565 . . . . 0.0 110.329 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.07 179.57 38.21 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.22 157.44 23.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.24 1.016 . . . . 0.0 111.071 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.18 81.3 1.67 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.61 2.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.6 2.047 . . . . 0.0 113.012 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.01 -32.02 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 111.043 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.406 HH22 ' HB2' ' A' ' 107' ' ' ASP . 62.1 mtp180 -69.49 162.56 27.22 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.7 mtp -139.49 145.96 39.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.24 130.15 36.72 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.9 mt -84.07 100.94 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.45 118.03 20.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.54 137.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -72.92 52.75 0.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.479 1.112 . . . . 0.0 110.077 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.83 -40.56 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.505 1.522 . . . . 0.0 114.784 -168.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.97 -20.91 51.79 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.669 -1.27 . . . . 0.0 111.432 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -41.96 21.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.7 tp -50.6 -45.0 57.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 110.184 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.29 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.714 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -75.93 -56.23 4.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -54.46 -46.24 73.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 110.425 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -74.33 -20.57 60.06 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.135 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.44 -47.02 80.65 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 122.122 2.237 . . . . 0.0 110.102 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.0 mtm -65.19 -45.95 82.72 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.85 96.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.074 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.3 -60.42 3.88 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.949 1.299 . . . . 0.0 109.548 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -27.98 68.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.992 -169.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.63 -23.15 26.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.317 0.647 . . . . 0.0 112.676 174.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.3 m -131.56 22.31 4.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.039 1.336 . . . . 0.0 111.705 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.07 46.3 0.68 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.447 1.499 . . . . 0.0 108.846 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.15 13.59 1.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.061 1.344 . . . . 0.0 112.983 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.6 m 63.3 41.49 7.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.328 1.451 . . . . 0.0 108.96 -169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -150.37 -77.55 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 108.694 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.41 -34.56 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.754 0.822 . . . . 0.0 110.568 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 C-N-CA 129.558 3.143 . . . . 0.0 104.692 169.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 m -143.91 148.12 34.95 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.56 -19.88 0.1 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.238 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.89 -32.02 60.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.996 1.898 . . . . 0.0 112.388 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -124.92 18.73 8.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.806 1.642 . . . . 0.0 110.391 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -151.83 46.6 0.78 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.825 2.05 . . . . 0.0 106.965 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -50.64 -31.11 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -168.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m 42.22 62.63 1.6 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.305 1.442 . . . . 0.0 110.765 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -58.25 144.25 41.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -120.08 -7.62 9.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.78 1.632 . . . . 0.0 110.607 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 62.45 15.71 8.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.066 2.146 . . . . 0.0 111.854 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -157.81 21.33 0.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.482 1.913 . . . . 0.0 110.416 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -67.0 142.37 97.29 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.511 0.725 . . . . 0.0 109.969 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.95 132.97 25.84 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.69 2.26 . . . . 0.0 111.485 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -66.41 163.11 19.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.722 1.209 . . . . 0.0 110.937 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.53 112.27 4.86 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -135.3 166.97 21.89 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.167 1.787 . . . . 0.0 110.655 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -117.79 148.52 41.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.78 135.45 29.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.918 0.887 . . . . 0.0 109.296 -169.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.9 tp -77.21 134.66 38.56 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 168.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -121.57 149.21 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.778 1.172 . . . . 0.0 109.127 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.65 150.86 44.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.477 1.111 . . . . 0.0 109.696 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -91.43 147.46 23.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 tp -140.73 101.41 4.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.37 -76.26 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.512 1.53 . . . . 0.0 112.026 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.17 31.13 0.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.428 1.491 . . . . 0.0 110.657 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.77 160.54 39.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.941 1.696 . . . . 0.0 107.952 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -119.89 153.57 35.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.191 1.472 . . . . 0.0 110.846 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -140.51 159.43 42.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.532 2.333 . . . . 0.0 107.274 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.55 164.26 26.34 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 118.669 0.668 . . . . 0.0 111.989 170.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 mt -142.29 135.85 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -49.0 115.81 1.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.664 1.186 . . . . 0.0 108.983 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.37 -34.12 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.438 0.695 . . . . 0.0 111.697 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.63 -24.92 67.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.759 0.824 . . . . 0.0 112.668 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -84.83 -18.64 34.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.813 0.733 . . . . 0.0 112.061 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.87 136.8 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -100.44 -56.44 2.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 108.912 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -162.31 -179.18 6.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.526 1.13 . . . . 0.0 109.75 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -136.2 147.09 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -145.28 169.38 18.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.154 1.382 . . . . 0.0 108.297 -172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.66 148.85 19.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -82.03 100.69 9.88 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.81 1.244 . . . . 0.0 107.922 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.3 165.99 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.6 1.96 . . . . 0.0 106.587 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . 0.299 1.0 OUTLIER 42.91 30.02 0.22 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.582 2.753 . . . . 0.0 117.498 171.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.01 127.92 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 112.691 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 45.34 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.67 2.388 . . . . 0.0 110.689 -169.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.0 mm -57.37 153.43 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -18.37 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.43 23.27 0.72 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.53 155.57 67.64 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.519 0.728 . . . . 0.0 110.079 169.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -61.98 161.17 26.83 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.387 2.058 . . . . 0.0 109.01 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.52 80.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.674 -172.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -59.89 -41.08 90.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.195 0.907 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 mt -71.81 82.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -53.18 -30.61 38.39 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.629 1.172 . . . . 0.0 109.455 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.98 -151.5 22.45 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.85 154.92 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -136.01 145.96 46.64 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.99 92.89 5.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.45 175.62 1.31 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -69.54 59.49 0.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.87 1.668 . . . . 0.0 113.249 -169.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.86 -6.89 3.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.168 2.318 . . . . 0.0 113.389 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.427 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER -153.71 -165.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.375 1.588 . . . . 0.0 108.458 -169.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' H ' HG11 ' A' ' 64' ' ' VAL . 4.6 tp -121.1 158.75 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.094 1.758 . . . . 0.0 108.403 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.82 142.39 15.43 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.817 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.15 147.18 59.78 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.408 2.072 . . . . 0.0 110.745 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -131.32 148.16 32.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.721 0.808 . . . . 0.0 109.04 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.84 137.31 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -95.7 124.74 39.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.78 -18.83 64.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.361 0.664 . . . . 0.0 111.98 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -60.23 -31.44 70.19 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.839 -1.163 . . . . 0.0 109.624 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.64 -47.83 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -71.79 -33.08 68.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.859 -1.067 . . . . 0.0 113.581 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -121.55 3.05 10.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.816 1.189 . . . . 0.0 112.552 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.3 m 58.67 29.59 18.78 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.986 0.812 . . . . 0.0 111.317 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -57.06 142.03 43.72 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.726 0.81 . . . . 0.0 110.41 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.22 140.47 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 122.092 0.949 . . . . 0.0 111.946 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 24.68 60.55 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 130.734 3.614 . . . . 0.0 115.557 168.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.5 146.92 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -160.33 162.27 33.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.678 0.791 . . . . 0.0 109.251 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.77 40.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.872 2.469 . . . . 0.0 111.562 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -155.28 -25.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.837 2.455 . . . . 0.0 110.978 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -135.32 9.32 3.45 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 111.491 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.12 36.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.602 1.961 . . . . 0.0 108.478 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 p -73.41 4.88 4.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.81 165.23 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.986 1.721 . . . . 0.0 108.948 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -141.06 140.8 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.283 1.833 . . . . 0.0 106.236 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.0 134.87 56.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.62 134.13 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.46 161.62 34.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.469 1.508 . . . . 0.0 108.316 -169.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.56 148.65 39.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.38 127.34 29.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 52.35 -99.1 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 CA-C-N 118.609 0.641 . . . . 0.0 111.791 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.64 20.94 5.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.347 1.459 . . . . 0.0 111.863 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.72 166.32 22.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.479 1.112 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.89 153.03 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.525 1.13 . . . . 0.0 109.883 -171.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -160.28 176.51 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.819 1.648 . . . . 0.0 107.05 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 176.82 38.97 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 120.538 -1.351 . . . . 0.0 111.025 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.2 pt -141.79 154.1 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 124.396 1.078 . . . . 0.0 109.032 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.05 137.2 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.321 1.048 . . . . 0.0 108.304 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.25 168.09 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.15 1.38 . . . . 0.0 110.38 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.28 -40.99 64.14 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.856 -1.153 . . . . 0.0 110.619 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.31 154.53 9.52 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.83 128.23 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.47 -43.29 9.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.236 0.615 . . . . 0.0 111.321 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -168.36 -174.32 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.739 0.816 . . . . 0.0 109.874 -168.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.0 t -134.19 129.61 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -138.21 169.75 17.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.867 1.267 . . . . 0.0 109.309 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -129.24 134.93 48.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.446 0.566 . . . . 0.0 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.19 160.25 41.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.815 1.246 . . . . 0.0 109.579 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -144.06 172.7 12.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.81 2.044 . . . . 0.0 107.347 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.6 0.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -78.1 -45.42 23.46 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 120.182 1.355 . . . . 0.0 108.669 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -84.31 -32.68 24.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.111 1.364 . . . . 0.0 111.656 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.93 121.67 50.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -147.96 -54.86 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.604 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.28 -178.78 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.114 1.876 . . . . 0.0 111.981 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.27 32.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.694 1.598 . . . . 0.0 109.36 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.01 58.09 6.78 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.052 3.168 . . . . 0.0 111.704 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 30.07 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.297 1.439 . . . . 0.0 112.456 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.91 30.26 0.11 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.236 2.215 . . . . 0.0 113.865 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.47 31.81 4.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.882 2.073 . . . . 0.0 113.456 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 m -78.33 175.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -57.05 -17.38 9.96 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.05 -29.34 49.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.564 0.746 . . . . 0.0 112.921 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.1 m -70.91 78.02 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.731 1.612 . . . . 0.0 111.003 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.2 p -140.21 -102.01 0.15 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.374 1.069 . . . . 0.0 112.279 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 131' ' ' LEU . 13.3 pt-20 -142.31 -36.18 0.41 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 127.333 2.253 . . . . 0.0 109.895 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -78.92 15.49 1.08 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -50.8 137.6 20.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.806 2.042 . . . . 0.0 109.896 -178.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.8 p -81.91 -168.86 2.09 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.823 2.049 . . . . 0.0 109.877 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.52 177.03 18.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 171.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -140.54 140.72 35.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.725 1.21 . . . . 0.0 107.783 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.73 173.97 30.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.84 155.11 50.83 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.69 0.796 . . . . 0.0 110.8 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.2 mt -142.31 78.11 1.61 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.002 1.721 . . . . 0.0 107.38 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.94 -51.48 3.15 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.43 1.967 . . . . 0.0 112.833 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.02 -30.56 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.278 1.831 . . . . 0.0 111.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -69.79 153.51 43.23 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 171.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.94 140.72 40.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.36 115.2 15.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.7 mt -75.61 107.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.67 111.44 21.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.17 126.28 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -76.43 56.89 1.13 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.674 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.66 -35.0 48.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.035 1.334 . . . . 0.0 111.51 -170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.77 -18.43 64.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.301 0.64 . . . . 0.0 112.348 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.99 -15.59 14.32 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 116.917 -1.516 . . . . 0.0 112.003 170.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.25 -63.91 1.03 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.932 1.696 . . . . 0.0 110.668 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.37 -39.55 81.72 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -60.1 -43.81 95.3 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.663 1.12 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -73.38 -16.22 61.35 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.902 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -115.58 -0.29 13.08 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.702 -1.142 . . . . 0.0 113.43 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -49.72 -53.1 26.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.022 1.737 . . . . 0.0 111.819 -173.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.62 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.551 1.069 . . . . 0.0 111.167 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.4 tp -59.77 -53.04 62.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.727 1.211 . . . . 0.0 108.46 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.07 -11.88 61.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 118.127 -0.94 . . . . 0.0 112.389 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -54.27 -27.19 33.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.028 1.286 . . . . 0.0 110.965 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 m -115.33 -44.5 2.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.936 0.894 . . . . 0.0 110.827 169.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 164' ' ' SER . . . -73.89 5.33 4.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 13.6 0.31 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.356 0.98 . . . . 0.0 111.52 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 162' ' ' ALA . 14.5 m 59.46 39.84 21.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.13 1.772 . . . . 0.0 110.326 -169.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.39 -43.1 3.08 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.324 0.65 . . . . 0.0 111.377 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.64 -27.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.658 0.383 . . . . 0.0 110.193 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.51 1.524 . . . . 0.0 107.566 171.857 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 tpp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.28 149.68 33.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.77 56.58 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.44 161.9 18.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.999 0.919 . . . . 0.0 110.11 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -60.48 -20.1 58.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.781 1.232 . . . . 0.0 113.04 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -74.71 55.7 0.68 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 110.297 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -56.72 -26.93 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.918 1.287 . . . . 0.0 113.323 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m 47.4 51.98 12.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.808 1.243 . . . . 0.0 111.536 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 37.27 -139.07 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.977 2.111 . . . . 0.0 112.548 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.31 -66.33 0.56 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.65 -159.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.774 2.429 . . . . 0.0 105.783 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -70.44 32.53 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.355 1.462 . . . . 0.0 114.353 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.19 126.28 88.83 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.29 1.436 . . . . 0.0 108.488 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.82 134.82 24.5 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.268 1.312 . . . . 0.0 108.713 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 m -61.71 158.32 15.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.065 0.936 . . . . 0.0 111.981 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.69 96.62 0.67 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.08 138.85 58.58 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.34 143.81 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.67 139.56 33.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.997 0.919 . . . . 0.0 109.346 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 tp -83.37 130.24 35.04 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.2 152.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 109.317 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.27 153.59 45.3 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.544 1.138 . . . . 0.0 109.596 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -93.4 144.78 25.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -133.03 88.28 2.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.695 1.598 . . . . 0.0 106.742 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.75 -70.15 0.4 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.935 1.731 . . . . 0.0 112.755 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -151.24 27.73 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.37 1.468 . . . . 0.0 111.223 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.75 161.71 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.579 1.552 . . . . 0.0 108.154 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.82 150.2 46.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.464 1.126 . . . . 0.0 109.663 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -141.16 155.19 46.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.409 1.884 . . . . 0.0 107.507 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.97 158.68 22.99 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.425 1.012 . . . . 0.0 110.584 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.58 140.62 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -49.89 117.26 2.2 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.83 0.852 . . . . 0.0 109.993 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.75 -30.56 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.457 0.703 . . . . 0.0 111.569 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 mt -66.43 -4.88 9.16 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -109.88 -13.52 14.43 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 112.878 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.51 142.17 17.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 119.548 1.067 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -103.68 -57.71 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.22 -179.37 6.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.7 1.2 . . . . 0.0 109.295 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.57 149.51 31.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -143.59 174.32 10.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.28 1.432 . . . . 0.0 107.743 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.0 161.59 26.9 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 169.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.19 129.19 39.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.78 -43.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.7 41.19 0.77 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.61 135.86 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -123.43 92.33 3.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.17 111.66 5.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.2 -45.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.207 -170.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 144.73 -62.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.461 3.504 . . . . 0.0 108.696 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.82 18.47 22.08 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.673 1.189 . . . . 0.0 112.544 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.53 155.77 2.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.74 1.616 . . . . 0.0 110.003 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.24 146.65 49.0 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.726 1.617 . . . . 0.0 108.641 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -33.0 74.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.581 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -53.63 -42.5 67.84 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.976 0.807 . . . . 0.0 109.959 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.9 87.17 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -49.77 -32.09 13.04 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.317 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.62 -162.32 35.74 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.49 145.15 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -136.55 161.03 37.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 119.801 1.182 . . . . 0.0 109.178 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -80.31 108.94 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.759 0.823 . . . . 0.0 110.125 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.72 171.81 14.09 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.62 55.19 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.76 1.624 . . . . 0.0 112.831 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.01 -11.76 1.24 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.392 2.425 . . . . 0.0 113.743 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.56 -159.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 119.87 1.835 . . . . 0.0 108.828 -169.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.443 ' H ' HG11 ' A' ' 64' ' ' VAL . 5.2 tp -121.36 155.35 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.839 1.655 . . . . 0.0 109.12 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.89 139.94 15.16 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.404 1.081 . . . . 0.0 109.314 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 141.26 47.22 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.228 1.952 . . . . 0.0 109.774 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -126.09 138.03 55.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.491 1.117 . . . . 0.0 108.602 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.12 130.44 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.11 119.47 25.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.55 -18.98 64.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.135 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -33.99 70.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 121.007 1.73 . . . . 0.0 110.278 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.03 0.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.51 1.124 . . . . 0.0 109.065 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -116.29 -30.6 5.89 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.757 -1.214 . . . . 0.0 111.616 172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -136.78 0.06 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 m 54.06 50.53 16.43 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.137 1.335 . . . . 0.0 111.941 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -54.94 169.28 0.23 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.469 1.108 . . . . 0.0 112.85 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.48 -66.46 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.391 1.477 . . . . 0.0 112.108 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.24 98.14 0.35 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 0.0 109.255 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.21 139.95 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.6 137.11 15.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.964 0.905 . . . . 0.0 109.351 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -73.23 34.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.118 2.167 . . . . 0.0 113.049 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -13.37 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.182 2.193 . . . . 0.0 110.636 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.01 8.63 4.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.628 1.171 . . . . 0.0 111.827 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.59 35.97 0.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.048 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -100.31 16.77 23.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -168.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.15 157.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.009 1.277 . . . . 0.0 107.68 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.43 111.65 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 mt -84.05 143.08 12.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.02 131.7 72.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.8 mt -134.18 166.15 23.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.957 1.703 . . . . 0.0 108.272 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.63 156.05 49.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.499 0.72 . . . . 0.0 109.845 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.54 96.93 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.51 -73.22 0.77 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.511 0.596 . . . . 0.0 113.752 174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -143.31 7.14 1.54 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.951 2.1 . . . . 0.0 111.879 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -137.73 161.99 35.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.77 1.628 . . . . 0.0 108.288 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.79 151.18 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.07 170.93 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.988 1.715 . . . . 0.0 106.92 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.83 176.96 37.4 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 120.77 -1.206 . . . . 0.0 111.233 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -145.68 144.97 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.106 0.962 . . . . 0.0 109.147 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 m -89.51 133.71 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.025 0.93 . . . . 0.0 109.119 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.08 169.59 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.34 1.456 . . . . 0.0 109.83 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.84 -43.85 67.67 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 170.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.05 156.15 11.3 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 m -71.93 123.84 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -53.97 6.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 109.857 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -174.48 177.31 2.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.015 1.726 . . . . 0.0 108.533 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.46 133.38 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.158 1.783 . . . . 0.0 107.481 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.87 178.26 10.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.936 1.294 . . . . 0.0 109.397 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 m -129.94 150.55 51.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.303 0.501 . . . . 0.0 111.91 -171.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -140.49 141.7 35.34 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.413 1.485 . . . . 0.0 107.227 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.8 p -76.95 162.71 27.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.356 0.598 . . . . 0.0 109.993 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.21 7.24 1.34 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.814 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -101.9 -37.32 8.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.719 2.008 . . . . 0.0 109.131 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.53 -41.26 98.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 106.891 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -144.23 -70.99 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.463 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.41 -174.35 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.4 2.067 . . . . 0.0 111.314 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.91 55.6 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.657 1.583 . . . . 0.0 108.929 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -82.58 38.45 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 124.133 3.222 . . . . 0.0 111.053 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.18 21.0 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.381 1.472 . . . . 0.0 114.135 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -137.52 144.74 42.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.674 1.19 . . . . 0.0 110.314 -171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.11 35.94 14.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.506 1.922 . . . . 0.0 114.479 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.24 176.84 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.42 1.488 . . . . 0.0 109.074 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -9.9 50.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 113.495 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.42 153.38 43.03 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.845 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -144.97 165.86 26.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.59 1.156 . . . . 0.0 109.318 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.7 p -56.14 -28.72 59.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.169 1.388 . . . . 0.0 113.119 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.88 -29.09 67.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.572 0.749 . . . . 0.0 112.148 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -123.67 -1.12 8.51 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.226 1.011 . . . . 0.0 112.892 -168.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.27 0.9 OUTLIER -61.71 164.87 5.64 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.378 1.085 . . . . 0.0 112.937 -171.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.8 p -122.05 -159.47 0.82 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.142 1.777 . . . . 0.0 109.346 -168.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.83 23.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 168.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.53 153.62 40.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.363 1.582 . . . . 0.0 109.577 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.19 172.68 39.24 Favored Glycine 0 C--N 1.333 0.377 0 O-C-N 123.09 0.244 . . . . 0.0 113.55 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.61 153.15 17.86 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.942 0.897 . . . . 0.0 110.967 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.75 79.79 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.64 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.611 2.053 . . . . 0.0 113.31 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -156.71 -33.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.504 2.322 . . . . 0.0 110.582 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -68.92 166.41 17.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.64 0.776 . . . . 0.0 110.493 172.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.8 mmm -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 169.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.66 151.08 46.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.2 mt -110.09 120.27 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.88 104.19 16.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.64 129.89 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 126.011 1.724 . . . . 0.0 108.133 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -62.96 -28.36 70.03 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . 0.315 8.2 tp 46.31 -48.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 131.421 3.888 . . . . 0.0 116.503 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -62.62 -17.26 59.94 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.278 1.854 . . . . 0.0 113.961 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -101.93 -10.34 19.89 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 116.575 -1.679 . . . . 0.0 112.502 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.55 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.533 1.515 . . . . 0.0 111.455 -169.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.24 -29.57 64.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.613 -0.68 . . . . 0.0 110.388 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.38 -36.16 70.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.682 0.674 . . . . 0.0 111.649 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 m -91.77 -27.7 17.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.081 0.553 . . . . 0.0 111.485 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.98 -15.37 38.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.133 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.4 -36.11 77.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.196 1.816 . . . . 0.0 112.498 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -63.62 -45.78 88.71 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.744 -0.597 . . . . 0.0 109.537 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.15 87.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.122 0.569 . . . . 0.0 111.089 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.23 -64.43 0.82 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.131 1.372 . . . . 0.0 108.311 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.62 -31.26 70.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -168.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.01 -20.91 42.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.4 m -136.0 7.86 3.2 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 113.148 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -151.41 15.6 0.7 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -173.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.6 10.45 0.65 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.424 1.011 . . . . 0.0 112.788 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 73.1 -32.69 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.304 2.642 . . . . 0.0 112.785 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.94 -23.49 63.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.796 1.638 . . . . 0.0 111.539 169.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.02 19.11 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.196 1.798 . . . . 0.0 111.184 -169.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.523 178.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.8 p -70.0 -43.95 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.459 0.703 . . . . 0.0 110.353 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.69 179.06 31.38 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.329 1.442 . . . . 0.0 109.887 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.43 89.33 2.33 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -69.17 -18.25 63.91 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.119 0.967 . . . . 0.0 113.279 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -76.67 83.7 3.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.037 0.835 . . . . 0.0 109.731 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -62.0 -37.42 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.235 0.614 . . . . 0.0 111.887 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m 45.8 52.36 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.785 1.279 . . . . 0.0 110.29 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -59.88 139.89 57.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 109.762 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.04 -4.52 57.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.071 0.949 . . . . 0.0 110.64 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.09 30.24 9.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.82 1.648 . . . . 0.0 110.785 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -145.83 30.58 1.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.902 1.681 . . . . 0.0 109.046 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.44 151.46 95.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.806 0.842 . . . . 0.0 110.274 -169.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -69.26 163.07 39.29 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 110.619 172.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -62.77 165.93 6.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 110.063 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.43 100.09 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.997 1.284 . . . . 0.0 110.673 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -67.8 138.06 55.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -106.02 144.16 33.14 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.96 140.21 32.67 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.03 0.932 . . . . 0.0 110.594 -169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.08 137.04 35.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 167.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.04 151.11 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 119.782 1.174 . . . . 0.0 109.066 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -139.45 150.04 44.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.466 1.106 . . . . 0.0 109.556 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -89.71 147.02 24.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.33 106.36 4.96 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.71 -80.37 0.24 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.653 1.121 . . . . 0.0 111.756 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -153.71 32.34 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.684 1.593 . . . . 0.0 110.158 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.58 162.06 36.86 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.462 1.905 . . . . 0.0 107.707 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.58 154.96 38.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.823 1.297 . . . . 0.0 111.042 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -140.86 156.28 46.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.182 2.193 . . . . 0.0 107.593 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.22 157.03 22.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.543 1.068 . . . . 0.0 111.31 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 136.34 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.97 123.56 13.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.22 -35.04 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.604 0.762 . . . . 0.0 112.822 -169.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.8 -18.71 60.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.984 1.266 . . . . 0.0 112.681 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.45 -23.32 50.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.731 0.696 . . . . 0.0 110.55 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.61 136.96 23.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -43.9 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.268 1.027 . . . . 0.0 110.26 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -159.81 170.99 20.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.0 . . . . 0.0 109.064 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.75 142.09 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -147.62 178.59 8.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.506 1.122 . . . . 0.0 108.252 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.21 165.43 15.07 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.94 128.75 38.76 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.59 -45.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -148.35 65.72 1.08 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.876 1.27 . . . . 0.0 108.907 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 37.4 t -85.07 112.13 21.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -75.88 81.98 2.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -60.77 133.7 56.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.16 151.83 8.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -30.38 66.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.81 28.34 0.85 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.96 156.83 9.25 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.458 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.52 132.93 32.65 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 84.98 0.68 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 122.755 1.264 . . . . 0.0 111.076 -170.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -167.8 -46.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.012 4.525 . . . . 0.0 102.889 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -78.37 97.06 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.116 1.766 . . . . 0.0 108.775 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -58.68 -36.03 73.53 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.58 -147.37 9.79 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.88 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 m -122.38 165.41 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.0 t -145.34 159.83 42.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.347 -1.471 . . . . 0.0 109.124 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -81.26 96.01 7.14 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.114 0.966 . . . . 0.0 111.275 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.15 164.06 13.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -74.06 58.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.493 1.042 . . . . 0.0 113.18 -169.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.39 -15.78 0.57 Allowed Glycine 0 CA--C 1.536 1.384 0 C-N-CA 127.3 2.381 . . . . 0.0 112.945 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.21 -158.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 119.302 1.551 . . . . 0.0 108.653 -169.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 tp -125.19 153.6 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.269 1.828 . . . . 0.0 108.276 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.7 139.23 14.58 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.426 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.79 146.05 82.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.33 2.02 . . . . 0.0 111.368 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 tp -130.48 132.37 64.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 124.157 0.983 . . . . 0.0 108.965 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.72 153.46 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.4 1.88 . . . . 0.0 106.629 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -131.1 128.66 40.62 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.08 -19.09 62.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.674 1.59 . . . . 0.0 111.056 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -57.32 -27.52 62.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.635 1.107 . . . . 0.0 111.568 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.82 -46.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.64 -27.74 68.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.745 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.96 1.84 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.041 1.291 . . . . 0.0 112.317 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.9 m 55.08 44.51 27.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.177 0.991 . . . . 0.0 112.091 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . 0.289 0.0 OUTLIER -54.45 148.76 11.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.114 -0.366 . . . . 0.0 111.363 176.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -37.91 -60.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 128.39 2.676 . . . . 0.0 114.337 -169.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -174.38 88.4 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.057 1.743 . . . . 0.0 108.968 -169.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.16 154.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.461 0.648 . . . . 0.0 110.882 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 83' ' ' ASN . 20.7 t0 -158.45 161.2 37.43 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.19 38.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.267 1.827 . . . . 0.0 111.375 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 81' ' ' ASP . 69.3 m-80 -151.69 -7.98 0.22 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.948 2.899 . . . . 0.0 110.282 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.34 -23.09 4.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.749 1.22 . . . . 0.0 112.664 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 34.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.666 0.787 . . . . 0.0 109.436 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 p -82.52 -13.37 56.76 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.94 153.02 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.752 1.614 . . . . 0.0 107.653 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.4 t -120.53 137.88 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 126.159 1.783 . . . . 0.0 106.326 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.77 134.66 58.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.42 136.27 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -133.38 153.56 51.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.905 1.682 . . . . 0.0 108.384 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.84 144.96 43.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.46 158.76 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 40.27 -98.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.158 1.361 . . . . 0.0 112.919 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -136.19 30.53 2.99 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.077 1.751 . . . . 0.0 110.52 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.51 178.55 8.72 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.965 -1.085 . . . . 0.0 112.256 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 p -136.82 146.32 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.473 1.509 . . . . 0.0 107.991 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.18 -178.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.636 1.574 . . . . 0.0 107.774 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.66 177.14 41.0 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 120.639 -1.288 . . . . 0.0 111.008 169.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 pt -140.22 163.21 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.11 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 m -106.82 142.1 20.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.131 0.972 . . . . 0.0 108.93 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.33 168.15 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.528 1.531 . . . . 0.0 110.019 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.42 -43.83 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.885 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.32 156.11 12.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.63 127.66 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.6 -41.88 9.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.901 0.48 . . . . 0.0 111.717 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -167.15 178.72 5.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.26 0.624 . . . . 0.0 110.576 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.4 t -136.3 125.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 pp -158.12 178.3 10.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.743 1.217 . . . . 0.0 109.677 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -129.78 150.08 51.24 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.444 0.565 . . . . 0.0 111.995 -171.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -143.32 169.31 17.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.782 1.633 . . . . 0.0 109.043 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -129.02 168.55 15.88 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.642 1.577 . . . . 0.0 109.566 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.32 -13.14 48.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.72 -33.83 75.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.603 1.092 . . . . 0.0 109.575 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -87.75 -39.6 14.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.585 1.154 . . . . 0.0 110.682 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.9 mt -91.58 101.86 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.913 0.885 . . . . 0.0 108.672 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 -143.3 -57.64 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 CA-C-O 116.624 -1.655 . . . . 0.0 113.372 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.98 175.87 3.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.951 1.767 . . . . 0.0 111.499 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.06 150.6 26.11 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.714 1.206 . . . . 0.0 109.227 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.89 44.25 1.68 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.93 3.753 . . . . 0.0 110.986 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.44 19.65 0.08 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.838 1.655 . . . . 0.0 114.053 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.5 155.85 42.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.335 1.454 . . . . 0.0 110.605 -169.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.66 33.29 10.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.525 1.93 . . . . 0.0 114.413 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.12 169.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.779 1.632 . . . . 0.0 108.858 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.98 -76.58 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.811 1.245 . . . . 0.0 109.534 172.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tp 49.71 -167.23 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.626 2.371 . . . . 0.0 113.626 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 p -155.51 145.54 21.58 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 120.976 -1.078 . . . . 0.0 110.401 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -64.41 -21.43 66.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.746 1.219 . . . . 0.0 113.91 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.69 -22.46 21.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.461 0.573 . . . . 0.0 110.464 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.31 7.82 11.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.169 0.988 . . . . 0.0 111.898 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -63.22 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.9 p 62.51 -170.91 0.17 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.5 1.92 . . . . 0.0 113.834 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -143.66 176.08 23.25 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 169.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.11 143.22 38.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.44 161.97 32.07 Favored Glycine 0 CA--C 1.519 0.321 0 O-C-N 123.61 0.569 . . . . 0.0 112.442 170.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.16 153.85 17.46 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 110.313 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.75 85.05 1.87 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.41 -52.79 2.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.622 2.058 . . . . 0.0 112.804 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.52 -30.31 0.1 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.034 2.134 . . . . 0.0 111.215 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -67.67 161.67 25.35 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.809 0.844 . . . . 0.0 108.993 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 76.8 mmm -127.44 140.53 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.34 135.21 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.31 106.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.72 111.18 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.2 m -65.93 143.05 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.84 59.29 4.75 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.8 0.727 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.51 -52.62 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.68 2.392 . . . . 0.0 113.511 -168.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.08 11.44 1.82 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.696 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -135.76 20.51 3.3 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.579 1.552 . . . . 0.0 110.499 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.05 -98.33 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.86 -29.03 65.04 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.606 -1.309 . . . . 0.0 109.92 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -62.27 -15.72 49.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.4 m -124.93 5.54 8.01 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 112.029 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -122.79 2.58 9.46 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.016 0.927 . . . . 0.0 112.952 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.75 -38.99 90.02 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 119.796 -1.815 . . . . 0.0 112.312 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -62.43 -36.1 81.34 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.285 0.634 . . . . 0.0 110.566 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.21 -38.13 66.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.771 0.829 . . . . 0.0 111.08 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.27 -61.9 2.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.829 1.252 . . . . 0.0 109.126 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.64 -29.6 69.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.441 -168.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -54.81 -24.76 24.33 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.0 m -136.67 20.52 3.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.312 1.045 . . . . 0.0 112.098 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.79 12.77 0.79 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.41 11.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 113.281 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.9 m 74.0 -34.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.669 2.388 . . . . 0.0 113.028 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.94 -11.58 39.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.361 1.064 . . . . 0.0 111.266 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.89 9.17 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 127.291 2.236 . . . . 0.0 110.775 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.567 -1.206 . . . . 0.0 107.903 -178.267 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -59.95 117.72 5.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.93 -50.05 0.9 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.5 mtt -81.4 -43.74 18.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m 46.6 45.37 14.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.499 1.92 . . . . 0.0 111.833 173.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -59.83 -14.79 16.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.454 1.902 . . . . 0.0 114.425 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.4 m -64.4 -23.52 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.395 -0.816 . . . . 0.0 112.011 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -63.82 138.8 58.63 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.96 125.0 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.56 -37.82 65.41 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.342 0.519 . . . . 0.0 111.198 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.45 -145.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -85.17 -5.89 59.31 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 60.05 173.89 0.05 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.96 2.504 . . . . 0.0 113.169 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.74 124.83 17.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.808 2.339 . . . . 0.0 113.657 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -66.99 164.86 16.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.58 0.752 . . . . 0.0 109.233 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.19 111.12 3.55 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 169.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -136.89 164.0 29.35 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.531 1.932 . . . . 0.0 110.414 -169.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -110.87 149.84 30.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -141.97 134.62 28.36 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.065 0.946 . . . . 0.0 109.33 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.4 tp -74.94 139.05 42.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.82 146.54 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.691 1.132 . . . . 0.0 108.795 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -140.81 150.19 43.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.413 1.085 . . . . 0.0 110.261 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -91.02 142.6 27.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -133.24 90.92 2.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.14 -71.71 0.31 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.18 1.848 . . . . 0.0 112.222 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.62 28.66 0.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.215 1.406 . . . . 0.0 111.164 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.72 162.41 34.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.611 1.564 . . . . 0.0 108.053 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.58 150.76 45.58 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.598 1.189 . . . . 0.0 110.098 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -140.49 156.86 46.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.97 2.108 . . . . 0.0 107.506 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.9 158.1 22.72 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.589 1.09 . . . . 0.0 111.463 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 mt -144.89 133.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -48.12 115.88 1.34 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.896 1.278 . . . . 0.0 109.584 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -53.94 -39.27 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -168.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.63 -17.14 64.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.319 0.963 . . . . 0.0 112.784 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -74.2 -24.26 59.33 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.537 0.608 . . . . 0.0 110.588 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.29 138.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 119.463 1.028 . . . . 0.0 108.723 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -102.15 -57.44 2.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.858 0.863 . . . . 0.0 109.293 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -160.69 174.62 13.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.581 1.152 . . . . 0.0 108.768 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.47 139.01 46.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -141.76 179.31 6.92 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.742 1.617 . . . . 0.0 107.856 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.92 161.5 14.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -56.44 131.18 47.74 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -155.14 -46.96 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.61 81.5 1.29 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.048 0.939 . . . . 0.0 109.525 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 115.67 32.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 90.32 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 173.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 118.87 10.95 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mm -81.95 -38.46 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.7 13.66 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.851 2.06 . . . . 0.0 114.798 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.93 13.91 2.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.525 2.33 . . . . 0.0 110.233 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.66 170.79 7.35 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 130.024 3.33 . . . . 0.0 110.333 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.94 -38.53 37.6 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.968 1.779 . . . . 0.0 112.134 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 139.42 170.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.657 4.383 . . . . 0.0 106.885 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 68.12 -53.72 0.52 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 128.137 2.575 . . . . 0.0 109.346 -169.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -72.75 82.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.326 2.25 . . . . 0.0 110.209 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -56.07 -36.59 68.28 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 109.725 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.48 -173.38 36.99 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.024 -1.56 . . . . 0.0 115.112 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.77 119.43 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -89.66 146.84 24.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.757 1.623 . . . . 0.0 110.033 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -62.02 101.58 0.22 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -78.79 64.89 3.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.161 1.384 . . . . 0.0 107.834 169.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 43.35 36.96 1.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.443 2.297 . . . . 0.0 112.72 170.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.44 -23.39 4.05 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.013 1.292 . . . . 0.0 112.981 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -160.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.327 1.851 . . . . 0.0 106.692 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.86 146.77 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.878 1.217 . . . . 0.0 112.398 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.12 132.5 13.64 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.049 0.94 . . . . 0.0 108.685 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.55 142.01 69.48 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 CA-C-N 121.249 1.482 . . . . 0.0 110.207 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -128.16 132.62 68.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 152.95 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.555 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -103.88 119.91 39.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.172 1.389 . . . . 0.0 107.945 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.93 -7.18 49.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.319 -0.848 . . . . 0.0 113.01 -170.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ttt85 -69.56 -38.15 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 121.338 1.881 . . . . 0.0 108.202 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.88 -17.73 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 0.0 110.497 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -122.46 -29.11 4.15 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.777 1.172 . . . . 0.0 113.698 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -131.72 15.32 4.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.787 1.176 . . . . 0.0 112.72 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 m 58.93 28.97 18.3 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.53 1.132 . . . . 0.0 113.113 171.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -48.51 140.92 7.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.383 0.673 . . . . 0.0 109.246 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.07 -54.15 27.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 125.301 1.44 . . . . 0.0 111.377 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -165.43 82.58 0.34 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.593 1.157 . . . . 0.0 108.423 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.3 114.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -153.21 148.98 27.51 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.368 1.067 . . . . 0.0 109.085 -175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.81 45.82 0.73 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.683 1.593 . . . . 0.0 111.944 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.82 -17.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.397 2.279 . . . . 0.0 111.284 169.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.93 -3.31 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.698 1.199 . . . . 0.0 112.178 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.58 38.03 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -85.3 -7.55 58.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.516 2.327 . . . . 0.0 117.177 -168.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.39 152.72 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 120.693 1.588 . . . . 0.0 107.911 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.17 111.99 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -87.52 142.78 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.82 134.65 63.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 mt -134.32 160.23 38.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 108.817 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 152.16 46.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.491 1.517 . . . . 0.0 107.479 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.8 130.69 13.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.89 -83.2 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.211 1.386 . . . . 0.0 113.162 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -142.19 12.48 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.337 1.855 . . . . 0.0 111.704 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -143.98 166.8 23.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.403 1.081 . . . . 0.0 110.315 -169.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.62 151.88 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.737 1.215 . . . . 0.0 109.836 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.02 177.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.057 1.743 . . . . 0.0 106.939 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.31 173.93 39.52 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 120.494 -1.379 . . . . 0.0 110.628 170.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.3 pt -142.81 145.3 23.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 108.792 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.46 135.75 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.767 0.827 . . . . 0.0 109.047 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.84 169.79 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.872 1.269 . . . . 0.0 110.091 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 -42.04 65.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.81 160.36 19.11 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.34 135.83 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.61 -42.19 6.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.95 0.9 . . . . 0.0 111.161 -173.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -168.94 -177.37 2.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.72 125.91 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -140.26 173.94 11.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.091 1.356 . . . . 0.0 109.382 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 m -129.18 138.71 51.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.153 0.888 . . . . 0.0 110.797 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -145.86 163.53 34.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.9 1.28 . . . . 0.0 110.229 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 m -141.76 174.07 10.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.382 2.273 . . . . 0.0 107.133 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.04 1.59 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.72 -51.01 8.62 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.859 -1.151 . . . . 0.0 108.04 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -70.85 -43.12 69.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.613 1.165 . . . . 0.0 110.157 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.43 116.29 33.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -142.19 -66.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 116.395 -1.765 . . . . 0.0 110.8 -171.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.8 -175.69 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.105 1.87 . . . . 0.0 111.099 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.7 154.41 31.47 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.902 1.681 . . . . 0.0 107.715 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.51 42.21 1.29 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.839 3.026 . . . . 0.0 110.987 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.17 -19.7 3.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -140.74 34.6 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.936 0.894 . . . . 0.0 110.669 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.13 19.57 2.79 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 172.36 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.592 1.957 . . . . 0.0 108.788 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 2.82 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.368 1.867 . . . . 0.0 113.75 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.14 164.6 15.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.211 2.204 . . . . 0.0 112.685 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.4 m -137.12 159.28 42.36 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.554 1.542 . . . . 0.0 108.924 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 p -61.35 -20.45 63.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.535 . . . . 0.0 113.434 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -70.09 -36.18 74.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.3 13.12 19.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.431 1.092 . . . . 0.0 109.68 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 121.43 9.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.37 1.068 . . . . 0.0 110.862 -169.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.44 HG21 ' H ' ' A' ' 146' ' ' ASN . 58.6 p -81.24 -162.22 0.48 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.991 2.517 . . . . 0.0 110.518 -175.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.53 174.86 21.08 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.88 141.96 44.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.05 177.71 32.14 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.37 156.04 47.98 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.379 1.071 . . . . 0.0 109.711 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.5 mt -141.78 77.87 1.61 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.706 1.603 . . . . 0.0 107.272 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.31 -52.28 3.38 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.512 2.005 . . . . 0.0 112.624 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.64 -29.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.398 1.879 . . . . 0.0 111.637 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -69.38 157.13 37.65 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mtp -136.0 153.69 51.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.095 170.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -145.51 135.86 24.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.4 mt -97.67 118.43 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.83 105.53 17.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.68 120.37 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.626 1.17 . . . . 0.0 107.918 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.44 ' H ' HG21 ' A' ' 132' ' ' THR . 27.2 t30 -75.62 66.2 1.93 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.966 0.889 . . . . 0.0 109.902 172.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tp -57.6 -35.89 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.567 1.147 . . . . 0.0 110.801 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.62 -18.84 65.62 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -114.15 -2.74 13.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.971 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.74 -75.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.971 1.308 . . . . 0.0 109.652 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.02 -28.53 63.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.887 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.39 -34.42 61.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.056 0.942 . . . . 0.0 111.83 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -103.77 -19.62 14.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.78 0.832 . . . . 0.0 111.73 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.55 -18.8 32.33 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.421 -0.799 . . . . 0.0 111.796 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.5 -35.82 76.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.94 1.245 . . . . 0.0 111.968 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.7 mtm -63.82 -41.1 97.93 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 109.952 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.84 -43.16 72.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.916 0.487 . . . . 0.0 110.459 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.63 -58.93 5.21 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.718 1.207 . . . . 0.0 109.647 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -18.37 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.36 -22.87 66.85 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -135.52 -6.55 2.23 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.64 31.2 0.65 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.452 1.101 . . . . 0.0 112.173 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 13.5 0.32 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.094 0.958 . . . . 0.0 112.644 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.2 m 71.41 -29.98 0.2 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 128.288 2.635 . . . . 0.0 113.046 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.23 -27.0 68.76 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.04 1.336 . . . . 0.0 111.215 169.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.0 m -128.3 -1.49 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 125.064 1.346 . . . . 0.0 112.556 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.849 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 p -65.54 -12.76 55.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.038 1.335 . . . . 0.0 113.745 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.2 171.74 35.77 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.54 173.69 16.33 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.447 1.499 . . . . 0.0 108.749 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.8 p -124.57 -34.57 2.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.081 0.952 . . . . 0.0 110.734 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.3 t30 42.93 43.59 3.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.415 1.886 . . . . 0.0 112.845 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.3 -170.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.977 1.311 . . . . 0.0 110.381 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -60.5 -37.59 81.57 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.301 -0.874 . . . . 0.0 111.251 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -67.99 135.39 52.25 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.32 35.55 2.51 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.153 0.981 . . . . 0.0 110.61 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.72 -53.33 13.81 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.534 -0.729 . . . . 0.0 109.626 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -147.75 10.26 0.93 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.574 1.15 . . . . 0.0 112.875 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -65.66 -32.07 5.6 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.325 1.85 . . . . 0.0 114.845 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.77 -18.52 41.87 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.432 2.088 . . . . 0.0 112.621 169.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m 46.38 40.85 8.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.255 2.222 . . . . 0.0 114.599 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.25 72.29 1.27 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -56.97 135.28 56.16 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -110.44 144.91 38.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -140.6 139.95 35.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.692 0.797 . . . . 0.0 109.554 -169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.33 134.01 35.25 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 168.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.61 148.79 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 119.274 0.943 . . . . 0.0 109.164 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -144.21 150.1 37.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.54 1.136 . . . . 0.0 109.506 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -86.71 148.0 25.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -143.42 111.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.495 1.518 . . . . 0.0 106.92 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -84.77 0.19 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.308 0.956 . . . . 0.0 111.398 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.21 32.17 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.114 1.366 . . . . 0.0 110.377 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -144.08 161.05 39.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.149 1.379 . . . . 0.0 108.236 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -118.58 150.4 39.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.648 1.213 . . . . 0.0 109.256 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.91 158.3 44.3 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.897 2.079 . . . . 0.0 107.142 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.28 24.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.856 0.741 . . . . 0.0 111.551 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mt -140.21 137.33 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.62 124.2 14.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.44 0.564 . . . . 0.0 109.708 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.99 -33.61 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.61 0.764 . . . . 0.0 112.5 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.46 -23.6 65.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.965 0.802 . . . . 0.0 111.961 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.79 -21.95 40.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.626 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.92 137.75 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.53 -43.23 2.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.759 1.223 . . . . 0.0 109.246 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -160.98 172.94 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 108.289 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.4 138.45 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -145.81 168.38 20.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.195 1.398 . . . . 0.0 107.552 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.06 164.7 27.5 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -70.1 3.88 2.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.088 1.355 . . . . 0.0 114.37 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -22.18 3.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.148 1.779 . . . . 0.0 115.714 -169.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.31 49.11 1.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.546 1.067 . . . . 0.0 112.64 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.95 110.79 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 90.45 5.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 27.0 tpt180 -67.87 110.67 3.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 mm -71.24 156.39 7.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.79 -24.58 65.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.7 p30 -145.98 22.63 1.39 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.494 1.117 . . . . 0.0 113.927 -169.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.445 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -64.03 153.74 84.05 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.28 151.33 83.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.852 1.701 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.46 75.67 4.01 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 122.097 0.951 . . . . 0.0 109.977 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -163.88 -46.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 130.613 3.565 . . . . 0.0 103.919 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.92 90.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 108.027 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -52.99 -27.83 21.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.158 0.983 . . . . 0.0 110.516 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.13 -168.69 40.54 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.905 1.229 . . . . 0.0 112.106 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.97 114.76 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -85.5 135.57 33.78 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.763 1.625 . . . . 0.0 109.049 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.39 91.48 3.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.46 174.04 2.38 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 169.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -68.86 52.59 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.417 2.287 . . . . 0.0 113.597 -169.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.34 -8.58 1.89 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.361 2.41 . . . . 0.0 113.512 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.451 HG11 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.96 -164.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 119.565 1.683 . . . . 0.0 108.848 -169.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.451 ' H ' HG11 ' A' ' 64' ' ' VAL . 5.5 tp -122.74 156.14 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.466 1.906 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.98 135.42 9.44 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.437 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.82 140.01 59.55 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 121.274 1.491 . . . . 0.0 110.451 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.96 130.87 73.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.25 158.64 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -121.57 121.51 37.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.97 -22.37 66.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HG3' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.29 -24.03 67.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.862 1.665 . . . . 0.0 111.785 170.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.34 -48.6 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.97 -18.25 65.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -132.13 -3.92 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.509 1.504 . . . . 0.0 112.636 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.5 m 50.08 37.41 14.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.29 1.036 . . . . 0.0 111.595 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -66.45 100.57 0.66 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.991 1.317 . . . . 0.0 109.439 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 t 39.15 -115.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 126.809 2.044 . . . . 0.0 108.733 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -158.0 100.07 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.25 1.42 . . . . 0.0 107.253 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.407 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 20.2 m -68.42 176.95 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 111.225 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 83' ' ' ASN . 21.1 t0 -149.24 169.67 20.24 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.678 1.591 . . . . 0.0 108.917 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.36 43.3 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.638 1.975 . . . . 0.0 111.646 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 81' ' ' ASP . 59.0 m-80 -152.89 -6.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.649 3.179 . . . . 0.0 109.978 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.12 12.53 1.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.766 1.626 . . . . 0.0 111.3 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.72 25.47 0.57 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.108 2.563 . . . . 0.0 108.648 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.5 p -97.66 -2.43 41.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.4 t -110.67 160.45 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.6 t -138.29 132.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.0 mt -104.8 129.27 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.33 141.6 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -134.24 160.52 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.604 1.562 . . . . 0.0 108.852 -169.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.76 146.74 38.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.515 1.126 . . . . 0.0 108.196 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -159.6 143.82 14.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.22 5.28 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 119.414 1.006 . . . . 0.0 114.581 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 56.86 35.25 26.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.3 1.44 . . . . 0.0 113.628 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.94 173.91 11.04 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.696 1.598 . . . . 0.0 109.151 169.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.21 152.47 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.705 0.802 . . . . 0.0 110.576 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.89 -175.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 106.355 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.04 -179.1 42.75 Favored Glycine 0 N--CA 1.448 -0.527 0 O-C-N 120.495 -1.378 . . . . 0.0 109.67 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 pt -141.94 144.49 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.844 0.457 . . . . 0.0 110.532 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.86 145.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 169.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.82 167.72 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.589 1.956 . . . . 0.0 108.547 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.02 -45.48 63.86 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.667 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.48 151.9 8.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.4 142.43 16.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 m -124.16 -26.96 3.91 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -168.71 178.74 4.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.653 1.115 . . . . 0.0 110.475 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.17 120.88 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.86 167.23 22.59 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.12 0.968 . . . . 0.0 110.291 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -128.07 138.15 52.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.77 0.428 . . . . 0.0 110.722 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.92 165.9 26.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 107.552 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.76 161.29 29.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -18.25 53.95 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.463 -0.773 . . . . 0.0 112.953 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.66 -36.74 83.27 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.986 -1.071 . . . . 0.0 110.45 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -76.69 -42.25 42.33 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.061 0.945 . . . . 0.0 109.848 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.78 88.91 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.203 1.001 . . . . 0.0 108.58 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -139.53 -55.32 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.981 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.55 175.27 4.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.716 1.611 . . . . 0.0 111.315 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.93 157.3 30.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.848 1.259 . . . . 0.0 109.723 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.36 59.83 6.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.354 3.369 . . . . 0.0 110.048 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.39 1.4 11.79 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -148.16 160.35 43.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.369 0.986 . . . . 0.0 110.948 -172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.25 34.87 21.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.034 2.133 . . . . 0.0 114.24 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.0 161.98 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.135 1.374 . . . . 0.0 109.006 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -10.09 58.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.089 1.356 . . . . 0.0 113.426 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.2 tp -52.75 125.78 17.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.68 1.592 . . . . 0.0 113.806 -169.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -63.78 148.53 49.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 111.026 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.2 p -76.92 -16.07 59.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.982 0.913 . . . . 0.0 113.109 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -94.45 -43.07 8.53 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -80.59 7.3 10.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.76 1.224 . . . . 0.0 110.699 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.85 118.34 5.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p -69.96 -177.27 1.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.782 2.433 . . . . 0.0 110.838 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -123.39 179.17 16.21 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 mt -136.45 147.56 47.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.673 1.589 . . . . 0.0 106.878 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.35 171.26 34.62 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.17 154.19 31.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.118 0.967 . . . . 0.0 109.972 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.06 81.71 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.411 1.485 . . . . 0.0 107.052 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 -47.94 2.0 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.662 2.077 . . . . 0.0 113.672 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.53 -36.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.3 2.24 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -71.51 167.19 20.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.759 0.79 . . . . 0.0 110.056 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.0 mtp -135.13 154.79 51.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -136.75 138.22 40.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.7 mt -87.86 113.74 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.88 107.46 14.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.36 120.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.211 1.404 . . . . 0.0 107.909 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -76.72 63.89 2.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.705 0.764 . . . . 0.0 110.27 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.58 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.396 1.478 . . . . 0.0 111.321 -172.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.49 -4.19 14.16 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -126.94 22.97 6.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.558 1.143 . . . . 0.0 110.839 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 -95.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.57 -35.62 81.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.985 -1.072 . . . . 0.0 110.112 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.16 -30.51 49.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.141 0.977 . . . . 0.0 113.051 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.5 m -114.7 -1.97 13.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.21 -9.14 11.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.771 -1.109 . . . . 0.0 113.195 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -52.66 -42.95 65.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.901 1.682 . . . . 0.0 112.168 -172.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.3 ptp -59.65 -27.56 66.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.02 1.328 . . . . 0.0 113.338 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.83 -33.48 12.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.093 1.357 . . . . 0.0 111.242 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.95 -60.12 4.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.488 1.115 . . . . 0.0 109.318 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -29.06 68.14 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.522 -169.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.47 -23.74 27.37 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.344 1.058 . . . . 0.0 112.725 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.0 m -136.05 15.93 3.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.487 1.115 . . . . 0.0 111.791 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.19 11.97 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.8 5.79 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.556 1.071 . . . . 0.0 113.369 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 73.04 -36.28 0.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.084 2.553 . . . . 0.0 113.6 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.2 -30.87 71.38 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -82.45 -6.96 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.708 1.603 . . . . 0.0 113.023 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-N 119.28 0.945 . . . . 0.0 109.289 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 m -140.05 151.62 45.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.93 179.37 48.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.16 152.45 31.26 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.553 1.141 . . . . 0.0 108.598 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -71.33 -18.07 62.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.629 0.772 . . . . 0.0 112.052 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -72.62 -5.44 37.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.682 1.193 . . . . 0.0 113.664 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.9 m -57.63 149.5 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.338 0.972 . . . . 0.0 110.574 174.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -58.98 128.55 37.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.966 0.906 . . . . 0.0 109.478 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -82.41 69.73 9.21 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.706 0.802 . . . . 0.0 109.579 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.72 10.89 6.64 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.641 1.176 . . . . 0.0 112.386 -177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.31 -52.71 0.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.493 0.717 . . . . 0.0 109.931 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -76.73 26.87 0.13 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 0.0 112.511 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.45 -26.78 2.64 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.33 -21.24 72.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.801 2.334 . . . . 0.0 114.105 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m 55.66 -162.99 0.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.739 1.216 . . . . 0.0 109.769 -169.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.11 78.0 0.81 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -65.22 151.0 47.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.252 1.421 . . . . 0.0 108.247 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.1 143.53 44.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -142.39 136.89 30.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.504 0.722 . . . . 0.0 110.272 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.74 135.87 36.62 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 167.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.16 149.49 31.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 109.098 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -146.11 151.97 38.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.255 1.022 . . . . 0.0 110.242 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.5 m -86.93 146.39 26.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.438 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -137.23 103.23 5.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.95 -86.86 0.17 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.958 0.789 . . . . 0.0 111.575 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.02 31.02 0.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.239 1.416 . . . . 0.0 110.376 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.66 159.2 42.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.711 1.605 . . . . 0.0 107.566 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -122.71 149.65 43.79 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.206 1.479 . . . . 0.0 110.785 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -137.92 161.56 36.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 107.621 -169.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.64 163.95 26.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.845 0.748 . . . . 0.0 112.145 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mt -142.75 138.04 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -48.04 114.59 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.169 . . . . 0.0 109.357 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -54.84 -34.12 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.968 0.907 . . . . 0.0 111.594 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.75 -23.87 67.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.717 0.807 . . . . 0.0 112.618 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -82.64 -19.0 39.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.948 0.794 . . . . 0.0 112.069 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.29 125.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -80.83 -57.58 3.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.02 -178.29 5.53 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.625 1.57 . . . . 0.0 108.537 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.34 141.71 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -143.4 -155.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.925 1.29 . . . . 0.0 108.186 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.15 161.84 26.41 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.33 136.09 57.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -160.3 -51.82 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.45 0.7 . . . . 0.0 110.27 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -157.63 73.06 0.69 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.173 1.389 . . . . 0.0 107.926 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.42 103.44 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 168.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.46 84.9 4.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 29.3 tpt180 -70.06 118.13 12.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.97 -24.06 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 118.222 0.464 . . . . 0.0 110.287 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.11 20.92 3.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.002 1.721 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -142.47 41.08 1.6 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.777 2.831 . . . . 0.0 105.127 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.478 ' HG1' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -148.88 151.18 34.42 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 109.096 -168.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.16 156.33 55.89 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.132 1.888 . . . . 0.0 108.846 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.64 -25.55 64.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -53.43 -50.33 65.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.427 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.7 mt -77.17 82.03 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -60.8 -27.39 67.99 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.562 -0.711 . . . . 0.0 110.069 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -166.45 34.81 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.903 0.774 . . . . 0.0 111.302 169.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.92 121.2 66.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -99.93 131.17 46.06 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.742 1.217 . . . . 0.0 110.739 -168.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -63.24 136.33 57.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.0 102.45 4.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 169.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.31 34.38 14.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.393 1.077 . . . . 0.0 113.139 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 9.39 55.56 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.035 0.826 . . . . 0.0 113.432 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 65' ' ' ILE . 1.6 t -131.8 -176.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 127.0 2.12 . . . . 0.0 106.816 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 64' ' ' VAL . 3.9 tp -136.82 159.07 37.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.831 1.253 . . . . 0.0 109.939 -173.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.18 140.47 13.75 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.09 132.21 23.9 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 N-CA-C 106.833 -2.026 . . . . 0.0 106.833 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -111.87 140.14 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.54 172.21 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -132.51 117.8 18.46 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.93 -24.86 67.65 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.363 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -66.46 -25.53 66.77 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 120.075 1.307 . . . . 0.0 111.687 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.7 mm -71.43 -50.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 120.053 1.297 . . . . 0.0 107.545 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -64.91 -16.93 63.87 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.94 1.81 9.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.653 1.181 . . . . 0.0 112.542 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m 47.59 38.15 7.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.579 1.152 . . . . 0.0 111.505 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.21 29.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.502 1.121 . . . . 0.0 110.681 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t 33.62 -109.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.6 2.36 . . . . 0.0 112.178 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -172.02 111.58 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.031 2.132 . . . . 0.0 105.888 -172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -56.31 160.41 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.963 0.905 . . . . 0.0 111.462 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -153.28 149.88 28.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.219 1.008 . . . . 0.0 108.305 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.18 38.21 0.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.643 1.977 . . . . 0.0 113.163 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.14 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.099 2.16 . . . . 0.0 110.747 169.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.11 6.72 5.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.854 1.262 . . . . 0.0 111.658 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.34 28.86 0.4 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.705 -1.247 . . . . 0.0 110.343 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 p -94.05 15.17 17.66 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -167.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.84 150.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.417 1.462 . . . . 0.0 107.144 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 m -119.61 135.1 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 119.691 1.132 . . . . 0.0 109.963 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -98.94 128.7 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.84 133.42 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -133.65 166.43 22.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.505 1.522 . . . . 0.0 109.617 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -139.93 154.83 47.33 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.89 0.876 . . . . 0.0 109.439 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -137.09 83.74 2.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.82 -68.66 1.9 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.057 0.837 . . . . 0.0 112.91 169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.04 2.25 2.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.804 1.642 . . . . 0.0 112.42 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 166.27 21.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.631 1.105 . . . . 0.0 110.189 174.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.81 154.5 34.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.697 1.199 . . . . 0.0 108.842 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.33 169.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.86 175.41 30.63 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 120.82 -1.175 . . . . 0.0 110.164 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 pt -135.48 140.85 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.17 135.7 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.486 0.714 . . . . 0.0 109.084 170.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 m -141.65 166.17 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.039 1.735 . . . . 0.0 108.862 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.17 -43.97 69.72 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.233 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.23 10.63 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.18 127.6 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.2 -53.69 7.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.226 0.61 . . . . 0.0 109.673 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -175.26 -176.63 0.95 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.003 1.721 . . . . 0.0 108.166 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.9 132.35 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -134.63 175.96 9.06 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.787 1.635 . . . . 0.0 108.192 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 m -133.33 143.66 49.14 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.53 141.34 33.57 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 158.9 15.56 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.445 1.098 . . . . 0.0 108.308 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.64 26.37 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.7 -31.13 63.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.937 1.295 . . . . 0.0 111.065 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.79 -39.65 30.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.375 1.47 . . . . 0.0 110.482 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.75 113.81 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.6 ttp-105 -155.2 -56.96 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 116.708 -1.615 . . . . 0.0 112.312 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.82 178.22 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.701 1.601 . . . . 0.0 111.567 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.81 156.01 29.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.43 1.492 . . . . 0.0 109.567 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.38 59.71 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.684 3.589 . . . . 0.0 111.574 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.66 31.29 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.149 1.779 . . . . 0.0 112.906 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.51 171.28 9.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.164 1.386 . . . . 0.0 110.418 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.22 30.74 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.767 1.627 . . . . 0.0 113.38 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.77 177.43 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.42 1.488 . . . . 0.0 110.119 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -9.13 15.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.425 1.49 . . . . 0.0 113.789 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.57 142.34 55.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.0 m -143.46 163.36 33.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 110.114 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -53.98 -31.54 51.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.884 1.673 . . . . 0.0 115.222 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -69.63 -26.07 64.24 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.455 1.025 . . . . 0.0 112.808 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.2 9.9 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.276 0.631 . . . . 0.0 112.597 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.11 154.73 12.35 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 118.382 0.537 . . . . 0.0 110.126 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.8 p -107.34 172.73 6.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.342 1.457 . . . . 0.0 109.335 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.39 -179.62 29.74 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.0 145.19 32.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 168.78 32.65 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.55 154.69 25.56 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.696 0.799 . . . . 0.0 109.517 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.31 80.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -174.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.42 -57.2 2.01 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.924 2.202 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -148.96 -24.91 0.3 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.315 2.246 . . . . 0.0 111.939 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -71.72 165.8 23.29 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.9 mtp -141.46 142.2 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -133.77 123.54 25.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 mt -77.42 112.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 170.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.52 108.36 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.02 128.35 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.792 1.637 . . . . 0.0 108.098 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -79.17 60.0 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.687 1.195 . . . . 0.0 110.191 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 149' ' ' LYS . 8.6 tp -59.84 168.67 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.821 0.848 . . . . 0.0 108.866 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.67 -18.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.136 1.775 . . . . 0.0 113.009 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' ILE . 18.0 mmmt -109.67 -33.56 6.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.09 -1.433 . . . . 0.0 111.38 169.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -48.65 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.528 1.531 . . . . 0.0 112.205 -170.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 tp -71.36 -25.96 62.6 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.176 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -56.78 -29.4 62.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.253 0.933 . . . . 0.0 112.136 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -114.82 -3.34 12.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.234 1.414 . . . . 0.0 111.678 -173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.08 2.35 19.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.534 1.534 . . . . 0.0 111.739 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.54 -44.86 77.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.444 1.098 . . . . 0.0 111.343 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.11 -37.79 88.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.003 0.921 . . . . 0.0 111.082 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 -37.25 72.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.644 0.778 . . . . 0.0 111.273 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.77 -55.1 33.71 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.06 -28.84 69.36 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.645 0.778 . . . . 0.0 112.118 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.74 -24.03 54.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.675 0.79 . . . . 0.0 112.478 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.9 m -133.19 27.62 4.15 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.31 1.044 . . . . 0.0 111.035 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.41 46.76 1.13 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.701 1.6 . . . . 0.0 108.31 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.86 14.08 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 112.82 -170.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 m 64.79 38.75 6.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.677 1.591 . . . . 0.0 109.153 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -142.5 -79.69 0.23 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.025 1.33 . . . . 0.0 108.401 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.9 m -64.53 -35.17 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.391 0 C-N-CA 129.556 3.142 . . . . 0.0 104.822 169.862 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -61.35 -14.52 27.92 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.11 -0.87 84.23 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.174 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -17.56 19.2 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.094 1.947 . . . . 0.0 113.22 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.7 p -64.94 -10.32 28.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.948 1.699 . . . . 0.0 113.147 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -71.42 37.19 0.06 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.261 1.824 . . . . 0.0 113.73 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.14 74.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 m -138.3 139.8 39.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.811 1.244 . . . . 0.0 108.753 -168.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 174.66 6.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.284 0.564 . . . . 0.0 111.409 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -69.11 51.27 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.393 2.277 . . . . 0.0 113.637 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.05 -29.29 12.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.175 1.79 . . . . 0.0 114.522 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 m -131.89 20.52 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.428 1.891 . . . . 0.0 111.14 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 22.84 73.23 0.27 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 129.567 3.147 . . . . 0.0 116.935 169.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.98 -170.41 0.62 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.652 2.234 . . . . 0.0 108.886 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.9 m -43.16 126.98 4.23 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.663 1.585 . . . . 0.0 111.681 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.74 94.64 1.05 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.788 1.661 . . . . 0.0 109.109 -174.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -80.76 153.1 27.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.512 1.525 . . . . 0.0 108.724 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.02 142.52 49.73 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -142.65 143.01 32.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.348 0.659 . . . . 0.0 111.608 -169.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -83.79 133.56 34.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 167.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.98 152.08 25.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 119.875 1.216 . . . . 0.0 109.514 -174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -146.55 153.76 40.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.379 1.072 . . . . 0.0 110.46 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.6 m -90.07 147.15 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.2 tp -144.97 105.59 4.12 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.512 1.525 . . . . 0.0 107.468 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.54 -77.68 0.61 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.146 1.355 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -153.45 22.97 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.061 1.344 . . . . 0.0 112.084 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.48 160.33 40.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.175 1.39 . . . . 0.0 108.555 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -120.17 150.35 40.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.911 1.339 . . . . 0.0 110.449 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -140.12 159.49 42.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.564 1.946 . . . . 0.0 108.029 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.18 160.31 23.88 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.487 1.041 . . . . 0.0 111.092 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -140.62 139.2 35.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -50.07 115.51 1.44 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.946 0.899 . . . . 0.0 109.667 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -54.13 -33.99 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.373 1.069 . . . . 0.0 112.212 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.5 -24.97 68.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.805 0.842 . . . . 0.0 112.988 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -79.85 -18.53 50.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.024 0.829 . . . . 0.0 112.22 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.93 139.75 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.385 0.674 . . . . 0.0 109.235 -175.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -103.17 -57.96 1.95 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.451 1.1 . . . . 0.0 108.722 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.02 178.73 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.484 1.114 . . . . 0.0 109.556 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.43 144.15 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -147.66 168.71 21.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.472 1.909 . . . . 0.0 107.146 -169.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.46 -178.0 52.12 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.089 -1.007 . . . . 0.0 111.411 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -124.08 93.39 3.91 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.511 1.525 . . . . 0.0 106.942 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.49 -43.76 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.549 1.139 . . . . 0.0 109.678 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -74.07 29.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.456 1.902 . . . . 0.0 114.13 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.63 157.49 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.041 0.936 . . . . 0.0 110.878 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.7 m -141.93 148.72 39.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.381 2.672 . . . . 0.0 104.576 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -146.63 142.97 28.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.324 1.42 . . . . 0.0 109.642 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -64.76 140.53 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.11 -26.33 26.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -169.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -139.29 37.83 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.767 1.627 . . . . 0.0 112.422 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -55.72 152.49 18.91 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.71 147.59 81.62 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 N-CA-C 106.163 -2.283 . . . . 0.0 106.163 167.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.35 32.48 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -61.24 -39.47 90.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.247 0.931 . . . . 0.0 110.806 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.37 80.93 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -60.73 -14.07 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.09 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.5 -141.25 9.12 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 120.579 1.536 . . . . 0.0 114.158 168.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 166.19 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 128.374 2.669 . . . . 0.0 105.144 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 t -147.96 151.23 35.45 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.507 -1.371 . . . . 0.0 110.33 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.46 112.8 15.87 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.488 0.715 . . . . 0.0 110.78 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.38 91.74 8.27 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.59 21.67 0.93 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.089 1.756 . . . . 0.0 115.417 169.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.7 5.55 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.515 1.052 . . . . 0.0 114.079 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.81 -172.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.75 1.62 . . . . 0.0 107.55 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tp -129.41 152.59 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 120.132 1.333 . . . . 0.0 110.844 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.61 142.55 18.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.32 151.74 84.22 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.691 1.594 . . . . 0.0 111.777 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tp -125.55 134.96 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.89 142.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -103.53 113.01 26.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.47 -170.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.52 -27.09 65.87 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.112 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -55.12 -46.22 75.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.019 0.827 . . . . 0.0 109.753 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.86 -38.78 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -64.73 -28.35 69.53 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.442 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.31 2.23 10.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.666 0.786 . . . . 0.0 112.725 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m 50.34 48.25 22.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.433 1.093 . . . . 0.0 111.551 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -174.99 0.3 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 111.148 175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.21 173.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.878 1.271 . . . . 0.0 110.949 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -80.78 65.61 5.99 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.589 2.356 . . . . 0.0 110.073 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 m -51.0 157.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.906 1.282 . . . . 0.0 112.744 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -151.53 176.11 11.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.9 1.68 . . . . 0.0 110.548 -171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -67.96 49.85 0.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.366 2.267 . . . . 0.0 110.686 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -149.72 -30.48 0.23 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.338 2.655 . . . . 0.0 109.986 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -141.9 19.22 2.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.127 1.371 . . . . 0.0 111.832 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -142.82 16.75 1.96 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.799 2.039 . . . . 0.0 110.484 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -73.56 3.29 6.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.631 2.772 . . . . 0.0 116.309 -168.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.04 157.45 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 119.781 1.173 . . . . 0.0 108.043 -175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.3 t -132.81 133.62 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.059 2.144 . . . . 0.0 107.632 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -99.99 134.14 40.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.293 -2.855 . . . . 0.0 103.293 168.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.91 134.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.5 mt -134.44 167.47 20.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.572 1.549 . . . . 0.0 108.703 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.04 153.4 42.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.08 141.95 20.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 170.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.36 0.02 OUTLIER Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.063 1.315 . . . . 0.0 112.148 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -146.29 9.12 1.08 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.832 1.653 . . . . 0.0 111.521 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 164.28 24.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.773 -1.204 . . . . 0.0 110.68 -173.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.46 149.73 26.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.195 1.398 . . . . 0.0 108.567 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.12 162.24 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.28 167.08 24.83 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.62 135.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.18 144.31 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -148.13 165.83 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.547 1.939 . . . . 0.0 108.315 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.37 -42.78 74.73 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.248 -0.908 . . . . 0.0 110.03 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.93 157.97 11.59 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.26 122.19 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.79 -48.43 18.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.254 0.622 . . . . 0.0 111.039 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.94 -179.78 2.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.724 1.21 . . . . 0.0 109.692 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.3 t -127.48 126.86 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.88 178.07 10.68 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.892 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.1 m -130.44 148.73 52.28 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.166 0.587 . . . . 0.0 111.053 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -143.07 143.19 31.76 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.9 p -82.84 164.92 20.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.352 0.596 . . . . 0.0 111.37 174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 14.61 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.719 1.208 . . . . 0.0 113.376 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.25 -38.49 3.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.228 1.811 . . . . 0.0 109.512 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.66 -39.5 88.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.97 121.91 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.66 1.984 . . . . 0.0 106.988 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -150.83 -56.33 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 117.088 -1.434 . . . . 0.0 110.61 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.78 178.35 2.33 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.889 2.392 . . . . 0.0 112.704 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.05 33.48 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.254 1.421 . . . . 0.0 109.415 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -80.98 50.42 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.086 3.191 . . . . 0.0 110.441 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.5 21.21 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.521 1.529 . . . . 0.0 114.424 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -148.86 152.39 36.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.844 1.658 . . . . 0.0 109.377 -169.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.31 40.14 17.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.734 . . . . 0.0 114.008 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.2 157.94 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.861 1.265 . . . . 0.0 109.396 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -15.69 61.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.194 1.397 . . . . 0.0 112.376 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 155.85 1.0 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.378 2.271 . . . . 0.0 112.22 176.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.5 m -130.38 156.21 45.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 110.261 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -60.05 -35.28 74.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -76.98 -15.56 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.123 1.329 . . . . 0.0 112.75 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -126.39 25.4 6.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.94 138.93 57.71 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.1 p -75.41 -174.45 2.43 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.32 1.848 . . . . 0.0 109.989 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.46 175.48 20.17 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.39 155.78 42.28 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.041 1.421 . . . . 0.0 109.506 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.38 179.82 29.43 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 123.696 0.665 . . . . 0.0 111.958 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.86 158.48 39.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -169.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.51 60.14 1.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.107 2.163 . . . . 0.0 107.463 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.25 2.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.22 1.867 . . . . 0.0 113.199 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.87 -32.35 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.73 2.012 . . . . 0.0 110.39 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -68.92 154.56 41.82 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.7 mtp -143.77 143.71 31.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.895 1.678 . . . . 0.0 106.496 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -137.01 140.48 42.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 92.4 mt -96.34 112.42 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.49 110.22 19.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.52 130.43 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.511 1.124 . . . . 0.0 108.277 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -79.98 60.61 3.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.022 1.329 . . . . 0.0 109.408 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.99 -37.14 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.514 1.126 . . . . 0.0 111.78 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.15 -26.78 68.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.374 0.534 . . . . 0.0 112.409 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -106.54 -17.47 14.24 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.856 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -50.35 -73.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.495 1.498 . . . . 0.0 110.858 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.3 tp -74.37 -26.51 60.16 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.31 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -63.56 -31.12 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.849 1.204 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -84.1 -27.59 28.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.872 0.869 . . . . 0.0 111.559 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.31 6.42 20.48 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -51.21 -48.9 61.92 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.991 1.316 . . . . 0.0 111.074 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -28.27 69.97 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.512 0.725 . . . . 0.0 112.554 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.08 -42.67 23.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.666 0.786 . . . . 0.0 110.593 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.43 -46.05 91.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.997 0.817 . . . . 0.0 109.547 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.93 -12.96 61.18 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.143 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.98 -23.57 65.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.038 1.29 . . . . 0.0 111.507 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -124.38 -42.38 2.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.493 0.717 . . . . 0.0 111.977 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.09 30.69 1.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.634 0.774 . . . . 0.0 112.795 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.75 7.3 2.02 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.54 0.736 . . . . 0.0 112.283 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 15.9 m 54.79 43.21 30.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.036 1.335 . . . . 0.0 109.873 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.19 -46.89 0.84 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.329 1.051 . . . . 0.0 110.681 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.12 -21.13 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.016 0.527 . . . . 0.0 110.528 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 C-N-CA 126.088 1.755 . . . . 0.0 107.048 169.831 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -134.84 165.87 24.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.872 2.069 . . . . 0.0 109.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.52 146.03 47.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.981 1.313 . . . . 0.0 107.485 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -141.75 138.24 32.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.477 0.711 . . . . 0.0 110.163 -168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.5 tp -78.71 132.63 37.07 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.267 2.0 m -117.91 146.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 119.24 0.927 . . . . 0.0 108.617 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -141.0 164.99 28.79 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.208 1.003 . . . . 0.0 110.537 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 m -121.01 146.02 47.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.78 134.04 14.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.8 -92.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.771 1.177 . . . . 0.0 110.363 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -151.28 37.84 0.62 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.06 1.344 . . . . 0.0 109.493 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -140.04 154.4 47.08 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.386 1.474 . . . . 0.0 108.433 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.93 155.46 31.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.799 1.285 . . . . 0.0 109.983 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -143.68 158.55 43.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.418 1.887 . . . . 0.0 107.901 -169.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.25 154.86 20.78 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.084 1.326 . . . . 0.0 110.024 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.1 mt -139.89 135.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.41 124.18 15.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.799 0.727 . . . . 0.0 109.177 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.69 -34.09 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.463 0.705 . . . . 0.0 112.631 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 mt -68.18 -24.36 64.96 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.853 0.751 . . . . 0.0 112.131 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.88 -14.51 50.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.953 0.797 . . . . 0.0 111.555 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.71 128.1 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -87.43 -55.7 3.68 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.432 1.093 . . . . 0.0 108.464 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -167.24 -178.06 3.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.866 1.266 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.91 142.69 43.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -167.77 2.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.448 1.499 . . . . 0.0 107.885 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.99 160.45 21.26 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -75.74 -0.96 22.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -5.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -168.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 34.19 1.39 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.343 1.429 . . . . 0.0 113.576 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.44 140.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.4 m -129.77 91.53 3.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -68.18 112.5 5.14 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.23 157.11 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.3 72.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -139.23 22.91 2.57 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.05 156.71 66.44 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -59.77 142.02 97.91 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.68 68.01 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.365 -0.835 . . . . 0.0 112.78 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -52.27 -40.56 61.9 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.541 0.609 . . . . 0.0 110.239 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.18 94.99 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -50.01 -33.12 17.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.286 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.62 177.01 31.3 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.9 153.92 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -140.63 163.42 32.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.732 1.151 . . . . 0.0 108.794 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -89.28 113.31 24.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.043 0.937 . . . . 0.0 110.75 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.48 171.66 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.4 mtp-105 -72.61 64.61 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.273 1.397 . . . . 0.0 112.81 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.96 -9.83 2.29 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 127.076 2.274 . . . . 0.0 113.24 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.34 -164.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 119.231 1.516 . . . . 0.0 108.536 -169.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.9 tp -127.81 157.04 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.174 1.79 . . . . 0.0 108.525 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p -151.38 141.99 14.93 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.44 138.36 42.17 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.183 1.922 . . . . 0.0 109.991 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.86 137.45 56.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.68 1.192 . . . . 0.0 108.319 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.99 139.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -97.89 120.69 38.72 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.303 0.641 . . . . 0.0 109.651 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -68.29 -18.87 64.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.175 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.21 -37.17 86.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.862 1.665 . . . . 0.0 110.455 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.26 -48.02 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -73.98 -27.4 60.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.324 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.31 11.44 2.56 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.948 1.249 . . . . 0.0 113.335 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m 60.63 34.1 20.2 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.606 -1.309 . . . . 0.0 112.926 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -50.85 155.2 1.22 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.645 0.778 . . . . 0.0 112.503 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 t -59.16 -64.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.786 1.234 . . . . 0.0 113.192 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -157.23 63.19 0.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.775 0.797 . . . . 0.0 111.457 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.54 135.55 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -158.39 158.52 34.38 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.482 1.513 . . . . 0.0 108.427 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.01 48.43 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.85 1.66 . . . . 0.0 112.767 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER -155.1 -16.08 0.11 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.961 2.904 . . . . 0.0 109.987 169.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 83' ' ' ASN . 32.2 t70 -119.69 -8.11 9.97 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.486 1.914 . . . . 0.0 111.562 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.48 35.14 1.84 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.687 1.595 . . . . 0.0 109.775 -169.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -100.08 -11.56 20.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -168.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.28 157.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.08 133.06 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.3 mt -107.67 133.76 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.27 137.92 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.8 mt -136.0 154.68 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.726 1.611 . . . . 0.0 107.549 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.47 149.64 42.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.32 176.02 8.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -11.67 -65.71 0.01 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 128.096 2.76 . . . . 0.0 116.24 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -137.95 26.63 2.72 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 111.638 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -151.4 164.63 36.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.778 -1.201 . . . . 0.0 111.952 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.17 144.12 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 0.0 109.015 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -157.64 -178.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.618 1.567 . . . . 0.0 107.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.62 -179.69 41.02 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.538 -1.352 . . . . 0.0 110.526 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.9 pt -141.91 144.21 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.108 0.963 . . . . 0.0 108.915 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 m -79.44 141.87 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.134 1.374 . . . . 0.0 108.46 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.98 163.21 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.256 1.822 . . . . 0.0 110.275 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -80.11 -46.7 16.01 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.954 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.56 161.94 31.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.71 116.49 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -41.57 34.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.573 0.749 . . . . 0.0 111.601 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -170.16 -174.82 1.83 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.65 123.45 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.6 mt -140.27 171.52 14.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.626 1.171 . . . . 0.0 109.994 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 m -125.6 139.38 53.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.091 0.556 . . . . 0.0 110.131 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.78 159.46 42.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.6 1.16 . . . . 0.0 109.366 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -122.38 155.18 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.117 2.167 . . . . 0.0 106.941 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -27.74 63.66 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.121 -0.987 . . . . 0.0 112.498 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.21 -33.64 73.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.634 1.173 . . . . 0.0 111.234 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -78.0 -42.31 33.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 109.617 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.5 mt -85.41 68.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.287 1.435 . . . . 0.0 109.11 -170.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 41.7 mtm180 -113.75 -60.53 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.367 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 42.2 Cg_endo -67.45 -179.1 1.74 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.034 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.19 32.52 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.774 1.63 . . . . 0.0 108.874 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.1 51.29 3.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.613 2.876 . . . . 0.0 110.709 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.83 27.89 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.832 2.053 . . . . 0.0 114.103 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -65.4 176.64 1.34 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 110.46 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.73 32.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.457 1.903 . . . . 0.0 113.685 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 m -66.93 167.09 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.188 0.995 . . . . 0.0 109.914 169.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -63.82 -16.1 60.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 0.0 113.391 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.44 108.61 4.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.562 1.145 . . . . 0.0 111.01 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 m -67.53 155.47 39.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.052 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -66.07 -34.07 77.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.611 1.164 . . . . 0.0 112.543 -171.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.16 -17.45 62.54 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.601 -1.312 . . . . 0.0 113.241 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.77 26.13 5.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.785 0.834 . . . . 0.0 109.939 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.54 140.02 54.83 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 145' ' ' VAL . 35.1 p -70.28 -176.5 1.21 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.597 1.959 . . . . 0.0 110.66 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.02 178.89 16.39 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 169.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.1 mt -134.64 150.72 50.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.46 171.1 34.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.65 157.21 25.76 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.209 1.004 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.8 79.12 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.99 -50.96 2.72 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.7 2.095 . . . . 0.0 112.869 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.31 -30.53 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.223 2.209 . . . . 0.0 111.023 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -66.55 164.75 15.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.139 0.976 . . . . 0.0 108.886 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.7 mtp -139.17 150.74 45.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.764 1.226 . . . . 0.0 108.072 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.4 mt -138.53 137.92 37.52 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.678 1.191 . . . . 0.0 107.908 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 98.8 mt -86.89 113.29 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.03 109.23 15.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.583 ' HA ' HG22 ' A' ' 132' ' ' THR . 67.3 t -64.24 128.92 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -75.24 51.61 0.55 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.77 1.228 . . . . 0.0 110.859 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 tp -57.23 -40.67 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.998 -1.064 . . . . 0.0 111.979 -169.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.94 -10.61 40.64 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.39 0.65 6.99 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.765 169.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.84 -69.07 0.25 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.838 1.199 . . . . 0.0 109.924 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.94 -33.25 74.31 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.89 -46.22 78.41 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.747 -0.595 . . . . 0.0 110.647 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -77.2 -22.46 52.32 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.282 0.633 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.44 -15.0 19.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.186 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.24 -48.08 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.495 1.498 . . . . 0.0 111.737 -169.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.9 ptp -60.86 -27.72 68.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.028 0.931 . . . . 0.0 113.007 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.62 -34.99 12.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.59 1.156 . . . . 0.0 111.282 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.78 -62.17 2.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.224 1.41 . . . . 0.0 109.004 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -26.68 66.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -169.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.466 0.361 0 C-N-CA 123.896 0.878 . . . . 0.0 112.643 -177.619 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.629 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.47 168.02 20.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.997 2.119 . . . . 0.0 110.291 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -121.54 147.39 45.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.85 137.28 31.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 109.416 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.4 tp -77.75 136.58 38.17 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 167.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.252 1.6 m -124.92 148.54 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 119.657 1.117 . . . . 0.0 109.078 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -140.64 150.17 43.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.677 1.191 . . . . 0.0 109.665 -172.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.3 m -91.09 146.71 23.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp -134.69 90.23 2.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.6 -71.53 0.37 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.815 1.674 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.56 28.85 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.504 1.522 . . . . 0.0 111.047 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.45 161.49 36.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.779 1.632 . . . . 0.0 107.939 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -122.99 151.07 42.19 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.516 1.15 . . . . 0.0 109.76 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -142.15 158.57 43.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.961 2.105 . . . . 0.0 107.437 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.87 161.27 24.52 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.43 1.014 . . . . 0.0 111.237 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.41 135.14 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -48.42 116.7 1.67 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 109.302 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.96 -33.34 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.332 0.653 . . . . 0.0 111.441 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.95 -22.94 67.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.591 0.756 . . . . 0.0 112.588 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -82.62 -19.93 37.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.99 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.65 142.15 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 119.194 0.907 . . . . 0.0 108.771 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.79 -53.92 2.66 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.401 1.081 . . . . 0.0 108.567 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.91 -176.5 4.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.569 1.147 . . . . 0.0 109.821 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.7 149.15 31.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -151.85 -157.9 0.85 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.379 1.872 . . . . 0.0 107.786 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.53 151.58 18.95 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 120.116 1.326 . . . . 0.0 112.691 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -77.02 91.23 3.62 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.122 1.369 . . . . 0.0 107.468 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -149.03 -18.11 0.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 51.91 1.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.094 0.861 . . . . 0.0 111.005 -169.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.45 152.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 O-C-N 120.674 -1.266 . . . . 0.0 110.463 169.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -133.56 131.03 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -128.26 133.74 48.85 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -168.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 mm -79.38 159.93 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.52 63.08 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.84 28.32 0.37 Allowed 'General case' 0 C--N 1.341 0.226 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -169.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.53 154.65 78.83 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.309 169.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -63.13 136.21 54.95 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.096 1.864 . . . . 0.0 107.671 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.83 -28.15 47.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -52.57 -46.08 66.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.663 0.665 . . . . 0.0 110.282 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.4 94.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -51.32 -47.44 62.64 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.96 -129.16 1.52 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 165.99 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.802 1.241 . . . . 0.0 107.866 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.5 t -145.54 173.33 12.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 p-10 -82.89 160.95 22.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 120.796 -1.19 . . . . 0.0 111.608 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -121.89 168.97 11.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 167.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.36 58.43 0.26 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.641 1.576 . . . . 0.0 111.942 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.72 -13.95 1.18 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 127.111 2.291 . . . . 0.0 113.563 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.63 -161.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.762 1.781 . . . . 0.0 109.036 -169.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.483 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.2 tp -119.28 158.77 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.924 1.689 . . . . 0.0 108.928 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.59 137.81 12.54 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 109.617 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.62 144.14 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.953 1.769 . . . . 0.0 109.469 169.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.3 136.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.39 150.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -123.83 128.76 49.98 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.76 -15.63 63.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.431 -0.319 . . . . 0.0 110.942 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -58.54 -21.35 52.19 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.879 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mt -127.91 23.16 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.351 2.26 . . . . 0.0 108.534 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -139.36 -27.88 0.79 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.724 -1.235 . . . . 0.0 112.352 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.24 15.57 4.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.962 0.905 . . . . 0.0 111.229 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m 51.16 47.45 24.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.738 1.615 . . . . 0.0 111.476 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -53.74 166.7 0.3 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.727 1.211 . . . . 0.0 111.4 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -60.99 169.66 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.81 0.844 . . . . 0.0 109.609 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.53 71.38 0.95 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 128.73 2.812 . . . . 0.0 110.691 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.5 m -38.81 153.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 128.627 2.771 . . . . 0.0 114.09 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.52 161.49 42.18 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.308 1.443 . . . . 0.0 108.518 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -72.11 49.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.869 1.668 . . . . 0.0 111.212 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.23 -19.67 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.808 2.843 . . . . 0.0 110.152 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.82 -15.31 3.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.779 1.232 . . . . 0.0 112.324 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -145.4 47.75 1.28 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.804 1.241 . . . . 0.0 108.322 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.3 p -78.15 -4.81 49.39 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.358 2.663 . . . . 0.0 117.644 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.11 153.85 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 121.463 1.938 . . . . 0.0 109.091 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.22 122.23 62.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.086 1.754 . . . . 0.0 107.233 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.4 mt -93.57 140.6 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.0 133.71 60.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.77 165.74 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.047 1.739 . . . . 0.0 108.953 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.13 153.39 51.85 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.295 1.038 . . . . 0.0 110.007 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -133.79 85.6 2.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.88 -67.7 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.781 1.658 . . . . 0.0 113.72 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -136.15 3.19 2.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.863 1.665 . . . . 0.0 112.338 -171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.71 169.25 16.45 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 110.066 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.871 1.269 . . . . 0.0 108.992 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.41 ' HB ' HD22 ' A' ' 151' ' ' LEU . 13.1 p -157.49 171.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.447 1.499 . . . . 0.0 107.194 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.07 171.59 32.06 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -138.46 143.7 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.877 0.871 . . . . 0.0 108.79 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.83 134.44 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 108.943 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.36 170.5 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 125.581 1.552 . . . . 0.0 109.914 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.41 -41.87 72.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.53 158.83 10.99 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.74 130.73 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.17 -42.64 7.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.266 1.026 . . . . 0.0 111.358 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -168.18 -175.57 2.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 109.877 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.04 127.27 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 169.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -137.36 165.31 26.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.429 1.092 . . . . 0.0 109.524 -169.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 m -124.41 130.56 52.7 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.33 162.52 33.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.927 . . . . 0.0 108.962 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -138.15 159.93 40.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.908 1.283 . . . . 0.0 108.538 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.18 -23.4 8.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.18 -34.43 74.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.04 -1.038 . . . . 0.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -85.29 -38.68 18.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.177 1.391 . . . . 0.0 110.554 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.54 102.67 13.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 36.6 mtm105 -140.15 -56.93 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.948 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.8 Cg_endo -65.53 168.68 14.17 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.712 1.608 . . . . 0.0 111.354 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.03 154.71 29.27 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.31 1.444 . . . . 0.0 108.957 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.26 146.57 71.31 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.739 2.293 . . . . 0.0 110.91 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.06 18.99 0.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.577 1.151 . . . . 0.0 110.757 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -73.65 170.29 15.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 111.121 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.97 65.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.701 1.6 . . . . 0.0 110.584 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.47 175.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.455 1.502 . . . . 0.0 109.66 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.92 11.53 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.413 1.885 . . . . 0.0 114.942 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.7 158.04 18.92 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.285 1.434 . . . . 0.0 110.227 -173.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -142.42 148.08 37.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 110.969 -171.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -55.77 -29.45 59.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.144 1.777 . . . . 0.0 114.406 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.68 -22.58 65.28 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.71 25.66 1.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.542 1.064 . . . . 0.0 112.517 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.62 18.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 145' ' ' VAL . 18.7 p 64.86 -170.99 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.429 1.492 . . . . 0.0 112.151 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.65 28.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 106.584 -2.606 . . . . 0.0 106.584 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.66 153.74 39.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.465 1.633 . . . . 0.0 109.491 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.97 173.2 35.22 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.11 157.8 16.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.266 1.026 . . . . 0.0 111.202 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.07 72.48 1.38 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.187 1.795 . . . . 0.0 107.143 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.8 -46.36 2.03 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.385 1.945 . . . . 0.0 113.724 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -36.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.19 2.196 . . . . 0.0 110.403 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -73.55 166.09 23.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.655 0.741 . . . . 0.0 110.031 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.5 mtp -141.03 148.4 40.19 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.4 153.94 36.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.689 0.796 . . . . 0.0 110.459 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 79.5 mt -104.89 109.97 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.349 1.459 . . . . 0.0 107.178 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.31 108.13 15.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.035 1.334 . . . . 0.0 107.736 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.8 t -62.3 131.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.547 1.139 . . . . 0.0 108.138 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -78.74 60.54 2.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.61 0.719 . . . . 0.0 109.643 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 tp -54.42 -39.01 42.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 C-N-CA 124.764 1.226 . . . . 0.0 111.147 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.45 -13.16 60.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.747 0.703 . . . . 0.0 112.568 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -111.81 -7.72 14.18 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.872 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.42 -77.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.641 1.11 . . . . 0.0 110.742 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 98' ' ' VAL . 54.2 tp -67.49 -20.1 65.41 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.33 -0.856 . . . . 0.0 110.443 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.49 -37.43 75.52 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.097 -1.002 . . . . 0.0 110.664 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 m -85.82 -30.14 23.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.695 0.798 . . . . 0.0 111.242 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -90.96 -9.44 46.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.938 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -49.31 -47.96 46.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.763 1.619 . . . . 0.0 111.792 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -63.42 -44.7 93.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.717 0.407 . . . . 0.0 109.956 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.49 82.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.325 0.65 . . . . 0.0 111.368 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.24 -58.62 7.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.718 1.207 . . . . 0.0 109.321 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.86 62.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.432 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 112.917 174.809 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -69.89 163.84 25.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.081 0.553 . . . . 0.0 109.609 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -124.91 143.28 50.94 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.539 1.536 . . . . 0.0 107.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -142.3 136.79 30.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.648 0.779 . . . . 0.0 110.501 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.6 tp -77.88 135.97 37.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 167.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.28 152.88 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.736 1.153 . . . . 0.0 109.57 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -140.38 151.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 109.56 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -93.38 146.53 23.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -156.0 134.95 11.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 169.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -98.52 0.53 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.31 36.71 0.67 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.348 1.459 . . . . 0.0 108.776 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.02 161.0 39.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.156 1.782 . . . . 0.0 107.852 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -120.1 156.4 31.09 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.117 1.437 . . . . 0.0 110.457 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -138.11 147.73 44.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.943 2.097 . . . . 0.0 106.457 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.48 156.64 15.97 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.49 134.9 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -49.52 115.5 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.034 0.934 . . . . 0.0 109.111 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.54 -33.1 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.702 . . . . 0.0 111.712 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.84 -24.8 67.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.687 0.795 . . . . 0.0 112.606 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -83.16 -17.73 41.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.682 0.674 . . . . 0.0 111.763 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.8 145.25 13.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.632 1.106 . . . . 0.0 109.087 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -123.05 -47.16 2.05 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.073 0.949 . . . . 0.0 111.346 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -162.84 172.41 15.2 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.609 0.764 . . . . 0.0 109.487 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.25 144.54 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 106.595 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -148.05 176.53 10.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.619 1.567 . . . . 0.0 108.04 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.33 168.92 44.97 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -83.49 -164.42 0.9 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 110.032 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 60.3 38.33 19.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.275 1.83 . . . . 0.0 112.859 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -141.14 26.76 1.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.635 1.574 . . . . 0.0 109.767 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 102.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 120.97 -1.082 . . . . 0.0 108.424 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -61.95 -44.51 96.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.518 . . . . 0.0 110.46 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' VAL . 6.7 mtm105 56.53 -176.52 0.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.828 2.051 . . . . 0.0 112.515 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mm -133.55 160.23 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.88 -23.12 67.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.74 27.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 148.26 57.71 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 122.765 0.426 . . . . 0.0 110.947 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.31 152.68 66.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.21 2.607 . . . . 0.0 110.041 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.33 73.81 0.98 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.599 1.19 . . . . 0.0 110.528 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -162.72 -52.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 130.12 3.368 . . . . 0.0 103.696 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.3 mt -75.42 92.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -51.01 -41.4 59.77 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.912 0.885 . . . . 0.0 108.9 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.85 -156.04 19.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 47' ' ' ARG . 25.6 m -124.1 151.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -136.34 148.26 47.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -80.62 92.34 5.95 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.404 1.081 . . . . 0.0 109.895 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.58 171.65 4.88 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -67.14 63.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.182 1.793 . . . . 0.0 113.155 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.21 -8.63 3.8 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.968 2.223 . . . . 0.0 113.507 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -152.83 -165.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 119.104 1.452 . . . . 0.0 108.342 -169.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.469 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.4 tp -121.62 157.88 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.546 1.938 . . . . 0.0 107.709 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.72 138.79 12.71 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.896 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.38 145.29 64.84 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.181 1.92 . . . . 0.0 110.049 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -129.05 138.31 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.82 164.34 11.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -132.14 126.98 34.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.0 -21.99 64.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.122 1.369 . . . . 0.0 111.665 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -37.67 80.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.274 1.397 . . . . 0.0 110.101 169.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.85 -57.0 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -66.64 -28.78 68.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.861 0.864 . . . . 0.0 113.199 -169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -135.11 5.93 3.32 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.3 m 53.14 41.87 32.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.183 0.901 . . . . 0.0 111.687 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -52.6 146.3 10.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.1 t -44.92 -61.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 112.742 -169.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -175.21 86.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.79 1.636 . . . . 0.0 108.657 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.7 144.1 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.84 163.92 31.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 109.493 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.55 42.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.722 2.409 . . . . 0.0 112.889 172.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.05 -12.87 0.16 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.161 2.184 . . . . 0.0 111.318 170.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.71 -5.94 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.335 1.454 . . . . 0.0 111.735 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.41 44.24 1.52 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.452 -1.405 . . . . 0.0 108.762 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 p -99.38 -2.97 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.344 1.858 . . . . 0.0 114.297 -169.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.6 t -128.06 154.79 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.16 130.68 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.129 1.771 . . . . 0.0 106.341 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.2 mt -102.7 138.22 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.17 133.76 54.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.3 mt -133.53 163.69 28.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.607 1.563 . . . . 0.0 107.922 -170.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.84 146.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.853 1.261 . . . . 0.0 107.674 171.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.7 157.34 43.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.52 -112.44 2.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.82 27.04 5.79 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.511 1.524 . . . . 0.0 110.383 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -141.14 171.27 14.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.401 1.081 . . . . 0.0 110.835 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.76 154.27 38.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.229 1.011 . . . . 0.0 110.704 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.6 p -161.28 176.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.324 1.85 . . . . 0.0 106.878 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.24 -179.87 37.98 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 120.548 -1.345 . . . . 0.0 111.785 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 pt -142.46 155.97 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.519 1.528 . . . . 0.0 108.579 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.2 143.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.55 171.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.411 1.884 . . . . 0.0 110.086 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.59 -42.51 42.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.776 0.716 . . . . 0.0 109.973 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.63 153.42 9.69 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 173.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.57 123.99 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.9 -52.86 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.313 0.645 . . . . 0.0 110.373 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -173.23 -177.17 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.941 1.697 . . . . 0.0 108.093 -169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -117.26 132.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.8 mt -135.09 174.42 10.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.762 1.625 . . . . 0.0 108.665 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -132.4 141.72 48.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.213 0.605 . . . . 0.0 109.587 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.7 134.97 27.52 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 51.8 p -76.77 163.76 26.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.321 0.581 . . . . 0.0 110.712 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.99 10.01 0.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.377 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.99 -40.46 5.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.418 2.287 . . . . 0.0 108.851 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -61.13 -47.43 86.31 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.1 mt -67.21 119.6 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -151.3 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.15 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -177.58 2.66 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.247 1.964 . . . . 0.0 111.257 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.36 153.64 29.56 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.377 1.471 . . . . 0.0 108.707 169.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.14 51.05 3.52 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.603 3.535 . . . . 0.0 110.65 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 7.7 1.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.634 1.573 . . . . 0.0 114.847 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -146.1 160.07 42.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.3 32.95 14.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.738 2.015 . . . . 0.0 114.367 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.21 166.13 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.599 1.56 . . . . 0.0 108.697 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -5.36 34.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 113.747 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.22 156.8 11.69 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.989 1.716 . . . . 0.0 111.632 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 m -133.45 151.14 51.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.362 0.665 . . . . 0.0 112.103 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -57.32 -23.95 52.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.399 1.88 . . . . 0.0 114.49 -169.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -66.25 -32.22 73.51 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.817 0.735 . . . . 0.0 111.414 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.25 29.41 1.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.772 0.829 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 145' ' ' VAL . 21.4 p 62.31 -163.35 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.238 1.415 . . . . 0.0 111.434 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -149.18 177.94 27.05 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 171.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -139.89 142.28 36.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.57 172.94 31.69 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.7 157.16 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.24 0.543 . . . . 0.0 111.83 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.53 68.01 1.38 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.539 2.336 . . . . 0.0 106.699 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.04 -48.18 2.7 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.471 1.986 . . . . 0.0 113.584 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -145.89 -32.2 0.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.429 1.892 . . . . 0.0 110.933 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -70.23 151.35 45.45 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.3 mtp -139.22 143.34 38.01 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.92 120.19 22.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.54 114.34 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.82 99.54 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 132' ' ' THR . 64.1 t -59.91 122.52 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 108.24 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -80.25 60.59 3.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.502 0.667 . . . . 0.0 110.371 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.69 -37.17 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.068 1.347 . . . . 0.0 111.578 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.37 -27.93 69.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.276 0.489 . . . . 0.0 111.554 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -97.01 -28.28 14.23 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 116.772 -1.585 . . . . 0.0 112.218 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -47.35 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.461 1.504 . . . . 0.0 112.451 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.65 -35.01 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -58.58 -34.11 70.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 112.535 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 m -99.4 -14.3 19.21 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.357 1.063 . . . . 0.0 111.473 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.7 -2.69 56.91 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.143 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -52.84 -42.98 65.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.208 1.367 . . . . 0.0 112.051 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -66.8 -24.08 66.13 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.202 1.401 . . . . 0.0 112.368 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.68 -31.21 13.92 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.415 1.486 . . . . 0.0 111.002 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.81 -62.81 1.59 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.738 1.215 . . . . 0.0 109.167 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -67.84 -29.73 68.95 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.891 -169.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 124.085 0.954 . . . . 0.0 112.81 177.709 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 112' ' ' THR . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -145.59 155.74 43.24 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.469 1.908 . . . . 0.0 109.266 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -103.29 147.45 27.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 144' ' ' LEU . 96.8 m-85 -141.88 135.45 29.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.451 1.1 . . . . 0.0 109.154 -169.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.43 132.74 37.43 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 167.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.93 149.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 119.719 1.145 . . . . 0.0 108.764 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.46 148.3 37.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.917 0.887 . . . . 0.0 110.039 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 m -89.4 146.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 102' ' ' VAL . 44.4 tp -150.41 133.29 15.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.61 -93.16 0.04 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.73 37.25 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.51 163.81 34.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.746 1.218 . . . . 0.0 108.755 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.29 151.13 36.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 123.026 1.393 . . . . 0.0 110.753 173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -138.5 158.02 45.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.457 2.303 . . . . 0.0 107.139 -171.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.82 158.81 23.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.107 0.86 . . . . 0.0 111.007 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -48.79 118.23 2.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.09 0.956 . . . . 0.0 108.696 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.42 -33.49 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.123 0.569 . . . . 0.0 111.754 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.91 -23.62 67.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.532 0.733 . . . . 0.0 112.701 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -80.97 -21.27 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.756 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.79 141.89 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.309 0.958 . . . . 0.0 108.452 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -118.07 -46.61 2.61 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.554 1.142 . . . . 0.0 110.278 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -162.47 172.09 16.07 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.622 1.169 . . . . 0.0 108.66 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -135.46 141.21 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -145.15 177.51 8.74 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.312 1.445 . . . . 0.0 107.672 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.28 162.45 18.99 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -56.61 136.79 54.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -153.96 -52.21 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.0 58.7 0.79 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.307 0.643 . . . . 0.0 110.773 -169.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.25 110.69 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.4 m -62.82 -38.03 89.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.29 1.436 . . . . 0.0 110.545 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 30.57 19.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.496 1.518 . . . . 0.0 112.599 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.0 mm 43.08 -95.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 127.675 2.39 . . . . 0.0 110.096 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.15 -44.3 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.912 1.285 . . . . 0.0 109.562 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.06 32.41 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.422 0.689 . . . . 0.0 112.13 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.88 143.56 60.63 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.702 1.201 . . . . 0.0 110.516 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.43 159.36 50.76 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 111.084 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.77 65.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.041 0.936 . . . . 0.0 112.1 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -71.63 4.07 3.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.26 -36.74 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.685 1.194 . . . . 0.0 110.737 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.251 63.2 mttt 50.9 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.566 2.346 . . . . 0.0 110.338 -167.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.77 -176.16 40.62 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 121.88 2.127 . . . . 0.0 113.102 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.11 156.51 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 122.071 -0.664 . . . . 0.0 110.625 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 t -134.47 160.49 37.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.913 1.285 . . . . 0.0 108.716 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -77.99 142.11 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.45 174.88 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.21 1.404 . . . . 0.0 108.159 168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 -35.78 -30.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.43 21.53 0.28 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.129 0.877 . . . . 0.0 113.183 169.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -152.45 -165.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.0 1.32 . . . . 0.0 108.108 -170.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.1 tp -130.79 157.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.716 1.606 . . . . 0.0 108.979 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.26 139.62 13.01 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.53 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 131.29 27.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.36 2.04 . . . . 0.0 109.429 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.63 128.46 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.57 165.07 20.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -121.37 128.88 52.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.702 0.801 . . . . 0.0 109.522 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.93 -10.38 58.37 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.58 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.02 -21.41 61.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.078 1.308 . . . . 0.0 110.06 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.84 18.29 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 126.036 1.734 . . . . 0.0 108.788 -171.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.52 -32.41 0.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 117.936 -1.03 . . . . 0.0 112.047 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -132.21 5.38 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.534 1.061 . . . . 0.0 112.428 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 m 51.52 36.25 16.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.37 1.468 . . . . 0.0 111.468 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -59.28 147.94 33.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -22.36 -61.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.041 3.337 . . . . 0.0 115.419 -169.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -157.39 27.58 0.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.766 0.826 . . . . 0.0 111.702 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 24' ' ' LEU . 8.5 p -68.7 140.87 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.111 -0.993 . . . . 0.0 109.886 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -171.62 178.07 3.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.014 2.925 . . . . 0.0 104.943 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HA ' HG21 ' A' ' 86' ' ' THR . 16.0 m-30 -65.7 60.58 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.716 2.406 . . . . 0.0 110.821 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -160.38 -30.43 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.558 2.743 . . . . 0.0 109.904 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 86' ' ' THR . 25.7 t0 -78.7 40.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.602 1.161 . . . . 0.0 111.855 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.99 -15.85 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.913 3.685 . . . . 0.0 114.997 -173.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 82' ' ' TYR 0.282 14.8 p 31.19 72.36 0.07 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.122 3.369 . . . . 0.0 117.307 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.1 155.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.7 119.65 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.368 -1.457 . . . . 0.0 107.772 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.65 139.38 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.33 134.76 52.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.6 mt -132.54 163.44 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 108.381 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 155.36 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.402 1.081 . . . . 0.0 108.959 173.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mp -131.22 -179.9 5.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -20.83 -61.84 0.02 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.694 2.568 . . . . 0.0 116.18 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -137.51 24.4 2.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.031 0.933 . . . . 0.0 111.923 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -150.67 165.37 33.61 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.772 -1.205 . . . . 0.0 111.262 -169.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.69 151.42 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.533 1.133 . . . . 0.0 109.214 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.32 166.86 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.997 1.319 . . . . 0.0 107.912 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.57 176.58 34.66 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.148 -0.97 . . . . 0.0 112.044 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.9 pt -146.03 152.11 14.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.66 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -82.95 144.45 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.628 1.171 . . . . 0.0 110.052 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.582 ' HA ' HD13 ' A' ' 24' ' ' LEU . 17.1 m -144.5 164.59 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.716 1.606 . . . . 0.0 109.119 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.81 -42.28 58.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.349 -0.844 . . . . 0.0 108.825 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.33 156.05 11.95 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.81 126.3 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -76.8 -55.53 5.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -176.61 176.99 1.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.644 1.978 . . . . 0.0 107.58 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -100.08 139.24 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.6 mt -140.12 172.13 13.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.551 . . . . 0.0 107.573 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.8 m -130.77 143.61 50.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.764 0.711 . . . . 0.0 110.344 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.17 171.09 14.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.025 1.33 . . . . 0.0 109.409 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.423 HG22 ' HA2' ' A' ' 16' ' ' GLY . 33.3 p -134.66 160.49 37.96 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.806 1.643 . . . . 0.0 108.467 -176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.33 1.93 3.4 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.42 -45.75 12.4 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.507 1.523 . . . . 0.0 107.721 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -67.44 -41.75 84.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.207 1.003 . . . . 0.0 109.928 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -82.42 112.52 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -142.45 -57.62 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.619 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.52 175.67 4.92 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.14 1.893 . . . . 0.0 111.683 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.44 156.94 33.77 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.614 1.565 . . . . 0.0 108.471 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.55 50.95 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.904 3.069 . . . . 0.0 111.071 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.56 26.26 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.585 1.954 . . . . 0.0 113.37 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -68.73 175.88 3.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.651 1.98 . . . . 0.0 111.381 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 67.85 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.631 1.572 . . . . 0.0 110.753 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.48 -179.21 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.898 1.679 . . . . 0.0 109.245 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -6.96 11.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -69.89 155.54 40.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.023 0.929 . . . . 0.0 110.635 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.4 m -139.29 157.73 45.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.843 1.257 . . . . 0.0 109.131 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 p -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.987 1.315 . . . . 0.0 113.131 -171.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.32 -36.37 83.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 111.103 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -129.13 33.05 4.63 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.576 1.55 . . . . 0.0 108.801 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 127.51 32.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 146' ' ' ASN . 81.8 p -74.92 -171.92 1.47 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.828 1.651 . . . . 0.0 110.134 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.07 172.86 22.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.319 -2.313 . . . . 0.0 107.319 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.33 151.67 37.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.101 1.451 . . . . 0.0 109.539 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.02 177.72 27.06 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.27 0.938 . . . . 0.0 111.163 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.82 159.08 36.86 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.41 0.684 . . . . 0.0 111.903 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.77 59.8 1.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.624 2.369 . . . . 0.0 107.241 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.57 -45.25 2.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.345 1.926 . . . . 0.0 113.93 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -140.17 -38.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.491 2.316 . . . . 0.0 109.678 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -73.76 153.2 40.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 89.1 mtp -141.72 140.52 33.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -133.43 137.54 45.8 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.82 110.48 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.405 HD12 ' CD2' ' A' ' 19' ' ' PHE . 2.7 mm? -84.79 112.37 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.85 136.16 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.438 ' H ' HG22 ' A' ' 132' ' ' THR . 45.1 t-20 -78.85 61.96 3.21 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 109.822 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 tp -54.81 -38.38 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.997 1.319 . . . . 0.0 111.126 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.0 -15.6 59.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -111.12 -9.35 14.37 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.333 -1.318 . . . . 0.0 111.556 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.74 -80.8 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.136 -169.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.76 -30.81 70.37 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.029 -1.044 . . . . 0.0 109.442 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.4 -21.86 62.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.3 m -115.17 -12.19 11.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.804 0.842 . . . . 0.0 112.078 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.42 -15.32 19.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.512 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.51 -40.49 78.8 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.891 1.678 . . . . 0.0 111.953 -169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.0 ptp -63.23 -31.82 73.07 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.42 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.53 25.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.75 1.22 . . . . 0.0 111.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.79 -55.64 9.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.69 -28.36 68.57 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.068 -0.395 . . . . 0.0 111.731 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 124.649 1.179 . . . . 0.0 112.807 176.569 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' N ' ' HG1' ' A' ' 112' ' ' THR . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -68.87 161.74 28.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 168.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.4 142.6 49.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -141.64 134.55 28.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 109.564 -169.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.19 133.22 35.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 151.34 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 119.531 1.06 . . . . 0.0 109.15 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.99 153.23 46.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.77 1.228 . . . . 0.0 109.407 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -96.65 146.46 24.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 tp -149.61 132.71 16.28 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.79 -104.74 0.69 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.23 37.39 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.664 1.585 . . . . 0.0 108.912 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.24 159.95 41.06 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.825 2.05 . . . . 0.0 107.594 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.82 160.85 20.69 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 110.281 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -142.68 152.57 42.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.932 2.093 . . . . 0.0 106.809 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.23 154.85 21.39 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mt -139.5 134.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.18 117.17 2.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 109.157 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -54.42 -35.56 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.895 0.878 . . . . 0.0 111.558 -170.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.93 -24.98 68.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.717 0.807 . . . . 0.0 112.508 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -80.65 -23.53 39.6 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.483 0.583 . . . . 0.0 111.464 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.71 132.96 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -90.09 -59.07 2.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.33 -179.42 7.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.435 1.094 . . . . 0.0 109.825 -172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.61 143.13 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -147.78 173.88 12.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.403 1.081 . . . . 0.0 108.483 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.64 157.8 33.09 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -77.26 106.71 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 108.654 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -157.76 163.53 38.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.736 1.214 . . . . 0.0 109.569 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.88 34.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.904 2.481 . . . . 0.0 114.484 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.17 143.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.709 0.766 . . . . 0.0 109.396 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -136.03 93.09 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -71.21 118.96 14.66 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -70.02 157.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -23.5 67.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -172.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.89 23.91 0.51 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 156.99 35.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 122.935 0.494 . . . . 0.0 110.906 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -59.18 145.69 96.94 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 N-CA-C 107.995 -1.579 . . . . 0.0 107.995 169.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.67 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.728 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.12 -38.27 67.96 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.994 0.816 . . . . 0.0 110.675 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.5 mt -75.57 90.7 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -58.31 -26.41 63.01 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.02 -158.96 32.09 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.24 153.69 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -134.67 165.15 25.92 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.244 0.929 . . . . 0.0 108.985 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -71.23 99.4 1.9 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.535 1.534 . . . . 0.0 110.857 -173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.25 0.5 OUTLIER -77.9 64.3 3.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 107.677 169.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 45.55 34.35 1.64 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.061 2.944 . . . . 0.0 114.145 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.79 -20.9 4.52 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.982 1.277 . . . . 0.0 112.136 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.66 -163.21 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 172.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 tp -138.27 147.14 25.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 121.156 -0.965 . . . . 0.0 111.979 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.59 135.99 18.48 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.89 147.95 75.56 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.998 1.799 . . . . 0.0 110.157 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.435 HD11 HG13 ' A' ' 88' ' ' VAL . 1.9 tp -126.61 131.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.59 155.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -140.48 143.08 35.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.22 1.009 . . . . 0.0 109.27 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.48 -16.74 62.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.943 1.297 . . . . 0.0 110.566 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -61.81 -20.19 63.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.093 1.315 . . . . 0.0 111.144 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.4 mt -115.89 -48.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.96 -25.36 67.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.811 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -135.0 -6.39 2.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.589 1.086 . . . . 0.0 113.116 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.5 m 55.92 46.02 22.84 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.086 -1.009 . . . . 0.0 111.716 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -47.04 142.88 3.33 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.34 -65.04 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.722 1.609 . . . . 0.0 112.65 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -162.28 79.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.161 0.985 . . . . 0.0 109.697 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.52 144.79 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -164.63 171.56 14.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.683 1.593 . . . . 0.0 107.462 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -70.17 48.32 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.736 2.014 . . . . 0.0 110.921 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.69 -12.91 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.741 3.216 . . . . 0.0 110.737 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.16 -3.26 1.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.428 1.491 . . . . 0.0 111.988 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -146.56 40.05 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.224 1.409 . . . . 0.0 109.095 -169.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 p -96.21 -11.6 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.293 1.837 . . . . 0.0 114.041 -169.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.68 155.67 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 68' ' ' ILE . 77.0 t -130.08 135.7 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.185 1.794 . . . . 0.0 106.231 -174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.61 124.61 65.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.29 134.31 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.7 mt -133.09 162.01 32.87 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.102 1.361 . . . . 0.0 108.822 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.35 153.9 41.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.5 136.55 18.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.6 -94.97 0.08 OUTLIER Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -169.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -139.91 22.33 2.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.054 1.742 . . . . 0.0 110.76 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -134.52 163.31 30.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.113 -0.992 . . . . 0.0 110.106 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.23 152.27 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 110.393 -170.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.94 177.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 126.224 1.809 . . . . 0.0 106.711 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.8 33.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.4 154.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.895 0.878 . . . . 0.0 109.082 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.96 144.61 13.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.83 170.96 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.737 1.615 . . . . 0.0 110.049 -168.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -76.72 -42.93 39.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.971 -0.456 . . . . 0.0 110.353 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.97 153.79 9.16 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.9 129.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 m -77.03 -57.83 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.405 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -176.62 175.33 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 107.796 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.5 140.09 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.28 176.34 8.8 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.994 1.718 . . . . 0.0 108.16 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 m -131.63 139.63 49.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.199 0.6 . . . . 0.0 109.566 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.53 165.72 26.79 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.238 1.415 . . . . 0.0 108.4 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 16' ' ' GLY . 28.7 m -137.58 158.8 43.6 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 107.811 -169.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.18 -13.01 2.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.8 -40.71 92.17 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.81 1.186 . . . . 0.0 110.129 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -82.72 -39.08 22.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.533 1.533 . . . . 0.0 109.692 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.77 85.83 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 44.6 mtm180 -140.88 -53.69 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 116.608 -1.663 . . . . 0.0 112.725 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.1 Cg_endo -65.01 175.93 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 121.699 1.643 . . . . 0.0 111.167 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.65 158.23 32.21 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.939 1.296 . . . . 0.0 109.157 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.02 60.7 7.94 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.778 2.986 . . . . 0.0 110.994 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.35 33.52 0.06 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.378 1.871 . . . . 0.0 112.495 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.2 178.3 4.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.52 1.528 . . . . 0.0 110.74 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.55 0.93 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.203 1.401 . . . . 0.0 110.568 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.71 159.16 39.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.799 1.639 . . . . 0.0 109.039 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -58.52 -25.05 61.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.881 0.872 . . . . 0.0 112.2 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.96 -26.92 68.51 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.796 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -76.11 75.46 2.96 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 124.319 2.009 . . . . 0.0 111.292 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 t -155.52 177.57 11.22 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 129.502 3.121 . . . . 0.0 103.776 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.6 -7.55 0.99 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 126.472 1.909 . . . . 0.0 115.963 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -73.21 -5.35 38.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.737 1.153 . . . . 0.0 110.438 168.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -46.59 135.52 8.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.108 2.163 . . . . 0.0 114.459 -169.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 145' ' ' VAL . 52.6 p -77.02 -165.7 0.6 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.878 2.871 . . . . 0.0 110.355 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.23 -179.72 16.84 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.464 1.983 . . . . 0.0 108.544 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mt -133.62 150.64 51.6 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.932 1.693 . . . . 0.0 106.948 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.33 171.85 32.87 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.09 158.06 43.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.089 0.956 . . . . 0.0 110.927 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 mt -144.89 69.37 1.25 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.231 1.812 . . . . 0.0 107.605 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.87 -49.56 2.85 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.337 1.922 . . . . 0.0 113.1 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -145.45 -31.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.379 1.872 . . . . 0.0 110.953 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -69.64 153.13 43.87 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.3 mtp -142.8 146.67 34.44 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.31 147.62 25.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.368 0.667 . . . . 0.0 109.879 -175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -93.02 112.42 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.53 107.77 10.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.529 ' HA ' HG22 ' A' ' 132' ' ' THR . 71.0 t -62.91 122.8 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -79.41 53.79 1.6 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.371 0.668 . . . . 0.0 110.683 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 tp -54.09 -37.39 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.52 1.128 . . . . 0.0 111.123 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -65.49 -6.45 10.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.867 1.267 . . . . 0.0 112.782 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -124.49 -28.9 3.55 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 0.0 111.608 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.2 tp -45.49 -64.5 0.71 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.875 1.67 . . . . 0.0 111.841 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.28 -46.34 56.24 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.95 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -65.09 -21.4 66.8 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.256 0.935 . . . . 0.0 113.064 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.7 m -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.68 1.127 . . . . 0.0 111.506 170.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.87 -15.01 46.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.881 0.872 . . . . 0.0 112.182 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -49.6 -44.64 47.32 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 125.754 1.622 . . . . 0.0 113.555 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -64.1 -40.78 96.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.552 0.614 . . . . 0.0 111.432 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.36 -37.86 65.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.342 0.657 . . . . 0.0 110.545 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.4 tt -59.67 -56.61 19.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.259 1.424 . . . . 0.0 109.742 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -26.24 61.9 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 122.807 0.443 . . . . 0.0 111.384 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 CA--C 1.54 0.58 0 C-N-CA 123.09 0.556 . . . . 0.0 112.416 171.024 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.16 160.14 24.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -116.43 144.76 43.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.84 136.79 30.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.624 0.77 . . . . 0.0 110.03 -169.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.8 tp -77.57 134.55 38.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 102.849 -3.019 . . . . 0.0 102.849 167.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.25 149.88 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.655 1.116 . . . . 0.0 108.781 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.92 151.81 44.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.225 1.01 . . . . 0.0 110.15 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -95.49 143.72 26.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -139.38 94.4 2.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.044 1.338 . . . . 0.0 107.517 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.47 -74.52 0.71 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.279 1.419 . . . . 0.0 111.456 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.69 29.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.067 1.347 . . . . 0.0 110.603 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.14 160.87 38.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.31 1.444 . . . . 0.0 108.111 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.18 151.64 45.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.808 1.289 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.9 155.76 47.03 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.634 1.974 . . . . 0.0 107.729 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.57 157.91 22.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -142.61 134.48 25.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -50.07 119.07 3.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.464 0.706 . . . . 0.0 109.378 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -54.8 -34.65 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.871 0.868 . . . . 0.0 111.285 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.65 -22.15 66.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.554 0.742 . . . . 0.0 112.735 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.66 -21.09 32.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.07 0.85 . . . . 0.0 111.688 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.09 140.72 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.84 -42.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.496 1.119 . . . . 0.0 110.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -161.53 171.02 18.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.383 1.073 . . . . 0.0 108.815 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.1 147.59 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -150.17 173.99 13.3 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.56 163.67 26.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -60.27 136.76 58.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.0 -55.14 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.96 84.25 1.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -169.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.14 119.02 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 m -78.64 93.2 4.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -78.1 88.73 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.79 137.46 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.2 -17.93 60.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -137.11 37.92 2.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.68 1.192 . . . . 0.0 111.017 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 53' ' ' ALA . 27.1 p -60.82 166.48 4.53 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 121.804 -0.56 . . . . 0.0 111.897 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.6 20.21 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 123.227 2.618 . . . . 0.0 111.358 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' THR . . . 59.1 -39.91 0.07 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 131.319 3.848 . . . . 0.0 116.938 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -52.97 -44.18 66.95 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 120.326 1.421 . . . . 0.0 108.509 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.99 110.29 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -67.79 -34.91 77.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.58 -153.52 21.19 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -117.71 162.4 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.45 150.41 34.55 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.287 -1.508 . . . . 0.0 110.117 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.05 135.22 46.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.226 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.37 97.44 5.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.512 1.125 . . . . 0.0 109.434 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 57.17 17.28 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 113.334 172.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.41 6.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.002 1.287 . . . . 0.0 113.007 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.34 -172.05 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.93 1.292 . . . . 0.0 108.295 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.15 155.01 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.834 1.253 . . . . 0.0 110.393 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.39 141.97 15.21 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.626 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.08 140.15 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.097 1.865 . . . . 0.0 109.27 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 tp -126.18 135.15 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.18 148.76 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.806 2.042 . . . . 0.0 106.028 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -125.78 128.56 47.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.06 -18.93 65.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.986 0.914 . . . . 0.0 111.346 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -58.88 -25.53 63.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.815 -1.178 . . . . 0.0 110.531 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.36 -30.8 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.516 1.526 . . . . 0.0 110.085 -169.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -92.77 -22.03 19.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.21 0.914 . . . . 0.0 113.004 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -132.83 3.1 3.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.278 0.944 . . . . 0.0 111.807 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 m 51.39 41.7 28.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.86 1.264 . . . . 0.0 111.402 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -57.41 170.96 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.715 0.806 . . . . 0.0 111.175 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 m -58.13 169.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.02 0.914 . . . . 0.0 109.416 168.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.28 62.51 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.468 2.307 . . . . 0.0 111.349 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -45.42 150.93 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.287 2.235 . . . . 0.0 111.759 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -152.11 165.15 35.66 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.249 1.42 . . . . 0.0 108.449 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -74.6 53.18 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 0.0 110.597 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -151.46 -21.96 0.2 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.245 3.418 . . . . 0.0 109.708 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.79 7.52 2.75 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.538 1.535 . . . . 0.0 111.659 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -154.69 40.52 0.45 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.137 2.175 . . . . 0.0 108.567 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 p -88.96 7.14 36.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.586 1.954 . . . . 0.0 115.362 -168.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.49 157.43 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.4 136.19 55.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.67 134.32 48.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.7 mt -133.82 164.22 27.74 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 108.007 -171.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.97 154.09 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.313 0.645 . . . . 0.0 110.113 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mp -136.51 80.81 1.84 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.4 -68.95 2.34 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.676 -0.64 . . . . 0.0 113.214 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -137.01 0.6 2.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.402 1.881 . . . . 0.0 111.833 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.92 165.55 22.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.502 1.121 . . . . 0.0 109.103 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.39 150.45 32.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.019 0.927 . . . . 0.0 109.18 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.91 165.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.02 32.15 Favored Glycine 0 N--CA 1.451 -0.364 0 O-C-N 121.118 -0.989 . . . . 0.0 111.683 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.29 164.56 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 109.847 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 m -111.37 132.13 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.153 1.781 . . . . 0.0 108.183 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.89 164.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.97 1.308 . . . . 0.0 109.611 -168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.3 -41.67 73.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.13 158.94 20.93 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.32 123.12 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -48.3 15.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.921 0.888 . . . . 0.0 109.682 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -173.44 -174.54 1.02 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 108.02 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.73 128.76 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.56 173.22 11.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.217 1.407 . . . . 0.0 108.923 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.3 m -130.92 139.05 50.03 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.3 161.12 38.65 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 m -132.9 157.21 45.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.09 1.756 . . . . 0.0 108.238 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -17.36 24.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.86 -36.33 80.09 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.24 -40.46 19.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.606 1.562 . . . . 0.0 110.434 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.05 103.67 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 91.9 mtt-85 -140.54 -55.84 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 116.936 -1.507 . . . . 0.0 111.423 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.5 Cg_endo -66.48 173.2 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.97 157.51 30.74 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.0 1.72 . . . . 0.0 108.89 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.41 143.66 48.36 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.817 1.678 . . . . 0.0 109.457 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.14 22.75 0.65 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.035 1.334 . . . . 0.0 110.335 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.63 176.85 5.83 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.275 1.43 . . . . 0.0 111.442 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.23 66.48 0.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.739 1.615 . . . . 0.0 110.603 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.45 172.83 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.846 1.658 . . . . 0.0 109.433 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -15.63 61.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.283 1.433 . . . . 0.0 113.724 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.82 144.41 54.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.937 . . . . 0.0 110.206 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.8 m -138.32 162.26 34.82 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.28 1.032 . . . . 0.0 109.791 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -57.45 -27.52 62.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 114.338 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -74.69 -24.09 58.72 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.623 -0.673 . . . . 0.0 111.895 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -127.2 -3.35 6.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.087 0.955 . . . . 0.0 112.73 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.08 161.47 5.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.614 0.643 . . . . 0.0 110.76 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.2 p -113.69 -166.54 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.8 1.64 . . . . 0.0 110.407 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.4 168.69 23.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.6 154.61 39.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.913 1.857 . . . . 0.0 111.0 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.3 173.38 40.27 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.092 0.377 . . . . 0.0 112.853 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.15 157.26 17.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.927 0.891 . . . . 0.0 111.13 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.06 85.06 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.16 -55.0 2.3 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.751 2.119 . . . . 0.0 112.862 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -150.34 -28.12 0.23 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.199 2.199 . . . . 0.0 111.524 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -69.12 163.3 25.12 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.754 0.707 . . . . 0.0 109.529 171.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.99 134.59 47.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.83 134.82 51.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.06 107.11 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.04 109.99 13.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.51 130.55 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.857 1.263 . . . . 0.0 108.434 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -74.87 57.03 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.442 1.897 . . . . 0.0 109.867 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -46.71 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.825 1.65 . . . . 0.0 111.268 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -66.86 -10.0 43.65 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.6 -14.93 16.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.471 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.6 tp -55.5 -78.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.812 1.245 . . . . 0.0 111.325 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.6 tp -77.32 -20.47 54.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.99 0.813 . . . . 0.0 111.257 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.07 -39.96 79.83 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.259 -0.9 . . . . 0.0 111.661 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 -19.92 17.29 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.024 -0.512 . . . . 0.0 112.058 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.98 -10.52 57.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.763 1.165 . . . . 0.0 112.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.73 -44.34 58.23 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 121.303 1.865 . . . . 0.0 112.028 -171.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.9 mtm -65.23 -46.09 82.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.29 0.636 . . . . 0.0 110.311 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.45 74.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.53 0.732 . . . . 0.0 111.787 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.58 -64.17 1.04 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.61 -31.46 72.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -169.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 175.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -69.67 167.08 17.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 110.143 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.93 146.15 50.73 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.604 1.561 . . . . 0.0 107.417 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -142.15 140.32 32.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.612 0.765 . . . . 0.0 110.289 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.5 tp -80.39 134.45 36.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.36 148.29 27.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 109.123 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.14 153.68 45.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.509 1.124 . . . . 0.0 110.123 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -95.52 149.39 21.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.46 128.41 7.35 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.31 -89.51 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.71 34.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.352 1.461 . . . . 0.0 109.145 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -143.44 158.89 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.829 1.651 . . . . 0.0 107.871 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 155.55 28.05 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 123.251 1.5 . . . . 0.0 110.299 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -142.23 160.97 39.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.913 2.085 . . . . 0.0 107.338 -171.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.8 164.12 26.45 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.784 0.707 . . . . 0.0 111.729 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -144.68 136.15 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -49.26 118.8 2.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.15 0.98 . . . . 0.0 109.343 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.21 -33.83 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.814 0.846 . . . . 0.0 111.566 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.73 -23.39 67.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.434 0.694 . . . . 0.0 112.604 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -81.01 -19.13 44.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.272 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.54 142.24 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.267 1.394 . . . . 0.0 109.162 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -125.57 -39.84 2.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.121 1.369 . . . . 0.0 110.781 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -167.04 171.24 11.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.663 1.585 . . . . 0.0 107.754 175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.19 140.81 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -149.95 176.67 10.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 108.564 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.63 173.89 44.19 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -59.11 -31.06 68.59 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.83 -0.806 . . . . 0.0 112.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.0 t0 34.22 -90.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 129.33 3.052 . . . . 0.0 116.588 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 66.53 1.34 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 113.405 -169.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.57 133.9 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 m -70.88 -42.18 70.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.579 1.152 . . . . 0.0 111.593 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.03 89.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.75 2.02 . . . . 0.0 109.33 -169.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.9 150.87 6.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.77 66.73 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.71 20.85 0.61 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -172.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.71 148.39 47.24 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.41 121.46 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 N-CA-C 105.639 -2.485 . . . . 0.0 105.639 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.84 -33.03 0.69 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -168.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.09 -38.24 37.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.023 0.829 . . . . 0.0 110.976 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.8 mt -93.39 105.2 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.8 -57.45 12.64 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.43 -173.19 36.19 Favored Glycine 0 C--O 1.227 -0.315 0 O-C-N 121.021 -1.049 . . . . 0.0 111.73 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -83.6 153.82 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -138.09 160.66 38.81 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.94 108.36 19.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.522 -0.736 . . . . 0.0 111.556 -172.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.2 72.67 3.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.66 -0.65 . . . . 0.0 110.685 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 49.89 28.78 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.684 1.594 . . . . 0.0 114.422 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.93 -20.61 2.15 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.371 0.986 . . . . 0.0 113.063 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -169.25 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.829 1.252 . . . . 0.0 107.806 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.72 148.63 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.766 -1.209 . . . . 0.0 110.08 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 p -148.87 134.56 9.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.93 138.9 45.7 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.314 2.676 . . . . 0.0 110.685 170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.84 135.32 63.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.386 1.089 . . . . 0.0 109.12 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.87 162.87 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.556 2.342 . . . . 0.0 105.188 169.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -139.79 145.05 37.71 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 120.652 -1.28 . . . . 0.0 109.409 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.11 -21.66 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.647 1.179 . . . . 0.0 112.917 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -70.34 -11.13 60.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.707 1.594 . . . . 0.0 112.213 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.16 20.92 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 0.0 109.034 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -141.55 -23.7 0.72 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.657 1.183 . . . . 0.0 111.449 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -139.39 12.16 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.561 1.144 . . . . 0.0 111.991 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.0 m 54.26 38.95 30.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.488 1.515 . . . . 0.0 112.427 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 156.2 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 78' ' ' VAL . 4.6 t -40.85 -67.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.657 2.383 . . . . 0.0 113.268 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -169.77 97.63 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.832 1.653 . . . . 0.0 109.13 -169.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.28 143.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.176 0.99 . . . . 0.0 109.593 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.25 158.23 35.75 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.109 1.364 . . . . 0.0 108.767 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -69.46 42.48 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.932 2.093 . . . . 0.0 113.143 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.86 -12.02 0.16 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.159 2.183 . . . . 0.0 110.671 169.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -125.51 -5.53 7.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.558 1.543 . . . . 0.0 111.98 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.98 38.83 2.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.271 1.428 . . . . 0.0 108.972 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -102.15 -4.73 25.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.561 . . . . 0.0 114.376 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.34 155.36 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.5 t -133.33 137.14 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.57 124.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.64 140.22 17.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -135.76 162.65 32.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.992 1.717 . . . . 0.0 107.843 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.05 148.86 39.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.178 1.391 . . . . 0.0 108.027 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.44 151.1 29.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.53 -102.54 0.11 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -139.62 34.07 2.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.498 1.519 . . . . 0.0 109.809 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.1 167.76 21.32 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.779 1.632 . . . . 0.0 109.297 -171.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.04 151.19 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 124.157 0.983 . . . . 0.0 109.547 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.67 176.78 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.854 1.661 . . . . 0.0 107.204 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.61 179.48 41.51 Favored Glycine 0 N--CA 1.448 -0.537 0 O-C-N 120.685 -1.259 . . . . 0.0 111.427 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.4 pt -141.65 158.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.587 1.155 . . . . 0.0 109.542 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.09 145.11 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.8 172.4 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.634 1.574 . . . . 0.0 110.606 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.22 -43.51 51.35 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.98 -0.45 . . . . 0.0 109.831 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.46 155.68 10.57 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 129.0 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -41.36 10.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.427 0.691 . . . . 0.0 111.802 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.2 t0 -167.57 -175.67 2.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 110.727 -168.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -135.84 125.28 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.18 166.53 24.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 110.191 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 m -125.37 141.24 52.18 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.201 0.6 . . . . 0.0 110.42 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.1 139.04 30.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.438 1.095 . . . . 0.0 108.398 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 p -82.95 153.31 25.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.18 -16.73 35.46 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.5 -42.04 75.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.003 1.321 . . . . 0.0 110.037 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -58.67 -39.58 81.05 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.749 0.819 . . . . 0.0 109.359 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.1 mt -77.77 0.63 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 126.314 1.846 . . . . 0.0 112.151 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -53.59 -53.57 55.57 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.167 -1.583 . . . . 0.0 114.344 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.39 175.71 9.68 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.346 2.03 . . . . 0.0 112.396 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.5 163.32 24.56 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.244 1.418 . . . . 0.0 109.313 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.4 -50.0 9.35 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.762 2.308 . . . . 0.0 113.018 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 51.24 20.15 0.87 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.912 2.085 . . . . 0.0 114.219 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -73.93 160.09 31.87 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 110.033 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.92 32.51 0.14 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.867 1.667 . . . . 0.0 112.8 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.27 -175.21 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.927 1.291 . . . . 0.0 109.952 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -11.23 21.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.885 1.274 . . . . 0.0 113.92 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.74 156.29 33.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.446 1.499 . . . . 0.0 110.459 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.1 m -137.13 156.45 48.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.044 0.938 . . . . 0.0 109.752 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 p -64.89 -24.12 67.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.957 1.303 . . . . 0.0 113.426 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.02 -34.24 73.03 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -127.18 30.74 5.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.261 1.424 . . . . 0.0 109.06 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 131.15 49.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.466 1.106 . . . . 0.0 108.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.8 p -69.78 -177.92 1.39 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.68 1.592 . . . . 0.0 110.491 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -125.53 179.14 16.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 169.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.32 157.59 43.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.253 1.527 . . . . 0.0 108.808 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.13 172.6 34.03 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.11 20.84 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.14 0.576 . . . . 0.0 109.778 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.1 82.56 1.76 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.77 2.66 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.582 2.039 . . . . 0.0 112.995 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.68 -31.25 0.09 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.033 2.133 . . . . 0.0 111.103 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.444 HH22 ' HB2' ' A' ' 107' ' ' ASP . 59.0 mtp180 -68.94 162.99 25.49 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.0 mtp -139.8 144.94 37.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.18 126.13 29.3 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.8 mt -81.47 111.62 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.53 111.08 22.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.1 t -67.41 131.09 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 108.329 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -75.79 62.22 1.51 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.225 1.01 . . . . 0.0 109.734 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -43.98 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.895 1.678 . . . . 0.0 110.33 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.23 -18.41 63.5 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 112.814 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -111.16 -10.74 14.3 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.956 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.0 -67.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.005 1.275 . . . . 0.0 110.08 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.67 -39.89 84.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.071 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -55.42 -48.51 74.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 0.0 110.717 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 m -82.15 -16.29 50.32 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 112.779 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.08 3.28 33.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.984 1.265 . . . . 0.0 112.783 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.26 -42.06 97.98 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.501 -1.374 . . . . 0.0 110.615 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.1 ptp -62.08 -28.97 69.99 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.719 -0.613 . . . . 0.0 112.004 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.86 32.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.0 tp -56.95 -53.62 55.99 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.97 -14.62 61.93 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.436 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 120.381 1.446 . . . . 0.0 111.849 175.919 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -66.02 146.79 54.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.18 145.6 33.97 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -142.01 138.38 31.81 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.171 0.989 . . . . 0.0 110.175 -169.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -84.19 137.47 33.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 167.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 30' ' ' GLY 0.256 1.5 m -125.7 146.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 119.439 1.018 . . . . 0.0 108.525 -175.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -143.23 153.79 43.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.085 1.354 . . . . 0.0 110.393 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 m -95.17 143.8 26.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.81 103.98 4.78 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.49 -78.49 0.25 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.331 1.443 . . . . 0.0 111.781 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.26 30.19 0.55 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.608 1.163 . . . . 0.0 111.032 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.77 161.04 39.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.577 1.151 . . . . 0.0 108.568 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -115.65 149.39 38.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.97 1.367 . . . . 0.0 109.817 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -139.3 165.65 26.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 107.403 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -147.41 169.06 28.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 119.15 0.886 . . . . 0.0 113.534 170.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 mt -144.01 137.73 24.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.06 118.65 3.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.881 0.872 . . . . 0.0 109.015 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -53.64 -32.81 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.708 0.803 . . . . 0.0 111.747 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.53 -24.49 67.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.04 0.836 . . . . 0.0 112.72 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.32 -21.36 39.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.278 0.945 . . . . 0.0 111.113 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.09 138.41 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -113.25 -46.18 3.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.559 1.144 . . . . 0.0 109.46 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -162.65 177.32 9.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.869 1.268 . . . . 0.0 108.803 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -139.41 143.27 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 172.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -134.29 -104.88 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 0.0 110.764 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 88' ' ' VAL . . . 176.44 154.65 11.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -68.42 125.72 27.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -156.84 -48.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -150.9 50.66 0.86 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.04 0.936 . . . . 0.0 109.894 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.74 112.07 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 m -95.31 89.17 5.37 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.69 144.85 56.69 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' HB ' HG23 ' A' ' 51' ' ' THR . 34.4 mm -84.39 28.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.236 1.014 . . . . 0.0 109.071 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 65.37 -31.4 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.127 2.571 . . . . 0.0 115.144 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.63 24.52 0.78 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.531 1.532 . . . . 0.0 112.924 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.28 144.88 97.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 110.232 169.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.69 142.34 14.26 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.752 2.968 . . . . 0.0 111.11 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.52 69.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.735 0.414 . . . . 0.0 110.59 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -65.75 0.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 0.0 114.191 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.04 -35.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 124.804 1.242 . . . . 0.0 110.996 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 mttm 57.17 -75.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.344 1.858 . . . . 0.0 110.795 -168.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.1 -123.93 1.13 Allowed Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 121.247 1.84 . . . . 0.0 110.99 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.13 169.47 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -143.53 158.79 43.38 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 120.838 -1.164 . . . . 0.0 108.383 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -72.9 137.86 45.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 110.013 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.39 173.64 7.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.21 65.44 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.38 1.072 . . . . 0.0 112.933 -169.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.23 -8.69 4.74 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.241 2.353 . . . . 0.0 113.106 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -152.94 -165.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 119.189 1.494 . . . . 0.0 109.417 -169.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -125.59 159.35 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.589 1.956 . . . . 0.0 108.035 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.45 133.49 10.05 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.3 130.72 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.653 1.568 . . . . 0.0 108.428 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.17 134.83 55.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -126.35 144.22 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.02 109.5 20.85 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.64 -17.21 45.86 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.923 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.0 -37.89 21.65 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.969 1.258 . . . . 0.0 111.005 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.34 -38.59 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -69.65 -12.91 62.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.755 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -122.59 -3.96 8.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.001 1.273 . . . . 0.0 113.547 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m 49.61 47.05 23.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.826 1.251 . . . . 0.0 111.796 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -177.71 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.649 0.737 . . . . 0.0 110.926 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.16 170.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.69 1.196 . . . . 0.0 110.997 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.53 63.3 5.77 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 110.541 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.73 164.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.611 1.164 . . . . 0.0 111.508 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -154.36 172.77 17.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.872 1.669 . . . . 0.0 108.58 -172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -70.89 54.92 0.17 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.001 1.381 . . . . 0.0 111.111 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 84' ' ' ASP . 42.1 t30 -154.66 -19.27 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 131.085 3.754 . . . . 0.0 109.288 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.413 ' H ' ' H ' ' A' ' 83' ' ' ASN . 27.6 t70 -141.0 16.92 2.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.803 2.041 . . . . 0.0 110.822 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -159.79 42.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.407 3.083 . . . . 0.0 106.929 -173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.7 p -99.18 6.78 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -168.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 74.5 t -126.36 151.4 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.349 1.431 . . . . 0.0 108.395 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' GLY . 27.0 m -121.43 141.99 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.48 128.12 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.52 135.37 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.1 mt -134.54 162.26 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.64 1.576 . . . . 0.0 109.046 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.69 145.64 33.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 107.676 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.64 151.56 20.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.29 -94.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.742 1.163 . . . . 0.0 112.728 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.03 21.14 3.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.189 1.796 . . . . 0.0 110.975 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -145.43 173.79 11.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.011 -1.055 . . . . 0.0 112.824 -169.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.73 142.42 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.767 2.027 . . . . 0.0 106.234 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.07 178.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 125.563 1.545 . . . . 0.0 106.859 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.78 179.0 41.39 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.97 146.65 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.1 144.22 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.25 166.67 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.845 2.058 . . . . 0.0 107.602 -173.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.22 -44.92 71.07 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.241 -0.912 . . . . 0.0 109.893 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.94 162.1 24.46 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 m -74.87 127.48 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.71 -43.53 13.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.254 1.021 . . . . 0.0 110.166 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -171.0 176.74 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 110.762 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.97 131.72 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.841 2.057 . . . . 0.0 106.971 169.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.86 -178.49 5.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.337 1.055 . . . . 0.0 109.863 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 m -130.17 151.88 50.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.948 0.795 . . . . 0.0 112.069 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.46 163.93 31.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.61 1.564 . . . . 0.0 109.914 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.7 p -114.22 167.44 10.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.687 1.195 . . . . 0.0 111.522 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.31 -9.66 35.08 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.939 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.85 -52.02 11.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.04 -36.4 83.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.379 1.072 . . . . 0.0 111.493 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.7 mt -103.56 106.57 20.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.508 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 23.7 mmt180 -145.82 -53.07 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.205 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.508 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.2 Cg_endo -65.79 176.64 3.46 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.879 1.719 . . . . 0.0 111.733 173.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.17 160.63 32.96 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.56 1.944 . . . . 0.0 107.775 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.01 -45.47 5.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.733 1.622 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 45.58 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 131.693 3.997 . . . . 0.0 119.932 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -153.59 160.31 42.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.437 1.471 . . . . 0.0 109.338 -173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.25 35.41 16.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.838 1.655 . . . . 0.0 112.647 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.89 156.57 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.901 1.681 . . . . 0.0 107.913 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -12.46 61.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.978 1.311 . . . . 0.0 113.015 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -54.79 162.52 1.21 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.171 2.988 . . . . 0.0 113.596 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m -135.6 151.24 50.07 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.963 0.905 . . . . 0.0 111.969 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.89 -29.21 27.01 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.877 2.471 . . . . 0.0 114.389 -169.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -62.07 -32.3 72.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -147.47 31.19 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.259 1.023 . . . . 0.0 110.61 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 18.49 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 145' ' ' VAL . 27.4 p 64.01 -175.27 0.16 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.936 1.694 . . . . 0.0 112.176 169.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.72 177.52 20.11 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 106.396 -2.681 . . . . 0.0 106.396 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.65 158.67 44.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.677 1.238 . . . . 0.0 109.268 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.06 177.46 32.29 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.98 152.96 33.49 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.817 0.847 . . . . 0.0 109.652 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.79 82.59 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.147 1.379 . . . . 0.0 107.405 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.23 -48.44 2.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.586 2.041 . . . . 0.0 113.56 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -156.43 -35.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.29 2.236 . . . . 0.0 110.353 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -71.09 165.97 22.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.848 0.832 . . . . 0.0 110.142 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.7 mtp -136.95 147.97 46.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -137.9 129.95 28.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.5 mt -85.38 114.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.82 112.62 24.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -64.85 133.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.317 1.047 . . . . 0.0 108.36 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.88 61.38 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.36 -39.83 45.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.701 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.0 -13.34 45.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.021 0.828 . . . . 0.0 112.729 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -111.16 -12.59 14.12 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 117.039 -1.458 . . . . 0.0 112.649 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -54.66 -73.26 0.05 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.801 1.24 . . . . 0.0 111.088 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.9 -23.98 28.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.801 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -58.56 -28.64 65.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 111.491 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.0 m -96.17 -39.83 9.5 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.77 0.713 . . . . 0.0 110.883 173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.88 -10.81 59.62 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.769 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -49.78 -47.83 50.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 121.613 2.006 . . . . 0.0 112.035 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -67.06 -43.87 81.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.099 0.56 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.74 -31.2 71.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.548 0.739 . . . . 0.0 111.964 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.45 -60.57 2.19 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.98 -28.06 69.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.978 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 111.989 175.782 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -75.85 165.13 25.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.815 1.246 . . . . 0.0 108.482 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -133.12 143.42 49.26 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -139.36 141.09 37.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.779 0.432 . . . . 0.0 110.424 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -82.33 128.86 34.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.38 147.31 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.329 0.968 . . . . 0.0 108.889 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.74 153.73 42.74 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.249 1.02 . . . . 0.0 109.898 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -92.73 146.92 23.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.23 125.74 14.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -88.7 0.16 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -154.26 34.76 0.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.331 1.452 . . . . 0.0 109.796 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.64 158.2 43.9 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 107.602 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.62 156.21 34.75 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.022 1.391 . . . . 0.0 111.887 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -144.92 161.25 39.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.021 2.528 . . . . 0.0 107.127 -171.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.96 25.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.364 0.983 . . . . 0.0 111.035 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 100' ' ' ILE . 3.4 mt -137.46 137.92 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -47.38 115.86 1.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.585 1.154 . . . . 0.0 110.213 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.09 -33.79 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.104 0.962 . . . . 0.0 111.753 -169.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.54 -25.73 68.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.672 0.789 . . . . 0.0 112.66 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -79.26 -20.18 48.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.868 0.758 . . . . 0.0 111.883 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.14 128.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 118.902 0.774 . . . . 0.0 109.027 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -86.99 -60.28 2.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -163.65 -176.74 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.274 1.43 . . . . 0.0 109.012 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.29 145.95 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 41' ' ' GLY . 1.3 tmm_? -144.0 173.84 11.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.561 1.944 . . . . 0.0 106.278 -177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' H ' ' HD2' ' A' ' 40' ' ' ARG . . . -101.73 172.1 22.49 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.133 -0.98 . . . . 0.0 111.172 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -67.88 120.97 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 168.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.44 -48.98 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -170.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -150.92 86.42 1.37 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.887 0.875 . . . . 0.0 109.01 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.15 161.21 2.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.77 130.82 17.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -134.99 129.67 34.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.367 0.985 . . . . 0.0 108.982 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' A' ' 51' ' ' THR . 1.5 mp -63.19 137.44 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -8.96 25.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 48' ' ' ILE . 73.4 m-80 -130.43 34.0 4.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.081 1.752 . . . . 0.0 109.829 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -61.67 149.45 84.55 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.141 0.576 . . . . 0.0 111.192 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.84 26.18 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.835 3.69 . . . . 0.0 112.026 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.87 -37.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.918 2.887 . . . . 0.0 115.821 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -56.17 -44.13 79.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.711 1.142 . . . . 0.0 109.565 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.25 88.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -60.14 -26.68 66.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.133 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.02 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.435 1.017 . . . . 0.0 111.019 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 151.12 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 t -134.33 151.09 51.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.986 0.812 . . . . 0.0 109.369 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -66.08 107.64 1.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.404 1.082 . . . . 0.0 109.173 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.51 64.81 3.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 49.81 30.22 3.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.467 1.507 . . . . 0.0 113.209 169.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.49 -25.46 1.08 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.856 1.217 . . . . 0.0 113.387 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.46 -165.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 107.877 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 tp -130.32 147.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.451 1.478 . . . . 0.0 110.624 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.55 138.73 15.63 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.5 143.78 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.404 2.069 . . . . 0.0 110.596 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -127.84 135.55 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.2 167.04 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -129.08 116.52 19.4 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 mt -66.82 -17.29 64.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.358 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -54.75 -42.33 71.52 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.835 1.198 . . . . 0.0 110.333 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.36 -44.19 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -60.89 -23.75 65.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.42 -3.54 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.043 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.9 m 49.55 48.64 21.13 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.031 1.287 . . . . 0.0 110.57 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.31 -171.22 0.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 110.864 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.78 164.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.36 1.064 . . . . 0.0 110.225 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -84.06 62.89 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.273 1.829 . . . . 0.0 110.575 -169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 m -53.25 158.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.714 0.806 . . . . 0.0 111.036 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -144.03 178.03 8.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.237 1.415 . . . . 0.0 108.643 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.65 64.18 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.123 1.769 . . . . 0.0 109.484 169.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.36 -35.73 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 131.563 3.945 . . . . 0.0 108.456 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -145.98 30.7 1.05 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.641 1.976 . . . . 0.0 110.072 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -154.97 28.81 0.42 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.268 3.027 . . . . 0.0 107.666 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 p -106.51 12.17 29.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.538 1.935 . . . . 0.0 115.95 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.77 154.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.33 113.79 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -82.21 141.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 137.02 47.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.0 mt -135.82 154.85 51.06 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.531 1.532 . . . . 0.0 109.112 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 139.67 37.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.97 155.25 35.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.28 -100.49 0.04 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.2 0.905 . . . . 0.0 111.656 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -136.57 27.7 3.05 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.613 1.965 . . . . 0.0 109.958 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -146.97 171.04 15.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.2 144.79 34.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 125.363 1.465 . . . . 0.0 107.456 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 99' ' ' GLY . 13.2 p -158.48 -176.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -166.78 176.54 41.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 31' ' ' ILE . 48.8 pt -140.33 144.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.191 0.519 . . . . 0.0 110.343 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.51 142.9 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.944 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.44 166.05 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.654 1.982 . . . . 0.0 108.021 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.53 -41.48 65.79 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.94 151.81 8.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.29 128.98 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -36.5 10.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.203 0.601 . . . . 0.0 111.772 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.3 t0 -169.09 -178.4 3.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.593 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.1 t -137.48 122.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 103.984 -2.598 . . . . 0.0 103.984 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -141.16 150.25 42.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.456 0.702 . . . . 0.0 110.718 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 p -94.86 135.68 36.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.418 0.687 . . . . 0.0 109.639 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mp -138.18 143.31 40.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 67.5 p -100.4 164.8 11.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.55 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.91 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -104.89 -36.2 7.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.772 1.629 . . . . 0.0 110.052 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.41 -45.92 82.04 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.49 112.75 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -148.19 -62.86 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.802 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.18 -178.08 3.03 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.105 1.87 . . . . 0.0 111.539 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.32 155.55 39.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.564 1.946 . . . . 0.0 108.097 169.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.23 59.43 7.39 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.111 3.207 . . . . 0.0 111.107 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.63 29.18 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.077 1.751 . . . . 0.0 112.863 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.11 -174.46 1.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.746 1.618 . . . . 0.0 110.401 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 28.75 0.06 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.269 1.428 . . . . 0.0 113.468 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 124' ' ' VAL . 11.1 m -70.72 161.37 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.828 1.651 . . . . 0.0 109.475 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -44.57 95.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -62.88 166.01 6.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 m -134.19 175.2 9.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.2 1.4 . . . . 0.0 110.64 -169.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -56.15 -27.71 55.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.88 -30.2 56.11 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.337 0.972 . . . . 0.0 111.157 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -110.97 -9.55 14.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.093 0.957 . . . . 0.0 112.505 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.7 160.91 5.15 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.559 0.744 . . . . 0.0 112.132 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 146' ' ' ASN . 38.8 p -114.15 166.31 11.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.392 1.877 . . . . 0.0 108.757 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.86 176.53 45.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.59 145.78 39.0 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.3 174.72 37.07 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.04 39.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.018 0.927 . . . . 0.0 110.184 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.25 82.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.33 -51.9 2.57 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.623 2.059 . . . . 0.0 112.98 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -157.35 -31.4 0.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.147 2.179 . . . . 0.0 111.076 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' A' ' 107' ' ' ASP . 66.0 mtp180 -68.79 162.21 26.82 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.6 mtp -138.87 144.15 39.06 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.25 128.09 35.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.55 120.72 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.51 102.9 15.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.44 120.74 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.068 1.347 . . . . 0.0 108.956 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.551 ' H ' HG22 ' A' ' 132' ' ' THR . 40.4 t30 -75.99 60.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.133 1.773 . . . . 0.0 110.121 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.45 -35.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.089 1.356 . . . . 0.0 111.24 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -68.7 -5.94 23.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -134.26 18.8 3.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.068 1.347 . . . . 0.0 110.667 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.1 tp -79.2 -88.28 0.06 Allowed 'General case' 0 C--N 1.341 0.222 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.0 tp -68.95 -31.51 70.44 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.543 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.74 -22.58 47.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -124.33 -3.66 7.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.405 1.082 . . . . 0.0 112.072 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -122.21 2.15 9.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 113.023 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.62 -34.35 67.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.293 1.406 . . . . 0.0 111.38 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -61.14 -45.92 92.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.0 109.932 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.06 73.72 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.212 0.605 . . . . 0.0 111.443 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.3 -56.68 10.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.329 0.652 . . . . 0.0 109.707 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.35 -30.4 71.23 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.063 -0.398 . . . . 0.0 111.08 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.469 0.501 0 C-N-CA 123.644 0.778 . . . . 0.0 112.855 175.073 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.37 165.99 22.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.766 1.227 . . . . 0.0 108.357 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.45 143.91 46.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -142.09 137.96 31.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.396 0.679 . . . . 0.0 109.815 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -83.27 134.6 34.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.42 151.71 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 119.212 0.914 . . . . 0.0 109.135 -173.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -140.46 150.97 44.46 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.643 1.177 . . . . 0.0 109.26 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -91.71 148.54 22.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 tp -144.63 109.46 5.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.06 -87.71 0.23 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.413 1.006 . . . . 0.0 111.326 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.23 32.46 0.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.245 1.418 . . . . 0.0 109.589 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.22 159.07 43.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.957 1.703 . . . . 0.0 107.794 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.76 153.74 37.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.918 1.342 . . . . 0.0 109.874 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -138.58 150.79 46.68 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.76 2.024 . . . . 0.0 106.867 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.93 157.3 19.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.8 134.25 42.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -48.66 116.67 1.7 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.394 1.078 . . . . 0.0 108.785 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.4 -34.75 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.513 0.725 . . . . 0.0 111.766 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.29 -24.53 67.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.795 0.838 . . . . 0.0 112.586 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -79.17 -24.0 43.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.48 0.582 . . . . 0.0 111.41 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -67.3 140.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -104.57 -59.57 1.72 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.118 0.967 . . . . 0.0 108.952 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.27 178.3 9.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.842 0.857 . . . . 0.0 110.222 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.58 146.69 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -148.51 176.5 10.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.389 1.475 . . . . 0.0 108.279 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.95 166.23 29.81 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.554 -0.716 . . . . 0.0 111.361 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -166.13 0.23 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.523 1.529 . . . . 0.0 112.28 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 67.34 27.89 8.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.455 1.902 . . . . 0.0 112.934 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 31.82 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.39 1.076 . . . . 0.0 109.72 174.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -75.74 116.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -60.85 -47.41 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 109.16 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 54.29 175.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.05 2.54 . . . . 0.0 113.106 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.52 155.86 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.55 -25.5 60.04 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -149.96 23.74 0.85 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.96 142.72 98.19 Favored Pre-proline 0 C--O 1.239 0.53 0 CA-C-O 119.019 -0.515 . . . . 0.0 109.743 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -61.41 148.67 92.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.953 2.435 . . . . 0.0 110.039 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.15 -24.87 67.84 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -61.17 -55.94 26.42 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.191 0.905 . . . . 0.0 109.702 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.421 HD12 ' HG2' ' A' ' 52' ' ' PRO . 70.4 mt -56.4 -37.0 48.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 C-N-CA 125.228 1.411 . . . . 0.0 109.993 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 58.54 -79.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.328 1.851 . . . . 0.0 107.768 -168.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.48 -132.61 2.19 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 121.358 1.89 . . . . 0.0 110.759 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.91 160.6 39.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.304 1.042 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -133.41 147.99 51.77 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -77.95 108.99 11.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.41 76.94 7.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.477 0.655 . . . . 0.0 109.854 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 49.88 29.04 3.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.023 1.329 . . . . 0.0 114.358 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.48 -19.43 2.81 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.671 1.129 . . . . 0.0 113.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.54 -169.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.842 1.321 . . . . 0.0 108.187 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.07 149.51 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.205 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.58 141.08 14.42 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.758 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.46 132.33 33.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.877 1.718 . . . . 0.0 109.682 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.61 119.21 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.46 154.04 9.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 125.589 1.556 . . . . 0.0 110.269 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -92.65 111.4 22.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.358 1.063 . . . . 0.0 110.545 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.71 -37.75 76.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -43.6 92.87 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.378 0.99 . . . . 0.0 109.484 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.8 -36.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.14 -31.16 67.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.208 0.913 . . . . 0.0 113.427 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -116.58 9.5 14.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.923 0.783 . . . . 0.0 112.376 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.6 m 47.92 41.74 15.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.279 1.032 . . . . 0.0 111.002 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -179.84 7.48 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.636 1.175 . . . . 0.0 109.51 -172.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.79 -84.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -173.57 106.04 0.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.034 1.334 . . . . 0.0 108.792 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.01 129.69 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.389 1.075 . . . . 0.0 108.266 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.78 149.38 26.41 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.693 0.797 . . . . 0.0 108.92 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.6 36.9 0.07 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.252 2.221 . . . . 0.0 112.758 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.48 -9.86 0.16 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.476 2.31 . . . . 0.0 111.005 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.48 -4.69 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.061 1.344 . . . . 0.0 111.866 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.66 24.11 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -172.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -80.95 9.75 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 117.826 2.528 . . . . 0.0 117.826 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.6 160.49 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 120.276 1.398 . . . . 0.0 107.902 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.68 127.47 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.88 142.59 15.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.91 134.16 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.59 163.84 29.19 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.008 1.723 . . . . 0.0 109.183 -169.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 148.37 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.449 1.499 . . . . 0.0 107.651 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.4 152.31 25.68 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.51 -90.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.049 1.309 . . . . 0.0 113.508 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.78 23.81 2.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.221 1.809 . . . . 0.0 110.699 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -149.46 173.41 13.61 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.732 -1.23 . . . . 0.0 111.57 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.95 151.95 36.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 125.078 1.351 . . . . 0.0 108.654 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.85 172.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 125.008 1.323 . . . . 0.0 107.6 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.24 177.21 40.03 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.07 142.89 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.56 140.16 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.68 168.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.125 1.77 . . . . 0.0 109.01 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.64 -43.47 72.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.824 1.193 . . . . 0.0 109.978 171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.64 153.67 8.97 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.33 121.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -46.62 12.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.498 0.719 . . . . 0.0 111.15 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -169.29 179.5 3.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.143 0.977 . . . . 0.0 109.767 -168.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.98 136.3 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.86 1.664 . . . . 0.0 107.026 169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -142.58 174.4 10.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.814 1.245 . . . . 0.0 109.16 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.5 m -131.84 137.79 48.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -141.25 155.15 46.05 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.932 0.893 . . . . 0.0 109.277 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -126.99 158.37 37.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.871 1.668 . . . . 0.0 108.365 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.28 42.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -65.97 -41.64 90.93 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.187 -0.946 . . . . 0.0 109.787 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.95 -40.07 40.67 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.348 1.459 . . . . 0.0 110.462 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -91.37 99.17 9.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 74.8 mtt-85 -139.6 -53.35 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.144 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 33.6 Cg_endo -64.77 170.96 9.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.425 1.544 . . . . 0.0 111.623 173.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.18 30.25 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.261 1.424 . . . . 0.0 108.667 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -80.72 50.47 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.797 2.998 . . . . 0.0 110.371 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 16.76 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.272 1.429 . . . . 0.0 113.921 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -146.92 152.97 39.55 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.886 2.074 . . . . 0.0 108.134 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.62 42.36 23.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.176 1.39 . . . . 0.0 112.773 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 166.08 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.738 1.615 . . . . 0.0 108.744 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -35.66 10.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.011 0.525 . . . . 0.0 111.583 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.41 171.77 2.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.655 1.182 . . . . 0.0 112.971 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.9 m -121.6 168.53 11.65 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.043 1.337 . . . . 0.0 110.441 -170.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 p -52.93 -21.98 5.02 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.858 2.463 . . . . 0.0 115.829 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -85.79 -34.42 21.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.825 0.85 . . . . 0.0 110.892 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -91.88 -14.36 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.225 0.61 . . . . 0.0 110.208 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.47 136.87 43.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.797 2.439 . . . . 0.0 111.207 -172.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 145' ' ' VAL . 42.1 p -80.59 -170.3 2.54 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.45 2.3 . . . . 0.0 110.918 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.06 172.06 22.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 106.402 -2.679 . . . . 0.0 106.402 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 154.54 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.624 1.712 . . . . 0.0 110.289 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.44 175.03 31.99 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.81 157.04 19.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.811 0.844 . . . . 0.0 110.168 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.73 82.29 1.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.43 -51.39 2.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.489 1.995 . . . . 0.0 113.11 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.38 -31.9 0.09 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.058 2.143 . . . . 0.0 110.97 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -69.09 161.01 29.96 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 170.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -137.94 140.43 40.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.22 130.94 45.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.9 104.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.35 110.89 9.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.9 t -62.08 129.83 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -78.92 54.8 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.496 1.118 . . . . 0.0 109.669 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 tp -56.01 -35.82 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.449 1.5 . . . . 0.0 111.762 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -67.54 -19.73 65.32 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.558 . . . . 0.0 112.375 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -105.81 -22.52 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 117.47 -1.252 . . . . 0.0 111.866 171.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -48.42 -75.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 111.562 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.6 tp -78.51 -25.46 45.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.177 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.66 -27.05 67.53 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.759 1.163 . . . . 0.0 112.911 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.7 m -115.23 -8.03 12.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.684 1.193 . . . . 0.0 111.888 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -97.69 -7.25 31.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.984 1.266 . . . . 0.0 111.429 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -54.5 -46.31 73.44 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.999 1.727 . . . . 0.0 110.236 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 ptp -59.14 -25.81 64.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.271 1.028 . . . . 0.0 112.932 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.92 -26.0 16.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.049 1.739 . . . . 0.0 112.046 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.68 -56.8 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.05 0.94 . . . . 0.0 108.655 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.802 -0.561 . . . . 0.0 112.125 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.567 1.547 . . . . 0.0 112.112 172.694 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -65.89 148.07 52.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -109.88 145.64 36.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -142.13 140.02 32.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.196 0.998 . . . . 0.0 110.736 -169.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.12 136.18 34.55 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 167.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.46 149.86 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.91 1.232 . . . . 0.0 109.223 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -141.17 152.09 44.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.244 1.018 . . . . 0.0 110.176 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.9 m -91.53 146.88 23.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 170.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -145.3 121.14 10.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.52 -98.62 0.21 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -141.67 37.09 1.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.211 1.404 . . . . 0.0 109.633 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.67 160.11 40.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.836 1.654 . . . . 0.0 107.92 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.3 152.54 44.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.093 1.425 . . . . 0.0 110.361 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.32 154.97 48.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.711 2.005 . . . . 0.0 107.459 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.32 159.13 21.31 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.904 1.24 . . . . 0.0 110.113 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mt -142.22 133.69 25.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -45.75 113.96 0.69 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 109.082 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -53.05 -39.0 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.49 -16.84 64.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.225 0.92 . . . . 0.0 112.941 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -74.2 -24.74 59.4 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.753 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -64.78 140.89 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -120.37 -42.0 2.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.479 1.112 . . . . 0.0 110.511 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 169.54 24.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.585 1.154 . . . . 0.0 108.386 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.6 142.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -149.11 174.4 12.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.928 0.891 . . . . 0.0 108.633 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.04 25.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.66 126.04 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.37 159.0 2.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.754 . . . . 0.0 108.2 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.57 43.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.935 2.894 . . . . 0.0 116.18 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 t -74.22 107.97 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -76.12 95.01 3.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.38 142.75 50.33 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.452 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.0 mm -82.7 8.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.691 0.796 . . . . 0.0 110.099 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.26 -4.8 0.26 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.349 2.26 . . . . 0.0 115.511 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.99 14.75 1.34 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.054 1.342 . . . . 0.0 112.449 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.452 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -76.0 144.4 75.7 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.259 1.024 . . . . 0.0 109.95 174.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.36 157.56 53.83 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.917 2.411 . . . . 0.0 109.274 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.53 -33.8 64.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.748 0.819 . . . . 0.0 112.728 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.91 -49.08 63.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.851 0.75 . . . . 0.0 110.549 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.54 -37.69 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.804 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? 48.58 -82.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.834 2.454 . . . . 0.0 111.352 -169.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.87 14.06 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 120.726 1.603 . . . . 0.0 112.713 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.73 156.79 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -140.07 157.03 46.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.924 1.238 . . . . 0.0 109.622 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -78.62 101.84 7.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.911 1.284 . . . . 0.0 110.98 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.75 70.71 2.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 109.931 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 50.81 27.7 3.24 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.7 1.6 . . . . 0.0 114.227 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.6 -17.85 2.03 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.391 0.996 . . . . 0.0 113.263 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -171.45 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.723 1.261 . . . . 0.0 107.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -132.18 150.4 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 120.768 -1.207 . . . . 0.0 110.202 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.87 141.5 14.97 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.676 -1.154 . . . . 0.0 109.289 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.1 131.08 24.28 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.884 1.723 . . . . 0.0 108.585 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.69 123.83 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.13 147.89 12.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.452 2.301 . . . . 0.0 107.117 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.84 118.56 37.1 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.747 0.819 . . . . 0.0 109.562 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.28 -20.39 66.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.055 0.942 . . . . 0.0 113.195 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -56.02 -39.8 72.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.425 1.466 . . . . 0.0 109.434 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.33 12.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 109.763 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -131.83 -27.44 1.88 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.859 -1.151 . . . . 0.0 112.079 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.55 6.3 3.23 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.746 1.157 . . . . 0.0 113.718 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m 59.18 23.39 11.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -61.12 149.37 37.48 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.48 0.712 . . . . 0.0 111.674 -169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 m -24.25 -75.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 129.054 2.942 . . . . 0.0 117.506 -169.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -164.93 67.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.362 1.065 . . . . 0.0 109.758 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -50.84 140.57 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.21 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -160.52 165.62 30.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.677 1.191 . . . . 0.0 109.009 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -73.99 43.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.281 2.232 . . . . 0.0 111.157 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' H ' ' A' ' 84' ' ' ASP . 26.0 t30 -159.22 -19.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.85 3.26 . . . . 0.0 110.028 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.412 ' H ' ' H ' ' A' ' 83' ' ' ASN . 38.2 t70 -135.75 6.54 3.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.638 1.575 . . . . 0.0 111.501 -172.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -154.8 37.27 0.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.434 1.893 . . . . 0.0 109.05 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p -94.87 11.57 31.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.32 1.848 . . . . 0.0 115.751 -168.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.64 160.37 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.44 135.05 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -171.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.6 mt -115.89 127.03 73.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.73 134.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 mt -129.79 164.03 24.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.411 1.484 . . . . 0.0 108.209 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.01 157.3 44.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.867 0.867 . . . . 0.0 108.696 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.29 -178.05 4.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.18 97.35 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.896 1.236 . . . . 0.0 113.136 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 63.16 22.48 13.41 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.541 1.936 . . . . 0.0 115.282 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -147.2 161.94 39.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.79 1.632 . . . . 0.0 111.016 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.5 m -135.54 151.45 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 123.799 0.84 . . . . 0.0 110.396 -170.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.55 174.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.235 1.814 . . . . 0.0 106.673 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.45 176.55 40.33 Favored Glycine 0 N--CA 1.448 -0.541 0 O-C-N 120.201 -1.562 . . . . 0.0 110.28 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.46 149.4 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.827 0.851 . . . . 0.0 109.559 -169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 m -94.32 136.1 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.836 1.254 . . . . 0.0 108.86 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.02 166.02 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.608 1.563 . . . . 0.0 109.363 -169.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.52 -43.0 67.27 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.07 154.0 10.73 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.45 123.41 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -49.38 12.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.867 0.467 . . . . 0.0 110.79 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.56 179.73 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.67 1.188 . . . . 0.0 109.618 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.45 127.92 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 pp -156.17 177.68 11.16 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.837 1.255 . . . . 0.0 109.753 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -129.86 148.82 51.77 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.866 0.757 . . . . 0.0 112.179 -169.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mp -139.96 145.89 38.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.175 1.39 . . . . 0.0 108.698 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -94.02 172.2 8.37 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 111.543 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.1 21.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.406 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.11 -39.36 12.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.704 1.202 . . . . 0.0 109.143 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -69.02 -41.6 77.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.821 0.848 . . . . 0.0 110.703 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -86.43 117.58 31.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -143.23 -64.32 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.562 0 CA-C-O 116.838 -1.554 . . . . 0.0 111.818 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.93 -175.1 1.97 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.243 1.962 . . . . 0.0 111.501 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.22 31.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.221 1.808 . . . . 0.0 107.978 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.69 149.63 61.3 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.203 1.935 . . . . 0.0 110.546 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.57 24.96 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.709 1.204 . . . . 0.0 110.549 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -76.82 34.67 0.15 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.191 1.796 . . . . 0.0 114.038 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.77 32.28 5.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.891 2.076 . . . . 0.0 113.608 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.67 -178.86 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.401 1.08 . . . . 0.0 109.755 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -8.63 8.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.483 1.513 . . . . 0.0 113.974 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.05 151.23 40.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.102 1.361 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -135.25 160.28 38.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.422 1.089 . . . . 0.0 108.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 p -62.07 -10.47 10.2 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -22.46 12.06 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.306 1.042 . . . . 0.0 111.365 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -84.8 -9.8 57.81 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.941 -0.475 . . . . 0.0 110.341 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.93 120.26 2.95 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.197 2.199 . . . . 0.0 112.327 -169.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 145' ' ' VAL . 41.1 p -75.91 -166.18 0.55 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.428 2.691 . . . . 0.0 111.431 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.74 175.18 20.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.48 143.59 39.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.32 170.14 31.56 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.7 154.49 29.45 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.22 1.008 . . . . 0.0 109.595 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.39 71.79 1.36 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.72 -38.64 1.27 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.894 2.188 . . . . 0.0 113.723 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.6 -34.92 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.99 2.116 . . . . 0.0 110.13 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -71.54 166.08 22.54 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -139.59 145.42 38.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -132.01 126.31 33.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.9 mt -79.7 110.88 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.07 105.64 11.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.0 t -60.15 120.89 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.52 60.33 2.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.305 0.574 . . . . 0.0 110.131 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -53.17 -37.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.615 1.166 . . . . 0.0 111.018 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.35 -23.52 66.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.187 0.995 . . . . 0.0 112.312 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -110.56 -20.41 12.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 117.337 -1.316 . . . . 0.0 111.841 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.21 -61.67 2.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.782 1.173 . . . . 0.0 109.885 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.04 -48.37 63.05 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.82 -40.07 75.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.32 0.509 . . . . 0.0 111.83 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.2 m -80.89 -29.55 35.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.187 0.449 . . . . 0.0 111.568 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.01 -9.31 57.02 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.477 0.711 . . . . 0.0 111.125 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.99 -49.05 66.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.895 1.225 . . . . 0.0 112.089 -169.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.6 ptp -66.02 -31.41 72.28 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.868 -0.52 . . . . 0.0 112.056 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.2 59.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.339 1.056 . . . . 0.0 110.35 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.95 -49.24 78.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.089 1.356 . . . . 0.0 109.041 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.1 -24.61 63.09 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 123.796 0.839 . . . . 0.0 111.977 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.535 0.382 0 CA-C-N 119.281 0.946 . . . . 0.0 112.35 178.826 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -75.52 170.17 16.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.737 0.815 . . . . 0.0 110.168 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.34 145.19 51.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.0 136.26 35.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.382 0.673 . . . . 0.0 110.136 -169.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.5 tp -78.44 133.94 37.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 167.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.28 148.14 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 119.324 0.965 . . . . 0.0 108.54 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.15 153.16 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.957 0.903 . . . . 0.0 110.125 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -93.55 145.92 24.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' CD1' HD21 ' A' ' 85' ' ' ASN . 56.4 tp -136.77 96.76 3.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.624 . . . . 0.0 107.5 173.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.48 -76.03 0.52 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.169 1.366 . . . . 0.0 111.907 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.08 30.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.285 1.434 . . . . 0.0 110.494 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.36 160.54 39.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 108.145 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -127.93 151.6 48.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.045 1.403 . . . . 0.0 110.824 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -137.33 156.84 47.76 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.878 2.071 . . . . 0.0 108.045 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.73 153.92 19.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.848 1.213 . . . . 0.0 110.419 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -136.63 130.99 47.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -48.65 120.36 3.71 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.94 -31.89 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.336 0.654 . . . . 0.0 111.595 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.99 -23.58 67.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.502 -0.749 . . . . 0.0 112.689 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -77.64 -22.91 49.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.928 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.94 140.2 20.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.637 1.108 . . . . 0.0 108.369 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 -40.67 2.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.522 1.129 . . . . 0.0 110.431 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -166.19 177.47 6.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.559 . . . . 0.0 107.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.86 135.6 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -120.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -170.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.85 164.07 32.77 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.732 1.634 . . . . 0.0 109.266 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -61.8 139.48 58.34 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -147.96 -65.31 0.25 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.465 0.306 . . . . 0.0 111.195 -174.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.48 72.84 0.55 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.491 1.116 . . . . 0.0 108.606 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.83 113.97 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 m -73.46 85.66 1.52 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -65.92 104.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 mm -69.82 148.04 11.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.85 -23.57 67.41 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -170.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.29 31.86 0.38 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 160.04 60.89 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.922 -1.111 . . . . 0.0 109.206 169.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -61.1 145.83 98.38 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.957 1.772 . . . . 0.0 108.176 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.72 -31.47 64.55 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -56.62 -41.91 77.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.227 0.467 . . . . 0.0 111.174 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.0 mt -92.23 89.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -51.7 -47.74 63.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.022 169.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.28 -177.04 28.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.977 1.262 . . . . 0.0 111.853 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 159.93 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 118.051 0.925 . . . . 0.0 109.788 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 t -141.24 158.56 43.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.519 1.054 . . . . 0.0 109.559 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -79.82 129.92 34.88 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.436 1.095 . . . . 0.0 110.233 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.19 84.42 2.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.902 1.281 . . . . 0.0 107.894 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 53.12 34.85 18.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.624 1.17 . . . . 0.0 113.425 169.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.1 -5.26 25.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.502 1.049 . . . . 0.0 112.974 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.72 177.49 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.153 1.781 . . . . 0.0 106.495 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -134.43 156.33 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 120.555 -1.341 . . . . 0.0 109.721 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -154.18 141.4 13.49 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.352 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.11 130.07 19.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.137 1.891 . . . . 0.0 108.747 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -106.85 135.88 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 108.422 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.61 139.35 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -96.26 104.49 16.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.312 1.045 . . . . 0.0 109.094 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -29.76 70.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.328 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -38.57 83.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.5 -36.82 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -71.72 -22.16 61.67 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.37 11.22 9.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.884 1.22 . . . . 0.0 112.842 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m 55.34 25.07 7.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.556 1.542 . . . . 0.0 113.023 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -68.77 161.62 28.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.878 0.871 . . . . 0.0 111.211 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.01 165.95 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 0.0 111.293 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.4 t70 45.05 68.14 0.61 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.106 2.962 . . . . 0.0 114.073 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.09 62.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.911 1.284 . . . . 0.0 109.5 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -143.54 164.67 29.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.61 1.164 . . . . 0.0 110.99 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -81.71 66.76 7.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 169.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.32 -60.16 0.27 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.076 1.351 . . . . 0.0 109.721 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.69 -38.86 73.73 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.014 0.825 . . . . 0.0 111.476 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.469 HD21 ' CD1' ' A' ' 24' ' ' LEU . 7.2 m120 -91.86 -79.31 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -169.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.7 p 60.67 -3.56 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.929 2.092 . . . . 0.0 116.073 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.68 144.97 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 120.468 1.485 . . . . 0.0 107.211 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -120.58 139.49 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.37 133.25 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.57 134.87 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.35 163.01 30.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.755 1.622 . . . . 0.0 108.839 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.28 145.03 35.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.006 1.723 . . . . 0.0 107.547 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -159.44 142.4 14.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.49 -85.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.567 1.556 . . . . 0.0 113.047 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -143.48 16.58 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.013 -170.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.2 177.98 9.41 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.153 -0.967 . . . . 0.0 112.089 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.97 157.41 38.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 110.027 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -160.39 169.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 126.205 1.802 . . . . 0.0 107.218 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.94 168.88 30.68 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.5 pt -140.72 147.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 123.966 0.906 . . . . 0.0 108.76 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.26 139.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.988 0.915 . . . . 0.0 109.16 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.86 156.68 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 108.736 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.26 -39.4 89.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.204 0.911 . . . . 0.0 110.578 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.96 162.56 20.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.62 117.97 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -49.26 42.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.194 0.597 . . . . 0.0 110.565 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -172.44 -174.82 1.26 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.292 1.437 . . . . 0.0 108.526 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.18 131.07 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.88 146.21 40.88 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.116 0.966 . . . . 0.0 109.604 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 p -84.8 144.43 28.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 109.568 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.08 138.48 29.92 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 p -77.57 153.86 32.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.19 -10.01 37.39 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.562 -0.711 . . . . 0.0 111.756 172.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.08 -30.78 70.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.687 1.195 . . . . 0.0 110.23 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -68.07 -41.45 81.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.908 0.776 . . . . 0.0 110.124 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.87 89.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.249 1.82 . . . . 0.0 109.315 -169.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -142.79 -60.24 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-O 116.809 -1.567 . . . . 0.0 112.846 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.13 176.8 4.24 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.944 1.762 . . . . 0.0 111.491 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.1 154.01 30.36 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.892 1.277 . . . . 0.0 109.38 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -80.6 50.04 3.42 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.417 3.411 . . . . 0.0 110.646 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.54 21.09 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.114 1.766 . . . . 0.0 114.621 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -142.81 146.96 34.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.973 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.32 6.95 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.08 2.152 . . . . 0.0 115.039 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.03 165.82 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.921 1.288 . . . . 0.0 109.457 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -0.38 13.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.739 1.216 . . . . 0.0 113.996 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.3 150.77 21.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.326 0.966 . . . . 0.0 110.59 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.6 m -136.67 147.71 46.98 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -57.13 -3.18 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.346 2.258 . . . . 0.0 116.015 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.91 -38.17 23.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.797 1.239 . . . . 0.0 110.575 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -132.16 1.74 3.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.71 1.604 . . . . 0.0 111.608 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.22 132.09 12.74 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.741 2.416 . . . . 0.0 109.963 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.1 p -80.93 -169.39 2.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.774 2.83 . . . . 0.0 111.875 -170.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.98 179.27 16.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.19 149.32 44.28 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 108.206 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.72 169.69 29.89 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 169.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.53 158.84 43.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.176 0.99 . . . . 0.0 110.644 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.5 mt -146.0 67.05 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.366 1.866 . . . . 0.0 107.483 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.34 2.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.168 1.842 . . . . 0.0 113.333 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.54 -32.82 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.695 1.998 . . . . 0.0 110.625 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -69.35 153.36 43.72 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -141.89 142.4 33.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -133.34 124.18 26.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.39 109.56 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.65 116.8 18.48 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.18 141.63 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.49 0.586 . . . . 0.0 109.92 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.43 57.25 3.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.805 0.812 . . . . 0.0 109.021 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.34 -38.69 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.428 1.491 . . . . 0.0 112.732 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -67.71 -7.06 23.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.807 0.843 . . . . 0.0 113.204 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -133.1 23.48 4.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.231 1.412 . . . . 0.0 110.232 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.41 -90.96 0.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -32.34 71.89 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.17 -20.55 54.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -117.63 4.21 12.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.064 0.945 . . . . 0.0 112.22 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -113.47 -9.65 13.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.651 1.18 . . . . 0.0 111.35 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.43 -39.28 83.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.117 1.326 . . . . 0.0 111.452 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.5 ptp -59.07 -23.73 62.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 112.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.43 -29.04 12.98 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.801 1.64 . . . . 0.0 111.484 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.9 -62.19 2.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.424 1.09 . . . . 0.0 109.438 170.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -18.26 60.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.09 -168.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 169.963 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -134.95 165.81 24.47 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.635 1.974 . . . . 0.0 110.412 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -111.16 147.78 34.17 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.34 137.49 32.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.186 0.994 . . . . 0.0 108.927 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.7 tp -78.64 137.04 37.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.01 147.99 30.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 119.579 1.082 . . . . 0.0 108.824 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -143.12 156.48 44.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.313 1.045 . . . . 0.0 110.168 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.5 m -95.8 145.3 25.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -159.95 129.99 5.43 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 125.791 1.636 . . . . 0.0 106.904 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 39.78 87.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.323 0.963 . . . . 0.0 113.509 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.5 37.43 19.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.144 1.778 . . . . 0.0 111.751 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.46 162.1 37.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.716 2.006 . . . . 0.0 107.058 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -118.39 152.73 35.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.819 1.295 . . . . 0.0 110.496 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -138.99 161.65 36.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.016 2.126 . . . . 0.0 107.72 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.75 164.11 27.15 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.407 0.527 . . . . 0.0 112.398 169.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.2 mt -143.65 138.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -46.41 119.08 2.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.426 1.091 . . . . 0.0 109.261 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.44 -32.47 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.481 0.712 . . . . 0.0 111.865 -170.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.98 -21.11 66.79 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.468 -0.77 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -23.47 60.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.261 0.937 . . . . 0.0 111.786 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.43 143.02 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 119.021 0.828 . . . . 0.0 109.377 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -106.67 -59.53 1.79 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.563 1.145 . . . . 0.0 108.41 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.65 177.57 10.35 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 109.774 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.32 147.67 32.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -149.8 164.74 34.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.974 2.11 . . . . 0.0 106.805 -170.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.75 168.46 51.2 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.04 -1.037 . . . . 0.0 110.817 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -74.16 109.6 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -162.81 154.57 18.08 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.411 1.484 . . . . 0.0 107.783 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 26.99 56.75 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.066 2.546 . . . . 0.0 115.119 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.45 97.47 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 167.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -50.94 -41.07 58.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.522 1.129 . . . . 0.0 110.461 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 52.99 -179.81 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.402 1.881 . . . . 0.0 111.763 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.4 mm -132.7 159.48 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.16 68.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.12 36.0 0.43 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.869 0.868 . . . . 0.0 112.688 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -55.51 145.31 49.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.312 -0.868 . . . . 0.0 111.219 173.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.22 161.69 29.51 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.563 2.842 . . . . 0.0 111.316 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.1 50.22 0.47 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.172 1.789 . . . . 0.0 113.352 -170.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -157.46 -46.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.228 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.3 mt -49.19 -42.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.275 1.03 . . . . 0.0 110.745 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.4 tttp 57.41 -81.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.888 2.075 . . . . 0.0 108.97 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.35 -160.11 10.07 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 120.705 1.593 . . . . 0.0 114.469 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.89 153.78 27.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.7 t -139.22 150.38 45.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.925 0.784 . . . . 0.0 110.48 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -79.21 89.86 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.869 1.668 . . . . 0.0 110.715 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.75 90.1 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.019 0.528 . . . . 0.0 110.107 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 49.62 29.36 3.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.691 1.196 . . . . 0.0 114.004 168.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.71 -3.67 14.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.683 1.135 . . . . 0.0 114.098 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.16 -174.39 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.839 1.656 . . . . 0.0 107.445 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.62 151.39 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.535 -1.353 . . . . 0.0 110.587 -172.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.27 143.38 16.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.532 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.44 129.47 21.47 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.748 1.632 . . . . 0.0 108.323 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.62 114.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.93 172.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.402 2.281 . . . . 0.0 106.232 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -138.45 124.75 20.42 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.611 -1.306 . . . . 0.0 108.749 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -62.45 -27.97 69.48 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.376 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.92 -39.11 53.87 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.189 0.904 . . . . 0.0 111.032 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.12 -41.63 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -81.65 -7.65 59.62 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.448 -0.782 . . . . 0.0 112.874 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.85 -12.66 14.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.285 0.948 . . . . 0.0 113.13 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m 53.46 35.18 19.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.532 1.06 . . . . 0.0 111.82 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.46 162.53 15.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.524 -0.735 . . . . 0.0 110.578 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -37.82 -92.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 128.258 2.623 . . . . 0.0 115.865 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -163.87 84.01 0.45 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.789 1.236 . . . . 0.0 108.997 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -51.16 139.02 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.086 0.954 . . . . 0.0 110.523 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.27 167.95 26.4 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.688 1.595 . . . . 0.0 108.51 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -70.25 50.78 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.355 1.462 . . . . 0.0 111.92 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.406 ' H ' ' H ' ' A' ' 84' ' ' ASP . 48.8 t30 -159.58 -16.09 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.758 3.223 . . . . 0.0 110.557 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 83' ' ' ASN . 33.2 t70 -141.3 3.4 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.771 1.628 . . . . 0.0 111.692 -176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -150.21 37.13 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.434 -1.416 . . . . 0.0 109.662 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.8 p -96.14 0.14 50.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.662 1.585 . . . . 0.0 114.494 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.2 t -134.49 159.76 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.591 1.157 . . . . 0.0 108.153 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.84 131.1 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 107.051 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.63 137.62 28.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.08 135.41 53.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -136.32 166.8 22.61 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.659 1.183 . . . . 0.0 109.854 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -139.3 131.91 28.86 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 92' ' ' ASN . 5.3 mp -135.73 124.47 23.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -168.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.87 -81.91 0.12 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.909 0.766 . . . . 0.0 112.564 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.42 13.92 1.09 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.223 1.809 . . . . 0.0 110.669 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -143.5 174.43 10.77 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.466 1.106 . . . . 0.0 110.246 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.71 155.52 26.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.859 0.864 . . . . 0.0 109.592 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.18 175.27 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 126.189 1.796 . . . . 0.0 107.01 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.65 178.47 41.03 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.29 146.93 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.47 146.41 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -149.78 168.17 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 126.433 1.893 . . . . 0.0 108.893 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.79 -42.09 64.29 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.811 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.85 154.93 9.64 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.97 124.34 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 172.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -40.85 13.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.1 0.56 . . . . 0.0 111.056 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB2' HH22 ' A' ' 140' ' ' ARG . 5.8 t0 -168.04 -177.24 3.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.865 0.466 . . . . 0.0 110.882 -168.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.19 124.14 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.4 mt -140.91 171.8 13.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.703 1.201 . . . . 0.0 109.815 -168.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.4 m -126.45 134.31 50.99 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.682 0.674 . . . . 0.0 110.699 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.23 160.35 39.68 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.125 0.97 . . . . 0.0 110.194 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -145.18 161.32 39.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.23 1.412 . . . . 0.0 109.297 -168.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.22 -25.26 13.45 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.7 -38.15 86.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.073 -1.017 . . . . 0.0 109.669 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -83.07 -37.92 23.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 110.969 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.58 108.93 22.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -146.53 -58.67 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.075 -175.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 41.5 Cg_endo -67.67 173.29 9.21 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.11 1.873 . . . . 0.0 112.052 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.07 162.27 27.07 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.215 1.806 . . . . 0.0 108.335 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.46 -54.98 2.42 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.991 2.461 . . . . 0.0 112.723 -175.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 53.37 -21.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 130.392 3.477 . . . . 0.0 117.969 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -144.49 159.93 41.94 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.305 1.442 . . . . 0.0 109.582 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.6 36.07 13.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.523 1.529 . . . . 0.0 112.758 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.39 155.75 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 108.121 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -35.39 76.57 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.562 0.745 . . . . 0.0 111.304 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.4 170.44 4.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.981 1.713 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.9 m -140.83 178.98 6.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.368 2.267 . . . . 0.0 107.276 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 -27.87 2.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.571 2.349 . . . . 0.0 114.227 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.83 -18.94 62.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.422 1.489 . . . . 0.0 112.344 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.17 23.3 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.33 1.852 . . . . 0.0 109.762 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.92 115.05 27.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.482 1.513 . . . . 0.0 111.604 -169.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 145' ' ' VAL . 44.8 p -72.27 -179.1 2.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.048 2.539 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.84 172.93 15.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.943 -2.463 . . . . 0.0 106.943 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.25 157.64 43.52 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.329 1.565 . . . . 0.0 110.329 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.07 179.57 38.21 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.22 157.44 23.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.24 1.016 . . . . 0.0 111.071 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.18 81.3 1.67 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.61 2.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.6 2.047 . . . . 0.0 113.012 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.01 -32.02 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 111.043 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 107' ' ' ASP . 62.1 mtp180 -69.49 162.56 27.22 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.7 mtp -139.49 145.96 39.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.24 130.15 36.72 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.9 mt -84.07 100.94 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.45 118.03 20.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.414 ' HA ' HG22 ' A' ' 132' ' ' THR . 61.5 t -63.54 137.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -72.92 52.75 0.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.479 1.112 . . . . 0.0 110.077 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.83 -40.56 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.505 1.522 . . . . 0.0 114.784 -168.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.97 -20.91 51.79 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.669 -1.27 . . . . 0.0 111.432 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -41.96 21.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.7 tp -50.6 -45.0 57.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 110.184 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.29 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.714 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -75.93 -56.23 4.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -54.46 -46.24 73.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 110.425 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -74.33 -20.57 60.06 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.135 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.44 -47.02 80.65 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 122.122 2.237 . . . . 0.0 110.102 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.0 mtm -65.19 -45.95 82.72 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.85 96.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.074 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.3 -60.42 3.88 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.949 1.299 . . . . 0.0 109.548 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -27.98 68.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.992 -169.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 123.317 0.647 . . . . 0.0 112.676 174.952 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -135.3 166.97 21.89 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.167 1.787 . . . . 0.0 110.655 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -117.79 148.52 41.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.78 135.45 29.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.918 0.887 . . . . 0.0 109.296 -169.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.9 tp -77.21 134.66 38.56 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 168.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.6 m -121.57 149.21 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.778 1.172 . . . . 0.0 109.127 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.65 150.86 44.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.477 1.111 . . . . 0.0 109.696 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -91.43 147.46 23.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 tp -140.73 101.41 4.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.37 -76.26 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.512 1.53 . . . . 0.0 112.026 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.17 31.13 0.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.428 1.491 . . . . 0.0 110.657 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.77 160.54 39.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.941 1.696 . . . . 0.0 107.952 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -119.89 153.57 35.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.191 1.472 . . . . 0.0 110.846 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -140.51 159.43 42.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.532 2.333 . . . . 0.0 107.274 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -140.55 164.26 26.34 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 118.669 0.668 . . . . 0.0 111.989 170.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 mt -142.29 135.85 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -49.0 115.81 1.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.664 1.186 . . . . 0.0 108.983 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.37 -34.12 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.438 0.695 . . . . 0.0 111.697 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.63 -24.92 67.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.759 0.824 . . . . 0.0 112.668 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -84.83 -18.64 34.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.813 0.733 . . . . 0.0 112.061 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.87 136.8 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -100.44 -56.44 2.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 108.912 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -162.31 -179.18 6.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.526 1.13 . . . . 0.0 109.75 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -136.2 147.09 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -145.28 169.38 18.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.154 1.382 . . . . 0.0 108.297 -172.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.66 148.85 19.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -82.03 100.69 9.88 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.81 1.244 . . . . 0.0 107.922 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.3 165.99 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.6 1.96 . . . . 0.0 106.587 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . 0.299 1.0 OUTLIER 42.91 30.02 0.22 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.582 2.753 . . . . 0.0 117.498 171.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.01 127.92 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 112.691 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 45.34 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.67 2.388 . . . . 0.0 110.689 -169.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.0 mm -57.37 153.43 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -18.37 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.43 23.27 0.72 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.53 155.57 67.64 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.519 0.728 . . . . 0.0 110.079 169.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -61.98 161.17 26.83 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.387 2.058 . . . . 0.0 109.01 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.52 80.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.674 -172.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -59.89 -41.08 90.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.195 0.907 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 158' ' ' LEU . 37.8 mt -71.81 82.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -53.18 -30.61 38.39 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.629 1.172 . . . . 0.0 109.455 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.98 -151.5 22.45 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.85 154.92 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -136.01 145.96 46.64 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.99 92.89 5.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.45 175.62 1.31 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -69.54 59.49 0.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.87 1.668 . . . . 0.0 113.249 -169.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.86 -6.89 3.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.168 2.318 . . . . 0.0 113.389 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER -153.71 -165.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.375 1.588 . . . . 0.0 108.458 -169.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -121.1 158.75 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.094 1.758 . . . . 0.0 108.403 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.82 142.39 15.43 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.817 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.15 147.18 59.78 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.408 2.072 . . . . 0.0 110.745 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -131.32 148.16 32.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.721 0.808 . . . . 0.0 109.04 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.84 137.31 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -95.7 124.74 39.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.78 -18.83 64.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.361 0.664 . . . . 0.0 111.98 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -60.23 -31.44 70.19 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.839 -1.163 . . . . 0.0 109.624 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.64 -47.83 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -71.79 -33.08 68.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.859 -1.067 . . . . 0.0 113.581 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' CD1' HD22 ' A' ' 126' ' ' LEU . 16.0 m-30 -121.55 3.05 10.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.816 1.189 . . . . 0.0 112.552 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.3 m 58.67 29.59 18.78 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.986 0.812 . . . . 0.0 111.317 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -57.06 142.03 43.72 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.726 0.81 . . . . 0.0 110.41 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.22 140.47 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 122.092 0.949 . . . . 0.0 111.946 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 24.68 60.55 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 130.734 3.614 . . . . 0.0 115.557 168.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.5 146.92 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -160.33 162.27 33.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.678 0.791 . . . . 0.0 109.251 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.77 40.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.872 2.469 . . . . 0.0 111.562 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -155.28 -25.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.837 2.455 . . . . 0.0 110.978 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -135.32 9.32 3.45 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 111.491 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -154.12 36.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.602 1.961 . . . . 0.0 108.478 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 p -73.41 4.88 4.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.81 165.23 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.986 1.721 . . . . 0.0 108.948 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -141.06 140.8 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.283 1.833 . . . . 0.0 106.236 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.0 134.87 56.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.62 134.13 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.46 161.62 34.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.469 1.508 . . . . 0.0 108.316 -169.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.56 148.65 39.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.38 127.34 29.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 52.35 -99.1 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 CA-C-N 118.609 0.641 . . . . 0.0 111.791 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.64 20.94 5.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.347 1.459 . . . . 0.0 111.863 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.72 166.32 22.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.479 1.112 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.89 153.03 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.525 1.13 . . . . 0.0 109.883 -171.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -160.28 176.51 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.819 1.648 . . . . 0.0 107.05 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 176.82 38.97 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 120.538 -1.351 . . . . 0.0 111.025 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.2 pt -141.79 154.1 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 124.396 1.078 . . . . 0.0 109.032 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.05 137.2 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.321 1.048 . . . . 0.0 108.304 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.25 168.09 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.15 1.38 . . . . 0.0 110.38 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.28 -40.99 64.14 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.856 -1.153 . . . . 0.0 110.619 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.31 154.53 9.52 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.83 128.23 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.47 -43.29 9.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.236 0.615 . . . . 0.0 111.321 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -168.36 -174.32 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.739 0.816 . . . . 0.0 109.874 -168.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.0 t -134.19 129.61 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -138.21 169.75 17.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.867 1.267 . . . . 0.0 109.309 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -129.24 134.93 48.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.446 0.566 . . . . 0.0 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.19 160.25 41.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.815 1.246 . . . . 0.0 109.579 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -144.06 172.7 12.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.81 2.044 . . . . 0.0 107.347 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.6 0.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -78.1 -45.42 23.46 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 120.182 1.355 . . . . 0.0 108.669 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -84.31 -32.68 24.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.111 1.364 . . . . 0.0 111.656 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.93 121.67 50.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 13.7 mmt180 -147.96 -54.86 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.604 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 52.0 Cg_endo -69.28 -178.78 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.114 1.876 . . . . 0.0 111.981 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.27 32.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.694 1.598 . . . . 0.0 109.36 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.01 58.09 6.78 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.052 3.168 . . . . 0.0 111.704 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 30.07 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.297 1.439 . . . . 0.0 112.456 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.91 30.26 0.11 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.236 2.215 . . . . 0.0 113.865 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.47 31.81 4.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.882 2.073 . . . . 0.0 113.456 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 m -78.33 175.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -57.05 -17.38 9.96 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 75' ' ' PHE . 15.7 tp -78.05 -29.34 49.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.564 0.746 . . . . 0.0 112.921 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.1 m -70.91 78.02 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.731 1.612 . . . . 0.0 111.003 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.2 p -140.21 -102.01 0.15 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.374 1.069 . . . . 0.0 112.279 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.31 -36.18 0.41 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 127.333 2.253 . . . . 0.0 109.895 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -78.92 15.49 1.08 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.8 137.6 20.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.806 2.042 . . . . 0.0 109.896 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 145' ' ' VAL . 51.8 p -81.91 -168.86 2.09 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.823 2.049 . . . . 0.0 109.877 -174.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.52 177.03 18.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 171.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -140.54 140.72 35.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.725 1.21 . . . . 0.0 107.783 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.73 173.97 30.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.84 155.11 50.83 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.69 0.796 . . . . 0.0 110.8 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.2 mt -142.31 78.11 1.61 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.002 1.721 . . . . 0.0 107.38 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.94 -51.48 3.15 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.43 1.967 . . . . 0.0 112.833 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.02 -30.56 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.278 1.831 . . . . 0.0 111.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -69.79 153.51 43.23 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 171.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.94 140.72 40.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.36 115.2 15.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.7 mt -75.61 107.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.67 111.44 21.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -65.17 126.28 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -76.43 56.89 1.13 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.674 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.66 -35.0 48.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.035 1.334 . . . . 0.0 111.51 -170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.77 -18.43 64.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.301 0.64 . . . . 0.0 112.348 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.99 -15.59 14.32 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 116.917 -1.516 . . . . 0.0 112.003 170.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.25 -63.91 1.03 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.932 1.696 . . . . 0.0 110.668 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.37 -39.55 81.72 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -60.1 -43.81 95.3 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.663 1.12 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -73.38 -16.22 61.35 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.902 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -115.58 -0.29 13.08 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.702 -1.142 . . . . 0.0 113.43 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -49.72 -53.1 26.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.022 1.737 . . . . 0.0 111.819 -173.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.62 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.551 1.069 . . . . 0.0 111.167 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 55' ' ' ILE . 23.4 tp -59.77 -53.04 62.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.727 1.211 . . . . 0.0 108.46 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.07 -11.88 61.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 118.127 -0.94 . . . . 0.0 112.389 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 120.028 1.286 . . . . 0.0 110.965 173.682 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.08 138.85 58.58 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.34 143.81 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.67 139.56 33.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.997 0.919 . . . . 0.0 109.346 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 tp -83.37 130.24 35.04 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.2 152.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 109.317 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.27 153.59 45.3 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.544 1.138 . . . . 0.0 109.596 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -93.4 144.78 25.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -133.03 88.28 2.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.695 1.598 . . . . 0.0 106.742 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.75 -70.15 0.4 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.935 1.731 . . . . 0.0 112.755 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -151.24 27.73 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.37 1.468 . . . . 0.0 111.223 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.75 161.71 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.579 1.552 . . . . 0.0 108.154 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.82 150.2 46.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.464 1.126 . . . . 0.0 109.663 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -141.16 155.19 46.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.409 1.884 . . . . 0.0 107.507 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.97 158.68 22.99 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.425 1.012 . . . . 0.0 110.584 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.58 140.62 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -49.89 117.26 2.2 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.83 0.852 . . . . 0.0 109.993 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.75 -30.56 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.457 0.703 . . . . 0.0 111.569 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 mt -66.43 -4.88 9.16 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -109.88 -13.52 14.43 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 112.878 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.51 142.17 17.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 119.548 1.067 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -103.68 -57.71 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.22 -179.37 6.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.7 1.2 . . . . 0.0 109.295 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.57 149.51 31.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -143.59 174.32 10.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.28 1.432 . . . . 0.0 107.743 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.0 161.59 26.9 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 169.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.19 129.19 39.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.78 -43.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.7 41.19 0.77 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.61 135.86 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -123.43 92.33 3.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.17 111.66 5.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.2 -45.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.207 -170.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 144.73 -62.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.461 3.504 . . . . 0.0 108.696 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.82 18.47 22.08 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.673 1.189 . . . . 0.0 112.544 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.53 155.77 2.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.74 1.616 . . . . 0.0 110.003 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.24 146.65 49.0 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.726 1.617 . . . . 0.0 108.641 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -33.0 74.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.581 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -53.63 -42.5 67.84 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.976 0.807 . . . . 0.0 109.959 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.9 87.17 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -49.77 -32.09 13.04 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.317 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.62 -162.32 35.74 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.49 145.15 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -136.55 161.03 37.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 119.801 1.182 . . . . 0.0 109.178 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -80.31 108.94 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.759 0.823 . . . . 0.0 110.125 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.72 171.81 14.09 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.62 55.19 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.76 1.624 . . . . 0.0 112.831 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.01 -11.76 1.24 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.392 2.425 . . . . 0.0 113.743 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.56 -159.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 119.87 1.835 . . . . 0.0 108.828 -169.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.2 tp -121.36 155.35 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.839 1.655 . . . . 0.0 109.12 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.89 139.94 15.16 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.404 1.081 . . . . 0.0 109.314 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 141.26 47.22 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.228 1.952 . . . . 0.0 109.774 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -126.09 138.03 55.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.491 1.117 . . . . 0.0 108.602 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.12 130.44 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.11 119.47 25.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.55 -18.98 64.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.135 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -33.99 70.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 121.007 1.73 . . . . 0.0 110.278 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.03 0.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.51 1.124 . . . . 0.0 109.065 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -116.29 -30.6 5.89 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.757 -1.214 . . . . 0.0 111.616 172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -136.78 0.06 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 m 54.06 50.53 16.43 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.137 1.335 . . . . 0.0 111.941 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -54.94 169.28 0.23 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.469 1.108 . . . . 0.0 112.85 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.48 -66.46 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.391 1.477 . . . . 0.0 112.108 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.24 98.14 0.35 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 0.0 109.255 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.21 139.95 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.6 137.11 15.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.964 0.905 . . . . 0.0 109.351 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -73.23 34.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.118 2.167 . . . . 0.0 113.049 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -13.37 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.182 2.193 . . . . 0.0 110.636 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.01 8.63 4.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.628 1.171 . . . . 0.0 111.827 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.59 35.97 0.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.048 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -100.31 16.77 23.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -168.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.15 157.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.009 1.277 . . . . 0.0 107.68 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.43 111.65 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 mt -84.05 143.08 12.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.02 131.7 72.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.8 mt -134.18 166.15 23.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.957 1.703 . . . . 0.0 108.272 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.63 156.05 49.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.499 0.72 . . . . 0.0 109.845 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.54 96.93 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.51 -73.22 0.77 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.511 0.596 . . . . 0.0 113.752 174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -143.31 7.14 1.54 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.951 2.1 . . . . 0.0 111.879 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -137.73 161.99 35.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.77 1.628 . . . . 0.0 108.288 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.79 151.18 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.07 170.93 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.988 1.715 . . . . 0.0 106.92 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.83 176.96 37.4 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 120.77 -1.206 . . . . 0.0 111.233 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -145.68 144.97 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.106 0.962 . . . . 0.0 109.147 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 m -89.51 133.71 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.025 0.93 . . . . 0.0 109.119 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.08 169.59 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.34 1.456 . . . . 0.0 109.83 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.84 -43.85 67.67 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 170.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.05 156.15 11.3 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 m -71.93 123.84 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -53.97 6.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 109.857 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -174.48 177.31 2.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.015 1.726 . . . . 0.0 108.533 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.46 133.38 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.158 1.783 . . . . 0.0 107.481 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.87 178.26 10.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.936 1.294 . . . . 0.0 109.397 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 m -129.94 150.55 51.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.303 0.501 . . . . 0.0 111.91 -171.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -140.49 141.7 35.34 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.413 1.485 . . . . 0.0 107.227 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.8 p -76.95 162.71 27.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.356 0.598 . . . . 0.0 109.993 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.21 7.24 1.34 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.814 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -101.9 -37.32 8.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.719 2.008 . . . . 0.0 109.131 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.53 -41.26 98.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 106.891 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -144.23 -70.99 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.463 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.41 -174.35 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.4 2.067 . . . . 0.0 111.314 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.91 55.6 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.657 1.583 . . . . 0.0 108.929 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -82.58 38.45 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 124.133 3.222 . . . . 0.0 111.053 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.18 21.0 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.381 1.472 . . . . 0.0 114.135 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -137.52 144.74 42.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.674 1.19 . . . . 0.0 110.314 -171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.11 35.94 14.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.506 1.922 . . . . 0.0 114.479 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.24 176.84 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.42 1.488 . . . . 0.0 109.074 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -9.9 50.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 113.495 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.42 153.38 43.03 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.845 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -144.97 165.86 26.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.59 1.156 . . . . 0.0 109.318 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.7 p -56.14 -28.72 59.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.169 1.388 . . . . 0.0 113.119 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.88 -29.09 67.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.572 0.749 . . . . 0.0 112.148 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -123.67 -1.12 8.51 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.226 1.011 . . . . 0.0 112.892 -168.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.27 0.9 OUTLIER -61.71 164.87 5.64 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.378 1.085 . . . . 0.0 112.937 -171.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 145' ' ' VAL . 39.8 p -122.05 -159.47 0.82 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.142 1.777 . . . . 0.0 109.346 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.83 23.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 168.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.53 153.62 40.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.363 1.582 . . . . 0.0 109.577 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.19 172.68 39.24 Favored Glycine 0 C--N 1.333 0.377 0 O-C-N 123.09 0.244 . . . . 0.0 113.55 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.61 153.15 17.86 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.942 0.897 . . . . 0.0 110.967 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.75 79.79 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.64 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.611 2.053 . . . . 0.0 113.31 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -156.71 -33.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.504 2.322 . . . . 0.0 110.582 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -68.92 166.41 17.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.64 0.776 . . . . 0.0 110.493 172.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.8 mmm -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.66 151.08 46.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.2 mt -110.09 120.27 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.88 104.19 16.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.432 ' HA ' HG22 ' A' ' 132' ' ' THR . 60.2 t -62.64 129.89 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 126.011 1.724 . . . . 0.0 108.133 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -62.96 -28.36 70.03 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . 0.315 8.2 tp 46.31 -48.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 131.421 3.888 . . . . 0.0 116.503 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -62.62 -17.26 59.94 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.278 1.854 . . . . 0.0 113.961 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -101.93 -10.34 19.89 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 116.575 -1.679 . . . . 0.0 112.502 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.55 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.533 1.515 . . . . 0.0 111.455 -169.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.24 -29.57 64.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.613 -0.68 . . . . 0.0 110.388 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.38 -36.16 70.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.682 0.674 . . . . 0.0 111.649 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 m -91.77 -27.7 17.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.081 0.553 . . . . 0.0 111.485 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.98 -15.37 38.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.133 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.4 -36.11 77.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.196 1.816 . . . . 0.0 112.498 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -63.62 -45.78 88.71 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.744 -0.597 . . . . 0.0 109.537 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.15 87.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.122 0.569 . . . . 0.0 111.089 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.23 -64.43 0.82 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.131 1.372 . . . . 0.0 108.311 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.62 -31.26 70.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -168.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.371 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -67.8 138.06 55.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -106.02 144.16 33.14 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.96 140.21 32.67 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.03 0.932 . . . . 0.0 110.594 -169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.08 137.04 35.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 167.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.04 151.11 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 119.782 1.174 . . . . 0.0 109.066 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -139.45 150.04 44.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.466 1.106 . . . . 0.0 109.556 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -89.71 147.02 24.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.33 106.36 4.96 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.71 -80.37 0.24 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.653 1.121 . . . . 0.0 111.756 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -153.71 32.34 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.684 1.593 . . . . 0.0 110.158 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.58 162.06 36.86 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.462 1.905 . . . . 0.0 107.707 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.58 154.96 38.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.823 1.297 . . . . 0.0 111.042 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -140.86 156.28 46.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.182 2.193 . . . . 0.0 107.593 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.22 157.03 22.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.543 1.068 . . . . 0.0 111.31 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 136.34 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.97 123.56 13.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.22 -35.04 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.604 0.762 . . . . 0.0 112.822 -169.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.8 -18.71 60.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.984 1.266 . . . . 0.0 112.681 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.45 -23.32 50.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.731 0.696 . . . . 0.0 110.55 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.61 136.96 23.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -43.9 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.268 1.027 . . . . 0.0 110.26 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -159.81 170.99 20.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.0 . . . . 0.0 109.064 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.75 142.09 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -147.62 178.59 8.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.506 1.122 . . . . 0.0 108.252 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.21 165.43 15.07 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.94 128.75 38.76 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.59 -45.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -148.35 65.72 1.08 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.876 1.27 . . . . 0.0 108.907 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 37.4 t -85.07 112.13 21.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -75.88 81.98 2.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -60.77 133.7 56.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.16 151.83 8.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -30.38 66.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.81 28.34 0.85 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.96 156.83 9.25 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.458 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.52 132.93 32.65 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 84.98 0.68 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 122.755 1.264 . . . . 0.0 111.076 -170.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -167.8 -46.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.012 4.525 . . . . 0.0 102.889 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -78.37 97.06 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.116 1.766 . . . . 0.0 108.775 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -58.68 -36.03 73.53 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.58 -147.37 9.79 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.88 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 m -122.38 165.41 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.0 t -145.34 159.83 42.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.347 -1.471 . . . . 0.0 109.124 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -81.26 96.01 7.14 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.114 0.966 . . . . 0.0 111.275 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.15 164.06 13.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -74.06 58.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.493 1.042 . . . . 0.0 113.18 -169.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.39 -15.78 0.57 Allowed Glycine 0 CA--C 1.536 1.384 0 C-N-CA 127.3 2.381 . . . . 0.0 112.945 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -151.21 -158.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 119.302 1.551 . . . . 0.0 108.653 -169.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.434 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.0 tp -125.19 153.6 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.269 1.828 . . . . 0.0 108.276 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.7 139.23 14.58 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.426 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.79 146.05 82.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.33 2.02 . . . . 0.0 111.368 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 tp -130.48 132.37 64.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 124.157 0.983 . . . . 0.0 108.965 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.72 153.46 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.4 1.88 . . . . 0.0 106.629 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -131.1 128.66 40.62 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.08 -19.09 62.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.674 1.59 . . . . 0.0 111.056 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -57.32 -27.52 62.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.635 1.107 . . . . 0.0 111.568 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.82 -46.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.64 -27.74 68.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.745 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.96 1.84 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.041 1.291 . . . . 0.0 112.317 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.9 m 55.08 44.51 27.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.177 0.991 . . . . 0.0 112.091 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . 0.289 0.0 OUTLIER -54.45 148.76 11.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.114 -0.366 . . . . 0.0 111.363 176.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 78' ' ' VAL . 6.5 t -37.91 -60.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 128.39 2.676 . . . . 0.0 114.337 -169.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -174.38 88.4 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.057 1.743 . . . . 0.0 108.968 -169.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.16 154.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.461 0.648 . . . . 0.0 110.882 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' ASN . 20.7 t0 -158.45 161.2 37.43 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.19 38.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.267 1.827 . . . . 0.0 111.375 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASP . 69.3 m-80 -151.69 -7.98 0.22 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.948 2.899 . . . . 0.0 110.282 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.34 -23.09 4.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.749 1.22 . . . . 0.0 112.664 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 34.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.666 0.787 . . . . 0.0 109.436 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 p -82.52 -13.37 56.76 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.94 153.02 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.752 1.614 . . . . 0.0 107.653 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.4 t -120.53 137.88 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 126.159 1.783 . . . . 0.0 106.326 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.77 134.66 58.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.42 136.27 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -133.38 153.56 51.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.905 1.682 . . . . 0.0 108.384 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.84 144.96 43.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.46 158.76 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 40.27 -98.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.158 1.361 . . . . 0.0 112.919 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -136.19 30.53 2.99 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.077 1.751 . . . . 0.0 110.52 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.51 178.55 8.72 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.965 -1.085 . . . . 0.0 112.256 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 p -136.82 146.32 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.473 1.509 . . . . 0.0 107.991 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.18 -178.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.636 1.574 . . . . 0.0 107.774 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.66 177.14 41.0 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 120.639 -1.288 . . . . 0.0 111.008 169.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 pt -140.22 163.21 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.11 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 m -106.82 142.1 20.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.131 0.972 . . . . 0.0 108.93 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.33 168.15 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.528 1.531 . . . . 0.0 110.019 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.42 -43.83 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.885 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.32 156.11 12.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.63 127.66 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.6 -41.88 9.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.901 0.48 . . . . 0.0 111.717 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -167.15 178.72 5.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.26 0.624 . . . . 0.0 110.576 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.4 t -136.3 125.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 pp -158.12 178.3 10.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.743 1.217 . . . . 0.0 109.677 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -129.78 150.08 51.24 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.444 0.565 . . . . 0.0 111.995 -171.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -143.32 169.31 17.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.782 1.633 . . . . 0.0 109.043 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -129.02 168.55 15.88 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.642 1.577 . . . . 0.0 109.566 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.32 -13.14 48.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.72 -33.83 75.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.603 1.092 . . . . 0.0 109.575 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -87.75 -39.6 14.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.585 1.154 . . . . 0.0 110.682 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.9 mt -91.58 101.86 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.913 0.885 . . . . 0.0 108.672 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 -143.3 -57.64 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 CA-C-O 116.624 -1.655 . . . . 0.0 113.372 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.98 175.87 3.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.951 1.767 . . . . 0.0 111.499 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.06 150.6 26.11 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.714 1.206 . . . . 0.0 109.227 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.89 44.25 1.68 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.93 3.753 . . . . 0.0 110.986 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.44 19.65 0.08 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.838 1.655 . . . . 0.0 114.053 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.5 155.85 42.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.335 1.454 . . . . 0.0 110.605 -169.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.66 33.29 10.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.525 1.93 . . . . 0.0 114.413 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.12 169.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.779 1.632 . . . . 0.0 108.858 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.98 -76.58 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.811 1.245 . . . . 0.0 109.534 172.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 127' ' ' SER . 8.1 tp 49.71 -167.23 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.626 2.371 . . . . 0.0 113.626 174.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.412 ' H ' ' HG ' ' A' ' 126' ' ' LEU . 1.6 p -155.51 145.54 21.58 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 120.976 -1.078 . . . . 0.0 110.401 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -64.41 -21.43 66.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.746 1.219 . . . . 0.0 113.91 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.69 -22.46 21.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.461 0.573 . . . . 0.0 110.464 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.31 7.82 11.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.169 0.988 . . . . 0.0 111.898 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -63.22 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.085 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 145' ' ' VAL . 22.9 p 62.51 -170.91 0.17 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.5 1.92 . . . . 0.0 113.834 168.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -143.66 176.08 23.25 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 169.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.11 143.22 38.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.44 161.97 32.07 Favored Glycine 0 CA--C 1.519 0.321 0 O-C-N 123.61 0.569 . . . . 0.0 112.442 170.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.16 153.85 17.46 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 110.313 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.75 85.05 1.87 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.41 -52.79 2.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.622 2.058 . . . . 0.0 112.804 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.52 -30.31 0.1 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.034 2.134 . . . . 0.0 111.215 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -67.67 161.67 25.35 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.809 0.844 . . . . 0.0 108.993 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 76.8 mmm -127.44 140.53 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.34 135.21 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.31 106.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.72 111.18 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 132' ' ' THR . 18.2 m -65.93 143.05 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.84 59.29 4.75 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.8 0.727 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.51 -52.62 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.68 2.392 . . . . 0.0 113.511 -168.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.08 11.44 1.82 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.696 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -135.76 20.51 3.3 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.579 1.552 . . . . 0.0 110.499 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.05 -98.33 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.86 -29.03 65.04 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.606 -1.309 . . . . 0.0 109.92 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -62.27 -15.72 49.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.4 m -124.93 5.54 8.01 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 112.029 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -122.79 2.58 9.46 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.016 0.927 . . . . 0.0 112.952 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.75 -38.99 90.02 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 119.796 -1.815 . . . . 0.0 112.312 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -62.43 -36.1 81.34 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.285 0.634 . . . . 0.0 110.566 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.21 -38.13 66.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.771 0.829 . . . . 0.0 111.08 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.27 -61.9 2.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.829 1.252 . . . . 0.0 109.126 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.64 -29.6 69.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.441 -168.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.309 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.422 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -136.89 164.0 29.35 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.531 1.932 . . . . 0.0 110.414 -169.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -110.87 149.84 30.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -141.97 134.62 28.36 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.065 0.946 . . . . 0.0 109.33 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.4 tp -74.94 139.05 42.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.82 146.54 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.691 1.132 . . . . 0.0 108.795 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -140.81 150.19 43.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.413 1.085 . . . . 0.0 110.261 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -91.02 142.6 27.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -133.24 90.92 2.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.14 -71.71 0.31 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.18 1.848 . . . . 0.0 112.222 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.62 28.66 0.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.215 1.406 . . . . 0.0 111.164 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.72 162.41 34.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.611 1.564 . . . . 0.0 108.053 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.58 150.76 45.58 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.598 1.189 . . . . 0.0 110.098 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -140.49 156.86 46.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.97 2.108 . . . . 0.0 107.506 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.9 158.1 22.72 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.589 1.09 . . . . 0.0 111.463 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 mt -144.89 133.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -48.12 115.88 1.34 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.896 1.278 . . . . 0.0 109.584 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -53.94 -39.27 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -168.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.63 -17.14 64.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.319 0.963 . . . . 0.0 112.784 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -74.2 -24.26 59.33 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.537 0.608 . . . . 0.0 110.588 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.29 138.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 119.463 1.028 . . . . 0.0 108.723 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -102.15 -57.44 2.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.858 0.863 . . . . 0.0 109.293 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -160.69 174.62 13.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.581 1.152 . . . . 0.0 108.768 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.47 139.01 46.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -141.76 179.31 6.92 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.742 1.617 . . . . 0.0 107.856 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.92 161.5 14.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -56.44 131.18 47.74 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -155.14 -46.96 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.61 81.5 1.29 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.048 0.939 . . . . 0.0 109.525 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 115.67 32.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 90.32 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 173.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 118.87 10.95 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mm -81.95 -38.46 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.7 13.66 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.851 2.06 . . . . 0.0 114.798 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.93 13.91 2.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.525 2.33 . . . . 0.0 110.233 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.66 170.79 7.35 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 130.024 3.33 . . . . 0.0 110.333 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.94 -38.53 37.6 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.968 1.779 . . . . 0.0 112.134 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 139.42 170.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.657 4.383 . . . . 0.0 106.885 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' H ' HG21 ' A' ' 73' ' ' ILE . 44.8 m-85 68.12 -53.72 0.52 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 128.137 2.575 . . . . 0.0 109.346 -169.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -72.75 82.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.326 2.25 . . . . 0.0 110.209 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -56.07 -36.59 68.28 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 109.725 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.48 -173.38 36.99 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.024 -1.56 . . . . 0.0 115.112 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.77 119.43 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -89.66 146.84 24.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.757 1.623 . . . . 0.0 110.033 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -62.02 101.58 0.22 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG 0.302 0.2 OUTLIER -78.79 64.89 3.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.161 1.384 . . . . 0.0 107.834 169.996 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 43.35 36.96 1.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.443 2.297 . . . . 0.0 112.72 170.025 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.44 -23.39 4.05 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.013 1.292 . . . . 0.0 112.981 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -160.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.327 1.851 . . . . 0.0 106.692 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.86 146.77 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.878 1.217 . . . . 0.0 112.398 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.12 132.5 13.64 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.049 0.94 . . . . 0.0 108.685 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.55 142.01 69.48 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 CA-C-N 121.249 1.482 . . . . 0.0 110.207 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -128.16 132.62 68.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 152.95 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.555 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -103.88 119.91 39.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.172 1.389 . . . . 0.0 107.945 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.93 -7.18 49.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.319 -0.848 . . . . 0.0 113.01 -170.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ttt85 -69.56 -38.15 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 121.338 1.881 . . . . 0.0 108.202 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.44 HG21 ' H ' ' A' ' 54' ' ' PHE . 12.3 mt -71.88 -17.73 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 0.0 110.497 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -122.46 -29.11 4.15 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.777 1.172 . . . . 0.0 113.698 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -131.72 15.32 4.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.787 1.176 . . . . 0.0 112.72 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 m 58.93 28.97 18.3 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.53 1.132 . . . . 0.0 113.113 171.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -48.51 140.92 7.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.383 0.673 . . . . 0.0 109.246 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.07 -54.15 27.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 125.301 1.44 . . . . 0.0 111.377 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -165.43 82.58 0.34 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.593 1.157 . . . . 0.0 108.423 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.3 114.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -153.21 148.98 27.51 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.368 1.067 . . . . 0.0 109.085 -175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.81 45.82 0.73 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.683 1.593 . . . . 0.0 111.944 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.82 -17.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.397 2.279 . . . . 0.0 111.284 169.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.93 -3.31 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.698 1.199 . . . . 0.0 112.178 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.58 38.03 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -85.3 -7.55 58.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.516 2.327 . . . . 0.0 117.177 -168.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.39 152.72 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 120.693 1.588 . . . . 0.0 107.911 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.17 111.99 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -87.52 142.78 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.82 134.65 63.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 mt -134.32 160.23 38.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 108.817 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 152.16 46.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.491 1.517 . . . . 0.0 107.479 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.8 130.69 13.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.89 -83.2 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.211 1.386 . . . . 0.0 113.162 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -142.19 12.48 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.337 1.855 . . . . 0.0 111.704 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -143.98 166.8 23.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.403 1.081 . . . . 0.0 110.315 -169.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.62 151.88 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.737 1.215 . . . . 0.0 109.836 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.02 177.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.057 1.743 . . . . 0.0 106.939 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.31 173.93 39.52 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 120.494 -1.379 . . . . 0.0 110.628 170.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.3 pt -142.81 145.3 23.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 108.792 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.46 135.75 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.767 0.827 . . . . 0.0 109.047 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.84 169.79 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.872 1.269 . . . . 0.0 110.091 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 -42.04 65.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.81 160.36 19.11 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.34 135.83 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.61 -42.19 6.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.95 0.9 . . . . 0.0 111.161 -173.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -168.94 -177.37 2.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.72 125.91 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -140.26 173.94 11.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.091 1.356 . . . . 0.0 109.382 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 m -129.18 138.71 51.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.153 0.888 . . . . 0.0 110.797 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -145.86 163.53 34.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.9 1.28 . . . . 0.0 110.229 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 m -141.76 174.07 10.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.382 2.273 . . . . 0.0 107.133 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.04 1.59 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.72 -51.01 8.62 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.859 -1.151 . . . . 0.0 108.04 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -70.85 -43.12 69.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.613 1.165 . . . . 0.0 110.157 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.43 116.29 33.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -142.19 -66.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 116.395 -1.765 . . . . 0.0 110.8 -171.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.8 -175.69 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.105 1.87 . . . . 0.0 111.099 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.7 154.41 31.47 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.902 1.681 . . . . 0.0 107.715 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.51 42.21 1.29 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.839 3.026 . . . . 0.0 110.987 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.17 -19.7 3.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -140.74 34.6 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.936 0.894 . . . . 0.0 110.669 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.13 19.57 2.79 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 172.36 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.592 1.957 . . . . 0.0 108.788 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 2.82 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.368 1.867 . . . . 0.0 113.75 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.14 164.6 15.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.211 2.204 . . . . 0.0 112.685 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.4 m -137.12 159.28 42.36 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.554 1.542 . . . . 0.0 108.924 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 p -61.35 -20.45 63.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.535 . . . . 0.0 113.434 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -70.09 -36.18 74.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.3 13.12 19.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.431 1.092 . . . . 0.0 109.68 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 121.43 9.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.37 1.068 . . . . 0.0 110.862 -169.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 58.6 p -81.24 -162.22 0.48 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.991 2.517 . . . . 0.0 110.518 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.53 174.86 21.08 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.88 141.96 44.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.05 177.71 32.14 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.37 156.04 47.98 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.379 1.071 . . . . 0.0 109.711 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.5 mt -141.78 77.87 1.61 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.706 1.603 . . . . 0.0 107.272 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.31 -52.28 3.38 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.512 2.005 . . . . 0.0 112.624 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.64 -29.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.398 1.879 . . . . 0.0 111.637 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -69.38 157.13 37.65 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mtp -136.0 153.69 51.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.095 170.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -145.51 135.86 24.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.4 mt -97.67 118.43 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.83 105.53 17.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.68 120.37 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.626 1.17 . . . . 0.0 107.918 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -75.62 66.2 1.93 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.966 0.889 . . . . 0.0 109.902 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tp -57.6 -35.89 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.567 1.147 . . . . 0.0 110.801 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.62 -18.84 65.62 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -114.15 -2.74 13.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.971 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.74 -75.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.971 1.308 . . . . 0.0 109.652 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.02 -28.53 63.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.887 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.39 -34.42 61.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.056 0.942 . . . . 0.0 111.83 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -103.77 -19.62 14.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.78 0.832 . . . . 0.0 111.73 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.55 -18.8 32.33 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.421 -0.799 . . . . 0.0 111.796 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.5 -35.82 76.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.94 1.245 . . . . 0.0 111.968 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.7 mtm -63.82 -41.1 97.93 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 109.952 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.84 -43.16 72.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.916 0.487 . . . . 0.0 110.459 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.63 -58.93 5.21 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.718 1.207 . . . . 0.0 109.647 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -18.37 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 170.415 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.721 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -56.97 135.28 56.16 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -110.44 144.91 38.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -140.6 139.95 35.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.692 0.797 . . . . 0.0 109.554 -169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.33 134.01 35.25 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 168.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.61 148.79 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 119.274 0.943 . . . . 0.0 109.164 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -144.21 150.1 37.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.54 1.136 . . . . 0.0 109.506 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -86.71 148.0 25.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -143.42 111.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.495 1.518 . . . . 0.0 106.92 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -84.77 0.19 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.308 0.956 . . . . 0.0 111.398 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.21 32.17 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.114 1.366 . . . . 0.0 110.377 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -144.08 161.05 39.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.149 1.379 . . . . 0.0 108.236 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -118.58 150.4 39.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.648 1.213 . . . . 0.0 109.256 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.91 158.3 44.3 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.897 2.079 . . . . 0.0 107.142 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.28 24.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.856 0.741 . . . . 0.0 111.551 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mt -140.21 137.33 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.62 124.2 14.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.44 0.564 . . . . 0.0 109.708 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.99 -33.61 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.61 0.764 . . . . 0.0 112.5 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.46 -23.6 65.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.965 0.802 . . . . 0.0 111.961 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.79 -21.95 40.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.626 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.92 137.75 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.53 -43.23 2.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.759 1.223 . . . . 0.0 109.246 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -160.98 172.94 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 108.289 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.4 138.45 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -145.81 168.38 20.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.195 1.398 . . . . 0.0 107.552 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.06 164.7 27.5 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -70.1 3.88 2.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.088 1.355 . . . . 0.0 114.37 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -22.18 3.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.148 1.779 . . . . 0.0 115.714 -169.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.31 49.11 1.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.546 1.067 . . . . 0.0 112.64 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.95 110.79 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 90.45 5.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -67.87 110.67 3.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 mm -71.24 156.39 7.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.79 -24.58 65.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.7 p30 -145.98 22.63 1.39 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.494 1.117 . . . . 0.0 113.927 -169.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.03 153.74 84.05 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.28 151.33 83.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.852 1.701 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.46 75.67 4.01 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 122.097 0.951 . . . . 0.0 109.977 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -163.88 -46.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 130.613 3.565 . . . . 0.0 103.919 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.92 90.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 108.027 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -52.99 -27.83 21.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.158 0.983 . . . . 0.0 110.516 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.13 -168.69 40.54 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.905 1.229 . . . . 0.0 112.106 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.97 114.76 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -85.5 135.57 33.78 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.763 1.625 . . . . 0.0 109.049 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.39 91.48 3.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.46 174.04 2.38 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 169.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -68.86 52.59 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.417 2.287 . . . . 0.0 113.597 -169.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.34 -8.58 1.89 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.361 2.41 . . . . 0.0 113.512 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.96 -164.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 119.565 1.683 . . . . 0.0 108.848 -169.427 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.481 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.5 tp -122.74 156.14 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.466 1.906 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.98 135.42 9.44 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.437 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.82 140.01 59.55 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 121.274 1.491 . . . . 0.0 110.451 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.96 130.87 73.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.25 158.64 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -121.57 121.51 37.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.97 -22.37 66.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.29 -24.03 67.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.862 1.665 . . . . 0.0 111.785 170.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.34 -48.6 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.97 -18.25 65.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -132.13 -3.92 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.509 1.504 . . . . 0.0 112.636 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.5 m 50.08 37.41 14.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.29 1.036 . . . . 0.0 111.595 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -66.45 100.57 0.66 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.991 1.317 . . . . 0.0 109.439 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 t 39.15 -115.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 126.809 2.044 . . . . 0.0 108.733 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -158.0 100.07 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.25 1.42 . . . . 0.0 107.253 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 20.2 m -68.42 176.95 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 111.225 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -149.24 169.67 20.24 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.678 1.591 . . . . 0.0 108.917 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.36 43.3 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.638 1.975 . . . . 0.0 111.646 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -152.89 -6.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.649 3.179 . . . . 0.0 109.978 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.12 12.53 1.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.766 1.626 . . . . 0.0 111.3 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.72 25.47 0.57 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.108 2.563 . . . . 0.0 108.648 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.5 p -97.66 -2.43 41.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.4 t -110.67 160.45 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.6 t -138.29 132.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.0 mt -104.8 129.27 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.33 141.6 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -134.24 160.52 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.604 1.562 . . . . 0.0 108.852 -169.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.76 146.74 38.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.515 1.126 . . . . 0.0 108.196 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -159.6 143.82 14.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.22 5.28 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 119.414 1.006 . . . . 0.0 114.581 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 56.86 35.25 26.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.3 1.44 . . . . 0.0 113.628 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.94 173.91 11.04 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.696 1.598 . . . . 0.0 109.151 169.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.21 152.47 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.705 0.802 . . . . 0.0 110.576 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 99' ' ' GLY . 11.0 p -157.89 -175.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 106.355 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -172.04 -179.1 42.75 Favored Glycine 0 N--CA 1.448 -0.527 0 O-C-N 120.495 -1.378 . . . . 0.0 109.67 169.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 pt -141.94 144.49 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.844 0.457 . . . . 0.0 110.532 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.86 145.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 169.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.82 167.72 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.589 1.956 . . . . 0.0 108.547 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.02 -45.48 63.86 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.667 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.48 151.9 8.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.4 142.43 16.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 m -124.16 -26.96 3.91 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -168.71 178.74 4.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.653 1.115 . . . . 0.0 110.475 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.17 120.88 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.86 167.23 22.59 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.12 0.968 . . . . 0.0 110.291 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -128.07 138.15 52.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.77 0.428 . . . . 0.0 110.722 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.92 165.9 26.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 107.552 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.76 161.29 29.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -18.25 53.95 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.463 -0.773 . . . . 0.0 112.953 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.66 -36.74 83.27 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.986 -1.071 . . . . 0.0 110.45 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -76.69 -42.25 42.33 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.061 0.945 . . . . 0.0 109.848 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.78 88.91 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.203 1.001 . . . . 0.0 108.58 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 59.6 mtm180 -139.53 -55.32 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.981 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.1 Cg_endo -65.55 175.27 4.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.716 1.611 . . . . 0.0 111.315 175.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.93 157.3 30.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.848 1.259 . . . . 0.0 109.723 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.36 59.83 6.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.354 3.369 . . . . 0.0 110.048 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.39 1.4 11.79 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -148.16 160.35 43.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.369 0.986 . . . . 0.0 110.948 -172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.25 34.87 21.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.034 2.133 . . . . 0.0 114.24 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.0 161.98 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.135 1.374 . . . . 0.0 109.006 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -10.09 58.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.089 1.356 . . . . 0.0 113.426 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.2 tp -52.75 125.78 17.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.68 1.592 . . . . 0.0 113.806 -169.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -63.78 148.53 49.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 111.026 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.2 p -76.92 -16.07 59.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.982 0.913 . . . . 0.0 113.109 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -94.45 -43.07 8.53 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -80.59 7.3 10.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.76 1.224 . . . . 0.0 110.699 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.85 118.34 5.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p -69.96 -177.27 1.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.782 2.433 . . . . 0.0 110.838 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -123.39 179.17 16.21 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 mt -136.45 147.56 47.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.673 1.589 . . . . 0.0 106.878 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.35 171.26 34.62 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.17 154.19 31.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.118 0.967 . . . . 0.0 109.972 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.06 81.71 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.411 1.485 . . . . 0.0 107.052 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 -47.94 2.0 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.662 2.077 . . . . 0.0 113.672 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.53 -36.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.3 2.24 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -71.51 167.19 20.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.759 0.79 . . . . 0.0 110.056 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.0 mtp -135.13 154.79 51.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -136.75 138.22 40.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.7 mt -87.86 113.74 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.88 107.46 14.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.36 120.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.211 1.404 . . . . 0.0 107.909 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -76.72 63.89 2.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.705 0.764 . . . . 0.0 110.27 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.58 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.396 1.478 . . . . 0.0 111.321 -172.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.49 -4.19 14.16 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -126.94 22.97 6.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.558 1.143 . . . . 0.0 110.839 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 -95.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -65.57 -35.62 81.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.985 -1.072 . . . . 0.0 110.112 -173.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.16 -30.51 49.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.141 0.977 . . . . 0.0 113.051 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.5 m -114.7 -1.97 13.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.21 -9.14 11.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.771 -1.109 . . . . 0.0 113.195 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -52.66 -42.95 65.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.901 1.682 . . . . 0.0 112.168 -172.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.3 ptp -59.65 -27.56 66.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.02 1.328 . . . . 0.0 113.338 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.83 -33.48 12.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.093 1.357 . . . . 0.0 111.242 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.95 -60.12 4.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.488 1.115 . . . . 0.0 109.318 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -29.06 68.14 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.522 -169.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 124.344 1.058 . . . . 0.0 112.725 179.068 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -65.22 151.0 47.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.252 1.421 . . . . 0.0 108.247 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.1 143.53 44.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -142.39 136.89 30.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.504 0.722 . . . . 0.0 110.272 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.74 135.87 36.62 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 167.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.16 149.49 31.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 109.098 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -146.11 151.97 38.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.255 1.022 . . . . 0.0 110.242 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.5 m -86.93 146.39 26.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.438 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -137.23 103.23 5.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.95 -86.86 0.17 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.958 0.789 . . . . 0.0 111.575 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.02 31.02 0.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.239 1.416 . . . . 0.0 110.376 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.66 159.2 42.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.711 1.605 . . . . 0.0 107.566 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -122.71 149.65 43.79 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.206 1.479 . . . . 0.0 110.785 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -137.92 161.56 36.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 107.621 -169.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.64 163.95 26.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.845 0.748 . . . . 0.0 112.145 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mt -142.75 138.04 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -48.04 114.59 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.169 . . . . 0.0 109.357 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -54.84 -34.12 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.968 0.907 . . . . 0.0 111.594 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.75 -23.87 67.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.717 0.807 . . . . 0.0 112.618 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -82.64 -19.0 39.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.948 0.794 . . . . 0.0 112.069 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.29 125.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -80.83 -57.58 3.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.02 -178.29 5.53 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.625 1.57 . . . . 0.0 108.537 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.34 141.71 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -143.4 -155.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.925 1.29 . . . . 0.0 108.186 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.15 161.84 26.41 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.33 136.09 57.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -160.3 -51.82 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.45 0.7 . . . . 0.0 110.27 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -157.63 73.06 0.69 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.173 1.389 . . . . 0.0 107.926 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.42 103.44 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 168.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.46 84.9 4.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -70.06 118.13 12.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.97 -24.06 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 118.222 0.464 . . . . 0.0 110.287 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.11 20.92 3.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.002 1.721 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -142.47 41.08 1.6 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.777 2.831 . . . . 0.0 105.127 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.88 151.18 34.42 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 109.096 -168.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.16 156.33 55.89 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.132 1.888 . . . . 0.0 108.846 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.64 -25.55 64.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -53.43 -50.33 65.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.427 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.7 mt -77.17 82.03 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -60.8 -27.39 67.99 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.562 -0.711 . . . . 0.0 110.069 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -166.45 34.81 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.903 0.774 . . . . 0.0 111.302 169.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.92 121.2 66.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -99.93 131.17 46.06 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.742 1.217 . . . . 0.0 110.739 -168.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -63.24 136.33 57.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.0 102.45 4.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 169.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.31 34.38 14.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.393 1.077 . . . . 0.0 113.139 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 9.39 55.56 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.035 0.826 . . . . 0.0 113.432 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 65' ' ' ILE . 1.6 t -131.8 -176.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 127.0 2.12 . . . . 0.0 106.816 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 64' ' ' VAL . 3.9 tp -136.82 159.07 37.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.831 1.253 . . . . 0.0 109.939 -173.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.18 140.47 13.75 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.09 132.21 23.9 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 N-CA-C 106.833 -2.026 . . . . 0.0 106.833 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -111.87 140.14 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.54 172.21 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -132.51 117.8 18.46 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.93 -24.86 67.65 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.363 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -66.46 -25.53 66.77 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 120.075 1.307 . . . . 0.0 111.687 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.7 mm -71.43 -50.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 120.053 1.297 . . . . 0.0 107.545 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -64.91 -16.93 63.87 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.94 1.81 9.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.653 1.181 . . . . 0.0 112.542 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m 47.59 38.15 7.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.579 1.152 . . . . 0.0 111.505 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.21 29.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.502 1.121 . . . . 0.0 110.681 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t 33.62 -109.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.6 2.36 . . . . 0.0 112.178 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -172.02 111.58 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.031 2.132 . . . . 0.0 105.888 -172.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -56.31 160.41 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.963 0.905 . . . . 0.0 111.462 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -153.28 149.88 28.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.219 1.008 . . . . 0.0 108.305 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.18 38.21 0.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.643 1.977 . . . . 0.0 113.163 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.14 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.099 2.16 . . . . 0.0 110.747 169.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.11 6.72 5.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.854 1.262 . . . . 0.0 111.658 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.458 HD22 ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -155.34 28.86 0.4 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.705 -1.247 . . . . 0.0 110.343 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 p -94.05 15.17 17.66 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -167.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.84 150.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.417 1.462 . . . . 0.0 107.144 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 m -119.61 135.1 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 119.691 1.132 . . . . 0.0 109.963 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -98.94 128.7 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.84 133.42 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -133.65 166.43 22.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.505 1.522 . . . . 0.0 109.617 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -139.93 154.83 47.33 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.89 0.876 . . . . 0.0 109.439 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -137.09 83.74 2.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.82 -68.66 1.9 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.057 0.837 . . . . 0.0 112.91 169.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.04 2.25 2.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.804 1.642 . . . . 0.0 112.42 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 166.27 21.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.631 1.105 . . . . 0.0 110.189 174.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.81 154.5 34.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.697 1.199 . . . . 0.0 108.842 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.33 169.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.86 175.41 30.63 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 120.82 -1.175 . . . . 0.0 110.164 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 pt -135.48 140.85 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 85' ' ' ASN . 1.4 m -75.17 135.7 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.486 0.714 . . . . 0.0 109.084 170.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 m -141.65 166.17 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.039 1.735 . . . . 0.0 108.862 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.17 -43.97 69.72 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.233 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.23 10.63 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.18 127.6 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.2 -53.69 7.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.226 0.61 . . . . 0.0 109.673 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -175.26 -176.63 0.95 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.003 1.721 . . . . 0.0 108.166 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.9 132.35 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -134.63 175.96 9.06 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.787 1.635 . . . . 0.0 108.192 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 m -133.33 143.66 49.14 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.53 141.34 33.57 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 158.9 15.56 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.445 1.098 . . . . 0.0 108.308 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.64 26.37 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.7 -31.13 63.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.937 1.295 . . . . 0.0 111.065 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.79 -39.65 30.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.375 1.47 . . . . 0.0 110.482 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.75 113.81 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.6 ttp-105 -155.2 -56.96 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 116.708 -1.615 . . . . 0.0 112.312 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.82 178.22 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.701 1.601 . . . . 0.0 111.567 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.81 156.01 29.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.43 1.492 . . . . 0.0 109.567 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.38 59.71 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.684 3.589 . . . . 0.0 111.574 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.66 31.29 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.149 1.779 . . . . 0.0 112.906 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.51 171.28 9.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.164 1.386 . . . . 0.0 110.418 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.22 30.74 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.767 1.627 . . . . 0.0 113.38 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.77 177.43 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.42 1.488 . . . . 0.0 110.119 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -9.13 15.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.425 1.49 . . . . 0.0 113.789 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.57 142.34 55.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.0 m -143.46 163.36 33.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 110.114 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -53.98 -31.54 51.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.884 1.673 . . . . 0.0 115.222 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -69.63 -26.07 64.24 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.455 1.025 . . . . 0.0 112.808 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.2 9.9 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.276 0.631 . . . . 0.0 112.597 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.11 154.73 12.35 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 118.382 0.537 . . . . 0.0 110.126 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.8 p -107.34 172.73 6.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.342 1.457 . . . . 0.0 109.335 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.39 -179.62 29.74 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.0 145.19 32.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 168.78 32.65 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.55 154.69 25.56 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.696 0.799 . . . . 0.0 109.517 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.31 80.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -174.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.42 -57.2 2.01 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.924 2.202 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -148.96 -24.91 0.3 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.315 2.246 . . . . 0.0 111.939 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -71.72 165.8 23.29 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.9 mtp -141.46 142.2 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -133.77 123.54 25.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 mt -77.42 112.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 170.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.52 108.36 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.02 128.35 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.792 1.637 . . . . 0.0 108.098 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -79.17 60.0 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.687 1.195 . . . . 0.0 110.191 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.84 168.67 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.821 0.848 . . . . 0.0 108.866 170.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.67 -18.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.136 1.775 . . . . 0.0 113.009 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -109.67 -33.56 6.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.09 -1.433 . . . . 0.0 111.38 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -48.65 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.528 1.531 . . . . 0.0 112.205 -170.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 tp -71.36 -25.96 62.6 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.176 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -56.78 -29.4 62.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.253 0.933 . . . . 0.0 112.136 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -114.82 -3.34 12.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.234 1.414 . . . . 0.0 111.678 -173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.08 2.35 19.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.534 1.534 . . . . 0.0 111.739 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.54 -44.86 77.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.444 1.098 . . . . 0.0 111.343 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.11 -37.79 88.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.003 0.921 . . . . 0.0 111.082 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 -37.25 72.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.644 0.778 . . . . 0.0 111.273 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.77 -55.1 33.71 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.06 -28.84 69.36 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.645 0.778 . . . . 0.0 112.118 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 123.675 0.79 . . . . 0.0 112.478 -177.78 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -80.76 153.1 27.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.512 1.525 . . . . 0.0 108.724 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.02 142.52 49.73 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -142.65 143.01 32.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.348 0.659 . . . . 0.0 111.608 -169.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -83.79 133.56 34.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 167.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.98 152.08 25.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 119.875 1.216 . . . . 0.0 109.514 -174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -146.55 153.76 40.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.379 1.072 . . . . 0.0 110.46 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.6 m -90.07 147.15 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.2 tp -144.97 105.59 4.12 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.512 1.525 . . . . 0.0 107.468 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.54 -77.68 0.61 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.146 1.355 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -153.45 22.97 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.061 1.344 . . . . 0.0 112.084 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.48 160.33 40.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.175 1.39 . . . . 0.0 108.555 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -120.17 150.35 40.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.911 1.339 . . . . 0.0 110.449 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -140.12 159.49 42.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.564 1.946 . . . . 0.0 108.029 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.18 160.31 23.88 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.487 1.041 . . . . 0.0 111.092 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -140.62 139.2 35.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -50.07 115.51 1.44 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.946 0.899 . . . . 0.0 109.667 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -54.13 -33.99 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.373 1.069 . . . . 0.0 112.212 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.5 -24.97 68.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.805 0.842 . . . . 0.0 112.988 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -79.85 -18.53 50.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.024 0.829 . . . . 0.0 112.22 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.93 139.75 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.385 0.674 . . . . 0.0 109.235 -175.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -103.17 -57.96 1.95 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.451 1.1 . . . . 0.0 108.722 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.02 178.73 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.484 1.114 . . . . 0.0 109.556 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.43 144.15 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -147.66 168.71 21.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.472 1.909 . . . . 0.0 107.146 -169.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.46 -178.0 52.12 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.089 -1.007 . . . . 0.0 111.411 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -124.08 93.39 3.91 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.511 1.525 . . . . 0.0 106.942 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.49 -43.76 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.549 1.139 . . . . 0.0 109.678 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -74.07 29.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.456 1.902 . . . . 0.0 114.13 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.63 157.49 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.041 0.936 . . . . 0.0 110.878 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.7 m -141.93 148.72 39.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.381 2.672 . . . . 0.0 104.576 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -146.63 142.97 28.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.324 1.42 . . . . 0.0 109.642 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.76 140.53 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 169.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.11 -26.33 26.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -169.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -139.29 37.83 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.767 1.627 . . . . 0.0 112.422 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 48' ' ' ILE . 39.9 p -55.72 152.49 18.91 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 172.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.71 147.59 81.62 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 N-CA-C 106.163 -2.283 . . . . 0.0 106.163 167.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.35 32.48 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -61.24 -39.47 90.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.247 0.931 . . . . 0.0 110.806 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.37 80.93 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -60.73 -14.07 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.09 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.5 -141.25 9.12 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 120.579 1.536 . . . . 0.0 114.158 168.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' PRO . 18.2 m -134.07 166.19 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 128.374 2.669 . . . . 0.0 105.144 169.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 t -147.96 151.23 35.45 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.507 -1.371 . . . . 0.0 110.33 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.46 112.8 15.87 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.488 0.715 . . . . 0.0 110.78 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.38 91.74 8.27 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.59 21.67 0.93 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.089 1.756 . . . . 0.0 115.417 169.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.7 5.55 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.515 1.052 . . . . 0.0 114.079 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.81 -172.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.75 1.62 . . . . 0.0 107.55 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tp -129.41 152.59 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 120.132 1.333 . . . . 0.0 110.844 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.61 142.55 18.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.8 Cg_endo -64.32 151.74 84.22 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.691 1.594 . . . . 0.0 111.777 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tp -125.55 134.96 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.89 142.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -103.53 113.01 26.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.47 -170.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.52 -27.09 65.87 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.112 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -55.12 -46.22 75.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.019 0.827 . . . . 0.0 109.753 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.86 -38.78 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -64.73 -28.35 69.53 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.442 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.31 2.23 10.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.666 0.786 . . . . 0.0 112.725 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m 50.34 48.25 22.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.433 1.093 . . . . 0.0 111.551 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -174.99 0.3 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 111.148 175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.21 173.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.878 1.271 . . . . 0.0 110.949 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -80.78 65.61 5.99 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.589 2.356 . . . . 0.0 110.073 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 m -51.0 157.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.906 1.282 . . . . 0.0 112.744 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -151.53 176.11 11.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.9 1.68 . . . . 0.0 110.548 -171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -67.96 49.85 0.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.366 2.267 . . . . 0.0 110.686 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -149.72 -30.48 0.23 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.338 2.655 . . . . 0.0 109.986 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -141.9 19.22 2.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.127 1.371 . . . . 0.0 111.832 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -142.82 16.75 1.96 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.799 2.039 . . . . 0.0 110.484 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -73.56 3.29 6.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.631 2.772 . . . . 0.0 116.309 -168.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.04 157.45 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 119.781 1.173 . . . . 0.0 108.043 -175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.3 t -132.81 133.62 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.059 2.144 . . . . 0.0 107.632 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -99.99 134.14 40.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.293 -2.855 . . . . 0.0 103.293 168.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.91 134.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.5 mt -134.44 167.47 20.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.572 1.549 . . . . 0.0 108.703 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.04 153.4 42.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.08 141.95 20.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 170.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.36 0.02 OUTLIER Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.063 1.315 . . . . 0.0 112.148 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -146.29 9.12 1.08 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.832 1.653 . . . . 0.0 111.521 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 164.28 24.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.773 -1.204 . . . . 0.0 110.68 -173.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.46 149.73 26.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.195 1.398 . . . . 0.0 108.567 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.12 162.24 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.28 167.08 24.83 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.62 135.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.18 144.31 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -148.13 165.83 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.547 1.939 . . . . 0.0 108.315 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.37 -42.78 74.73 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.248 -0.908 . . . . 0.0 110.03 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.93 157.97 11.59 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.26 122.19 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.79 -48.43 18.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.254 0.622 . . . . 0.0 111.039 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.94 -179.78 2.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.724 1.21 . . . . 0.0 109.692 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.3 t -127.48 126.86 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.88 178.07 10.68 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.892 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.1 m -130.44 148.73 52.28 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.166 0.587 . . . . 0.0 111.053 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -143.07 143.19 31.76 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.9 p -82.84 164.92 20.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.352 0.596 . . . . 0.0 111.37 174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 14.61 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.719 1.208 . . . . 0.0 113.376 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.25 -38.49 3.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.228 1.811 . . . . 0.0 109.512 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.66 -39.5 88.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.97 121.91 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.66 1.984 . . . . 0.0 106.988 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 63.9 mtt85 -150.83 -56.33 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 117.088 -1.434 . . . . 0.0 110.61 169.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 36.5 Cg_endo -65.78 178.35 2.33 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.889 2.392 . . . . 0.0 112.704 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.05 33.48 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.254 1.421 . . . . 0.0 109.415 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -80.98 50.42 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.086 3.191 . . . . 0.0 110.441 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.5 21.21 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.521 1.529 . . . . 0.0 114.424 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -148.86 152.39 36.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.844 1.658 . . . . 0.0 109.377 -169.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.31 40.14 17.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.734 . . . . 0.0 114.008 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.2 157.94 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.861 1.265 . . . . 0.0 109.396 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -15.69 61.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.194 1.397 . . . . 0.0 112.376 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.524 HD13 ' H ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -50.52 155.85 1.0 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.378 2.271 . . . . 0.0 112.22 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' LEU . 5.5 m -130.38 156.21 45.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 110.261 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -60.05 -35.28 74.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -76.98 -15.56 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.123 1.329 . . . . 0.0 112.75 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -126.39 25.4 6.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.94 138.93 57.71 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.1 p -75.41 -174.45 2.43 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.32 1.848 . . . . 0.0 109.989 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.46 175.48 20.17 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.39 155.78 42.28 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.041 1.421 . . . . 0.0 109.506 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.38 179.82 29.43 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 123.696 0.665 . . . . 0.0 111.958 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.86 158.48 39.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -169.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.51 60.14 1.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.107 2.163 . . . . 0.0 107.463 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.25 2.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.22 1.867 . . . . 0.0 113.199 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.87 -32.35 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.73 2.012 . . . . 0.0 110.39 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -68.92 154.56 41.82 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.7 mtp -143.77 143.71 31.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.895 1.678 . . . . 0.0 106.496 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -137.01 140.48 42.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 92.4 mt -96.34 112.42 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.49 110.22 19.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.52 130.43 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.511 1.124 . . . . 0.0 108.277 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -79.98 60.61 3.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.022 1.329 . . . . 0.0 109.408 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.99 -37.14 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.514 1.126 . . . . 0.0 111.78 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.15 -26.78 68.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.374 0.534 . . . . 0.0 112.409 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -106.54 -17.47 14.24 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.856 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -50.35 -73.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.495 1.498 . . . . 0.0 110.858 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.3 tp -74.37 -26.51 60.16 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.31 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -63.56 -31.12 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.849 1.204 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -84.1 -27.59 28.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.872 0.869 . . . . 0.0 111.559 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.31 6.42 20.48 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -51.21 -48.9 61.92 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.991 1.316 . . . . 0.0 111.074 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -28.27 69.97 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.512 0.725 . . . . 0.0 112.554 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.08 -42.67 23.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.666 0.786 . . . . 0.0 110.593 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.43 -46.05 91.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.997 0.817 . . . . 0.0 109.547 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.93 -12.96 61.18 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.143 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 120.038 1.29 . . . . 0.0 111.507 177.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.45 165.93 11.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.239 1.016 . . . . 0.0 111.234 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.63 -59.1 0.51 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -145.51 159.16 43.52 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.545 1.538 . . . . 0.0 108.26 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m 52.42 39.27 27.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.894 1.278 . . . . 0.0 112.5 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -77.69 43.86 0.43 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.343 1.057 . . . . 0.0 111.353 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.1 m -60.01 -23.64 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.859 1.264 . . . . 0.0 112.533 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m 55.44 80.39 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.621 1.568 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.89 -20.95 25.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.833 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.4 tp 50.74 52.46 14.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.498 2.319 . . . . 0.0 110.485 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.56 -24.26 2.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.197 0.999 . . . . 0.0 112.851 -173.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -155.19 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.099 0.952 . . . . 0.0 112.411 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.11 159.91 84.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.521 1.929 . . . . 0.0 109.637 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.92 -28.18 85.95 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.802 2.335 . . . . 0.0 113.172 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m 48.85 41.81 19.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.53 1.532 . . . . 0.0 114.155 169.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.16 105.52 0.45 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 171.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -134.84 165.87 24.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.872 2.069 . . . . 0.0 109.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.52 146.03 47.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.981 1.313 . . . . 0.0 107.485 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -141.75 138.24 32.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.477 0.711 . . . . 0.0 110.163 -168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.5 tp -78.71 132.63 37.07 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.267 2.0 m -117.91 146.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 119.24 0.927 . . . . 0.0 108.617 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -141.0 164.99 28.79 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.208 1.003 . . . . 0.0 110.537 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 m -121.01 146.02 47.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.78 134.04 14.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.8 -92.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.771 1.177 . . . . 0.0 110.363 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -151.28 37.84 0.62 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.06 1.344 . . . . 0.0 109.493 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -140.04 154.4 47.08 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.386 1.474 . . . . 0.0 108.433 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.93 155.46 31.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.799 1.285 . . . . 0.0 109.983 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -143.68 158.55 43.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.418 1.887 . . . . 0.0 107.901 -169.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.25 154.86 20.78 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.084 1.326 . . . . 0.0 110.024 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.1 mt -139.89 135.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.41 124.18 15.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.799 0.727 . . . . 0.0 109.177 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.69 -34.09 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.463 0.705 . . . . 0.0 112.631 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 mt -68.18 -24.36 64.96 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.853 0.751 . . . . 0.0 112.131 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.88 -14.51 50.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.953 0.797 . . . . 0.0 111.555 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.71 128.1 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -87.43 -55.7 3.68 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.432 1.093 . . . . 0.0 108.464 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -167.24 -178.06 3.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.866 1.266 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.91 142.69 43.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -167.77 2.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.448 1.499 . . . . 0.0 107.885 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.99 160.45 21.26 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -75.74 -0.96 22.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -5.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -168.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 34.19 1.39 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.343 1.429 . . . . 0.0 113.576 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.44 140.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.4 m -129.77 91.53 3.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -68.18 112.5 5.14 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.23 157.11 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.3 72.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -139.23 22.91 2.57 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.05 156.71 66.44 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -59.77 142.02 97.91 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.68 68.01 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.365 -0.835 . . . . 0.0 112.78 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -52.27 -40.56 61.9 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.541 0.609 . . . . 0.0 110.239 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.18 94.99 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -50.01 -33.12 17.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.286 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.62 177.01 31.3 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.9 153.92 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -140.63 163.42 32.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.732 1.151 . . . . 0.0 108.794 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -89.28 113.31 24.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.043 0.937 . . . . 0.0 110.75 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.48 171.66 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.4 mtp-105 -72.61 64.61 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.273 1.397 . . . . 0.0 112.81 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.96 -9.83 2.29 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 127.076 2.274 . . . . 0.0 113.24 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.34 -164.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 119.231 1.516 . . . . 0.0 108.536 -169.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.9 tp -127.81 157.04 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.174 1.79 . . . . 0.0 108.525 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p -151.38 141.99 14.93 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.44 138.36 42.17 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.183 1.922 . . . . 0.0 109.991 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.86 137.45 56.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.68 1.192 . . . . 0.0 108.319 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.99 139.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -97.89 120.69 38.72 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.303 0.641 . . . . 0.0 109.651 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -68.29 -18.87 64.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.175 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.21 -37.17 86.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.862 1.665 . . . . 0.0 110.455 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.26 -48.02 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -73.98 -27.4 60.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.324 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.31 11.44 2.56 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.948 1.249 . . . . 0.0 113.335 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m 60.63 34.1 20.2 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.606 -1.309 . . . . 0.0 112.926 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -50.85 155.2 1.22 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.645 0.778 . . . . 0.0 112.503 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 t -59.16 -64.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.786 1.234 . . . . 0.0 113.192 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -157.23 63.19 0.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.775 0.797 . . . . 0.0 111.457 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.54 135.55 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -158.39 158.52 34.38 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.482 1.513 . . . . 0.0 108.427 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.01 48.43 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.85 1.66 . . . . 0.0 112.767 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER -155.1 -16.08 0.11 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.961 2.904 . . . . 0.0 109.987 169.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 83' ' ' ASN . 32.2 t70 -119.69 -8.11 9.97 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.486 1.914 . . . . 0.0 111.562 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.48 35.14 1.84 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.687 1.595 . . . . 0.0 109.775 -169.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -100.08 -11.56 20.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -168.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.28 157.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.08 133.06 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.3 mt -107.67 133.76 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.27 137.92 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.8 mt -136.0 154.68 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.726 1.611 . . . . 0.0 107.549 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.47 149.64 42.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.32 176.02 8.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -11.67 -65.71 0.01 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 128.096 2.76 . . . . 0.0 116.24 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -137.95 26.63 2.72 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 111.638 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -151.4 164.63 36.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.778 -1.201 . . . . 0.0 111.952 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.17 144.12 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 0.0 109.015 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -157.64 -178.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.618 1.567 . . . . 0.0 107.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.62 -179.69 41.02 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.538 -1.352 . . . . 0.0 110.526 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.9 pt -141.91 144.21 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.108 0.963 . . . . 0.0 108.915 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 m -79.44 141.87 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.134 1.374 . . . . 0.0 108.46 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.98 163.21 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.256 1.822 . . . . 0.0 110.275 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -80.11 -46.7 16.01 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.954 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.56 161.94 31.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.71 116.49 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -41.57 34.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.573 0.749 . . . . 0.0 111.601 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -170.16 -174.82 1.83 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.65 123.45 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.6 mt -140.27 171.52 14.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.626 1.171 . . . . 0.0 109.994 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 m -125.6 139.38 53.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.091 0.556 . . . . 0.0 110.131 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.78 159.46 42.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.6 1.16 . . . . 0.0 109.366 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -122.38 155.18 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.117 2.167 . . . . 0.0 106.941 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -27.74 63.66 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.121 -0.987 . . . . 0.0 112.498 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.21 -33.64 73.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.634 1.173 . . . . 0.0 111.234 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -78.0 -42.31 33.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 109.617 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.5 mt -85.41 68.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.287 1.435 . . . . 0.0 109.11 -170.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 41.7 mtm180 -113.75 -60.53 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.367 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 42.2 Cg_endo -67.45 -179.1 1.74 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.034 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.19 32.52 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.774 1.63 . . . . 0.0 108.874 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.1 51.29 3.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.613 2.876 . . . . 0.0 110.709 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.83 27.89 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.832 2.053 . . . . 0.0 114.103 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -65.4 176.64 1.34 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 110.46 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.73 32.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.457 1.903 . . . . 0.0 113.685 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 m -66.93 167.09 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.188 0.995 . . . . 0.0 109.914 169.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -63.82 -16.1 60.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 0.0 113.391 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.44 108.61 4.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.562 1.145 . . . . 0.0 111.01 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 m -67.53 155.47 39.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.052 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -66.07 -34.07 77.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.611 1.164 . . . . 0.0 112.543 -171.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.16 -17.45 62.54 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.601 -1.312 . . . . 0.0 113.241 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.77 26.13 5.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.785 0.834 . . . . 0.0 109.939 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.54 140.02 54.83 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 145' ' ' VAL . 35.1 p -70.28 -176.5 1.21 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.597 1.959 . . . . 0.0 110.66 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.02 178.89 16.39 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 169.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.1 mt -134.64 150.72 50.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.46 171.1 34.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.65 157.21 25.76 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.209 1.004 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.8 79.12 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.99 -50.96 2.72 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.7 2.095 . . . . 0.0 112.869 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.31 -30.53 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.223 2.209 . . . . 0.0 111.023 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -66.55 164.75 15.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.139 0.976 . . . . 0.0 108.886 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.7 mtp -139.17 150.74 45.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.764 1.226 . . . . 0.0 108.072 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.4 mt -138.53 137.92 37.52 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.678 1.191 . . . . 0.0 107.908 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 98.8 mt -86.89 113.29 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.03 109.23 15.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.583 ' HA ' HG22 ' A' ' 132' ' ' THR . 67.3 t -64.24 128.92 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -75.24 51.61 0.55 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.77 1.228 . . . . 0.0 110.859 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 tp -57.23 -40.67 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.998 -1.064 . . . . 0.0 111.979 -169.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.94 -10.61 40.64 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.39 0.65 6.99 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.765 169.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.84 -69.07 0.25 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.838 1.199 . . . . 0.0 109.924 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.94 -33.25 74.31 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.89 -46.22 78.41 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.747 -0.595 . . . . 0.0 110.647 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -77.2 -22.46 52.32 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.282 0.633 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.44 -15.0 19.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.186 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.24 -48.08 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.495 1.498 . . . . 0.0 111.737 -169.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.9 ptp -60.86 -27.72 68.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.028 0.931 . . . . 0.0 113.007 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.62 -34.99 12.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.59 1.156 . . . . 0.0 111.282 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.78 -62.17 2.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.224 1.41 . . . . 0.0 109.004 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -26.68 66.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -169.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -54.58 -28.38 45.71 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.896 0.878 . . . . 0.0 112.643 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.8 m -136.07 23.37 3.28 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.964 0.905 . . . . 0.0 111.52 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.36 8.68 1.6 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.11 7.92 1.49 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.513 1.052 . . . . 0.0 113.282 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.2 m 72.63 -34.71 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.063 2.545 . . . . 0.0 113.298 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -66.53 -6.64 15.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.081 1.353 . . . . 0.0 111.784 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.25 3.42 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.025 2.13 . . . . 0.0 111.273 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.583 -0.723 . . . . 0.0 109.156 172.76 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -66.65 -25.9 66.8 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.405 1.082 . . . . 0.0 112.249 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.95 -171.69 40.79 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ttt -60.74 -39.79 89.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.448 0.624 . . . . 0.0 110.604 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p 53.09 18.27 1.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.565 1.946 . . . . 0.0 114.517 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -148.82 36.34 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.67 1.588 . . . . 0.0 109.147 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.83 129.36 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 108.612 -174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -61.2 -41.9 97.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.397 0.679 . . . . 0.0 110.009 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -80.49 72.07 7.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -139.07 69.3 1.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 171.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.46 -12.73 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.705 1.602 . . . . 0.0 112.45 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.26 26.07 1.67 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.966 1.706 . . . . 0.0 109.166 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -122.74 135.56 25.85 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.581 1.552 . . . . 0.0 108.865 -169.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.57 -20.05 20.92 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.545 2.163 . . . . 0.0 113.116 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m 56.66 178.11 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.559 1.544 . . . . 0.0 113.775 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.34 120.22 21.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.47 168.02 20.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.997 2.119 . . . . 0.0 110.291 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -121.54 147.39 45.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.85 137.28 31.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 109.416 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.4 tp -77.75 136.58 38.17 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 167.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.252 1.6 m -124.92 148.54 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 119.657 1.117 . . . . 0.0 109.078 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -140.64 150.17 43.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.677 1.191 . . . . 0.0 109.665 -172.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.3 m -91.09 146.71 23.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp -134.69 90.23 2.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.6 -71.53 0.37 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.815 1.674 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.56 28.85 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.504 1.522 . . . . 0.0 111.047 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.45 161.49 36.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.779 1.632 . . . . 0.0 107.939 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -122.99 151.07 42.19 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.516 1.15 . . . . 0.0 109.76 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -142.15 158.57 43.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.961 2.105 . . . . 0.0 107.437 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.87 161.27 24.52 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.43 1.014 . . . . 0.0 111.237 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.41 135.14 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -48.42 116.7 1.67 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 109.302 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.96 -33.34 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.332 0.653 . . . . 0.0 111.441 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.95 -22.94 67.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.591 0.756 . . . . 0.0 112.588 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -82.62 -19.93 37.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.99 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.65 142.15 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 119.194 0.907 . . . . 0.0 108.771 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.79 -53.92 2.66 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.401 1.081 . . . . 0.0 108.567 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.91 -176.5 4.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.569 1.147 . . . . 0.0 109.821 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.7 149.15 31.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -151.85 -157.9 0.85 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.379 1.872 . . . . 0.0 107.786 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.53 151.58 18.95 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 120.116 1.326 . . . . 0.0 112.691 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -77.02 91.23 3.62 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.122 1.369 . . . . 0.0 107.468 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -149.03 -18.11 0.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 51.91 1.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.094 0.861 . . . . 0.0 111.005 -169.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.45 152.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 O-C-N 120.674 -1.266 . . . . 0.0 110.463 169.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -133.56 131.03 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -128.26 133.74 48.85 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -168.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 mm -79.38 159.93 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.52 63.08 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.84 28.32 0.37 Allowed 'General case' 0 C--N 1.341 0.226 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -169.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.53 154.65 78.83 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.309 169.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -63.13 136.21 54.95 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.096 1.864 . . . . 0.0 107.671 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.83 -28.15 47.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -52.57 -46.08 66.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.663 0.665 . . . . 0.0 110.282 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.4 94.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -51.32 -47.44 62.64 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.96 -129.16 1.52 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 165.99 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.802 1.241 . . . . 0.0 107.866 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.5 t -145.54 173.33 12.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 p-10 -82.89 160.95 22.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 120.796 -1.19 . . . . 0.0 111.608 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -121.89 168.97 11.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 167.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.36 58.43 0.26 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.641 1.576 . . . . 0.0 111.942 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.72 -13.95 1.18 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 127.111 2.291 . . . . 0.0 113.563 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.63 -161.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.762 1.781 . . . . 0.0 109.036 -169.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.483 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.2 tp -119.28 158.77 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.924 1.689 . . . . 0.0 108.928 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.59 137.81 12.54 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 109.617 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.62 144.14 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.953 1.769 . . . . 0.0 109.469 169.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.3 136.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.39 150.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -123.83 128.76 49.98 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.76 -15.63 63.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.431 -0.319 . . . . 0.0 110.942 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -58.54 -21.35 52.19 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.879 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mt -127.91 23.16 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.351 2.26 . . . . 0.0 108.534 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -139.36 -27.88 0.79 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.724 -1.235 . . . . 0.0 112.352 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.24 15.57 4.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.962 0.905 . . . . 0.0 111.229 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m 51.16 47.45 24.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.738 1.615 . . . . 0.0 111.476 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -53.74 166.7 0.3 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.727 1.211 . . . . 0.0 111.4 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -60.99 169.66 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.81 0.844 . . . . 0.0 109.609 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.53 71.38 0.95 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 128.73 2.812 . . . . 0.0 110.691 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.5 m -38.81 153.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 128.627 2.771 . . . . 0.0 114.09 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.52 161.49 42.18 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.308 1.443 . . . . 0.0 108.518 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -72.11 49.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.869 1.668 . . . . 0.0 111.212 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.23 -19.67 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.808 2.843 . . . . 0.0 110.152 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.82 -15.31 3.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.779 1.232 . . . . 0.0 112.324 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -145.4 47.75 1.28 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.804 1.241 . . . . 0.0 108.322 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.3 p -78.15 -4.81 49.39 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.358 2.663 . . . . 0.0 117.644 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.11 153.85 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 121.463 1.938 . . . . 0.0 109.091 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.22 122.23 62.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.086 1.754 . . . . 0.0 107.233 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.4 mt -93.57 140.6 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.0 133.71 60.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.77 165.74 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.047 1.739 . . . . 0.0 108.953 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.13 153.39 51.85 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.295 1.038 . . . . 0.0 110.007 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -133.79 85.6 2.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.88 -67.7 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.781 1.658 . . . . 0.0 113.72 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -136.15 3.19 2.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.863 1.665 . . . . 0.0 112.338 -171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.71 169.25 16.45 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 110.066 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.871 1.269 . . . . 0.0 108.992 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.41 ' HB ' HD22 ' A' ' 151' ' ' LEU . 13.1 p -157.49 171.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.447 1.499 . . . . 0.0 107.194 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.07 171.59 32.06 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -138.46 143.7 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.877 0.871 . . . . 0.0 108.79 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.83 134.44 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 108.943 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.36 170.5 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 125.581 1.552 . . . . 0.0 109.914 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.41 -41.87 72.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.53 158.83 10.99 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.74 130.73 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.17 -42.64 7.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.266 1.026 . . . . 0.0 111.358 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -168.18 -175.57 2.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 109.877 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.04 127.27 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 169.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -137.36 165.31 26.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.429 1.092 . . . . 0.0 109.524 -169.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 m -124.41 130.56 52.7 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.33 162.52 33.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.927 . . . . 0.0 108.962 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -138.15 159.93 40.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.908 1.283 . . . . 0.0 108.538 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.18 -23.4 8.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.18 -34.43 74.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.04 -1.038 . . . . 0.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -85.29 -38.68 18.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.177 1.391 . . . . 0.0 110.554 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.54 102.67 13.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 36.6 mtm105 -140.15 -56.93 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.948 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.8 Cg_endo -65.53 168.68 14.17 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.712 1.608 . . . . 0.0 111.354 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.03 154.71 29.27 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.31 1.444 . . . . 0.0 108.957 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.26 146.57 71.31 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.739 2.293 . . . . 0.0 110.91 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.06 18.99 0.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.577 1.151 . . . . 0.0 110.757 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -73.65 170.29 15.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 111.121 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.97 65.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.701 1.6 . . . . 0.0 110.584 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.47 175.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.455 1.502 . . . . 0.0 109.66 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.92 11.53 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.413 1.885 . . . . 0.0 114.942 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.7 158.04 18.92 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.285 1.434 . . . . 0.0 110.227 -173.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -142.42 148.08 37.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 110.969 -171.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -55.77 -29.45 59.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.144 1.777 . . . . 0.0 114.406 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.68 -22.58 65.28 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.71 25.66 1.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.542 1.064 . . . . 0.0 112.517 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.62 18.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 145' ' ' VAL . 18.7 p 64.86 -170.99 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.429 1.492 . . . . 0.0 112.151 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.65 28.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 106.584 -2.606 . . . . 0.0 106.584 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.66 153.74 39.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.465 1.633 . . . . 0.0 109.491 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.97 173.2 35.22 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.11 157.8 16.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.266 1.026 . . . . 0.0 111.202 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.07 72.48 1.38 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.187 1.795 . . . . 0.0 107.143 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.8 -46.36 2.03 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.385 1.945 . . . . 0.0 113.724 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -36.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.19 2.196 . . . . 0.0 110.403 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -73.55 166.09 23.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.655 0.741 . . . . 0.0 110.031 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.5 mtp -141.03 148.4 40.19 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.4 153.94 36.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.689 0.796 . . . . 0.0 110.459 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 79.5 mt -104.89 109.97 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.349 1.459 . . . . 0.0 107.178 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.31 108.13 15.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.035 1.334 . . . . 0.0 107.736 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.8 t -62.3 131.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.547 1.139 . . . . 0.0 108.138 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -78.74 60.54 2.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.61 0.719 . . . . 0.0 109.643 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 tp -54.42 -39.01 42.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 C-N-CA 124.764 1.226 . . . . 0.0 111.147 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.45 -13.16 60.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.747 0.703 . . . . 0.0 112.568 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -111.81 -7.72 14.18 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.872 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.42 -77.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.641 1.11 . . . . 0.0 110.742 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 98' ' ' VAL . 54.2 tp -67.49 -20.1 65.41 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.33 -0.856 . . . . 0.0 110.443 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.49 -37.43 75.52 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.097 -1.002 . . . . 0.0 110.664 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 m -85.82 -30.14 23.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.695 0.798 . . . . 0.0 111.242 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -90.96 -9.44 46.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.938 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -49.31 -47.96 46.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.763 1.619 . . . . 0.0 111.792 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -63.42 -44.7 93.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.717 0.407 . . . . 0.0 109.956 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.49 82.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.325 0.65 . . . . 0.0 111.368 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.24 -58.62 7.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.718 1.207 . . . . 0.0 109.321 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.86 62.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.432 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.58 -20.88 5.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 112.917 174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 26.7 m -123.05 -46.54 2.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -84.64 -2.26 57.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.62 82.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 110.672 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.2 p 173.22 -22.78 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.397 1.879 . . . . 0.0 111.428 -169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.98 -34.5 76.27 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.06 0.944 . . . . 0.0 111.497 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.27 -45.31 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.104 0.962 . . . . 0.0 110.609 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.754 174.853 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttm . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.5 p -75.45 148.18 39.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.55 -157.99 27.4 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.1 mtt -59.22 -17.66 29.92 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.517 0.658 . . . . 0.0 111.953 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -60.69 -12.28 9.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.348 2.259 . . . . 0.0 113.669 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -62.27 0.91 0.38 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.907 1.683 . . . . 0.0 115.0 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.4 t -53.25 -30.14 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.561 -1.337 . . . . 0.0 111.231 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -58.98 -23.17 61.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.839 1.256 . . . . 0.0 113.46 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -138.53 33.86 2.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.258 1.423 . . . . 0.0 108.889 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -3.62 0.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.47 170.1 16.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.701 2.8 . . . . 0.0 104.258 -169.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 52.63 40.77 30.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.372 0.606 . . . . 0.0 109.594 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.09 150.18 75.34 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.712 1.605 . . . . 0.0 107.86 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.53 172.33 16.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.38 2.053 . . . . 0.0 111.536 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.9 m -53.04 143.55 17.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.833 1.653 . . . . 0.0 111.906 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.46 97.2 1.93 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 125.979 1.752 . . . . 0.0 108.862 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -69.89 163.84 25.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.081 0.553 . . . . 0.0 109.609 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -124.91 143.28 50.94 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.539 1.536 . . . . 0.0 107.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -142.3 136.79 30.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.648 0.779 . . . . 0.0 110.501 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.6 tp -77.88 135.97 37.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 167.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.28 152.88 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.736 1.153 . . . . 0.0 109.57 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -140.38 151.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 109.56 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -93.38 146.53 23.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -156.0 134.95 11.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 169.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -98.52 0.53 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.31 36.71 0.67 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.348 1.459 . . . . 0.0 108.776 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.02 161.0 39.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.156 1.782 . . . . 0.0 107.852 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -120.1 156.4 31.09 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.117 1.437 . . . . 0.0 110.457 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -138.11 147.73 44.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.943 2.097 . . . . 0.0 106.457 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.48 156.64 15.97 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.49 134.9 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -49.52 115.5 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.034 0.934 . . . . 0.0 109.111 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.54 -33.1 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.702 . . . . 0.0 111.712 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.84 -24.8 67.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.687 0.795 . . . . 0.0 112.606 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -83.16 -17.73 41.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.682 0.674 . . . . 0.0 111.763 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.8 145.25 13.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.632 1.106 . . . . 0.0 109.087 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -123.05 -47.16 2.05 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.073 0.949 . . . . 0.0 111.346 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -162.84 172.41 15.2 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.609 0.764 . . . . 0.0 109.487 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.25 144.54 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 106.595 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -148.05 176.53 10.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.619 1.567 . . . . 0.0 108.04 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.33 168.92 44.97 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -83.49 -164.42 0.9 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 110.032 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 60.3 38.33 19.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.275 1.83 . . . . 0.0 112.859 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -141.14 26.76 1.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.635 1.574 . . . . 0.0 109.767 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 102.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 120.97 -1.082 . . . . 0.0 108.424 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -61.95 -44.51 96.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.518 . . . . 0.0 110.46 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' VAL . 6.7 mtm105 56.53 -176.52 0.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.828 2.051 . . . . 0.0 112.515 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mm -133.55 160.23 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.88 -23.12 67.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.74 27.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 148.26 57.71 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 122.765 0.426 . . . . 0.0 110.947 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.31 152.68 66.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.21 2.607 . . . . 0.0 110.041 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.33 73.81 0.98 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.599 1.19 . . . . 0.0 110.528 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -162.72 -52.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 130.12 3.368 . . . . 0.0 103.696 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.3 mt -75.42 92.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -51.01 -41.4 59.77 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.912 0.885 . . . . 0.0 108.9 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.85 -156.04 19.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 47' ' ' ARG . 25.6 m -124.1 151.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -136.34 148.26 47.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -80.62 92.34 5.95 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.404 1.081 . . . . 0.0 109.895 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.58 171.65 4.88 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -67.14 63.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.182 1.793 . . . . 0.0 113.155 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.21 -8.63 3.8 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.968 2.223 . . . . 0.0 113.507 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -152.83 -165.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 119.104 1.452 . . . . 0.0 108.342 -169.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.469 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.4 tp -121.62 157.88 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.546 1.938 . . . . 0.0 107.709 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.72 138.79 12.71 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.896 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.38 145.29 64.84 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.181 1.92 . . . . 0.0 110.049 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -129.05 138.31 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.82 164.34 11.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -132.14 126.98 34.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.0 -21.99 64.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.122 1.369 . . . . 0.0 111.665 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -37.67 80.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.274 1.397 . . . . 0.0 110.101 169.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.85 -57.0 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -66.64 -28.78 68.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.861 0.864 . . . . 0.0 113.199 -169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -135.11 5.93 3.32 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.3 m 53.14 41.87 32.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.183 0.901 . . . . 0.0 111.687 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -52.6 146.3 10.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.1 t -44.92 -61.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 112.742 -169.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -175.21 86.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.79 1.636 . . . . 0.0 108.657 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.7 144.1 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.84 163.92 31.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 109.493 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.55 42.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.722 2.409 . . . . 0.0 112.889 172.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.05 -12.87 0.16 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.161 2.184 . . . . 0.0 111.318 170.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.71 -5.94 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.335 1.454 . . . . 0.0 111.735 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.41 44.24 1.52 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.452 -1.405 . . . . 0.0 108.762 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 p -99.38 -2.97 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.344 1.858 . . . . 0.0 114.297 -169.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.6 t -128.06 154.79 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.16 130.68 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.129 1.771 . . . . 0.0 106.341 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.2 mt -102.7 138.22 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.17 133.76 54.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.3 mt -133.53 163.69 28.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.607 1.563 . . . . 0.0 107.922 -170.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.84 146.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.853 1.261 . . . . 0.0 107.674 171.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.7 157.34 43.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.52 -112.44 2.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.82 27.04 5.79 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.511 1.524 . . . . 0.0 110.383 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -141.14 171.27 14.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.401 1.081 . . . . 0.0 110.835 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.76 154.27 38.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.229 1.011 . . . . 0.0 110.704 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.6 p -161.28 176.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.324 1.85 . . . . 0.0 106.878 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.24 -179.87 37.98 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 120.548 -1.345 . . . . 0.0 111.785 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 pt -142.46 155.97 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.519 1.528 . . . . 0.0 108.579 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.2 143.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.55 171.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.411 1.884 . . . . 0.0 110.086 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.59 -42.51 42.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.776 0.716 . . . . 0.0 109.973 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.63 153.42 9.69 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 173.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.57 123.99 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.9 -52.86 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.313 0.645 . . . . 0.0 110.373 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -173.23 -177.17 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.941 1.697 . . . . 0.0 108.093 -169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -117.26 132.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.8 mt -135.09 174.42 10.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.762 1.625 . . . . 0.0 108.665 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -132.4 141.72 48.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.213 0.605 . . . . 0.0 109.587 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.7 134.97 27.52 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 51.8 p -76.77 163.76 26.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.321 0.581 . . . . 0.0 110.712 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.99 10.01 0.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.377 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.99 -40.46 5.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.418 2.287 . . . . 0.0 108.851 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -61.13 -47.43 86.31 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.1 mt -67.21 119.6 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -151.3 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.15 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -177.58 2.66 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.247 1.964 . . . . 0.0 111.257 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.36 153.64 29.56 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.377 1.471 . . . . 0.0 108.707 169.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.14 51.05 3.52 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.603 3.535 . . . . 0.0 110.65 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 7.7 1.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.634 1.573 . . . . 0.0 114.847 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -146.1 160.07 42.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.3 32.95 14.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.738 2.015 . . . . 0.0 114.367 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.21 166.13 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.599 1.56 . . . . 0.0 108.697 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -5.36 34.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 113.747 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.22 156.8 11.69 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.989 1.716 . . . . 0.0 111.632 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 m -133.45 151.14 51.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.362 0.665 . . . . 0.0 112.103 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -57.32 -23.95 52.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.399 1.88 . . . . 0.0 114.49 -169.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -66.25 -32.22 73.51 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.817 0.735 . . . . 0.0 111.414 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.25 29.41 1.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.772 0.829 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 145' ' ' VAL . 21.4 p 62.31 -163.35 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.238 1.415 . . . . 0.0 111.434 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -149.18 177.94 27.05 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 171.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -139.89 142.28 36.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.57 172.94 31.69 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.7 157.16 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.24 0.543 . . . . 0.0 111.83 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.53 68.01 1.38 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.539 2.336 . . . . 0.0 106.699 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.04 -48.18 2.7 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.471 1.986 . . . . 0.0 113.584 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -145.89 -32.2 0.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.429 1.892 . . . . 0.0 110.933 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -70.23 151.35 45.45 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.3 mtp -139.22 143.34 38.01 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.92 120.19 22.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.54 114.34 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.82 99.54 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 132' ' ' THR . 64.1 t -59.91 122.52 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 108.24 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -80.25 60.59 3.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.502 0.667 . . . . 0.0 110.371 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.69 -37.17 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.068 1.347 . . . . 0.0 111.578 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.37 -27.93 69.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.276 0.489 . . . . 0.0 111.554 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -97.01 -28.28 14.23 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 116.772 -1.585 . . . . 0.0 112.218 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -47.35 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.461 1.504 . . . . 0.0 112.451 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.65 -35.01 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -58.58 -34.11 70.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 112.535 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 m -99.4 -14.3 19.21 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.357 1.063 . . . . 0.0 111.473 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.7 -2.69 56.91 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.143 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -52.84 -42.98 65.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.208 1.367 . . . . 0.0 112.051 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -66.8 -24.08 66.13 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.202 1.401 . . . . 0.0 112.368 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.68 -31.21 13.92 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.415 1.486 . . . . 0.0 111.002 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.81 -62.81 1.59 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.738 1.215 . . . . 0.0 109.167 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -67.84 -29.73 68.95 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.891 -169.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.07 -25.19 29.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.085 0.954 . . . . 0.0 112.81 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.5 m -133.18 15.18 4.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.418 1.087 . . . . 0.0 112.254 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.45 12.99 0.83 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.28 6.91 1.48 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.431 1.014 . . . . 0.0 112.967 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 72.53 -34.23 0.29 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.135 2.574 . . . . 0.0 113.398 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.65 -7.22 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.877 1.271 . . . . 0.0 111.895 169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -121.51 2.47 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.676 1.99 . . . . 0.0 111.478 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.81 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m -60.15 -36.34 77.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.35 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.59 -177.66 46.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -150.25 156.41 41.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.578 1.151 . . . . 0.0 108.803 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -76.87 -0.41 24.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.274 1.029 . . . . 0.0 112.558 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -55.22 -25.3 32.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.531 1.132 . . . . 0.0 113.866 -171.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.14 -16.14 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.217 1.407 . . . . 0.0 113.478 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.3 m -59.97 -19.95 54.94 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.618 1.567 . . . . 0.0 112.507 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.08 148.29 6.38 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.368 0.986 . . . . 0.0 111.531 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.32 -43.26 99.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.47 0.308 . . . . 0.0 110.572 -172.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.94 -58.86 0.06 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 m -164.25 124.79 2.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' HB2' HG21 ' A' ' 112' ' ' THR . 71.6 mm-40 -145.4 164.26 27.41 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.708 1.603 . . . . 0.0 107.506 -169.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.29 152.65 78.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.289 1.993 . . . . 0.0 111.154 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m 44.89 38.97 3.23 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.604 1.561 . . . . 0.0 114.25 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 112' ' ' THR . . . -57.83 119.72 18.06 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 170.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -145.59 155.74 43.24 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.469 1.908 . . . . 0.0 109.266 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -103.29 147.45 27.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 144' ' ' LEU . 96.8 m-85 -141.88 135.45 29.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.451 1.1 . . . . 0.0 109.154 -169.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.43 132.74 37.43 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 167.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.93 149.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 119.719 1.145 . . . . 0.0 108.764 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.46 148.3 37.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.917 0.887 . . . . 0.0 110.039 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 m -89.4 146.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 102' ' ' VAL . 44.4 tp -150.41 133.29 15.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.61 -93.16 0.04 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.73 37.25 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.51 163.81 34.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.746 1.218 . . . . 0.0 108.755 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.29 151.13 36.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 123.026 1.393 . . . . 0.0 110.753 173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -138.5 158.02 45.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.457 2.303 . . . . 0.0 107.139 -171.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.82 158.81 23.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.107 0.86 . . . . 0.0 111.007 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -48.79 118.23 2.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.09 0.956 . . . . 0.0 108.696 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.42 -33.49 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.123 0.569 . . . . 0.0 111.754 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.91 -23.62 67.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.532 0.733 . . . . 0.0 112.701 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -80.97 -21.27 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.756 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.79 141.89 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.309 0.958 . . . . 0.0 108.452 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -118.07 -46.61 2.61 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.554 1.142 . . . . 0.0 110.278 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -162.47 172.09 16.07 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.622 1.169 . . . . 0.0 108.66 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -135.46 141.21 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -145.15 177.51 8.74 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.312 1.445 . . . . 0.0 107.672 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.28 162.45 18.99 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -56.61 136.79 54.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -153.96 -52.21 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.0 58.7 0.79 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.307 0.643 . . . . 0.0 110.773 -169.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.25 110.69 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.4 m -62.82 -38.03 89.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.29 1.436 . . . . 0.0 110.545 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 30.57 19.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.496 1.518 . . . . 0.0 112.599 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.0 mm 43.08 -95.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 127.675 2.39 . . . . 0.0 110.096 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.15 -44.3 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.912 1.285 . . . . 0.0 109.562 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.06 32.41 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.422 0.689 . . . . 0.0 112.13 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.88 143.56 60.63 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.702 1.201 . . . . 0.0 110.516 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.43 159.36 50.76 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 111.084 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.77 65.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.041 0.936 . . . . 0.0 112.1 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -71.63 4.07 3.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.26 -36.74 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.685 1.194 . . . . 0.0 110.737 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.251 63.2 mttt 50.9 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.566 2.346 . . . . 0.0 110.338 -167.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.77 -176.16 40.62 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 121.88 2.127 . . . . 0.0 113.102 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.11 156.51 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 122.071 -0.664 . . . . 0.0 110.625 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 t -134.47 160.49 37.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.913 1.285 . . . . 0.0 108.716 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -77.99 142.11 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.45 174.88 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.21 1.404 . . . . 0.0 108.159 168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 -35.78 -30.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.43 21.53 0.28 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.129 0.877 . . . . 0.0 113.183 169.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -152.45 -165.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.0 1.32 . . . . 0.0 108.108 -170.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.1 tp -130.79 157.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.716 1.606 . . . . 0.0 108.979 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.26 139.62 13.01 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.53 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 131.29 27.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.36 2.04 . . . . 0.0 109.429 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.63 128.46 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.57 165.07 20.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -121.37 128.88 52.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.702 0.801 . . . . 0.0 109.522 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.93 -10.38 58.37 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.58 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.02 -21.41 61.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.078 1.308 . . . . 0.0 110.06 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.84 18.29 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 126.036 1.734 . . . . 0.0 108.788 -171.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.52 -32.41 0.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 117.936 -1.03 . . . . 0.0 112.047 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -132.21 5.38 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.534 1.061 . . . . 0.0 112.428 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 m 51.52 36.25 16.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.37 1.468 . . . . 0.0 111.468 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -59.28 147.94 33.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -22.36 -61.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.041 3.337 . . . . 0.0 115.419 -169.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -157.39 27.58 0.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.766 0.826 . . . . 0.0 111.702 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 24' ' ' LEU . 8.5 p -68.7 140.87 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.111 -0.993 . . . . 0.0 109.886 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -171.62 178.07 3.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.014 2.925 . . . . 0.0 104.943 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HA ' HG21 ' A' ' 86' ' ' THR . 16.0 m-30 -65.7 60.58 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.716 2.406 . . . . 0.0 110.821 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -160.38 -30.43 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.558 2.743 . . . . 0.0 109.904 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 86' ' ' THR . 25.7 t0 -78.7 40.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.602 1.161 . . . . 0.0 111.855 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.99 -15.85 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.913 3.685 . . . . 0.0 114.997 -173.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 82' ' ' TYR 0.282 14.8 p 31.19 72.36 0.07 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.122 3.369 . . . . 0.0 117.307 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.1 155.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.7 119.65 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.368 -1.457 . . . . 0.0 107.772 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.65 139.38 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.33 134.76 52.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.6 mt -132.54 163.44 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 108.381 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 155.36 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.402 1.081 . . . . 0.0 108.959 173.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mp -131.22 -179.9 5.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -20.83 -61.84 0.02 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.694 2.568 . . . . 0.0 116.18 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -137.51 24.4 2.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.031 0.933 . . . . 0.0 111.923 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -150.67 165.37 33.61 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.772 -1.205 . . . . 0.0 111.262 -169.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.69 151.42 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.533 1.133 . . . . 0.0 109.214 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.32 166.86 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.997 1.319 . . . . 0.0 107.912 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.57 176.58 34.66 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.148 -0.97 . . . . 0.0 112.044 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.9 pt -146.03 152.11 14.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.66 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -82.95 144.45 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.628 1.171 . . . . 0.0 110.052 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.582 ' HA ' HD13 ' A' ' 24' ' ' LEU . 17.1 m -144.5 164.59 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.716 1.606 . . . . 0.0 109.119 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.81 -42.28 58.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.349 -0.844 . . . . 0.0 108.825 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.33 156.05 11.95 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.81 126.3 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -76.8 -55.53 5.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -176.61 176.99 1.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.644 1.978 . . . . 0.0 107.58 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -100.08 139.24 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.6 mt -140.12 172.13 13.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.551 . . . . 0.0 107.573 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.8 m -130.77 143.61 50.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.764 0.711 . . . . 0.0 110.344 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.17 171.09 14.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.025 1.33 . . . . 0.0 109.409 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 13' ' ' GLU . 33.3 p -134.66 160.49 37.96 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.806 1.643 . . . . 0.0 108.467 -176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.33 1.93 3.4 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.42 -45.75 12.4 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.507 1.523 . . . . 0.0 107.721 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -67.44 -41.75 84.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.207 1.003 . . . . 0.0 109.928 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -82.42 112.52 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -142.45 -57.62 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.619 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.52 175.67 4.92 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.14 1.893 . . . . 0.0 111.683 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.44 156.94 33.77 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.614 1.565 . . . . 0.0 108.471 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.55 50.95 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.904 3.069 . . . . 0.0 111.071 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.56 26.26 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.585 1.954 . . . . 0.0 113.37 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -68.73 175.88 3.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.651 1.98 . . . . 0.0 111.381 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 67.85 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.631 1.572 . . . . 0.0 110.753 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.48 -179.21 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.898 1.679 . . . . 0.0 109.245 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -6.96 11.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -69.89 155.54 40.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.023 0.929 . . . . 0.0 110.635 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.4 m -139.29 157.73 45.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.843 1.257 . . . . 0.0 109.131 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 p -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.987 1.315 . . . . 0.0 113.131 -171.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.32 -36.37 83.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 111.103 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -129.13 33.05 4.63 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.576 1.55 . . . . 0.0 108.801 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 127.51 32.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 146' ' ' ASN . 81.8 p -74.92 -171.92 1.47 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.828 1.651 . . . . 0.0 110.134 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.07 172.86 22.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.319 -2.313 . . . . 0.0 107.319 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.33 151.67 37.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.101 1.451 . . . . 0.0 109.539 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.02 177.72 27.06 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.27 0.938 . . . . 0.0 111.163 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.82 159.08 36.86 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.41 0.684 . . . . 0.0 111.903 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.77 59.8 1.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.624 2.369 . . . . 0.0 107.241 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.57 -45.25 2.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.345 1.926 . . . . 0.0 113.93 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -140.17 -38.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.491 2.316 . . . . 0.0 109.678 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -73.76 153.2 40.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 89.1 mtp -141.72 140.52 33.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -133.43 137.54 45.8 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.82 110.48 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD12 ' CD2' ' A' ' 19' ' ' PHE . 2.7 mm? -84.79 112.37 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.85 136.16 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.438 ' H ' HG22 ' A' ' 132' ' ' THR . 45.1 t-20 -78.85 61.96 3.21 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 109.822 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 tp -54.81 -38.38 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.997 1.319 . . . . 0.0 111.126 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.0 -15.6 59.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -111.12 -9.35 14.37 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.333 -1.318 . . . . 0.0 111.556 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.74 -80.8 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.136 -169.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.76 -30.81 70.37 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.029 -1.044 . . . . 0.0 109.442 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.4 -21.86 62.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.3 m -115.17 -12.19 11.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.804 0.842 . . . . 0.0 112.078 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.42 -15.32 19.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.512 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.51 -40.49 78.8 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.891 1.678 . . . . 0.0 111.953 -169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.0 ptp -63.23 -31.82 73.07 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.42 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.53 25.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.75 1.22 . . . . 0.0 111.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.79 -55.64 9.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.69 -28.36 68.57 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.068 -0.395 . . . . 0.0 111.731 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.63 -28.71 9.35 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.649 1.179 . . . . 0.0 112.807 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.9 m -134.12 19.62 3.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.661 1.185 . . . . 0.0 111.812 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.61 15.53 1.11 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.006 0.922 . . . . 0.0 112.579 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.32 12.73 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.353 1.061 . . . . 0.0 111.84 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 15.2 m 62.31 17.81 9.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.392 1.877 . . . . 0.0 112.649 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.24 -40.92 58.55 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.599 -0.688 . . . . 0.0 109.808 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.9 -28.34 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.704 0.801 . . . . 0.0 111.156 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.819 -179.711 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 121.015 0.436 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -60.39 177.61 0.26 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.876 1.671 . . . . 0.0 111.912 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.1 15.95 1.24 Allowed Glycine 0 CA--C 1.54 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 113.484 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 ptm -153.09 160.45 42.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.054 2.542 . . . . 0.0 106.51 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -74.97 72.12 2.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.168 1.387 . . . . 0.0 110.723 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -76.48 60.64 1.63 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.36 121.33 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 130.22 43.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.53 0.732 . . . . 0.0 110.199 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -159.58 128.98 5.32 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.316 1.047 . . . . 0.0 108.282 169.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.72 99.68 4.4 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.46 -11.45 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.447 1.099 . . . . 0.0 111.994 171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -154.77 41.7 0.46 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.559 1.544 . . . . 0.0 108.546 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.48 148.71 44.65 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.2 1.4 . . . . 0.0 109.625 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.79 1.15 8.42 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.03 3.154 . . . . 0.0 113.474 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m 54.0 53.05 11.75 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.502 1.521 . . . . 0.0 113.645 173.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.66 75.23 1.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.309 0.481 . . . . 0.0 114.282 169.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -68.87 161.74 28.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 168.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.4 142.6 49.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -141.64 134.55 28.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 109.564 -169.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.19 133.22 35.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 151.34 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 119.531 1.06 . . . . 0.0 109.15 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.99 153.23 46.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.77 1.228 . . . . 0.0 109.407 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -96.65 146.46 24.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 tp -149.61 132.71 16.28 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.79 -104.74 0.69 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.23 37.39 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.664 1.585 . . . . 0.0 108.912 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.24 159.95 41.06 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.825 2.05 . . . . 0.0 107.594 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.82 160.85 20.69 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 110.281 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -142.68 152.57 42.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.932 2.093 . . . . 0.0 106.809 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.23 154.85 21.39 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mt -139.5 134.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.18 117.17 2.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 109.157 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -54.42 -35.56 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.895 0.878 . . . . 0.0 111.558 -170.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.93 -24.98 68.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.717 0.807 . . . . 0.0 112.508 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -80.65 -23.53 39.6 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.483 0.583 . . . . 0.0 111.464 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.71 132.96 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -90.09 -59.07 2.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.33 -179.42 7.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.435 1.094 . . . . 0.0 109.825 -172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.61 143.13 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -147.78 173.88 12.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.403 1.081 . . . . 0.0 108.483 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.64 157.8 33.09 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -77.26 106.71 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 108.654 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -157.76 163.53 38.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.736 1.214 . . . . 0.0 109.569 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.88 34.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.904 2.481 . . . . 0.0 114.484 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.17 143.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.709 0.766 . . . . 0.0 109.396 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -136.03 93.09 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -71.21 118.96 14.66 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -70.02 157.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -23.5 67.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -172.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.89 23.91 0.51 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 156.99 35.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 122.935 0.494 . . . . 0.0 110.906 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -59.18 145.69 96.94 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 N-CA-C 107.995 -1.579 . . . . 0.0 107.995 169.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.67 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.728 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.12 -38.27 67.96 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.994 0.816 . . . . 0.0 110.675 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.5 mt -75.57 90.7 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -58.31 -26.41 63.01 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.02 -158.96 32.09 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.24 153.69 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -134.67 165.15 25.92 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.244 0.929 . . . . 0.0 108.985 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -71.23 99.4 1.9 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.535 1.534 . . . . 0.0 110.857 -173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.25 0.5 OUTLIER -77.9 64.3 3.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 107.677 169.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 45.55 34.35 1.64 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.061 2.944 . . . . 0.0 114.145 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.79 -20.9 4.52 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.982 1.277 . . . . 0.0 112.136 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.66 -163.21 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 172.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 tp -138.27 147.14 25.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 121.156 -0.965 . . . . 0.0 111.979 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.59 135.99 18.48 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.89 147.95 75.56 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.998 1.799 . . . . 0.0 110.157 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.435 HD11 HG13 ' A' ' 88' ' ' VAL . 1.9 tp -126.61 131.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.59 155.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -140.48 143.08 35.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.22 1.009 . . . . 0.0 109.27 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.48 -16.74 62.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.943 1.297 . . . . 0.0 110.566 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -61.81 -20.19 63.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.093 1.315 . . . . 0.0 111.144 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.4 mt -115.89 -48.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.96 -25.36 67.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.811 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -135.0 -6.39 2.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.589 1.086 . . . . 0.0 113.116 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.5 m 55.92 46.02 22.84 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.086 -1.009 . . . . 0.0 111.716 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -47.04 142.88 3.33 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.34 -65.04 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.722 1.609 . . . . 0.0 112.65 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -162.28 79.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.161 0.985 . . . . 0.0 109.697 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.52 144.79 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -164.63 171.56 14.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.683 1.593 . . . . 0.0 107.462 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -70.17 48.32 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.736 2.014 . . . . 0.0 110.921 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.69 -12.91 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.741 3.216 . . . . 0.0 110.737 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.16 -3.26 1.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.428 1.491 . . . . 0.0 111.988 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -146.56 40.05 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.224 1.409 . . . . 0.0 109.095 -169.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 p -96.21 -11.6 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.293 1.837 . . . . 0.0 114.041 -169.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.68 155.67 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 68' ' ' ILE . 77.0 t -130.08 135.7 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.185 1.794 . . . . 0.0 106.231 -174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.61 124.61 65.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.29 134.31 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.7 mt -133.09 162.01 32.87 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.102 1.361 . . . . 0.0 108.822 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.35 153.9 41.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.5 136.55 18.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.6 -94.97 0.08 OUTLIER Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -169.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -139.91 22.33 2.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.054 1.742 . . . . 0.0 110.76 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -134.52 163.31 30.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.113 -0.992 . . . . 0.0 110.106 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.23 152.27 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 110.393 -170.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.94 177.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 126.224 1.809 . . . . 0.0 106.711 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.8 33.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.4 154.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.895 0.878 . . . . 0.0 109.082 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.96 144.61 13.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.83 170.96 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.737 1.615 . . . . 0.0 110.049 -168.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -76.72 -42.93 39.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.971 -0.456 . . . . 0.0 110.353 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.97 153.79 9.16 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.9 129.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 m -77.03 -57.83 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.405 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -176.62 175.33 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 107.796 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.5 140.09 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.28 176.34 8.8 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.994 1.718 . . . . 0.0 108.16 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 m -131.63 139.63 49.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.199 0.6 . . . . 0.0 109.566 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.53 165.72 26.79 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.238 1.415 . . . . 0.0 108.4 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.7 m -137.58 158.8 43.6 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 107.811 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.18 -13.01 2.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.8 -40.71 92.17 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.81 1.186 . . . . 0.0 110.129 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -82.72 -39.08 22.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.533 1.533 . . . . 0.0 109.692 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.77 85.83 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 44.6 mtm180 -140.88 -53.69 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 116.608 -1.663 . . . . 0.0 112.725 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.1 Cg_endo -65.01 175.93 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 121.699 1.643 . . . . 0.0 111.167 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.65 158.23 32.21 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.939 1.296 . . . . 0.0 109.157 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.02 60.7 7.94 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.778 2.986 . . . . 0.0 110.994 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.35 33.52 0.06 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.378 1.871 . . . . 0.0 112.495 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.2 178.3 4.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.52 1.528 . . . . 0.0 110.74 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.55 0.93 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.203 1.401 . . . . 0.0 110.568 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.71 159.16 39.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.799 1.639 . . . . 0.0 109.039 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -58.52 -25.05 61.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.881 0.872 . . . . 0.0 112.2 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.96 -26.92 68.51 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.796 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -76.11 75.46 2.96 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 124.319 2.009 . . . . 0.0 111.292 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 t -155.52 177.57 11.22 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 129.502 3.121 . . . . 0.0 103.776 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.6 -7.55 0.99 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 126.472 1.909 . . . . 0.0 115.963 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -73.21 -5.35 38.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.737 1.153 . . . . 0.0 110.438 168.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -46.59 135.52 8.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.108 2.163 . . . . 0.0 114.459 -169.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 145' ' ' VAL . 52.6 p -77.02 -165.7 0.6 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.878 2.871 . . . . 0.0 110.355 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.23 -179.72 16.84 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.464 1.983 . . . . 0.0 108.544 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mt -133.62 150.64 51.6 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.932 1.693 . . . . 0.0 106.948 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.33 171.85 32.87 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.09 158.06 43.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.089 0.956 . . . . 0.0 110.927 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 mt -144.89 69.37 1.25 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.231 1.812 . . . . 0.0 107.605 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.87 -49.56 2.85 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.337 1.922 . . . . 0.0 113.1 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -145.45 -31.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.379 1.872 . . . . 0.0 110.953 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -69.64 153.13 43.87 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.3 mtp -142.8 146.67 34.44 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.31 147.62 25.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.368 0.667 . . . . 0.0 109.879 -175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -93.02 112.42 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.53 107.77 10.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.529 ' HA ' HG22 ' A' ' 132' ' ' THR . 71.0 t -62.91 122.8 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -79.41 53.79 1.6 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.371 0.668 . . . . 0.0 110.683 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 tp -54.09 -37.39 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.52 1.128 . . . . 0.0 111.123 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -65.49 -6.45 10.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.867 1.267 . . . . 0.0 112.782 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -124.49 -28.9 3.55 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 0.0 111.608 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.2 tp -45.49 -64.5 0.71 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.875 1.67 . . . . 0.0 111.841 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.28 -46.34 56.24 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.95 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -65.09 -21.4 66.8 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.256 0.935 . . . . 0.0 113.064 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.7 m -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.68 1.127 . . . . 0.0 111.506 170.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.87 -15.01 46.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.881 0.872 . . . . 0.0 112.182 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -49.6 -44.64 47.32 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 125.754 1.622 . . . . 0.0 113.555 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -64.1 -40.78 96.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.552 0.614 . . . . 0.0 111.432 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.36 -37.86 65.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.342 0.657 . . . . 0.0 110.545 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.4 tt -59.67 -56.61 19.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.259 1.424 . . . . 0.0 109.742 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -26.24 61.9 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 122.807 0.443 . . . . 0.0 111.384 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -55.67 -18.57 8.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.09 0.556 . . . . 0.0 112.416 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.8 m -131.35 19.39 4.83 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.537 1.535 . . . . 0.0 111.551 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.04 46.97 0.61 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.475 1.51 . . . . 0.0 108.524 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.18 15.78 2.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 112.81 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.4 m 64.34 41.92 5.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 108.776 -169.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -147.73 -78.08 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.489 1.115 . . . . 0.0 108.804 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.83 -34.64 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.297 0.639 . . . . 0.0 110.444 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 129.926 3.29 . . . . 0.0 104.69 169.739 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.771 0.319 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -66.89 165.04 16.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.955 0.902 . . . . 0.0 110.958 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.1 -127.51 0.92 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.3 mmt -59.84 -15.14 18.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.828 0.814 . . . . 0.0 112.393 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -57.02 -25.73 59.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.262 1.425 . . . . 0.0 112.163 169.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.31 71.85 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.311 1.044 . . . . 0.0 108.437 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.18 -8.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.23 153.06 38.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.096 1.316 . . . . 0.0 109.187 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.3 tptt 54.18 35.46 22.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.285 1.434 . . . . 0.0 111.306 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.85 -10.42 59.54 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.713 -0.617 . . . . 0.0 111.712 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.66 -170.82 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.831 2.452 . . . . 0.0 106.142 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -70.23 42.91 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.448 1.899 . . . . 0.0 112.842 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.67 154.25 66.91 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.116 1.366 . . . . 0.0 110.251 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.12 145.28 54.59 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.733 2.288 . . . . 0.0 112.27 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -127.59 31.06 5.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.289 1.036 . . . . 0.0 112.132 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.17 55.72 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.118 0.866 . . . . 0.0 111.03 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.16 160.14 24.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -116.43 144.76 43.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.84 136.79 30.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.624 0.77 . . . . 0.0 110.03 -169.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.8 tp -77.57 134.55 38.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 102.849 -3.019 . . . . 0.0 102.849 167.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.25 149.88 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.655 1.116 . . . . 0.0 108.781 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.92 151.81 44.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.225 1.01 . . . . 0.0 110.15 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -95.49 143.72 26.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -139.38 94.4 2.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.044 1.338 . . . . 0.0 107.517 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.47 -74.52 0.71 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.279 1.419 . . . . 0.0 111.456 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.69 29.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.067 1.347 . . . . 0.0 110.603 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.14 160.87 38.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.31 1.444 . . . . 0.0 108.111 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.18 151.64 45.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.808 1.289 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.9 155.76 47.03 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.634 1.974 . . . . 0.0 107.729 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.57 157.91 22.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -142.61 134.48 25.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -50.07 119.07 3.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.464 0.706 . . . . 0.0 109.378 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -54.8 -34.65 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.871 0.868 . . . . 0.0 111.285 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.65 -22.15 66.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.554 0.742 . . . . 0.0 112.735 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.66 -21.09 32.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.07 0.85 . . . . 0.0 111.688 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.09 140.72 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.84 -42.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.496 1.119 . . . . 0.0 110.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -161.53 171.02 18.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.383 1.073 . . . . 0.0 108.815 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.1 147.59 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -150.17 173.99 13.3 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.56 163.67 26.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -60.27 136.76 58.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.0 -55.14 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.96 84.25 1.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -169.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.14 119.02 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 m -78.64 93.2 4.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -78.1 88.73 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.79 137.46 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.2 -17.93 60.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -137.11 37.92 2.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.68 1.192 . . . . 0.0 111.017 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 53' ' ' ALA . 27.1 p -60.82 166.48 4.53 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 121.804 -0.56 . . . . 0.0 111.897 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.6 20.21 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 123.227 2.618 . . . . 0.0 111.358 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' THR . . . 59.1 -39.91 0.07 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 131.319 3.848 . . . . 0.0 116.938 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -52.97 -44.18 66.95 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 120.326 1.421 . . . . 0.0 108.509 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.99 110.29 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -67.79 -34.91 77.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.58 -153.52 21.19 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -117.71 162.4 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.45 150.41 34.55 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.287 -1.508 . . . . 0.0 110.117 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.05 135.22 46.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.226 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.37 97.44 5.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.512 1.125 . . . . 0.0 109.434 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 57.17 17.28 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 113.334 172.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.41 6.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.002 1.287 . . . . 0.0 113.007 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.34 -172.05 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.93 1.292 . . . . 0.0 108.295 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.15 155.01 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.834 1.253 . . . . 0.0 110.393 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.39 141.97 15.21 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.626 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.08 140.15 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.097 1.865 . . . . 0.0 109.27 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 tp -126.18 135.15 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.18 148.76 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.806 2.042 . . . . 0.0 106.028 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -125.78 128.56 47.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.06 -18.93 65.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.986 0.914 . . . . 0.0 111.346 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -58.88 -25.53 63.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.815 -1.178 . . . . 0.0 110.531 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.36 -30.8 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.516 1.526 . . . . 0.0 110.085 -169.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -92.77 -22.03 19.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.21 0.914 . . . . 0.0 113.004 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -132.83 3.1 3.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.278 0.944 . . . . 0.0 111.807 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 m 51.39 41.7 28.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.86 1.264 . . . . 0.0 111.402 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -57.41 170.96 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.715 0.806 . . . . 0.0 111.175 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 m -58.13 169.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.02 0.914 . . . . 0.0 109.416 168.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.28 62.51 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.468 2.307 . . . . 0.0 111.349 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -45.42 150.93 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.287 2.235 . . . . 0.0 111.759 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -152.11 165.15 35.66 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.249 1.42 . . . . 0.0 108.449 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -74.6 53.18 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 0.0 110.597 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -151.46 -21.96 0.2 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.245 3.418 . . . . 0.0 109.708 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.79 7.52 2.75 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.538 1.535 . . . . 0.0 111.659 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -154.69 40.52 0.45 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.137 2.175 . . . . 0.0 108.567 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 p -88.96 7.14 36.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.586 1.954 . . . . 0.0 115.362 -168.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.49 157.43 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.4 136.19 55.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.67 134.32 48.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.7 mt -133.82 164.22 27.74 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 108.007 -171.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.97 154.09 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.313 0.645 . . . . 0.0 110.113 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mp -136.51 80.81 1.84 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.4 -68.95 2.34 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.676 -0.64 . . . . 0.0 113.214 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -137.01 0.6 2.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.402 1.881 . . . . 0.0 111.833 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.92 165.55 22.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.502 1.121 . . . . 0.0 109.103 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.39 150.45 32.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.019 0.927 . . . . 0.0 109.18 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.91 165.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.02 32.15 Favored Glycine 0 N--CA 1.451 -0.364 0 O-C-N 121.118 -0.989 . . . . 0.0 111.683 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.29 164.56 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 109.847 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 m -111.37 132.13 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.153 1.781 . . . . 0.0 108.183 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.89 164.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.97 1.308 . . . . 0.0 109.611 -168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.3 -41.67 73.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.13 158.94 20.93 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.32 123.12 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -48.3 15.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.921 0.888 . . . . 0.0 109.682 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -173.44 -174.54 1.02 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 108.02 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.73 128.76 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.56 173.22 11.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.217 1.407 . . . . 0.0 108.923 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.3 m -130.92 139.05 50.03 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.3 161.12 38.65 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 m -132.9 157.21 45.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.09 1.756 . . . . 0.0 108.238 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -17.36 24.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.86 -36.33 80.09 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.24 -40.46 19.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.606 1.562 . . . . 0.0 110.434 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.05 103.67 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 91.9 mtt-85 -140.54 -55.84 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 116.936 -1.507 . . . . 0.0 111.423 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.5 Cg_endo -66.48 173.2 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.97 157.51 30.74 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.0 1.72 . . . . 0.0 108.89 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.41 143.66 48.36 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.817 1.678 . . . . 0.0 109.457 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.14 22.75 0.65 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.035 1.334 . . . . 0.0 110.335 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.63 176.85 5.83 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.275 1.43 . . . . 0.0 111.442 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.23 66.48 0.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.739 1.615 . . . . 0.0 110.603 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.45 172.83 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.846 1.658 . . . . 0.0 109.433 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -15.63 61.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.283 1.433 . . . . 0.0 113.724 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.82 144.41 54.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.937 . . . . 0.0 110.206 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.8 m -138.32 162.26 34.82 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.28 1.032 . . . . 0.0 109.791 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -57.45 -27.52 62.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 114.338 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -74.69 -24.09 58.72 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.623 -0.673 . . . . 0.0 111.895 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -127.2 -3.35 6.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.087 0.955 . . . . 0.0 112.73 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.08 161.47 5.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.614 0.643 . . . . 0.0 110.76 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.2 p -113.69 -166.54 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.8 1.64 . . . . 0.0 110.407 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.4 168.69 23.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.6 154.61 39.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.913 1.857 . . . . 0.0 111.0 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.3 173.38 40.27 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.092 0.377 . . . . 0.0 112.853 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.15 157.26 17.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.927 0.891 . . . . 0.0 111.13 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.06 85.06 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.16 -55.0 2.3 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.751 2.119 . . . . 0.0 112.862 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -150.34 -28.12 0.23 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.199 2.199 . . . . 0.0 111.524 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -69.12 163.3 25.12 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.754 0.707 . . . . 0.0 109.529 171.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.99 134.59 47.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.83 134.82 51.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.06 107.11 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.04 109.99 13.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.51 130.55 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.857 1.263 . . . . 0.0 108.434 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -74.87 57.03 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.442 1.897 . . . . 0.0 109.867 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -46.71 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.825 1.65 . . . . 0.0 111.268 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -66.86 -10.0 43.65 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.6 -14.93 16.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.471 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.6 tp -55.5 -78.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.812 1.245 . . . . 0.0 111.325 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.6 tp -77.32 -20.47 54.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.99 0.813 . . . . 0.0 111.257 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.07 -39.96 79.83 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.259 -0.9 . . . . 0.0 111.661 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 -19.92 17.29 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.024 -0.512 . . . . 0.0 112.058 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.98 -10.52 57.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.763 1.165 . . . . 0.0 112.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.73 -44.34 58.23 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 121.303 1.865 . . . . 0.0 112.028 -171.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.9 mtm -65.23 -46.09 82.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.29 0.636 . . . . 0.0 110.311 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.45 74.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.53 0.732 . . . . 0.0 111.787 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.58 -64.17 1.04 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.61 -31.46 72.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -169.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -55.21 -23.1 20.39 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.2 m -137.13 19.82 2.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.96 1.304 . . . . 0.0 111.892 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -152.74 13.03 0.53 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.92 12.21 0.56 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.523 1.129 . . . . 0.0 112.955 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.0 m 74.37 -34.79 0.28 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.134 2.574 . . . . 0.0 113.173 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.51 -11.99 48.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.734 1.213 . . . . 0.0 111.935 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.23 6.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.372 1.869 . . . . 0.0 111.419 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.399 178.174 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.1 m -144.77 146.36 32.1 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.62 -21.07 1.84 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.651 0.643 . . . . 0.0 112.749 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -61.07 162.42 7.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.133 0.973 . . . . 0.0 110.518 170.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -57.28 -17.04 10.09 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.44 1.496 . . . . 0.0 114.318 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -46.74 -33.46 4.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.876 1.271 . . . . 0.0 112.884 171.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -58.28 -19.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -135.24 23.76 3.5 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.2 1.4 . . . . 0.0 109.322 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -152.23 57.89 0.83 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.87 -35.92 75.82 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.526 0.731 . . . . 0.0 109.407 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.74 -66.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.05 1.34 . . . . 0.0 108.544 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -172.73 47.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.649 1.18 . . . . 0.0 110.616 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.08 140.57 31.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.754 1.222 . . . . 0.0 110.73 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.45 168.11 25.2 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.666 2.244 . . . . 0.0 111.753 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -55.33 147.58 16.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.669 1.587 . . . . 0.0 111.825 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.35 94.72 1.43 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.854 1.693 . . . . 0.0 109.151 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -69.67 167.08 17.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 110.143 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.93 146.15 50.73 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.604 1.561 . . . . 0.0 107.417 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -142.15 140.32 32.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.612 0.765 . . . . 0.0 110.289 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.5 tp -80.39 134.45 36.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.36 148.29 27.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 109.123 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.14 153.68 45.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.509 1.124 . . . . 0.0 110.123 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -95.52 149.39 21.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.46 128.41 7.35 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.31 -89.51 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.71 34.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.352 1.461 . . . . 0.0 109.145 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -143.44 158.89 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.829 1.651 . . . . 0.0 107.871 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 155.55 28.05 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 123.251 1.5 . . . . 0.0 110.299 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -142.23 160.97 39.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.913 2.085 . . . . 0.0 107.338 -171.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.8 164.12 26.45 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.784 0.707 . . . . 0.0 111.729 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -144.68 136.15 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -49.26 118.8 2.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.15 0.98 . . . . 0.0 109.343 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.21 -33.83 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.814 0.846 . . . . 0.0 111.566 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.73 -23.39 67.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.434 0.694 . . . . 0.0 112.604 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -81.01 -19.13 44.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.272 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.54 142.24 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.267 1.394 . . . . 0.0 109.162 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -125.57 -39.84 2.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.121 1.369 . . . . 0.0 110.781 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -167.04 171.24 11.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.663 1.585 . . . . 0.0 107.754 175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.19 140.81 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -149.95 176.67 10.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 108.564 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.63 173.89 44.19 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -59.11 -31.06 68.59 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.83 -0.806 . . . . 0.0 112.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.0 t0 34.22 -90.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 129.33 3.052 . . . . 0.0 116.588 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 66.53 1.34 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 113.405 -169.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.57 133.9 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 m -70.88 -42.18 70.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.579 1.152 . . . . 0.0 111.593 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.03 89.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.75 2.02 . . . . 0.0 109.33 -169.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.9 150.87 6.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.77 66.73 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.71 20.85 0.61 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -172.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.71 148.39 47.24 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.41 121.46 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 N-CA-C 105.639 -2.485 . . . . 0.0 105.639 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.84 -33.03 0.69 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -168.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.09 -38.24 37.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.023 0.829 . . . . 0.0 110.976 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.8 mt -93.39 105.2 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.8 -57.45 12.64 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.43 -173.19 36.19 Favored Glycine 0 C--O 1.227 -0.315 0 O-C-N 121.021 -1.049 . . . . 0.0 111.73 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -83.6 153.82 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -138.09 160.66 38.81 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.94 108.36 19.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.522 -0.736 . . . . 0.0 111.556 -172.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.2 72.67 3.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.66 -0.65 . . . . 0.0 110.685 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 49.89 28.78 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.684 1.594 . . . . 0.0 114.422 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.93 -20.61 2.15 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.371 0.986 . . . . 0.0 113.063 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -169.25 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.829 1.252 . . . . 0.0 107.806 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.72 148.63 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.766 -1.209 . . . . 0.0 110.08 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 p -148.87 134.56 9.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.93 138.9 45.7 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.314 2.676 . . . . 0.0 110.685 170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.84 135.32 63.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.386 1.089 . . . . 0.0 109.12 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.87 162.87 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.556 2.342 . . . . 0.0 105.188 169.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -139.79 145.05 37.71 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 120.652 -1.28 . . . . 0.0 109.409 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.11 -21.66 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.647 1.179 . . . . 0.0 112.917 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -70.34 -11.13 60.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.707 1.594 . . . . 0.0 112.213 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.16 20.92 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 0.0 109.034 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -141.55 -23.7 0.72 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.657 1.183 . . . . 0.0 111.449 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -139.39 12.16 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.561 1.144 . . . . 0.0 111.991 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.0 m 54.26 38.95 30.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.488 1.515 . . . . 0.0 112.427 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 156.2 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 78' ' ' VAL . 4.6 t -40.85 -67.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.657 2.383 . . . . 0.0 113.268 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -169.77 97.63 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.832 1.653 . . . . 0.0 109.13 -169.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.28 143.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.176 0.99 . . . . 0.0 109.593 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.25 158.23 35.75 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.109 1.364 . . . . 0.0 108.767 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -69.46 42.48 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.932 2.093 . . . . 0.0 113.143 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.86 -12.02 0.16 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.159 2.183 . . . . 0.0 110.671 169.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -125.51 -5.53 7.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.558 1.543 . . . . 0.0 111.98 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.98 38.83 2.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.271 1.428 . . . . 0.0 108.972 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -102.15 -4.73 25.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.561 . . . . 0.0 114.376 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.34 155.36 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.5 t -133.33 137.14 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.57 124.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.64 140.22 17.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -135.76 162.65 32.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.992 1.717 . . . . 0.0 107.843 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.05 148.86 39.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.178 1.391 . . . . 0.0 108.027 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.44 151.1 29.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.53 -102.54 0.11 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -139.62 34.07 2.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.498 1.519 . . . . 0.0 109.809 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.1 167.76 21.32 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.779 1.632 . . . . 0.0 109.297 -171.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.04 151.19 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 124.157 0.983 . . . . 0.0 109.547 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.67 176.78 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.854 1.661 . . . . 0.0 107.204 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.61 179.48 41.51 Favored Glycine 0 N--CA 1.448 -0.537 0 O-C-N 120.685 -1.259 . . . . 0.0 111.427 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.4 pt -141.65 158.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.587 1.155 . . . . 0.0 109.542 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.09 145.11 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.8 172.4 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.634 1.574 . . . . 0.0 110.606 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.22 -43.51 51.35 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.98 -0.45 . . . . 0.0 109.831 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.46 155.68 10.57 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 129.0 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -41.36 10.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.427 0.691 . . . . 0.0 111.802 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.2 t0 -167.57 -175.67 2.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 110.727 -168.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -135.84 125.28 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.18 166.53 24.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 110.191 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 m -125.37 141.24 52.18 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.201 0.6 . . . . 0.0 110.42 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.1 139.04 30.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.438 1.095 . . . . 0.0 108.398 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 p -82.95 153.31 25.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.18 -16.73 35.46 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.5 -42.04 75.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.003 1.321 . . . . 0.0 110.037 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -58.67 -39.58 81.05 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.749 0.819 . . . . 0.0 109.359 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.1 mt -77.77 0.63 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 126.314 1.846 . . . . 0.0 112.151 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -53.59 -53.57 55.57 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.167 -1.583 . . . . 0.0 114.344 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.39 175.71 9.68 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.346 2.03 . . . . 0.0 112.396 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.5 163.32 24.56 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.244 1.418 . . . . 0.0 109.313 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.4 -50.0 9.35 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.762 2.308 . . . . 0.0 113.018 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 51.24 20.15 0.87 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.912 2.085 . . . . 0.0 114.219 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -73.93 160.09 31.87 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 110.033 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.92 32.51 0.14 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.867 1.667 . . . . 0.0 112.8 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.27 -175.21 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.927 1.291 . . . . 0.0 109.952 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -11.23 21.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.885 1.274 . . . . 0.0 113.92 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.74 156.29 33.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.446 1.499 . . . . 0.0 110.459 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.1 m -137.13 156.45 48.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.044 0.938 . . . . 0.0 109.752 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 p -64.89 -24.12 67.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.957 1.303 . . . . 0.0 113.426 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.02 -34.24 73.03 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -127.18 30.74 5.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.261 1.424 . . . . 0.0 109.06 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 131.15 49.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.466 1.106 . . . . 0.0 108.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.8 p -69.78 -177.92 1.39 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.68 1.592 . . . . 0.0 110.491 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -125.53 179.14 16.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 169.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.32 157.59 43.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.253 1.527 . . . . 0.0 108.808 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.13 172.6 34.03 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.11 20.84 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.14 0.576 . . . . 0.0 109.778 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.1 82.56 1.76 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.77 2.66 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.582 2.039 . . . . 0.0 112.995 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.68 -31.25 0.09 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.033 2.133 . . . . 0.0 111.103 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.444 HH22 ' HB2' ' A' ' 107' ' ' ASP . 59.0 mtp180 -68.94 162.99 25.49 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.0 mtp -139.8 144.94 37.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.18 126.13 29.3 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.8 mt -81.47 111.62 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.53 111.08 22.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.1 t -67.41 131.09 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 108.329 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -75.79 62.22 1.51 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.225 1.01 . . . . 0.0 109.734 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -43.98 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.895 1.678 . . . . 0.0 110.33 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.23 -18.41 63.5 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 112.814 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -111.16 -10.74 14.3 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.956 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.0 -67.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.005 1.275 . . . . 0.0 110.08 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.67 -39.89 84.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.071 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -55.42 -48.51 74.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 0.0 110.717 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 m -82.15 -16.29 50.32 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 112.779 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.08 3.28 33.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.984 1.265 . . . . 0.0 112.783 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.26 -42.06 97.98 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.501 -1.374 . . . . 0.0 110.615 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.1 ptp -62.08 -28.97 69.99 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.719 -0.613 . . . . 0.0 112.004 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.86 32.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.0 tp -56.95 -53.62 55.99 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.97 -14.62 61.93 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.436 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -55.51 -25.84 39.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.381 1.446 . . . . 0.0 111.849 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 m -123.16 -34.33 3.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.698 1.199 . . . . 0.0 111.535 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 164' ' ' SER . . . -82.71 4.98 22.84 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.52 12.56 0.33 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.47 1.032 . . . . 0.0 111.456 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 162' ' ' ALA . 9.8 m 70.44 14.89 7.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.531 2.332 . . . . 0.0 111.784 -169.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.89 -28.76 49.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.5 0.72 . . . . 0.0 111.09 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -136.02 -42.92 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.128 0.971 . . . . 0.0 110.166 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.85 173.743 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -59.13 -39.43 82.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.828 1.251 . . . . 0.0 113.2 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.92 9.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.215 1.388 . . . . 0.0 110.032 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.3 ptm -59.42 -25.61 64.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 p -63.02 -25.33 68.33 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.727 1.211 . . . . 0.0 112.031 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -78.43 87.39 4.44 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.5 m -57.23 -19.79 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 0.0 112.625 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.5 m 67.46 -50.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.022 2.529 . . . . 0.0 113.243 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -152.89 -57.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.4 1.08 . . . . 0.0 109.052 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.1 tp 45.65 50.84 10.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.189 1.796 . . . . 0.0 111.864 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.05 -20.02 2.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.193 0.997 . . . . 0.0 112.633 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -142.75 38.34 1.48 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.651 1.58 . . . . 0.0 108.258 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.37 156.94 74.9 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 0.0 108.938 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.37 136.96 57.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.435 2.09 . . . . 0.0 111.824 -173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.6 m -122.81 31.65 5.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.77 1.228 . . . . 0.0 110.65 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.39 52.69 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.997 1.284 . . . . 0.0 110.523 171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -66.02 146.79 54.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.18 145.6 33.97 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -142.01 138.38 31.81 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.171 0.989 . . . . 0.0 110.175 -169.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -84.19 137.47 33.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 167.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 30' ' ' GLY 0.256 1.5 m -125.7 146.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 119.439 1.018 . . . . 0.0 108.525 -175.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -143.23 153.79 43.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.085 1.354 . . . . 0.0 110.393 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 m -95.17 143.8 26.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.81 103.98 4.78 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.49 -78.49 0.25 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.331 1.443 . . . . 0.0 111.781 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.26 30.19 0.55 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.608 1.163 . . . . 0.0 111.032 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.77 161.04 39.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.577 1.151 . . . . 0.0 108.568 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -115.65 149.39 38.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.97 1.367 . . . . 0.0 109.817 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -139.3 165.65 26.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 107.403 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -147.41 169.06 28.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 119.15 0.886 . . . . 0.0 113.534 170.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 mt -144.01 137.73 24.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.06 118.65 3.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.881 0.872 . . . . 0.0 109.015 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -53.64 -32.81 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.708 0.803 . . . . 0.0 111.747 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.53 -24.49 67.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.04 0.836 . . . . 0.0 112.72 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.32 -21.36 39.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.278 0.945 . . . . 0.0 111.113 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.09 138.41 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -113.25 -46.18 3.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.559 1.144 . . . . 0.0 109.46 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -162.65 177.32 9.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.869 1.268 . . . . 0.0 108.803 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -139.41 143.27 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 172.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -134.29 -104.88 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 0.0 110.764 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 88' ' ' VAL . . . 176.44 154.65 11.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -68.42 125.72 27.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -156.84 -48.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -150.9 50.66 0.86 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.04 0.936 . . . . 0.0 109.894 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.74 112.07 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 m -95.31 89.17 5.37 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.69 144.85 56.69 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' HB ' HG23 ' A' ' 51' ' ' THR . 34.4 mm -84.39 28.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.236 1.014 . . . . 0.0 109.071 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 65.37 -31.4 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.127 2.571 . . . . 0.0 115.144 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.63 24.52 0.78 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.531 1.532 . . . . 0.0 112.924 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.28 144.88 97.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 110.232 169.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.69 142.34 14.26 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.752 2.968 . . . . 0.0 111.11 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.52 69.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.735 0.414 . . . . 0.0 110.59 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -65.75 0.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 0.0 114.191 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.04 -35.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 124.804 1.242 . . . . 0.0 110.996 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 mttm 57.17 -75.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.344 1.858 . . . . 0.0 110.795 -168.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.1 -123.93 1.13 Allowed Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 121.247 1.84 . . . . 0.0 110.99 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.13 169.47 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -143.53 158.79 43.38 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 120.838 -1.164 . . . . 0.0 108.383 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -72.9 137.86 45.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 110.013 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.39 173.64 7.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.21 65.44 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.38 1.072 . . . . 0.0 112.933 -169.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.23 -8.69 4.74 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.241 2.353 . . . . 0.0 113.106 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -152.94 -165.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 119.189 1.494 . . . . 0.0 109.417 -169.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -125.59 159.35 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.589 1.956 . . . . 0.0 108.035 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.45 133.49 10.05 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.3 130.72 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.653 1.568 . . . . 0.0 108.428 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.17 134.83 55.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -126.35 144.22 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.02 109.5 20.85 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.64 -17.21 45.86 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.923 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.0 -37.89 21.65 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.969 1.258 . . . . 0.0 111.005 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.34 -38.59 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -69.65 -12.91 62.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.755 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -122.59 -3.96 8.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.001 1.273 . . . . 0.0 113.547 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m 49.61 47.05 23.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.826 1.251 . . . . 0.0 111.796 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -177.71 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.649 0.737 . . . . 0.0 110.926 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.16 170.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.69 1.196 . . . . 0.0 110.997 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.53 63.3 5.77 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 110.541 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.73 164.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.611 1.164 . . . . 0.0 111.508 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -154.36 172.77 17.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.872 1.669 . . . . 0.0 108.58 -172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -70.89 54.92 0.17 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.001 1.381 . . . . 0.0 111.111 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 84' ' ' ASP . 42.1 t30 -154.66 -19.27 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 131.085 3.754 . . . . 0.0 109.288 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' H ' ' H ' ' A' ' 83' ' ' ASN . 27.6 t70 -141.0 16.92 2.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.803 2.041 . . . . 0.0 110.822 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -159.79 42.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.407 3.083 . . . . 0.0 106.929 -173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.7 p -99.18 6.78 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -168.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 74.5 t -126.36 151.4 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.349 1.431 . . . . 0.0 108.395 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' GLY . 27.0 m -121.43 141.99 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.48 128.12 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.52 135.37 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.1 mt -134.54 162.26 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.64 1.576 . . . . 0.0 109.046 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.69 145.64 33.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 107.676 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.64 151.56 20.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.29 -94.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.742 1.163 . . . . 0.0 112.728 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.03 21.14 3.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.189 1.796 . . . . 0.0 110.975 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -145.43 173.79 11.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.011 -1.055 . . . . 0.0 112.824 -169.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.73 142.42 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.767 2.027 . . . . 0.0 106.234 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.07 178.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 125.563 1.545 . . . . 0.0 106.859 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.78 179.0 41.39 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.97 146.65 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.1 144.22 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.25 166.67 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.845 2.058 . . . . 0.0 107.602 -173.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.22 -44.92 71.07 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.241 -0.912 . . . . 0.0 109.893 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.94 162.1 24.46 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 m -74.87 127.48 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.71 -43.53 13.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.254 1.021 . . . . 0.0 110.166 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -171.0 176.74 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 110.762 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.97 131.72 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.841 2.057 . . . . 0.0 106.971 169.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.86 -178.49 5.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.337 1.055 . . . . 0.0 109.863 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 m -130.17 151.88 50.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.948 0.795 . . . . 0.0 112.069 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.46 163.93 31.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.61 1.564 . . . . 0.0 109.914 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.7 p -114.22 167.44 10.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.687 1.195 . . . . 0.0 111.522 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.31 -9.66 35.08 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.939 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.85 -52.02 11.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.04 -36.4 83.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.379 1.072 . . . . 0.0 111.493 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.7 mt -103.56 106.57 20.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.508 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 23.7 mmt180 -145.82 -53.07 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.205 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.508 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.2 Cg_endo -65.79 176.64 3.46 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.879 1.719 . . . . 0.0 111.733 173.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.17 160.63 32.96 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.56 1.944 . . . . 0.0 107.775 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.01 -45.47 5.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.733 1.622 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 45.58 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 131.693 3.997 . . . . 0.0 119.932 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -153.59 160.31 42.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.437 1.471 . . . . 0.0 109.338 -173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.25 35.41 16.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.838 1.655 . . . . 0.0 112.647 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.89 156.57 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.901 1.681 . . . . 0.0 107.913 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -12.46 61.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.978 1.311 . . . . 0.0 113.015 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -54.79 162.52 1.21 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.171 2.988 . . . . 0.0 113.596 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m -135.6 151.24 50.07 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.963 0.905 . . . . 0.0 111.969 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.89 -29.21 27.01 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.877 2.471 . . . . 0.0 114.389 -169.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -62.07 -32.3 72.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -147.47 31.19 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.259 1.023 . . . . 0.0 110.61 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 18.49 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 145' ' ' VAL . 27.4 p 64.01 -175.27 0.16 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.936 1.694 . . . . 0.0 112.176 169.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.72 177.52 20.11 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 106.396 -2.681 . . . . 0.0 106.396 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.65 158.67 44.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.677 1.238 . . . . 0.0 109.268 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.06 177.46 32.29 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.98 152.96 33.49 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.817 0.847 . . . . 0.0 109.652 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.79 82.59 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.147 1.379 . . . . 0.0 107.405 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.23 -48.44 2.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.586 2.041 . . . . 0.0 113.56 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -156.43 -35.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.29 2.236 . . . . 0.0 110.353 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -71.09 165.97 22.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.848 0.832 . . . . 0.0 110.142 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.7 mtp -136.95 147.97 46.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -137.9 129.95 28.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.5 mt -85.38 114.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.82 112.62 24.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -64.85 133.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.317 1.047 . . . . 0.0 108.36 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.88 61.38 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.36 -39.83 45.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.701 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.0 -13.34 45.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.021 0.828 . . . . 0.0 112.729 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -111.16 -12.59 14.12 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 117.039 -1.458 . . . . 0.0 112.649 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -54.66 -73.26 0.05 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.801 1.24 . . . . 0.0 111.088 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.9 -23.98 28.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.801 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -58.56 -28.64 65.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 111.491 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.0 m -96.17 -39.83 9.5 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.77 0.713 . . . . 0.0 110.883 173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.88 -10.81 59.62 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.769 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -49.78 -47.83 50.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 121.613 2.006 . . . . 0.0 112.035 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -67.06 -43.87 81.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.099 0.56 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.74 -31.2 71.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.548 0.739 . . . . 0.0 111.964 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.45 -60.57 2.19 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.98 -28.06 69.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.978 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.58 -37.32 7.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 111.989 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 73.7 m -137.42 32.15 2.57 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.275 1.03 . . . . 0.0 111.081 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.53 25.68 1.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.763 1.225 . . . . 0.0 110.739 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.27 -0.26 9.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.149 0.98 . . . . 0.0 113.154 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.0 m 68.97 -32.74 0.23 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.659 2.383 . . . . 0.0 112.873 -171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.62 -28.25 69.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.718 1.207 . . . . 0.0 110.573 169.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.67 -22.64 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.945 1.298 . . . . 0.0 112.429 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.955 0.902 . . . . 0.0 111.194 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.3 p -67.2 -19.97 65.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.695 1.198 . . . . 0.0 112.723 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.69 -179.22 39.75 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.8 mtm -143.34 170.21 16.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.811 1.244 . . . . 0.0 109.153 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.259 16.7 p 49.59 39.76 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.594 1.957 . . . . 0.0 112.626 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -73.96 62.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.078 1.351 . . . . 0.0 109.159 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -57.73 142.3 13.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.429 1.092 . . . . 0.0 110.707 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -72.38 139.27 47.76 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 169.11 9.17 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.619 -0.676 . . . . 0.0 110.076 172.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 85.56 2.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.52 -18.21 0.54 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.133 0.973 . . . . 0.0 113.473 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -151.09 41.76 0.75 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.85 1.66 . . . . 0.0 108.027 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -133.8 159.09 73.81 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.478 1.911 . . . . 0.0 109.592 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.93 -163.06 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.436 2.757 . . . . 0.0 109.353 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -45.12 134.11 6.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.417 1.487 . . . . 0.0 111.096 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.18 95.84 0.73 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -75.85 165.13 25.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.815 1.246 . . . . 0.0 108.482 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -133.12 143.42 49.26 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -139.36 141.09 37.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.779 0.432 . . . . 0.0 110.424 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -82.33 128.86 34.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.38 147.31 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.329 0.968 . . . . 0.0 108.889 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.74 153.73 42.74 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.249 1.02 . . . . 0.0 109.898 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -92.73 146.92 23.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.23 125.74 14.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -88.7 0.16 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -154.26 34.76 0.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.331 1.452 . . . . 0.0 109.796 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.64 158.2 43.9 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 107.602 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.62 156.21 34.75 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.022 1.391 . . . . 0.0 111.887 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -144.92 161.25 39.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.021 2.528 . . . . 0.0 107.127 -171.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.96 25.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.364 0.983 . . . . 0.0 111.035 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 100' ' ' ILE . 3.4 mt -137.46 137.92 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -47.38 115.86 1.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.585 1.154 . . . . 0.0 110.213 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.09 -33.79 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.104 0.962 . . . . 0.0 111.753 -169.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.54 -25.73 68.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.672 0.789 . . . . 0.0 112.66 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -79.26 -20.18 48.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.868 0.758 . . . . 0.0 111.883 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.14 128.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 118.902 0.774 . . . . 0.0 109.027 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -86.99 -60.28 2.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -163.65 -176.74 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.274 1.43 . . . . 0.0 109.012 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.29 145.95 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 41' ' ' GLY . 1.3 tmm_? -144.0 173.84 11.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.561 1.944 . . . . 0.0 106.278 -177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' H ' ' HD2' ' A' ' 40' ' ' ARG . . . -101.73 172.1 22.49 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.133 -0.98 . . . . 0.0 111.172 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -67.88 120.97 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 168.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.44 -48.98 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -170.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -150.92 86.42 1.37 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.887 0.875 . . . . 0.0 109.01 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.15 161.21 2.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.77 130.82 17.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -134.99 129.67 34.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.367 0.985 . . . . 0.0 108.982 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' A' ' 51' ' ' THR . 1.5 mp -63.19 137.44 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -8.96 25.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 48' ' ' ILE . 73.4 m-80 -130.43 34.0 4.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.081 1.752 . . . . 0.0 109.829 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -61.67 149.45 84.55 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.141 0.576 . . . . 0.0 111.192 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.84 26.18 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.835 3.69 . . . . 0.0 112.026 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.87 -37.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.918 2.887 . . . . 0.0 115.821 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -56.17 -44.13 79.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.711 1.142 . . . . 0.0 109.565 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.25 88.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -60.14 -26.68 66.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.133 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.02 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.435 1.017 . . . . 0.0 111.019 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 151.12 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 t -134.33 151.09 51.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.986 0.812 . . . . 0.0 109.369 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -66.08 107.64 1.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.404 1.082 . . . . 0.0 109.173 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.51 64.81 3.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 49.81 30.22 3.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.467 1.507 . . . . 0.0 113.209 169.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.49 -25.46 1.08 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.856 1.217 . . . . 0.0 113.387 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.46 -165.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 107.877 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 tp -130.32 147.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.451 1.478 . . . . 0.0 110.624 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.55 138.73 15.63 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.5 143.78 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.404 2.069 . . . . 0.0 110.596 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -127.84 135.55 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.2 167.04 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -129.08 116.52 19.4 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 mt -66.82 -17.29 64.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.358 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -54.75 -42.33 71.52 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.835 1.198 . . . . 0.0 110.333 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.36 -44.19 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -60.89 -23.75 65.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.42 -3.54 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.043 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.9 m 49.55 48.64 21.13 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.031 1.287 . . . . 0.0 110.57 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.31 -171.22 0.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 110.864 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.78 164.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.36 1.064 . . . . 0.0 110.225 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -84.06 62.89 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.273 1.829 . . . . 0.0 110.575 -169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 m -53.25 158.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.714 0.806 . . . . 0.0 111.036 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -144.03 178.03 8.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.237 1.415 . . . . 0.0 108.643 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.65 64.18 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.123 1.769 . . . . 0.0 109.484 169.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.36 -35.73 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 131.563 3.945 . . . . 0.0 108.456 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -145.98 30.7 1.05 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.641 1.976 . . . . 0.0 110.072 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -154.97 28.81 0.42 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.268 3.027 . . . . 0.0 107.666 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 p -106.51 12.17 29.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.538 1.935 . . . . 0.0 115.95 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.77 154.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.33 113.79 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -82.21 141.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 137.02 47.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.0 mt -135.82 154.85 51.06 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.531 1.532 . . . . 0.0 109.112 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 139.67 37.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.97 155.25 35.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.28 -100.49 0.04 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.2 0.905 . . . . 0.0 111.656 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -136.57 27.7 3.05 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.613 1.965 . . . . 0.0 109.958 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -146.97 171.04 15.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.2 144.79 34.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 125.363 1.465 . . . . 0.0 107.456 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 99' ' ' GLY . 13.2 p -158.48 -176.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -166.78 176.54 41.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 31' ' ' ILE . 48.8 pt -140.33 144.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.191 0.519 . . . . 0.0 110.343 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.51 142.9 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.944 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.44 166.05 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.654 1.982 . . . . 0.0 108.021 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.53 -41.48 65.79 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.94 151.81 8.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.29 128.98 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -36.5 10.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.203 0.601 . . . . 0.0 111.772 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.3 t0 -169.09 -178.4 3.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.593 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.1 t -137.48 122.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 103.984 -2.598 . . . . 0.0 103.984 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -141.16 150.25 42.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.456 0.702 . . . . 0.0 110.718 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 p -94.86 135.68 36.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.418 0.687 . . . . 0.0 109.639 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mp -138.18 143.31 40.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 67.5 p -100.4 164.8 11.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.55 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.91 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -104.89 -36.2 7.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.772 1.629 . . . . 0.0 110.052 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.41 -45.92 82.04 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.49 112.75 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -148.19 -62.86 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.802 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.18 -178.08 3.03 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.105 1.87 . . . . 0.0 111.539 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.32 155.55 39.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.564 1.946 . . . . 0.0 108.097 169.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.23 59.43 7.39 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.111 3.207 . . . . 0.0 111.107 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.63 29.18 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.077 1.751 . . . . 0.0 112.863 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.11 -174.46 1.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.746 1.618 . . . . 0.0 110.401 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 28.75 0.06 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.269 1.428 . . . . 0.0 113.468 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 124' ' ' VAL . 11.1 m -70.72 161.37 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.828 1.651 . . . . 0.0 109.475 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -44.57 95.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -62.88 166.01 6.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 m -134.19 175.2 9.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.2 1.4 . . . . 0.0 110.64 -169.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -56.15 -27.71 55.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.88 -30.2 56.11 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.337 0.972 . . . . 0.0 111.157 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -110.97 -9.55 14.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.093 0.957 . . . . 0.0 112.505 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.7 160.91 5.15 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.559 0.744 . . . . 0.0 112.132 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 146' ' ' ASN . 38.8 p -114.15 166.31 11.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.392 1.877 . . . . 0.0 108.757 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.86 176.53 45.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.59 145.78 39.0 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.3 174.72 37.07 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.04 39.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.018 0.927 . . . . 0.0 110.184 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.25 82.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.33 -51.9 2.57 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.623 2.059 . . . . 0.0 112.98 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -157.35 -31.4 0.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.147 2.179 . . . . 0.0 111.076 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' A' ' 107' ' ' ASP . 66.0 mtp180 -68.79 162.21 26.82 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.6 mtp -138.87 144.15 39.06 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.25 128.09 35.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.55 120.72 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.51 102.9 15.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.44 120.74 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.068 1.347 . . . . 0.0 108.956 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.551 ' H ' HG22 ' A' ' 132' ' ' THR . 40.4 t30 -75.99 60.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.133 1.773 . . . . 0.0 110.121 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.45 -35.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.089 1.356 . . . . 0.0 111.24 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -68.7 -5.94 23.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -134.26 18.8 3.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.068 1.347 . . . . 0.0 110.667 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.1 tp -79.2 -88.28 0.06 Allowed 'General case' 0 C--N 1.341 0.222 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.0 tp -68.95 -31.51 70.44 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.543 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.74 -22.58 47.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -124.33 -3.66 7.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.405 1.082 . . . . 0.0 112.072 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -122.21 2.15 9.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 113.023 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.62 -34.35 67.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.293 1.406 . . . . 0.0 111.38 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -61.14 -45.92 92.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.0 109.932 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.06 73.72 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.212 0.605 . . . . 0.0 111.443 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.3 -56.68 10.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.329 0.652 . . . . 0.0 109.707 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.35 -30.4 71.23 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.063 -0.398 . . . . 0.0 111.08 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -19.9 7.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.644 0.778 . . . . 0.0 112.855 175.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.9 m -130.57 14.63 5.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.878 1.271 . . . . 0.0 112.204 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -151.17 11.04 0.62 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 13.29 1.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.489 1.116 . . . . 0.0 111.888 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.7 m 68.09 7.88 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.171 2.188 . . . . 0.0 112.58 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.38 -20.63 60.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.357 1.063 . . . . 0.0 111.578 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.78 -0.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.239 1.015 . . . . 0.0 111.248 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 O-C-N 121.378 -0.826 . . . . 0.0 109.113 169.89 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -39.03 93.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.51 1.124 . . . . 0.0 111.051 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.84 -171.7 43.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.31 -8.95 57.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.231 0.516 . . . . 0.0 111.785 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -139.07 165.55 26.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.521 1.928 . . . . 0.0 106.828 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.3 t30 52.85 65.34 1.54 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 111.452 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.29 23.25 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.946 1.698 . . . . 0.0 110.263 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -139.33 162.12 35.78 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.469 1.107 . . . . 0.0 109.308 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -141.97 161.21 38.56 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.192 1.397 . . . . 0.0 109.213 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.79 -60.4 3.9 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.087 0.555 . . . . 0.0 109.677 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.72 -46.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.345 1.858 . . . . 0.0 109.586 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -143.2 42.28 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 111.322 -169.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.21 155.21 57.75 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 146.54 95.01 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.108 1.872 . . . . 0.0 113.256 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -63.24 170.51 2.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.427 1.891 . . . . 0.0 111.968 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.2 102.68 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.114 1.34 . . . . 0.0 111.35 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.37 165.99 22.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.766 1.227 . . . . 0.0 108.357 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.45 143.91 46.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -142.09 137.96 31.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.396 0.679 . . . . 0.0 109.815 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -83.27 134.6 34.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.42 151.71 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 119.212 0.914 . . . . 0.0 109.135 -173.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -140.46 150.97 44.46 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.643 1.177 . . . . 0.0 109.26 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -91.71 148.54 22.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 tp -144.63 109.46 5.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.06 -87.71 0.23 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.413 1.006 . . . . 0.0 111.326 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.23 32.46 0.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.245 1.418 . . . . 0.0 109.589 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.22 159.07 43.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.957 1.703 . . . . 0.0 107.794 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.76 153.74 37.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.918 1.342 . . . . 0.0 109.874 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -138.58 150.79 46.68 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.76 2.024 . . . . 0.0 106.867 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.93 157.3 19.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.8 134.25 42.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -48.66 116.67 1.7 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.394 1.078 . . . . 0.0 108.785 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.4 -34.75 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.513 0.725 . . . . 0.0 111.766 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.29 -24.53 67.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.795 0.838 . . . . 0.0 112.586 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -79.17 -24.0 43.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.48 0.582 . . . . 0.0 111.41 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -67.3 140.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -104.57 -59.57 1.72 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.118 0.967 . . . . 0.0 108.952 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.27 178.3 9.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.842 0.857 . . . . 0.0 110.222 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.58 146.69 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -148.51 176.5 10.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.389 1.475 . . . . 0.0 108.279 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.95 166.23 29.81 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.554 -0.716 . . . . 0.0 111.361 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -166.13 0.23 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.523 1.529 . . . . 0.0 112.28 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 67.34 27.89 8.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.455 1.902 . . . . 0.0 112.934 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 31.82 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.39 1.076 . . . . 0.0 109.72 174.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -75.74 116.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -60.85 -47.41 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 109.16 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 54.29 175.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.05 2.54 . . . . 0.0 113.106 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.52 155.86 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.55 -25.5 60.04 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -149.96 23.74 0.85 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.96 142.72 98.19 Favored Pre-proline 0 C--O 1.239 0.53 0 CA-C-O 119.019 -0.515 . . . . 0.0 109.743 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -61.41 148.67 92.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.953 2.435 . . . . 0.0 110.039 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.15 -24.87 67.84 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -61.17 -55.94 26.42 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.191 0.905 . . . . 0.0 109.702 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.421 HD12 ' HG2' ' A' ' 52' ' ' PRO . 70.4 mt -56.4 -37.0 48.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 C-N-CA 125.228 1.411 . . . . 0.0 109.993 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 58.54 -79.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.328 1.851 . . . . 0.0 107.768 -168.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.48 -132.61 2.19 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 121.358 1.89 . . . . 0.0 110.759 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.91 160.6 39.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.304 1.042 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -133.41 147.99 51.77 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -77.95 108.99 11.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.41 76.94 7.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.477 0.655 . . . . 0.0 109.854 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 49.88 29.04 3.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.023 1.329 . . . . 0.0 114.358 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.48 -19.43 2.81 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.671 1.129 . . . . 0.0 113.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.54 -169.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.842 1.321 . . . . 0.0 108.187 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.07 149.51 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.205 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.58 141.08 14.42 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.758 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.46 132.33 33.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.877 1.718 . . . . 0.0 109.682 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.61 119.21 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.46 154.04 9.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 125.589 1.556 . . . . 0.0 110.269 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -92.65 111.4 22.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.358 1.063 . . . . 0.0 110.545 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.71 -37.75 76.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -43.6 92.87 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.378 0.99 . . . . 0.0 109.484 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.8 -36.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.14 -31.16 67.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.208 0.913 . . . . 0.0 113.427 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -116.58 9.5 14.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.923 0.783 . . . . 0.0 112.376 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.6 m 47.92 41.74 15.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.279 1.032 . . . . 0.0 111.002 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -179.84 7.48 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.636 1.175 . . . . 0.0 109.51 -172.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.79 -84.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -173.57 106.04 0.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.034 1.334 . . . . 0.0 108.792 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.01 129.69 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.389 1.075 . . . . 0.0 108.266 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.78 149.38 26.41 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.693 0.797 . . . . 0.0 108.92 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.6 36.9 0.07 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.252 2.221 . . . . 0.0 112.758 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.48 -9.86 0.16 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.476 2.31 . . . . 0.0 111.005 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.48 -4.69 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.061 1.344 . . . . 0.0 111.866 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.66 24.11 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -172.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -80.95 9.75 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 117.826 2.528 . . . . 0.0 117.826 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.6 160.49 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 120.276 1.398 . . . . 0.0 107.902 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.68 127.47 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.88 142.59 15.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.91 134.16 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.59 163.84 29.19 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.008 1.723 . . . . 0.0 109.183 -169.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 148.37 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.449 1.499 . . . . 0.0 107.651 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.4 152.31 25.68 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.51 -90.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.049 1.309 . . . . 0.0 113.508 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.78 23.81 2.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.221 1.809 . . . . 0.0 110.699 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -149.46 173.41 13.61 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.732 -1.23 . . . . 0.0 111.57 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.95 151.95 36.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 125.078 1.351 . . . . 0.0 108.654 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.85 172.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 125.008 1.323 . . . . 0.0 107.6 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.24 177.21 40.03 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.07 142.89 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.56 140.16 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.68 168.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.125 1.77 . . . . 0.0 109.01 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.64 -43.47 72.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.824 1.193 . . . . 0.0 109.978 171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.64 153.67 8.97 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.33 121.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -46.62 12.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.498 0.719 . . . . 0.0 111.15 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -169.29 179.5 3.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.143 0.977 . . . . 0.0 109.767 -168.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.98 136.3 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.86 1.664 . . . . 0.0 107.026 169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -142.58 174.4 10.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.814 1.245 . . . . 0.0 109.16 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.5 m -131.84 137.79 48.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -141.25 155.15 46.05 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.932 0.893 . . . . 0.0 109.277 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -126.99 158.37 37.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.871 1.668 . . . . 0.0 108.365 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.28 42.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -65.97 -41.64 90.93 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.187 -0.946 . . . . 0.0 109.787 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.95 -40.07 40.67 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.348 1.459 . . . . 0.0 110.462 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -91.37 99.17 9.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 74.8 mtt-85 -139.6 -53.35 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.144 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 33.6 Cg_endo -64.77 170.96 9.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.425 1.544 . . . . 0.0 111.623 173.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.18 30.25 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.261 1.424 . . . . 0.0 108.667 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -80.72 50.47 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.797 2.998 . . . . 0.0 110.371 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 16.76 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.272 1.429 . . . . 0.0 113.921 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -146.92 152.97 39.55 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.886 2.074 . . . . 0.0 108.134 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.62 42.36 23.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.176 1.39 . . . . 0.0 112.773 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 166.08 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.738 1.615 . . . . 0.0 108.744 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -35.66 10.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.011 0.525 . . . . 0.0 111.583 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.41 171.77 2.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.655 1.182 . . . . 0.0 112.971 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.9 m -121.6 168.53 11.65 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.043 1.337 . . . . 0.0 110.441 -170.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 p -52.93 -21.98 5.02 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.858 2.463 . . . . 0.0 115.829 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -85.79 -34.42 21.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.825 0.85 . . . . 0.0 110.892 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -91.88 -14.36 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.225 0.61 . . . . 0.0 110.208 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.47 136.87 43.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.797 2.439 . . . . 0.0 111.207 -172.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 145' ' ' VAL . 42.1 p -80.59 -170.3 2.54 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.45 2.3 . . . . 0.0 110.918 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.06 172.06 22.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 106.402 -2.679 . . . . 0.0 106.402 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 154.54 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.624 1.712 . . . . 0.0 110.289 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.44 175.03 31.99 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.81 157.04 19.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.811 0.844 . . . . 0.0 110.168 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.73 82.29 1.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.43 -51.39 2.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.489 1.995 . . . . 0.0 113.11 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.38 -31.9 0.09 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.058 2.143 . . . . 0.0 110.97 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -69.09 161.01 29.96 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 170.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -137.94 140.43 40.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.22 130.94 45.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.9 104.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.35 110.89 9.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.9 t -62.08 129.83 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -78.92 54.8 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.496 1.118 . . . . 0.0 109.669 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 tp -56.01 -35.82 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.449 1.5 . . . . 0.0 111.762 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -67.54 -19.73 65.32 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.558 . . . . 0.0 112.375 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -105.81 -22.52 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 117.47 -1.252 . . . . 0.0 111.866 171.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -48.42 -75.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 111.562 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.6 tp -78.51 -25.46 45.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.177 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.66 -27.05 67.53 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.759 1.163 . . . . 0.0 112.911 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.7 m -115.23 -8.03 12.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.684 1.193 . . . . 0.0 111.888 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -97.69 -7.25 31.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.984 1.266 . . . . 0.0 111.429 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -54.5 -46.31 73.44 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.999 1.727 . . . . 0.0 110.236 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 ptp -59.14 -25.81 64.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.271 1.028 . . . . 0.0 112.932 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.92 -26.0 16.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.049 1.739 . . . . 0.0 112.046 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.68 -56.8 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.05 0.94 . . . . 0.0 108.655 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.802 -0.561 . . . . 0.0 112.125 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -45.87 -42.15 12.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.567 1.547 . . . . 0.0 112.112 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 65.7 m -133.12 28.07 4.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.426 1.091 . . . . 0.0 110.892 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -141.29 31.49 1.73 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.338 1.455 . . . . 0.0 109.486 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.28 -4.53 22.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.456 1.103 . . . . 0.0 112.978 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.5 m 68.35 -24.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.18 2.192 . . . . 0.0 113.005 -171.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.16 -33.43 74.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.118 0.967 . . . . 0.0 110.15 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.44 -23.06 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 112.554 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 123.822 0.849 . . . . 0.0 110.477 -175.242 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p -130.55 6.97 4.83 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.842 1.257 . . . . 0.0 111.756 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.87 53.1 2.91 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.431 1.491 . . . . 0.0 112.744 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.69 -175.98 0.59 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.766 1.626 . . . . 0.0 110.233 174.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -62.0 -21.12 64.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.775 -1.203 . . . . 0.0 112.752 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -67.66 -10.92 56.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.685 0.794 . . . . 0.0 112.075 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t 67.38 -45.38 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 130.335 3.454 . . . . 0.0 112.079 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 m 45.1 -107.62 0.13 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.388 1.475 . . . . 0.0 109.637 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -156.95 167.06 31.6 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.37 2.268 . . . . 0.0 106.261 169.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.09 -50.45 72.74 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.523 1.129 . . . . 0.0 111.677 -170.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.39 -169.2 3.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -70.66 38.77 0.05 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.572 1.549 . . . . 0.0 113.316 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -59.24 150.19 64.43 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 125.462 1.505 . . . . 0.0 108.779 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 162.51 36.34 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.719 2.28 . . . . 0.0 114.221 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -127.5 28.77 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.715 1.206 . . . . 0.0 111.603 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.01 65.18 0.02 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.578 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -65.89 148.07 52.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -109.88 145.64 36.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -142.13 140.02 32.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.196 0.998 . . . . 0.0 110.736 -169.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.12 136.18 34.55 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 167.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.46 149.86 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.91 1.232 . . . . 0.0 109.223 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -141.17 152.09 44.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.244 1.018 . . . . 0.0 110.176 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.9 m -91.53 146.88 23.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 170.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -145.3 121.14 10.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.52 -98.62 0.21 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -141.67 37.09 1.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.211 1.404 . . . . 0.0 109.633 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.67 160.11 40.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.836 1.654 . . . . 0.0 107.92 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.3 152.54 44.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.093 1.425 . . . . 0.0 110.361 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.32 154.97 48.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.711 2.005 . . . . 0.0 107.459 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.32 159.13 21.31 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.904 1.24 . . . . 0.0 110.113 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mt -142.22 133.69 25.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -45.75 113.96 0.69 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 109.082 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -53.05 -39.0 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.49 -16.84 64.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.225 0.92 . . . . 0.0 112.941 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -74.2 -24.74 59.4 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.753 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -64.78 140.89 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -120.37 -42.0 2.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.479 1.112 . . . . 0.0 110.511 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 169.54 24.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.585 1.154 . . . . 0.0 108.386 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.6 142.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -149.11 174.4 12.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.928 0.891 . . . . 0.0 108.633 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.04 25.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.66 126.04 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.37 159.0 2.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.754 . . . . 0.0 108.2 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.57 43.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.935 2.894 . . . . 0.0 116.18 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 t -74.22 107.97 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -76.12 95.01 3.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.38 142.75 50.33 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.452 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.0 mm -82.7 8.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.691 0.796 . . . . 0.0 110.099 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.26 -4.8 0.26 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.349 2.26 . . . . 0.0 115.511 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.99 14.75 1.34 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.054 1.342 . . . . 0.0 112.449 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.452 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -76.0 144.4 75.7 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.259 1.024 . . . . 0.0 109.95 174.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.36 157.56 53.83 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.917 2.411 . . . . 0.0 109.274 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.53 -33.8 64.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.748 0.819 . . . . 0.0 112.728 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.91 -49.08 63.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.851 0.75 . . . . 0.0 110.549 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.54 -37.69 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.804 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? 48.58 -82.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.834 2.454 . . . . 0.0 111.352 -169.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.87 14.06 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 120.726 1.603 . . . . 0.0 112.713 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.73 156.79 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -140.07 157.03 46.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.924 1.238 . . . . 0.0 109.622 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -78.62 101.84 7.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.911 1.284 . . . . 0.0 110.98 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.75 70.71 2.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 109.931 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 50.81 27.7 3.24 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.7 1.6 . . . . 0.0 114.227 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.6 -17.85 2.03 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.391 0.996 . . . . 0.0 113.263 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -171.45 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.723 1.261 . . . . 0.0 107.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -132.18 150.4 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 120.768 -1.207 . . . . 0.0 110.202 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.87 141.5 14.97 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.676 -1.154 . . . . 0.0 109.289 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.1 131.08 24.28 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.884 1.723 . . . . 0.0 108.585 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.69 123.83 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.13 147.89 12.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.452 2.301 . . . . 0.0 107.117 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.84 118.56 37.1 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.747 0.819 . . . . 0.0 109.562 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.28 -20.39 66.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.055 0.942 . . . . 0.0 113.195 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -56.02 -39.8 72.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.425 1.466 . . . . 0.0 109.434 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.33 12.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 109.763 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -131.83 -27.44 1.88 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.859 -1.151 . . . . 0.0 112.079 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.55 6.3 3.23 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.746 1.157 . . . . 0.0 113.718 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m 59.18 23.39 11.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -61.12 149.37 37.48 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.48 0.712 . . . . 0.0 111.674 -169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 m -24.25 -75.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 129.054 2.942 . . . . 0.0 117.506 -169.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -164.93 67.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.362 1.065 . . . . 0.0 109.758 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -50.84 140.57 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.21 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -160.52 165.62 30.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.677 1.191 . . . . 0.0 109.009 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -73.99 43.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.281 2.232 . . . . 0.0 111.157 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' H ' ' A' ' 84' ' ' ASP . 26.0 t30 -159.22 -19.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.85 3.26 . . . . 0.0 110.028 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.412 ' H ' ' H ' ' A' ' 83' ' ' ASN . 38.2 t70 -135.75 6.54 3.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.638 1.575 . . . . 0.0 111.501 -172.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -154.8 37.27 0.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.434 1.893 . . . . 0.0 109.05 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p -94.87 11.57 31.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.32 1.848 . . . . 0.0 115.751 -168.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.64 160.37 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.44 135.05 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -171.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.6 mt -115.89 127.03 73.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.73 134.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 mt -129.79 164.03 24.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.411 1.484 . . . . 0.0 108.209 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.01 157.3 44.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.867 0.867 . . . . 0.0 108.696 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.29 -178.05 4.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.18 97.35 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.896 1.236 . . . . 0.0 113.136 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 63.16 22.48 13.41 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.541 1.936 . . . . 0.0 115.282 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -147.2 161.94 39.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.79 1.632 . . . . 0.0 111.016 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.5 m -135.54 151.45 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 123.799 0.84 . . . . 0.0 110.396 -170.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.55 174.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.235 1.814 . . . . 0.0 106.673 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.45 176.55 40.33 Favored Glycine 0 N--CA 1.448 -0.541 0 O-C-N 120.201 -1.562 . . . . 0.0 110.28 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.46 149.4 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.827 0.851 . . . . 0.0 109.559 -169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 m -94.32 136.1 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.836 1.254 . . . . 0.0 108.86 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.02 166.02 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.608 1.563 . . . . 0.0 109.363 -169.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.52 -43.0 67.27 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.07 154.0 10.73 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.45 123.41 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -49.38 12.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.867 0.467 . . . . 0.0 110.79 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.56 179.73 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.67 1.188 . . . . 0.0 109.618 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.45 127.92 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 pp -156.17 177.68 11.16 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.837 1.255 . . . . 0.0 109.753 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -129.86 148.82 51.77 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.866 0.757 . . . . 0.0 112.179 -169.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mp -139.96 145.89 38.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.175 1.39 . . . . 0.0 108.698 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -94.02 172.2 8.37 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 111.543 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.1 21.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.406 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.11 -39.36 12.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.704 1.202 . . . . 0.0 109.143 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -69.02 -41.6 77.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.821 0.848 . . . . 0.0 110.703 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -86.43 117.58 31.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -143.23 -64.32 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.562 0 CA-C-O 116.838 -1.554 . . . . 0.0 111.818 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.93 -175.1 1.97 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.243 1.962 . . . . 0.0 111.501 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.22 31.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.221 1.808 . . . . 0.0 107.978 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.69 149.63 61.3 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.203 1.935 . . . . 0.0 110.546 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.57 24.96 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.709 1.204 . . . . 0.0 110.549 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -76.82 34.67 0.15 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.191 1.796 . . . . 0.0 114.038 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.77 32.28 5.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.891 2.076 . . . . 0.0 113.608 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.67 -178.86 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.401 1.08 . . . . 0.0 109.755 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -8.63 8.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.483 1.513 . . . . 0.0 113.974 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.05 151.23 40.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.102 1.361 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -135.25 160.28 38.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.422 1.089 . . . . 0.0 108.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 p -62.07 -10.47 10.2 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -22.46 12.06 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.306 1.042 . . . . 0.0 111.365 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -84.8 -9.8 57.81 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.941 -0.475 . . . . 0.0 110.341 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.93 120.26 2.95 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.197 2.199 . . . . 0.0 112.327 -169.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 145' ' ' VAL . 41.1 p -75.91 -166.18 0.55 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.428 2.691 . . . . 0.0 111.431 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.74 175.18 20.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.48 143.59 39.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.32 170.14 31.56 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.7 154.49 29.45 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.22 1.008 . . . . 0.0 109.595 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.39 71.79 1.36 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.72 -38.64 1.27 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.894 2.188 . . . . 0.0 113.723 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.6 -34.92 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.99 2.116 . . . . 0.0 110.13 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -71.54 166.08 22.54 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -139.59 145.42 38.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -132.01 126.31 33.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.9 mt -79.7 110.88 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.07 105.64 11.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.0 t -60.15 120.89 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.52 60.33 2.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.305 0.574 . . . . 0.0 110.131 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -53.17 -37.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.615 1.166 . . . . 0.0 111.018 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.35 -23.52 66.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.187 0.995 . . . . 0.0 112.312 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -110.56 -20.41 12.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 117.337 -1.316 . . . . 0.0 111.841 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.21 -61.67 2.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.782 1.173 . . . . 0.0 109.885 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.04 -48.37 63.05 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.82 -40.07 75.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.32 0.509 . . . . 0.0 111.83 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.2 m -80.89 -29.55 35.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.187 0.449 . . . . 0.0 111.568 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.01 -9.31 57.02 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.477 0.711 . . . . 0.0 111.125 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.99 -49.05 66.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.895 1.225 . . . . 0.0 112.089 -169.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.6 ptp -66.02 -31.41 72.28 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.868 -0.52 . . . . 0.0 112.056 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.2 59.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.339 1.056 . . . . 0.0 110.35 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.95 -49.24 78.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.089 1.356 . . . . 0.0 109.041 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.1 -24.61 63.09 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 123.796 0.839 . . . . 0.0 111.977 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.21 -22.06 64.42 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.281 0.946 . . . . 0.0 112.35 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.6 m -130.91 23.6 4.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 111.428 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.75 48.84 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.384 1.474 . . . . 0.0 108.476 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.71 14.74 1.22 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.172 1.389 . . . . 0.0 112.87 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.6 m 64.01 41.93 6.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.412 1.485 . . . . 0.0 108.882 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.08 -77.31 0.16 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.424 1.09 . . . . 0.0 109.117 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -65.66 -35.18 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 173.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.384 0 C-N-CA 129.59 3.156 . . . . 0.0 104.738 169.828 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 18.45 2.94 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.438 1.095 . . . . 0.0 110.297 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.54 -53.8 4.29 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 125.122 1.344 . . . . 0.0 111.2 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.7 mtm -58.11 -27.37 63.65 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.278 1.431 . . . . 0.0 111.42 174.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -70.94 -28.37 64.44 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.712 . . . . 0.0 112.443 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -87.62 16.05 6.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.853 1.261 . . . . 0.0 113.505 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.35 165.04 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 110.577 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.17 137.94 12.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.786 1.234 . . . . 0.0 109.661 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -122.68 109.32 14.12 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -169.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.26 -5.78 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.533 1.133 . . . . 0.0 112.667 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.17 20.7 2.79 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.628 1.571 . . . . 0.0 110.115 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 51.67 36.5 17.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.223 1.409 . . . . 0.0 111.669 -172.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.36 134.94 88.5 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 123.796 0.838 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.77 -42.07 5.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.563 2.175 . . . . 0.0 112.881 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.4 m -167.98 158.71 10.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 127.208 2.203 . . . . 0.0 106.951 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 88.48 0.29 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -75.52 170.17 16.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.737 0.815 . . . . 0.0 110.168 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.34 145.19 51.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.0 136.26 35.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.382 0.673 . . . . 0.0 110.136 -169.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.5 tp -78.44 133.94 37.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 167.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.28 148.14 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 119.324 0.965 . . . . 0.0 108.54 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.15 153.16 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.957 0.903 . . . . 0.0 110.125 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -93.55 145.92 24.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' CD1' HD21 ' A' ' 85' ' ' ASN . 56.4 tp -136.77 96.76 3.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.624 . . . . 0.0 107.5 173.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.48 -76.03 0.52 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.169 1.366 . . . . 0.0 111.907 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.08 30.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.285 1.434 . . . . 0.0 110.494 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.36 160.54 39.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 108.145 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -127.93 151.6 48.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.045 1.403 . . . . 0.0 110.824 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -137.33 156.84 47.76 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.878 2.071 . . . . 0.0 108.045 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.73 153.92 19.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.848 1.213 . . . . 0.0 110.419 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -136.63 130.99 47.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -48.65 120.36 3.71 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.94 -31.89 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.336 0.654 . . . . 0.0 111.595 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.99 -23.58 67.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.502 -0.749 . . . . 0.0 112.689 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -77.64 -22.91 49.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.928 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.94 140.2 20.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.637 1.108 . . . . 0.0 108.369 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 -40.67 2.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.522 1.129 . . . . 0.0 110.431 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -166.19 177.47 6.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.559 . . . . 0.0 107.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.86 135.6 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -120.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -170.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.85 164.07 32.77 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.732 1.634 . . . . 0.0 109.266 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -61.8 139.48 58.34 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -147.96 -65.31 0.25 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.465 0.306 . . . . 0.0 111.195 -174.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.48 72.84 0.55 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.491 1.116 . . . . 0.0 108.606 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.83 113.97 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 m -73.46 85.66 1.52 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -65.92 104.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 mm -69.82 148.04 11.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.85 -23.57 67.41 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -170.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.29 31.86 0.38 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 160.04 60.89 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.922 -1.111 . . . . 0.0 109.206 169.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -61.1 145.83 98.38 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.957 1.772 . . . . 0.0 108.176 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.72 -31.47 64.55 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -56.62 -41.91 77.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.227 0.467 . . . . 0.0 111.174 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.0 mt -92.23 89.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -51.7 -47.74 63.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.022 169.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.28 -177.04 28.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.977 1.262 . . . . 0.0 111.853 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 159.93 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 118.051 0.925 . . . . 0.0 109.788 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 t -141.24 158.56 43.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.519 1.054 . . . . 0.0 109.559 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -79.82 129.92 34.88 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.436 1.095 . . . . 0.0 110.233 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.19 84.42 2.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.902 1.281 . . . . 0.0 107.894 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 53.12 34.85 18.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.624 1.17 . . . . 0.0 113.425 169.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.1 -5.26 25.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.502 1.049 . . . . 0.0 112.974 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.72 177.49 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.153 1.781 . . . . 0.0 106.495 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -134.43 156.33 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 120.555 -1.341 . . . . 0.0 109.721 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -154.18 141.4 13.49 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.352 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.11 130.07 19.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.137 1.891 . . . . 0.0 108.747 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -106.85 135.88 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 108.422 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.61 139.35 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -96.26 104.49 16.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.312 1.045 . . . . 0.0 109.094 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -29.76 70.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.328 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -38.57 83.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.5 -36.82 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -71.72 -22.16 61.67 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.37 11.22 9.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.884 1.22 . . . . 0.0 112.842 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m 55.34 25.07 7.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.556 1.542 . . . . 0.0 113.023 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -68.77 161.62 28.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.878 0.871 . . . . 0.0 111.211 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.01 165.95 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 0.0 111.293 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.4 t70 45.05 68.14 0.61 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.106 2.962 . . . . 0.0 114.073 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.09 62.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.911 1.284 . . . . 0.0 109.5 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -143.54 164.67 29.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.61 1.164 . . . . 0.0 110.99 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -81.71 66.76 7.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 169.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.32 -60.16 0.27 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.076 1.351 . . . . 0.0 109.721 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.69 -38.86 73.73 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.014 0.825 . . . . 0.0 111.476 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.469 HD21 ' CD1' ' A' ' 24' ' ' LEU . 7.2 m120 -91.86 -79.31 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -169.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.7 p 60.67 -3.56 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.929 2.092 . . . . 0.0 116.073 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.68 144.97 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 120.468 1.485 . . . . 0.0 107.211 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -120.58 139.49 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.37 133.25 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.57 134.87 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.35 163.01 30.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.755 1.622 . . . . 0.0 108.839 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.28 145.03 35.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.006 1.723 . . . . 0.0 107.547 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -159.44 142.4 14.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.49 -85.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.567 1.556 . . . . 0.0 113.047 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -143.48 16.58 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.013 -170.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.2 177.98 9.41 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.153 -0.967 . . . . 0.0 112.089 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.97 157.41 38.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 110.027 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -160.39 169.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 126.205 1.802 . . . . 0.0 107.218 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.94 168.88 30.68 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.5 pt -140.72 147.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 123.966 0.906 . . . . 0.0 108.76 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.26 139.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.988 0.915 . . . . 0.0 109.16 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.86 156.68 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 108.736 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.26 -39.4 89.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.204 0.911 . . . . 0.0 110.578 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.96 162.56 20.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.62 117.97 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -49.26 42.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.194 0.597 . . . . 0.0 110.565 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -172.44 -174.82 1.26 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.292 1.437 . . . . 0.0 108.526 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.18 131.07 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.88 146.21 40.88 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.116 0.966 . . . . 0.0 109.604 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 p -84.8 144.43 28.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 109.568 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.08 138.48 29.92 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 p -77.57 153.86 32.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.19 -10.01 37.39 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.562 -0.711 . . . . 0.0 111.756 172.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.08 -30.78 70.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.687 1.195 . . . . 0.0 110.23 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -68.07 -41.45 81.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.908 0.776 . . . . 0.0 110.124 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.87 89.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.249 1.82 . . . . 0.0 109.315 -169.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -142.79 -60.24 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-O 116.809 -1.567 . . . . 0.0 112.846 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.13 176.8 4.24 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.944 1.762 . . . . 0.0 111.491 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.1 154.01 30.36 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.892 1.277 . . . . 0.0 109.38 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -80.6 50.04 3.42 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.417 3.411 . . . . 0.0 110.646 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.54 21.09 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.114 1.766 . . . . 0.0 114.621 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -142.81 146.96 34.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.973 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.32 6.95 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.08 2.152 . . . . 0.0 115.039 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.03 165.82 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.921 1.288 . . . . 0.0 109.457 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -0.38 13.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.739 1.216 . . . . 0.0 113.996 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.3 150.77 21.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.326 0.966 . . . . 0.0 110.59 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.6 m -136.67 147.71 46.98 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -57.13 -3.18 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.346 2.258 . . . . 0.0 116.015 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.91 -38.17 23.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.797 1.239 . . . . 0.0 110.575 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -132.16 1.74 3.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.71 1.604 . . . . 0.0 111.608 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.22 132.09 12.74 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.741 2.416 . . . . 0.0 109.963 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.1 p -80.93 -169.39 2.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.774 2.83 . . . . 0.0 111.875 -170.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.98 179.27 16.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.19 149.32 44.28 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 108.206 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.72 169.69 29.89 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 169.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.53 158.84 43.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.176 0.99 . . . . 0.0 110.644 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.5 mt -146.0 67.05 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.366 1.866 . . . . 0.0 107.483 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.34 2.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.168 1.842 . . . . 0.0 113.333 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.54 -32.82 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.695 1.998 . . . . 0.0 110.625 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -69.35 153.36 43.72 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -141.89 142.4 33.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -133.34 124.18 26.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.39 109.56 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.65 116.8 18.48 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.18 141.63 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.49 0.586 . . . . 0.0 109.92 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.43 57.25 3.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.805 0.812 . . . . 0.0 109.021 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.34 -38.69 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.428 1.491 . . . . 0.0 112.732 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -67.71 -7.06 23.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.807 0.843 . . . . 0.0 113.204 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -133.1 23.48 4.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.231 1.412 . . . . 0.0 110.232 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.41 -90.96 0.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -32.34 71.89 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.17 -20.55 54.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -117.63 4.21 12.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.064 0.945 . . . . 0.0 112.22 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -113.47 -9.65 13.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.651 1.18 . . . . 0.0 111.35 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.43 -39.28 83.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.117 1.326 . . . . 0.0 111.452 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.5 ptp -59.07 -23.73 62.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 112.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.43 -29.04 12.98 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.801 1.64 . . . . 0.0 111.484 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.9 -62.19 2.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.424 1.09 . . . . 0.0 109.438 170.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -18.26 60.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.09 -168.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -52.89 -22.1 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 169.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.3 m -124.82 -41.28 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.338 1.055 . . . . 0.0 111.415 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.93 -4.33 56.36 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.35 18.33 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.17 1.35 . . . . 0.0 111.833 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.5 m 69.9 16.3 7.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.768 2.027 . . . . 0.0 111.723 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.66 -32.54 71.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.726 0.81 . . . . 0.0 109.81 169.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -132.06 -41.33 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.651 1.58 . . . . 0.0 109.631 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.694 175.621 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.6 p -77.33 -34.11 55.38 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.59 -0.694 . . . . 0.0 110.307 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 119.15 -43.06 1.64 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.994 -2.043 . . . . 0.0 107.994 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.49 -28.85 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.065 -0.668 . . . . 0.0 110.445 170.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -54.13 -17.34 2.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.55 1.54 . . . . 0.0 114.012 171.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -66.95 -22.42 65.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.147 0.885 . . . . 0.0 113.219 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.1 167.86 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.207 0.912 . . . . 0.0 111.421 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.5 167.61 10.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -141.64 81.46 1.77 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.69 -13.1 0.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.774 1.629 . . . . 0.0 112.141 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.02 27.95 1.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.196 2.198 . . . . 0.0 108.493 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -141.47 159.84 59.12 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.477 1.911 . . . . 0.0 109.033 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 132.59 31.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.723 2.282 . . . . 0.0 112.016 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 m -62.62 161.55 12.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.132 1.373 . . . . 0.0 111.591 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.67 111.56 4.01 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 169.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -134.95 165.81 24.47 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.635 1.974 . . . . 0.0 110.412 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -111.16 147.78 34.17 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.34 137.49 32.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.186 0.994 . . . . 0.0 108.927 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.7 tp -78.64 137.04 37.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.01 147.99 30.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 119.579 1.082 . . . . 0.0 108.824 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -143.12 156.48 44.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.313 1.045 . . . . 0.0 110.168 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.5 m -95.8 145.3 25.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -159.95 129.99 5.43 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 125.791 1.636 . . . . 0.0 106.904 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 39.78 87.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.323 0.963 . . . . 0.0 113.509 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.5 37.43 19.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.144 1.778 . . . . 0.0 111.751 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.46 162.1 37.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.716 2.006 . . . . 0.0 107.058 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -118.39 152.73 35.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.819 1.295 . . . . 0.0 110.496 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -138.99 161.65 36.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.016 2.126 . . . . 0.0 107.72 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.75 164.11 27.15 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.407 0.527 . . . . 0.0 112.398 169.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.2 mt -143.65 138.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -46.41 119.08 2.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.426 1.091 . . . . 0.0 109.261 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.44 -32.47 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.481 0.712 . . . . 0.0 111.865 -170.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.98 -21.11 66.79 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.468 -0.77 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -23.47 60.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.261 0.937 . . . . 0.0 111.786 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.43 143.02 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 119.021 0.828 . . . . 0.0 109.377 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -106.67 -59.53 1.79 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.563 1.145 . . . . 0.0 108.41 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.65 177.57 10.35 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 109.774 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.32 147.67 32.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -149.8 164.74 34.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.974 2.11 . . . . 0.0 106.805 -170.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.75 168.46 51.2 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.04 -1.037 . . . . 0.0 110.817 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -74.16 109.6 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -162.81 154.57 18.08 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.411 1.484 . . . . 0.0 107.783 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 26.99 56.75 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.066 2.546 . . . . 0.0 115.119 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.45 97.47 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 167.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -50.94 -41.07 58.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.522 1.129 . . . . 0.0 110.461 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 52.99 -179.81 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.402 1.881 . . . . 0.0 111.763 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.4 mm -132.7 159.48 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.16 68.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.12 36.0 0.43 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.869 0.868 . . . . 0.0 112.688 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -55.51 145.31 49.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.312 -0.868 . . . . 0.0 111.219 173.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.22 161.69 29.51 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.563 2.842 . . . . 0.0 111.316 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.1 50.22 0.47 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.172 1.789 . . . . 0.0 113.352 -170.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -157.46 -46.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.228 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.3 mt -49.19 -42.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.275 1.03 . . . . 0.0 110.745 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.4 tttp 57.41 -81.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.888 2.075 . . . . 0.0 108.97 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.35 -160.11 10.07 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 120.705 1.593 . . . . 0.0 114.469 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.89 153.78 27.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.7 t -139.22 150.38 45.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.925 0.784 . . . . 0.0 110.48 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -79.21 89.86 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.869 1.668 . . . . 0.0 110.715 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.75 90.1 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.019 0.528 . . . . 0.0 110.107 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 49.62 29.36 3.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.691 1.196 . . . . 0.0 114.004 168.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.71 -3.67 14.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.683 1.135 . . . . 0.0 114.098 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.16 -174.39 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.839 1.656 . . . . 0.0 107.445 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.62 151.39 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.535 -1.353 . . . . 0.0 110.587 -172.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.27 143.38 16.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.532 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.44 129.47 21.47 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.748 1.632 . . . . 0.0 108.323 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.62 114.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.93 172.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.402 2.281 . . . . 0.0 106.232 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -138.45 124.75 20.42 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.611 -1.306 . . . . 0.0 108.749 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -62.45 -27.97 69.48 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.376 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.92 -39.11 53.87 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.189 0.904 . . . . 0.0 111.032 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.12 -41.63 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -81.65 -7.65 59.62 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.448 -0.782 . . . . 0.0 112.874 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.85 -12.66 14.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.285 0.948 . . . . 0.0 113.13 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m 53.46 35.18 19.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.532 1.06 . . . . 0.0 111.82 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.46 162.53 15.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.524 -0.735 . . . . 0.0 110.578 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -37.82 -92.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 128.258 2.623 . . . . 0.0 115.865 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -163.87 84.01 0.45 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.789 1.236 . . . . 0.0 108.997 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -51.16 139.02 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.086 0.954 . . . . 0.0 110.523 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.27 167.95 26.4 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.688 1.595 . . . . 0.0 108.51 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -70.25 50.78 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.355 1.462 . . . . 0.0 111.92 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.406 ' H ' ' H ' ' A' ' 84' ' ' ASP . 48.8 t30 -159.58 -16.09 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.758 3.223 . . . . 0.0 110.557 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 83' ' ' ASN . 33.2 t70 -141.3 3.4 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.771 1.628 . . . . 0.0 111.692 -176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -150.21 37.13 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.434 -1.416 . . . . 0.0 109.662 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.8 p -96.14 0.14 50.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.662 1.585 . . . . 0.0 114.494 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.2 t -134.49 159.76 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.591 1.157 . . . . 0.0 108.153 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.84 131.1 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 107.051 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.63 137.62 28.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.08 135.41 53.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -136.32 166.8 22.61 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.659 1.183 . . . . 0.0 109.854 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -139.3 131.91 28.86 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 92' ' ' ASN . 5.3 mp -135.73 124.47 23.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -168.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.87 -81.91 0.12 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.909 0.766 . . . . 0.0 112.564 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.42 13.92 1.09 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.223 1.809 . . . . 0.0 110.669 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -143.5 174.43 10.77 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.466 1.106 . . . . 0.0 110.246 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.71 155.52 26.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.859 0.864 . . . . 0.0 109.592 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.18 175.27 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 126.189 1.796 . . . . 0.0 107.01 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.65 178.47 41.03 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.29 146.93 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.47 146.41 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -149.78 168.17 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 126.433 1.893 . . . . 0.0 108.893 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.79 -42.09 64.29 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.811 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.85 154.93 9.64 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.97 124.34 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 172.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -40.85 13.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.1 0.56 . . . . 0.0 111.056 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB2' HH22 ' A' ' 140' ' ' ARG . 5.8 t0 -168.04 -177.24 3.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.865 0.466 . . . . 0.0 110.882 -168.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.19 124.14 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.4 mt -140.91 171.8 13.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.703 1.201 . . . . 0.0 109.815 -168.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.4 m -126.45 134.31 50.99 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.682 0.674 . . . . 0.0 110.699 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.23 160.35 39.68 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.125 0.97 . . . . 0.0 110.194 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -145.18 161.32 39.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.23 1.412 . . . . 0.0 109.297 -168.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.22 -25.26 13.45 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.7 -38.15 86.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.073 -1.017 . . . . 0.0 109.669 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -83.07 -37.92 23.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 110.969 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.58 108.93 22.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -146.53 -58.67 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.075 -175.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 41.5 Cg_endo -67.67 173.29 9.21 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.11 1.873 . . . . 0.0 112.052 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.07 162.27 27.07 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.215 1.806 . . . . 0.0 108.335 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.46 -54.98 2.42 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.991 2.461 . . . . 0.0 112.723 -175.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 53.37 -21.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 130.392 3.477 . . . . 0.0 117.969 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -144.49 159.93 41.94 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.305 1.442 . . . . 0.0 109.582 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.6 36.07 13.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.523 1.529 . . . . 0.0 112.758 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.39 155.75 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 108.121 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -35.39 76.57 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.562 0.745 . . . . 0.0 111.304 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.4 170.44 4.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.981 1.713 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.9 m -140.83 178.98 6.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.368 2.267 . . . . 0.0 107.276 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 -27.87 2.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.571 2.349 . . . . 0.0 114.227 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.83 -18.94 62.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.422 1.489 . . . . 0.0 112.344 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.17 23.3 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.33 1.852 . . . . 0.0 109.762 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.92 115.05 27.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.482 1.513 . . . . 0.0 111.604 -169.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 145' ' ' VAL . 44.8 p -72.27 -179.1 2.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.048 2.539 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.84 172.93 15.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.943 -2.463 . . . . 0.0 106.943 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.25 157.64 43.52 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.329 1.565 . . . . 0.0 110.329 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.07 179.57 38.21 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.22 157.44 23.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.24 1.016 . . . . 0.0 111.071 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.18 81.3 1.67 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.61 2.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.6 2.047 . . . . 0.0 113.012 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.01 -32.02 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 111.043 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 107' ' ' ASP . 62.1 mtp180 -69.49 162.56 27.22 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.7 mtp -139.49 145.96 39.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.24 130.15 36.72 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.9 mt -84.07 100.94 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.45 118.03 20.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.414 ' HA ' HG22 ' A' ' 132' ' ' THR . 61.5 t -63.54 137.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -72.92 52.75 0.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.479 1.112 . . . . 0.0 110.077 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.83 -40.56 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.505 1.522 . . . . 0.0 114.784 -168.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.97 -20.91 51.79 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.669 -1.27 . . . . 0.0 111.432 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -41.96 21.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.7 tp -50.6 -45.0 57.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 110.184 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.29 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.714 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -75.93 -56.23 4.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -54.46 -46.24 73.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 110.425 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -74.33 -20.57 60.06 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.135 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.44 -47.02 80.65 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 122.122 2.237 . . . . 0.0 110.102 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.0 mtm -65.19 -45.95 82.72 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.85 96.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.074 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.3 -60.42 3.88 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.949 1.299 . . . . 0.0 109.548 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -27.98 68.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.992 -169.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.63 -23.15 26.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.317 0.647 . . . . 0.0 112.676 174.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.3 m -131.56 22.31 4.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.039 1.336 . . . . 0.0 111.705 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.07 46.3 0.68 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.447 1.499 . . . . 0.0 108.846 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.15 13.59 1.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.061 1.344 . . . . 0.0 112.983 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.6 m 63.3 41.49 7.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.328 1.451 . . . . 0.0 108.96 -169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -150.37 -77.55 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 108.694 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.41 -34.56 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.754 0.822 . . . . 0.0 110.568 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 C-N-CA 129.558 3.143 . . . . 0.0 104.692 169.73 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 m -143.91 148.12 34.95 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.56 -19.88 0.1 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.238 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.89 -32.02 60.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.996 1.898 . . . . 0.0 112.388 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -124.92 18.73 8.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.806 1.642 . . . . 0.0 110.391 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -151.83 46.6 0.78 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.825 2.05 . . . . 0.0 106.965 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -50.64 -31.11 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -168.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m 42.22 62.63 1.6 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.305 1.442 . . . . 0.0 110.765 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' A' ' 11' ' ' ALA . 50.4 tttp -58.25 144.25 41.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.469 -171.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -120.08 -7.62 9.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.78 1.632 . . . . 0.0 110.607 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 62.45 15.71 8.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.066 2.146 . . . . 0.0 111.854 -169.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -157.81 21.33 0.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.482 1.913 . . . . 0.0 110.416 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -67.0 142.37 97.29 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.511 0.725 . . . . 0.0 109.969 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.95 132.97 25.84 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.69 2.26 . . . . 0.0 111.485 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -66.41 163.11 19.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.722 1.209 . . . . 0.0 110.937 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.53 112.27 4.86 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -135.3 166.97 21.89 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.167 1.787 . . . . 0.0 110.655 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -117.79 148.52 41.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.78 135.45 29.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.918 0.887 . . . . 0.0 109.296 -169.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.9 tp -77.21 134.66 38.56 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 168.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.6 m -121.57 149.21 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.778 1.172 . . . . 0.0 109.127 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.65 150.86 44.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.477 1.111 . . . . 0.0 109.696 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -91.43 147.46 23.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 tp -140.73 101.41 4.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.37 -76.26 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.512 1.53 . . . . 0.0 112.026 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.17 31.13 0.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.428 1.491 . . . . 0.0 110.657 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.77 160.54 39.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.941 1.696 . . . . 0.0 107.952 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -119.89 153.57 35.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.191 1.472 . . . . 0.0 110.846 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -140.51 159.43 42.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.532 2.333 . . . . 0.0 107.274 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -140.55 164.26 26.34 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 118.669 0.668 . . . . 0.0 111.989 170.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 mt -142.29 135.85 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -49.0 115.81 1.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.664 1.186 . . . . 0.0 108.983 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.37 -34.12 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.438 0.695 . . . . 0.0 111.697 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.63 -24.92 67.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.759 0.824 . . . . 0.0 112.668 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -84.83 -18.64 34.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.813 0.733 . . . . 0.0 112.061 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.87 136.8 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -100.44 -56.44 2.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 108.912 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -162.31 -179.18 6.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.526 1.13 . . . . 0.0 109.75 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -136.2 147.09 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -145.28 169.38 18.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.154 1.382 . . . . 0.0 108.297 -172.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.66 148.85 19.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -82.03 100.69 9.88 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.81 1.244 . . . . 0.0 107.922 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.3 165.99 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.6 1.96 . . . . 0.0 106.587 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . 0.299 1.0 OUTLIER 42.91 30.02 0.22 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.582 2.753 . . . . 0.0 117.498 171.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.01 127.92 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 112.691 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 45.34 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.67 2.388 . . . . 0.0 110.689 -169.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.0 mm -57.37 153.43 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -18.37 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.43 23.27 0.72 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.53 155.57 67.64 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.519 0.728 . . . . 0.0 110.079 169.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -61.98 161.17 26.83 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.387 2.058 . . . . 0.0 109.01 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.52 80.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.674 -172.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -59.89 -41.08 90.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.195 0.907 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 158' ' ' LEU . 37.8 mt -71.81 82.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -53.18 -30.61 38.39 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.629 1.172 . . . . 0.0 109.455 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.98 -151.5 22.45 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.85 154.92 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -136.01 145.96 46.64 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.99 92.89 5.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.45 175.62 1.31 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -69.54 59.49 0.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.87 1.668 . . . . 0.0 113.249 -169.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.86 -6.89 3.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.168 2.318 . . . . 0.0 113.389 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER -153.71 -165.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.375 1.588 . . . . 0.0 108.458 -169.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -121.1 158.75 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.094 1.758 . . . . 0.0 108.403 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.82 142.39 15.43 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.817 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.15 147.18 59.78 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.408 2.072 . . . . 0.0 110.745 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -131.32 148.16 32.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.721 0.808 . . . . 0.0 109.04 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.84 137.31 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -95.7 124.74 39.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.78 -18.83 64.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.361 0.664 . . . . 0.0 111.98 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -60.23 -31.44 70.19 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.839 -1.163 . . . . 0.0 109.624 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.64 -47.83 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -71.79 -33.08 68.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.859 -1.067 . . . . 0.0 113.581 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.432 ' CD1' HD22 ' A' ' 126' ' ' LEU . 16.0 m-30 -121.55 3.05 10.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.816 1.189 . . . . 0.0 112.552 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.3 m 58.67 29.59 18.78 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.986 0.812 . . . . 0.0 111.317 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -57.06 142.03 43.72 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.726 0.81 . . . . 0.0 110.41 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.22 140.47 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 122.092 0.949 . . . . 0.0 111.946 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 24.68 60.55 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 130.734 3.614 . . . . 0.0 115.557 168.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.5 146.92 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -160.33 162.27 33.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.678 0.791 . . . . 0.0 109.251 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.77 40.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.872 2.469 . . . . 0.0 111.562 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -155.28 -25.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.837 2.455 . . . . 0.0 110.978 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -135.32 9.32 3.45 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 111.491 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -154.12 36.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.602 1.961 . . . . 0.0 108.478 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 p -73.41 4.88 4.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.81 165.23 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.986 1.721 . . . . 0.0 108.948 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -141.06 140.8 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.283 1.833 . . . . 0.0 106.236 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.0 134.87 56.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.62 134.13 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.46 161.62 34.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.469 1.508 . . . . 0.0 108.316 -169.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.56 148.65 39.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.38 127.34 29.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 52.35 -99.1 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 CA-C-N 118.609 0.641 . . . . 0.0 111.791 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.64 20.94 5.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.347 1.459 . . . . 0.0 111.863 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.72 166.32 22.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.479 1.112 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.89 153.03 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.525 1.13 . . . . 0.0 109.883 -171.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -160.28 176.51 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.819 1.648 . . . . 0.0 107.05 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 176.82 38.97 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 120.538 -1.351 . . . . 0.0 111.025 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.2 pt -141.79 154.1 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 124.396 1.078 . . . . 0.0 109.032 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.05 137.2 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.321 1.048 . . . . 0.0 108.304 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.25 168.09 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.15 1.38 . . . . 0.0 110.38 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.28 -40.99 64.14 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.856 -1.153 . . . . 0.0 110.619 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.31 154.53 9.52 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.83 128.23 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.47 -43.29 9.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.236 0.615 . . . . 0.0 111.321 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -168.36 -174.32 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.739 0.816 . . . . 0.0 109.874 -168.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.0 t -134.19 129.61 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -138.21 169.75 17.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.867 1.267 . . . . 0.0 109.309 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -129.24 134.93 48.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.446 0.566 . . . . 0.0 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.19 160.25 41.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.815 1.246 . . . . 0.0 109.579 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -144.06 172.7 12.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.81 2.044 . . . . 0.0 107.347 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.6 0.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -78.1 -45.42 23.46 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 120.182 1.355 . . . . 0.0 108.669 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -84.31 -32.68 24.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.111 1.364 . . . . 0.0 111.656 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.93 121.67 50.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 13.7 mmt180 -147.96 -54.86 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.604 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 52.0 Cg_endo -69.28 -178.78 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.114 1.876 . . . . 0.0 111.981 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.27 32.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.694 1.598 . . . . 0.0 109.36 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.01 58.09 6.78 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.052 3.168 . . . . 0.0 111.704 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 30.07 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.297 1.439 . . . . 0.0 112.456 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.91 30.26 0.11 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.236 2.215 . . . . 0.0 113.865 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.47 31.81 4.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.882 2.073 . . . . 0.0 113.456 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 m -78.33 175.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -57.05 -17.38 9.96 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 75' ' ' PHE . 15.7 tp -78.05 -29.34 49.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.564 0.746 . . . . 0.0 112.921 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.1 m -70.91 78.02 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.731 1.612 . . . . 0.0 111.003 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.2 p -140.21 -102.01 0.15 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.374 1.069 . . . . 0.0 112.279 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.31 -36.18 0.41 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 127.333 2.253 . . . . 0.0 109.895 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -78.92 15.49 1.08 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.8 137.6 20.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.806 2.042 . . . . 0.0 109.896 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 145' ' ' VAL . 51.8 p -81.91 -168.86 2.09 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.823 2.049 . . . . 0.0 109.877 -174.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.52 177.03 18.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 171.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -140.54 140.72 35.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.725 1.21 . . . . 0.0 107.783 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.73 173.97 30.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.84 155.11 50.83 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.69 0.796 . . . . 0.0 110.8 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.2 mt -142.31 78.11 1.61 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.002 1.721 . . . . 0.0 107.38 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.94 -51.48 3.15 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.43 1.967 . . . . 0.0 112.833 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.02 -30.56 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.278 1.831 . . . . 0.0 111.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -69.79 153.51 43.23 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 171.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.94 140.72 40.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.36 115.2 15.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.7 mt -75.61 107.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.67 111.44 21.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -65.17 126.28 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -76.43 56.89 1.13 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.674 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.66 -35.0 48.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.035 1.334 . . . . 0.0 111.51 -170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.77 -18.43 64.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.301 0.64 . . . . 0.0 112.348 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.99 -15.59 14.32 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 116.917 -1.516 . . . . 0.0 112.003 170.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.25 -63.91 1.03 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.932 1.696 . . . . 0.0 110.668 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.37 -39.55 81.72 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -60.1 -43.81 95.3 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.663 1.12 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -73.38 -16.22 61.35 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.902 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -115.58 -0.29 13.08 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.702 -1.142 . . . . 0.0 113.43 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -49.72 -53.1 26.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.022 1.737 . . . . 0.0 111.819 -173.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.62 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.551 1.069 . . . . 0.0 111.167 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 55' ' ' ILE . 23.4 tp -59.77 -53.04 62.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.727 1.211 . . . . 0.0 108.46 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.07 -11.88 61.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 118.127 -0.94 . . . . 0.0 112.389 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -54.27 -27.19 33.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.028 1.286 . . . . 0.0 110.965 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 m -115.33 -44.5 2.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.936 0.894 . . . . 0.0 110.827 169.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.89 5.33 4.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 13.6 0.31 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.356 0.98 . . . . 0.0 111.52 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 m 59.46 39.84 21.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.13 1.772 . . . . 0.0 110.326 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.39 -43.1 3.08 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.324 0.65 . . . . 0.0 111.377 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.64 -27.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.658 0.383 . . . . 0.0 110.193 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.51 1.524 . . . . 0.0 107.566 171.857 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 tpp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.28 149.68 33.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.77 56.58 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.44 161.9 18.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.999 0.919 . . . . 0.0 110.11 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -60.48 -20.1 58.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.781 1.232 . . . . 0.0 113.04 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -74.71 55.7 0.68 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 110.297 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -56.72 -26.93 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.918 1.287 . . . . 0.0 113.323 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m 47.4 51.98 12.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.808 1.243 . . . . 0.0 111.536 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 37.27 -139.07 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.977 2.111 . . . . 0.0 112.548 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.31 -66.33 0.56 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.65 -159.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.774 2.429 . . . . 0.0 105.783 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -70.44 32.53 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.355 1.462 . . . . 0.0 114.353 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.19 126.28 88.83 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.29 1.436 . . . . 0.0 108.488 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.82 134.82 24.5 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.268 1.312 . . . . 0.0 108.713 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 m -61.71 158.32 15.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.065 0.936 . . . . 0.0 111.981 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.69 96.62 0.67 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.08 138.85 58.58 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.34 143.81 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.67 139.56 33.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.997 0.919 . . . . 0.0 109.346 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 tp -83.37 130.24 35.04 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.2 152.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 109.317 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.27 153.59 45.3 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.544 1.138 . . . . 0.0 109.596 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -93.4 144.78 25.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -133.03 88.28 2.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.695 1.598 . . . . 0.0 106.742 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.75 -70.15 0.4 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.935 1.731 . . . . 0.0 112.755 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -151.24 27.73 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.37 1.468 . . . . 0.0 111.223 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.75 161.71 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.579 1.552 . . . . 0.0 108.154 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.82 150.2 46.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.464 1.126 . . . . 0.0 109.663 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -141.16 155.19 46.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.409 1.884 . . . . 0.0 107.507 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.97 158.68 22.99 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.425 1.012 . . . . 0.0 110.584 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.58 140.62 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -49.89 117.26 2.2 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.83 0.852 . . . . 0.0 109.993 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.75 -30.56 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.457 0.703 . . . . 0.0 111.569 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 mt -66.43 -4.88 9.16 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -109.88 -13.52 14.43 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 112.878 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.51 142.17 17.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 119.548 1.067 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -103.68 -57.71 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.22 -179.37 6.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.7 1.2 . . . . 0.0 109.295 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.57 149.51 31.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -143.59 174.32 10.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.28 1.432 . . . . 0.0 107.743 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.0 161.59 26.9 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 169.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.19 129.19 39.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.78 -43.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.7 41.19 0.77 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.61 135.86 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -123.43 92.33 3.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.17 111.66 5.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.2 -45.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.207 -170.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 144.73 -62.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.461 3.504 . . . . 0.0 108.696 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.82 18.47 22.08 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.673 1.189 . . . . 0.0 112.544 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.53 155.77 2.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.74 1.616 . . . . 0.0 110.003 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.24 146.65 49.0 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.726 1.617 . . . . 0.0 108.641 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -33.0 74.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.581 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -53.63 -42.5 67.84 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.976 0.807 . . . . 0.0 109.959 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.9 87.17 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -49.77 -32.09 13.04 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.317 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.62 -162.32 35.74 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.49 145.15 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -136.55 161.03 37.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 119.801 1.182 . . . . 0.0 109.178 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -80.31 108.94 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.759 0.823 . . . . 0.0 110.125 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.72 171.81 14.09 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.62 55.19 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.76 1.624 . . . . 0.0 112.831 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.01 -11.76 1.24 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.392 2.425 . . . . 0.0 113.743 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.56 -159.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 119.87 1.835 . . . . 0.0 108.828 -169.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.2 tp -121.36 155.35 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.839 1.655 . . . . 0.0 109.12 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.89 139.94 15.16 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.404 1.081 . . . . 0.0 109.314 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 141.26 47.22 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.228 1.952 . . . . 0.0 109.774 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -126.09 138.03 55.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.491 1.117 . . . . 0.0 108.602 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.12 130.44 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.11 119.47 25.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.55 -18.98 64.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.135 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -33.99 70.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 121.007 1.73 . . . . 0.0 110.278 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.03 0.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.51 1.124 . . . . 0.0 109.065 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -116.29 -30.6 5.89 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.757 -1.214 . . . . 0.0 111.616 172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -136.78 0.06 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 m 54.06 50.53 16.43 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.137 1.335 . . . . 0.0 111.941 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -54.94 169.28 0.23 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.469 1.108 . . . . 0.0 112.85 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.48 -66.46 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.391 1.477 . . . . 0.0 112.108 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.24 98.14 0.35 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 0.0 109.255 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.21 139.95 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.6 137.11 15.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.964 0.905 . . . . 0.0 109.351 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -73.23 34.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.118 2.167 . . . . 0.0 113.049 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -13.37 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.182 2.193 . . . . 0.0 110.636 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.01 8.63 4.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.628 1.171 . . . . 0.0 111.827 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.59 35.97 0.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.048 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -100.31 16.77 23.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -168.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.15 157.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.009 1.277 . . . . 0.0 107.68 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.43 111.65 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 mt -84.05 143.08 12.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.02 131.7 72.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.8 mt -134.18 166.15 23.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.957 1.703 . . . . 0.0 108.272 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.63 156.05 49.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.499 0.72 . . . . 0.0 109.845 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.54 96.93 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.51 -73.22 0.77 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.511 0.596 . . . . 0.0 113.752 174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -143.31 7.14 1.54 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.951 2.1 . . . . 0.0 111.879 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -137.73 161.99 35.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.77 1.628 . . . . 0.0 108.288 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.79 151.18 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.07 170.93 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.988 1.715 . . . . 0.0 106.92 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.83 176.96 37.4 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 120.77 -1.206 . . . . 0.0 111.233 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -145.68 144.97 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.106 0.962 . . . . 0.0 109.147 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 m -89.51 133.71 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.025 0.93 . . . . 0.0 109.119 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.08 169.59 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.34 1.456 . . . . 0.0 109.83 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.84 -43.85 67.67 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 170.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.05 156.15 11.3 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 m -71.93 123.84 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -53.97 6.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 109.857 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -174.48 177.31 2.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.015 1.726 . . . . 0.0 108.533 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.46 133.38 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.158 1.783 . . . . 0.0 107.481 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.87 178.26 10.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.936 1.294 . . . . 0.0 109.397 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 m -129.94 150.55 51.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.303 0.501 . . . . 0.0 111.91 -171.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -140.49 141.7 35.34 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.413 1.485 . . . . 0.0 107.227 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.8 p -76.95 162.71 27.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.356 0.598 . . . . 0.0 109.993 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.21 7.24 1.34 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.814 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -101.9 -37.32 8.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.719 2.008 . . . . 0.0 109.131 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.53 -41.26 98.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 106.891 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -144.23 -70.99 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.463 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.41 -174.35 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.4 2.067 . . . . 0.0 111.314 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.91 55.6 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.657 1.583 . . . . 0.0 108.929 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -82.58 38.45 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 124.133 3.222 . . . . 0.0 111.053 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.18 21.0 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.381 1.472 . . . . 0.0 114.135 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -137.52 144.74 42.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.674 1.19 . . . . 0.0 110.314 -171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.11 35.94 14.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.506 1.922 . . . . 0.0 114.479 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.24 176.84 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.42 1.488 . . . . 0.0 109.074 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -9.9 50.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 113.495 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.42 153.38 43.03 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.845 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -144.97 165.86 26.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.59 1.156 . . . . 0.0 109.318 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.7 p -56.14 -28.72 59.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.169 1.388 . . . . 0.0 113.119 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.88 -29.09 67.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.572 0.749 . . . . 0.0 112.148 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -123.67 -1.12 8.51 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.226 1.011 . . . . 0.0 112.892 -168.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.27 0.9 OUTLIER -61.71 164.87 5.64 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.378 1.085 . . . . 0.0 112.937 -171.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 145' ' ' VAL . 39.8 p -122.05 -159.47 0.82 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.142 1.777 . . . . 0.0 109.346 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.83 23.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 168.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.53 153.62 40.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.363 1.582 . . . . 0.0 109.577 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.19 172.68 39.24 Favored Glycine 0 C--N 1.333 0.377 0 O-C-N 123.09 0.244 . . . . 0.0 113.55 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.61 153.15 17.86 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.942 0.897 . . . . 0.0 110.967 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.75 79.79 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.64 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.611 2.053 . . . . 0.0 113.31 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -156.71 -33.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.504 2.322 . . . . 0.0 110.582 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -68.92 166.41 17.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.64 0.776 . . . . 0.0 110.493 172.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.8 mmm -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.66 151.08 46.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.2 mt -110.09 120.27 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.88 104.19 16.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.432 ' HA ' HG22 ' A' ' 132' ' ' THR . 60.2 t -62.64 129.89 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 126.011 1.724 . . . . 0.0 108.133 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -62.96 -28.36 70.03 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . 0.315 8.2 tp 46.31 -48.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 131.421 3.888 . . . . 0.0 116.503 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -62.62 -17.26 59.94 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.278 1.854 . . . . 0.0 113.961 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -101.93 -10.34 19.89 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 116.575 -1.679 . . . . 0.0 112.502 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.55 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.533 1.515 . . . . 0.0 111.455 -169.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.24 -29.57 64.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.613 -0.68 . . . . 0.0 110.388 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.38 -36.16 70.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.682 0.674 . . . . 0.0 111.649 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 m -91.77 -27.7 17.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.081 0.553 . . . . 0.0 111.485 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.98 -15.37 38.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.133 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.4 -36.11 77.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.196 1.816 . . . . 0.0 112.498 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -63.62 -45.78 88.71 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.744 -0.597 . . . . 0.0 109.537 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.15 87.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.122 0.569 . . . . 0.0 111.089 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.23 -64.43 0.82 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.131 1.372 . . . . 0.0 108.311 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.62 -31.26 70.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -168.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.01 -20.91 42.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.4 m -136.0 7.86 3.2 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 113.148 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -151.41 15.6 0.7 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -173.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.6 10.45 0.65 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.424 1.011 . . . . 0.0 112.788 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 73.1 -32.69 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.304 2.642 . . . . 0.0 112.785 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.94 -23.49 63.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.796 1.638 . . . . 0.0 111.539 169.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.02 19.11 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.196 1.798 . . . . 0.0 111.184 -169.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.523 178.875 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.8 p -70.0 -43.95 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.459 0.703 . . . . 0.0 110.353 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.69 179.06 31.38 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.329 1.442 . . . . 0.0 109.887 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.43 89.33 2.33 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -69.17 -18.25 63.91 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.119 0.967 . . . . 0.0 113.279 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -76.67 83.7 3.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.037 0.835 . . . . 0.0 109.731 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -62.0 -37.42 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.235 0.614 . . . . 0.0 111.887 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m 45.8 52.36 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.785 1.279 . . . . 0.0 110.29 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HG2' ' H ' ' A' ' 11' ' ' ALA . 66.2 tttt -59.88 139.89 57.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 109.762 -175.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.04 -4.52 57.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.071 0.949 . . . . 0.0 110.64 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.452 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 53.09 30.24 9.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.82 1.648 . . . . 0.0 110.785 -169.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -145.83 30.58 1.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.902 1.681 . . . . 0.0 109.046 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.44 151.46 95.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.806 0.842 . . . . 0.0 110.274 -169.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -69.26 163.07 39.29 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 110.619 172.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -62.77 165.93 6.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 110.063 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.43 100.09 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.997 1.284 . . . . 0.0 110.673 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -67.8 138.06 55.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -106.02 144.16 33.14 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.96 140.21 32.67 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.03 0.932 . . . . 0.0 110.594 -169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.08 137.04 35.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 167.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.04 151.11 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 119.782 1.174 . . . . 0.0 109.066 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -139.45 150.04 44.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.466 1.106 . . . . 0.0 109.556 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -89.71 147.02 24.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.33 106.36 4.96 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.71 -80.37 0.24 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.653 1.121 . . . . 0.0 111.756 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -153.71 32.34 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.684 1.593 . . . . 0.0 110.158 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.58 162.06 36.86 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.462 1.905 . . . . 0.0 107.707 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.58 154.96 38.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.823 1.297 . . . . 0.0 111.042 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -140.86 156.28 46.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.182 2.193 . . . . 0.0 107.593 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.22 157.03 22.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.543 1.068 . . . . 0.0 111.31 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 136.34 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.97 123.56 13.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.22 -35.04 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.604 0.762 . . . . 0.0 112.822 -169.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.8 -18.71 60.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.984 1.266 . . . . 0.0 112.681 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.45 -23.32 50.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.731 0.696 . . . . 0.0 110.55 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.61 136.96 23.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -43.9 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.268 1.027 . . . . 0.0 110.26 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -159.81 170.99 20.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.0 . . . . 0.0 109.064 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.75 142.09 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -147.62 178.59 8.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.506 1.122 . . . . 0.0 108.252 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.21 165.43 15.07 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.94 128.75 38.76 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.59 -45.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -148.35 65.72 1.08 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.876 1.27 . . . . 0.0 108.907 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 37.4 t -85.07 112.13 21.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -75.88 81.98 2.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -60.77 133.7 56.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.16 151.83 8.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -30.38 66.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.81 28.34 0.85 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.96 156.83 9.25 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.458 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.52 132.93 32.65 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 84.98 0.68 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 122.755 1.264 . . . . 0.0 111.076 -170.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -167.8 -46.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.012 4.525 . . . . 0.0 102.889 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -78.37 97.06 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.116 1.766 . . . . 0.0 108.775 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -58.68 -36.03 73.53 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.58 -147.37 9.79 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.88 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 m -122.38 165.41 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.0 t -145.34 159.83 42.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.347 -1.471 . . . . 0.0 109.124 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -81.26 96.01 7.14 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.114 0.966 . . . . 0.0 111.275 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.15 164.06 13.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -74.06 58.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.493 1.042 . . . . 0.0 113.18 -169.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.39 -15.78 0.57 Allowed Glycine 0 CA--C 1.536 1.384 0 C-N-CA 127.3 2.381 . . . . 0.0 112.945 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -151.21 -158.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 119.302 1.551 . . . . 0.0 108.653 -169.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.434 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.0 tp -125.19 153.6 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.269 1.828 . . . . 0.0 108.276 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.7 139.23 14.58 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.426 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.79 146.05 82.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.33 2.02 . . . . 0.0 111.368 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 tp -130.48 132.37 64.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 124.157 0.983 . . . . 0.0 108.965 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.72 153.46 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.4 1.88 . . . . 0.0 106.629 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -131.1 128.66 40.62 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.08 -19.09 62.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.674 1.59 . . . . 0.0 111.056 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -57.32 -27.52 62.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.635 1.107 . . . . 0.0 111.568 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.82 -46.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.64 -27.74 68.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.745 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.96 1.84 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.041 1.291 . . . . 0.0 112.317 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.9 m 55.08 44.51 27.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.177 0.991 . . . . 0.0 112.091 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . 0.289 0.0 OUTLIER -54.45 148.76 11.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.114 -0.366 . . . . 0.0 111.363 176.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 78' ' ' VAL . 6.5 t -37.91 -60.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 128.39 2.676 . . . . 0.0 114.337 -169.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -174.38 88.4 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.057 1.743 . . . . 0.0 108.968 -169.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.16 154.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.461 0.648 . . . . 0.0 110.882 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' ASN . 20.7 t0 -158.45 161.2 37.43 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.19 38.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.267 1.827 . . . . 0.0 111.375 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASP . 69.3 m-80 -151.69 -7.98 0.22 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.948 2.899 . . . . 0.0 110.282 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.34 -23.09 4.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.749 1.22 . . . . 0.0 112.664 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 34.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.666 0.787 . . . . 0.0 109.436 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 p -82.52 -13.37 56.76 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.94 153.02 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.752 1.614 . . . . 0.0 107.653 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.4 t -120.53 137.88 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 126.159 1.783 . . . . 0.0 106.326 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.77 134.66 58.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.42 136.27 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -133.38 153.56 51.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.905 1.682 . . . . 0.0 108.384 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.84 144.96 43.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.46 158.76 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 40.27 -98.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.158 1.361 . . . . 0.0 112.919 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -136.19 30.53 2.99 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.077 1.751 . . . . 0.0 110.52 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.51 178.55 8.72 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.965 -1.085 . . . . 0.0 112.256 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 p -136.82 146.32 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.473 1.509 . . . . 0.0 107.991 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.18 -178.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.636 1.574 . . . . 0.0 107.774 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.66 177.14 41.0 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 120.639 -1.288 . . . . 0.0 111.008 169.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 pt -140.22 163.21 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.11 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 m -106.82 142.1 20.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.131 0.972 . . . . 0.0 108.93 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.33 168.15 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.528 1.531 . . . . 0.0 110.019 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.42 -43.83 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.885 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.32 156.11 12.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.63 127.66 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.6 -41.88 9.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.901 0.48 . . . . 0.0 111.717 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -167.15 178.72 5.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.26 0.624 . . . . 0.0 110.576 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.4 t -136.3 125.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 pp -158.12 178.3 10.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.743 1.217 . . . . 0.0 109.677 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -129.78 150.08 51.24 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.444 0.565 . . . . 0.0 111.995 -171.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -143.32 169.31 17.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.782 1.633 . . . . 0.0 109.043 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -129.02 168.55 15.88 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.642 1.577 . . . . 0.0 109.566 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.32 -13.14 48.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.72 -33.83 75.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.603 1.092 . . . . 0.0 109.575 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -87.75 -39.6 14.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.585 1.154 . . . . 0.0 110.682 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.9 mt -91.58 101.86 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.913 0.885 . . . . 0.0 108.672 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 -143.3 -57.64 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 CA-C-O 116.624 -1.655 . . . . 0.0 113.372 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.98 175.87 3.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.951 1.767 . . . . 0.0 111.499 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.06 150.6 26.11 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.714 1.206 . . . . 0.0 109.227 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.89 44.25 1.68 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.93 3.753 . . . . 0.0 110.986 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.44 19.65 0.08 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.838 1.655 . . . . 0.0 114.053 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.5 155.85 42.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.335 1.454 . . . . 0.0 110.605 -169.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.66 33.29 10.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.525 1.93 . . . . 0.0 114.413 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.12 169.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.779 1.632 . . . . 0.0 108.858 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.98 -76.58 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.811 1.245 . . . . 0.0 109.534 172.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 127' ' ' SER . 8.1 tp 49.71 -167.23 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.626 2.371 . . . . 0.0 113.626 174.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.412 ' H ' ' HG ' ' A' ' 126' ' ' LEU . 1.6 p -155.51 145.54 21.58 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 120.976 -1.078 . . . . 0.0 110.401 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -64.41 -21.43 66.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.746 1.219 . . . . 0.0 113.91 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.69 -22.46 21.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.461 0.573 . . . . 0.0 110.464 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.31 7.82 11.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.169 0.988 . . . . 0.0 111.898 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -63.22 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 145' ' ' VAL . 22.9 p 62.51 -170.91 0.17 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.5 1.92 . . . . 0.0 113.834 168.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -143.66 176.08 23.25 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 169.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.11 143.22 38.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.44 161.97 32.07 Favored Glycine 0 CA--C 1.519 0.321 0 O-C-N 123.61 0.569 . . . . 0.0 112.442 170.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.16 153.85 17.46 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 110.313 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.75 85.05 1.87 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.41 -52.79 2.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.622 2.058 . . . . 0.0 112.804 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.52 -30.31 0.1 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.034 2.134 . . . . 0.0 111.215 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -67.67 161.67 25.35 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.809 0.844 . . . . 0.0 108.993 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 76.8 mmm -127.44 140.53 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.34 135.21 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.31 106.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.72 111.18 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 132' ' ' THR . 18.2 m -65.93 143.05 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.84 59.29 4.75 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.8 0.727 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.51 -52.62 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.68 2.392 . . . . 0.0 113.511 -168.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.08 11.44 1.82 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.696 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -135.76 20.51 3.3 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.579 1.552 . . . . 0.0 110.499 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.05 -98.33 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.86 -29.03 65.04 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.606 -1.309 . . . . 0.0 109.92 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -62.27 -15.72 49.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.4 m -124.93 5.54 8.01 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 112.029 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -122.79 2.58 9.46 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.016 0.927 . . . . 0.0 112.952 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.75 -38.99 90.02 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 119.796 -1.815 . . . . 0.0 112.312 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -62.43 -36.1 81.34 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.285 0.634 . . . . 0.0 110.566 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.21 -38.13 66.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.771 0.829 . . . . 0.0 111.08 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.27 -61.9 2.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.829 1.252 . . . . 0.0 109.126 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.64 -29.6 69.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.441 -168.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -54.81 -24.76 24.33 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.0 m -136.67 20.52 3.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.312 1.045 . . . . 0.0 112.098 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.79 12.77 0.79 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.41 11.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 113.281 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.9 m 74.0 -34.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.669 2.388 . . . . 0.0 113.028 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.94 -11.58 39.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.361 1.064 . . . . 0.0 111.266 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.89 9.17 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 127.291 2.236 . . . . 0.0 110.775 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.567 -1.206 . . . . 0.0 107.903 -178.267 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -59.95 117.72 5.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.93 -50.05 0.9 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.5 mtt -81.4 -43.74 18.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m 46.6 45.37 14.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.499 1.92 . . . . 0.0 111.833 173.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -59.83 -14.79 16.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.454 1.902 . . . . 0.0 114.425 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.4 m -64.4 -23.52 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.395 -0.816 . . . . 0.0 112.011 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -63.82 138.8 58.63 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.96 125.0 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.56 -37.82 65.41 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.342 0.519 . . . . 0.0 111.198 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.45 -145.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -85.17 -5.89 59.31 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 60.05 173.89 0.05 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.96 2.504 . . . . 0.0 113.169 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.74 124.83 17.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.808 2.339 . . . . 0.0 113.657 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -66.99 164.86 16.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.58 0.752 . . . . 0.0 109.233 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.19 111.12 3.55 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 169.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -136.89 164.0 29.35 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.531 1.932 . . . . 0.0 110.414 -169.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -110.87 149.84 30.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -141.97 134.62 28.36 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.065 0.946 . . . . 0.0 109.33 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.4 tp -74.94 139.05 42.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.82 146.54 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.691 1.132 . . . . 0.0 108.795 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -140.81 150.19 43.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.413 1.085 . . . . 0.0 110.261 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -91.02 142.6 27.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -133.24 90.92 2.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.14 -71.71 0.31 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.18 1.848 . . . . 0.0 112.222 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.62 28.66 0.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.215 1.406 . . . . 0.0 111.164 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.72 162.41 34.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.611 1.564 . . . . 0.0 108.053 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.58 150.76 45.58 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.598 1.189 . . . . 0.0 110.098 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -140.49 156.86 46.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.97 2.108 . . . . 0.0 107.506 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.9 158.1 22.72 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.589 1.09 . . . . 0.0 111.463 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 mt -144.89 133.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -48.12 115.88 1.34 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.896 1.278 . . . . 0.0 109.584 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -53.94 -39.27 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -168.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.63 -17.14 64.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.319 0.963 . . . . 0.0 112.784 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -74.2 -24.26 59.33 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.537 0.608 . . . . 0.0 110.588 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.29 138.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 119.463 1.028 . . . . 0.0 108.723 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -102.15 -57.44 2.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.858 0.863 . . . . 0.0 109.293 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -160.69 174.62 13.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.581 1.152 . . . . 0.0 108.768 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.47 139.01 46.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -141.76 179.31 6.92 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.742 1.617 . . . . 0.0 107.856 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.92 161.5 14.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -56.44 131.18 47.74 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -155.14 -46.96 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.61 81.5 1.29 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.048 0.939 . . . . 0.0 109.525 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 115.67 32.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 90.32 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 173.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 118.87 10.95 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mm -81.95 -38.46 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.7 13.66 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.851 2.06 . . . . 0.0 114.798 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.93 13.91 2.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.525 2.33 . . . . 0.0 110.233 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.66 170.79 7.35 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 130.024 3.33 . . . . 0.0 110.333 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.94 -38.53 37.6 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.968 1.779 . . . . 0.0 112.134 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 139.42 170.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.657 4.383 . . . . 0.0 106.885 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' H ' HG21 ' A' ' 73' ' ' ILE . 44.8 m-85 68.12 -53.72 0.52 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 128.137 2.575 . . . . 0.0 109.346 -169.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -72.75 82.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.326 2.25 . . . . 0.0 110.209 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -56.07 -36.59 68.28 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 109.725 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.48 -173.38 36.99 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.024 -1.56 . . . . 0.0 115.112 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.77 119.43 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -89.66 146.84 24.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.757 1.623 . . . . 0.0 110.033 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -62.02 101.58 0.22 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG 0.302 0.2 OUTLIER -78.79 64.89 3.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.161 1.384 . . . . 0.0 107.834 169.996 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 43.35 36.96 1.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.443 2.297 . . . . 0.0 112.72 170.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.44 -23.39 4.05 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.013 1.292 . . . . 0.0 112.981 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -160.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.327 1.851 . . . . 0.0 106.692 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.86 146.77 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.878 1.217 . . . . 0.0 112.398 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.12 132.5 13.64 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.049 0.94 . . . . 0.0 108.685 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.55 142.01 69.48 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 CA-C-N 121.249 1.482 . . . . 0.0 110.207 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -128.16 132.62 68.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 152.95 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.555 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -103.88 119.91 39.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.172 1.389 . . . . 0.0 107.945 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.93 -7.18 49.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.319 -0.848 . . . . 0.0 113.01 -170.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ttt85 -69.56 -38.15 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 121.338 1.881 . . . . 0.0 108.202 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.44 HG21 ' H ' ' A' ' 54' ' ' PHE . 12.3 mt -71.88 -17.73 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 0.0 110.497 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -122.46 -29.11 4.15 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.777 1.172 . . . . 0.0 113.698 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -131.72 15.32 4.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.787 1.176 . . . . 0.0 112.72 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 m 58.93 28.97 18.3 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.53 1.132 . . . . 0.0 113.113 171.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -48.51 140.92 7.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.383 0.673 . . . . 0.0 109.246 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.07 -54.15 27.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 125.301 1.44 . . . . 0.0 111.377 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -165.43 82.58 0.34 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.593 1.157 . . . . 0.0 108.423 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.3 114.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -153.21 148.98 27.51 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.368 1.067 . . . . 0.0 109.085 -175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.81 45.82 0.73 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.683 1.593 . . . . 0.0 111.944 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.82 -17.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.397 2.279 . . . . 0.0 111.284 169.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.93 -3.31 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.698 1.199 . . . . 0.0 112.178 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.58 38.03 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -85.3 -7.55 58.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.516 2.327 . . . . 0.0 117.177 -168.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.39 152.72 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 120.693 1.588 . . . . 0.0 107.911 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.17 111.99 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -87.52 142.78 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.82 134.65 63.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 mt -134.32 160.23 38.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 108.817 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 152.16 46.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.491 1.517 . . . . 0.0 107.479 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.8 130.69 13.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.89 -83.2 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.211 1.386 . . . . 0.0 113.162 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -142.19 12.48 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.337 1.855 . . . . 0.0 111.704 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -143.98 166.8 23.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.403 1.081 . . . . 0.0 110.315 -169.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.62 151.88 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.737 1.215 . . . . 0.0 109.836 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.02 177.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.057 1.743 . . . . 0.0 106.939 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.31 173.93 39.52 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 120.494 -1.379 . . . . 0.0 110.628 170.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.3 pt -142.81 145.3 23.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 108.792 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.46 135.75 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.767 0.827 . . . . 0.0 109.047 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.84 169.79 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.872 1.269 . . . . 0.0 110.091 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 -42.04 65.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.81 160.36 19.11 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.34 135.83 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.61 -42.19 6.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.95 0.9 . . . . 0.0 111.161 -173.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -168.94 -177.37 2.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.72 125.91 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -140.26 173.94 11.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.091 1.356 . . . . 0.0 109.382 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 m -129.18 138.71 51.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.153 0.888 . . . . 0.0 110.797 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -145.86 163.53 34.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.9 1.28 . . . . 0.0 110.229 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 m -141.76 174.07 10.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.382 2.273 . . . . 0.0 107.133 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.04 1.59 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.72 -51.01 8.62 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.859 -1.151 . . . . 0.0 108.04 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -70.85 -43.12 69.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.613 1.165 . . . . 0.0 110.157 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.43 116.29 33.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -142.19 -66.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 116.395 -1.765 . . . . 0.0 110.8 -171.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.8 -175.69 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.105 1.87 . . . . 0.0 111.099 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.7 154.41 31.47 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.902 1.681 . . . . 0.0 107.715 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.51 42.21 1.29 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.839 3.026 . . . . 0.0 110.987 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.17 -19.7 3.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -140.74 34.6 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.936 0.894 . . . . 0.0 110.669 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.13 19.57 2.79 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 172.36 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.592 1.957 . . . . 0.0 108.788 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 2.82 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.368 1.867 . . . . 0.0 113.75 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.14 164.6 15.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.211 2.204 . . . . 0.0 112.685 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.4 m -137.12 159.28 42.36 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.554 1.542 . . . . 0.0 108.924 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 p -61.35 -20.45 63.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.535 . . . . 0.0 113.434 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -70.09 -36.18 74.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.3 13.12 19.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.431 1.092 . . . . 0.0 109.68 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 121.43 9.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.37 1.068 . . . . 0.0 110.862 -169.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 58.6 p -81.24 -162.22 0.48 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.991 2.517 . . . . 0.0 110.518 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.53 174.86 21.08 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.88 141.96 44.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.05 177.71 32.14 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.37 156.04 47.98 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.379 1.071 . . . . 0.0 109.711 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.5 mt -141.78 77.87 1.61 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.706 1.603 . . . . 0.0 107.272 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.31 -52.28 3.38 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.512 2.005 . . . . 0.0 112.624 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.64 -29.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.398 1.879 . . . . 0.0 111.637 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -69.38 157.13 37.65 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mtp -136.0 153.69 51.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.095 170.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -145.51 135.86 24.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.4 mt -97.67 118.43 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.83 105.53 17.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.68 120.37 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.626 1.17 . . . . 0.0 107.918 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -75.62 66.2 1.93 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.966 0.889 . . . . 0.0 109.902 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tp -57.6 -35.89 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.567 1.147 . . . . 0.0 110.801 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.62 -18.84 65.62 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -114.15 -2.74 13.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.971 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.74 -75.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.971 1.308 . . . . 0.0 109.652 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.02 -28.53 63.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.887 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.39 -34.42 61.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.056 0.942 . . . . 0.0 111.83 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -103.77 -19.62 14.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.78 0.832 . . . . 0.0 111.73 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.55 -18.8 32.33 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.421 -0.799 . . . . 0.0 111.796 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.5 -35.82 76.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.94 1.245 . . . . 0.0 111.968 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.7 mtm -63.82 -41.1 97.93 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 109.952 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.84 -43.16 72.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.916 0.487 . . . . 0.0 110.459 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.63 -58.93 5.21 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.718 1.207 . . . . 0.0 109.647 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -18.37 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.36 -22.87 66.85 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -135.52 -6.55 2.23 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.64 31.2 0.65 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.452 1.101 . . . . 0.0 112.173 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 13.5 0.32 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.094 0.958 . . . . 0.0 112.644 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.2 m 71.41 -29.98 0.2 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 128.288 2.635 . . . . 0.0 113.046 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.23 -27.0 68.76 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.04 1.336 . . . . 0.0 111.215 169.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.0 m -128.3 -1.49 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 125.064 1.346 . . . . 0.0 112.556 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.849 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 p -65.54 -12.76 55.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.038 1.335 . . . . 0.0 113.745 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.2 171.74 35.77 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.54 173.69 16.33 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.447 1.499 . . . . 0.0 108.749 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.8 p -124.57 -34.57 2.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.081 0.952 . . . . 0.0 110.734 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.3 t30 42.93 43.59 3.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.415 1.886 . . . . 0.0 112.845 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.3 -170.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.977 1.311 . . . . 0.0 110.381 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -60.5 -37.59 81.57 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.301 -0.874 . . . . 0.0 111.251 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -67.99 135.39 52.25 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.32 35.55 2.51 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.153 0.981 . . . . 0.0 110.61 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.72 -53.33 13.81 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.534 -0.729 . . . . 0.0 109.626 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -147.75 10.26 0.93 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.574 1.15 . . . . 0.0 112.875 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -65.66 -32.07 5.6 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.325 1.85 . . . . 0.0 114.845 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.77 -18.52 41.87 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.432 2.088 . . . . 0.0 112.621 169.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m 46.38 40.85 8.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.255 2.222 . . . . 0.0 114.599 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.25 72.29 1.27 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -56.97 135.28 56.16 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -110.44 144.91 38.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -140.6 139.95 35.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.692 0.797 . . . . 0.0 109.554 -169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.33 134.01 35.25 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 168.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.61 148.79 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 119.274 0.943 . . . . 0.0 109.164 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -144.21 150.1 37.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.54 1.136 . . . . 0.0 109.506 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -86.71 148.0 25.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -143.42 111.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.495 1.518 . . . . 0.0 106.92 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -84.77 0.19 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.308 0.956 . . . . 0.0 111.398 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.21 32.17 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.114 1.366 . . . . 0.0 110.377 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -144.08 161.05 39.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.149 1.379 . . . . 0.0 108.236 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -118.58 150.4 39.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.648 1.213 . . . . 0.0 109.256 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.91 158.3 44.3 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.897 2.079 . . . . 0.0 107.142 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.28 24.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.856 0.741 . . . . 0.0 111.551 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mt -140.21 137.33 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.62 124.2 14.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.44 0.564 . . . . 0.0 109.708 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.99 -33.61 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.61 0.764 . . . . 0.0 112.5 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.46 -23.6 65.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.965 0.802 . . . . 0.0 111.961 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.79 -21.95 40.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.626 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.92 137.75 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.53 -43.23 2.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.759 1.223 . . . . 0.0 109.246 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -160.98 172.94 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 108.289 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.4 138.45 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -145.81 168.38 20.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.195 1.398 . . . . 0.0 107.552 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.06 164.7 27.5 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -70.1 3.88 2.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.088 1.355 . . . . 0.0 114.37 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -22.18 3.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.148 1.779 . . . . 0.0 115.714 -169.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.31 49.11 1.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.546 1.067 . . . . 0.0 112.64 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.95 110.79 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 90.45 5.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -67.87 110.67 3.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 mm -71.24 156.39 7.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.79 -24.58 65.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.7 p30 -145.98 22.63 1.39 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.494 1.117 . . . . 0.0 113.927 -169.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.03 153.74 84.05 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.28 151.33 83.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.852 1.701 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.46 75.67 4.01 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 122.097 0.951 . . . . 0.0 109.977 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -163.88 -46.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 130.613 3.565 . . . . 0.0 103.919 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.92 90.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 108.027 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -52.99 -27.83 21.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.158 0.983 . . . . 0.0 110.516 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.13 -168.69 40.54 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.905 1.229 . . . . 0.0 112.106 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.97 114.76 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -85.5 135.57 33.78 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.763 1.625 . . . . 0.0 109.049 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.39 91.48 3.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.46 174.04 2.38 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 169.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -68.86 52.59 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.417 2.287 . . . . 0.0 113.597 -169.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.34 -8.58 1.89 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.361 2.41 . . . . 0.0 113.512 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.96 -164.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 119.565 1.683 . . . . 0.0 108.848 -169.427 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.481 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.5 tp -122.74 156.14 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.466 1.906 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.98 135.42 9.44 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.437 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.82 140.01 59.55 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 121.274 1.491 . . . . 0.0 110.451 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.96 130.87 73.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.25 158.64 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -121.57 121.51 37.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.97 -22.37 66.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.29 -24.03 67.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.862 1.665 . . . . 0.0 111.785 170.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.34 -48.6 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.97 -18.25 65.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -132.13 -3.92 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.509 1.504 . . . . 0.0 112.636 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.5 m 50.08 37.41 14.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.29 1.036 . . . . 0.0 111.595 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -66.45 100.57 0.66 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.991 1.317 . . . . 0.0 109.439 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 t 39.15 -115.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 126.809 2.044 . . . . 0.0 108.733 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -158.0 100.07 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.25 1.42 . . . . 0.0 107.253 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 20.2 m -68.42 176.95 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 111.225 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -149.24 169.67 20.24 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.678 1.591 . . . . 0.0 108.917 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.36 43.3 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.638 1.975 . . . . 0.0 111.646 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -152.89 -6.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.649 3.179 . . . . 0.0 109.978 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.12 12.53 1.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.766 1.626 . . . . 0.0 111.3 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.72 25.47 0.57 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.108 2.563 . . . . 0.0 108.648 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.5 p -97.66 -2.43 41.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.4 t -110.67 160.45 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.6 t -138.29 132.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.0 mt -104.8 129.27 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.33 141.6 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -134.24 160.52 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.604 1.562 . . . . 0.0 108.852 -169.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.76 146.74 38.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.515 1.126 . . . . 0.0 108.196 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -159.6 143.82 14.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.22 5.28 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 119.414 1.006 . . . . 0.0 114.581 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 56.86 35.25 26.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.3 1.44 . . . . 0.0 113.628 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.94 173.91 11.04 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.696 1.598 . . . . 0.0 109.151 169.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.21 152.47 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.705 0.802 . . . . 0.0 110.576 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 99' ' ' GLY . 11.0 p -157.89 -175.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 106.355 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -172.04 -179.1 42.75 Favored Glycine 0 N--CA 1.448 -0.527 0 O-C-N 120.495 -1.378 . . . . 0.0 109.67 169.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 pt -141.94 144.49 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.844 0.457 . . . . 0.0 110.532 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.86 145.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 169.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.82 167.72 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.589 1.956 . . . . 0.0 108.547 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.02 -45.48 63.86 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.667 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.48 151.9 8.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.4 142.43 16.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 m -124.16 -26.96 3.91 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -168.71 178.74 4.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.653 1.115 . . . . 0.0 110.475 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.17 120.88 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.86 167.23 22.59 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.12 0.968 . . . . 0.0 110.291 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -128.07 138.15 52.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.77 0.428 . . . . 0.0 110.722 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.92 165.9 26.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 107.552 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.76 161.29 29.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -18.25 53.95 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.463 -0.773 . . . . 0.0 112.953 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.66 -36.74 83.27 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.986 -1.071 . . . . 0.0 110.45 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -76.69 -42.25 42.33 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.061 0.945 . . . . 0.0 109.848 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.78 88.91 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.203 1.001 . . . . 0.0 108.58 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 59.6 mtm180 -139.53 -55.32 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.981 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.1 Cg_endo -65.55 175.27 4.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.716 1.611 . . . . 0.0 111.315 175.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.93 157.3 30.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.848 1.259 . . . . 0.0 109.723 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.36 59.83 6.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.354 3.369 . . . . 0.0 110.048 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.39 1.4 11.79 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -148.16 160.35 43.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.369 0.986 . . . . 0.0 110.948 -172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.25 34.87 21.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.034 2.133 . . . . 0.0 114.24 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.0 161.98 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.135 1.374 . . . . 0.0 109.006 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -10.09 58.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.089 1.356 . . . . 0.0 113.426 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.2 tp -52.75 125.78 17.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.68 1.592 . . . . 0.0 113.806 -169.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -63.78 148.53 49.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 111.026 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.2 p -76.92 -16.07 59.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.982 0.913 . . . . 0.0 113.109 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -94.45 -43.07 8.53 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -80.59 7.3 10.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.76 1.224 . . . . 0.0 110.699 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.85 118.34 5.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p -69.96 -177.27 1.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.782 2.433 . . . . 0.0 110.838 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -123.39 179.17 16.21 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 mt -136.45 147.56 47.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.673 1.589 . . . . 0.0 106.878 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.35 171.26 34.62 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.17 154.19 31.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.118 0.967 . . . . 0.0 109.972 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.06 81.71 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.411 1.485 . . . . 0.0 107.052 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 -47.94 2.0 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.662 2.077 . . . . 0.0 113.672 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.53 -36.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.3 2.24 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -71.51 167.19 20.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.759 0.79 . . . . 0.0 110.056 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.0 mtp -135.13 154.79 51.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -136.75 138.22 40.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.7 mt -87.86 113.74 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.88 107.46 14.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.36 120.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.211 1.404 . . . . 0.0 107.909 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -76.72 63.89 2.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.705 0.764 . . . . 0.0 110.27 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.58 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.396 1.478 . . . . 0.0 111.321 -172.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.49 -4.19 14.16 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -126.94 22.97 6.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.558 1.143 . . . . 0.0 110.839 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 -95.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -65.57 -35.62 81.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.985 -1.072 . . . . 0.0 110.112 -173.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.16 -30.51 49.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.141 0.977 . . . . 0.0 113.051 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.5 m -114.7 -1.97 13.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.21 -9.14 11.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.771 -1.109 . . . . 0.0 113.195 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -52.66 -42.95 65.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.901 1.682 . . . . 0.0 112.168 -172.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.3 ptp -59.65 -27.56 66.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.02 1.328 . . . . 0.0 113.338 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.83 -33.48 12.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.093 1.357 . . . . 0.0 111.242 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.95 -60.12 4.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.488 1.115 . . . . 0.0 109.318 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -29.06 68.14 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.522 -169.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.47 -23.74 27.37 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.344 1.058 . . . . 0.0 112.725 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.0 m -136.05 15.93 3.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.487 1.115 . . . . 0.0 111.791 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.19 11.97 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.8 5.79 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.556 1.071 . . . . 0.0 113.369 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 73.04 -36.28 0.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.084 2.553 . . . . 0.0 113.6 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.2 -30.87 71.38 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -82.45 -6.96 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.708 1.603 . . . . 0.0 113.023 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-N 119.28 0.945 . . . . 0.0 109.289 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 m -140.05 151.62 45.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.93 179.37 48.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.16 152.45 31.26 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.553 1.141 . . . . 0.0 108.598 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -71.33 -18.07 62.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.629 0.772 . . . . 0.0 112.052 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -72.62 -5.44 37.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.682 1.193 . . . . 0.0 113.664 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.9 m -57.63 149.5 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.338 0.972 . . . . 0.0 110.574 174.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -58.98 128.55 37.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.966 0.906 . . . . 0.0 109.478 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -82.41 69.73 9.21 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.706 0.802 . . . . 0.0 109.579 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.72 10.89 6.64 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.641 1.176 . . . . 0.0 112.386 -177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.31 -52.71 0.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.493 0.717 . . . . 0.0 109.931 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -76.73 26.87 0.13 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 0.0 112.511 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.45 -26.78 2.64 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.33 -21.24 72.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.801 2.334 . . . . 0.0 114.105 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m 55.66 -162.99 0.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.739 1.216 . . . . 0.0 109.769 -169.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.11 78.0 0.81 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -65.22 151.0 47.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.252 1.421 . . . . 0.0 108.247 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.1 143.53 44.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -142.39 136.89 30.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.504 0.722 . . . . 0.0 110.272 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.74 135.87 36.62 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 167.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.16 149.49 31.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 109.098 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -146.11 151.97 38.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.255 1.022 . . . . 0.0 110.242 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.5 m -86.93 146.39 26.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.438 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -137.23 103.23 5.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.95 -86.86 0.17 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.958 0.789 . . . . 0.0 111.575 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.02 31.02 0.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.239 1.416 . . . . 0.0 110.376 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.66 159.2 42.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.711 1.605 . . . . 0.0 107.566 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -122.71 149.65 43.79 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.206 1.479 . . . . 0.0 110.785 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -137.92 161.56 36.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 107.621 -169.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.64 163.95 26.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.845 0.748 . . . . 0.0 112.145 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mt -142.75 138.04 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -48.04 114.59 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.169 . . . . 0.0 109.357 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -54.84 -34.12 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.968 0.907 . . . . 0.0 111.594 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.75 -23.87 67.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.717 0.807 . . . . 0.0 112.618 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -82.64 -19.0 39.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.948 0.794 . . . . 0.0 112.069 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.29 125.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -80.83 -57.58 3.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.02 -178.29 5.53 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.625 1.57 . . . . 0.0 108.537 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.34 141.71 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -143.4 -155.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.925 1.29 . . . . 0.0 108.186 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.15 161.84 26.41 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.33 136.09 57.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -160.3 -51.82 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.45 0.7 . . . . 0.0 110.27 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -157.63 73.06 0.69 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.173 1.389 . . . . 0.0 107.926 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.42 103.44 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 168.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.46 84.9 4.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -70.06 118.13 12.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.97 -24.06 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 118.222 0.464 . . . . 0.0 110.287 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.11 20.92 3.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.002 1.721 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -142.47 41.08 1.6 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.777 2.831 . . . . 0.0 105.127 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.88 151.18 34.42 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 109.096 -168.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.16 156.33 55.89 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.132 1.888 . . . . 0.0 108.846 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.64 -25.55 64.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -53.43 -50.33 65.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.427 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.7 mt -77.17 82.03 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -60.8 -27.39 67.99 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.562 -0.711 . . . . 0.0 110.069 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -166.45 34.81 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.903 0.774 . . . . 0.0 111.302 169.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.92 121.2 66.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -99.93 131.17 46.06 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.742 1.217 . . . . 0.0 110.739 -168.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -63.24 136.33 57.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.0 102.45 4.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 169.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.31 34.38 14.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.393 1.077 . . . . 0.0 113.139 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 9.39 55.56 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.035 0.826 . . . . 0.0 113.432 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 65' ' ' ILE . 1.6 t -131.8 -176.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 127.0 2.12 . . . . 0.0 106.816 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 64' ' ' VAL . 3.9 tp -136.82 159.07 37.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.831 1.253 . . . . 0.0 109.939 -173.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.18 140.47 13.75 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.09 132.21 23.9 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 N-CA-C 106.833 -2.026 . . . . 0.0 106.833 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -111.87 140.14 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.54 172.21 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -132.51 117.8 18.46 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.93 -24.86 67.65 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.363 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -66.46 -25.53 66.77 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 120.075 1.307 . . . . 0.0 111.687 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.7 mm -71.43 -50.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 120.053 1.297 . . . . 0.0 107.545 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -64.91 -16.93 63.87 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.94 1.81 9.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.653 1.181 . . . . 0.0 112.542 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m 47.59 38.15 7.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.579 1.152 . . . . 0.0 111.505 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.21 29.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.502 1.121 . . . . 0.0 110.681 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t 33.62 -109.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.6 2.36 . . . . 0.0 112.178 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -172.02 111.58 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.031 2.132 . . . . 0.0 105.888 -172.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -56.31 160.41 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.963 0.905 . . . . 0.0 111.462 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -153.28 149.88 28.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.219 1.008 . . . . 0.0 108.305 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.18 38.21 0.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.643 1.977 . . . . 0.0 113.163 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.14 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.099 2.16 . . . . 0.0 110.747 169.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.11 6.72 5.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.854 1.262 . . . . 0.0 111.658 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.458 HD22 ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -155.34 28.86 0.4 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.705 -1.247 . . . . 0.0 110.343 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 p -94.05 15.17 17.66 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -167.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.84 150.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.417 1.462 . . . . 0.0 107.144 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 m -119.61 135.1 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 119.691 1.132 . . . . 0.0 109.963 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -98.94 128.7 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.84 133.42 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -133.65 166.43 22.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.505 1.522 . . . . 0.0 109.617 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -139.93 154.83 47.33 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.89 0.876 . . . . 0.0 109.439 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -137.09 83.74 2.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.82 -68.66 1.9 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.057 0.837 . . . . 0.0 112.91 169.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.04 2.25 2.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.804 1.642 . . . . 0.0 112.42 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 166.27 21.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.631 1.105 . . . . 0.0 110.189 174.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.81 154.5 34.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.697 1.199 . . . . 0.0 108.842 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.33 169.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.86 175.41 30.63 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 120.82 -1.175 . . . . 0.0 110.164 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 pt -135.48 140.85 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 85' ' ' ASN . 1.4 m -75.17 135.7 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.486 0.714 . . . . 0.0 109.084 170.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 m -141.65 166.17 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.039 1.735 . . . . 0.0 108.862 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.17 -43.97 69.72 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.233 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.23 10.63 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.18 127.6 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.2 -53.69 7.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.226 0.61 . . . . 0.0 109.673 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -175.26 -176.63 0.95 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.003 1.721 . . . . 0.0 108.166 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.9 132.35 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -134.63 175.96 9.06 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.787 1.635 . . . . 0.0 108.192 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 m -133.33 143.66 49.14 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.53 141.34 33.57 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 158.9 15.56 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.445 1.098 . . . . 0.0 108.308 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.64 26.37 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.7 -31.13 63.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.937 1.295 . . . . 0.0 111.065 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.79 -39.65 30.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.375 1.47 . . . . 0.0 110.482 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.75 113.81 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.6 ttp-105 -155.2 -56.96 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 116.708 -1.615 . . . . 0.0 112.312 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.82 178.22 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.701 1.601 . . . . 0.0 111.567 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.81 156.01 29.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.43 1.492 . . . . 0.0 109.567 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.38 59.71 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.684 3.589 . . . . 0.0 111.574 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.66 31.29 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.149 1.779 . . . . 0.0 112.906 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.51 171.28 9.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.164 1.386 . . . . 0.0 110.418 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.22 30.74 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.767 1.627 . . . . 0.0 113.38 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.77 177.43 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.42 1.488 . . . . 0.0 110.119 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -9.13 15.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.425 1.49 . . . . 0.0 113.789 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.57 142.34 55.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.0 m -143.46 163.36 33.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 110.114 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -53.98 -31.54 51.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.884 1.673 . . . . 0.0 115.222 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -69.63 -26.07 64.24 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.455 1.025 . . . . 0.0 112.808 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.2 9.9 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.276 0.631 . . . . 0.0 112.597 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.11 154.73 12.35 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 118.382 0.537 . . . . 0.0 110.126 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.8 p -107.34 172.73 6.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.342 1.457 . . . . 0.0 109.335 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.39 -179.62 29.74 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.0 145.19 32.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 168.78 32.65 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.55 154.69 25.56 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.696 0.799 . . . . 0.0 109.517 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.31 80.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -174.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.42 -57.2 2.01 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.924 2.202 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -148.96 -24.91 0.3 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.315 2.246 . . . . 0.0 111.939 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -71.72 165.8 23.29 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.9 mtp -141.46 142.2 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -133.77 123.54 25.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 mt -77.42 112.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 170.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.52 108.36 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.02 128.35 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.792 1.637 . . . . 0.0 108.098 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -79.17 60.0 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.687 1.195 . . . . 0.0 110.191 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.84 168.67 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.821 0.848 . . . . 0.0 108.866 170.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.67 -18.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.136 1.775 . . . . 0.0 113.009 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -109.67 -33.56 6.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.09 -1.433 . . . . 0.0 111.38 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -48.65 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.528 1.531 . . . . 0.0 112.205 -170.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 tp -71.36 -25.96 62.6 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.176 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -56.78 -29.4 62.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.253 0.933 . . . . 0.0 112.136 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -114.82 -3.34 12.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.234 1.414 . . . . 0.0 111.678 -173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.08 2.35 19.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.534 1.534 . . . . 0.0 111.739 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.54 -44.86 77.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.444 1.098 . . . . 0.0 111.343 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.11 -37.79 88.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.003 0.921 . . . . 0.0 111.082 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 -37.25 72.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.644 0.778 . . . . 0.0 111.273 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.77 -55.1 33.71 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.06 -28.84 69.36 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.645 0.778 . . . . 0.0 112.118 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.74 -24.03 54.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.675 0.79 . . . . 0.0 112.478 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.9 m -133.19 27.62 4.15 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.31 1.044 . . . . 0.0 111.035 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.41 46.76 1.13 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.701 1.6 . . . . 0.0 108.31 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.86 14.08 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 112.82 -170.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 m 64.79 38.75 6.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.677 1.591 . . . . 0.0 109.153 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -142.5 -79.69 0.23 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.025 1.33 . . . . 0.0 108.401 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.9 m -64.53 -35.17 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.391 0 C-N-CA 129.556 3.142 . . . . 0.0 104.822 169.862 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -61.35 -14.52 27.92 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.11 -0.87 84.23 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.174 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -17.56 19.2 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.094 1.947 . . . . 0.0 113.22 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.7 p -64.94 -10.32 28.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.948 1.699 . . . . 0.0 113.147 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -71.42 37.19 0.06 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.261 1.824 . . . . 0.0 113.73 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.14 74.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 m -138.3 139.8 39.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.811 1.244 . . . . 0.0 108.753 -168.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 174.66 6.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.284 0.564 . . . . 0.0 111.409 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 10' ' ' LEU . 1.2 pt? -69.11 51.27 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.393 2.277 . . . . 0.0 113.637 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.05 -29.29 12.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.175 1.79 . . . . 0.0 114.522 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 m -131.89 20.52 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.428 1.891 . . . . 0.0 111.14 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 22.84 73.23 0.27 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 129.567 3.147 . . . . 0.0 116.935 169.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.98 -170.41 0.62 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.652 2.234 . . . . 0.0 108.886 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.9 m -43.16 126.98 4.23 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.663 1.585 . . . . 0.0 111.681 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.74 94.64 1.05 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.788 1.661 . . . . 0.0 109.109 -174.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -80.76 153.1 27.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.512 1.525 . . . . 0.0 108.724 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.02 142.52 49.73 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -142.65 143.01 32.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.348 0.659 . . . . 0.0 111.608 -169.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -83.79 133.56 34.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 167.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.98 152.08 25.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 119.875 1.216 . . . . 0.0 109.514 -174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -146.55 153.76 40.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.379 1.072 . . . . 0.0 110.46 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.6 m -90.07 147.15 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.2 tp -144.97 105.59 4.12 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.512 1.525 . . . . 0.0 107.468 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.54 -77.68 0.61 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.146 1.355 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -153.45 22.97 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.061 1.344 . . . . 0.0 112.084 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.48 160.33 40.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.175 1.39 . . . . 0.0 108.555 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -120.17 150.35 40.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.911 1.339 . . . . 0.0 110.449 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -140.12 159.49 42.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.564 1.946 . . . . 0.0 108.029 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.18 160.31 23.88 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.487 1.041 . . . . 0.0 111.092 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -140.62 139.2 35.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -50.07 115.51 1.44 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.946 0.899 . . . . 0.0 109.667 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -54.13 -33.99 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.373 1.069 . . . . 0.0 112.212 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.5 -24.97 68.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.805 0.842 . . . . 0.0 112.988 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -79.85 -18.53 50.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.024 0.829 . . . . 0.0 112.22 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.93 139.75 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.385 0.674 . . . . 0.0 109.235 -175.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -103.17 -57.96 1.95 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.451 1.1 . . . . 0.0 108.722 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.02 178.73 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.484 1.114 . . . . 0.0 109.556 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.43 144.15 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -147.66 168.71 21.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.472 1.909 . . . . 0.0 107.146 -169.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.46 -178.0 52.12 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.089 -1.007 . . . . 0.0 111.411 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -124.08 93.39 3.91 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.511 1.525 . . . . 0.0 106.942 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.49 -43.76 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.549 1.139 . . . . 0.0 109.678 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -74.07 29.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.456 1.902 . . . . 0.0 114.13 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.63 157.49 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.041 0.936 . . . . 0.0 110.878 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.7 m -141.93 148.72 39.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.381 2.672 . . . . 0.0 104.576 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -146.63 142.97 28.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.324 1.42 . . . . 0.0 109.642 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.76 140.53 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 169.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.11 -26.33 26.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -169.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -139.29 37.83 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.767 1.627 . . . . 0.0 112.422 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 48' ' ' ILE . 39.9 p -55.72 152.49 18.91 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 172.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.71 147.59 81.62 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 N-CA-C 106.163 -2.283 . . . . 0.0 106.163 167.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.35 32.48 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -61.24 -39.47 90.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.247 0.931 . . . . 0.0 110.806 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.37 80.93 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -60.73 -14.07 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.09 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.5 -141.25 9.12 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 120.579 1.536 . . . . 0.0 114.158 168.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' PRO . 18.2 m -134.07 166.19 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 128.374 2.669 . . . . 0.0 105.144 169.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 t -147.96 151.23 35.45 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.507 -1.371 . . . . 0.0 110.33 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.46 112.8 15.87 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.488 0.715 . . . . 0.0 110.78 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.38 91.74 8.27 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.59 21.67 0.93 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.089 1.756 . . . . 0.0 115.417 169.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.7 5.55 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.515 1.052 . . . . 0.0 114.079 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.81 -172.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.75 1.62 . . . . 0.0 107.55 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tp -129.41 152.59 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 120.132 1.333 . . . . 0.0 110.844 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.61 142.55 18.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.8 Cg_endo -64.32 151.74 84.22 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.691 1.594 . . . . 0.0 111.777 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tp -125.55 134.96 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.89 142.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -103.53 113.01 26.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.47 -170.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.52 -27.09 65.87 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.112 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -55.12 -46.22 75.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.019 0.827 . . . . 0.0 109.753 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.86 -38.78 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -64.73 -28.35 69.53 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.442 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.31 2.23 10.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.666 0.786 . . . . 0.0 112.725 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m 50.34 48.25 22.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.433 1.093 . . . . 0.0 111.551 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -174.99 0.3 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 111.148 175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.21 173.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.878 1.271 . . . . 0.0 110.949 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -80.78 65.61 5.99 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.589 2.356 . . . . 0.0 110.073 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 m -51.0 157.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.906 1.282 . . . . 0.0 112.744 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -151.53 176.11 11.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.9 1.68 . . . . 0.0 110.548 -171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -67.96 49.85 0.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.366 2.267 . . . . 0.0 110.686 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -149.72 -30.48 0.23 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.338 2.655 . . . . 0.0 109.986 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -141.9 19.22 2.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.127 1.371 . . . . 0.0 111.832 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -142.82 16.75 1.96 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.799 2.039 . . . . 0.0 110.484 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -73.56 3.29 6.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.631 2.772 . . . . 0.0 116.309 -168.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.04 157.45 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 119.781 1.173 . . . . 0.0 108.043 -175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.3 t -132.81 133.62 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.059 2.144 . . . . 0.0 107.632 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -99.99 134.14 40.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.293 -2.855 . . . . 0.0 103.293 168.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.91 134.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.5 mt -134.44 167.47 20.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.572 1.549 . . . . 0.0 108.703 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.04 153.4 42.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.08 141.95 20.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 170.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.36 0.02 OUTLIER Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.063 1.315 . . . . 0.0 112.148 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -146.29 9.12 1.08 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.832 1.653 . . . . 0.0 111.521 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 164.28 24.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.773 -1.204 . . . . 0.0 110.68 -173.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.46 149.73 26.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.195 1.398 . . . . 0.0 108.567 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.12 162.24 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.28 167.08 24.83 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.62 135.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.18 144.31 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -148.13 165.83 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.547 1.939 . . . . 0.0 108.315 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.37 -42.78 74.73 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.248 -0.908 . . . . 0.0 110.03 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.93 157.97 11.59 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.26 122.19 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.79 -48.43 18.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.254 0.622 . . . . 0.0 111.039 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.94 -179.78 2.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.724 1.21 . . . . 0.0 109.692 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.3 t -127.48 126.86 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.88 178.07 10.68 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.892 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.1 m -130.44 148.73 52.28 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.166 0.587 . . . . 0.0 111.053 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -143.07 143.19 31.76 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.9 p -82.84 164.92 20.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.352 0.596 . . . . 0.0 111.37 174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 14.61 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.719 1.208 . . . . 0.0 113.376 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.25 -38.49 3.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.228 1.811 . . . . 0.0 109.512 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.66 -39.5 88.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.97 121.91 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.66 1.984 . . . . 0.0 106.988 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 63.9 mtt85 -150.83 -56.33 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 117.088 -1.434 . . . . 0.0 110.61 169.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 36.5 Cg_endo -65.78 178.35 2.33 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.889 2.392 . . . . 0.0 112.704 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.05 33.48 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.254 1.421 . . . . 0.0 109.415 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -80.98 50.42 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.086 3.191 . . . . 0.0 110.441 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.5 21.21 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.521 1.529 . . . . 0.0 114.424 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -148.86 152.39 36.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.844 1.658 . . . . 0.0 109.377 -169.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.31 40.14 17.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.734 . . . . 0.0 114.008 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.2 157.94 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.861 1.265 . . . . 0.0 109.396 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -15.69 61.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.194 1.397 . . . . 0.0 112.376 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.524 HD13 ' H ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -50.52 155.85 1.0 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.378 2.271 . . . . 0.0 112.22 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' LEU . 5.5 m -130.38 156.21 45.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 110.261 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -60.05 -35.28 74.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -76.98 -15.56 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.123 1.329 . . . . 0.0 112.75 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -126.39 25.4 6.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.94 138.93 57.71 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.1 p -75.41 -174.45 2.43 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.32 1.848 . . . . 0.0 109.989 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.46 175.48 20.17 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.39 155.78 42.28 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.041 1.421 . . . . 0.0 109.506 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.38 179.82 29.43 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 123.696 0.665 . . . . 0.0 111.958 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.86 158.48 39.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -169.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.51 60.14 1.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.107 2.163 . . . . 0.0 107.463 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.25 2.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.22 1.867 . . . . 0.0 113.199 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.87 -32.35 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.73 2.012 . . . . 0.0 110.39 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -68.92 154.56 41.82 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.7 mtp -143.77 143.71 31.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.895 1.678 . . . . 0.0 106.496 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -137.01 140.48 42.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 92.4 mt -96.34 112.42 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.49 110.22 19.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.52 130.43 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.511 1.124 . . . . 0.0 108.277 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -79.98 60.61 3.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.022 1.329 . . . . 0.0 109.408 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.99 -37.14 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.514 1.126 . . . . 0.0 111.78 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.15 -26.78 68.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.374 0.534 . . . . 0.0 112.409 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -106.54 -17.47 14.24 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.856 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -50.35 -73.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.495 1.498 . . . . 0.0 110.858 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.3 tp -74.37 -26.51 60.16 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.31 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -63.56 -31.12 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.849 1.204 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -84.1 -27.59 28.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.872 0.869 . . . . 0.0 111.559 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.31 6.42 20.48 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -51.21 -48.9 61.92 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.991 1.316 . . . . 0.0 111.074 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -28.27 69.97 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.512 0.725 . . . . 0.0 112.554 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.08 -42.67 23.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.666 0.786 . . . . 0.0 110.593 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.43 -46.05 91.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.997 0.817 . . . . 0.0 109.547 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.93 -12.96 61.18 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.143 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.98 -23.57 65.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.038 1.29 . . . . 0.0 111.507 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -124.38 -42.38 2.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.493 0.717 . . . . 0.0 111.977 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.09 30.69 1.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.634 0.774 . . . . 0.0 112.795 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.75 7.3 2.02 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.54 0.736 . . . . 0.0 112.283 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 15.9 m 54.79 43.21 30.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.036 1.335 . . . . 0.0 109.873 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.19 -46.89 0.84 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.329 1.051 . . . . 0.0 110.681 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.12 -21.13 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.016 0.527 . . . . 0.0 110.528 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 C-N-CA 126.088 1.755 . . . . 0.0 107.048 169.831 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -134.84 165.87 24.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.872 2.069 . . . . 0.0 109.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.52 146.03 47.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.981 1.313 . . . . 0.0 107.485 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -141.75 138.24 32.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.477 0.711 . . . . 0.0 110.163 -168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.5 tp -78.71 132.63 37.07 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.267 2.0 m -117.91 146.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 119.24 0.927 . . . . 0.0 108.617 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -141.0 164.99 28.79 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.208 1.003 . . . . 0.0 110.537 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 m -121.01 146.02 47.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.78 134.04 14.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.8 -92.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.771 1.177 . . . . 0.0 110.363 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -151.28 37.84 0.62 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.06 1.344 . . . . 0.0 109.493 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -140.04 154.4 47.08 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.386 1.474 . . . . 0.0 108.433 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.93 155.46 31.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.799 1.285 . . . . 0.0 109.983 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -143.68 158.55 43.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.418 1.887 . . . . 0.0 107.901 -169.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.25 154.86 20.78 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.084 1.326 . . . . 0.0 110.024 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.1 mt -139.89 135.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.41 124.18 15.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.799 0.727 . . . . 0.0 109.177 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.69 -34.09 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.463 0.705 . . . . 0.0 112.631 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 mt -68.18 -24.36 64.96 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.853 0.751 . . . . 0.0 112.131 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.88 -14.51 50.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.953 0.797 . . . . 0.0 111.555 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.71 128.1 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -87.43 -55.7 3.68 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.432 1.093 . . . . 0.0 108.464 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -167.24 -178.06 3.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.866 1.266 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.91 142.69 43.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -167.77 2.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.448 1.499 . . . . 0.0 107.885 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.99 160.45 21.26 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -75.74 -0.96 22.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -5.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -168.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 34.19 1.39 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.343 1.429 . . . . 0.0 113.576 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.44 140.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.4 m -129.77 91.53 3.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -68.18 112.5 5.14 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.23 157.11 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.3 72.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -139.23 22.91 2.57 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.05 156.71 66.44 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -59.77 142.02 97.91 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.68 68.01 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.365 -0.835 . . . . 0.0 112.78 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -52.27 -40.56 61.9 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.541 0.609 . . . . 0.0 110.239 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.18 94.99 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -50.01 -33.12 17.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.286 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.62 177.01 31.3 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.9 153.92 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -140.63 163.42 32.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.732 1.151 . . . . 0.0 108.794 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -89.28 113.31 24.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.043 0.937 . . . . 0.0 110.75 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.48 171.66 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.4 mtp-105 -72.61 64.61 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.273 1.397 . . . . 0.0 112.81 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.96 -9.83 2.29 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 127.076 2.274 . . . . 0.0 113.24 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.34 -164.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 119.231 1.516 . . . . 0.0 108.536 -169.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.9 tp -127.81 157.04 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.174 1.79 . . . . 0.0 108.525 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p -151.38 141.99 14.93 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.44 138.36 42.17 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.183 1.922 . . . . 0.0 109.991 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.86 137.45 56.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.68 1.192 . . . . 0.0 108.319 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.99 139.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -97.89 120.69 38.72 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.303 0.641 . . . . 0.0 109.651 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -68.29 -18.87 64.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.175 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.21 -37.17 86.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.862 1.665 . . . . 0.0 110.455 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.26 -48.02 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -73.98 -27.4 60.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.324 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.31 11.44 2.56 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.948 1.249 . . . . 0.0 113.335 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m 60.63 34.1 20.2 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.606 -1.309 . . . . 0.0 112.926 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -50.85 155.2 1.22 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.645 0.778 . . . . 0.0 112.503 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 t -59.16 -64.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.786 1.234 . . . . 0.0 113.192 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -157.23 63.19 0.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.775 0.797 . . . . 0.0 111.457 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.54 135.55 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -158.39 158.52 34.38 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.482 1.513 . . . . 0.0 108.427 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.01 48.43 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.85 1.66 . . . . 0.0 112.767 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER -155.1 -16.08 0.11 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.961 2.904 . . . . 0.0 109.987 169.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 83' ' ' ASN . 32.2 t70 -119.69 -8.11 9.97 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.486 1.914 . . . . 0.0 111.562 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.48 35.14 1.84 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.687 1.595 . . . . 0.0 109.775 -169.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -100.08 -11.56 20.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -168.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.28 157.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.08 133.06 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.3 mt -107.67 133.76 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.27 137.92 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.8 mt -136.0 154.68 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.726 1.611 . . . . 0.0 107.549 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.47 149.64 42.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.32 176.02 8.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -11.67 -65.71 0.01 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 128.096 2.76 . . . . 0.0 116.24 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -137.95 26.63 2.72 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 111.638 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -151.4 164.63 36.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.778 -1.201 . . . . 0.0 111.952 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.17 144.12 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 0.0 109.015 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -157.64 -178.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.618 1.567 . . . . 0.0 107.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.62 -179.69 41.02 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.538 -1.352 . . . . 0.0 110.526 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.9 pt -141.91 144.21 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.108 0.963 . . . . 0.0 108.915 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 m -79.44 141.87 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.134 1.374 . . . . 0.0 108.46 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.98 163.21 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.256 1.822 . . . . 0.0 110.275 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -80.11 -46.7 16.01 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.954 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.56 161.94 31.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.71 116.49 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -41.57 34.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.573 0.749 . . . . 0.0 111.601 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -170.16 -174.82 1.83 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.65 123.45 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.6 mt -140.27 171.52 14.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.626 1.171 . . . . 0.0 109.994 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 m -125.6 139.38 53.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.091 0.556 . . . . 0.0 110.131 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.78 159.46 42.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.6 1.16 . . . . 0.0 109.366 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -122.38 155.18 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.117 2.167 . . . . 0.0 106.941 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -27.74 63.66 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.121 -0.987 . . . . 0.0 112.498 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.21 -33.64 73.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.634 1.173 . . . . 0.0 111.234 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -78.0 -42.31 33.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 109.617 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.5 mt -85.41 68.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.287 1.435 . . . . 0.0 109.11 -170.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 41.7 mtm180 -113.75 -60.53 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.367 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 42.2 Cg_endo -67.45 -179.1 1.74 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.034 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.19 32.52 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.774 1.63 . . . . 0.0 108.874 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.1 51.29 3.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.613 2.876 . . . . 0.0 110.709 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.83 27.89 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.832 2.053 . . . . 0.0 114.103 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -65.4 176.64 1.34 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 110.46 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.73 32.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.457 1.903 . . . . 0.0 113.685 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 m -66.93 167.09 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.188 0.995 . . . . 0.0 109.914 169.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -63.82 -16.1 60.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 0.0 113.391 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.44 108.61 4.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.562 1.145 . . . . 0.0 111.01 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 m -67.53 155.47 39.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.052 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -66.07 -34.07 77.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.611 1.164 . . . . 0.0 112.543 -171.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.16 -17.45 62.54 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.601 -1.312 . . . . 0.0 113.241 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.77 26.13 5.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.785 0.834 . . . . 0.0 109.939 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.54 140.02 54.83 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 145' ' ' VAL . 35.1 p -70.28 -176.5 1.21 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.597 1.959 . . . . 0.0 110.66 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.02 178.89 16.39 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 169.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.1 mt -134.64 150.72 50.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.46 171.1 34.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.65 157.21 25.76 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.209 1.004 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.8 79.12 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.99 -50.96 2.72 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.7 2.095 . . . . 0.0 112.869 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.31 -30.53 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.223 2.209 . . . . 0.0 111.023 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -66.55 164.75 15.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.139 0.976 . . . . 0.0 108.886 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.7 mtp -139.17 150.74 45.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.764 1.226 . . . . 0.0 108.072 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.4 mt -138.53 137.92 37.52 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.678 1.191 . . . . 0.0 107.908 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 98.8 mt -86.89 113.29 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.03 109.23 15.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.583 ' HA ' HG22 ' A' ' 132' ' ' THR . 67.3 t -64.24 128.92 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -75.24 51.61 0.55 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.77 1.228 . . . . 0.0 110.859 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 tp -57.23 -40.67 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.998 -1.064 . . . . 0.0 111.979 -169.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.94 -10.61 40.64 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.39 0.65 6.99 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.765 169.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.84 -69.07 0.25 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.838 1.199 . . . . 0.0 109.924 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.94 -33.25 74.31 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.89 -46.22 78.41 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.747 -0.595 . . . . 0.0 110.647 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -77.2 -22.46 52.32 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.282 0.633 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.44 -15.0 19.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.186 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.24 -48.08 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.495 1.498 . . . . 0.0 111.737 -169.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.9 ptp -60.86 -27.72 68.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.028 0.931 . . . . 0.0 113.007 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.62 -34.99 12.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.59 1.156 . . . . 0.0 111.282 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.78 -62.17 2.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.224 1.41 . . . . 0.0 109.004 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -26.68 66.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -169.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.466 0.361 0 C-N-CA 123.896 0.878 . . . . 0.0 112.643 -177.619 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.629 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.47 168.02 20.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.997 2.119 . . . . 0.0 110.291 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -121.54 147.39 45.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.85 137.28 31.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 109.416 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.4 tp -77.75 136.58 38.17 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 167.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.252 1.6 m -124.92 148.54 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 119.657 1.117 . . . . 0.0 109.078 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -140.64 150.17 43.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.677 1.191 . . . . 0.0 109.665 -172.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.3 m -91.09 146.71 23.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp -134.69 90.23 2.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.6 -71.53 0.37 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.815 1.674 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.56 28.85 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.504 1.522 . . . . 0.0 111.047 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.45 161.49 36.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.779 1.632 . . . . 0.0 107.939 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -122.99 151.07 42.19 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.516 1.15 . . . . 0.0 109.76 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -142.15 158.57 43.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.961 2.105 . . . . 0.0 107.437 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.87 161.27 24.52 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.43 1.014 . . . . 0.0 111.237 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.41 135.14 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -48.42 116.7 1.67 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 109.302 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.96 -33.34 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.332 0.653 . . . . 0.0 111.441 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.95 -22.94 67.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.591 0.756 . . . . 0.0 112.588 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -82.62 -19.93 37.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.99 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.65 142.15 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 119.194 0.907 . . . . 0.0 108.771 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.79 -53.92 2.66 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.401 1.081 . . . . 0.0 108.567 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.91 -176.5 4.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.569 1.147 . . . . 0.0 109.821 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.7 149.15 31.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -151.85 -157.9 0.85 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.379 1.872 . . . . 0.0 107.786 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.53 151.58 18.95 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 120.116 1.326 . . . . 0.0 112.691 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -77.02 91.23 3.62 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.122 1.369 . . . . 0.0 107.468 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -149.03 -18.11 0.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 51.91 1.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.094 0.861 . . . . 0.0 111.005 -169.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.45 152.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 O-C-N 120.674 -1.266 . . . . 0.0 110.463 169.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -133.56 131.03 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -128.26 133.74 48.85 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -168.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 mm -79.38 159.93 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.52 63.08 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.84 28.32 0.37 Allowed 'General case' 0 C--N 1.341 0.226 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -169.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.53 154.65 78.83 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.309 169.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -63.13 136.21 54.95 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.096 1.864 . . . . 0.0 107.671 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.83 -28.15 47.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -52.57 -46.08 66.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.663 0.665 . . . . 0.0 110.282 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.4 94.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -51.32 -47.44 62.64 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.96 -129.16 1.52 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 165.99 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.802 1.241 . . . . 0.0 107.866 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.5 t -145.54 173.33 12.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 p-10 -82.89 160.95 22.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 120.796 -1.19 . . . . 0.0 111.608 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -121.89 168.97 11.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 167.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.36 58.43 0.26 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.641 1.576 . . . . 0.0 111.942 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.72 -13.95 1.18 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 127.111 2.291 . . . . 0.0 113.563 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.63 -161.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.762 1.781 . . . . 0.0 109.036 -169.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.483 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.2 tp -119.28 158.77 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.924 1.689 . . . . 0.0 108.928 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.59 137.81 12.54 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 109.617 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.62 144.14 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.953 1.769 . . . . 0.0 109.469 169.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.3 136.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.39 150.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -123.83 128.76 49.98 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.76 -15.63 63.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.431 -0.319 . . . . 0.0 110.942 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -58.54 -21.35 52.19 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.879 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mt -127.91 23.16 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.351 2.26 . . . . 0.0 108.534 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -139.36 -27.88 0.79 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.724 -1.235 . . . . 0.0 112.352 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.24 15.57 4.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.962 0.905 . . . . 0.0 111.229 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m 51.16 47.45 24.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.738 1.615 . . . . 0.0 111.476 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -53.74 166.7 0.3 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.727 1.211 . . . . 0.0 111.4 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -60.99 169.66 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.81 0.844 . . . . 0.0 109.609 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.53 71.38 0.95 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 128.73 2.812 . . . . 0.0 110.691 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.5 m -38.81 153.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 128.627 2.771 . . . . 0.0 114.09 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.52 161.49 42.18 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.308 1.443 . . . . 0.0 108.518 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -72.11 49.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.869 1.668 . . . . 0.0 111.212 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.23 -19.67 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.808 2.843 . . . . 0.0 110.152 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.82 -15.31 3.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.779 1.232 . . . . 0.0 112.324 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -145.4 47.75 1.28 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.804 1.241 . . . . 0.0 108.322 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.3 p -78.15 -4.81 49.39 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.358 2.663 . . . . 0.0 117.644 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.11 153.85 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 121.463 1.938 . . . . 0.0 109.091 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.22 122.23 62.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.086 1.754 . . . . 0.0 107.233 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.4 mt -93.57 140.6 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.0 133.71 60.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.77 165.74 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.047 1.739 . . . . 0.0 108.953 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.13 153.39 51.85 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.295 1.038 . . . . 0.0 110.007 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -133.79 85.6 2.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.88 -67.7 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.781 1.658 . . . . 0.0 113.72 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -136.15 3.19 2.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.863 1.665 . . . . 0.0 112.338 -171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.71 169.25 16.45 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 110.066 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.871 1.269 . . . . 0.0 108.992 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.41 ' HB ' HD22 ' A' ' 151' ' ' LEU . 13.1 p -157.49 171.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.447 1.499 . . . . 0.0 107.194 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.07 171.59 32.06 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -138.46 143.7 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.877 0.871 . . . . 0.0 108.79 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.83 134.44 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 108.943 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.36 170.5 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 125.581 1.552 . . . . 0.0 109.914 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.41 -41.87 72.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.53 158.83 10.99 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.74 130.73 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.17 -42.64 7.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.266 1.026 . . . . 0.0 111.358 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -168.18 -175.57 2.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 109.877 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.04 127.27 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 169.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -137.36 165.31 26.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.429 1.092 . . . . 0.0 109.524 -169.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 m -124.41 130.56 52.7 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.33 162.52 33.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.927 . . . . 0.0 108.962 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -138.15 159.93 40.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.908 1.283 . . . . 0.0 108.538 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.18 -23.4 8.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.18 -34.43 74.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.04 -1.038 . . . . 0.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -85.29 -38.68 18.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.177 1.391 . . . . 0.0 110.554 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.54 102.67 13.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 36.6 mtm105 -140.15 -56.93 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.948 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.8 Cg_endo -65.53 168.68 14.17 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.712 1.608 . . . . 0.0 111.354 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.03 154.71 29.27 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.31 1.444 . . . . 0.0 108.957 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.26 146.57 71.31 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.739 2.293 . . . . 0.0 110.91 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.06 18.99 0.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.577 1.151 . . . . 0.0 110.757 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -73.65 170.29 15.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 111.121 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.97 65.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.701 1.6 . . . . 0.0 110.584 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.47 175.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.455 1.502 . . . . 0.0 109.66 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.92 11.53 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.413 1.885 . . . . 0.0 114.942 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.7 158.04 18.92 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.285 1.434 . . . . 0.0 110.227 -173.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -142.42 148.08 37.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 110.969 -171.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -55.77 -29.45 59.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.144 1.777 . . . . 0.0 114.406 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.68 -22.58 65.28 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.71 25.66 1.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.542 1.064 . . . . 0.0 112.517 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.62 18.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 145' ' ' VAL . 18.7 p 64.86 -170.99 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.429 1.492 . . . . 0.0 112.151 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.65 28.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 106.584 -2.606 . . . . 0.0 106.584 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.66 153.74 39.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.465 1.633 . . . . 0.0 109.491 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.97 173.2 35.22 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.11 157.8 16.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.266 1.026 . . . . 0.0 111.202 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.07 72.48 1.38 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.187 1.795 . . . . 0.0 107.143 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.8 -46.36 2.03 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.385 1.945 . . . . 0.0 113.724 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -36.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.19 2.196 . . . . 0.0 110.403 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -73.55 166.09 23.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.655 0.741 . . . . 0.0 110.031 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.5 mtp -141.03 148.4 40.19 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.4 153.94 36.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.689 0.796 . . . . 0.0 110.459 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 79.5 mt -104.89 109.97 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.349 1.459 . . . . 0.0 107.178 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.31 108.13 15.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.035 1.334 . . . . 0.0 107.736 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.8 t -62.3 131.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.547 1.139 . . . . 0.0 108.138 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -78.74 60.54 2.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.61 0.719 . . . . 0.0 109.643 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 tp -54.42 -39.01 42.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 C-N-CA 124.764 1.226 . . . . 0.0 111.147 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.45 -13.16 60.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.747 0.703 . . . . 0.0 112.568 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -111.81 -7.72 14.18 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.872 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.42 -77.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.641 1.11 . . . . 0.0 110.742 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 98' ' ' VAL . 54.2 tp -67.49 -20.1 65.41 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.33 -0.856 . . . . 0.0 110.443 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.49 -37.43 75.52 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.097 -1.002 . . . . 0.0 110.664 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 m -85.82 -30.14 23.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.695 0.798 . . . . 0.0 111.242 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -90.96 -9.44 46.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.938 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -49.31 -47.96 46.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.763 1.619 . . . . 0.0 111.792 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -63.42 -44.7 93.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.717 0.407 . . . . 0.0 109.956 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.49 82.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.325 0.65 . . . . 0.0 111.368 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.24 -58.62 7.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.718 1.207 . . . . 0.0 109.321 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.86 62.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.432 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 112.917 174.809 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -69.89 163.84 25.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.081 0.553 . . . . 0.0 109.609 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -124.91 143.28 50.94 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.539 1.536 . . . . 0.0 107.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -142.3 136.79 30.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.648 0.779 . . . . 0.0 110.501 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.6 tp -77.88 135.97 37.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 167.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.28 152.88 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.736 1.153 . . . . 0.0 109.57 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -140.38 151.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 109.56 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -93.38 146.53 23.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -156.0 134.95 11.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 169.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -98.52 0.53 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.31 36.71 0.67 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.348 1.459 . . . . 0.0 108.776 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.02 161.0 39.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.156 1.782 . . . . 0.0 107.852 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -120.1 156.4 31.09 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.117 1.437 . . . . 0.0 110.457 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -138.11 147.73 44.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.943 2.097 . . . . 0.0 106.457 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.48 156.64 15.97 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.49 134.9 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -49.52 115.5 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.034 0.934 . . . . 0.0 109.111 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.54 -33.1 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.702 . . . . 0.0 111.712 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.84 -24.8 67.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.687 0.795 . . . . 0.0 112.606 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -83.16 -17.73 41.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.682 0.674 . . . . 0.0 111.763 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.8 145.25 13.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.632 1.106 . . . . 0.0 109.087 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -123.05 -47.16 2.05 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.073 0.949 . . . . 0.0 111.346 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -162.84 172.41 15.2 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.609 0.764 . . . . 0.0 109.487 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.25 144.54 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 106.595 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -148.05 176.53 10.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.619 1.567 . . . . 0.0 108.04 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.33 168.92 44.97 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -83.49 -164.42 0.9 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 110.032 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 60.3 38.33 19.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.275 1.83 . . . . 0.0 112.859 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -141.14 26.76 1.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.635 1.574 . . . . 0.0 109.767 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 102.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 120.97 -1.082 . . . . 0.0 108.424 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -61.95 -44.51 96.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.518 . . . . 0.0 110.46 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' VAL . 6.7 mtm105 56.53 -176.52 0.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.828 2.051 . . . . 0.0 112.515 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mm -133.55 160.23 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.88 -23.12 67.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.74 27.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 148.26 57.71 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 122.765 0.426 . . . . 0.0 110.947 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.31 152.68 66.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.21 2.607 . . . . 0.0 110.041 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.33 73.81 0.98 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.599 1.19 . . . . 0.0 110.528 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -162.72 -52.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 130.12 3.368 . . . . 0.0 103.696 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.3 mt -75.42 92.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -51.01 -41.4 59.77 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.912 0.885 . . . . 0.0 108.9 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.85 -156.04 19.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 47' ' ' ARG . 25.6 m -124.1 151.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -136.34 148.26 47.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -80.62 92.34 5.95 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.404 1.081 . . . . 0.0 109.895 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.58 171.65 4.88 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -67.14 63.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.182 1.793 . . . . 0.0 113.155 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.21 -8.63 3.8 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.968 2.223 . . . . 0.0 113.507 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -152.83 -165.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 119.104 1.452 . . . . 0.0 108.342 -169.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.469 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.4 tp -121.62 157.88 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.546 1.938 . . . . 0.0 107.709 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.72 138.79 12.71 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.896 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.38 145.29 64.84 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.181 1.92 . . . . 0.0 110.049 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -129.05 138.31 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.82 164.34 11.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -132.14 126.98 34.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.0 -21.99 64.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.122 1.369 . . . . 0.0 111.665 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -37.67 80.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.274 1.397 . . . . 0.0 110.101 169.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.85 -57.0 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -66.64 -28.78 68.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.861 0.864 . . . . 0.0 113.199 -169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -135.11 5.93 3.32 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.3 m 53.14 41.87 32.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.183 0.901 . . . . 0.0 111.687 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -52.6 146.3 10.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.1 t -44.92 -61.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 112.742 -169.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -175.21 86.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.79 1.636 . . . . 0.0 108.657 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.7 144.1 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.84 163.92 31.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 109.493 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.55 42.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.722 2.409 . . . . 0.0 112.889 172.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.05 -12.87 0.16 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.161 2.184 . . . . 0.0 111.318 170.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.71 -5.94 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.335 1.454 . . . . 0.0 111.735 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.41 44.24 1.52 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.452 -1.405 . . . . 0.0 108.762 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 p -99.38 -2.97 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.344 1.858 . . . . 0.0 114.297 -169.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.6 t -128.06 154.79 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.16 130.68 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.129 1.771 . . . . 0.0 106.341 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.2 mt -102.7 138.22 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.17 133.76 54.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.3 mt -133.53 163.69 28.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.607 1.563 . . . . 0.0 107.922 -170.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.84 146.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.853 1.261 . . . . 0.0 107.674 171.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.7 157.34 43.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.52 -112.44 2.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.82 27.04 5.79 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.511 1.524 . . . . 0.0 110.383 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -141.14 171.27 14.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.401 1.081 . . . . 0.0 110.835 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.76 154.27 38.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.229 1.011 . . . . 0.0 110.704 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.6 p -161.28 176.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.324 1.85 . . . . 0.0 106.878 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.24 -179.87 37.98 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 120.548 -1.345 . . . . 0.0 111.785 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 pt -142.46 155.97 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.519 1.528 . . . . 0.0 108.579 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.2 143.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.55 171.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.411 1.884 . . . . 0.0 110.086 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.59 -42.51 42.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.776 0.716 . . . . 0.0 109.973 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.63 153.42 9.69 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 173.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.57 123.99 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.9 -52.86 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.313 0.645 . . . . 0.0 110.373 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -173.23 -177.17 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.941 1.697 . . . . 0.0 108.093 -169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -117.26 132.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.8 mt -135.09 174.42 10.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.762 1.625 . . . . 0.0 108.665 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -132.4 141.72 48.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.213 0.605 . . . . 0.0 109.587 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.7 134.97 27.52 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 51.8 p -76.77 163.76 26.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.321 0.581 . . . . 0.0 110.712 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.99 10.01 0.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.377 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.99 -40.46 5.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.418 2.287 . . . . 0.0 108.851 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -61.13 -47.43 86.31 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.1 mt -67.21 119.6 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -151.3 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.15 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -177.58 2.66 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.247 1.964 . . . . 0.0 111.257 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.36 153.64 29.56 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.377 1.471 . . . . 0.0 108.707 169.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.14 51.05 3.52 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.603 3.535 . . . . 0.0 110.65 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 7.7 1.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.634 1.573 . . . . 0.0 114.847 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -146.1 160.07 42.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.3 32.95 14.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.738 2.015 . . . . 0.0 114.367 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.21 166.13 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.599 1.56 . . . . 0.0 108.697 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -5.36 34.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 113.747 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.22 156.8 11.69 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.989 1.716 . . . . 0.0 111.632 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 m -133.45 151.14 51.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.362 0.665 . . . . 0.0 112.103 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -57.32 -23.95 52.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.399 1.88 . . . . 0.0 114.49 -169.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -66.25 -32.22 73.51 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.817 0.735 . . . . 0.0 111.414 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.25 29.41 1.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.772 0.829 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 145' ' ' VAL . 21.4 p 62.31 -163.35 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.238 1.415 . . . . 0.0 111.434 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -149.18 177.94 27.05 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 171.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -139.89 142.28 36.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.57 172.94 31.69 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.7 157.16 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.24 0.543 . . . . 0.0 111.83 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.53 68.01 1.38 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.539 2.336 . . . . 0.0 106.699 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.04 -48.18 2.7 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.471 1.986 . . . . 0.0 113.584 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -145.89 -32.2 0.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.429 1.892 . . . . 0.0 110.933 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -70.23 151.35 45.45 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.3 mtp -139.22 143.34 38.01 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.92 120.19 22.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.54 114.34 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.82 99.54 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 132' ' ' THR . 64.1 t -59.91 122.52 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 108.24 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -80.25 60.59 3.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.502 0.667 . . . . 0.0 110.371 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.69 -37.17 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.068 1.347 . . . . 0.0 111.578 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.37 -27.93 69.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.276 0.489 . . . . 0.0 111.554 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -97.01 -28.28 14.23 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 116.772 -1.585 . . . . 0.0 112.218 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -47.35 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.461 1.504 . . . . 0.0 112.451 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.65 -35.01 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -58.58 -34.11 70.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 112.535 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 m -99.4 -14.3 19.21 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.357 1.063 . . . . 0.0 111.473 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.7 -2.69 56.91 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.143 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -52.84 -42.98 65.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.208 1.367 . . . . 0.0 112.051 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -66.8 -24.08 66.13 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.202 1.401 . . . . 0.0 112.368 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.68 -31.21 13.92 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.415 1.486 . . . . 0.0 111.002 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.81 -62.81 1.59 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.738 1.215 . . . . 0.0 109.167 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -67.84 -29.73 68.95 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.891 -169.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 124.085 0.954 . . . . 0.0 112.81 177.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 112' ' ' THR . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -145.59 155.74 43.24 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.469 1.908 . . . . 0.0 109.266 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -103.29 147.45 27.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 144' ' ' LEU . 96.8 m-85 -141.88 135.45 29.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.451 1.1 . . . . 0.0 109.154 -169.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.43 132.74 37.43 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 167.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.93 149.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 119.719 1.145 . . . . 0.0 108.764 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.46 148.3 37.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.917 0.887 . . . . 0.0 110.039 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 m -89.4 146.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 102' ' ' VAL . 44.4 tp -150.41 133.29 15.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.61 -93.16 0.04 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.73 37.25 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.51 163.81 34.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.746 1.218 . . . . 0.0 108.755 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.29 151.13 36.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 123.026 1.393 . . . . 0.0 110.753 173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -138.5 158.02 45.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.457 2.303 . . . . 0.0 107.139 -171.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.82 158.81 23.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.107 0.86 . . . . 0.0 111.007 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -48.79 118.23 2.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.09 0.956 . . . . 0.0 108.696 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.42 -33.49 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.123 0.569 . . . . 0.0 111.754 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.91 -23.62 67.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.532 0.733 . . . . 0.0 112.701 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -80.97 -21.27 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.756 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.79 141.89 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.309 0.958 . . . . 0.0 108.452 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -118.07 -46.61 2.61 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.554 1.142 . . . . 0.0 110.278 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -162.47 172.09 16.07 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.622 1.169 . . . . 0.0 108.66 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -135.46 141.21 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -145.15 177.51 8.74 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.312 1.445 . . . . 0.0 107.672 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.28 162.45 18.99 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -56.61 136.79 54.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -153.96 -52.21 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.0 58.7 0.79 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.307 0.643 . . . . 0.0 110.773 -169.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.25 110.69 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.4 m -62.82 -38.03 89.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.29 1.436 . . . . 0.0 110.545 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 30.57 19.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.496 1.518 . . . . 0.0 112.599 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.0 mm 43.08 -95.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 127.675 2.39 . . . . 0.0 110.096 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.15 -44.3 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.912 1.285 . . . . 0.0 109.562 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.06 32.41 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.422 0.689 . . . . 0.0 112.13 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.88 143.56 60.63 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.702 1.201 . . . . 0.0 110.516 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.43 159.36 50.76 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 111.084 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.77 65.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.041 0.936 . . . . 0.0 112.1 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -71.63 4.07 3.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.26 -36.74 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.685 1.194 . . . . 0.0 110.737 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.251 63.2 mttt 50.9 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.566 2.346 . . . . 0.0 110.338 -167.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.77 -176.16 40.62 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 121.88 2.127 . . . . 0.0 113.102 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.11 156.51 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 122.071 -0.664 . . . . 0.0 110.625 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 t -134.47 160.49 37.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.913 1.285 . . . . 0.0 108.716 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -77.99 142.11 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.45 174.88 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.21 1.404 . . . . 0.0 108.159 168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 -35.78 -30.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.43 21.53 0.28 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.129 0.877 . . . . 0.0 113.183 169.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -152.45 -165.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.0 1.32 . . . . 0.0 108.108 -170.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.1 tp -130.79 157.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.716 1.606 . . . . 0.0 108.979 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.26 139.62 13.01 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.53 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 131.29 27.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.36 2.04 . . . . 0.0 109.429 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.63 128.46 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.57 165.07 20.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -121.37 128.88 52.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.702 0.801 . . . . 0.0 109.522 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.93 -10.38 58.37 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.58 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.02 -21.41 61.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.078 1.308 . . . . 0.0 110.06 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.84 18.29 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 126.036 1.734 . . . . 0.0 108.788 -171.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.52 -32.41 0.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 117.936 -1.03 . . . . 0.0 112.047 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -132.21 5.38 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.534 1.061 . . . . 0.0 112.428 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 m 51.52 36.25 16.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.37 1.468 . . . . 0.0 111.468 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -59.28 147.94 33.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -22.36 -61.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.041 3.337 . . . . 0.0 115.419 -169.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -157.39 27.58 0.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.766 0.826 . . . . 0.0 111.702 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 24' ' ' LEU . 8.5 p -68.7 140.87 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.111 -0.993 . . . . 0.0 109.886 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -171.62 178.07 3.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.014 2.925 . . . . 0.0 104.943 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HA ' HG21 ' A' ' 86' ' ' THR . 16.0 m-30 -65.7 60.58 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.716 2.406 . . . . 0.0 110.821 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -160.38 -30.43 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.558 2.743 . . . . 0.0 109.904 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 86' ' ' THR . 25.7 t0 -78.7 40.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.602 1.161 . . . . 0.0 111.855 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.99 -15.85 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.913 3.685 . . . . 0.0 114.997 -173.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 82' ' ' TYR 0.282 14.8 p 31.19 72.36 0.07 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.122 3.369 . . . . 0.0 117.307 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.1 155.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.7 119.65 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.368 -1.457 . . . . 0.0 107.772 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.65 139.38 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.33 134.76 52.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.6 mt -132.54 163.44 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 108.381 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 155.36 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.402 1.081 . . . . 0.0 108.959 173.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mp -131.22 -179.9 5.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -20.83 -61.84 0.02 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.694 2.568 . . . . 0.0 116.18 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -137.51 24.4 2.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.031 0.933 . . . . 0.0 111.923 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -150.67 165.37 33.61 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.772 -1.205 . . . . 0.0 111.262 -169.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.69 151.42 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.533 1.133 . . . . 0.0 109.214 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.32 166.86 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.997 1.319 . . . . 0.0 107.912 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.57 176.58 34.66 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.148 -0.97 . . . . 0.0 112.044 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.9 pt -146.03 152.11 14.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.66 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -82.95 144.45 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.628 1.171 . . . . 0.0 110.052 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.582 ' HA ' HD13 ' A' ' 24' ' ' LEU . 17.1 m -144.5 164.59 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.716 1.606 . . . . 0.0 109.119 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.81 -42.28 58.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.349 -0.844 . . . . 0.0 108.825 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.33 156.05 11.95 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.81 126.3 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -76.8 -55.53 5.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -176.61 176.99 1.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.644 1.978 . . . . 0.0 107.58 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -100.08 139.24 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.6 mt -140.12 172.13 13.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.551 . . . . 0.0 107.573 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.8 m -130.77 143.61 50.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.764 0.711 . . . . 0.0 110.344 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.17 171.09 14.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.025 1.33 . . . . 0.0 109.409 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.423 HG22 ' HA2' ' A' ' 16' ' ' GLY . 33.3 p -134.66 160.49 37.96 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.806 1.643 . . . . 0.0 108.467 -176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.33 1.93 3.4 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.42 -45.75 12.4 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.507 1.523 . . . . 0.0 107.721 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -67.44 -41.75 84.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.207 1.003 . . . . 0.0 109.928 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -82.42 112.52 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -142.45 -57.62 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.619 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.52 175.67 4.92 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.14 1.893 . . . . 0.0 111.683 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.44 156.94 33.77 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.614 1.565 . . . . 0.0 108.471 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.55 50.95 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.904 3.069 . . . . 0.0 111.071 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.56 26.26 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.585 1.954 . . . . 0.0 113.37 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -68.73 175.88 3.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.651 1.98 . . . . 0.0 111.381 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 67.85 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.631 1.572 . . . . 0.0 110.753 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.48 -179.21 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.898 1.679 . . . . 0.0 109.245 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -6.96 11.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -69.89 155.54 40.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.023 0.929 . . . . 0.0 110.635 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.4 m -139.29 157.73 45.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.843 1.257 . . . . 0.0 109.131 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 p -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.987 1.315 . . . . 0.0 113.131 -171.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.32 -36.37 83.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 111.103 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -129.13 33.05 4.63 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.576 1.55 . . . . 0.0 108.801 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 127.51 32.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 146' ' ' ASN . 81.8 p -74.92 -171.92 1.47 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.828 1.651 . . . . 0.0 110.134 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.07 172.86 22.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.319 -2.313 . . . . 0.0 107.319 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.33 151.67 37.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.101 1.451 . . . . 0.0 109.539 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.02 177.72 27.06 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.27 0.938 . . . . 0.0 111.163 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.82 159.08 36.86 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.41 0.684 . . . . 0.0 111.903 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.77 59.8 1.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.624 2.369 . . . . 0.0 107.241 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.57 -45.25 2.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.345 1.926 . . . . 0.0 113.93 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -140.17 -38.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.491 2.316 . . . . 0.0 109.678 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -73.76 153.2 40.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 89.1 mtp -141.72 140.52 33.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -133.43 137.54 45.8 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.82 110.48 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.405 HD12 ' CD2' ' A' ' 19' ' ' PHE . 2.7 mm? -84.79 112.37 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.85 136.16 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.438 ' H ' HG22 ' A' ' 132' ' ' THR . 45.1 t-20 -78.85 61.96 3.21 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 109.822 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 tp -54.81 -38.38 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.997 1.319 . . . . 0.0 111.126 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.0 -15.6 59.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -111.12 -9.35 14.37 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.333 -1.318 . . . . 0.0 111.556 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.74 -80.8 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.136 -169.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.76 -30.81 70.37 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.029 -1.044 . . . . 0.0 109.442 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.4 -21.86 62.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.3 m -115.17 -12.19 11.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.804 0.842 . . . . 0.0 112.078 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.42 -15.32 19.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.512 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.51 -40.49 78.8 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.891 1.678 . . . . 0.0 111.953 -169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.0 ptp -63.23 -31.82 73.07 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.42 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.53 25.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.75 1.22 . . . . 0.0 111.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.79 -55.64 9.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.69 -28.36 68.57 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.068 -0.395 . . . . 0.0 111.731 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 124.649 1.179 . . . . 0.0 112.807 176.569 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' N ' ' HG1' ' A' ' 112' ' ' THR . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -68.87 161.74 28.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 168.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.4 142.6 49.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -141.64 134.55 28.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 109.564 -169.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.19 133.22 35.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 151.34 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 119.531 1.06 . . . . 0.0 109.15 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.99 153.23 46.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.77 1.228 . . . . 0.0 109.407 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -96.65 146.46 24.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 tp -149.61 132.71 16.28 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.79 -104.74 0.69 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.23 37.39 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.664 1.585 . . . . 0.0 108.912 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.24 159.95 41.06 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.825 2.05 . . . . 0.0 107.594 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.82 160.85 20.69 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 110.281 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -142.68 152.57 42.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.932 2.093 . . . . 0.0 106.809 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.23 154.85 21.39 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mt -139.5 134.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.18 117.17 2.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 109.157 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -54.42 -35.56 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.895 0.878 . . . . 0.0 111.558 -170.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.93 -24.98 68.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.717 0.807 . . . . 0.0 112.508 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -80.65 -23.53 39.6 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.483 0.583 . . . . 0.0 111.464 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.71 132.96 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.429 HE22 ' CD1' ' A' ' 61' ' ' LEU . 42.3 tt0 -90.09 -59.07 2.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.33 -179.42 7.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.435 1.094 . . . . 0.0 109.825 -172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.61 143.13 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -147.78 173.88 12.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.403 1.081 . . . . 0.0 108.483 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.64 157.8 33.09 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -77.26 106.71 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 108.654 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -157.76 163.53 38.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.736 1.214 . . . . 0.0 109.569 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.88 34.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.904 2.481 . . . . 0.0 114.484 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.17 143.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.709 0.766 . . . . 0.0 109.396 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -136.03 93.09 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -71.21 118.96 14.66 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -70.02 157.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -23.5 67.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -172.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.89 23.91 0.51 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 156.99 35.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 122.935 0.494 . . . . 0.0 110.906 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -59.18 145.69 96.94 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 N-CA-C 107.995 -1.579 . . . . 0.0 107.995 169.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.67 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.728 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.12 -38.27 67.96 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.994 0.816 . . . . 0.0 110.675 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.5 mt -75.57 90.7 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -58.31 -26.41 63.01 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.02 -158.96 32.09 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.24 153.69 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -134.67 165.15 25.92 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.244 0.929 . . . . 0.0 108.985 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -71.23 99.4 1.9 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.535 1.534 . . . . 0.0 110.857 -173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' CD1' HE22 ' A' ' 37' ' ' GLN 0.25 0.5 OUTLIER -77.9 64.3 3.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 107.677 169.645 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 45.55 34.35 1.64 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.061 2.944 . . . . 0.0 114.145 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.79 -20.9 4.52 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.982 1.277 . . . . 0.0 112.136 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.66 -163.21 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 172.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 tp -138.27 147.14 25.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 121.156 -0.965 . . . . 0.0 111.979 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.59 135.99 18.48 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.89 147.95 75.56 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.998 1.799 . . . . 0.0 110.157 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.435 HD11 HG13 ' A' ' 88' ' ' VAL . 1.9 tp -126.61 131.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.59 155.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -140.48 143.08 35.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.22 1.009 . . . . 0.0 109.27 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.48 -16.74 62.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.943 1.297 . . . . 0.0 110.566 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -61.81 -20.19 63.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.093 1.315 . . . . 0.0 111.144 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.4 mt -115.89 -48.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.96 -25.36 67.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.811 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -135.0 -6.39 2.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.589 1.086 . . . . 0.0 113.116 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.5 m 55.92 46.02 22.84 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.086 -1.009 . . . . 0.0 111.716 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -47.04 142.88 3.33 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.34 -65.04 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.722 1.609 . . . . 0.0 112.65 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -162.28 79.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.161 0.985 . . . . 0.0 109.697 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.52 144.79 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -164.63 171.56 14.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.683 1.593 . . . . 0.0 107.462 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -70.17 48.32 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.736 2.014 . . . . 0.0 110.921 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.69 -12.91 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.741 3.216 . . . . 0.0 110.737 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.16 -3.26 1.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.428 1.491 . . . . 0.0 111.988 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -146.56 40.05 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.224 1.409 . . . . 0.0 109.095 -169.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 p -96.21 -11.6 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.293 1.837 . . . . 0.0 114.041 -169.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.68 155.67 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 68' ' ' ILE . 77.0 t -130.08 135.7 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.185 1.794 . . . . 0.0 106.231 -174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.61 124.61 65.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.29 134.31 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.7 mt -133.09 162.01 32.87 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.102 1.361 . . . . 0.0 108.822 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.35 153.9 41.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.5 136.55 18.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.6 -94.97 0.08 OUTLIER Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -169.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -139.91 22.33 2.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.054 1.742 . . . . 0.0 110.76 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -134.52 163.31 30.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.113 -0.992 . . . . 0.0 110.106 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.23 152.27 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 110.393 -170.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.94 177.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 126.224 1.809 . . . . 0.0 106.711 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.8 33.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.4 154.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.895 0.878 . . . . 0.0 109.082 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.96 144.61 13.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.83 170.96 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.737 1.615 . . . . 0.0 110.049 -168.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -76.72 -42.93 39.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.971 -0.456 . . . . 0.0 110.353 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.97 153.79 9.16 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.9 129.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 m -77.03 -57.83 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.405 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -176.62 175.33 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 107.796 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.5 140.09 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.28 176.34 8.8 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.994 1.718 . . . . 0.0 108.16 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 m -131.63 139.63 49.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.199 0.6 . . . . 0.0 109.566 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.53 165.72 26.79 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.238 1.415 . . . . 0.0 108.4 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 16' ' ' GLY . 28.7 m -137.58 158.8 43.6 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 107.811 -169.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.18 -13.01 2.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.8 -40.71 92.17 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.81 1.186 . . . . 0.0 110.129 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -82.72 -39.08 22.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.533 1.533 . . . . 0.0 109.692 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.77 85.83 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 44.6 mtm180 -140.88 -53.69 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 116.608 -1.663 . . . . 0.0 112.725 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.1 Cg_endo -65.01 175.93 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 121.699 1.643 . . . . 0.0 111.167 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.65 158.23 32.21 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.939 1.296 . . . . 0.0 109.157 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.02 60.7 7.94 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.778 2.986 . . . . 0.0 110.994 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.35 33.52 0.06 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.378 1.871 . . . . 0.0 112.495 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.2 178.3 4.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.52 1.528 . . . . 0.0 110.74 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.55 0.93 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.203 1.401 . . . . 0.0 110.568 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.71 159.16 39.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.799 1.639 . . . . 0.0 109.039 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -58.52 -25.05 61.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.881 0.872 . . . . 0.0 112.2 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.96 -26.92 68.51 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.796 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -76.11 75.46 2.96 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 124.319 2.009 . . . . 0.0 111.292 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 t -155.52 177.57 11.22 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 129.502 3.121 . . . . 0.0 103.776 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.6 -7.55 0.99 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 126.472 1.909 . . . . 0.0 115.963 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -73.21 -5.35 38.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.737 1.153 . . . . 0.0 110.438 168.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -46.59 135.52 8.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.108 2.163 . . . . 0.0 114.459 -169.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 145' ' ' VAL . 52.6 p -77.02 -165.7 0.6 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.878 2.871 . . . . 0.0 110.355 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.23 -179.72 16.84 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.464 1.983 . . . . 0.0 108.544 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mt -133.62 150.64 51.6 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.932 1.693 . . . . 0.0 106.948 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.33 171.85 32.87 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.09 158.06 43.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.089 0.956 . . . . 0.0 110.927 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 mt -144.89 69.37 1.25 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.231 1.812 . . . . 0.0 107.605 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.87 -49.56 2.85 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.337 1.922 . . . . 0.0 113.1 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -145.45 -31.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.379 1.872 . . . . 0.0 110.953 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -69.64 153.13 43.87 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.3 mtp -142.8 146.67 34.44 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.31 147.62 25.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.368 0.667 . . . . 0.0 109.879 -175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -93.02 112.42 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.53 107.77 10.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.529 ' HA ' HG22 ' A' ' 132' ' ' THR . 71.0 t -62.91 122.8 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -79.41 53.79 1.6 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.371 0.668 . . . . 0.0 110.683 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 tp -54.09 -37.39 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.52 1.128 . . . . 0.0 111.123 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -65.49 -6.45 10.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.867 1.267 . . . . 0.0 112.782 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -124.49 -28.9 3.55 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 0.0 111.608 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.2 tp -45.49 -64.5 0.71 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.875 1.67 . . . . 0.0 111.841 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.28 -46.34 56.24 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.95 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -65.09 -21.4 66.8 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.256 0.935 . . . . 0.0 113.064 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.7 m -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.68 1.127 . . . . 0.0 111.506 170.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.87 -15.01 46.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.881 0.872 . . . . 0.0 112.182 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -49.6 -44.64 47.32 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 125.754 1.622 . . . . 0.0 113.555 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -64.1 -40.78 96.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.552 0.614 . . . . 0.0 111.432 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.36 -37.86 65.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.342 0.657 . . . . 0.0 110.545 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.4 tt -59.67 -56.61 19.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.259 1.424 . . . . 0.0 109.742 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -26.24 61.9 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 122.807 0.443 . . . . 0.0 111.384 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 CA--C 1.54 0.58 0 C-N-CA 123.09 0.556 . . . . 0.0 112.416 171.024 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.16 160.14 24.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -116.43 144.76 43.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.84 136.79 30.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.624 0.77 . . . . 0.0 110.03 -169.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.8 tp -77.57 134.55 38.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 102.849 -3.019 . . . . 0.0 102.849 167.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.25 149.88 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.655 1.116 . . . . 0.0 108.781 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.92 151.81 44.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.225 1.01 . . . . 0.0 110.15 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -95.49 143.72 26.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -139.38 94.4 2.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.044 1.338 . . . . 0.0 107.517 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.47 -74.52 0.71 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.279 1.419 . . . . 0.0 111.456 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.69 29.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.067 1.347 . . . . 0.0 110.603 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.14 160.87 38.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.31 1.444 . . . . 0.0 108.111 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.18 151.64 45.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.808 1.289 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.9 155.76 47.03 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.634 1.974 . . . . 0.0 107.729 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.57 157.91 22.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -142.61 134.48 25.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -50.07 119.07 3.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.464 0.706 . . . . 0.0 109.378 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -54.8 -34.65 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.871 0.868 . . . . 0.0 111.285 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.65 -22.15 66.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.554 0.742 . . . . 0.0 112.735 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.66 -21.09 32.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.07 0.85 . . . . 0.0 111.688 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.09 140.72 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.84 -42.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.496 1.119 . . . . 0.0 110.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -161.53 171.02 18.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.383 1.073 . . . . 0.0 108.815 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.1 147.59 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -150.17 173.99 13.3 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.56 163.67 26.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -60.27 136.76 58.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.0 -55.14 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.96 84.25 1.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -169.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.14 119.02 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 m -78.64 93.2 4.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -78.1 88.73 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.79 137.46 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.2 -17.93 60.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -137.11 37.92 2.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.68 1.192 . . . . 0.0 111.017 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 53' ' ' ALA . 27.1 p -60.82 166.48 4.53 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 121.804 -0.56 . . . . 0.0 111.897 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.6 20.21 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 123.227 2.618 . . . . 0.0 111.358 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' THR . . . 59.1 -39.91 0.07 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 131.319 3.848 . . . . 0.0 116.938 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -52.97 -44.18 66.95 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 120.326 1.421 . . . . 0.0 108.509 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.99 110.29 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -67.79 -34.91 77.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.58 -153.52 21.19 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -117.71 162.4 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.45 150.41 34.55 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.287 -1.508 . . . . 0.0 110.117 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.05 135.22 46.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.226 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.37 97.44 5.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.512 1.125 . . . . 0.0 109.434 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 57.17 17.28 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 113.334 172.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.41 6.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.002 1.287 . . . . 0.0 113.007 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.34 -172.05 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.93 1.292 . . . . 0.0 108.295 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.15 155.01 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.834 1.253 . . . . 0.0 110.393 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.39 141.97 15.21 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.626 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.08 140.15 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.097 1.865 . . . . 0.0 109.27 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 tp -126.18 135.15 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.18 148.76 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.806 2.042 . . . . 0.0 106.028 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -125.78 128.56 47.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.06 -18.93 65.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.986 0.914 . . . . 0.0 111.346 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -58.88 -25.53 63.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.815 -1.178 . . . . 0.0 110.531 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.36 -30.8 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.516 1.526 . . . . 0.0 110.085 -169.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -92.77 -22.03 19.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.21 0.914 . . . . 0.0 113.004 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -132.83 3.1 3.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.278 0.944 . . . . 0.0 111.807 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 m 51.39 41.7 28.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.86 1.264 . . . . 0.0 111.402 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -57.41 170.96 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.715 0.806 . . . . 0.0 111.175 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 m -58.13 169.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.02 0.914 . . . . 0.0 109.416 168.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.28 62.51 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.468 2.307 . . . . 0.0 111.349 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -45.42 150.93 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.287 2.235 . . . . 0.0 111.759 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -152.11 165.15 35.66 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.249 1.42 . . . . 0.0 108.449 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -74.6 53.18 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 0.0 110.597 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -151.46 -21.96 0.2 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.245 3.418 . . . . 0.0 109.708 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.79 7.52 2.75 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.538 1.535 . . . . 0.0 111.659 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -154.69 40.52 0.45 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.137 2.175 . . . . 0.0 108.567 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 p -88.96 7.14 36.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.586 1.954 . . . . 0.0 115.362 -168.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.49 157.43 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.4 136.19 55.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.67 134.32 48.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.7 mt -133.82 164.22 27.74 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 108.007 -171.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.97 154.09 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.313 0.645 . . . . 0.0 110.113 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mp -136.51 80.81 1.84 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.4 -68.95 2.34 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.676 -0.64 . . . . 0.0 113.214 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -137.01 0.6 2.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.402 1.881 . . . . 0.0 111.833 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.92 165.55 22.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.502 1.121 . . . . 0.0 109.103 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.39 150.45 32.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.019 0.927 . . . . 0.0 109.18 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.91 165.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.02 32.15 Favored Glycine 0 N--CA 1.451 -0.364 0 O-C-N 121.118 -0.989 . . . . 0.0 111.683 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.29 164.56 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 109.847 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 m -111.37 132.13 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.153 1.781 . . . . 0.0 108.183 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.89 164.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.97 1.308 . . . . 0.0 109.611 -168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.3 -41.67 73.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.13 158.94 20.93 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.32 123.12 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -48.3 15.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.921 0.888 . . . . 0.0 109.682 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -173.44 -174.54 1.02 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 108.02 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.73 128.76 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.56 173.22 11.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.217 1.407 . . . . 0.0 108.923 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.3 m -130.92 139.05 50.03 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.3 161.12 38.65 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 m -132.9 157.21 45.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.09 1.756 . . . . 0.0 108.238 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -17.36 24.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.86 -36.33 80.09 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.24 -40.46 19.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.606 1.562 . . . . 0.0 110.434 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.05 103.67 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 91.9 mtt-85 -140.54 -55.84 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 116.936 -1.507 . . . . 0.0 111.423 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.5 Cg_endo -66.48 173.2 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.97 157.51 30.74 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.0 1.72 . . . . 0.0 108.89 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.41 143.66 48.36 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.817 1.678 . . . . 0.0 109.457 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.14 22.75 0.65 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.035 1.334 . . . . 0.0 110.335 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.63 176.85 5.83 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.275 1.43 . . . . 0.0 111.442 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.23 66.48 0.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.739 1.615 . . . . 0.0 110.603 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.45 172.83 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.846 1.658 . . . . 0.0 109.433 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -15.63 61.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.283 1.433 . . . . 0.0 113.724 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.82 144.41 54.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.937 . . . . 0.0 110.206 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.8 m -138.32 162.26 34.82 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.28 1.032 . . . . 0.0 109.791 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -57.45 -27.52 62.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 114.338 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -74.69 -24.09 58.72 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.623 -0.673 . . . . 0.0 111.895 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -127.2 -3.35 6.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.087 0.955 . . . . 0.0 112.73 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.08 161.47 5.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.614 0.643 . . . . 0.0 110.76 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.2 p -113.69 -166.54 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.8 1.64 . . . . 0.0 110.407 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.4 168.69 23.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.6 154.61 39.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.913 1.857 . . . . 0.0 111.0 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.3 173.38 40.27 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.092 0.377 . . . . 0.0 112.853 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.15 157.26 17.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.927 0.891 . . . . 0.0 111.13 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.06 85.06 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.16 -55.0 2.3 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.751 2.119 . . . . 0.0 112.862 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -150.34 -28.12 0.23 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.199 2.199 . . . . 0.0 111.524 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -69.12 163.3 25.12 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.754 0.707 . . . . 0.0 109.529 171.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.99 134.59 47.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.83 134.82 51.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.06 107.11 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.04 109.99 13.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.51 130.55 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.857 1.263 . . . . 0.0 108.434 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -74.87 57.03 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.442 1.897 . . . . 0.0 109.867 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -46.71 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.825 1.65 . . . . 0.0 111.268 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -66.86 -10.0 43.65 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.6 -14.93 16.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.471 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.6 tp -55.5 -78.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.812 1.245 . . . . 0.0 111.325 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.6 tp -77.32 -20.47 54.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.99 0.813 . . . . 0.0 111.257 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.07 -39.96 79.83 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.259 -0.9 . . . . 0.0 111.661 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 -19.92 17.29 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.024 -0.512 . . . . 0.0 112.058 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.98 -10.52 57.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.763 1.165 . . . . 0.0 112.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.73 -44.34 58.23 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 121.303 1.865 . . . . 0.0 112.028 -171.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.9 mtm -65.23 -46.09 82.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.29 0.636 . . . . 0.0 110.311 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.45 74.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.53 0.732 . . . . 0.0 111.787 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.58 -64.17 1.04 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.61 -31.46 72.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -169.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 175.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -69.67 167.08 17.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 110.143 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.93 146.15 50.73 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.604 1.561 . . . . 0.0 107.417 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -142.15 140.32 32.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.612 0.765 . . . . 0.0 110.289 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.5 tp -80.39 134.45 36.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.36 148.29 27.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 109.123 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.14 153.68 45.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.509 1.124 . . . . 0.0 110.123 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -95.52 149.39 21.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.46 128.41 7.35 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.31 -89.51 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.71 34.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.352 1.461 . . . . 0.0 109.145 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -143.44 158.89 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.829 1.651 . . . . 0.0 107.871 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 155.55 28.05 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 123.251 1.5 . . . . 0.0 110.299 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -142.23 160.97 39.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.913 2.085 . . . . 0.0 107.338 -171.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.8 164.12 26.45 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.784 0.707 . . . . 0.0 111.729 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -144.68 136.15 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -49.26 118.8 2.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.15 0.98 . . . . 0.0 109.343 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.21 -33.83 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.814 0.846 . . . . 0.0 111.566 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.73 -23.39 67.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.434 0.694 . . . . 0.0 112.604 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -81.01 -19.13 44.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.272 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.54 142.24 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.267 1.394 . . . . 0.0 109.162 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -125.57 -39.84 2.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.121 1.369 . . . . 0.0 110.781 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -167.04 171.24 11.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.663 1.585 . . . . 0.0 107.754 175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.19 140.81 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -149.95 176.67 10.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 108.564 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.63 173.89 44.19 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -59.11 -31.06 68.59 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.83 -0.806 . . . . 0.0 112.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.0 t0 34.22 -90.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 129.33 3.052 . . . . 0.0 116.588 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 66.53 1.34 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 113.405 -169.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.57 133.9 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 m -70.88 -42.18 70.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.579 1.152 . . . . 0.0 111.593 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.03 89.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.75 2.02 . . . . 0.0 109.33 -169.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.9 150.87 6.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.77 66.73 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.71 20.85 0.61 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -172.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.71 148.39 47.24 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.41 121.46 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 N-CA-C 105.639 -2.485 . . . . 0.0 105.639 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.84 -33.03 0.69 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -168.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.09 -38.24 37.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.023 0.829 . . . . 0.0 110.976 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.8 mt -93.39 105.2 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.8 -57.45 12.64 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.43 -173.19 36.19 Favored Glycine 0 C--O 1.227 -0.315 0 O-C-N 121.021 -1.049 . . . . 0.0 111.73 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -83.6 153.82 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -138.09 160.66 38.81 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.94 108.36 19.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.522 -0.736 . . . . 0.0 111.556 -172.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.2 72.67 3.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.66 -0.65 . . . . 0.0 110.685 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 49.89 28.78 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.684 1.594 . . . . 0.0 114.422 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.93 -20.61 2.15 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.371 0.986 . . . . 0.0 113.063 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -169.25 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.829 1.252 . . . . 0.0 107.806 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.72 148.63 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.766 -1.209 . . . . 0.0 110.08 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 p -148.87 134.56 9.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.93 138.9 45.7 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.314 2.676 . . . . 0.0 110.685 170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.84 135.32 63.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.386 1.089 . . . . 0.0 109.12 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.87 162.87 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.556 2.342 . . . . 0.0 105.188 169.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -139.79 145.05 37.71 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 120.652 -1.28 . . . . 0.0 109.409 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.11 -21.66 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.647 1.179 . . . . 0.0 112.917 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -70.34 -11.13 60.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.707 1.594 . . . . 0.0 112.213 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.16 20.92 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 0.0 109.034 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -141.55 -23.7 0.72 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.657 1.183 . . . . 0.0 111.449 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -139.39 12.16 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.561 1.144 . . . . 0.0 111.991 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.0 m 54.26 38.95 30.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.488 1.515 . . . . 0.0 112.427 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 156.2 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 78' ' ' VAL . 4.6 t -40.85 -67.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.657 2.383 . . . . 0.0 113.268 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -169.77 97.63 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.832 1.653 . . . . 0.0 109.13 -169.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.28 143.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.176 0.99 . . . . 0.0 109.593 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.25 158.23 35.75 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.109 1.364 . . . . 0.0 108.767 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -69.46 42.48 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.932 2.093 . . . . 0.0 113.143 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.86 -12.02 0.16 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.159 2.183 . . . . 0.0 110.671 169.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -125.51 -5.53 7.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.558 1.543 . . . . 0.0 111.98 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.98 38.83 2.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.271 1.428 . . . . 0.0 108.972 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -102.15 -4.73 25.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.561 . . . . 0.0 114.376 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.34 155.36 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.5 t -133.33 137.14 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.57 124.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.64 140.22 17.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -135.76 162.65 32.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.992 1.717 . . . . 0.0 107.843 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.05 148.86 39.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.178 1.391 . . . . 0.0 108.027 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.44 151.1 29.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.53 -102.54 0.11 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -139.62 34.07 2.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.498 1.519 . . . . 0.0 109.809 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.1 167.76 21.32 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.779 1.632 . . . . 0.0 109.297 -171.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.04 151.19 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 124.157 0.983 . . . . 0.0 109.547 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.67 176.78 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.854 1.661 . . . . 0.0 107.204 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.61 179.48 41.51 Favored Glycine 0 N--CA 1.448 -0.537 0 O-C-N 120.685 -1.259 . . . . 0.0 111.427 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.4 pt -141.65 158.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.587 1.155 . . . . 0.0 109.542 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.09 145.11 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.8 172.4 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.634 1.574 . . . . 0.0 110.606 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.22 -43.51 51.35 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.98 -0.45 . . . . 0.0 109.831 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.46 155.68 10.57 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 129.0 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -41.36 10.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.427 0.691 . . . . 0.0 111.802 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.2 t0 -167.57 -175.67 2.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 110.727 -168.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -135.84 125.28 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.18 166.53 24.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 110.191 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 m -125.37 141.24 52.18 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.201 0.6 . . . . 0.0 110.42 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.1 139.04 30.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.438 1.095 . . . . 0.0 108.398 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 p -82.95 153.31 25.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.18 -16.73 35.46 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.5 -42.04 75.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.003 1.321 . . . . 0.0 110.037 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -58.67 -39.58 81.05 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.749 0.819 . . . . 0.0 109.359 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.1 mt -77.77 0.63 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 126.314 1.846 . . . . 0.0 112.151 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -53.59 -53.57 55.57 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.167 -1.583 . . . . 0.0 114.344 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.39 175.71 9.68 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.346 2.03 . . . . 0.0 112.396 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.5 163.32 24.56 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.244 1.418 . . . . 0.0 109.313 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.4 -50.0 9.35 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.762 2.308 . . . . 0.0 113.018 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 51.24 20.15 0.87 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.912 2.085 . . . . 0.0 114.219 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -73.93 160.09 31.87 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 110.033 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.92 32.51 0.14 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.867 1.667 . . . . 0.0 112.8 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.27 -175.21 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.927 1.291 . . . . 0.0 109.952 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -11.23 21.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.885 1.274 . . . . 0.0 113.92 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.74 156.29 33.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.446 1.499 . . . . 0.0 110.459 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.1 m -137.13 156.45 48.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.044 0.938 . . . . 0.0 109.752 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 p -64.89 -24.12 67.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.957 1.303 . . . . 0.0 113.426 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.02 -34.24 73.03 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -127.18 30.74 5.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.261 1.424 . . . . 0.0 109.06 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 131.15 49.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.466 1.106 . . . . 0.0 108.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.8 p -69.78 -177.92 1.39 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.68 1.592 . . . . 0.0 110.491 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -125.53 179.14 16.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 169.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.32 157.59 43.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.253 1.527 . . . . 0.0 108.808 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.13 172.6 34.03 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.11 20.84 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.14 0.576 . . . . 0.0 109.778 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.1 82.56 1.76 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.77 2.66 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.582 2.039 . . . . 0.0 112.995 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.68 -31.25 0.09 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.033 2.133 . . . . 0.0 111.103 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.444 HH22 ' HB2' ' A' ' 107' ' ' ASP . 59.0 mtp180 -68.94 162.99 25.49 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.0 mtp -139.8 144.94 37.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.18 126.13 29.3 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.8 mt -81.47 111.62 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.53 111.08 22.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.1 t -67.41 131.09 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 108.329 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -75.79 62.22 1.51 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.225 1.01 . . . . 0.0 109.734 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -43.98 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.895 1.678 . . . . 0.0 110.33 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.23 -18.41 63.5 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 112.814 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -111.16 -10.74 14.3 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.956 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.0 -67.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.005 1.275 . . . . 0.0 110.08 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.67 -39.89 84.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.071 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -55.42 -48.51 74.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 0.0 110.717 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 m -82.15 -16.29 50.32 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 112.779 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.08 3.28 33.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.984 1.265 . . . . 0.0 112.783 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.26 -42.06 97.98 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.501 -1.374 . . . . 0.0 110.615 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.1 ptp -62.08 -28.97 69.99 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.719 -0.613 . . . . 0.0 112.004 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.86 32.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.0 tp -56.95 -53.62 55.99 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.97 -14.62 61.93 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.436 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 120.381 1.446 . . . . 0.0 111.849 175.919 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -66.02 146.79 54.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.18 145.6 33.97 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -142.01 138.38 31.81 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.171 0.989 . . . . 0.0 110.175 -169.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -84.19 137.47 33.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 167.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 30' ' ' GLY 0.256 1.5 m -125.7 146.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 119.439 1.018 . . . . 0.0 108.525 -175.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -143.23 153.79 43.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.085 1.354 . . . . 0.0 110.393 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 m -95.17 143.8 26.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.81 103.98 4.78 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.49 -78.49 0.25 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.331 1.443 . . . . 0.0 111.781 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.26 30.19 0.55 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.608 1.163 . . . . 0.0 111.032 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.77 161.04 39.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.577 1.151 . . . . 0.0 108.568 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -115.65 149.39 38.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.97 1.367 . . . . 0.0 109.817 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -139.3 165.65 26.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 107.403 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -147.41 169.06 28.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 119.15 0.886 . . . . 0.0 113.534 170.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 mt -144.01 137.73 24.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.06 118.65 3.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.881 0.872 . . . . 0.0 109.015 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -53.64 -32.81 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.708 0.803 . . . . 0.0 111.747 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.53 -24.49 67.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.04 0.836 . . . . 0.0 112.72 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.32 -21.36 39.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.278 0.945 . . . . 0.0 111.113 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.09 138.41 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -113.25 -46.18 3.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.559 1.144 . . . . 0.0 109.46 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -162.65 177.32 9.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.869 1.268 . . . . 0.0 108.803 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -139.41 143.27 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 172.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -134.29 -104.88 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 0.0 110.764 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 88' ' ' VAL . . . 176.44 154.65 11.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -68.42 125.72 27.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -156.84 -48.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -150.9 50.66 0.86 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.04 0.936 . . . . 0.0 109.894 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.74 112.07 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 m -95.31 89.17 5.37 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.69 144.85 56.69 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' HB ' HG23 ' A' ' 51' ' ' THR . 34.4 mm -84.39 28.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.236 1.014 . . . . 0.0 109.071 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 65.37 -31.4 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.127 2.571 . . . . 0.0 115.144 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.63 24.52 0.78 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.531 1.532 . . . . 0.0 112.924 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.28 144.88 97.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 110.232 169.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.69 142.34 14.26 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.752 2.968 . . . . 0.0 111.11 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.52 69.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.735 0.414 . . . . 0.0 110.59 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -65.75 0.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 0.0 114.191 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.04 -35.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 124.804 1.242 . . . . 0.0 110.996 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 mttm 57.17 -75.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.344 1.858 . . . . 0.0 110.795 -168.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.1 -123.93 1.13 Allowed Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 121.247 1.84 . . . . 0.0 110.99 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.13 169.47 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -143.53 158.79 43.38 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 120.838 -1.164 . . . . 0.0 108.383 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -72.9 137.86 45.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 110.013 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.39 173.64 7.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.21 65.44 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.38 1.072 . . . . 0.0 112.933 -169.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.23 -8.69 4.74 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.241 2.353 . . . . 0.0 113.106 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -152.94 -165.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 119.189 1.494 . . . . 0.0 109.417 -169.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -125.59 159.35 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.589 1.956 . . . . 0.0 108.035 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.45 133.49 10.05 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.3 130.72 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.653 1.568 . . . . 0.0 108.428 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.17 134.83 55.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -126.35 144.22 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.02 109.5 20.85 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.64 -17.21 45.86 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.923 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.0 -37.89 21.65 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.969 1.258 . . . . 0.0 111.005 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.34 -38.59 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -69.65 -12.91 62.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.755 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -122.59 -3.96 8.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.001 1.273 . . . . 0.0 113.547 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m 49.61 47.05 23.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.826 1.251 . . . . 0.0 111.796 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -177.71 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.649 0.737 . . . . 0.0 110.926 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.16 170.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.69 1.196 . . . . 0.0 110.997 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.53 63.3 5.77 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 110.541 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.73 164.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.611 1.164 . . . . 0.0 111.508 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -154.36 172.77 17.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.872 1.669 . . . . 0.0 108.58 -172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -70.89 54.92 0.17 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.001 1.381 . . . . 0.0 111.111 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 84' ' ' ASP . 42.1 t30 -154.66 -19.27 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 131.085 3.754 . . . . 0.0 109.288 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.413 ' H ' ' H ' ' A' ' 83' ' ' ASN . 27.6 t70 -141.0 16.92 2.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.803 2.041 . . . . 0.0 110.822 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -159.79 42.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.407 3.083 . . . . 0.0 106.929 -173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.7 p -99.18 6.78 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -168.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 74.5 t -126.36 151.4 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.349 1.431 . . . . 0.0 108.395 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' GLY . 27.0 m -121.43 141.99 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.48 128.12 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.52 135.37 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.1 mt -134.54 162.26 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.64 1.576 . . . . 0.0 109.046 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.69 145.64 33.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 107.676 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.64 151.56 20.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.29 -94.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.742 1.163 . . . . 0.0 112.728 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.03 21.14 3.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.189 1.796 . . . . 0.0 110.975 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -145.43 173.79 11.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.011 -1.055 . . . . 0.0 112.824 -169.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.73 142.42 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.767 2.027 . . . . 0.0 106.234 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.07 178.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 125.563 1.545 . . . . 0.0 106.859 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.78 179.0 41.39 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.97 146.65 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.1 144.22 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.25 166.67 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.845 2.058 . . . . 0.0 107.602 -173.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.22 -44.92 71.07 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.241 -0.912 . . . . 0.0 109.893 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.94 162.1 24.46 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 m -74.87 127.48 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.71 -43.53 13.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.254 1.021 . . . . 0.0 110.166 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -171.0 176.74 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 110.762 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.97 131.72 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.841 2.057 . . . . 0.0 106.971 169.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.86 -178.49 5.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.337 1.055 . . . . 0.0 109.863 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 m -130.17 151.88 50.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.948 0.795 . . . . 0.0 112.069 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.46 163.93 31.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.61 1.564 . . . . 0.0 109.914 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.7 p -114.22 167.44 10.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.687 1.195 . . . . 0.0 111.522 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.31 -9.66 35.08 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.939 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.85 -52.02 11.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.04 -36.4 83.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.379 1.072 . . . . 0.0 111.493 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.7 mt -103.56 106.57 20.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.508 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 23.7 mmt180 -145.82 -53.07 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.205 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.508 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.2 Cg_endo -65.79 176.64 3.46 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.879 1.719 . . . . 0.0 111.733 173.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.17 160.63 32.96 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.56 1.944 . . . . 0.0 107.775 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.01 -45.47 5.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.733 1.622 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 45.58 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 131.693 3.997 . . . . 0.0 119.932 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -153.59 160.31 42.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.437 1.471 . . . . 0.0 109.338 -173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.25 35.41 16.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.838 1.655 . . . . 0.0 112.647 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.89 156.57 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.901 1.681 . . . . 0.0 107.913 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -12.46 61.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.978 1.311 . . . . 0.0 113.015 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -54.79 162.52 1.21 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.171 2.988 . . . . 0.0 113.596 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m -135.6 151.24 50.07 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.963 0.905 . . . . 0.0 111.969 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.89 -29.21 27.01 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.877 2.471 . . . . 0.0 114.389 -169.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -62.07 -32.3 72.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -147.47 31.19 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.259 1.023 . . . . 0.0 110.61 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 18.49 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 145' ' ' VAL . 27.4 p 64.01 -175.27 0.16 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.936 1.694 . . . . 0.0 112.176 169.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.72 177.52 20.11 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 106.396 -2.681 . . . . 0.0 106.396 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.65 158.67 44.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.677 1.238 . . . . 0.0 109.268 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.06 177.46 32.29 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.98 152.96 33.49 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.817 0.847 . . . . 0.0 109.652 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.79 82.59 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.147 1.379 . . . . 0.0 107.405 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.23 -48.44 2.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.586 2.041 . . . . 0.0 113.56 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -156.43 -35.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.29 2.236 . . . . 0.0 110.353 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -71.09 165.97 22.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.848 0.832 . . . . 0.0 110.142 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.7 mtp -136.95 147.97 46.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -137.9 129.95 28.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.5 mt -85.38 114.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.82 112.62 24.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -64.85 133.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.317 1.047 . . . . 0.0 108.36 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.88 61.38 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.36 -39.83 45.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.701 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.0 -13.34 45.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.021 0.828 . . . . 0.0 112.729 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -111.16 -12.59 14.12 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 117.039 -1.458 . . . . 0.0 112.649 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -54.66 -73.26 0.05 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.801 1.24 . . . . 0.0 111.088 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.9 -23.98 28.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.801 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -58.56 -28.64 65.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 111.491 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.0 m -96.17 -39.83 9.5 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.77 0.713 . . . . 0.0 110.883 173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.88 -10.81 59.62 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.769 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -49.78 -47.83 50.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 121.613 2.006 . . . . 0.0 112.035 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -67.06 -43.87 81.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.099 0.56 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.74 -31.2 71.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.548 0.739 . . . . 0.0 111.964 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.45 -60.57 2.19 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.98 -28.06 69.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.978 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 111.989 175.782 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -75.85 165.13 25.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.815 1.246 . . . . 0.0 108.482 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -133.12 143.42 49.26 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -139.36 141.09 37.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.779 0.432 . . . . 0.0 110.424 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -82.33 128.86 34.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.38 147.31 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.329 0.968 . . . . 0.0 108.889 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.74 153.73 42.74 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.249 1.02 . . . . 0.0 109.898 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -92.73 146.92 23.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.23 125.74 14.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -88.7 0.16 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -154.26 34.76 0.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.331 1.452 . . . . 0.0 109.796 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.64 158.2 43.9 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 107.602 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.62 156.21 34.75 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.022 1.391 . . . . 0.0 111.887 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -144.92 161.25 39.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.021 2.528 . . . . 0.0 107.127 -171.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.96 25.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.364 0.983 . . . . 0.0 111.035 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 100' ' ' ILE . 3.4 mt -137.46 137.92 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -47.38 115.86 1.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.585 1.154 . . . . 0.0 110.213 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.09 -33.79 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.104 0.962 . . . . 0.0 111.753 -169.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.54 -25.73 68.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.672 0.789 . . . . 0.0 112.66 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -79.26 -20.18 48.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.868 0.758 . . . . 0.0 111.883 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.14 128.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 118.902 0.774 . . . . 0.0 109.027 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -86.99 -60.28 2.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -163.65 -176.74 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.274 1.43 . . . . 0.0 109.012 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.29 145.95 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 41' ' ' GLY . 1.3 tmm_? -144.0 173.84 11.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.561 1.944 . . . . 0.0 106.278 -177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' H ' ' HD2' ' A' ' 40' ' ' ARG . . . -101.73 172.1 22.49 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.133 -0.98 . . . . 0.0 111.172 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -67.88 120.97 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 168.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.44 -48.98 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -170.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -150.92 86.42 1.37 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.887 0.875 . . . . 0.0 109.01 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.15 161.21 2.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.77 130.82 17.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -134.99 129.67 34.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.367 0.985 . . . . 0.0 108.982 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' A' ' 51' ' ' THR . 1.5 mp -63.19 137.44 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -8.96 25.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 48' ' ' ILE . 73.4 m-80 -130.43 34.0 4.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.081 1.752 . . . . 0.0 109.829 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -61.67 149.45 84.55 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.141 0.576 . . . . 0.0 111.192 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.84 26.18 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.835 3.69 . . . . 0.0 112.026 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.87 -37.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.918 2.887 . . . . 0.0 115.821 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -56.17 -44.13 79.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.711 1.142 . . . . 0.0 109.565 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.25 88.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -60.14 -26.68 66.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.133 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.02 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.435 1.017 . . . . 0.0 111.019 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 151.12 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 t -134.33 151.09 51.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.986 0.812 . . . . 0.0 109.369 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -66.08 107.64 1.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.404 1.082 . . . . 0.0 109.173 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.51 64.81 3.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 49.81 30.22 3.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.467 1.507 . . . . 0.0 113.209 169.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.49 -25.46 1.08 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.856 1.217 . . . . 0.0 113.387 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.46 -165.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 107.877 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 tp -130.32 147.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.451 1.478 . . . . 0.0 110.624 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.55 138.73 15.63 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.5 143.78 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.404 2.069 . . . . 0.0 110.596 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -127.84 135.55 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.2 167.04 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -129.08 116.52 19.4 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 mt -66.82 -17.29 64.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.358 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -54.75 -42.33 71.52 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.835 1.198 . . . . 0.0 110.333 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.36 -44.19 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -60.89 -23.75 65.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.42 -3.54 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.043 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.9 m 49.55 48.64 21.13 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.031 1.287 . . . . 0.0 110.57 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.31 -171.22 0.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 110.864 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.78 164.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.36 1.064 . . . . 0.0 110.225 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -84.06 62.89 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.273 1.829 . . . . 0.0 110.575 -169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 m -53.25 158.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.714 0.806 . . . . 0.0 111.036 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -144.03 178.03 8.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.237 1.415 . . . . 0.0 108.643 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.65 64.18 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.123 1.769 . . . . 0.0 109.484 169.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.36 -35.73 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 131.563 3.945 . . . . 0.0 108.456 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -145.98 30.7 1.05 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.641 1.976 . . . . 0.0 110.072 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -154.97 28.81 0.42 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.268 3.027 . . . . 0.0 107.666 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 p -106.51 12.17 29.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.538 1.935 . . . . 0.0 115.95 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.77 154.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.33 113.79 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -82.21 141.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 137.02 47.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.0 mt -135.82 154.85 51.06 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.531 1.532 . . . . 0.0 109.112 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 139.67 37.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.97 155.25 35.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.28 -100.49 0.04 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.2 0.905 . . . . 0.0 111.656 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -136.57 27.7 3.05 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.613 1.965 . . . . 0.0 109.958 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -146.97 171.04 15.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.2 144.79 34.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 125.363 1.465 . . . . 0.0 107.456 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 99' ' ' GLY . 13.2 p -158.48 -176.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -166.78 176.54 41.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 31' ' ' ILE . 48.8 pt -140.33 144.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.191 0.519 . . . . 0.0 110.343 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.51 142.9 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.944 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.44 166.05 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.654 1.982 . . . . 0.0 108.021 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.53 -41.48 65.79 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.94 151.81 8.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.29 128.98 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -36.5 10.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.203 0.601 . . . . 0.0 111.772 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.3 t0 -169.09 -178.4 3.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.593 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.1 t -137.48 122.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 103.984 -2.598 . . . . 0.0 103.984 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -141.16 150.25 42.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.456 0.702 . . . . 0.0 110.718 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 p -94.86 135.68 36.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.418 0.687 . . . . 0.0 109.639 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mp -138.18 143.31 40.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 67.5 p -100.4 164.8 11.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.55 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.91 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -104.89 -36.2 7.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.772 1.629 . . . . 0.0 110.052 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.41 -45.92 82.04 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.49 112.75 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -148.19 -62.86 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.802 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.18 -178.08 3.03 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.105 1.87 . . . . 0.0 111.539 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.32 155.55 39.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.564 1.946 . . . . 0.0 108.097 169.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.23 59.43 7.39 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.111 3.207 . . . . 0.0 111.107 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.63 29.18 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.077 1.751 . . . . 0.0 112.863 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.11 -174.46 1.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.746 1.618 . . . . 0.0 110.401 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 28.75 0.06 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.269 1.428 . . . . 0.0 113.468 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 124' ' ' VAL . 11.1 m -70.72 161.37 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.828 1.651 . . . . 0.0 109.475 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -44.57 95.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -62.88 166.01 6.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 m -134.19 175.2 9.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.2 1.4 . . . . 0.0 110.64 -169.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -56.15 -27.71 55.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.88 -30.2 56.11 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.337 0.972 . . . . 0.0 111.157 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -110.97 -9.55 14.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.093 0.957 . . . . 0.0 112.505 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.7 160.91 5.15 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.559 0.744 . . . . 0.0 112.132 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 146' ' ' ASN . 38.8 p -114.15 166.31 11.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.392 1.877 . . . . 0.0 108.757 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.86 176.53 45.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.59 145.78 39.0 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.3 174.72 37.07 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.04 39.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.018 0.927 . . . . 0.0 110.184 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.25 82.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.33 -51.9 2.57 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.623 2.059 . . . . 0.0 112.98 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -157.35 -31.4 0.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.147 2.179 . . . . 0.0 111.076 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' A' ' 107' ' ' ASP . 66.0 mtp180 -68.79 162.21 26.82 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.6 mtp -138.87 144.15 39.06 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.25 128.09 35.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.55 120.72 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.51 102.9 15.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.44 120.74 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.068 1.347 . . . . 0.0 108.956 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.551 ' H ' HG22 ' A' ' 132' ' ' THR . 40.4 t30 -75.99 60.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.133 1.773 . . . . 0.0 110.121 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.45 -35.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.089 1.356 . . . . 0.0 111.24 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -68.7 -5.94 23.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -134.26 18.8 3.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.068 1.347 . . . . 0.0 110.667 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.1 tp -79.2 -88.28 0.06 Allowed 'General case' 0 C--N 1.341 0.222 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.0 tp -68.95 -31.51 70.44 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.543 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.74 -22.58 47.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -124.33 -3.66 7.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.405 1.082 . . . . 0.0 112.072 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -122.21 2.15 9.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 113.023 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.62 -34.35 67.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.293 1.406 . . . . 0.0 111.38 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -61.14 -45.92 92.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.0 109.932 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.06 73.72 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.212 0.605 . . . . 0.0 111.443 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.3 -56.68 10.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.329 0.652 . . . . 0.0 109.707 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.35 -30.4 71.23 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.063 -0.398 . . . . 0.0 111.08 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.469 0.501 0 C-N-CA 123.644 0.778 . . . . 0.0 112.855 175.073 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.37 165.99 22.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.766 1.227 . . . . 0.0 108.357 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.45 143.91 46.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -142.09 137.96 31.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.396 0.679 . . . . 0.0 109.815 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -83.27 134.6 34.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.42 151.71 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 119.212 0.914 . . . . 0.0 109.135 -173.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -140.46 150.97 44.46 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.643 1.177 . . . . 0.0 109.26 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -91.71 148.54 22.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 tp -144.63 109.46 5.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.06 -87.71 0.23 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.413 1.006 . . . . 0.0 111.326 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.23 32.46 0.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.245 1.418 . . . . 0.0 109.589 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.22 159.07 43.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.957 1.703 . . . . 0.0 107.794 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.76 153.74 37.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.918 1.342 . . . . 0.0 109.874 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -138.58 150.79 46.68 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.76 2.024 . . . . 0.0 106.867 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.93 157.3 19.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.8 134.25 42.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -48.66 116.67 1.7 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.394 1.078 . . . . 0.0 108.785 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.4 -34.75 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.513 0.725 . . . . 0.0 111.766 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.29 -24.53 67.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.795 0.838 . . . . 0.0 112.586 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -79.17 -24.0 43.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.48 0.582 . . . . 0.0 111.41 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -67.3 140.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -104.57 -59.57 1.72 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.118 0.967 . . . . 0.0 108.952 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.27 178.3 9.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.842 0.857 . . . . 0.0 110.222 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.58 146.69 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -148.51 176.5 10.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.389 1.475 . . . . 0.0 108.279 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.95 166.23 29.81 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.554 -0.716 . . . . 0.0 111.361 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -166.13 0.23 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.523 1.529 . . . . 0.0 112.28 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 67.34 27.89 8.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.455 1.902 . . . . 0.0 112.934 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 31.82 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.39 1.076 . . . . 0.0 109.72 174.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -75.74 116.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -60.85 -47.41 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 109.16 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 54.29 175.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.05 2.54 . . . . 0.0 113.106 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.52 155.86 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.55 -25.5 60.04 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -149.96 23.74 0.85 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.96 142.72 98.19 Favored Pre-proline 0 C--O 1.239 0.53 0 CA-C-O 119.019 -0.515 . . . . 0.0 109.743 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -61.41 148.67 92.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.953 2.435 . . . . 0.0 110.039 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.15 -24.87 67.84 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -61.17 -55.94 26.42 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.191 0.905 . . . . 0.0 109.702 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.421 HD12 ' HG2' ' A' ' 52' ' ' PRO . 70.4 mt -56.4 -37.0 48.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 C-N-CA 125.228 1.411 . . . . 0.0 109.993 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 58.54 -79.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.328 1.851 . . . . 0.0 107.768 -168.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.48 -132.61 2.19 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 121.358 1.89 . . . . 0.0 110.759 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.91 160.6 39.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.304 1.042 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -133.41 147.99 51.77 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -77.95 108.99 11.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.41 76.94 7.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.477 0.655 . . . . 0.0 109.854 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 49.88 29.04 3.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.023 1.329 . . . . 0.0 114.358 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.48 -19.43 2.81 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.671 1.129 . . . . 0.0 113.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.54 -169.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.842 1.321 . . . . 0.0 108.187 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.07 149.51 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.205 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.58 141.08 14.42 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.758 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.46 132.33 33.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.877 1.718 . . . . 0.0 109.682 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.61 119.21 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.46 154.04 9.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 125.589 1.556 . . . . 0.0 110.269 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -92.65 111.4 22.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.358 1.063 . . . . 0.0 110.545 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.71 -37.75 76.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -43.6 92.87 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.378 0.99 . . . . 0.0 109.484 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.8 -36.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.14 -31.16 67.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.208 0.913 . . . . 0.0 113.427 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -116.58 9.5 14.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.923 0.783 . . . . 0.0 112.376 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.6 m 47.92 41.74 15.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.279 1.032 . . . . 0.0 111.002 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -179.84 7.48 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.636 1.175 . . . . 0.0 109.51 -172.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.79 -84.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -173.57 106.04 0.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.034 1.334 . . . . 0.0 108.792 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.01 129.69 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.389 1.075 . . . . 0.0 108.266 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.78 149.38 26.41 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.693 0.797 . . . . 0.0 108.92 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.6 36.9 0.07 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.252 2.221 . . . . 0.0 112.758 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.48 -9.86 0.16 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.476 2.31 . . . . 0.0 111.005 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.48 -4.69 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.061 1.344 . . . . 0.0 111.866 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.66 24.11 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -172.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -80.95 9.75 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 117.826 2.528 . . . . 0.0 117.826 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.6 160.49 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 120.276 1.398 . . . . 0.0 107.902 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.68 127.47 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.88 142.59 15.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.91 134.16 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.59 163.84 29.19 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.008 1.723 . . . . 0.0 109.183 -169.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 148.37 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.449 1.499 . . . . 0.0 107.651 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.4 152.31 25.68 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.51 -90.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.049 1.309 . . . . 0.0 113.508 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.78 23.81 2.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.221 1.809 . . . . 0.0 110.699 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -149.46 173.41 13.61 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.732 -1.23 . . . . 0.0 111.57 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.95 151.95 36.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 125.078 1.351 . . . . 0.0 108.654 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.85 172.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 125.008 1.323 . . . . 0.0 107.6 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.24 177.21 40.03 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.07 142.89 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.56 140.16 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.68 168.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.125 1.77 . . . . 0.0 109.01 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.64 -43.47 72.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.824 1.193 . . . . 0.0 109.978 171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.64 153.67 8.97 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.33 121.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -46.62 12.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.498 0.719 . . . . 0.0 111.15 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -169.29 179.5 3.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.143 0.977 . . . . 0.0 109.767 -168.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.98 136.3 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.86 1.664 . . . . 0.0 107.026 169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -142.58 174.4 10.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.814 1.245 . . . . 0.0 109.16 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.5 m -131.84 137.79 48.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -141.25 155.15 46.05 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.932 0.893 . . . . 0.0 109.277 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -126.99 158.37 37.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.871 1.668 . . . . 0.0 108.365 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.28 42.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -65.97 -41.64 90.93 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.187 -0.946 . . . . 0.0 109.787 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.95 -40.07 40.67 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.348 1.459 . . . . 0.0 110.462 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -91.37 99.17 9.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 74.8 mtt-85 -139.6 -53.35 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.144 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 33.6 Cg_endo -64.77 170.96 9.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.425 1.544 . . . . 0.0 111.623 173.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.18 30.25 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.261 1.424 . . . . 0.0 108.667 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -80.72 50.47 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.797 2.998 . . . . 0.0 110.371 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 16.76 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.272 1.429 . . . . 0.0 113.921 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -146.92 152.97 39.55 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.886 2.074 . . . . 0.0 108.134 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.62 42.36 23.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.176 1.39 . . . . 0.0 112.773 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 166.08 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.738 1.615 . . . . 0.0 108.744 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -35.66 10.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.011 0.525 . . . . 0.0 111.583 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.41 171.77 2.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.655 1.182 . . . . 0.0 112.971 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.9 m -121.6 168.53 11.65 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.043 1.337 . . . . 0.0 110.441 -170.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 p -52.93 -21.98 5.02 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.858 2.463 . . . . 0.0 115.829 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -85.79 -34.42 21.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.825 0.85 . . . . 0.0 110.892 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -91.88 -14.36 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.225 0.61 . . . . 0.0 110.208 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.47 136.87 43.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.797 2.439 . . . . 0.0 111.207 -172.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 145' ' ' VAL . 42.1 p -80.59 -170.3 2.54 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.45 2.3 . . . . 0.0 110.918 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.06 172.06 22.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 106.402 -2.679 . . . . 0.0 106.402 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 154.54 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.624 1.712 . . . . 0.0 110.289 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.44 175.03 31.99 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.81 157.04 19.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.811 0.844 . . . . 0.0 110.168 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.73 82.29 1.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.43 -51.39 2.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.489 1.995 . . . . 0.0 113.11 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.38 -31.9 0.09 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.058 2.143 . . . . 0.0 110.97 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -69.09 161.01 29.96 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 170.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -137.94 140.43 40.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.22 130.94 45.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.9 104.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.35 110.89 9.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.9 t -62.08 129.83 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -78.92 54.8 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.496 1.118 . . . . 0.0 109.669 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 tp -56.01 -35.82 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.449 1.5 . . . . 0.0 111.762 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -67.54 -19.73 65.32 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.558 . . . . 0.0 112.375 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -105.81 -22.52 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 117.47 -1.252 . . . . 0.0 111.866 171.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -48.42 -75.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 111.562 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.6 tp -78.51 -25.46 45.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.177 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.66 -27.05 67.53 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.759 1.163 . . . . 0.0 112.911 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.7 m -115.23 -8.03 12.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.684 1.193 . . . . 0.0 111.888 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -97.69 -7.25 31.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.984 1.266 . . . . 0.0 111.429 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -54.5 -46.31 73.44 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.999 1.727 . . . . 0.0 110.236 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 ptp -59.14 -25.81 64.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.271 1.028 . . . . 0.0 112.932 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.92 -26.0 16.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.049 1.739 . . . . 0.0 112.046 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.68 -56.8 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.05 0.94 . . . . 0.0 108.655 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.802 -0.561 . . . . 0.0 112.125 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.567 1.547 . . . . 0.0 112.112 172.694 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -65.89 148.07 52.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -109.88 145.64 36.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -142.13 140.02 32.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.196 0.998 . . . . 0.0 110.736 -169.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.12 136.18 34.55 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 167.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.46 149.86 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.91 1.232 . . . . 0.0 109.223 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -141.17 152.09 44.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.244 1.018 . . . . 0.0 110.176 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.9 m -91.53 146.88 23.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 170.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -145.3 121.14 10.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.52 -98.62 0.21 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -141.67 37.09 1.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.211 1.404 . . . . 0.0 109.633 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.67 160.11 40.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.836 1.654 . . . . 0.0 107.92 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.3 152.54 44.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.093 1.425 . . . . 0.0 110.361 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.32 154.97 48.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.711 2.005 . . . . 0.0 107.459 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.32 159.13 21.31 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.904 1.24 . . . . 0.0 110.113 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mt -142.22 133.69 25.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -45.75 113.96 0.69 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 109.082 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -53.05 -39.0 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.49 -16.84 64.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.225 0.92 . . . . 0.0 112.941 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -74.2 -24.74 59.4 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.753 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -64.78 140.89 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -120.37 -42.0 2.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.479 1.112 . . . . 0.0 110.511 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 169.54 24.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.585 1.154 . . . . 0.0 108.386 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.6 142.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -149.11 174.4 12.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.928 0.891 . . . . 0.0 108.633 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.04 25.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.66 126.04 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.37 159.0 2.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.754 . . . . 0.0 108.2 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.57 43.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.935 2.894 . . . . 0.0 116.18 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 t -74.22 107.97 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -76.12 95.01 3.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.38 142.75 50.33 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.452 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.0 mm -82.7 8.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.691 0.796 . . . . 0.0 110.099 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.26 -4.8 0.26 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.349 2.26 . . . . 0.0 115.511 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.99 14.75 1.34 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.054 1.342 . . . . 0.0 112.449 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.452 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -76.0 144.4 75.7 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.259 1.024 . . . . 0.0 109.95 174.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.36 157.56 53.83 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.917 2.411 . . . . 0.0 109.274 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.53 -33.8 64.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.748 0.819 . . . . 0.0 112.728 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.91 -49.08 63.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.851 0.75 . . . . 0.0 110.549 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.54 -37.69 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.804 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? 48.58 -82.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.834 2.454 . . . . 0.0 111.352 -169.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.87 14.06 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 120.726 1.603 . . . . 0.0 112.713 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.73 156.79 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -140.07 157.03 46.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.924 1.238 . . . . 0.0 109.622 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -78.62 101.84 7.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.911 1.284 . . . . 0.0 110.98 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.75 70.71 2.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 109.931 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 50.81 27.7 3.24 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.7 1.6 . . . . 0.0 114.227 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.6 -17.85 2.03 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.391 0.996 . . . . 0.0 113.263 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -171.45 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.723 1.261 . . . . 0.0 107.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -132.18 150.4 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 120.768 -1.207 . . . . 0.0 110.202 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.87 141.5 14.97 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.676 -1.154 . . . . 0.0 109.289 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.1 131.08 24.28 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.884 1.723 . . . . 0.0 108.585 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.69 123.83 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.13 147.89 12.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.452 2.301 . . . . 0.0 107.117 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.84 118.56 37.1 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.747 0.819 . . . . 0.0 109.562 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.28 -20.39 66.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.055 0.942 . . . . 0.0 113.195 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -56.02 -39.8 72.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.425 1.466 . . . . 0.0 109.434 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.33 12.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 109.763 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -131.83 -27.44 1.88 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.859 -1.151 . . . . 0.0 112.079 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.55 6.3 3.23 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.746 1.157 . . . . 0.0 113.718 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m 59.18 23.39 11.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -61.12 149.37 37.48 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.48 0.712 . . . . 0.0 111.674 -169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 m -24.25 -75.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 129.054 2.942 . . . . 0.0 117.506 -169.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -164.93 67.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.362 1.065 . . . . 0.0 109.758 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -50.84 140.57 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.21 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -160.52 165.62 30.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.677 1.191 . . . . 0.0 109.009 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -73.99 43.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.281 2.232 . . . . 0.0 111.157 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' H ' ' A' ' 84' ' ' ASP . 26.0 t30 -159.22 -19.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.85 3.26 . . . . 0.0 110.028 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.412 ' H ' ' H ' ' A' ' 83' ' ' ASN . 38.2 t70 -135.75 6.54 3.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.638 1.575 . . . . 0.0 111.501 -172.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -154.8 37.27 0.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.434 1.893 . . . . 0.0 109.05 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p -94.87 11.57 31.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.32 1.848 . . . . 0.0 115.751 -168.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.64 160.37 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.44 135.05 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -171.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.6 mt -115.89 127.03 73.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.73 134.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 mt -129.79 164.03 24.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.411 1.484 . . . . 0.0 108.209 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.01 157.3 44.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.867 0.867 . . . . 0.0 108.696 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.29 -178.05 4.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.18 97.35 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.896 1.236 . . . . 0.0 113.136 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 63.16 22.48 13.41 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.541 1.936 . . . . 0.0 115.282 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -147.2 161.94 39.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.79 1.632 . . . . 0.0 111.016 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.5 m -135.54 151.45 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 123.799 0.84 . . . . 0.0 110.396 -170.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.55 174.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.235 1.814 . . . . 0.0 106.673 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.45 176.55 40.33 Favored Glycine 0 N--CA 1.448 -0.541 0 O-C-N 120.201 -1.562 . . . . 0.0 110.28 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.46 149.4 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.827 0.851 . . . . 0.0 109.559 -169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 m -94.32 136.1 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.836 1.254 . . . . 0.0 108.86 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.02 166.02 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.608 1.563 . . . . 0.0 109.363 -169.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.52 -43.0 67.27 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.07 154.0 10.73 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.45 123.41 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -49.38 12.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.867 0.467 . . . . 0.0 110.79 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.56 179.73 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.67 1.188 . . . . 0.0 109.618 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.45 127.92 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 pp -156.17 177.68 11.16 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.837 1.255 . . . . 0.0 109.753 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -129.86 148.82 51.77 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.866 0.757 . . . . 0.0 112.179 -169.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mp -139.96 145.89 38.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.175 1.39 . . . . 0.0 108.698 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -94.02 172.2 8.37 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 111.543 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.1 21.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.406 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.11 -39.36 12.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.704 1.202 . . . . 0.0 109.143 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -69.02 -41.6 77.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.821 0.848 . . . . 0.0 110.703 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -86.43 117.58 31.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -143.23 -64.32 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.562 0 CA-C-O 116.838 -1.554 . . . . 0.0 111.818 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.93 -175.1 1.97 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.243 1.962 . . . . 0.0 111.501 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.22 31.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.221 1.808 . . . . 0.0 107.978 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.69 149.63 61.3 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.203 1.935 . . . . 0.0 110.546 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.57 24.96 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.709 1.204 . . . . 0.0 110.549 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -76.82 34.67 0.15 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.191 1.796 . . . . 0.0 114.038 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.77 32.28 5.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.891 2.076 . . . . 0.0 113.608 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.67 -178.86 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.401 1.08 . . . . 0.0 109.755 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -8.63 8.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.483 1.513 . . . . 0.0 113.974 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.05 151.23 40.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.102 1.361 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -135.25 160.28 38.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.422 1.089 . . . . 0.0 108.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 p -62.07 -10.47 10.2 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -22.46 12.06 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.306 1.042 . . . . 0.0 111.365 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -84.8 -9.8 57.81 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.941 -0.475 . . . . 0.0 110.341 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.93 120.26 2.95 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.197 2.199 . . . . 0.0 112.327 -169.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 145' ' ' VAL . 41.1 p -75.91 -166.18 0.55 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.428 2.691 . . . . 0.0 111.431 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.74 175.18 20.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.48 143.59 39.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.32 170.14 31.56 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.7 154.49 29.45 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.22 1.008 . . . . 0.0 109.595 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.39 71.79 1.36 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.72 -38.64 1.27 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.894 2.188 . . . . 0.0 113.723 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.6 -34.92 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.99 2.116 . . . . 0.0 110.13 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -71.54 166.08 22.54 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -139.59 145.42 38.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -132.01 126.31 33.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.9 mt -79.7 110.88 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.07 105.64 11.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.0 t -60.15 120.89 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.52 60.33 2.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.305 0.574 . . . . 0.0 110.131 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -53.17 -37.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.615 1.166 . . . . 0.0 111.018 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.35 -23.52 66.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.187 0.995 . . . . 0.0 112.312 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -110.56 -20.41 12.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 117.337 -1.316 . . . . 0.0 111.841 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.21 -61.67 2.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.782 1.173 . . . . 0.0 109.885 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.04 -48.37 63.05 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.82 -40.07 75.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.32 0.509 . . . . 0.0 111.83 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.2 m -80.89 -29.55 35.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.187 0.449 . . . . 0.0 111.568 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.01 -9.31 57.02 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.477 0.711 . . . . 0.0 111.125 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.99 -49.05 66.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.895 1.225 . . . . 0.0 112.089 -169.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.6 ptp -66.02 -31.41 72.28 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.868 -0.52 . . . . 0.0 112.056 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.2 59.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.339 1.056 . . . . 0.0 110.35 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.95 -49.24 78.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.089 1.356 . . . . 0.0 109.041 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.1 -24.61 63.09 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 123.796 0.839 . . . . 0.0 111.977 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.535 0.382 0 CA-C-N 119.281 0.946 . . . . 0.0 112.35 178.826 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -75.52 170.17 16.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.737 0.815 . . . . 0.0 110.168 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.34 145.19 51.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.0 136.26 35.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.382 0.673 . . . . 0.0 110.136 -169.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.5 tp -78.44 133.94 37.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 167.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.28 148.14 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 119.324 0.965 . . . . 0.0 108.54 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.15 153.16 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.957 0.903 . . . . 0.0 110.125 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -93.55 145.92 24.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' CD1' HD21 ' A' ' 85' ' ' ASN . 56.4 tp -136.77 96.76 3.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.624 . . . . 0.0 107.5 173.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.48 -76.03 0.52 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.169 1.366 . . . . 0.0 111.907 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.08 30.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.285 1.434 . . . . 0.0 110.494 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.36 160.54 39.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 108.145 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -127.93 151.6 48.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.045 1.403 . . . . 0.0 110.824 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -137.33 156.84 47.76 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.878 2.071 . . . . 0.0 108.045 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.73 153.92 19.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.848 1.213 . . . . 0.0 110.419 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -136.63 130.99 47.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -48.65 120.36 3.71 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.94 -31.89 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.336 0.654 . . . . 0.0 111.595 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.99 -23.58 67.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.502 -0.749 . . . . 0.0 112.689 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -77.64 -22.91 49.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.928 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.94 140.2 20.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.637 1.108 . . . . 0.0 108.369 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 -40.67 2.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.522 1.129 . . . . 0.0 110.431 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -166.19 177.47 6.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.559 . . . . 0.0 107.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.86 135.6 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -120.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -170.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.85 164.07 32.77 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.732 1.634 . . . . 0.0 109.266 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -61.8 139.48 58.34 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -147.96 -65.31 0.25 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.465 0.306 . . . . 0.0 111.195 -174.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.48 72.84 0.55 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.491 1.116 . . . . 0.0 108.606 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.83 113.97 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 m -73.46 85.66 1.52 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -65.92 104.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 mm -69.82 148.04 11.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.85 -23.57 67.41 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -170.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.29 31.86 0.38 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 160.04 60.89 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.922 -1.111 . . . . 0.0 109.206 169.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -61.1 145.83 98.38 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.957 1.772 . . . . 0.0 108.176 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.72 -31.47 64.55 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -56.62 -41.91 77.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.227 0.467 . . . . 0.0 111.174 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.0 mt -92.23 89.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -51.7 -47.74 63.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.022 169.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.28 -177.04 28.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.977 1.262 . . . . 0.0 111.853 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 159.93 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 118.051 0.925 . . . . 0.0 109.788 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 t -141.24 158.56 43.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.519 1.054 . . . . 0.0 109.559 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -79.82 129.92 34.88 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.436 1.095 . . . . 0.0 110.233 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.19 84.42 2.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.902 1.281 . . . . 0.0 107.894 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 53.12 34.85 18.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.624 1.17 . . . . 0.0 113.425 169.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.1 -5.26 25.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.502 1.049 . . . . 0.0 112.974 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.72 177.49 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.153 1.781 . . . . 0.0 106.495 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -134.43 156.33 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 120.555 -1.341 . . . . 0.0 109.721 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -154.18 141.4 13.49 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.352 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.11 130.07 19.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.137 1.891 . . . . 0.0 108.747 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -106.85 135.88 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 108.422 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.61 139.35 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -96.26 104.49 16.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.312 1.045 . . . . 0.0 109.094 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -29.76 70.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.328 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -38.57 83.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.5 -36.82 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -71.72 -22.16 61.67 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.37 11.22 9.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.884 1.22 . . . . 0.0 112.842 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m 55.34 25.07 7.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.556 1.542 . . . . 0.0 113.023 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -68.77 161.62 28.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.878 0.871 . . . . 0.0 111.211 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.01 165.95 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 0.0 111.293 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.4 t70 45.05 68.14 0.61 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.106 2.962 . . . . 0.0 114.073 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.09 62.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.911 1.284 . . . . 0.0 109.5 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -143.54 164.67 29.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.61 1.164 . . . . 0.0 110.99 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -81.71 66.76 7.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 169.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.32 -60.16 0.27 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.076 1.351 . . . . 0.0 109.721 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.69 -38.86 73.73 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.014 0.825 . . . . 0.0 111.476 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.469 HD21 ' CD1' ' A' ' 24' ' ' LEU . 7.2 m120 -91.86 -79.31 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -169.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.7 p 60.67 -3.56 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.929 2.092 . . . . 0.0 116.073 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.68 144.97 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 120.468 1.485 . . . . 0.0 107.211 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -120.58 139.49 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.37 133.25 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.57 134.87 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.35 163.01 30.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.755 1.622 . . . . 0.0 108.839 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.28 145.03 35.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.006 1.723 . . . . 0.0 107.547 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -159.44 142.4 14.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.49 -85.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.567 1.556 . . . . 0.0 113.047 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -143.48 16.58 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.013 -170.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.2 177.98 9.41 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.153 -0.967 . . . . 0.0 112.089 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.97 157.41 38.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 110.027 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -160.39 169.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 126.205 1.802 . . . . 0.0 107.218 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.94 168.88 30.68 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.5 pt -140.72 147.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 123.966 0.906 . . . . 0.0 108.76 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.26 139.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.988 0.915 . . . . 0.0 109.16 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.86 156.68 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 108.736 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.26 -39.4 89.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.204 0.911 . . . . 0.0 110.578 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.96 162.56 20.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.62 117.97 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -49.26 42.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.194 0.597 . . . . 0.0 110.565 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -172.44 -174.82 1.26 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.292 1.437 . . . . 0.0 108.526 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.18 131.07 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.88 146.21 40.88 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.116 0.966 . . . . 0.0 109.604 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 p -84.8 144.43 28.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 109.568 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.08 138.48 29.92 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 p -77.57 153.86 32.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.19 -10.01 37.39 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.562 -0.711 . . . . 0.0 111.756 172.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.08 -30.78 70.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.687 1.195 . . . . 0.0 110.23 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -68.07 -41.45 81.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.908 0.776 . . . . 0.0 110.124 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.87 89.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.249 1.82 . . . . 0.0 109.315 -169.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -142.79 -60.24 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-O 116.809 -1.567 . . . . 0.0 112.846 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.13 176.8 4.24 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.944 1.762 . . . . 0.0 111.491 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.1 154.01 30.36 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.892 1.277 . . . . 0.0 109.38 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -80.6 50.04 3.42 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.417 3.411 . . . . 0.0 110.646 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.54 21.09 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.114 1.766 . . . . 0.0 114.621 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -142.81 146.96 34.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.973 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.32 6.95 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.08 2.152 . . . . 0.0 115.039 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.03 165.82 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.921 1.288 . . . . 0.0 109.457 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -0.38 13.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.739 1.216 . . . . 0.0 113.996 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.3 150.77 21.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.326 0.966 . . . . 0.0 110.59 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.6 m -136.67 147.71 46.98 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -57.13 -3.18 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.346 2.258 . . . . 0.0 116.015 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.91 -38.17 23.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.797 1.239 . . . . 0.0 110.575 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -132.16 1.74 3.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.71 1.604 . . . . 0.0 111.608 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.22 132.09 12.74 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.741 2.416 . . . . 0.0 109.963 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.1 p -80.93 -169.39 2.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.774 2.83 . . . . 0.0 111.875 -170.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.98 179.27 16.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.19 149.32 44.28 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 108.206 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.72 169.69 29.89 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 169.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.53 158.84 43.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.176 0.99 . . . . 0.0 110.644 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.5 mt -146.0 67.05 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.366 1.866 . . . . 0.0 107.483 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.34 2.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.168 1.842 . . . . 0.0 113.333 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.54 -32.82 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.695 1.998 . . . . 0.0 110.625 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -69.35 153.36 43.72 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -141.89 142.4 33.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -133.34 124.18 26.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.39 109.56 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.65 116.8 18.48 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.18 141.63 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.49 0.586 . . . . 0.0 109.92 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.43 57.25 3.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.805 0.812 . . . . 0.0 109.021 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.34 -38.69 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.428 1.491 . . . . 0.0 112.732 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -67.71 -7.06 23.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.807 0.843 . . . . 0.0 113.204 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -133.1 23.48 4.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.231 1.412 . . . . 0.0 110.232 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.41 -90.96 0.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -32.34 71.89 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.17 -20.55 54.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -117.63 4.21 12.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.064 0.945 . . . . 0.0 112.22 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -113.47 -9.65 13.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.651 1.18 . . . . 0.0 111.35 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.43 -39.28 83.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.117 1.326 . . . . 0.0 111.452 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.5 ptp -59.07 -23.73 62.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 112.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.43 -29.04 12.98 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.801 1.64 . . . . 0.0 111.484 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.9 -62.19 2.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.424 1.09 . . . . 0.0 109.438 170.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -18.26 60.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.09 -168.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 169.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -134.95 165.81 24.47 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.635 1.974 . . . . 0.0 110.412 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -111.16 147.78 34.17 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.34 137.49 32.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.186 0.994 . . . . 0.0 108.927 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.7 tp -78.64 137.04 37.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.01 147.99 30.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 119.579 1.082 . . . . 0.0 108.824 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -143.12 156.48 44.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.313 1.045 . . . . 0.0 110.168 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.5 m -95.8 145.3 25.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -159.95 129.99 5.43 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 125.791 1.636 . . . . 0.0 106.904 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 39.78 87.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.323 0.963 . . . . 0.0 113.509 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.5 37.43 19.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.144 1.778 . . . . 0.0 111.751 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.46 162.1 37.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.716 2.006 . . . . 0.0 107.058 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -118.39 152.73 35.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.819 1.295 . . . . 0.0 110.496 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -138.99 161.65 36.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.016 2.126 . . . . 0.0 107.72 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.75 164.11 27.15 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.407 0.527 . . . . 0.0 112.398 169.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.2 mt -143.65 138.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -46.41 119.08 2.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.426 1.091 . . . . 0.0 109.261 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.44 -32.47 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.481 0.712 . . . . 0.0 111.865 -170.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.98 -21.11 66.79 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.468 -0.77 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -23.47 60.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.261 0.937 . . . . 0.0 111.786 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.43 143.02 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 119.021 0.828 . . . . 0.0 109.377 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -106.67 -59.53 1.79 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.563 1.145 . . . . 0.0 108.41 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.65 177.57 10.35 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 109.774 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.32 147.67 32.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -149.8 164.74 34.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.974 2.11 . . . . 0.0 106.805 -170.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.75 168.46 51.2 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.04 -1.037 . . . . 0.0 110.817 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -74.16 109.6 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -162.81 154.57 18.08 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.411 1.484 . . . . 0.0 107.783 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 26.99 56.75 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.066 2.546 . . . . 0.0 115.119 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.45 97.47 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 167.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -50.94 -41.07 58.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.522 1.129 . . . . 0.0 110.461 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 52.99 -179.81 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.402 1.881 . . . . 0.0 111.763 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.4 mm -132.7 159.48 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.16 68.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.12 36.0 0.43 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.869 0.868 . . . . 0.0 112.688 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -55.51 145.31 49.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.312 -0.868 . . . . 0.0 111.219 173.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.22 161.69 29.51 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.563 2.842 . . . . 0.0 111.316 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.1 50.22 0.47 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.172 1.789 . . . . 0.0 113.352 -170.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -157.46 -46.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.228 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.3 mt -49.19 -42.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.275 1.03 . . . . 0.0 110.745 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.4 tttp 57.41 -81.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.888 2.075 . . . . 0.0 108.97 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.35 -160.11 10.07 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 120.705 1.593 . . . . 0.0 114.469 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.89 153.78 27.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.7 t -139.22 150.38 45.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.925 0.784 . . . . 0.0 110.48 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -79.21 89.86 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.869 1.668 . . . . 0.0 110.715 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.75 90.1 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.019 0.528 . . . . 0.0 110.107 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 49.62 29.36 3.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.691 1.196 . . . . 0.0 114.004 168.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.71 -3.67 14.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.683 1.135 . . . . 0.0 114.098 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.16 -174.39 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.839 1.656 . . . . 0.0 107.445 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.62 151.39 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.535 -1.353 . . . . 0.0 110.587 -172.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.27 143.38 16.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.532 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.44 129.47 21.47 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.748 1.632 . . . . 0.0 108.323 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.62 114.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.93 172.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.402 2.281 . . . . 0.0 106.232 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -138.45 124.75 20.42 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.611 -1.306 . . . . 0.0 108.749 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -62.45 -27.97 69.48 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.376 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.92 -39.11 53.87 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.189 0.904 . . . . 0.0 111.032 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.12 -41.63 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -81.65 -7.65 59.62 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.448 -0.782 . . . . 0.0 112.874 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.85 -12.66 14.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.285 0.948 . . . . 0.0 113.13 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m 53.46 35.18 19.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.532 1.06 . . . . 0.0 111.82 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.46 162.53 15.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.524 -0.735 . . . . 0.0 110.578 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -37.82 -92.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 128.258 2.623 . . . . 0.0 115.865 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -163.87 84.01 0.45 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.789 1.236 . . . . 0.0 108.997 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -51.16 139.02 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.086 0.954 . . . . 0.0 110.523 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.27 167.95 26.4 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.688 1.595 . . . . 0.0 108.51 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -70.25 50.78 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.355 1.462 . . . . 0.0 111.92 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.406 ' H ' ' H ' ' A' ' 84' ' ' ASP . 48.8 t30 -159.58 -16.09 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.758 3.223 . . . . 0.0 110.557 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 83' ' ' ASN . 33.2 t70 -141.3 3.4 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.771 1.628 . . . . 0.0 111.692 -176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -150.21 37.13 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.434 -1.416 . . . . 0.0 109.662 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.8 p -96.14 0.14 50.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.662 1.585 . . . . 0.0 114.494 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.2 t -134.49 159.76 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.591 1.157 . . . . 0.0 108.153 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.84 131.1 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 107.051 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.63 137.62 28.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.08 135.41 53.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -136.32 166.8 22.61 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.659 1.183 . . . . 0.0 109.854 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -139.3 131.91 28.86 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 92' ' ' ASN . 5.3 mp -135.73 124.47 23.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -168.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.87 -81.91 0.12 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.909 0.766 . . . . 0.0 112.564 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.42 13.92 1.09 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.223 1.809 . . . . 0.0 110.669 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -143.5 174.43 10.77 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.466 1.106 . . . . 0.0 110.246 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.71 155.52 26.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.859 0.864 . . . . 0.0 109.592 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.18 175.27 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 126.189 1.796 . . . . 0.0 107.01 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.65 178.47 41.03 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.29 146.93 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.47 146.41 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -149.78 168.17 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 126.433 1.893 . . . . 0.0 108.893 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.79 -42.09 64.29 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.811 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.85 154.93 9.64 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.97 124.34 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 172.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -40.85 13.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.1 0.56 . . . . 0.0 111.056 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB2' HH22 ' A' ' 140' ' ' ARG . 5.8 t0 -168.04 -177.24 3.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.865 0.466 . . . . 0.0 110.882 -168.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.19 124.14 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.4 mt -140.91 171.8 13.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.703 1.201 . . . . 0.0 109.815 -168.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.4 m -126.45 134.31 50.99 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.682 0.674 . . . . 0.0 110.699 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.23 160.35 39.68 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.125 0.97 . . . . 0.0 110.194 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -145.18 161.32 39.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.23 1.412 . . . . 0.0 109.297 -168.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.22 -25.26 13.45 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.7 -38.15 86.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.073 -1.017 . . . . 0.0 109.669 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -83.07 -37.92 23.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 110.969 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.58 108.93 22.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -146.53 -58.67 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.075 -175.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 41.5 Cg_endo -67.67 173.29 9.21 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.11 1.873 . . . . 0.0 112.052 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.07 162.27 27.07 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.215 1.806 . . . . 0.0 108.335 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.46 -54.98 2.42 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.991 2.461 . . . . 0.0 112.723 -175.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 53.37 -21.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 130.392 3.477 . . . . 0.0 117.969 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -144.49 159.93 41.94 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.305 1.442 . . . . 0.0 109.582 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.6 36.07 13.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.523 1.529 . . . . 0.0 112.758 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.39 155.75 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 108.121 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -35.39 76.57 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.562 0.745 . . . . 0.0 111.304 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.4 170.44 4.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.981 1.713 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.9 m -140.83 178.98 6.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.368 2.267 . . . . 0.0 107.276 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 -27.87 2.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.571 2.349 . . . . 0.0 114.227 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.83 -18.94 62.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.422 1.489 . . . . 0.0 112.344 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.17 23.3 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.33 1.852 . . . . 0.0 109.762 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.92 115.05 27.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.482 1.513 . . . . 0.0 111.604 -169.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 145' ' ' VAL . 44.8 p -72.27 -179.1 2.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.048 2.539 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.84 172.93 15.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.943 -2.463 . . . . 0.0 106.943 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.25 157.64 43.52 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.329 1.565 . . . . 0.0 110.329 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.07 179.57 38.21 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.22 157.44 23.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.24 1.016 . . . . 0.0 111.071 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.18 81.3 1.67 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.61 2.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.6 2.047 . . . . 0.0 113.012 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.01 -32.02 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 111.043 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 107' ' ' ASP . 62.1 mtp180 -69.49 162.56 27.22 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.7 mtp -139.49 145.96 39.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.24 130.15 36.72 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.9 mt -84.07 100.94 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.45 118.03 20.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.414 ' HA ' HG22 ' A' ' 132' ' ' THR . 61.5 t -63.54 137.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -72.92 52.75 0.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.479 1.112 . . . . 0.0 110.077 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.83 -40.56 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.505 1.522 . . . . 0.0 114.784 -168.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.97 -20.91 51.79 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.669 -1.27 . . . . 0.0 111.432 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -41.96 21.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.7 tp -50.6 -45.0 57.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 110.184 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.29 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.714 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -75.93 -56.23 4.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -54.46 -46.24 73.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 110.425 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -74.33 -20.57 60.06 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.135 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.44 -47.02 80.65 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 122.122 2.237 . . . . 0.0 110.102 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.0 mtm -65.19 -45.95 82.72 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.85 96.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.074 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.3 -60.42 3.88 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.949 1.299 . . . . 0.0 109.548 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -27.98 68.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.992 -169.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 123.317 0.647 . . . . 0.0 112.676 174.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -135.3 166.97 21.89 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.167 1.787 . . . . 0.0 110.655 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -117.79 148.52 41.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.78 135.45 29.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.918 0.887 . . . . 0.0 109.296 -169.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.9 tp -77.21 134.66 38.56 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 168.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.6 m -121.57 149.21 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.778 1.172 . . . . 0.0 109.127 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.65 150.86 44.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.477 1.111 . . . . 0.0 109.696 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -91.43 147.46 23.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 tp -140.73 101.41 4.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.37 -76.26 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.512 1.53 . . . . 0.0 112.026 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.17 31.13 0.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.428 1.491 . . . . 0.0 110.657 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.77 160.54 39.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.941 1.696 . . . . 0.0 107.952 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -119.89 153.57 35.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.191 1.472 . . . . 0.0 110.846 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -140.51 159.43 42.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.532 2.333 . . . . 0.0 107.274 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -140.55 164.26 26.34 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 118.669 0.668 . . . . 0.0 111.989 170.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 mt -142.29 135.85 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -49.0 115.81 1.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.664 1.186 . . . . 0.0 108.983 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.37 -34.12 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.438 0.695 . . . . 0.0 111.697 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.63 -24.92 67.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.759 0.824 . . . . 0.0 112.668 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -84.83 -18.64 34.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.813 0.733 . . . . 0.0 112.061 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.87 136.8 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -100.44 -56.44 2.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 108.912 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -162.31 -179.18 6.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.526 1.13 . . . . 0.0 109.75 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -136.2 147.09 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -145.28 169.38 18.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.154 1.382 . . . . 0.0 108.297 -172.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.66 148.85 19.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -82.03 100.69 9.88 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.81 1.244 . . . . 0.0 107.922 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.3 165.99 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.6 1.96 . . . . 0.0 106.587 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . 0.299 1.0 OUTLIER 42.91 30.02 0.22 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.582 2.753 . . . . 0.0 117.498 171.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.01 127.92 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 112.691 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 45.34 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.67 2.388 . . . . 0.0 110.689 -169.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.0 mm -57.37 153.43 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -18.37 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.43 23.27 0.72 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.53 155.57 67.64 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.519 0.728 . . . . 0.0 110.079 169.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -61.98 161.17 26.83 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.387 2.058 . . . . 0.0 109.01 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.52 80.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.674 -172.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -59.89 -41.08 90.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.195 0.907 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 158' ' ' LEU . 37.8 mt -71.81 82.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -53.18 -30.61 38.39 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.629 1.172 . . . . 0.0 109.455 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.98 -151.5 22.45 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.85 154.92 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -136.01 145.96 46.64 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.99 92.89 5.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.45 175.62 1.31 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -69.54 59.49 0.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.87 1.668 . . . . 0.0 113.249 -169.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.86 -6.89 3.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.168 2.318 . . . . 0.0 113.389 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER -153.71 -165.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.375 1.588 . . . . 0.0 108.458 -169.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -121.1 158.75 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.094 1.758 . . . . 0.0 108.403 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.82 142.39 15.43 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.817 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.15 147.18 59.78 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.408 2.072 . . . . 0.0 110.745 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -131.32 148.16 32.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.721 0.808 . . . . 0.0 109.04 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.84 137.31 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -95.7 124.74 39.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.78 -18.83 64.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.361 0.664 . . . . 0.0 111.98 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -60.23 -31.44 70.19 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.839 -1.163 . . . . 0.0 109.624 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.64 -47.83 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -71.79 -33.08 68.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.859 -1.067 . . . . 0.0 113.581 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' CD1' HD22 ' A' ' 126' ' ' LEU . 16.0 m-30 -121.55 3.05 10.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.816 1.189 . . . . 0.0 112.552 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.3 m 58.67 29.59 18.78 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.986 0.812 . . . . 0.0 111.317 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -57.06 142.03 43.72 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.726 0.81 . . . . 0.0 110.41 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.22 140.47 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 122.092 0.949 . . . . 0.0 111.946 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 24.68 60.55 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 130.734 3.614 . . . . 0.0 115.557 168.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.5 146.92 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -160.33 162.27 33.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.678 0.791 . . . . 0.0 109.251 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.77 40.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.872 2.469 . . . . 0.0 111.562 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -155.28 -25.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.837 2.455 . . . . 0.0 110.978 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -135.32 9.32 3.45 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 111.491 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.12 36.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.602 1.961 . . . . 0.0 108.478 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 p -73.41 4.88 4.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.81 165.23 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.986 1.721 . . . . 0.0 108.948 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -141.06 140.8 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.283 1.833 . . . . 0.0 106.236 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.0 134.87 56.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.62 134.13 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.46 161.62 34.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.469 1.508 . . . . 0.0 108.316 -169.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.56 148.65 39.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.38 127.34 29.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 52.35 -99.1 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 CA-C-N 118.609 0.641 . . . . 0.0 111.791 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.64 20.94 5.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.347 1.459 . . . . 0.0 111.863 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.72 166.32 22.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.479 1.112 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.89 153.03 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.525 1.13 . . . . 0.0 109.883 -171.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -160.28 176.51 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.819 1.648 . . . . 0.0 107.05 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 176.82 38.97 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 120.538 -1.351 . . . . 0.0 111.025 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.2 pt -141.79 154.1 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 124.396 1.078 . . . . 0.0 109.032 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.05 137.2 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.321 1.048 . . . . 0.0 108.304 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.25 168.09 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.15 1.38 . . . . 0.0 110.38 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.28 -40.99 64.14 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.856 -1.153 . . . . 0.0 110.619 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.31 154.53 9.52 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.83 128.23 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.47 -43.29 9.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.236 0.615 . . . . 0.0 111.321 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -168.36 -174.32 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.739 0.816 . . . . 0.0 109.874 -168.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.0 t -134.19 129.61 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -138.21 169.75 17.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.867 1.267 . . . . 0.0 109.309 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -129.24 134.93 48.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.446 0.566 . . . . 0.0 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.19 160.25 41.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.815 1.246 . . . . 0.0 109.579 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -144.06 172.7 12.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.81 2.044 . . . . 0.0 107.347 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.6 0.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -78.1 -45.42 23.46 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 120.182 1.355 . . . . 0.0 108.669 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -84.31 -32.68 24.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.111 1.364 . . . . 0.0 111.656 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.93 121.67 50.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 13.7 mmt180 -147.96 -54.86 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.604 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 52.0 Cg_endo -69.28 -178.78 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.114 1.876 . . . . 0.0 111.981 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.27 32.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.694 1.598 . . . . 0.0 109.36 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.01 58.09 6.78 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.052 3.168 . . . . 0.0 111.704 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 30.07 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.297 1.439 . . . . 0.0 112.456 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.91 30.26 0.11 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.236 2.215 . . . . 0.0 113.865 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.47 31.81 4.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.882 2.073 . . . . 0.0 113.456 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 m -78.33 175.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -57.05 -17.38 9.96 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 75' ' ' PHE . 15.7 tp -78.05 -29.34 49.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.564 0.746 . . . . 0.0 112.921 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.1 m -70.91 78.02 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.731 1.612 . . . . 0.0 111.003 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.2 p -140.21 -102.01 0.15 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.374 1.069 . . . . 0.0 112.279 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.31 -36.18 0.41 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 127.333 2.253 . . . . 0.0 109.895 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -78.92 15.49 1.08 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.8 137.6 20.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.806 2.042 . . . . 0.0 109.896 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 145' ' ' VAL . 51.8 p -81.91 -168.86 2.09 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.823 2.049 . . . . 0.0 109.877 -174.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.52 177.03 18.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 171.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -140.54 140.72 35.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.725 1.21 . . . . 0.0 107.783 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.73 173.97 30.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.84 155.11 50.83 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.69 0.796 . . . . 0.0 110.8 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.2 mt -142.31 78.11 1.61 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.002 1.721 . . . . 0.0 107.38 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.94 -51.48 3.15 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.43 1.967 . . . . 0.0 112.833 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.02 -30.56 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.278 1.831 . . . . 0.0 111.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -69.79 153.51 43.23 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 171.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.94 140.72 40.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.36 115.2 15.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.7 mt -75.61 107.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.67 111.44 21.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -65.17 126.28 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -76.43 56.89 1.13 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.674 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.66 -35.0 48.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.035 1.334 . . . . 0.0 111.51 -170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.77 -18.43 64.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.301 0.64 . . . . 0.0 112.348 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.99 -15.59 14.32 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 116.917 -1.516 . . . . 0.0 112.003 170.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.25 -63.91 1.03 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.932 1.696 . . . . 0.0 110.668 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.37 -39.55 81.72 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -60.1 -43.81 95.3 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.663 1.12 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -73.38 -16.22 61.35 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.902 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -115.58 -0.29 13.08 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.702 -1.142 . . . . 0.0 113.43 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -49.72 -53.1 26.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.022 1.737 . . . . 0.0 111.819 -173.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.62 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.551 1.069 . . . . 0.0 111.167 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 55' ' ' ILE . 23.4 tp -59.77 -53.04 62.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.727 1.211 . . . . 0.0 108.46 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.07 -11.88 61.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 118.127 -0.94 . . . . 0.0 112.389 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 120.028 1.286 . . . . 0.0 110.965 173.682 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.08 138.85 58.58 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.34 143.81 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.67 139.56 33.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.997 0.919 . . . . 0.0 109.346 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 tp -83.37 130.24 35.04 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.2 152.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 109.317 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.27 153.59 45.3 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.544 1.138 . . . . 0.0 109.596 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -93.4 144.78 25.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -133.03 88.28 2.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.695 1.598 . . . . 0.0 106.742 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.75 -70.15 0.4 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.935 1.731 . . . . 0.0 112.755 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -151.24 27.73 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.37 1.468 . . . . 0.0 111.223 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.75 161.71 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.579 1.552 . . . . 0.0 108.154 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.82 150.2 46.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.464 1.126 . . . . 0.0 109.663 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -141.16 155.19 46.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.409 1.884 . . . . 0.0 107.507 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.97 158.68 22.99 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.425 1.012 . . . . 0.0 110.584 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.58 140.62 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -49.89 117.26 2.2 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.83 0.852 . . . . 0.0 109.993 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.75 -30.56 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.457 0.703 . . . . 0.0 111.569 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 mt -66.43 -4.88 9.16 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -109.88 -13.52 14.43 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 112.878 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.51 142.17 17.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 119.548 1.067 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -103.68 -57.71 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.22 -179.37 6.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.7 1.2 . . . . 0.0 109.295 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.57 149.51 31.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -143.59 174.32 10.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.28 1.432 . . . . 0.0 107.743 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.0 161.59 26.9 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 169.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.19 129.19 39.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.78 -43.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.7 41.19 0.77 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.61 135.86 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -123.43 92.33 3.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.17 111.66 5.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.2 -45.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.207 -170.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 144.73 -62.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.461 3.504 . . . . 0.0 108.696 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.82 18.47 22.08 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.673 1.189 . . . . 0.0 112.544 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.53 155.77 2.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.74 1.616 . . . . 0.0 110.003 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.24 146.65 49.0 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.726 1.617 . . . . 0.0 108.641 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -33.0 74.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.581 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -53.63 -42.5 67.84 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.976 0.807 . . . . 0.0 109.959 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.9 87.17 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -49.77 -32.09 13.04 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.317 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.62 -162.32 35.74 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.49 145.15 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -136.55 161.03 37.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 119.801 1.182 . . . . 0.0 109.178 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -80.31 108.94 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.759 0.823 . . . . 0.0 110.125 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.72 171.81 14.09 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.62 55.19 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.76 1.624 . . . . 0.0 112.831 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.01 -11.76 1.24 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.392 2.425 . . . . 0.0 113.743 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.56 -159.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 119.87 1.835 . . . . 0.0 108.828 -169.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.2 tp -121.36 155.35 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.839 1.655 . . . . 0.0 109.12 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.89 139.94 15.16 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.404 1.081 . . . . 0.0 109.314 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 141.26 47.22 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.228 1.952 . . . . 0.0 109.774 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -126.09 138.03 55.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.491 1.117 . . . . 0.0 108.602 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.12 130.44 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.11 119.47 25.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.55 -18.98 64.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.135 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -33.99 70.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 121.007 1.73 . . . . 0.0 110.278 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.03 0.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.51 1.124 . . . . 0.0 109.065 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -116.29 -30.6 5.89 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.757 -1.214 . . . . 0.0 111.616 172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -136.78 0.06 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 m 54.06 50.53 16.43 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.137 1.335 . . . . 0.0 111.941 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -54.94 169.28 0.23 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.469 1.108 . . . . 0.0 112.85 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.48 -66.46 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.391 1.477 . . . . 0.0 112.108 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.24 98.14 0.35 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 0.0 109.255 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.21 139.95 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.6 137.11 15.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.964 0.905 . . . . 0.0 109.351 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -73.23 34.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.118 2.167 . . . . 0.0 113.049 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -13.37 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.182 2.193 . . . . 0.0 110.636 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.01 8.63 4.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.628 1.171 . . . . 0.0 111.827 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.59 35.97 0.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.048 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -100.31 16.77 23.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -168.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.15 157.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.009 1.277 . . . . 0.0 107.68 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.43 111.65 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 mt -84.05 143.08 12.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.02 131.7 72.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.8 mt -134.18 166.15 23.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.957 1.703 . . . . 0.0 108.272 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.63 156.05 49.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.499 0.72 . . . . 0.0 109.845 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.54 96.93 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.51 -73.22 0.77 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.511 0.596 . . . . 0.0 113.752 174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -143.31 7.14 1.54 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.951 2.1 . . . . 0.0 111.879 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -137.73 161.99 35.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.77 1.628 . . . . 0.0 108.288 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.79 151.18 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.07 170.93 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.988 1.715 . . . . 0.0 106.92 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.83 176.96 37.4 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 120.77 -1.206 . . . . 0.0 111.233 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -145.68 144.97 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.106 0.962 . . . . 0.0 109.147 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 m -89.51 133.71 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.025 0.93 . . . . 0.0 109.119 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.08 169.59 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.34 1.456 . . . . 0.0 109.83 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.84 -43.85 67.67 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 170.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.05 156.15 11.3 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 m -71.93 123.84 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -53.97 6.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 109.857 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -174.48 177.31 2.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.015 1.726 . . . . 0.0 108.533 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.46 133.38 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.158 1.783 . . . . 0.0 107.481 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.87 178.26 10.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.936 1.294 . . . . 0.0 109.397 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 m -129.94 150.55 51.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.303 0.501 . . . . 0.0 111.91 -171.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -140.49 141.7 35.34 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.413 1.485 . . . . 0.0 107.227 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.8 p -76.95 162.71 27.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.356 0.598 . . . . 0.0 109.993 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.21 7.24 1.34 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.814 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -101.9 -37.32 8.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.719 2.008 . . . . 0.0 109.131 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.53 -41.26 98.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 106.891 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -144.23 -70.99 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.463 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.41 -174.35 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.4 2.067 . . . . 0.0 111.314 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.91 55.6 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.657 1.583 . . . . 0.0 108.929 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -82.58 38.45 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 124.133 3.222 . . . . 0.0 111.053 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.18 21.0 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.381 1.472 . . . . 0.0 114.135 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -137.52 144.74 42.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.674 1.19 . . . . 0.0 110.314 -171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.11 35.94 14.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.506 1.922 . . . . 0.0 114.479 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.24 176.84 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.42 1.488 . . . . 0.0 109.074 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -9.9 50.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 113.495 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.42 153.38 43.03 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.845 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -144.97 165.86 26.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.59 1.156 . . . . 0.0 109.318 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.7 p -56.14 -28.72 59.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.169 1.388 . . . . 0.0 113.119 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.88 -29.09 67.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.572 0.749 . . . . 0.0 112.148 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -123.67 -1.12 8.51 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.226 1.011 . . . . 0.0 112.892 -168.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.27 0.9 OUTLIER -61.71 164.87 5.64 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.378 1.085 . . . . 0.0 112.937 -171.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 145' ' ' VAL . 39.8 p -122.05 -159.47 0.82 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.142 1.777 . . . . 0.0 109.346 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.83 23.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 168.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.53 153.62 40.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.363 1.582 . . . . 0.0 109.577 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.19 172.68 39.24 Favored Glycine 0 C--N 1.333 0.377 0 O-C-N 123.09 0.244 . . . . 0.0 113.55 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.61 153.15 17.86 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.942 0.897 . . . . 0.0 110.967 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.75 79.79 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.64 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.611 2.053 . . . . 0.0 113.31 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -156.71 -33.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.504 2.322 . . . . 0.0 110.582 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -68.92 166.41 17.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.64 0.776 . . . . 0.0 110.493 172.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.8 mmm -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 169.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.66 151.08 46.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.2 mt -110.09 120.27 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.88 104.19 16.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.432 ' HA ' HG22 ' A' ' 132' ' ' THR . 60.2 t -62.64 129.89 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 126.011 1.724 . . . . 0.0 108.133 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -62.96 -28.36 70.03 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . 0.315 8.2 tp 46.31 -48.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 131.421 3.888 . . . . 0.0 116.503 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -62.62 -17.26 59.94 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.278 1.854 . . . . 0.0 113.961 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -101.93 -10.34 19.89 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 116.575 -1.679 . . . . 0.0 112.502 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.55 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.533 1.515 . . . . 0.0 111.455 -169.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.24 -29.57 64.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.613 -0.68 . . . . 0.0 110.388 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.38 -36.16 70.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.682 0.674 . . . . 0.0 111.649 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 m -91.77 -27.7 17.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.081 0.553 . . . . 0.0 111.485 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.98 -15.37 38.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.133 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.4 -36.11 77.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.196 1.816 . . . . 0.0 112.498 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -63.62 -45.78 88.71 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.744 -0.597 . . . . 0.0 109.537 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.15 87.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.122 0.569 . . . . 0.0 111.089 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.23 -64.43 0.82 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.131 1.372 . . . . 0.0 108.311 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.62 -31.26 70.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -168.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.371 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -67.8 138.06 55.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -106.02 144.16 33.14 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.96 140.21 32.67 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.03 0.932 . . . . 0.0 110.594 -169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.08 137.04 35.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 167.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.04 151.11 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 119.782 1.174 . . . . 0.0 109.066 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -139.45 150.04 44.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.466 1.106 . . . . 0.0 109.556 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -89.71 147.02 24.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.33 106.36 4.96 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.71 -80.37 0.24 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.653 1.121 . . . . 0.0 111.756 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -153.71 32.34 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.684 1.593 . . . . 0.0 110.158 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.58 162.06 36.86 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.462 1.905 . . . . 0.0 107.707 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.58 154.96 38.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.823 1.297 . . . . 0.0 111.042 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -140.86 156.28 46.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.182 2.193 . . . . 0.0 107.593 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.22 157.03 22.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.543 1.068 . . . . 0.0 111.31 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 136.34 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.97 123.56 13.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.22 -35.04 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.604 0.762 . . . . 0.0 112.822 -169.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.8 -18.71 60.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.984 1.266 . . . . 0.0 112.681 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.45 -23.32 50.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.731 0.696 . . . . 0.0 110.55 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.61 136.96 23.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -43.9 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.268 1.027 . . . . 0.0 110.26 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -159.81 170.99 20.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.0 . . . . 0.0 109.064 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.75 142.09 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -147.62 178.59 8.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.506 1.122 . . . . 0.0 108.252 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.21 165.43 15.07 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.94 128.75 38.76 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.59 -45.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -148.35 65.72 1.08 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.876 1.27 . . . . 0.0 108.907 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 37.4 t -85.07 112.13 21.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -75.88 81.98 2.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -60.77 133.7 56.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.16 151.83 8.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -30.38 66.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.81 28.34 0.85 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.96 156.83 9.25 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.458 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.52 132.93 32.65 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 84.98 0.68 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 122.755 1.264 . . . . 0.0 111.076 -170.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -167.8 -46.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.012 4.525 . . . . 0.0 102.889 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -78.37 97.06 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.116 1.766 . . . . 0.0 108.775 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -58.68 -36.03 73.53 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.58 -147.37 9.79 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.88 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 m -122.38 165.41 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.0 t -145.34 159.83 42.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.347 -1.471 . . . . 0.0 109.124 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -81.26 96.01 7.14 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.114 0.966 . . . . 0.0 111.275 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.15 164.06 13.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -74.06 58.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.493 1.042 . . . . 0.0 113.18 -169.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.39 -15.78 0.57 Allowed Glycine 0 CA--C 1.536 1.384 0 C-N-CA 127.3 2.381 . . . . 0.0 112.945 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -151.21 -158.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 119.302 1.551 . . . . 0.0 108.653 -169.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.434 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.0 tp -125.19 153.6 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.269 1.828 . . . . 0.0 108.276 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.7 139.23 14.58 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.426 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.79 146.05 82.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.33 2.02 . . . . 0.0 111.368 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 tp -130.48 132.37 64.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 124.157 0.983 . . . . 0.0 108.965 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.72 153.46 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.4 1.88 . . . . 0.0 106.629 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -131.1 128.66 40.62 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.08 -19.09 62.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.674 1.59 . . . . 0.0 111.056 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -57.32 -27.52 62.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.635 1.107 . . . . 0.0 111.568 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.82 -46.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.64 -27.74 68.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.745 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.96 1.84 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.041 1.291 . . . . 0.0 112.317 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.9 m 55.08 44.51 27.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.177 0.991 . . . . 0.0 112.091 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . 0.289 0.0 OUTLIER -54.45 148.76 11.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.114 -0.366 . . . . 0.0 111.363 176.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 78' ' ' VAL . 6.5 t -37.91 -60.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 128.39 2.676 . . . . 0.0 114.337 -169.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -174.38 88.4 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.057 1.743 . . . . 0.0 108.968 -169.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.16 154.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.461 0.648 . . . . 0.0 110.882 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' ASN . 20.7 t0 -158.45 161.2 37.43 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.19 38.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.267 1.827 . . . . 0.0 111.375 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASP . 69.3 m-80 -151.69 -7.98 0.22 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.948 2.899 . . . . 0.0 110.282 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.34 -23.09 4.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.749 1.22 . . . . 0.0 112.664 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 34.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.666 0.787 . . . . 0.0 109.436 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 p -82.52 -13.37 56.76 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.94 153.02 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.752 1.614 . . . . 0.0 107.653 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.4 t -120.53 137.88 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 126.159 1.783 . . . . 0.0 106.326 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.77 134.66 58.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.42 136.27 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -133.38 153.56 51.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.905 1.682 . . . . 0.0 108.384 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.84 144.96 43.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.46 158.76 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 40.27 -98.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.158 1.361 . . . . 0.0 112.919 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -136.19 30.53 2.99 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.077 1.751 . . . . 0.0 110.52 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.51 178.55 8.72 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.965 -1.085 . . . . 0.0 112.256 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 p -136.82 146.32 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.473 1.509 . . . . 0.0 107.991 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.18 -178.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.636 1.574 . . . . 0.0 107.774 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.66 177.14 41.0 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 120.639 -1.288 . . . . 0.0 111.008 169.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 pt -140.22 163.21 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.11 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 m -106.82 142.1 20.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.131 0.972 . . . . 0.0 108.93 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.33 168.15 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.528 1.531 . . . . 0.0 110.019 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.42 -43.83 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.885 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.32 156.11 12.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.63 127.66 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.6 -41.88 9.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.901 0.48 . . . . 0.0 111.717 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -167.15 178.72 5.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.26 0.624 . . . . 0.0 110.576 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.4 t -136.3 125.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 pp -158.12 178.3 10.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.743 1.217 . . . . 0.0 109.677 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -129.78 150.08 51.24 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.444 0.565 . . . . 0.0 111.995 -171.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -143.32 169.31 17.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.782 1.633 . . . . 0.0 109.043 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -129.02 168.55 15.88 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.642 1.577 . . . . 0.0 109.566 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.32 -13.14 48.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.72 -33.83 75.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.603 1.092 . . . . 0.0 109.575 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -87.75 -39.6 14.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.585 1.154 . . . . 0.0 110.682 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.9 mt -91.58 101.86 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.913 0.885 . . . . 0.0 108.672 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 -143.3 -57.64 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 CA-C-O 116.624 -1.655 . . . . 0.0 113.372 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.98 175.87 3.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.951 1.767 . . . . 0.0 111.499 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.06 150.6 26.11 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.714 1.206 . . . . 0.0 109.227 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.89 44.25 1.68 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.93 3.753 . . . . 0.0 110.986 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.44 19.65 0.08 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.838 1.655 . . . . 0.0 114.053 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.5 155.85 42.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.335 1.454 . . . . 0.0 110.605 -169.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.66 33.29 10.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.525 1.93 . . . . 0.0 114.413 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.12 169.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.779 1.632 . . . . 0.0 108.858 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.98 -76.58 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.811 1.245 . . . . 0.0 109.534 172.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 127' ' ' SER . 8.1 tp 49.71 -167.23 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.626 2.371 . . . . 0.0 113.626 174.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.412 ' H ' ' HG ' ' A' ' 126' ' ' LEU . 1.6 p -155.51 145.54 21.58 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 120.976 -1.078 . . . . 0.0 110.401 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -64.41 -21.43 66.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.746 1.219 . . . . 0.0 113.91 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.69 -22.46 21.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.461 0.573 . . . . 0.0 110.464 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.31 7.82 11.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.169 0.988 . . . . 0.0 111.898 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -63.22 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 145' ' ' VAL . 22.9 p 62.51 -170.91 0.17 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.5 1.92 . . . . 0.0 113.834 168.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -143.66 176.08 23.25 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 169.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.11 143.22 38.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.44 161.97 32.07 Favored Glycine 0 CA--C 1.519 0.321 0 O-C-N 123.61 0.569 . . . . 0.0 112.442 170.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.16 153.85 17.46 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 110.313 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.75 85.05 1.87 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.41 -52.79 2.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.622 2.058 . . . . 0.0 112.804 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.52 -30.31 0.1 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.034 2.134 . . . . 0.0 111.215 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -67.67 161.67 25.35 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.809 0.844 . . . . 0.0 108.993 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 76.8 mmm -127.44 140.53 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.34 135.21 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.31 106.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.72 111.18 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 132' ' ' THR . 18.2 m -65.93 143.05 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.84 59.29 4.75 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.8 0.727 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.51 -52.62 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.68 2.392 . . . . 0.0 113.511 -168.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.08 11.44 1.82 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.696 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -135.76 20.51 3.3 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.579 1.552 . . . . 0.0 110.499 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.05 -98.33 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.86 -29.03 65.04 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.606 -1.309 . . . . 0.0 109.92 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -62.27 -15.72 49.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.4 m -124.93 5.54 8.01 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 112.029 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -122.79 2.58 9.46 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.016 0.927 . . . . 0.0 112.952 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.75 -38.99 90.02 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 119.796 -1.815 . . . . 0.0 112.312 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -62.43 -36.1 81.34 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.285 0.634 . . . . 0.0 110.566 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.21 -38.13 66.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.771 0.829 . . . . 0.0 111.08 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.27 -61.9 2.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.829 1.252 . . . . 0.0 109.126 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.64 -29.6 69.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.441 -168.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.309 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.422 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -136.89 164.0 29.35 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.531 1.932 . . . . 0.0 110.414 -169.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -110.87 149.84 30.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -141.97 134.62 28.36 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.065 0.946 . . . . 0.0 109.33 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.4 tp -74.94 139.05 42.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.82 146.54 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.691 1.132 . . . . 0.0 108.795 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -140.81 150.19 43.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.413 1.085 . . . . 0.0 110.261 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -91.02 142.6 27.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -133.24 90.92 2.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.14 -71.71 0.31 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.18 1.848 . . . . 0.0 112.222 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.62 28.66 0.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.215 1.406 . . . . 0.0 111.164 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.72 162.41 34.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.611 1.564 . . . . 0.0 108.053 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.58 150.76 45.58 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.598 1.189 . . . . 0.0 110.098 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -140.49 156.86 46.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.97 2.108 . . . . 0.0 107.506 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.9 158.1 22.72 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.589 1.09 . . . . 0.0 111.463 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 mt -144.89 133.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -48.12 115.88 1.34 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.896 1.278 . . . . 0.0 109.584 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -53.94 -39.27 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -168.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.63 -17.14 64.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.319 0.963 . . . . 0.0 112.784 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -74.2 -24.26 59.33 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.537 0.608 . . . . 0.0 110.588 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.29 138.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 119.463 1.028 . . . . 0.0 108.723 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -102.15 -57.44 2.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.858 0.863 . . . . 0.0 109.293 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -160.69 174.62 13.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.581 1.152 . . . . 0.0 108.768 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.47 139.01 46.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -141.76 179.31 6.92 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.742 1.617 . . . . 0.0 107.856 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.92 161.5 14.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -56.44 131.18 47.74 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -155.14 -46.96 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.61 81.5 1.29 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.048 0.939 . . . . 0.0 109.525 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 115.67 32.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 90.32 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 173.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 118.87 10.95 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mm -81.95 -38.46 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.7 13.66 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.851 2.06 . . . . 0.0 114.798 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.93 13.91 2.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.525 2.33 . . . . 0.0 110.233 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.66 170.79 7.35 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 130.024 3.33 . . . . 0.0 110.333 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.94 -38.53 37.6 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.968 1.779 . . . . 0.0 112.134 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 139.42 170.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.657 4.383 . . . . 0.0 106.885 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' H ' HG21 ' A' ' 73' ' ' ILE . 44.8 m-85 68.12 -53.72 0.52 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 128.137 2.575 . . . . 0.0 109.346 -169.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -72.75 82.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.326 2.25 . . . . 0.0 110.209 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -56.07 -36.59 68.28 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 109.725 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.48 -173.38 36.99 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.024 -1.56 . . . . 0.0 115.112 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.77 119.43 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -89.66 146.84 24.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.757 1.623 . . . . 0.0 110.033 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -62.02 101.58 0.22 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG 0.302 0.2 OUTLIER -78.79 64.89 3.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.161 1.384 . . . . 0.0 107.834 169.996 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 43.35 36.96 1.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.443 2.297 . . . . 0.0 112.72 170.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.44 -23.39 4.05 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.013 1.292 . . . . 0.0 112.981 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -160.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.327 1.851 . . . . 0.0 106.692 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.86 146.77 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.878 1.217 . . . . 0.0 112.398 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.12 132.5 13.64 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.049 0.94 . . . . 0.0 108.685 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.55 142.01 69.48 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 CA-C-N 121.249 1.482 . . . . 0.0 110.207 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -128.16 132.62 68.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 152.95 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.555 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -103.88 119.91 39.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.172 1.389 . . . . 0.0 107.945 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.93 -7.18 49.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.319 -0.848 . . . . 0.0 113.01 -170.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ttt85 -69.56 -38.15 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 121.338 1.881 . . . . 0.0 108.202 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.44 HG21 ' H ' ' A' ' 54' ' ' PHE . 12.3 mt -71.88 -17.73 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 0.0 110.497 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -122.46 -29.11 4.15 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.777 1.172 . . . . 0.0 113.698 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -131.72 15.32 4.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.787 1.176 . . . . 0.0 112.72 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 m 58.93 28.97 18.3 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.53 1.132 . . . . 0.0 113.113 171.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -48.51 140.92 7.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.383 0.673 . . . . 0.0 109.246 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.07 -54.15 27.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 125.301 1.44 . . . . 0.0 111.377 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -165.43 82.58 0.34 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.593 1.157 . . . . 0.0 108.423 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.3 114.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -153.21 148.98 27.51 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.368 1.067 . . . . 0.0 109.085 -175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.81 45.82 0.73 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.683 1.593 . . . . 0.0 111.944 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.82 -17.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.397 2.279 . . . . 0.0 111.284 169.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.93 -3.31 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.698 1.199 . . . . 0.0 112.178 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.58 38.03 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -85.3 -7.55 58.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.516 2.327 . . . . 0.0 117.177 -168.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.39 152.72 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 120.693 1.588 . . . . 0.0 107.911 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.17 111.99 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -87.52 142.78 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.82 134.65 63.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 mt -134.32 160.23 38.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 108.817 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 152.16 46.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.491 1.517 . . . . 0.0 107.479 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.8 130.69 13.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.89 -83.2 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.211 1.386 . . . . 0.0 113.162 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -142.19 12.48 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.337 1.855 . . . . 0.0 111.704 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -143.98 166.8 23.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.403 1.081 . . . . 0.0 110.315 -169.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.62 151.88 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.737 1.215 . . . . 0.0 109.836 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.02 177.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.057 1.743 . . . . 0.0 106.939 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.31 173.93 39.52 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 120.494 -1.379 . . . . 0.0 110.628 170.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.3 pt -142.81 145.3 23.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 108.792 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.46 135.75 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.767 0.827 . . . . 0.0 109.047 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.84 169.79 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.872 1.269 . . . . 0.0 110.091 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 -42.04 65.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.81 160.36 19.11 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.34 135.83 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.61 -42.19 6.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.95 0.9 . . . . 0.0 111.161 -173.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -168.94 -177.37 2.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.72 125.91 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -140.26 173.94 11.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.091 1.356 . . . . 0.0 109.382 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 m -129.18 138.71 51.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.153 0.888 . . . . 0.0 110.797 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -145.86 163.53 34.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.9 1.28 . . . . 0.0 110.229 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 m -141.76 174.07 10.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.382 2.273 . . . . 0.0 107.133 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.04 1.59 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.72 -51.01 8.62 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.859 -1.151 . . . . 0.0 108.04 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -70.85 -43.12 69.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.613 1.165 . . . . 0.0 110.157 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.43 116.29 33.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -142.19 -66.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 116.395 -1.765 . . . . 0.0 110.8 -171.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.8 -175.69 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.105 1.87 . . . . 0.0 111.099 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.7 154.41 31.47 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.902 1.681 . . . . 0.0 107.715 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.51 42.21 1.29 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.839 3.026 . . . . 0.0 110.987 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.17 -19.7 3.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -140.74 34.6 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.936 0.894 . . . . 0.0 110.669 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.13 19.57 2.79 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 172.36 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.592 1.957 . . . . 0.0 108.788 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 2.82 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.368 1.867 . . . . 0.0 113.75 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.14 164.6 15.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.211 2.204 . . . . 0.0 112.685 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.4 m -137.12 159.28 42.36 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.554 1.542 . . . . 0.0 108.924 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 p -61.35 -20.45 63.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.535 . . . . 0.0 113.434 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -70.09 -36.18 74.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.3 13.12 19.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.431 1.092 . . . . 0.0 109.68 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 121.43 9.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.37 1.068 . . . . 0.0 110.862 -169.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 58.6 p -81.24 -162.22 0.48 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.991 2.517 . . . . 0.0 110.518 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.53 174.86 21.08 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.88 141.96 44.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.05 177.71 32.14 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.37 156.04 47.98 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.379 1.071 . . . . 0.0 109.711 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.5 mt -141.78 77.87 1.61 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.706 1.603 . . . . 0.0 107.272 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.31 -52.28 3.38 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.512 2.005 . . . . 0.0 112.624 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.64 -29.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.398 1.879 . . . . 0.0 111.637 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -69.38 157.13 37.65 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mtp -136.0 153.69 51.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.095 170.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -145.51 135.86 24.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.4 mt -97.67 118.43 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.83 105.53 17.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.68 120.37 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.626 1.17 . . . . 0.0 107.918 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -75.62 66.2 1.93 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.966 0.889 . . . . 0.0 109.902 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tp -57.6 -35.89 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.567 1.147 . . . . 0.0 110.801 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.62 -18.84 65.62 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -114.15 -2.74 13.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.971 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.74 -75.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.971 1.308 . . . . 0.0 109.652 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.02 -28.53 63.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.887 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.39 -34.42 61.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.056 0.942 . . . . 0.0 111.83 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -103.77 -19.62 14.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.78 0.832 . . . . 0.0 111.73 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.55 -18.8 32.33 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.421 -0.799 . . . . 0.0 111.796 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.5 -35.82 76.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.94 1.245 . . . . 0.0 111.968 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.7 mtm -63.82 -41.1 97.93 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 109.952 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.84 -43.16 72.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.916 0.487 . . . . 0.0 110.459 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.63 -58.93 5.21 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.718 1.207 . . . . 0.0 109.647 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -18.37 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 170.415 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.721 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -56.97 135.28 56.16 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -110.44 144.91 38.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -140.6 139.95 35.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.692 0.797 . . . . 0.0 109.554 -169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.33 134.01 35.25 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 168.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.61 148.79 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 119.274 0.943 . . . . 0.0 109.164 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -144.21 150.1 37.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.54 1.136 . . . . 0.0 109.506 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -86.71 148.0 25.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -143.42 111.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.495 1.518 . . . . 0.0 106.92 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -84.77 0.19 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.308 0.956 . . . . 0.0 111.398 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.21 32.17 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.114 1.366 . . . . 0.0 110.377 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -144.08 161.05 39.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.149 1.379 . . . . 0.0 108.236 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -118.58 150.4 39.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.648 1.213 . . . . 0.0 109.256 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.91 158.3 44.3 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.897 2.079 . . . . 0.0 107.142 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.28 24.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.856 0.741 . . . . 0.0 111.551 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mt -140.21 137.33 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.62 124.2 14.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.44 0.564 . . . . 0.0 109.708 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.99 -33.61 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.61 0.764 . . . . 0.0 112.5 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.46 -23.6 65.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.965 0.802 . . . . 0.0 111.961 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.79 -21.95 40.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.626 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.92 137.75 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.53 -43.23 2.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.759 1.223 . . . . 0.0 109.246 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -160.98 172.94 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 108.289 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.4 138.45 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -145.81 168.38 20.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.195 1.398 . . . . 0.0 107.552 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.06 164.7 27.5 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -70.1 3.88 2.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.088 1.355 . . . . 0.0 114.37 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -22.18 3.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.148 1.779 . . . . 0.0 115.714 -169.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.31 49.11 1.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.546 1.067 . . . . 0.0 112.64 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.95 110.79 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 90.45 5.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -67.87 110.67 3.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 mm -71.24 156.39 7.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.79 -24.58 65.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.7 p30 -145.98 22.63 1.39 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.494 1.117 . . . . 0.0 113.927 -169.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.03 153.74 84.05 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.28 151.33 83.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.852 1.701 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.46 75.67 4.01 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 122.097 0.951 . . . . 0.0 109.977 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -163.88 -46.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 130.613 3.565 . . . . 0.0 103.919 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.92 90.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 108.027 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -52.99 -27.83 21.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.158 0.983 . . . . 0.0 110.516 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.13 -168.69 40.54 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.905 1.229 . . . . 0.0 112.106 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.97 114.76 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -85.5 135.57 33.78 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.763 1.625 . . . . 0.0 109.049 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.39 91.48 3.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.46 174.04 2.38 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 169.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -68.86 52.59 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.417 2.287 . . . . 0.0 113.597 -169.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.34 -8.58 1.89 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.361 2.41 . . . . 0.0 113.512 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.96 -164.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 119.565 1.683 . . . . 0.0 108.848 -169.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.481 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.5 tp -122.74 156.14 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.466 1.906 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.98 135.42 9.44 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.437 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.82 140.01 59.55 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 121.274 1.491 . . . . 0.0 110.451 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.96 130.87 73.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.25 158.64 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -121.57 121.51 37.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.97 -22.37 66.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.29 -24.03 67.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.862 1.665 . . . . 0.0 111.785 170.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.34 -48.6 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.97 -18.25 65.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -132.13 -3.92 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.509 1.504 . . . . 0.0 112.636 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.5 m 50.08 37.41 14.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.29 1.036 . . . . 0.0 111.595 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -66.45 100.57 0.66 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.991 1.317 . . . . 0.0 109.439 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 t 39.15 -115.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 126.809 2.044 . . . . 0.0 108.733 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -158.0 100.07 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.25 1.42 . . . . 0.0 107.253 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 20.2 m -68.42 176.95 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 111.225 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -149.24 169.67 20.24 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.678 1.591 . . . . 0.0 108.917 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.36 43.3 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.638 1.975 . . . . 0.0 111.646 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -152.89 -6.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.649 3.179 . . . . 0.0 109.978 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.12 12.53 1.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.766 1.626 . . . . 0.0 111.3 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.72 25.47 0.57 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.108 2.563 . . . . 0.0 108.648 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.5 p -97.66 -2.43 41.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.4 t -110.67 160.45 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.6 t -138.29 132.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.0 mt -104.8 129.27 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.33 141.6 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -134.24 160.52 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.604 1.562 . . . . 0.0 108.852 -169.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.76 146.74 38.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.515 1.126 . . . . 0.0 108.196 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -159.6 143.82 14.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.22 5.28 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 119.414 1.006 . . . . 0.0 114.581 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 56.86 35.25 26.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.3 1.44 . . . . 0.0 113.628 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.94 173.91 11.04 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.696 1.598 . . . . 0.0 109.151 169.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.21 152.47 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.705 0.802 . . . . 0.0 110.576 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 99' ' ' GLY . 11.0 p -157.89 -175.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 106.355 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -172.04 -179.1 42.75 Favored Glycine 0 N--CA 1.448 -0.527 0 O-C-N 120.495 -1.378 . . . . 0.0 109.67 169.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 pt -141.94 144.49 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.844 0.457 . . . . 0.0 110.532 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.86 145.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 169.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.82 167.72 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.589 1.956 . . . . 0.0 108.547 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.02 -45.48 63.86 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.667 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.48 151.9 8.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.4 142.43 16.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 m -124.16 -26.96 3.91 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -168.71 178.74 4.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.653 1.115 . . . . 0.0 110.475 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.17 120.88 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.86 167.23 22.59 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.12 0.968 . . . . 0.0 110.291 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -128.07 138.15 52.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.77 0.428 . . . . 0.0 110.722 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.92 165.9 26.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 107.552 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.76 161.29 29.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -18.25 53.95 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.463 -0.773 . . . . 0.0 112.953 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.66 -36.74 83.27 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.986 -1.071 . . . . 0.0 110.45 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -76.69 -42.25 42.33 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.061 0.945 . . . . 0.0 109.848 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.78 88.91 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.203 1.001 . . . . 0.0 108.58 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 59.6 mtm180 -139.53 -55.32 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.981 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.1 Cg_endo -65.55 175.27 4.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.716 1.611 . . . . 0.0 111.315 175.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.93 157.3 30.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.848 1.259 . . . . 0.0 109.723 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.36 59.83 6.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.354 3.369 . . . . 0.0 110.048 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.39 1.4 11.79 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -148.16 160.35 43.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.369 0.986 . . . . 0.0 110.948 -172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.25 34.87 21.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.034 2.133 . . . . 0.0 114.24 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.0 161.98 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.135 1.374 . . . . 0.0 109.006 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -10.09 58.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.089 1.356 . . . . 0.0 113.426 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.2 tp -52.75 125.78 17.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.68 1.592 . . . . 0.0 113.806 -169.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -63.78 148.53 49.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 111.026 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.2 p -76.92 -16.07 59.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.982 0.913 . . . . 0.0 113.109 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -94.45 -43.07 8.53 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -80.59 7.3 10.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.76 1.224 . . . . 0.0 110.699 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.85 118.34 5.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p -69.96 -177.27 1.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.782 2.433 . . . . 0.0 110.838 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -123.39 179.17 16.21 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 mt -136.45 147.56 47.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.673 1.589 . . . . 0.0 106.878 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.35 171.26 34.62 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.17 154.19 31.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.118 0.967 . . . . 0.0 109.972 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.06 81.71 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.411 1.485 . . . . 0.0 107.052 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 -47.94 2.0 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.662 2.077 . . . . 0.0 113.672 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.53 -36.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.3 2.24 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -71.51 167.19 20.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.759 0.79 . . . . 0.0 110.056 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.0 mtp -135.13 154.79 51.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -136.75 138.22 40.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.7 mt -87.86 113.74 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.88 107.46 14.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.36 120.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.211 1.404 . . . . 0.0 107.909 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -76.72 63.89 2.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.705 0.764 . . . . 0.0 110.27 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.58 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.396 1.478 . . . . 0.0 111.321 -172.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.49 -4.19 14.16 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -126.94 22.97 6.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.558 1.143 . . . . 0.0 110.839 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 -95.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -65.57 -35.62 81.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.985 -1.072 . . . . 0.0 110.112 -173.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.16 -30.51 49.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.141 0.977 . . . . 0.0 113.051 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.5 m -114.7 -1.97 13.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.21 -9.14 11.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.771 -1.109 . . . . 0.0 113.195 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -52.66 -42.95 65.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.901 1.682 . . . . 0.0 112.168 -172.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.3 ptp -59.65 -27.56 66.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.02 1.328 . . . . 0.0 113.338 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.83 -33.48 12.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.093 1.357 . . . . 0.0 111.242 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.95 -60.12 4.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.488 1.115 . . . . 0.0 109.318 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -29.06 68.14 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.522 -169.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 124.344 1.058 . . . . 0.0 112.725 179.068 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -65.22 151.0 47.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.252 1.421 . . . . 0.0 108.247 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.1 143.53 44.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -142.39 136.89 30.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.504 0.722 . . . . 0.0 110.272 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.74 135.87 36.62 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 167.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.16 149.49 31.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 109.098 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -146.11 151.97 38.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.255 1.022 . . . . 0.0 110.242 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.5 m -86.93 146.39 26.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.438 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -137.23 103.23 5.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.95 -86.86 0.17 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.958 0.789 . . . . 0.0 111.575 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.02 31.02 0.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.239 1.416 . . . . 0.0 110.376 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.66 159.2 42.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.711 1.605 . . . . 0.0 107.566 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -122.71 149.65 43.79 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.206 1.479 . . . . 0.0 110.785 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -137.92 161.56 36.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 107.621 -169.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.64 163.95 26.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.845 0.748 . . . . 0.0 112.145 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mt -142.75 138.04 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -48.04 114.59 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.169 . . . . 0.0 109.357 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -54.84 -34.12 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.968 0.907 . . . . 0.0 111.594 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.75 -23.87 67.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.717 0.807 . . . . 0.0 112.618 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -82.64 -19.0 39.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.948 0.794 . . . . 0.0 112.069 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.29 125.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -80.83 -57.58 3.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.02 -178.29 5.53 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.625 1.57 . . . . 0.0 108.537 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.34 141.71 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -143.4 -155.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.925 1.29 . . . . 0.0 108.186 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.15 161.84 26.41 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.33 136.09 57.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -160.3 -51.82 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.45 0.7 . . . . 0.0 110.27 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -157.63 73.06 0.69 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.173 1.389 . . . . 0.0 107.926 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.42 103.44 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 168.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.46 84.9 4.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -70.06 118.13 12.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.97 -24.06 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 118.222 0.464 . . . . 0.0 110.287 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.11 20.92 3.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.002 1.721 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -142.47 41.08 1.6 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.777 2.831 . . . . 0.0 105.127 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.88 151.18 34.42 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 109.096 -168.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.16 156.33 55.89 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.132 1.888 . . . . 0.0 108.846 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.64 -25.55 64.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -53.43 -50.33 65.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.427 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.7 mt -77.17 82.03 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -60.8 -27.39 67.99 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.562 -0.711 . . . . 0.0 110.069 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -166.45 34.81 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.903 0.774 . . . . 0.0 111.302 169.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.92 121.2 66.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -99.93 131.17 46.06 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.742 1.217 . . . . 0.0 110.739 -168.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -63.24 136.33 57.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.0 102.45 4.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 169.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.31 34.38 14.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.393 1.077 . . . . 0.0 113.139 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 9.39 55.56 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.035 0.826 . . . . 0.0 113.432 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 65' ' ' ILE . 1.6 t -131.8 -176.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 127.0 2.12 . . . . 0.0 106.816 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 64' ' ' VAL . 3.9 tp -136.82 159.07 37.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.831 1.253 . . . . 0.0 109.939 -173.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.18 140.47 13.75 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.09 132.21 23.9 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 N-CA-C 106.833 -2.026 . . . . 0.0 106.833 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -111.87 140.14 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.54 172.21 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -132.51 117.8 18.46 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.93 -24.86 67.65 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.363 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -66.46 -25.53 66.77 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 120.075 1.307 . . . . 0.0 111.687 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.7 mm -71.43 -50.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 120.053 1.297 . . . . 0.0 107.545 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -64.91 -16.93 63.87 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.94 1.81 9.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.653 1.181 . . . . 0.0 112.542 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m 47.59 38.15 7.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.579 1.152 . . . . 0.0 111.505 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.21 29.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.502 1.121 . . . . 0.0 110.681 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t 33.62 -109.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.6 2.36 . . . . 0.0 112.178 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -172.02 111.58 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.031 2.132 . . . . 0.0 105.888 -172.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -56.31 160.41 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.963 0.905 . . . . 0.0 111.462 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -153.28 149.88 28.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.219 1.008 . . . . 0.0 108.305 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.18 38.21 0.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.643 1.977 . . . . 0.0 113.163 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.14 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.099 2.16 . . . . 0.0 110.747 169.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.11 6.72 5.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.854 1.262 . . . . 0.0 111.658 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.458 HD22 ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -155.34 28.86 0.4 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.705 -1.247 . . . . 0.0 110.343 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 p -94.05 15.17 17.66 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -167.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.84 150.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.417 1.462 . . . . 0.0 107.144 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 m -119.61 135.1 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 119.691 1.132 . . . . 0.0 109.963 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -98.94 128.7 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.84 133.42 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -133.65 166.43 22.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.505 1.522 . . . . 0.0 109.617 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -139.93 154.83 47.33 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.89 0.876 . . . . 0.0 109.439 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -137.09 83.74 2.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.82 -68.66 1.9 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.057 0.837 . . . . 0.0 112.91 169.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.04 2.25 2.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.804 1.642 . . . . 0.0 112.42 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 166.27 21.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.631 1.105 . . . . 0.0 110.189 174.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.81 154.5 34.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.697 1.199 . . . . 0.0 108.842 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.33 169.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.86 175.41 30.63 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 120.82 -1.175 . . . . 0.0 110.164 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 pt -135.48 140.85 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 85' ' ' ASN . 1.4 m -75.17 135.7 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.486 0.714 . . . . 0.0 109.084 170.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 m -141.65 166.17 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.039 1.735 . . . . 0.0 108.862 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.17 -43.97 69.72 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.233 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.23 10.63 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.18 127.6 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.2 -53.69 7.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.226 0.61 . . . . 0.0 109.673 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -175.26 -176.63 0.95 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.003 1.721 . . . . 0.0 108.166 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.9 132.35 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -134.63 175.96 9.06 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.787 1.635 . . . . 0.0 108.192 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 m -133.33 143.66 49.14 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.53 141.34 33.57 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 158.9 15.56 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.445 1.098 . . . . 0.0 108.308 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.64 26.37 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.7 -31.13 63.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.937 1.295 . . . . 0.0 111.065 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.79 -39.65 30.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.375 1.47 . . . . 0.0 110.482 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.75 113.81 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.6 ttp-105 -155.2 -56.96 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 116.708 -1.615 . . . . 0.0 112.312 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.82 178.22 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.701 1.601 . . . . 0.0 111.567 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.81 156.01 29.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.43 1.492 . . . . 0.0 109.567 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.38 59.71 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.684 3.589 . . . . 0.0 111.574 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.66 31.29 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.149 1.779 . . . . 0.0 112.906 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.51 171.28 9.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.164 1.386 . . . . 0.0 110.418 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.22 30.74 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.767 1.627 . . . . 0.0 113.38 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.77 177.43 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.42 1.488 . . . . 0.0 110.119 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -9.13 15.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.425 1.49 . . . . 0.0 113.789 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.57 142.34 55.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.0 m -143.46 163.36 33.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 110.114 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -53.98 -31.54 51.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.884 1.673 . . . . 0.0 115.222 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -69.63 -26.07 64.24 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.455 1.025 . . . . 0.0 112.808 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.2 9.9 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.276 0.631 . . . . 0.0 112.597 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.11 154.73 12.35 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 118.382 0.537 . . . . 0.0 110.126 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.8 p -107.34 172.73 6.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.342 1.457 . . . . 0.0 109.335 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.39 -179.62 29.74 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.0 145.19 32.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 168.78 32.65 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.55 154.69 25.56 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.696 0.799 . . . . 0.0 109.517 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.31 80.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -174.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.42 -57.2 2.01 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.924 2.202 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -148.96 -24.91 0.3 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.315 2.246 . . . . 0.0 111.939 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -71.72 165.8 23.29 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.9 mtp -141.46 142.2 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -133.77 123.54 25.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 mt -77.42 112.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 170.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.52 108.36 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.02 128.35 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.792 1.637 . . . . 0.0 108.098 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -79.17 60.0 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.687 1.195 . . . . 0.0 110.191 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.84 168.67 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.821 0.848 . . . . 0.0 108.866 170.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.67 -18.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.136 1.775 . . . . 0.0 113.009 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -109.67 -33.56 6.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.09 -1.433 . . . . 0.0 111.38 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -48.65 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.528 1.531 . . . . 0.0 112.205 -170.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 tp -71.36 -25.96 62.6 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.176 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -56.78 -29.4 62.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.253 0.933 . . . . 0.0 112.136 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -114.82 -3.34 12.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.234 1.414 . . . . 0.0 111.678 -173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.08 2.35 19.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.534 1.534 . . . . 0.0 111.739 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.54 -44.86 77.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.444 1.098 . . . . 0.0 111.343 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.11 -37.79 88.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.003 0.921 . . . . 0.0 111.082 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 -37.25 72.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.644 0.778 . . . . 0.0 111.273 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.77 -55.1 33.71 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.06 -28.84 69.36 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.645 0.778 . . . . 0.0 112.118 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 123.675 0.79 . . . . 0.0 112.478 -177.78 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -80.76 153.1 27.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.512 1.525 . . . . 0.0 108.724 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.02 142.52 49.73 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -142.65 143.01 32.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.348 0.659 . . . . 0.0 111.608 -169.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -83.79 133.56 34.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 167.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.98 152.08 25.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 119.875 1.216 . . . . 0.0 109.514 -174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -146.55 153.76 40.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.379 1.072 . . . . 0.0 110.46 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.6 m -90.07 147.15 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.2 tp -144.97 105.59 4.12 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.512 1.525 . . . . 0.0 107.468 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.54 -77.68 0.61 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.146 1.355 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -153.45 22.97 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.061 1.344 . . . . 0.0 112.084 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.48 160.33 40.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.175 1.39 . . . . 0.0 108.555 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -120.17 150.35 40.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.911 1.339 . . . . 0.0 110.449 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -140.12 159.49 42.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.564 1.946 . . . . 0.0 108.029 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.18 160.31 23.88 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.487 1.041 . . . . 0.0 111.092 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -140.62 139.2 35.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -50.07 115.51 1.44 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.946 0.899 . . . . 0.0 109.667 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -54.13 -33.99 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.373 1.069 . . . . 0.0 112.212 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.5 -24.97 68.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.805 0.842 . . . . 0.0 112.988 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -79.85 -18.53 50.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.024 0.829 . . . . 0.0 112.22 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.93 139.75 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.385 0.674 . . . . 0.0 109.235 -175.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -103.17 -57.96 1.95 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.451 1.1 . . . . 0.0 108.722 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.02 178.73 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.484 1.114 . . . . 0.0 109.556 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.43 144.15 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -147.66 168.71 21.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.472 1.909 . . . . 0.0 107.146 -169.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.46 -178.0 52.12 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.089 -1.007 . . . . 0.0 111.411 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -124.08 93.39 3.91 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.511 1.525 . . . . 0.0 106.942 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.49 -43.76 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.549 1.139 . . . . 0.0 109.678 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -74.07 29.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.456 1.902 . . . . 0.0 114.13 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.63 157.49 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.041 0.936 . . . . 0.0 110.878 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.7 m -141.93 148.72 39.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.381 2.672 . . . . 0.0 104.576 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -146.63 142.97 28.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.324 1.42 . . . . 0.0 109.642 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.76 140.53 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 169.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.11 -26.33 26.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -169.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -139.29 37.83 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.767 1.627 . . . . 0.0 112.422 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 48' ' ' ILE . 39.9 p -55.72 152.49 18.91 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 172.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.71 147.59 81.62 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 N-CA-C 106.163 -2.283 . . . . 0.0 106.163 167.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.35 32.48 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -61.24 -39.47 90.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.247 0.931 . . . . 0.0 110.806 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.37 80.93 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -60.73 -14.07 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.09 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.5 -141.25 9.12 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 120.579 1.536 . . . . 0.0 114.158 168.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' PRO . 18.2 m -134.07 166.19 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 128.374 2.669 . . . . 0.0 105.144 169.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 t -147.96 151.23 35.45 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.507 -1.371 . . . . 0.0 110.33 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.46 112.8 15.87 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.488 0.715 . . . . 0.0 110.78 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.38 91.74 8.27 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.59 21.67 0.93 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.089 1.756 . . . . 0.0 115.417 169.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.7 5.55 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.515 1.052 . . . . 0.0 114.079 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.81 -172.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.75 1.62 . . . . 0.0 107.55 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tp -129.41 152.59 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 120.132 1.333 . . . . 0.0 110.844 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.61 142.55 18.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.8 Cg_endo -64.32 151.74 84.22 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.691 1.594 . . . . 0.0 111.777 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tp -125.55 134.96 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.89 142.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -103.53 113.01 26.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.47 -170.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.52 -27.09 65.87 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.112 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -55.12 -46.22 75.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.019 0.827 . . . . 0.0 109.753 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.86 -38.78 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -64.73 -28.35 69.53 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.442 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.31 2.23 10.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.666 0.786 . . . . 0.0 112.725 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m 50.34 48.25 22.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.433 1.093 . . . . 0.0 111.551 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -174.99 0.3 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 111.148 175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.21 173.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.878 1.271 . . . . 0.0 110.949 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -80.78 65.61 5.99 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.589 2.356 . . . . 0.0 110.073 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 m -51.0 157.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.906 1.282 . . . . 0.0 112.744 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -151.53 176.11 11.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.9 1.68 . . . . 0.0 110.548 -171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -67.96 49.85 0.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.366 2.267 . . . . 0.0 110.686 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -149.72 -30.48 0.23 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.338 2.655 . . . . 0.0 109.986 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -141.9 19.22 2.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.127 1.371 . . . . 0.0 111.832 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -142.82 16.75 1.96 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.799 2.039 . . . . 0.0 110.484 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -73.56 3.29 6.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.631 2.772 . . . . 0.0 116.309 -168.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.04 157.45 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 119.781 1.173 . . . . 0.0 108.043 -175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.3 t -132.81 133.62 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.059 2.144 . . . . 0.0 107.632 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -99.99 134.14 40.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.293 -2.855 . . . . 0.0 103.293 168.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.91 134.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.5 mt -134.44 167.47 20.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.572 1.549 . . . . 0.0 108.703 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.04 153.4 42.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.08 141.95 20.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 170.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.36 0.02 OUTLIER Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.063 1.315 . . . . 0.0 112.148 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -146.29 9.12 1.08 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.832 1.653 . . . . 0.0 111.521 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 164.28 24.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.773 -1.204 . . . . 0.0 110.68 -173.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.46 149.73 26.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.195 1.398 . . . . 0.0 108.567 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.12 162.24 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.28 167.08 24.83 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.62 135.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.18 144.31 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -148.13 165.83 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.547 1.939 . . . . 0.0 108.315 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.37 -42.78 74.73 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.248 -0.908 . . . . 0.0 110.03 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.93 157.97 11.59 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.26 122.19 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.79 -48.43 18.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.254 0.622 . . . . 0.0 111.039 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.94 -179.78 2.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.724 1.21 . . . . 0.0 109.692 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.3 t -127.48 126.86 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.88 178.07 10.68 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.892 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.1 m -130.44 148.73 52.28 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.166 0.587 . . . . 0.0 111.053 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -143.07 143.19 31.76 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.9 p -82.84 164.92 20.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.352 0.596 . . . . 0.0 111.37 174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 14.61 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.719 1.208 . . . . 0.0 113.376 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.25 -38.49 3.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.228 1.811 . . . . 0.0 109.512 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.66 -39.5 88.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.97 121.91 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.66 1.984 . . . . 0.0 106.988 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 63.9 mtt85 -150.83 -56.33 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 117.088 -1.434 . . . . 0.0 110.61 169.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 36.5 Cg_endo -65.78 178.35 2.33 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.889 2.392 . . . . 0.0 112.704 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.05 33.48 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.254 1.421 . . . . 0.0 109.415 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -80.98 50.42 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.086 3.191 . . . . 0.0 110.441 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.5 21.21 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.521 1.529 . . . . 0.0 114.424 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -148.86 152.39 36.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.844 1.658 . . . . 0.0 109.377 -169.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.31 40.14 17.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.734 . . . . 0.0 114.008 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.2 157.94 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.861 1.265 . . . . 0.0 109.396 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -15.69 61.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.194 1.397 . . . . 0.0 112.376 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.524 HD13 ' H ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -50.52 155.85 1.0 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.378 2.271 . . . . 0.0 112.22 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' LEU . 5.5 m -130.38 156.21 45.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 110.261 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -60.05 -35.28 74.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -76.98 -15.56 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.123 1.329 . . . . 0.0 112.75 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -126.39 25.4 6.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.94 138.93 57.71 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.1 p -75.41 -174.45 2.43 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.32 1.848 . . . . 0.0 109.989 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.46 175.48 20.17 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.39 155.78 42.28 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.041 1.421 . . . . 0.0 109.506 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.38 179.82 29.43 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 123.696 0.665 . . . . 0.0 111.958 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.86 158.48 39.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -169.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.51 60.14 1.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.107 2.163 . . . . 0.0 107.463 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.25 2.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.22 1.867 . . . . 0.0 113.199 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.87 -32.35 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.73 2.012 . . . . 0.0 110.39 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -68.92 154.56 41.82 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.7 mtp -143.77 143.71 31.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.895 1.678 . . . . 0.0 106.496 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -137.01 140.48 42.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 92.4 mt -96.34 112.42 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.49 110.22 19.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.52 130.43 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.511 1.124 . . . . 0.0 108.277 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -79.98 60.61 3.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.022 1.329 . . . . 0.0 109.408 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.99 -37.14 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.514 1.126 . . . . 0.0 111.78 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.15 -26.78 68.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.374 0.534 . . . . 0.0 112.409 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -106.54 -17.47 14.24 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.856 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -50.35 -73.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.495 1.498 . . . . 0.0 110.858 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.3 tp -74.37 -26.51 60.16 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.31 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -63.56 -31.12 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.849 1.204 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -84.1 -27.59 28.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.872 0.869 . . . . 0.0 111.559 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.31 6.42 20.48 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -51.21 -48.9 61.92 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.991 1.316 . . . . 0.0 111.074 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -28.27 69.97 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.512 0.725 . . . . 0.0 112.554 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.08 -42.67 23.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.666 0.786 . . . . 0.0 110.593 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.43 -46.05 91.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.997 0.817 . . . . 0.0 109.547 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.93 -12.96 61.18 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.143 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 120.038 1.29 . . . . 0.0 111.507 177.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.45 165.93 11.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.239 1.016 . . . . 0.0 111.234 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.63 -59.1 0.51 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -145.51 159.16 43.52 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.545 1.538 . . . . 0.0 108.26 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m 52.42 39.27 27.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.894 1.278 . . . . 0.0 112.5 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -77.69 43.86 0.43 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.343 1.057 . . . . 0.0 111.353 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.1 m -60.01 -23.64 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.859 1.264 . . . . 0.0 112.533 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m 55.44 80.39 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.621 1.568 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -56.89 -20.95 25.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.833 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.4 tp 50.74 52.46 14.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.498 2.319 . . . . 0.0 110.485 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.56 -24.26 2.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.197 0.999 . . . . 0.0 112.851 -173.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -155.19 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.099 0.952 . . . . 0.0 112.411 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.11 159.91 84.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.521 1.929 . . . . 0.0 109.637 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.92 -28.18 85.95 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.802 2.335 . . . . 0.0 113.172 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m 48.85 41.81 19.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.53 1.532 . . . . 0.0 114.155 169.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.16 105.52 0.45 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 171.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -134.84 165.87 24.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.872 2.069 . . . . 0.0 109.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.52 146.03 47.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.981 1.313 . . . . 0.0 107.485 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -141.75 138.24 32.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.477 0.711 . . . . 0.0 110.163 -168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.5 tp -78.71 132.63 37.07 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.267 2.0 m -117.91 146.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 119.24 0.927 . . . . 0.0 108.617 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -141.0 164.99 28.79 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.208 1.003 . . . . 0.0 110.537 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 m -121.01 146.02 47.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -152.78 134.04 14.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.8 -92.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.771 1.177 . . . . 0.0 110.363 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -151.28 37.84 0.62 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.06 1.344 . . . . 0.0 109.493 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -140.04 154.4 47.08 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.386 1.474 . . . . 0.0 108.433 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.93 155.46 31.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.799 1.285 . . . . 0.0 109.983 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -143.68 158.55 43.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.418 1.887 . . . . 0.0 107.901 -169.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.25 154.86 20.78 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.084 1.326 . . . . 0.0 110.024 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.1 mt -139.89 135.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.41 124.18 15.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.799 0.727 . . . . 0.0 109.177 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.69 -34.09 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.463 0.705 . . . . 0.0 112.631 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 mt -68.18 -24.36 64.96 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.853 0.751 . . . . 0.0 112.131 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.88 -14.51 50.94 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.953 0.797 . . . . 0.0 111.555 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.71 128.1 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -87.43 -55.7 3.68 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.432 1.093 . . . . 0.0 108.464 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -167.24 -178.06 3.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.866 1.266 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.91 142.69 43.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -167.77 2.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.448 1.499 . . . . 0.0 107.885 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.99 160.45 21.26 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -75.74 -0.96 22.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -5.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -168.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 34.19 1.39 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.343 1.429 . . . . 0.0 113.576 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.44 140.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.4 m -129.77 91.53 3.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -68.18 112.5 5.14 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.23 157.11 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.3 72.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -139.23 22.91 2.57 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.05 156.71 66.44 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -59.77 142.02 97.91 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 169.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.68 68.01 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.365 -0.835 . . . . 0.0 112.78 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -52.27 -40.56 61.9 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.541 0.609 . . . . 0.0 110.239 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.2 mt -77.18 94.99 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -50.01 -33.12 17.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.286 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.62 177.01 31.3 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.9 153.92 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -140.63 163.42 32.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.732 1.151 . . . . 0.0 108.794 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -89.28 113.31 24.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.043 0.937 . . . . 0.0 110.75 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.48 171.66 11.6 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.4 mtp-105 -72.61 64.61 0.64 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.273 1.397 . . . . 0.0 112.81 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.96 -9.83 2.29 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 127.076 2.274 . . . . 0.0 113.24 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.34 -164.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 119.231 1.516 . . . . 0.0 108.536 -169.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.9 tp -127.81 157.04 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.174 1.79 . . . . 0.0 108.525 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.4 p -151.38 141.99 14.93 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.44 138.36 42.17 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.183 1.922 . . . . 0.0 109.991 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.86 137.45 56.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.68 1.192 . . . . 0.0 108.319 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.99 139.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -97.89 120.69 38.72 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.303 0.641 . . . . 0.0 109.651 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -68.29 -18.87 64.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.175 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.21 -37.17 86.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.862 1.665 . . . . 0.0 110.455 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.26 -48.02 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -73.98 -27.4 60.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.324 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.31 11.44 2.56 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.948 1.249 . . . . 0.0 113.335 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m 60.63 34.1 20.2 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.606 -1.309 . . . . 0.0 112.926 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -50.85 155.2 1.22 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.645 0.778 . . . . 0.0 112.503 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 t -59.16 -64.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.786 1.234 . . . . 0.0 113.192 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -157.23 63.19 0.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.775 0.797 . . . . 0.0 111.457 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.54 135.55 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -158.39 158.52 34.38 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.482 1.513 . . . . 0.0 108.427 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.01 48.43 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.85 1.66 . . . . 0.0 112.767 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER -155.1 -16.08 0.11 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.961 2.904 . . . . 0.0 109.987 169.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 83' ' ' ASN . 32.2 t70 -119.69 -8.11 9.97 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.486 1.914 . . . . 0.0 111.562 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.48 35.14 1.84 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.687 1.595 . . . . 0.0 109.775 -169.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -100.08 -11.56 20.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -168.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.28 157.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.08 133.06 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.3 mt -107.67 133.76 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.27 137.92 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.8 mt -136.0 154.68 50.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.726 1.611 . . . . 0.0 107.549 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.47 149.64 42.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.32 176.02 8.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -11.67 -65.71 0.01 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 128.096 2.76 . . . . 0.0 116.24 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -137.95 26.63 2.72 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 111.638 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -151.4 164.63 36.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.778 -1.201 . . . . 0.0 111.952 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.17 144.12 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 0.0 109.015 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -157.64 -178.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.618 1.567 . . . . 0.0 107.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.62 -179.69 41.02 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.538 -1.352 . . . . 0.0 110.526 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.9 pt -141.91 144.21 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.108 0.963 . . . . 0.0 108.915 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 m -79.44 141.87 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.134 1.374 . . . . 0.0 108.46 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.98 163.21 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.256 1.822 . . . . 0.0 110.275 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -80.11 -46.7 16.01 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.954 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.56 161.94 31.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.71 116.49 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -41.57 34.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.573 0.749 . . . . 0.0 111.601 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -170.16 -174.82 1.83 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.65 123.45 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.6 mt -140.27 171.52 14.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.626 1.171 . . . . 0.0 109.994 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 m -125.6 139.38 53.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.091 0.556 . . . . 0.0 110.131 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.78 159.46 42.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.6 1.16 . . . . 0.0 109.366 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -122.38 155.18 36.57 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.117 2.167 . . . . 0.0 106.941 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.94 -27.74 63.66 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.121 -0.987 . . . . 0.0 112.498 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.21 -33.64 73.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.634 1.173 . . . . 0.0 111.234 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -78.0 -42.31 33.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 109.617 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.5 mt -85.41 68.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.287 1.435 . . . . 0.0 109.11 -170.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 41.7 mtm180 -113.75 -60.53 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.367 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 42.2 Cg_endo -67.45 -179.1 1.74 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.034 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.19 32.52 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.774 1.63 . . . . 0.0 108.874 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.1 51.29 3.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.613 2.876 . . . . 0.0 110.709 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.83 27.89 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.832 2.053 . . . . 0.0 114.103 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -65.4 176.64 1.34 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 110.46 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.73 32.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.457 1.903 . . . . 0.0 113.685 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 m -66.93 167.09 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.188 0.995 . . . . 0.0 109.914 169.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -63.82 -16.1 60.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 0.0 113.391 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.44 108.61 4.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.562 1.145 . . . . 0.0 111.01 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 m -67.53 155.47 39.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.052 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -66.07 -34.07 77.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.611 1.164 . . . . 0.0 112.543 -171.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.16 -17.45 62.54 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.601 -1.312 . . . . 0.0 113.241 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.77 26.13 5.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.785 0.834 . . . . 0.0 109.939 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.54 140.02 54.83 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 145' ' ' VAL . 35.1 p -70.28 -176.5 1.21 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.597 1.959 . . . . 0.0 110.66 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.02 178.89 16.39 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 169.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.1 mt -134.64 150.72 50.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.46 171.1 34.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.65 157.21 25.76 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.209 1.004 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.8 79.12 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.99 -50.96 2.72 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.7 2.095 . . . . 0.0 112.869 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.31 -30.53 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.223 2.209 . . . . 0.0 111.023 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -66.55 164.75 15.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.139 0.976 . . . . 0.0 108.886 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.7 mtp -139.17 150.74 45.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.764 1.226 . . . . 0.0 108.072 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.4 mt -138.53 137.92 37.52 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.678 1.191 . . . . 0.0 107.908 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 98.8 mt -86.89 113.29 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.03 109.23 15.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.583 ' HA ' HG22 ' A' ' 132' ' ' THR . 67.3 t -64.24 128.92 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -75.24 51.61 0.55 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.77 1.228 . . . . 0.0 110.859 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 tp -57.23 -40.67 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.998 -1.064 . . . . 0.0 111.979 -169.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.94 -10.61 40.64 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.39 0.65 6.99 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.765 169.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.84 -69.07 0.25 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.838 1.199 . . . . 0.0 109.924 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.94 -33.25 74.31 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.89 -46.22 78.41 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.747 -0.595 . . . . 0.0 110.647 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -77.2 -22.46 52.32 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.282 0.633 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.44 -15.0 19.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.186 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.24 -48.08 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.495 1.498 . . . . 0.0 111.737 -169.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.9 ptp -60.86 -27.72 68.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.028 0.931 . . . . 0.0 113.007 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.62 -34.99 12.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.59 1.156 . . . . 0.0 111.282 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.78 -62.17 2.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.224 1.41 . . . . 0.0 109.004 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -26.68 66.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -169.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -54.58 -28.38 45.71 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.896 0.878 . . . . 0.0 112.643 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.8 m -136.07 23.37 3.28 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.964 0.905 . . . . 0.0 111.52 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.36 8.68 1.6 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.11 7.92 1.49 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.513 1.052 . . . . 0.0 113.282 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.2 m 72.63 -34.71 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.063 2.545 . . . . 0.0 113.298 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -66.53 -6.64 15.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.081 1.353 . . . . 0.0 111.784 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.25 3.42 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.025 2.13 . . . . 0.0 111.273 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.583 -0.723 . . . . 0.0 109.156 172.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -66.65 -25.9 66.8 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.405 1.082 . . . . 0.0 112.249 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.95 -171.69 40.79 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ttt -60.74 -39.79 89.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.448 0.624 . . . . 0.0 110.604 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p 53.09 18.27 1.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.565 1.946 . . . . 0.0 114.517 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -148.82 36.34 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.67 1.588 . . . . 0.0 109.147 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.83 129.36 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.281 1.032 . . . . 0.0 108.612 -174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -61.2 -41.9 97.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.397 0.679 . . . . 0.0 110.009 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -80.49 72.07 7.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -139.07 69.3 1.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 171.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.46 -12.73 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.705 1.602 . . . . 0.0 112.45 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.26 26.07 1.67 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.966 1.706 . . . . 0.0 109.166 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -122.74 135.56 25.85 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.581 1.552 . . . . 0.0 108.865 -169.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.57 -20.05 20.92 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.545 2.163 . . . . 0.0 113.116 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m 56.66 178.11 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.559 1.544 . . . . 0.0 113.775 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.34 120.22 21.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.47 168.02 20.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.997 2.119 . . . . 0.0 110.291 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -121.54 147.39 45.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.85 137.28 31.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 109.416 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.4 tp -77.75 136.58 38.17 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 167.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.252 1.6 m -124.92 148.54 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 119.657 1.117 . . . . 0.0 109.078 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -140.64 150.17 43.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.677 1.191 . . . . 0.0 109.665 -172.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.3 m -91.09 146.71 23.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 tp -134.69 90.23 2.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.6 -71.53 0.37 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.815 1.674 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.56 28.85 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.504 1.522 . . . . 0.0 111.047 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.45 161.49 36.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.779 1.632 . . . . 0.0 107.939 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -122.99 151.07 42.19 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.516 1.15 . . . . 0.0 109.76 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -142.15 158.57 43.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.961 2.105 . . . . 0.0 107.437 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.87 161.27 24.52 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.43 1.014 . . . . 0.0 111.237 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.41 135.14 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -48.42 116.7 1.67 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 109.302 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.96 -33.34 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.332 0.653 . . . . 0.0 111.441 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.95 -22.94 67.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.591 0.756 . . . . 0.0 112.588 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -82.62 -19.93 37.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.99 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.65 142.15 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 119.194 0.907 . . . . 0.0 108.771 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.79 -53.92 2.66 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.401 1.081 . . . . 0.0 108.567 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.91 -176.5 4.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.569 1.147 . . . . 0.0 109.821 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.7 149.15 31.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -151.85 -157.9 0.85 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.379 1.872 . . . . 0.0 107.786 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.53 151.58 18.95 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 120.116 1.326 . . . . 0.0 112.691 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -77.02 91.23 3.62 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.122 1.369 . . . . 0.0 107.468 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -149.03 -18.11 0.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 51.91 1.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.094 0.861 . . . . 0.0 111.005 -169.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.45 152.14 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 O-C-N 120.674 -1.266 . . . . 0.0 110.463 169.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -133.56 131.03 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -128.26 133.74 48.85 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -168.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 mm -79.38 159.93 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.52 63.08 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.84 28.32 0.37 Allowed 'General case' 0 C--N 1.341 0.226 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -169.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.53 154.65 78.83 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.309 169.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -63.13 136.21 54.95 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.096 1.864 . . . . 0.0 107.671 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.83 -28.15 47.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -52.57 -46.08 66.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.663 0.665 . . . . 0.0 110.282 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.4 94.56 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -51.32 -47.44 62.64 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.96 -129.16 1.52 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 165.99 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.802 1.241 . . . . 0.0 107.866 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.5 t -145.54 173.33 12.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 p-10 -82.89 160.95 22.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 120.796 -1.19 . . . . 0.0 111.608 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -121.89 168.97 11.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 167.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.36 58.43 0.26 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.641 1.576 . . . . 0.0 111.942 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.72 -13.95 1.18 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 127.111 2.291 . . . . 0.0 113.563 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.63 -161.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.762 1.781 . . . . 0.0 109.036 -169.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.483 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.2 tp -119.28 158.77 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.924 1.689 . . . . 0.0 108.928 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.59 137.81 12.54 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 109.617 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.62 144.14 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.953 1.769 . . . . 0.0 109.469 169.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.3 136.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.39 150.64 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -123.83 128.76 49.98 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.76 -15.63 63.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.431 -0.319 . . . . 0.0 110.942 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -58.54 -21.35 52.19 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.879 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mt -127.91 23.16 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.351 2.26 . . . . 0.0 108.534 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -139.36 -27.88 0.79 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.724 -1.235 . . . . 0.0 112.352 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.24 15.57 4.14 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.962 0.905 . . . . 0.0 111.229 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m 51.16 47.45 24.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.738 1.615 . . . . 0.0 111.476 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -53.74 166.7 0.3 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.727 1.211 . . . . 0.0 111.4 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -60.99 169.66 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.81 0.844 . . . . 0.0 109.609 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.53 71.38 0.95 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 128.73 2.812 . . . . 0.0 110.691 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.5 m -38.81 153.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 128.627 2.771 . . . . 0.0 114.09 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.52 161.49 42.18 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.308 1.443 . . . . 0.0 108.518 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -72.11 49.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.869 1.668 . . . . 0.0 111.212 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.23 -19.67 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.808 2.843 . . . . 0.0 110.152 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.82 -15.31 3.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.779 1.232 . . . . 0.0 112.324 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -145.4 47.75 1.28 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.804 1.241 . . . . 0.0 108.322 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.3 p -78.15 -4.81 49.39 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.358 2.663 . . . . 0.0 117.644 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.11 153.85 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 121.463 1.938 . . . . 0.0 109.091 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.22 122.23 62.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.086 1.754 . . . . 0.0 107.233 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.4 mt -93.57 140.6 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.0 133.71 60.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.77 165.74 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.047 1.739 . . . . 0.0 108.953 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.13 153.39 51.85 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.295 1.038 . . . . 0.0 110.007 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -133.79 85.6 2.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.88 -67.7 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.781 1.658 . . . . 0.0 113.72 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -136.15 3.19 2.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.863 1.665 . . . . 0.0 112.338 -171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.71 169.25 16.45 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.254 1.022 . . . . 0.0 110.066 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.21 156.87 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.871 1.269 . . . . 0.0 108.992 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.41 ' HB ' HD22 ' A' ' 151' ' ' LEU . 13.1 p -157.49 171.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.447 1.499 . . . . 0.0 107.194 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.07 171.59 32.06 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -138.46 143.7 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.877 0.871 . . . . 0.0 108.79 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.83 134.44 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 108.943 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -143.36 170.5 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 125.581 1.552 . . . . 0.0 109.914 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.41 -41.87 72.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.53 158.83 10.99 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.74 130.73 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.17 -42.64 7.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.266 1.026 . . . . 0.0 111.358 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -168.18 -175.57 2.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 109.877 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.04 127.27 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 169.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -137.36 165.31 26.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.429 1.092 . . . . 0.0 109.524 -169.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 m -124.41 130.56 52.7 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.33 162.52 33.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.927 . . . . 0.0 108.962 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 m -138.15 159.93 40.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.908 1.283 . . . . 0.0 108.538 -168.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.18 -23.4 8.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.18 -34.43 74.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.04 -1.038 . . . . 0.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -85.29 -38.68 18.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.177 1.391 . . . . 0.0 110.554 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.54 102.67 13.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 36.6 mtm105 -140.15 -56.93 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.948 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.8 Cg_endo -65.53 168.68 14.17 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.712 1.608 . . . . 0.0 111.354 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.03 154.71 29.27 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.31 1.444 . . . . 0.0 108.957 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.26 146.57 71.31 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.739 2.293 . . . . 0.0 110.91 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.06 18.99 0.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.577 1.151 . . . . 0.0 110.757 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -73.65 170.29 15.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 111.121 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.97 65.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.701 1.6 . . . . 0.0 110.584 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.47 175.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.455 1.502 . . . . 0.0 109.66 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.92 11.53 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.413 1.885 . . . . 0.0 114.942 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.7 158.04 18.92 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.285 1.434 . . . . 0.0 110.227 -173.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -142.42 148.08 37.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 110.969 -171.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -55.77 -29.45 59.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.144 1.777 . . . . 0.0 114.406 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.68 -22.58 65.28 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.71 25.66 1.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.542 1.064 . . . . 0.0 112.517 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.62 18.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 145' ' ' VAL . 18.7 p 64.86 -170.99 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.429 1.492 . . . . 0.0 112.151 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.24 172.65 28.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 106.584 -2.606 . . . . 0.0 106.584 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.66 153.74 39.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 119.465 1.633 . . . . 0.0 109.491 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.97 173.2 35.22 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.11 157.8 16.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.266 1.026 . . . . 0.0 111.202 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.07 72.48 1.38 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.187 1.795 . . . . 0.0 107.143 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.8 -46.36 2.03 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.385 1.945 . . . . 0.0 113.724 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -36.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.19 2.196 . . . . 0.0 110.403 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -73.55 166.09 23.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.655 0.741 . . . . 0.0 110.031 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.5 mtp -141.03 148.4 40.19 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.4 153.94 36.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.689 0.796 . . . . 0.0 110.459 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 79.5 mt -104.89 109.97 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.349 1.459 . . . . 0.0 107.178 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.31 108.13 15.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.035 1.334 . . . . 0.0 107.736 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.8 t -62.3 131.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.547 1.139 . . . . 0.0 108.138 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -78.74 60.54 2.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.61 0.719 . . . . 0.0 109.643 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 tp -54.42 -39.01 42.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 C-N-CA 124.764 1.226 . . . . 0.0 111.147 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.45 -13.16 60.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.747 0.703 . . . . 0.0 112.568 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -111.81 -7.72 14.18 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.872 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.42 -77.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.641 1.11 . . . . 0.0 110.742 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 98' ' ' VAL . 54.2 tp -67.49 -20.1 65.41 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.33 -0.856 . . . . 0.0 110.443 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.49 -37.43 75.52 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.097 -1.002 . . . . 0.0 110.664 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 m -85.82 -30.14 23.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.695 0.798 . . . . 0.0 111.242 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -90.96 -9.44 46.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.938 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -49.31 -47.96 46.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.763 1.619 . . . . 0.0 111.792 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -63.42 -44.7 93.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.717 0.407 . . . . 0.0 109.956 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.49 82.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.325 0.65 . . . . 0.0 111.368 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.24 -58.62 7.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.718 1.207 . . . . 0.0 109.321 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.86 62.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.432 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.58 -20.88 5.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 112.917 174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 26.7 m -123.05 -46.54 2.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -84.64 -2.26 57.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.62 82.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 110.672 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.2 p 173.22 -22.78 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.397 1.879 . . . . 0.0 111.428 -169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.98 -34.5 76.27 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.06 0.944 . . . . 0.0 111.497 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.27 -45.31 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.104 0.962 . . . . 0.0 110.609 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.754 174.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttm . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.5 p -75.45 148.18 39.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.55 -157.99 27.4 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.1 mtt -59.22 -17.66 29.92 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.517 0.658 . . . . 0.0 111.953 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -60.69 -12.28 9.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.348 2.259 . . . . 0.0 113.669 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -62.27 0.91 0.38 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.907 1.683 . . . . 0.0 115.0 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.4 t -53.25 -30.14 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.561 -1.337 . . . . 0.0 111.231 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -58.98 -23.17 61.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.839 1.256 . . . . 0.0 113.46 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -138.53 33.86 2.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.258 1.423 . . . . 0.0 108.889 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -3.62 0.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.47 170.1 16.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.701 2.8 . . . . 0.0 104.258 -169.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 52.63 40.77 30.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.372 0.606 . . . . 0.0 109.594 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.09 150.18 75.34 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.712 1.605 . . . . 0.0 107.86 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.53 172.33 16.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.38 2.053 . . . . 0.0 111.536 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.9 m -53.04 143.55 17.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.833 1.653 . . . . 0.0 111.906 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.46 97.2 1.93 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 125.979 1.752 . . . . 0.0 108.862 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -69.89 163.84 25.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.081 0.553 . . . . 0.0 109.609 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -124.91 143.28 50.94 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.539 1.536 . . . . 0.0 107.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -142.3 136.79 30.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.648 0.779 . . . . 0.0 110.501 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.6 tp -77.88 135.97 37.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 167.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.28 152.88 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.736 1.153 . . . . 0.0 109.57 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -140.38 151.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 109.56 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -93.38 146.53 23.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp -156.0 134.95 11.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 169.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -98.52 0.53 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.31 36.71 0.67 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.348 1.459 . . . . 0.0 108.776 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.02 161.0 39.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.156 1.782 . . . . 0.0 107.852 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -120.1 156.4 31.09 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.117 1.437 . . . . 0.0 110.457 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -138.11 147.73 44.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.943 2.097 . . . . 0.0 106.457 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.48 156.64 15.97 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.49 134.9 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -49.52 115.5 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.034 0.934 . . . . 0.0 109.111 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.54 -33.1 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.702 . . . . 0.0 111.712 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.84 -24.8 67.96 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.687 0.795 . . . . 0.0 112.606 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -83.16 -17.73 41.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.682 0.674 . . . . 0.0 111.763 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.8 145.25 13.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.632 1.106 . . . . 0.0 109.087 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -123.05 -47.16 2.05 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.073 0.949 . . . . 0.0 111.346 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -162.84 172.41 15.2 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.609 0.764 . . . . 0.0 109.487 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.25 144.54 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.877 1.671 . . . . 0.0 106.595 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -148.05 176.53 10.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.619 1.567 . . . . 0.0 108.04 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.33 168.92 44.97 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -83.49 -164.42 0.9 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 110.032 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 60.3 38.33 19.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.275 1.83 . . . . 0.0 112.859 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -141.14 26.76 1.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.635 1.574 . . . . 0.0 109.767 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 102.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 120.97 -1.082 . . . . 0.0 108.424 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -61.95 -44.51 96.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.494 1.518 . . . . 0.0 110.46 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' VAL . 6.7 mtm105 56.53 -176.52 0.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.828 2.051 . . . . 0.0 112.515 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mm -133.55 160.23 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.88 -23.12 67.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.74 27.76 0.38 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 148.26 57.71 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 122.765 0.426 . . . . 0.0 110.947 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.31 152.68 66.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.21 2.607 . . . . 0.0 110.041 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.33 73.81 0.98 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.599 1.19 . . . . 0.0 110.528 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -162.72 -52.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 130.12 3.368 . . . . 0.0 103.696 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.3 mt -75.42 92.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -51.01 -41.4 59.77 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.912 0.885 . . . . 0.0 108.9 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.85 -156.04 19.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 47' ' ' ARG . 25.6 m -124.1 151.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -136.34 148.26 47.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -80.62 92.34 5.95 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.404 1.081 . . . . 0.0 109.895 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.58 171.65 4.88 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -67.14 63.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.182 1.793 . . . . 0.0 113.155 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.21 -8.63 3.8 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.968 2.223 . . . . 0.0 113.507 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -152.83 -165.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 119.104 1.452 . . . . 0.0 108.342 -169.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.469 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.4 tp -121.62 157.88 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.546 1.938 . . . . 0.0 107.709 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.72 138.79 12.71 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.896 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.38 145.29 64.84 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.181 1.92 . . . . 0.0 110.049 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -129.05 138.31 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 m -114.82 164.34 11.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -132.14 126.98 34.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.0 -21.99 64.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.122 1.369 . . . . 0.0 111.665 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -37.67 80.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.274 1.397 . . . . 0.0 110.101 169.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.85 -57.0 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -66.64 -28.78 68.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.861 0.864 . . . . 0.0 113.199 -169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -135.11 5.93 3.32 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.3 m 53.14 41.87 32.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.183 0.901 . . . . 0.0 111.687 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -52.6 146.3 10.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.1 t -44.92 -61.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 112.742 -169.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -175.21 86.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.79 1.636 . . . . 0.0 108.657 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.7 144.1 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -160.84 163.92 31.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 109.493 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -67.55 42.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.722 2.409 . . . . 0.0 112.889 172.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.05 -12.87 0.16 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.161 2.184 . . . . 0.0 111.318 170.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.71 -5.94 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.335 1.454 . . . . 0.0 111.735 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.41 44.24 1.52 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.452 -1.405 . . . . 0.0 108.762 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 p -99.38 -2.97 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.344 1.858 . . . . 0.0 114.297 -169.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.6 t -128.06 154.79 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.16 130.68 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.129 1.771 . . . . 0.0 106.341 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.2 mt -102.7 138.22 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.17 133.76 54.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.3 mt -133.53 163.69 28.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.607 1.563 . . . . 0.0 107.922 -170.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.84 146.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.853 1.261 . . . . 0.0 107.674 171.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.7 157.34 43.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.52 -112.44 2.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.82 27.04 5.79 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.511 1.524 . . . . 0.0 110.383 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -141.14 171.27 14.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.401 1.081 . . . . 0.0 110.835 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.76 154.27 38.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.229 1.011 . . . . 0.0 110.704 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.6 p -161.28 176.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.324 1.85 . . . . 0.0 106.878 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.24 -179.87 37.98 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 120.548 -1.345 . . . . 0.0 111.785 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 pt -142.46 155.97 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.519 1.528 . . . . 0.0 108.579 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.2 143.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.55 171.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.411 1.884 . . . . 0.0 110.086 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.59 -42.51 42.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.776 0.716 . . . . 0.0 109.973 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.63 153.42 9.69 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 173.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.57 123.99 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.9 -52.86 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.313 0.645 . . . . 0.0 110.373 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -173.23 -177.17 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.941 1.697 . . . . 0.0 108.093 -169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -117.26 132.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.8 mt -135.09 174.42 10.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.762 1.625 . . . . 0.0 108.665 -171.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -132.4 141.72 48.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.213 0.605 . . . . 0.0 109.587 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -142.7 134.97 27.52 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 51.8 p -76.77 163.76 26.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.321 0.581 . . . . 0.0 110.712 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.99 10.01 0.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.377 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -107.99 -40.46 5.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.418 2.287 . . . . 0.0 108.851 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -61.13 -47.43 86.31 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.1 mt -67.21 119.6 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -151.3 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.15 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -177.58 2.66 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.247 1.964 . . . . 0.0 111.257 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.36 153.64 29.56 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.377 1.471 . . . . 0.0 108.707 169.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.14 51.05 3.52 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.603 3.535 . . . . 0.0 110.65 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 7.7 1.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.634 1.573 . . . . 0.0 114.847 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -146.1 160.07 42.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 53.3 32.95 14.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.738 2.015 . . . . 0.0 114.367 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.21 166.13 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.599 1.56 . . . . 0.0 108.697 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -5.36 34.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 113.747 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.22 156.8 11.69 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.989 1.716 . . . . 0.0 111.632 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.3 m -133.45 151.14 51.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.362 0.665 . . . . 0.0 112.103 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -57.32 -23.95 52.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.399 1.88 . . . . 0.0 114.49 -169.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -66.25 -32.22 73.51 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.817 0.735 . . . . 0.0 111.414 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.25 29.41 1.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.772 0.829 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 145' ' ' VAL . 21.4 p 62.31 -163.35 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.238 1.415 . . . . 0.0 111.434 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -149.18 177.94 27.05 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 171.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -139.89 142.28 36.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.57 172.94 31.69 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.7 157.16 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.24 0.543 . . . . 0.0 111.83 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.53 68.01 1.38 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.539 2.336 . . . . 0.0 106.699 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.04 -48.18 2.7 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.471 1.986 . . . . 0.0 113.584 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -145.89 -32.2 0.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.429 1.892 . . . . 0.0 110.933 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -70.23 151.35 45.45 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.3 mtp -139.22 143.34 38.01 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.92 120.19 22.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.54 114.34 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.82 99.54 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 132' ' ' THR . 64.1 t -59.91 122.52 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 108.24 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -80.25 60.59 3.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.502 0.667 . . . . 0.0 110.371 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.69 -37.17 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.068 1.347 . . . . 0.0 111.578 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.37 -27.93 69.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.276 0.489 . . . . 0.0 111.554 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -97.01 -28.28 14.23 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 116.772 -1.585 . . . . 0.0 112.218 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -47.35 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.461 1.504 . . . . 0.0 112.451 -170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.65 -35.01 72.65 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -58.58 -34.11 70.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 112.535 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 m -99.4 -14.3 19.21 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.357 1.063 . . . . 0.0 111.473 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.7 -2.69 56.91 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.143 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -52.84 -42.98 65.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.208 1.367 . . . . 0.0 112.051 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -66.8 -24.08 66.13 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.202 1.401 . . . . 0.0 112.368 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.68 -31.21 13.92 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.415 1.486 . . . . 0.0 111.002 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.81 -62.81 1.59 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.738 1.215 . . . . 0.0 109.167 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -67.84 -29.73 68.95 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.891 -169.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.07 -25.19 29.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.085 0.954 . . . . 0.0 112.81 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.5 m -133.18 15.18 4.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.418 1.087 . . . . 0.0 112.254 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.45 12.99 0.83 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.28 6.91 1.48 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.431 1.014 . . . . 0.0 112.967 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 72.53 -34.23 0.29 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.135 2.574 . . . . 0.0 113.398 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.65 -7.22 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.877 1.271 . . . . 0.0 111.895 169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -121.51 2.47 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.676 1.99 . . . . 0.0 111.478 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.81 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m -60.15 -36.34 77.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.35 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.59 -177.66 46.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -150.25 156.41 41.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.578 1.151 . . . . 0.0 108.803 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -76.87 -0.41 24.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.274 1.029 . . . . 0.0 112.558 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -55.22 -25.3 32.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.531 1.132 . . . . 0.0 113.866 -171.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.14 -16.14 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.217 1.407 . . . . 0.0 113.478 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.3 m -59.97 -19.95 54.94 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.618 1.567 . . . . 0.0 112.507 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.08 148.29 6.38 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.368 0.986 . . . . 0.0 111.531 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.32 -43.26 99.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.47 0.308 . . . . 0.0 110.572 -172.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.94 -58.86 0.06 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 m -164.25 124.79 2.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' HB2' HG21 ' A' ' 112' ' ' THR . 71.6 mm-40 -145.4 164.26 27.41 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.708 1.603 . . . . 0.0 107.506 -169.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.29 152.65 78.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.289 1.993 . . . . 0.0 111.154 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m 44.89 38.97 3.23 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.604 1.561 . . . . 0.0 114.25 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 112' ' ' THR . . . -57.83 119.72 18.06 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 170.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -145.59 155.74 43.24 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.469 1.908 . . . . 0.0 109.266 -169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -103.29 147.45 27.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 144' ' ' LEU . 96.8 m-85 -141.88 135.45 29.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.451 1.1 . . . . 0.0 109.154 -169.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.43 132.74 37.43 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 167.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.93 149.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 119.719 1.145 . . . . 0.0 108.764 -176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.46 148.3 37.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.917 0.887 . . . . 0.0 110.039 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 m -89.4 146.17 24.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 102' ' ' VAL . 44.4 tp -150.41 133.29 15.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.61 -93.16 0.04 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.73 37.25 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.51 163.81 34.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.746 1.218 . . . . 0.0 108.755 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.29 151.13 36.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 123.026 1.393 . . . . 0.0 110.753 173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -138.5 158.02 45.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.457 2.303 . . . . 0.0 107.139 -171.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.82 158.81 23.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.107 0.86 . . . . 0.0 111.007 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.66 133.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -48.79 118.23 2.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.09 0.956 . . . . 0.0 108.696 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.42 -33.49 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.123 0.569 . . . . 0.0 111.754 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.91 -23.62 67.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.532 0.733 . . . . 0.0 112.701 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -80.97 -21.27 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.756 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.79 141.89 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.309 0.958 . . . . 0.0 108.452 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -118.07 -46.61 2.61 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.554 1.142 . . . . 0.0 110.278 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -162.47 172.09 16.07 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.622 1.169 . . . . 0.0 108.66 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -135.46 141.21 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -145.15 177.51 8.74 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.312 1.445 . . . . 0.0 107.672 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.28 162.45 18.99 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -56.61 136.79 54.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -153.96 -52.21 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.0 58.7 0.79 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.307 0.643 . . . . 0.0 110.773 -169.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.25 110.69 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.4 m -62.82 -38.03 89.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.29 1.436 . . . . 0.0 110.545 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 30.57 19.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.496 1.518 . . . . 0.0 112.599 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.0 mm 43.08 -95.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 127.675 2.39 . . . . 0.0 110.096 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.15 -44.3 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.912 1.285 . . . . 0.0 109.562 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.06 32.41 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.422 0.689 . . . . 0.0 112.13 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.88 143.56 60.63 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.702 1.201 . . . . 0.0 110.516 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.43 159.36 50.76 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 111.084 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.77 65.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.041 0.936 . . . . 0.0 112.1 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -71.63 4.07 3.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.26 -36.74 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.685 1.194 . . . . 0.0 110.737 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.251 63.2 mttt 50.9 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.566 2.346 . . . . 0.0 110.338 -167.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.77 -176.16 40.62 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 121.88 2.127 . . . . 0.0 113.102 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.11 156.51 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 122.071 -0.664 . . . . 0.0 110.625 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 t -134.47 160.49 37.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.913 1.285 . . . . 0.0 108.716 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -77.99 142.11 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.45 174.88 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.21 1.404 . . . . 0.0 108.159 168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 -35.78 -30.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.43 21.53 0.28 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.129 0.877 . . . . 0.0 113.183 169.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -152.45 -165.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.0 1.32 . . . . 0.0 108.108 -170.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.1 tp -130.79 157.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.716 1.606 . . . . 0.0 108.979 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.26 139.62 13.01 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.53 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 131.29 27.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.36 2.04 . . . . 0.0 109.429 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.63 128.46 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.57 165.07 20.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -121.37 128.88 52.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.702 0.801 . . . . 0.0 109.522 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.93 -10.38 58.37 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.58 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.02 -21.41 61.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.078 1.308 . . . . 0.0 110.06 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.84 18.29 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 126.036 1.734 . . . . 0.0 108.788 -171.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.52 -32.41 0.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 117.936 -1.03 . . . . 0.0 112.047 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -132.21 5.38 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.534 1.061 . . . . 0.0 112.428 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 m 51.52 36.25 16.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.37 1.468 . . . . 0.0 111.468 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -59.28 147.94 33.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -22.36 -61.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.041 3.337 . . . . 0.0 115.419 -169.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -157.39 27.58 0.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.766 0.826 . . . . 0.0 111.702 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 24' ' ' LEU . 8.5 p -68.7 140.87 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.111 -0.993 . . . . 0.0 109.886 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -171.62 178.07 3.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.014 2.925 . . . . 0.0 104.943 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HA ' HG21 ' A' ' 86' ' ' THR . 16.0 m-30 -65.7 60.58 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.716 2.406 . . . . 0.0 110.821 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -160.38 -30.43 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.558 2.743 . . . . 0.0 109.904 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 86' ' ' THR . 25.7 t0 -78.7 40.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.602 1.161 . . . . 0.0 111.855 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.99 -15.85 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.913 3.685 . . . . 0.0 114.997 -173.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 82' ' ' TYR 0.282 14.8 p 31.19 72.36 0.07 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.122 3.369 . . . . 0.0 117.307 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.1 155.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 166.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.7 119.65 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.368 -1.457 . . . . 0.0 107.772 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.65 139.38 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.33 134.76 52.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.6 mt -132.54 163.44 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 108.381 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 155.36 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.402 1.081 . . . . 0.0 108.959 173.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mp -131.22 -179.9 5.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -20.83 -61.84 0.02 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.694 2.568 . . . . 0.0 116.18 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -137.51 24.4 2.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.031 0.933 . . . . 0.0 111.923 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -150.67 165.37 33.61 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.772 -1.205 . . . . 0.0 111.262 -169.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.4 m -135.69 151.42 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.533 1.133 . . . . 0.0 109.214 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -161.32 166.86 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.997 1.319 . . . . 0.0 107.912 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.57 176.58 34.66 Favored Glycine 0 CA--C 1.521 0.458 0 O-C-N 121.148 -0.97 . . . . 0.0 112.044 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.9 pt -146.03 152.11 14.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.66 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -82.95 144.45 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.628 1.171 . . . . 0.0 110.052 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.582 ' HA ' HD13 ' A' ' 24' ' ' LEU . 17.1 m -144.5 164.59 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.716 1.606 . . . . 0.0 109.119 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.81 -42.28 58.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.349 -0.844 . . . . 0.0 108.825 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.33 156.05 11.95 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.81 126.3 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -76.8 -55.53 5.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -176.61 176.99 1.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.644 1.978 . . . . 0.0 107.58 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -100.08 139.24 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.6 mt -140.12 172.13 13.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.551 . . . . 0.0 107.573 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.8 m -130.77 143.61 50.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.764 0.711 . . . . 0.0 110.344 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.17 171.09 14.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.025 1.33 . . . . 0.0 109.409 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 13' ' ' GLU . 33.3 p -134.66 160.49 37.96 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.806 1.643 . . . . 0.0 108.467 -176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.33 1.93 3.4 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.42 -45.75 12.4 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.507 1.523 . . . . 0.0 107.721 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -67.44 -41.75 84.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.207 1.003 . . . . 0.0 109.928 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -82.42 112.52 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -142.45 -57.62 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.619 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.52 175.67 4.92 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.14 1.893 . . . . 0.0 111.683 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.44 156.94 33.77 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.614 1.565 . . . . 0.0 108.471 173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.55 50.95 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.904 3.069 . . . . 0.0 111.071 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.56 26.26 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.585 1.954 . . . . 0.0 113.37 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -68.73 175.88 3.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.651 1.98 . . . . 0.0 111.381 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 67.85 0.7 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.631 1.572 . . . . 0.0 110.753 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.48 -179.21 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.898 1.679 . . . . 0.0 109.245 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -6.96 11.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -69.89 155.54 40.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.023 0.929 . . . . 0.0 110.635 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.4 m -139.29 157.73 45.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.843 1.257 . . . . 0.0 109.131 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 p -64.59 -26.73 68.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.987 1.315 . . . . 0.0 113.131 -171.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.32 -36.37 83.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 111.103 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -129.13 33.05 4.63 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.576 1.55 . . . . 0.0 108.801 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 127.51 32.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 146' ' ' ASN . 81.8 p -74.92 -171.92 1.47 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.828 1.651 . . . . 0.0 110.134 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.07 172.86 22.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.319 -2.313 . . . . 0.0 107.319 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.33 151.67 37.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.101 1.451 . . . . 0.0 109.539 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.02 177.72 27.06 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.27 0.938 . . . . 0.0 111.163 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.82 159.08 36.86 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.41 0.684 . . . . 0.0 111.903 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.77 59.8 1.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.624 2.369 . . . . 0.0 107.241 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.57 -45.25 2.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.345 1.926 . . . . 0.0 113.93 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -140.17 -38.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.491 2.316 . . . . 0.0 109.678 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -73.76 153.2 40.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 89.1 mtp -141.72 140.52 33.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -133.43 137.54 45.8 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.82 110.48 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD12 ' CD2' ' A' ' 19' ' ' PHE . 2.7 mm? -84.79 112.37 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.85 136.16 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.438 ' H ' HG22 ' A' ' 132' ' ' THR . 45.1 t-20 -78.85 61.96 3.21 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.796 0.838 . . . . 0.0 109.822 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 tp -54.81 -38.38 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.997 1.319 . . . . 0.0 111.126 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.0 -15.6 59.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -111.12 -9.35 14.37 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.333 -1.318 . . . . 0.0 111.556 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.74 -80.8 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.136 -169.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.76 -30.81 70.37 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.029 -1.044 . . . . 0.0 109.442 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.4 -21.86 62.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.3 m -115.17 -12.19 11.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.804 0.842 . . . . 0.0 112.078 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.42 -15.32 19.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.512 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.51 -40.49 78.8 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.891 1.678 . . . . 0.0 111.953 -169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.0 ptp -63.23 -31.82 73.07 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.42 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.53 25.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.75 1.22 . . . . 0.0 111.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.79 -55.64 9.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.69 -28.36 68.57 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.068 -0.395 . . . . 0.0 111.731 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.63 -28.71 9.35 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.649 1.179 . . . . 0.0 112.807 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.9 m -134.12 19.62 3.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.661 1.185 . . . . 0.0 111.812 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.61 15.53 1.11 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.006 0.922 . . . . 0.0 112.579 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.32 12.73 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.353 1.061 . . . . 0.0 111.84 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 15.2 m 62.31 17.81 9.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.392 1.877 . . . . 0.0 112.649 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.24 -40.92 58.55 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.599 -0.688 . . . . 0.0 109.808 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.9 -28.34 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.704 0.801 . . . . 0.0 111.156 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.819 -179.711 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 121.015 0.436 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -60.39 177.61 0.26 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.876 1.671 . . . . 0.0 111.912 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.1 15.95 1.24 Allowed Glycine 0 CA--C 1.54 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 113.484 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 ptm -153.09 160.45 42.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.054 2.542 . . . . 0.0 106.51 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -74.97 72.12 2.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.168 1.387 . . . . 0.0 110.723 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -76.48 60.64 1.63 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.36 121.33 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 130.22 43.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.53 0.732 . . . . 0.0 110.199 -174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -159.58 128.98 5.32 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.316 1.047 . . . . 0.0 108.282 169.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.72 99.68 4.4 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.46 -11.45 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.447 1.099 . . . . 0.0 111.994 171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -154.77 41.7 0.46 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.559 1.544 . . . . 0.0 108.546 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.48 148.71 44.65 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.2 1.4 . . . . 0.0 109.625 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.79 1.15 8.42 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.03 3.154 . . . . 0.0 113.474 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m 54.0 53.05 11.75 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.502 1.521 . . . . 0.0 113.645 173.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.66 75.23 1.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.309 0.481 . . . . 0.0 114.282 169.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -68.87 161.74 28.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 168.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.4 142.6 49.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -141.64 134.55 28.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 109.564 -169.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.19 133.22 35.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 151.34 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 119.531 1.06 . . . . 0.0 109.15 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.99 153.23 46.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.77 1.228 . . . . 0.0 109.407 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -96.65 146.46 24.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 tp -149.61 132.71 16.28 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.79 -104.74 0.69 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.23 37.39 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.664 1.585 . . . . 0.0 108.912 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.24 159.95 41.06 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.825 2.05 . . . . 0.0 107.594 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.82 160.85 20.69 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 110.281 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -142.68 152.57 42.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.932 2.093 . . . . 0.0 106.809 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.23 154.85 21.39 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mt -139.5 134.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.18 117.17 2.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 109.157 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -54.42 -35.56 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.895 0.878 . . . . 0.0 111.558 -170.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.93 -24.98 68.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.717 0.807 . . . . 0.0 112.508 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -80.65 -23.53 39.6 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.483 0.583 . . . . 0.0 111.464 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.71 132.96 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.429 HE22 ' CD1' ' A' ' 61' ' ' LEU . 42.3 tt0 -90.09 -59.07 2.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.33 -179.42 7.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.435 1.094 . . . . 0.0 109.825 -172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.61 143.13 41.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -147.78 173.88 12.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.403 1.081 . . . . 0.0 108.483 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.64 157.8 33.09 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -77.26 106.71 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 108.654 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -157.76 163.53 38.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.736 1.214 . . . . 0.0 109.569 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.88 34.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.904 2.481 . . . . 0.0 114.484 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.17 143.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.709 0.766 . . . . 0.0 109.396 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -136.03 93.09 2.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -71.21 118.96 14.66 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -70.02 157.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -23.5 67.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -172.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.89 23.91 0.51 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 156.99 35.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 122.935 0.494 . . . . 0.0 110.906 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -59.18 145.69 96.94 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 N-CA-C 107.995 -1.579 . . . . 0.0 107.995 169.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.67 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.728 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.12 -38.27 67.96 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.994 0.816 . . . . 0.0 110.675 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.5 mt -75.57 90.7 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -58.31 -26.41 63.01 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.02 -158.96 32.09 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.24 153.69 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -134.67 165.15 25.92 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.244 0.929 . . . . 0.0 108.985 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -71.23 99.4 1.9 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.535 1.534 . . . . 0.0 110.857 -173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' CD1' HE22 ' A' ' 37' ' ' GLN 0.25 0.5 OUTLIER -77.9 64.3 3.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 107.677 169.645 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 45.55 34.35 1.64 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.061 2.944 . . . . 0.0 114.145 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.79 -20.9 4.52 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.982 1.277 . . . . 0.0 112.136 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.66 -163.21 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 172.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 tp -138.27 147.14 25.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 121.156 -0.965 . . . . 0.0 111.979 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.59 135.99 18.48 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.89 147.95 75.56 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.998 1.799 . . . . 0.0 110.157 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.435 HD11 HG13 ' A' ' 88' ' ' VAL . 1.9 tp -126.61 131.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.59 155.65 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -140.48 143.08 35.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.22 1.009 . . . . 0.0 109.27 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.48 -16.74 62.37 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.943 1.297 . . . . 0.0 110.566 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -61.81 -20.19 63.36 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.093 1.315 . . . . 0.0 111.144 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.4 mt -115.89 -48.53 4.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.96 -25.36 67.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.811 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -135.0 -6.39 2.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.589 1.086 . . . . 0.0 113.116 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.5 m 55.92 46.02 22.84 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.086 -1.009 . . . . 0.0 111.716 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -47.04 142.88 3.33 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.34 -65.04 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.722 1.609 . . . . 0.0 112.65 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -162.28 79.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.161 0.985 . . . . 0.0 109.697 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.52 144.79 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -164.63 171.56 14.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.683 1.593 . . . . 0.0 107.462 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -70.17 48.32 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.736 2.014 . . . . 0.0 110.921 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.69 -12.91 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.741 3.216 . . . . 0.0 110.737 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.16 -3.26 1.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.428 1.491 . . . . 0.0 111.988 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -146.56 40.05 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.224 1.409 . . . . 0.0 109.095 -169.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 p -96.21 -11.6 25.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.293 1.837 . . . . 0.0 114.041 -169.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.68 155.67 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 68' ' ' ILE . 77.0 t -130.08 135.7 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.185 1.794 . . . . 0.0 106.231 -174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.61 124.61 65.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.29 134.31 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.7 mt -133.09 162.01 32.87 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.102 1.361 . . . . 0.0 108.822 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.35 153.9 41.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.5 136.55 18.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.6 -94.97 0.08 OUTLIER Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -169.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -139.91 22.33 2.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.054 1.742 . . . . 0.0 110.76 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -134.52 163.31 30.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.113 -0.992 . . . . 0.0 110.106 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.23 152.27 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 110.393 -170.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.94 177.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 126.224 1.809 . . . . 0.0 106.711 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.96 170.8 33.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.4 154.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.895 0.878 . . . . 0.0 109.082 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.96 144.61 13.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.83 170.96 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.737 1.615 . . . . 0.0 110.049 -168.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -76.72 -42.93 39.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.971 -0.456 . . . . 0.0 110.353 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.97 153.79 9.16 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.9 129.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 m -77.03 -57.83 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.405 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -176.62 175.33 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 107.796 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.5 140.09 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.28 176.34 8.8 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.994 1.718 . . . . 0.0 108.16 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 m -131.63 139.63 49.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.199 0.6 . . . . 0.0 109.566 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.53 165.72 26.79 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.238 1.415 . . . . 0.0 108.4 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.7 m -137.58 158.8 43.6 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.8 1.24 . . . . 0.0 107.811 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.18 -13.01 2.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.8 -40.71 92.17 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.81 1.186 . . . . 0.0 110.129 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -82.72 -39.08 22.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.533 1.533 . . . . 0.0 109.692 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.77 85.83 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 44.6 mtm180 -140.88 -53.69 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 116.608 -1.663 . . . . 0.0 112.725 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 35.1 Cg_endo -65.01 175.93 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 121.699 1.643 . . . . 0.0 111.167 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.65 158.23 32.21 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.939 1.296 . . . . 0.0 109.157 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.02 60.7 7.94 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.778 2.986 . . . . 0.0 110.994 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.35 33.52 0.06 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.378 1.871 . . . . 0.0 112.495 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.2 178.3 4.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.52 1.528 . . . . 0.0 110.74 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.55 0.93 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.203 1.401 . . . . 0.0 110.568 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.71 159.16 39.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.799 1.639 . . . . 0.0 109.039 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -58.52 -25.05 61.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.881 0.872 . . . . 0.0 112.2 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.96 -26.92 68.51 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.796 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -76.11 75.46 2.96 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 124.319 2.009 . . . . 0.0 111.292 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 t -155.52 177.57 11.22 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 129.502 3.121 . . . . 0.0 103.776 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.6 -7.55 0.99 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 126.472 1.909 . . . . 0.0 115.963 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -73.21 -5.35 38.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.737 1.153 . . . . 0.0 110.438 168.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -46.59 135.52 8.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.108 2.163 . . . . 0.0 114.459 -169.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 145' ' ' VAL . 52.6 p -77.02 -165.7 0.6 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 128.878 2.871 . . . . 0.0 110.355 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.23 -179.72 16.84 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.464 1.983 . . . . 0.0 108.544 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mt -133.62 150.64 51.6 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.932 1.693 . . . . 0.0 106.948 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.33 171.85 32.87 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.09 158.06 43.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.089 0.956 . . . . 0.0 110.927 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 mt -144.89 69.37 1.25 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.231 1.812 . . . . 0.0 107.605 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.87 -49.56 2.85 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.337 1.922 . . . . 0.0 113.1 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -145.45 -31.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.379 1.872 . . . . 0.0 110.953 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -69.64 153.13 43.87 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.3 mtp -142.8 146.67 34.44 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.31 147.62 25.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.368 0.667 . . . . 0.0 109.879 -175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -93.02 112.42 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.53 107.77 10.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.529 ' HA ' HG22 ' A' ' 132' ' ' THR . 71.0 t -62.91 122.8 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -79.41 53.79 1.6 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.371 0.668 . . . . 0.0 110.683 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 tp -54.09 -37.39 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.52 1.128 . . . . 0.0 111.123 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -65.49 -6.45 10.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.867 1.267 . . . . 0.0 112.782 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -124.49 -28.9 3.55 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 0.0 111.608 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.2 tp -45.49 -64.5 0.71 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.875 1.67 . . . . 0.0 111.841 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.28 -46.34 56.24 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.95 -170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -65.09 -21.4 66.8 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.256 0.935 . . . . 0.0 113.064 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.7 m -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.68 1.127 . . . . 0.0 111.506 170.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.87 -15.01 46.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.881 0.872 . . . . 0.0 112.182 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -49.6 -44.64 47.32 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 125.754 1.622 . . . . 0.0 113.555 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.6 ptp -64.1 -40.78 96.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.552 0.614 . . . . 0.0 111.432 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.36 -37.86 65.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.342 0.657 . . . . 0.0 110.545 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.4 tt -59.67 -56.61 19.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.259 1.424 . . . . 0.0 109.742 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -26.24 61.9 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 122.807 0.443 . . . . 0.0 111.384 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -55.67 -18.57 8.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.09 0.556 . . . . 0.0 112.416 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.8 m -131.35 19.39 4.83 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.537 1.535 . . . . 0.0 111.551 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.04 46.97 0.61 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.475 1.51 . . . . 0.0 108.524 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.18 15.78 2.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 112.81 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.4 m 64.34 41.92 5.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 108.776 -169.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -147.73 -78.08 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.489 1.115 . . . . 0.0 108.804 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.83 -34.64 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.297 0.639 . . . . 0.0 110.444 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 129.926 3.29 . . . . 0.0 104.69 169.739 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.771 0.319 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -66.89 165.04 16.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.955 0.902 . . . . 0.0 110.958 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.1 -127.51 0.92 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.3 mmt -59.84 -15.14 18.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.828 0.814 . . . . 0.0 112.393 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -57.02 -25.73 59.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.262 1.425 . . . . 0.0 112.163 169.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.31 71.85 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.311 1.044 . . . . 0.0 108.437 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.18 -8.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.23 153.06 38.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.096 1.316 . . . . 0.0 109.187 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.3 tptt 54.18 35.46 22.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.285 1.434 . . . . 0.0 111.306 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.85 -10.42 59.54 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.713 -0.617 . . . . 0.0 111.712 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.66 -170.82 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.831 2.452 . . . . 0.0 106.142 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -70.23 42.91 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.448 1.899 . . . . 0.0 112.842 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.67 154.25 66.91 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.116 1.366 . . . . 0.0 110.251 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.12 145.28 54.59 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.733 2.288 . . . . 0.0 112.27 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -127.59 31.06 5.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.289 1.036 . . . . 0.0 112.132 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.17 55.72 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.118 0.866 . . . . 0.0 111.03 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.16 160.14 24.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -116.43 144.76 43.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.84 136.79 30.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.624 0.77 . . . . 0.0 110.03 -169.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.8 tp -77.57 134.55 38.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 102.849 -3.019 . . . . 0.0 102.849 167.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.25 149.88 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.655 1.116 . . . . 0.0 108.781 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.92 151.81 44.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.225 1.01 . . . . 0.0 110.15 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -95.49 143.72 26.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -139.38 94.4 2.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.044 1.338 . . . . 0.0 107.517 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.47 -74.52 0.71 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.279 1.419 . . . . 0.0 111.456 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.69 29.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.067 1.347 . . . . 0.0 110.603 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.14 160.87 38.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.31 1.444 . . . . 0.0 108.111 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.18 151.64 45.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.808 1.289 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.9 155.76 47.03 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.634 1.974 . . . . 0.0 107.729 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.57 157.91 22.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -142.61 134.48 25.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -50.07 119.07 3.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.464 0.706 . . . . 0.0 109.378 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -54.8 -34.65 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.871 0.868 . . . . 0.0 111.285 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.7 mt -65.65 -22.15 66.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.554 0.742 . . . . 0.0 112.735 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.66 -21.09 32.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.07 0.85 . . . . 0.0 111.688 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.09 140.72 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.84 -42.48 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.496 1.119 . . . . 0.0 110.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -161.53 171.02 18.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.383 1.073 . . . . 0.0 108.815 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.1 147.59 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -150.17 173.99 13.3 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.56 163.67 26.27 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -60.27 136.76 58.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.0 -55.14 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.96 84.25 1.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -169.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.14 119.02 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 m -78.64 93.2 4.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -78.1 88.73 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.79 137.46 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.2 -17.93 60.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -137.11 37.92 2.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.68 1.192 . . . . 0.0 111.017 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 53' ' ' ALA . 27.1 p -60.82 166.48 4.53 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 121.804 -0.56 . . . . 0.0 111.897 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.6 20.21 0.38 Allowed 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 123.227 2.618 . . . . 0.0 111.358 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' THR . . . 59.1 -39.91 0.07 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 131.319 3.848 . . . . 0.0 116.938 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -52.97 -44.18 66.95 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 120.326 1.421 . . . . 0.0 108.509 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.99 110.29 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -67.79 -34.91 77.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.58 -153.52 21.19 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -117.71 162.4 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.45 150.41 34.55 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.287 -1.508 . . . . 0.0 110.117 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -72.05 135.22 46.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.226 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.37 97.44 5.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.512 1.125 . . . . 0.0 109.434 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 57.17 17.28 3.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.663 1.185 . . . . 0.0 113.334 172.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.41 6.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.002 1.287 . . . . 0.0 113.007 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.34 -172.05 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.93 1.292 . . . . 0.0 108.295 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.15 155.01 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.834 1.253 . . . . 0.0 110.393 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.39 141.97 15.21 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.626 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.08 140.15 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.097 1.865 . . . . 0.0 109.27 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 tp -126.18 135.15 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.18 148.76 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.806 2.042 . . . . 0.0 106.028 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -125.78 128.56 47.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.06 -18.93 65.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.986 0.914 . . . . 0.0 111.346 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -58.88 -25.53 63.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.815 -1.178 . . . . 0.0 110.531 169.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.36 -30.8 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.516 1.526 . . . . 0.0 110.085 -169.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -92.77 -22.03 19.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.21 0.914 . . . . 0.0 113.004 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -132.83 3.1 3.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.278 0.944 . . . . 0.0 111.807 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 m 51.39 41.7 28.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.86 1.264 . . . . 0.0 111.402 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -57.41 170.96 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.715 0.806 . . . . 0.0 111.175 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 m -58.13 169.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 122.02 0.914 . . . . 0.0 109.416 168.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.28 62.51 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.468 2.307 . . . . 0.0 111.349 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -45.42 150.93 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.287 2.235 . . . . 0.0 111.759 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -152.11 165.15 35.66 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.249 1.42 . . . . 0.0 108.449 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -74.6 53.18 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 0.0 110.597 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -151.46 -21.96 0.2 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.245 3.418 . . . . 0.0 109.708 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.79 7.52 2.75 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.538 1.535 . . . . 0.0 111.659 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -154.69 40.52 0.45 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.137 2.175 . . . . 0.0 108.567 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 p -88.96 7.14 36.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.586 1.954 . . . . 0.0 115.362 -168.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.49 157.43 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.4 136.19 55.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.67 134.32 48.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.7 mt -133.82 164.22 27.74 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 108.007 -171.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.97 154.09 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.313 0.645 . . . . 0.0 110.113 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mp -136.51 80.81 1.84 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.4 -68.95 2.34 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.676 -0.64 . . . . 0.0 113.214 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -137.01 0.6 2.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.402 1.881 . . . . 0.0 111.833 -173.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.92 165.55 22.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.502 1.121 . . . . 0.0 109.103 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.39 150.45 32.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.019 0.927 . . . . 0.0 109.18 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.2 p -158.91 165.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.45 174.02 32.15 Favored Glycine 0 N--CA 1.451 -0.364 0 O-C-N 121.118 -0.989 . . . . 0.0 111.683 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.29 164.56 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 109.847 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 m -111.37 132.13 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.153 1.781 . . . . 0.0 108.183 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.89 164.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.97 1.308 . . . . 0.0 109.611 -168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.3 -41.67 73.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.13 158.94 20.93 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.32 123.12 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -48.3 15.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.921 0.888 . . . . 0.0 109.682 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -173.44 -174.54 1.02 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 108.02 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.73 128.76 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.56 173.22 11.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.217 1.407 . . . . 0.0 108.923 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.3 m -130.92 139.05 50.03 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.3 161.12 38.65 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 m -132.9 157.21 45.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.09 1.756 . . . . 0.0 108.238 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.05 -17.36 24.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.86 -36.33 80.09 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.24 -40.46 19.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.606 1.562 . . . . 0.0 110.434 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.05 103.67 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 91.9 mtt-85 -140.54 -55.84 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 116.936 -1.507 . . . . 0.0 111.423 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.5 Cg_endo -66.48 173.2 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.97 157.51 30.74 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.0 1.72 . . . . 0.0 108.89 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.41 143.66 48.36 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.817 1.678 . . . . 0.0 109.457 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.14 22.75 0.65 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.035 1.334 . . . . 0.0 110.335 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -73.63 176.85 5.83 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.275 1.43 . . . . 0.0 111.442 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.23 66.48 0.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.739 1.615 . . . . 0.0 110.603 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.45 172.83 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.846 1.658 . . . . 0.0 109.433 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -15.63 61.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.283 1.433 . . . . 0.0 113.724 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.82 144.41 54.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.937 . . . . 0.0 110.206 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.8 m -138.32 162.26 34.82 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.28 1.032 . . . . 0.0 109.791 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -57.45 -27.52 62.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 114.338 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -74.69 -24.09 58.72 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.623 -0.673 . . . . 0.0 111.895 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -127.2 -3.35 6.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.087 0.955 . . . . 0.0 112.73 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.08 161.47 5.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.614 0.643 . . . . 0.0 110.76 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 42.2 p -113.69 -166.54 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.8 1.64 . . . . 0.0 110.407 -168.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.4 168.69 23.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.6 154.61 39.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.913 1.857 . . . . 0.0 111.0 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.3 173.38 40.27 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.092 0.377 . . . . 0.0 112.853 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.15 157.26 17.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.927 0.891 . . . . 0.0 111.13 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.06 85.06 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.16 -55.0 2.3 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.751 2.119 . . . . 0.0 112.862 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -150.34 -28.12 0.23 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.199 2.199 . . . . 0.0 111.524 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -69.12 163.3 25.12 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.754 0.707 . . . . 0.0 109.529 171.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.99 134.59 47.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.83 134.82 51.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.06 107.11 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.04 109.99 13.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.51 130.55 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.857 1.263 . . . . 0.0 108.434 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -74.87 57.03 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.442 1.897 . . . . 0.0 109.867 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -46.71 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.825 1.65 . . . . 0.0 111.268 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -66.86 -10.0 43.65 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.6 -14.93 16.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.471 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.6 tp -55.5 -78.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.812 1.245 . . . . 0.0 111.325 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.6 tp -77.32 -20.47 54.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.99 0.813 . . . . 0.0 111.257 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.07 -39.96 79.83 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.259 -0.9 . . . . 0.0 111.661 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 -19.92 17.29 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.024 -0.512 . . . . 0.0 112.058 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -83.98 -10.52 57.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.763 1.165 . . . . 0.0 112.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.73 -44.34 58.23 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 121.303 1.865 . . . . 0.0 112.028 -171.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.9 mtm -65.23 -46.09 82.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.29 0.636 . . . . 0.0 110.311 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.45 74.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.53 0.732 . . . . 0.0 111.787 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.58 -64.17 1.04 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.61 -31.46 72.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -169.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -55.21 -23.1 20.39 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.2 m -137.13 19.82 2.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.96 1.304 . . . . 0.0 111.892 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -152.74 13.03 0.53 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.92 12.21 0.56 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.523 1.129 . . . . 0.0 112.955 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.0 m 74.37 -34.79 0.28 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.134 2.574 . . . . 0.0 113.173 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.51 -11.99 48.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.734 1.213 . . . . 0.0 111.935 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.23 6.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.372 1.869 . . . . 0.0 111.419 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.399 178.174 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.1 m -144.77 146.36 32.1 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.62 -21.07 1.84 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.651 0.643 . . . . 0.0 112.749 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -61.07 162.42 7.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.133 0.973 . . . . 0.0 110.518 170.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -57.28 -17.04 10.09 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.44 1.496 . . . . 0.0 114.318 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -46.74 -33.46 4.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.876 1.271 . . . . 0.0 112.884 171.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -58.28 -19.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -135.24 23.76 3.5 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.2 1.4 . . . . 0.0 109.322 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -152.23 57.89 0.83 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.87 -35.92 75.82 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.526 0.731 . . . . 0.0 109.407 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.74 -66.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.05 1.34 . . . . 0.0 108.544 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -172.73 47.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.649 1.18 . . . . 0.0 110.616 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.08 140.57 31.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.754 1.222 . . . . 0.0 110.73 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.45 168.11 25.2 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.666 2.244 . . . . 0.0 111.753 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -55.33 147.58 16.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.669 1.587 . . . . 0.0 111.825 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.35 94.72 1.43 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.854 1.693 . . . . 0.0 109.151 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -69.67 167.08 17.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 110.143 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.93 146.15 50.73 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.604 1.561 . . . . 0.0 107.417 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -142.15 140.32 32.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.612 0.765 . . . . 0.0 110.289 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.5 tp -80.39 134.45 36.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.36 148.29 27.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 109.123 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.14 153.68 45.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.509 1.124 . . . . 0.0 110.123 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -95.52 149.39 21.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.46 128.41 7.35 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.31 -89.51 0.51 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.71 34.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.352 1.461 . . . . 0.0 109.145 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -143.44 158.89 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.829 1.651 . . . . 0.0 107.871 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 155.55 28.05 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 123.251 1.5 . . . . 0.0 110.299 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -142.23 160.97 39.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.913 2.085 . . . . 0.0 107.338 -171.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.8 164.12 26.45 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 123.784 0.707 . . . . 0.0 111.729 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -144.68 136.15 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -49.26 118.8 2.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.15 0.98 . . . . 0.0 109.343 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.21 -33.83 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.814 0.846 . . . . 0.0 111.566 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.73 -23.39 67.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.434 0.694 . . . . 0.0 112.604 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -81.01 -19.13 44.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.272 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.54 142.24 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.267 1.394 . . . . 0.0 109.162 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -125.57 -39.84 2.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.121 1.369 . . . . 0.0 110.781 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -167.04 171.24 11.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.663 1.585 . . . . 0.0 107.754 175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.19 140.81 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -149.95 176.67 10.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 108.564 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.63 173.89 44.19 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -59.11 -31.06 68.59 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.83 -0.806 . . . . 0.0 112.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.0 t0 34.22 -90.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 129.33 3.052 . . . . 0.0 116.588 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 66.53 1.34 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 113.405 -169.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.57 133.9 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 m -70.88 -42.18 70.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.579 1.152 . . . . 0.0 111.593 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.03 89.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.75 2.02 . . . . 0.0 109.33 -169.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.9 150.87 6.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.77 66.73 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.71 20.85 0.61 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -172.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.71 148.39 47.24 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.41 121.46 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 N-CA-C 105.639 -2.485 . . . . 0.0 105.639 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.84 -33.03 0.69 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -168.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.09 -38.24 37.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.023 0.829 . . . . 0.0 110.976 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.8 mt -93.39 105.2 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.8 -57.45 12.64 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.43 -173.19 36.19 Favored Glycine 0 C--O 1.227 -0.315 0 O-C-N 121.021 -1.049 . . . . 0.0 111.73 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -83.6 153.82 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -138.09 160.66 38.81 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.94 108.36 19.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.522 -0.736 . . . . 0.0 111.556 -172.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.2 72.67 3.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.66 -0.65 . . . . 0.0 110.685 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 49.89 28.78 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.684 1.594 . . . . 0.0 114.422 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.93 -20.61 2.15 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.371 0.986 . . . . 0.0 113.063 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -169.25 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.829 1.252 . . . . 0.0 107.806 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 tp -133.72 148.63 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 120.766 -1.209 . . . . 0.0 110.08 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 p -148.87 134.56 9.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.147 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.93 138.9 45.7 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.314 2.676 . . . . 0.0 110.685 170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -122.84 135.32 63.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.386 1.089 . . . . 0.0 109.12 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.87 162.87 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.556 2.342 . . . . 0.0 105.188 169.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -139.79 145.05 37.71 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 120.652 -1.28 . . . . 0.0 109.409 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.11 -21.66 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.647 1.179 . . . . 0.0 112.917 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -70.34 -11.13 60.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.707 1.594 . . . . 0.0 112.213 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.16 20.92 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 0.0 109.034 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -141.55 -23.7 0.72 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.657 1.183 . . . . 0.0 111.449 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -139.39 12.16 2.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.561 1.144 . . . . 0.0 111.991 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.0 m 54.26 38.95 30.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.488 1.515 . . . . 0.0 112.427 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 156.2 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 78' ' ' VAL . 4.6 t -40.85 -67.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.657 2.383 . . . . 0.0 113.268 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -169.77 97.63 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.832 1.653 . . . . 0.0 109.13 -169.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.28 143.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.176 0.99 . . . . 0.0 109.593 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.25 158.23 35.75 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.109 1.364 . . . . 0.0 108.767 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -69.46 42.48 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.932 2.093 . . . . 0.0 113.143 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.86 -12.02 0.16 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.159 2.183 . . . . 0.0 110.671 169.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -125.51 -5.53 7.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.558 1.543 . . . . 0.0 111.98 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.98 38.83 2.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.271 1.428 . . . . 0.0 108.972 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -102.15 -4.73 25.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.561 . . . . 0.0 114.376 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.34 155.36 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.5 t -133.33 137.14 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.57 124.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.64 140.22 17.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -135.76 162.65 32.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.992 1.717 . . . . 0.0 107.843 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.05 148.86 39.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.178 1.391 . . . . 0.0 108.027 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.44 151.1 29.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.53 -102.54 0.11 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -139.62 34.07 2.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.498 1.519 . . . . 0.0 109.809 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.1 167.76 21.32 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.779 1.632 . . . . 0.0 109.297 -171.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.04 151.19 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 124.157 0.983 . . . . 0.0 109.547 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.67 176.78 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.854 1.661 . . . . 0.0 107.204 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.61 179.48 41.51 Favored Glycine 0 N--CA 1.448 -0.537 0 O-C-N 120.685 -1.259 . . . . 0.0 111.427 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.4 pt -141.65 158.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.587 1.155 . . . . 0.0 109.542 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.09 145.11 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.8 172.4 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.634 1.574 . . . . 0.0 110.606 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.22 -43.51 51.35 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.98 -0.45 . . . . 0.0 109.831 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.46 155.68 10.57 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 129.0 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -41.36 10.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.427 0.691 . . . . 0.0 111.802 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.2 t0 -167.57 -175.67 2.9 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 110.727 -168.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -135.84 125.28 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.18 166.53 24.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 110.191 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 m -125.37 141.24 52.18 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.201 0.6 . . . . 0.0 110.42 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.1 139.04 30.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.438 1.095 . . . . 0.0 108.398 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 p -82.95 153.31 25.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.18 -16.73 35.46 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.5 -42.04 75.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.003 1.321 . . . . 0.0 110.037 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -58.67 -39.58 81.05 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.749 0.819 . . . . 0.0 109.359 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.1 mt -77.77 0.63 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 126.314 1.846 . . . . 0.0 112.151 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -53.59 -53.57 55.57 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.167 -1.583 . . . . 0.0 114.344 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.39 175.71 9.68 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.346 2.03 . . . . 0.0 112.396 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.5 163.32 24.56 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.244 1.418 . . . . 0.0 109.313 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.4 -50.0 9.35 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.762 2.308 . . . . 0.0 113.018 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 51.24 20.15 0.87 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.912 2.085 . . . . 0.0 114.219 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -73.93 160.09 31.87 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.003 -1.061 . . . . 0.0 110.033 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.92 32.51 0.14 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.867 1.667 . . . . 0.0 112.8 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.27 -175.21 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.927 1.291 . . . . 0.0 109.952 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -11.23 21.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.885 1.274 . . . . 0.0 113.92 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.74 156.29 33.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.446 1.499 . . . . 0.0 110.459 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.1 m -137.13 156.45 48.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.044 0.938 . . . . 0.0 109.752 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 p -64.89 -24.12 67.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.957 1.303 . . . . 0.0 113.426 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.02 -34.24 73.03 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -127.18 30.74 5.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.261 1.424 . . . . 0.0 109.06 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 131.15 49.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.466 1.106 . . . . 0.0 108.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.8 p -69.78 -177.92 1.39 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.68 1.592 . . . . 0.0 110.491 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -125.53 179.14 16.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 169.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.32 157.59 43.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.253 1.527 . . . . 0.0 108.808 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.13 172.6 34.03 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.11 20.84 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.14 0.576 . . . . 0.0 109.778 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.1 82.56 1.76 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.77 2.66 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.582 2.039 . . . . 0.0 112.995 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -156.68 -31.25 0.09 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.033 2.133 . . . . 0.0 111.103 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.444 HH22 ' HB2' ' A' ' 107' ' ' ASP . 59.0 mtp180 -68.94 162.99 25.49 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.0 mtp -139.8 144.94 37.59 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.18 126.13 29.3 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.8 mt -81.47 111.62 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.53 111.08 22.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.1 t -67.41 131.09 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 108.329 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -75.79 62.22 1.51 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.225 1.01 . . . . 0.0 109.734 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -43.98 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.895 1.678 . . . . 0.0 110.33 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.23 -18.41 63.5 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 112.814 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -111.16 -10.74 14.3 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.956 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.0 -67.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.005 1.275 . . . . 0.0 110.08 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.67 -39.89 84.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.071 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -55.42 -48.51 74.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 0.0 110.717 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 m -82.15 -16.29 50.32 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 112.779 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -104.08 3.28 33.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.984 1.265 . . . . 0.0 112.783 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.26 -42.06 97.98 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.501 -1.374 . . . . 0.0 110.615 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.1 ptp -62.08 -28.97 69.99 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.719 -0.613 . . . . 0.0 112.004 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.86 32.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.492 1.117 . . . . 0.0 110.587 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.0 tp -56.95 -53.62 55.99 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.97 -14.62 61.93 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.436 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -55.51 -25.84 39.51 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.381 1.446 . . . . 0.0 111.849 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 m -123.16 -34.33 3.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.698 1.199 . . . . 0.0 111.535 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 164' ' ' SER . . . -82.71 4.98 22.84 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.52 12.56 0.33 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.47 1.032 . . . . 0.0 111.456 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 162' ' ' ALA . 9.8 m 70.44 14.89 7.35 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.531 2.332 . . . . 0.0 111.784 -169.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.89 -28.76 49.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.5 0.72 . . . . 0.0 111.09 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -136.02 -42.92 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.128 0.971 . . . . 0.0 110.166 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.85 173.743 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -59.13 -39.43 82.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.828 1.251 . . . . 0.0 113.2 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.92 9.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.215 1.388 . . . . 0.0 110.032 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.3 ptm -59.42 -25.61 64.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 p -63.02 -25.33 68.33 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.727 1.211 . . . . 0.0 112.031 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -78.43 87.39 4.44 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.5 m -57.23 -19.79 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 0.0 112.625 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.5 m 67.46 -50.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.022 2.529 . . . . 0.0 113.243 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -152.89 -57.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.4 1.08 . . . . 0.0 109.052 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.1 tp 45.65 50.84 10.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.189 1.796 . . . . 0.0 111.864 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.05 -20.02 2.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.193 0.997 . . . . 0.0 112.633 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -142.75 38.34 1.48 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.651 1.58 . . . . 0.0 108.258 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.37 156.94 74.9 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 0.0 108.938 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.37 136.96 57.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.435 2.09 . . . . 0.0 111.824 -173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.6 m -122.81 31.65 5.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.77 1.228 . . . . 0.0 110.65 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.39 52.69 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.997 1.284 . . . . 0.0 110.523 171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -66.02 146.79 54.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.18 145.6 33.97 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -142.01 138.38 31.81 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.171 0.989 . . . . 0.0 110.175 -169.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -84.19 137.47 33.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 167.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 30' ' ' GLY 0.256 1.5 m -125.7 146.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 119.439 1.018 . . . . 0.0 108.525 -175.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -143.23 153.79 43.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.085 1.354 . . . . 0.0 110.393 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 m -95.17 143.8 26.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.81 103.98 4.78 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.49 -78.49 0.25 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.331 1.443 . . . . 0.0 111.781 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.26 30.19 0.55 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.608 1.163 . . . . 0.0 111.032 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.77 161.04 39.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.577 1.151 . . . . 0.0 108.568 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -115.65 149.39 38.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.97 1.367 . . . . 0.0 109.817 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -139.3 165.65 26.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 107.403 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -147.41 169.06 28.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 119.15 0.886 . . . . 0.0 113.534 170.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 mt -144.01 137.73 24.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.06 118.65 3.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.881 0.872 . . . . 0.0 109.015 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -53.64 -32.81 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.708 0.803 . . . . 0.0 111.747 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.53 -24.49 67.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.04 0.836 . . . . 0.0 112.72 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.32 -21.36 39.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.278 0.945 . . . . 0.0 111.113 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.09 138.41 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -113.25 -46.18 3.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.559 1.144 . . . . 0.0 109.46 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -162.65 177.32 9.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.869 1.268 . . . . 0.0 108.803 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -139.41 143.27 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 172.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -134.29 -104.88 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 0.0 110.764 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 88' ' ' VAL . . . 176.44 154.65 11.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -68.42 125.72 27.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -156.84 -48.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -150.9 50.66 0.86 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.04 0.936 . . . . 0.0 109.894 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.74 112.07 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 m -95.31 89.17 5.37 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.69 144.85 56.69 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' HB ' HG23 ' A' ' 51' ' ' THR . 34.4 mm -84.39 28.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.236 1.014 . . . . 0.0 109.071 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 65.37 -31.4 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.127 2.571 . . . . 0.0 115.144 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.63 24.52 0.78 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.531 1.532 . . . . 0.0 112.924 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.28 144.88 97.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 110.232 169.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.69 142.34 14.26 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.752 2.968 . . . . 0.0 111.11 168.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.52 69.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.735 0.414 . . . . 0.0 110.59 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -65.75 0.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 0.0 114.191 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.04 -35.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 124.804 1.242 . . . . 0.0 110.996 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 mttm 57.17 -75.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.344 1.858 . . . . 0.0 110.795 -168.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.1 -123.93 1.13 Allowed Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 121.247 1.84 . . . . 0.0 110.99 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.13 169.47 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -143.53 158.79 43.38 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 120.838 -1.164 . . . . 0.0 108.383 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -72.9 137.86 45.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 110.013 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.39 173.64 7.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 168.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.21 65.44 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.38 1.072 . . . . 0.0 112.933 -169.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.23 -8.69 4.74 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.241 2.353 . . . . 0.0 113.106 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -152.94 -165.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 119.189 1.494 . . . . 0.0 109.417 -169.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -125.59 159.35 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.589 1.956 . . . . 0.0 108.035 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.45 133.49 10.05 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.3 130.72 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.653 1.568 . . . . 0.0 108.428 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.17 134.83 55.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -126.35 144.22 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.02 109.5 20.85 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.64 -17.21 45.86 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.923 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.0 -37.89 21.65 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.969 1.258 . . . . 0.0 111.005 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.34 -38.59 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -69.65 -12.91 62.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.755 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -122.59 -3.96 8.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.001 1.273 . . . . 0.0 113.547 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m 49.61 47.05 23.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.826 1.251 . . . . 0.0 111.796 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -177.71 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.649 0.737 . . . . 0.0 110.926 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.16 170.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.69 1.196 . . . . 0.0 110.997 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.53 63.3 5.77 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 110.541 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.73 164.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.611 1.164 . . . . 0.0 111.508 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -154.36 172.77 17.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.872 1.669 . . . . 0.0 108.58 -172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -70.89 54.92 0.17 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.001 1.381 . . . . 0.0 111.111 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 84' ' ' ASP . 42.1 t30 -154.66 -19.27 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 131.085 3.754 . . . . 0.0 109.288 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' H ' ' H ' ' A' ' 83' ' ' ASN . 27.6 t70 -141.0 16.92 2.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.803 2.041 . . . . 0.0 110.822 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -159.79 42.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.407 3.083 . . . . 0.0 106.929 -173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.7 p -99.18 6.78 46.27 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -168.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 74.5 t -126.36 151.4 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.349 1.431 . . . . 0.0 108.395 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' GLY . 27.0 m -121.43 141.99 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.48 128.12 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.52 135.37 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.1 mt -134.54 162.26 32.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.64 1.576 . . . . 0.0 109.046 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.69 145.64 33.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 107.676 173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -159.64 151.56 20.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.29 -94.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.742 1.163 . . . . 0.0 112.728 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.03 21.14 3.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.189 1.796 . . . . 0.0 110.975 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -145.43 173.79 11.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.011 -1.055 . . . . 0.0 112.824 -169.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.73 142.42 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.767 2.027 . . . . 0.0 106.234 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.07 178.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 125.563 1.545 . . . . 0.0 106.859 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.78 179.0 41.39 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.97 146.65 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 t -82.1 144.22 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 m -147.25 166.67 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.845 2.058 . . . . 0.0 107.602 -173.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.22 -44.92 71.07 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.241 -0.912 . . . . 0.0 109.893 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.94 162.1 24.46 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 m -74.87 127.48 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.71 -43.53 13.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.254 1.021 . . . . 0.0 110.166 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -171.0 176.74 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 110.762 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.97 131.72 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.841 2.057 . . . . 0.0 106.971 169.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.86 -178.49 5.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.337 1.055 . . . . 0.0 109.863 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 m -130.17 151.88 50.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.948 0.795 . . . . 0.0 112.069 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mp -143.46 163.93 31.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.61 1.564 . . . . 0.0 109.914 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.7 p -114.22 167.44 10.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.687 1.195 . . . . 0.0 111.522 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.31 -9.66 35.08 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.939 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.85 -52.02 11.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.04 -36.4 83.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.379 1.072 . . . . 0.0 111.493 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.7 mt -103.56 106.57 20.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.508 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 23.7 mmt180 -145.82 -53.07 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.205 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.508 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 39.2 Cg_endo -65.79 176.64 3.46 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.879 1.719 . . . . 0.0 111.733 173.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.17 160.63 32.96 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.56 1.944 . . . . 0.0 107.775 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.01 -45.47 5.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.733 1.622 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 45.58 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 131.693 3.997 . . . . 0.0 119.932 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -153.59 160.31 42.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.437 1.471 . . . . 0.0 109.338 -173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 52.25 35.41 16.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.838 1.655 . . . . 0.0 112.647 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.6 m -140.89 156.57 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.901 1.681 . . . . 0.0 107.913 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -12.46 61.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.978 1.311 . . . . 0.0 113.015 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -54.79 162.52 1.21 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.171 2.988 . . . . 0.0 113.596 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m -135.6 151.24 50.07 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.963 0.905 . . . . 0.0 111.969 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.89 -29.21 27.01 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.877 2.471 . . . . 0.0 114.389 -169.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -62.07 -32.3 72.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -147.47 31.19 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.259 1.023 . . . . 0.0 110.61 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 18.49 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 145' ' ' VAL . 27.4 p 64.01 -175.27 0.16 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.936 1.694 . . . . 0.0 112.176 169.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.72 177.52 20.11 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 106.396 -2.681 . . . . 0.0 106.396 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.65 158.67 44.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.677 1.238 . . . . 0.0 109.268 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.06 177.46 32.29 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.98 152.96 33.49 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.817 0.847 . . . . 0.0 109.652 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.79 82.59 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.147 1.379 . . . . 0.0 107.405 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.23 -48.44 2.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.586 2.041 . . . . 0.0 113.56 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -156.43 -35.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.29 2.236 . . . . 0.0 110.353 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -71.09 165.97 22.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.848 0.832 . . . . 0.0 110.142 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.7 mtp -136.95 147.97 46.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -137.9 129.95 28.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.5 mt -85.38 114.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.82 112.62 24.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -64.85 133.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.317 1.047 . . . . 0.0 108.36 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.88 61.38 2.49 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.36 -39.83 45.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.701 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.0 -13.34 45.75 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.021 0.828 . . . . 0.0 112.729 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -111.16 -12.59 14.12 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 117.039 -1.458 . . . . 0.0 112.649 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -54.66 -73.26 0.05 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.801 1.24 . . . . 0.0 111.088 -169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.9 -23.98 28.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.801 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -58.56 -28.64 65.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 111.491 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.0 m -96.17 -39.83 9.5 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.77 0.713 . . . . 0.0 110.883 173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.88 -10.81 59.62 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.769 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -49.78 -47.83 50.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 121.613 2.006 . . . . 0.0 112.035 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -67.06 -43.87 81.57 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.099 0.56 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.74 -31.2 71.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.548 0.739 . . . . 0.0 111.964 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.45 -60.57 2.19 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.98 -28.06 69.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.978 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.58 -37.32 7.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 111.989 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 73.7 m -137.42 32.15 2.57 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.275 1.03 . . . . 0.0 111.081 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.53 25.68 1.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.763 1.225 . . . . 0.0 110.739 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.27 -0.26 9.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.149 0.98 . . . . 0.0 113.154 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.0 m 68.97 -32.74 0.23 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.659 2.383 . . . . 0.0 112.873 -171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.62 -28.25 69.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.718 1.207 . . . . 0.0 110.573 169.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.67 -22.64 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.945 1.298 . . . . 0.0 112.429 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.955 0.902 . . . . 0.0 111.194 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.3 p -67.2 -19.97 65.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.695 1.198 . . . . 0.0 112.723 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.69 -179.22 39.75 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.8 mtm -143.34 170.21 16.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.811 1.244 . . . . 0.0 109.153 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.259 16.7 p 49.59 39.76 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.594 1.957 . . . . 0.0 112.626 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -73.96 62.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.078 1.351 . . . . 0.0 109.159 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -57.73 142.3 13.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.429 1.092 . . . . 0.0 110.707 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -72.38 139.27 47.76 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 169.11 9.17 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.619 -0.676 . . . . 0.0 110.076 172.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.35 85.56 2.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.52 -18.21 0.54 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.133 0.973 . . . . 0.0 113.473 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -151.09 41.76 0.75 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.85 1.66 . . . . 0.0 108.027 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -133.8 159.09 73.81 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.478 1.911 . . . . 0.0 109.592 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.93 -163.06 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.436 2.757 . . . . 0.0 109.353 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -45.12 134.11 6.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.417 1.487 . . . . 0.0 111.096 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.18 95.84 0.73 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -75.85 165.13 25.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.815 1.246 . . . . 0.0 108.482 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -133.12 143.42 49.26 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -139.36 141.09 37.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.779 0.432 . . . . 0.0 110.424 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -82.33 128.86 34.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 167.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.38 147.31 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 119.329 0.968 . . . . 0.0 108.889 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.74 153.73 42.74 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.249 1.02 . . . . 0.0 109.898 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -92.73 146.92 23.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.23 125.74 14.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -88.7 0.16 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -154.26 34.76 0.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.331 1.452 . . . . 0.0 109.796 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.64 158.2 43.9 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 107.602 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.62 156.21 34.75 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 123.022 1.391 . . . . 0.0 111.887 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -144.92 161.25 39.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.021 2.528 . . . . 0.0 107.127 -171.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.96 25.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.364 0.983 . . . . 0.0 111.035 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 100' ' ' ILE . 3.4 mt -137.46 137.92 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -47.38 115.86 1.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.585 1.154 . . . . 0.0 110.213 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.09 -33.79 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.104 0.962 . . . . 0.0 111.753 -169.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.54 -25.73 68.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.672 0.789 . . . . 0.0 112.66 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -79.26 -20.18 48.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.868 0.758 . . . . 0.0 111.883 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.14 128.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 118.902 0.774 . . . . 0.0 109.027 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -86.99 -60.28 2.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -163.65 -176.74 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.274 1.43 . . . . 0.0 109.012 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.29 145.95 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 41' ' ' GLY . 1.3 tmm_? -144.0 173.84 11.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.561 1.944 . . . . 0.0 106.278 -177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' H ' ' HD2' ' A' ' 40' ' ' ARG . . . -101.73 172.1 22.49 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.133 -0.98 . . . . 0.0 111.172 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -67.88 120.97 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 168.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.44 -48.98 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -170.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -150.92 86.42 1.37 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.887 0.875 . . . . 0.0 109.01 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.15 161.21 2.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.77 130.82 17.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -134.99 129.67 34.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.367 0.985 . . . . 0.0 108.982 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' A' ' 51' ' ' THR . 1.5 mp -63.19 137.44 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -8.96 25.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 48' ' ' ILE . 73.4 m-80 -130.43 34.0 4.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.081 1.752 . . . . 0.0 109.829 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.576 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -61.67 149.45 84.55 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.141 0.576 . . . . 0.0 111.192 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.84 26.18 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.835 3.69 . . . . 0.0 112.026 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.87 -37.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.918 2.887 . . . . 0.0 115.821 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -56.17 -44.13 79.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.711 1.142 . . . . 0.0 109.565 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.25 88.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -60.14 -26.68 66.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.133 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.02 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.435 1.017 . . . . 0.0 111.019 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 151.12 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 t -134.33 151.09 51.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.986 0.812 . . . . 0.0 109.369 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -66.08 107.64 1.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.404 1.082 . . . . 0.0 109.173 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.51 64.81 3.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 49.81 30.22 3.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.467 1.507 . . . . 0.0 113.209 169.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.49 -25.46 1.08 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.856 1.217 . . . . 0.0 113.387 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.46 -165.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 107.877 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 tp -130.32 147.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.451 1.478 . . . . 0.0 110.624 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.55 138.73 15.63 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.5 143.78 64.38 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.404 2.069 . . . . 0.0 110.596 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -127.84 135.55 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.2 167.04 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -129.08 116.52 19.4 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 mt -66.82 -17.29 64.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.358 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -54.75 -42.33 71.52 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.835 1.198 . . . . 0.0 110.333 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.36 -44.19 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -60.89 -23.75 65.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.42 -3.54 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.043 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.9 m 49.55 48.64 21.13 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.031 1.287 . . . . 0.0 110.57 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.31 -171.22 0.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 110.864 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.78 164.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.36 1.064 . . . . 0.0 110.225 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -84.06 62.89 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.273 1.829 . . . . 0.0 110.575 -169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 m -53.25 158.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.714 0.806 . . . . 0.0 111.036 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -144.03 178.03 8.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.237 1.415 . . . . 0.0 108.643 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.65 64.18 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.123 1.769 . . . . 0.0 109.484 169.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.36 -35.73 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 131.563 3.945 . . . . 0.0 108.456 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -145.98 30.7 1.05 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.641 1.976 . . . . 0.0 110.072 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -154.97 28.81 0.42 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.268 3.027 . . . . 0.0 107.666 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 p -106.51 12.17 29.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.538 1.935 . . . . 0.0 115.95 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.77 154.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.33 113.79 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -82.21 141.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 137.02 47.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.0 mt -135.82 154.85 51.06 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.531 1.532 . . . . 0.0 109.112 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 139.67 37.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.97 155.25 35.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.28 -100.49 0.04 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.2 0.905 . . . . 0.0 111.656 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -136.57 27.7 3.05 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.613 1.965 . . . . 0.0 109.958 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -146.97 171.04 15.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.2 144.79 34.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 125.363 1.465 . . . . 0.0 107.456 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 99' ' ' GLY . 13.2 p -158.48 -176.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -166.78 176.54 41.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 31' ' ' ILE . 48.8 pt -140.33 144.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.191 0.519 . . . . 0.0 110.343 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.51 142.9 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.944 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.44 166.05 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.654 1.982 . . . . 0.0 108.021 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.53 -41.48 65.79 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.94 151.81 8.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.29 128.98 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -36.5 10.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.203 0.601 . . . . 0.0 111.772 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB2' HH22 ' A' ' 140' ' ' ARG . 7.3 t0 -169.09 -178.4 3.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.593 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.1 t -137.48 122.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 103.984 -2.598 . . . . 0.0 103.984 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -141.16 150.25 42.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.456 0.702 . . . . 0.0 110.718 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 p -94.86 135.68 36.07 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.418 0.687 . . . . 0.0 109.639 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mp -138.18 143.31 40.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 67.5 p -100.4 164.8 11.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.55 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.91 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -104.89 -36.2 7.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.772 1.629 . . . . 0.0 110.052 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.41 -45.92 82.04 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.49 112.75 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -148.19 -62.86 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.802 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.18 -178.08 3.03 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.105 1.87 . . . . 0.0 111.539 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.32 155.55 39.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.564 1.946 . . . . 0.0 108.097 169.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.23 59.43 7.39 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.111 3.207 . . . . 0.0 111.107 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.63 29.18 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.077 1.751 . . . . 0.0 112.863 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.11 -174.46 1.26 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.746 1.618 . . . . 0.0 110.401 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 28.75 0.06 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.269 1.428 . . . . 0.0 113.468 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 124' ' ' VAL . 11.1 m -70.72 161.37 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.828 1.651 . . . . 0.0 109.475 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -44.57 95.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -169.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -62.88 166.01 6.12 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 m -134.19 175.2 9.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.2 1.4 . . . . 0.0 110.64 -169.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.7 p -56.15 -27.71 55.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.88 -30.2 56.11 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.337 0.972 . . . . 0.0 111.157 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -110.97 -9.55 14.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.093 0.957 . . . . 0.0 112.505 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.7 160.91 5.15 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.559 0.744 . . . . 0.0 112.132 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 146' ' ' ASN . 38.8 p -114.15 166.31 11.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.392 1.877 . . . . 0.0 108.757 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.86 176.53 45.94 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.59 145.78 39.0 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.3 174.72 37.07 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.04 39.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.018 0.927 . . . . 0.0 110.184 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.25 82.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.33 -51.9 2.57 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.623 2.059 . . . . 0.0 112.98 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -157.35 -31.4 0.08 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.147 2.179 . . . . 0.0 111.076 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' A' ' 107' ' ' ASP . 66.0 mtp180 -68.79 162.21 26.82 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.6 mtp -138.87 144.15 39.06 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.25 128.09 35.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.55 120.72 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.51 102.9 15.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.44 120.74 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.068 1.347 . . . . 0.0 108.956 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.551 ' H ' HG22 ' A' ' 132' ' ' THR . 40.4 t30 -75.99 60.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.133 1.773 . . . . 0.0 110.121 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.45 -35.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.089 1.356 . . . . 0.0 111.24 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -68.7 -5.94 23.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -134.26 18.8 3.7 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.068 1.347 . . . . 0.0 110.667 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.1 tp -79.2 -88.28 0.06 Allowed 'General case' 0 C--N 1.341 0.222 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.0 tp -68.95 -31.51 70.44 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.543 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.74 -22.58 47.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -124.33 -3.66 7.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.405 1.082 . . . . 0.0 112.072 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -122.21 2.15 9.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 113.023 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.62 -34.35 67.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.293 1.406 . . . . 0.0 111.38 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -61.14 -45.92 92.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.0 109.932 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.06 73.72 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.212 0.605 . . . . 0.0 111.443 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.3 -56.68 10.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.329 0.652 . . . . 0.0 109.707 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.35 -30.4 71.23 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.063 -0.398 . . . . 0.0 111.08 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -19.9 7.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.644 0.778 . . . . 0.0 112.855 175.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.9 m -130.57 14.63 5.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.878 1.271 . . . . 0.0 112.204 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -151.17 11.04 0.62 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 13.29 1.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.489 1.116 . . . . 0.0 111.888 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.7 m 68.09 7.88 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.171 2.188 . . . . 0.0 112.58 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.38 -20.63 60.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.357 1.063 . . . . 0.0 111.578 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.78 -0.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.239 1.015 . . . . 0.0 111.248 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 O-C-N 121.378 -0.826 . . . . 0.0 109.113 169.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -39.03 93.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.51 1.124 . . . . 0.0 111.051 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.84 -171.7 43.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.31 -8.95 57.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.231 0.516 . . . . 0.0 111.785 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -139.07 165.55 26.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.521 1.928 . . . . 0.0 106.828 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.3 t30 52.85 65.34 1.54 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 111.452 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.29 23.25 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.946 1.698 . . . . 0.0 110.263 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -139.33 162.12 35.78 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.469 1.107 . . . . 0.0 109.308 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -141.97 161.21 38.56 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.192 1.397 . . . . 0.0 109.213 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.79 -60.4 3.9 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.087 0.555 . . . . 0.0 109.677 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.72 -46.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.345 1.858 . . . . 0.0 109.586 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -143.2 42.28 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 111.322 -169.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.21 155.21 57.75 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 146.54 95.01 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.108 1.872 . . . . 0.0 113.256 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -63.24 170.51 2.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.427 1.891 . . . . 0.0 111.968 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.2 102.68 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.114 1.34 . . . . 0.0 111.35 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.37 165.99 22.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.766 1.227 . . . . 0.0 108.357 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.45 143.91 46.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -142.09 137.96 31.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.396 0.679 . . . . 0.0 109.815 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -83.27 134.6 34.93 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.42 151.71 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 119.212 0.914 . . . . 0.0 109.135 -173.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -140.46 150.97 44.46 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.643 1.177 . . . . 0.0 109.26 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -91.71 148.54 22.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 tp -144.63 109.46 5.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.06 -87.71 0.23 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.413 1.006 . . . . 0.0 111.326 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.23 32.46 0.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.245 1.418 . . . . 0.0 109.589 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.22 159.07 43.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.957 1.703 . . . . 0.0 107.794 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.76 153.74 37.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.918 1.342 . . . . 0.0 109.874 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -138.58 150.79 46.68 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.76 2.024 . . . . 0.0 106.867 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.93 157.3 19.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.8 134.25 42.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -48.66 116.67 1.7 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.394 1.078 . . . . 0.0 108.785 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.4 -34.75 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.513 0.725 . . . . 0.0 111.766 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.29 -24.53 67.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.795 0.838 . . . . 0.0 112.586 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -79.17 -24.0 43.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.48 0.582 . . . . 0.0 111.41 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -67.3 140.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -104.57 -59.57 1.72 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.118 0.967 . . . . 0.0 108.952 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.27 178.3 9.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.842 0.857 . . . . 0.0 110.222 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.58 146.69 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -148.51 176.5 10.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.389 1.475 . . . . 0.0 108.279 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.95 166.23 29.81 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.554 -0.716 . . . . 0.0 111.361 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -166.13 0.23 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.523 1.529 . . . . 0.0 112.28 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 67.34 27.89 8.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.455 1.902 . . . . 0.0 112.934 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 31.82 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.39 1.076 . . . . 0.0 109.72 174.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -75.74 116.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -60.85 -47.41 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 109.16 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 54.29 175.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.05 2.54 . . . . 0.0 113.106 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.52 155.86 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.55 -25.5 60.04 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -149.96 23.74 0.85 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.96 142.72 98.19 Favored Pre-proline 0 C--O 1.239 0.53 0 CA-C-O 119.019 -0.515 . . . . 0.0 109.743 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -61.41 148.67 92.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.953 2.435 . . . . 0.0 110.039 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.15 -24.87 67.84 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -61.17 -55.94 26.42 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.191 0.905 . . . . 0.0 109.702 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.421 HD12 ' HG2' ' A' ' 52' ' ' PRO . 70.4 mt -56.4 -37.0 48.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 C-N-CA 125.228 1.411 . . . . 0.0 109.993 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 58.54 -79.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.328 1.851 . . . . 0.0 107.768 -168.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.48 -132.61 2.19 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 121.358 1.89 . . . . 0.0 110.759 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.91 160.6 39.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 124.304 1.042 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -133.41 147.99 51.77 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -77.95 108.99 11.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.41 76.94 7.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.477 0.655 . . . . 0.0 109.854 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 49.88 29.04 3.09 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.023 1.329 . . . . 0.0 114.358 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.48 -19.43 2.81 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.671 1.129 . . . . 0.0 113.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.54 -169.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.842 1.321 . . . . 0.0 108.187 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.07 149.51 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.205 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.58 141.08 14.42 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.758 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.46 132.33 33.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.877 1.718 . . . . 0.0 109.682 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.61 119.21 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.46 154.04 9.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 125.589 1.556 . . . . 0.0 110.269 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -92.65 111.4 22.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.358 1.063 . . . . 0.0 110.545 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.71 -37.75 76.69 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -43.6 92.87 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 119.378 0.99 . . . . 0.0 109.484 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mt -69.8 -36.41 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.14 -31.16 67.38 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.208 0.913 . . . . 0.0 113.427 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -116.58 9.5 14.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.923 0.783 . . . . 0.0 112.376 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.6 m 47.92 41.74 15.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.279 1.032 . . . . 0.0 111.002 -172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -179.84 7.48 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.636 1.175 . . . . 0.0 109.51 -172.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -48.79 -84.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -173.57 106.04 0.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.034 1.334 . . . . 0.0 108.792 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.01 129.69 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.389 1.075 . . . . 0.0 108.266 169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.78 149.38 26.41 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.693 0.797 . . . . 0.0 108.92 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.6 36.9 0.07 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.252 2.221 . . . . 0.0 112.758 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.48 -9.86 0.16 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.476 2.31 . . . . 0.0 111.005 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.48 -4.69 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.061 1.344 . . . . 0.0 111.866 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.66 24.11 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -172.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -80.95 9.75 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 117.826 2.528 . . . . 0.0 117.826 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.6 160.49 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 120.276 1.398 . . . . 0.0 107.902 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.68 127.47 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.88 142.59 15.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.91 134.16 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.59 163.84 29.19 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.008 1.723 . . . . 0.0 109.183 -169.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 148.37 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.449 1.499 . . . . 0.0 107.651 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.4 152.31 25.68 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 50.51 -90.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.049 1.309 . . . . 0.0 113.508 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.78 23.81 2.07 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.221 1.809 . . . . 0.0 110.699 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -149.46 173.41 13.61 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.732 -1.23 . . . . 0.0 111.57 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.95 151.95 36.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 125.078 1.351 . . . . 0.0 108.654 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.85 172.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 125.008 1.323 . . . . 0.0 107.6 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.24 177.21 40.03 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.07 142.89 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 m -75.56 140.16 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.68 168.33 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.125 1.77 . . . . 0.0 109.01 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.64 -43.47 72.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.824 1.193 . . . . 0.0 109.978 171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.64 153.67 8.97 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.33 121.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -46.62 12.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.498 0.719 . . . . 0.0 111.15 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -169.29 179.5 3.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.143 0.977 . . . . 0.0 109.767 -168.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.98 136.3 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.86 1.664 . . . . 0.0 107.026 169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -142.58 174.4 10.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.814 1.245 . . . . 0.0 109.16 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.5 m -131.84 137.79 48.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -141.25 155.15 46.05 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.932 0.893 . . . . 0.0 109.277 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -126.99 158.37 37.07 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.871 1.668 . . . . 0.0 108.365 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.28 42.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -65.97 -41.64 90.93 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.187 -0.946 . . . . 0.0 109.787 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.95 -40.07 40.67 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.348 1.459 . . . . 0.0 110.462 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -91.37 99.17 9.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 74.8 mtt-85 -139.6 -53.35 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.144 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 33.6 Cg_endo -64.77 170.96 9.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.425 1.544 . . . . 0.0 111.623 173.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.18 30.25 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.261 1.424 . . . . 0.0 108.667 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -80.72 50.47 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.797 2.998 . . . . 0.0 110.371 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.73 16.76 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.272 1.429 . . . . 0.0 113.921 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -146.92 152.97 39.55 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.886 2.074 . . . . 0.0 108.134 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.62 42.36 23.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.176 1.39 . . . . 0.0 112.773 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 166.08 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.738 1.615 . . . . 0.0 108.744 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -35.66 10.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.011 0.525 . . . . 0.0 111.583 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.41 171.77 2.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.655 1.182 . . . . 0.0 112.971 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.9 m -121.6 168.53 11.65 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.043 1.337 . . . . 0.0 110.441 -170.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 p -52.93 -21.98 5.02 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.858 2.463 . . . . 0.0 115.829 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -85.79 -34.42 21.12 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.825 0.85 . . . . 0.0 110.892 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -91.88 -14.36 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.225 0.61 . . . . 0.0 110.208 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.47 136.87 43.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.797 2.439 . . . . 0.0 111.207 -172.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 145' ' ' VAL . 42.1 p -80.59 -170.3 2.54 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.45 2.3 . . . . 0.0 110.918 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.06 172.06 22.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 106.402 -2.679 . . . . 0.0 106.402 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 154.54 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.624 1.712 . . . . 0.0 110.289 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.44 175.03 31.99 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.81 157.04 19.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.811 0.844 . . . . 0.0 110.168 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.73 82.29 1.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.43 -51.39 2.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.489 1.995 . . . . 0.0 113.11 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.38 -31.9 0.09 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.058 2.143 . . . . 0.0 110.97 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -69.09 161.01 29.96 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 170.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -137.94 140.43 40.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -130.22 130.94 45.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.9 104.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.35 110.89 9.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.9 t -62.08 129.83 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -78.92 54.8 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.496 1.118 . . . . 0.0 109.669 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 tp -56.01 -35.82 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.449 1.5 . . . . 0.0 111.762 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -67.54 -19.73 65.32 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.558 . . . . 0.0 112.375 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -105.81 -22.52 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 117.47 -1.252 . . . . 0.0 111.866 171.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -48.42 -75.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 111.562 -170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.6 tp -78.51 -25.46 45.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.177 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.66 -27.05 67.53 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.759 1.163 . . . . 0.0 112.911 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.7 m -115.23 -8.03 12.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.684 1.193 . . . . 0.0 111.888 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -97.69 -7.25 31.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.984 1.266 . . . . 0.0 111.429 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -54.5 -46.31 73.44 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.999 1.727 . . . . 0.0 110.236 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.6 ptp -59.14 -25.81 64.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.271 1.028 . . . . 0.0 112.932 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.92 -26.0 16.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.049 1.739 . . . . 0.0 112.046 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.68 -56.8 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.05 0.94 . . . . 0.0 108.655 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.802 -0.561 . . . . 0.0 112.125 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -45.87 -42.15 12.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.567 1.547 . . . . 0.0 112.112 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 65.7 m -133.12 28.07 4.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.426 1.091 . . . . 0.0 110.892 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -141.29 31.49 1.73 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.338 1.455 . . . . 0.0 109.486 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.28 -4.53 22.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.456 1.103 . . . . 0.0 112.978 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.5 m 68.35 -24.17 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.18 2.192 . . . . 0.0 113.005 -171.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.16 -33.43 74.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.118 0.967 . . . . 0.0 110.15 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.44 -23.06 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 112.554 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 123.822 0.849 . . . . 0.0 110.477 -175.242 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p -130.55 6.97 4.83 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.842 1.257 . . . . 0.0 111.756 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.87 53.1 2.91 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.431 1.491 . . . . 0.0 112.744 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.69 -175.98 0.59 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.766 1.626 . . . . 0.0 110.233 174.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -62.0 -21.12 64.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.775 -1.203 . . . . 0.0 112.752 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -67.66 -10.92 56.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.685 0.794 . . . . 0.0 112.075 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t 67.38 -45.38 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 130.335 3.454 . . . . 0.0 112.079 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 m 45.1 -107.62 0.13 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.388 1.475 . . . . 0.0 109.637 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -156.95 167.06 31.6 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.37 2.268 . . . . 0.0 106.261 169.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.09 -50.45 72.74 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.523 1.129 . . . . 0.0 111.677 -170.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.39 -169.2 3.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -70.66 38.77 0.05 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.572 1.549 . . . . 0.0 113.316 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -59.24 150.19 64.43 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 125.462 1.505 . . . . 0.0 108.779 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 162.51 36.34 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.719 2.28 . . . . 0.0 114.221 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -127.5 28.77 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.715 1.206 . . . . 0.0 111.603 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.01 65.18 0.02 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.578 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -65.89 148.07 52.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -109.88 145.64 36.47 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -142.13 140.02 32.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.196 0.998 . . . . 0.0 110.736 -169.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.12 136.18 34.55 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 167.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -123.46 149.86 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.91 1.232 . . . . 0.0 109.223 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -141.17 152.09 44.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.244 1.018 . . . . 0.0 110.176 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.9 m -91.53 146.88 23.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 170.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -145.3 121.14 10.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.52 -98.62 0.21 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -141.67 37.09 1.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.211 1.404 . . . . 0.0 109.633 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.67 160.11 40.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.836 1.654 . . . . 0.0 107.92 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.3 152.54 44.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.093 1.425 . . . . 0.0 110.361 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.32 154.97 48.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.711 2.005 . . . . 0.0 107.459 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.32 159.13 21.31 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.904 1.24 . . . . 0.0 110.113 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mt -142.22 133.69 25.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -45.75 113.96 0.69 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.388 1.475 . . . . 0.0 109.082 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -53.05 -39.0 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.49 -16.84 64.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.225 0.92 . . . . 0.0 112.941 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -74.2 -24.74 59.4 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.753 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -64.78 140.89 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -120.37 -42.0 2.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.479 1.112 . . . . 0.0 110.511 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 169.54 24.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.585 1.154 . . . . 0.0 108.386 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.6 142.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -149.11 174.4 12.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.928 0.891 . . . . 0.0 108.633 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.04 25.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.66 126.04 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.37 159.0 2.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.754 . . . . 0.0 108.2 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.57 43.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.935 2.894 . . . . 0.0 116.18 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 t -74.22 107.97 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -76.12 95.01 3.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -71.38 142.75 50.33 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.452 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.0 mm -82.7 8.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.691 0.796 . . . . 0.0 110.099 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.26 -4.8 0.26 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.349 2.26 . . . . 0.0 115.511 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.99 14.75 1.34 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.054 1.342 . . . . 0.0 112.449 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.452 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -76.0 144.4 75.7 Favored Pre-proline 0 N--CA 1.448 -0.536 0 C-N-CA 124.259 1.024 . . . . 0.0 109.95 174.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.36 157.56 53.83 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.917 2.411 . . . . 0.0 109.274 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.53 -33.8 64.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.748 0.819 . . . . 0.0 112.728 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.91 -49.08 63.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.851 0.75 . . . . 0.0 110.549 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.54 -37.69 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.804 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? 48.58 -82.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.834 2.454 . . . . 0.0 111.352 -169.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.98 -164.87 14.06 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 120.726 1.603 . . . . 0.0 112.713 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.73 156.79 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 t -140.07 157.03 46.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.924 1.238 . . . . 0.0 109.622 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -78.62 101.84 7.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.911 1.284 . . . . 0.0 110.98 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.75 70.71 2.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 109.931 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 50.81 27.7 3.24 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.7 1.6 . . . . 0.0 114.227 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.6 -17.85 2.03 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.391 0.996 . . . . 0.0 113.263 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -171.45 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.723 1.261 . . . . 0.0 107.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 tp -132.18 150.4 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 O-C-N 120.768 -1.207 . . . . 0.0 110.202 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.87 141.5 14.97 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.676 -1.154 . . . . 0.0 109.289 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.1 131.08 24.28 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.884 1.723 . . . . 0.0 108.585 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.69 123.83 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.13 147.89 12.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.452 2.301 . . . . 0.0 107.117 -169.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.84 118.56 37.1 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.747 0.819 . . . . 0.0 109.562 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.28 -20.39 66.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.055 0.942 . . . . 0.0 113.195 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -56.02 -39.8 72.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.425 1.466 . . . . 0.0 109.434 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.33 12.2 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 109.763 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -131.83 -27.44 1.88 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.859 -1.151 . . . . 0.0 112.079 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.55 6.3 3.23 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.746 1.157 . . . . 0.0 113.718 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m 59.18 23.39 11.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -61.12 149.37 37.48 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.48 0.712 . . . . 0.0 111.674 -169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 m -24.25 -75.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 129.054 2.942 . . . . 0.0 117.506 -169.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -164.93 67.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.362 1.065 . . . . 0.0 109.758 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -50.84 140.57 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.21 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -160.52 165.62 30.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.677 1.191 . . . . 0.0 109.009 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -73.99 43.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.281 2.232 . . . . 0.0 111.157 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' H ' ' A' ' 84' ' ' ASP . 26.0 t30 -159.22 -19.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.85 3.26 . . . . 0.0 110.028 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.412 ' H ' ' H ' ' A' ' 83' ' ' ASN . 38.2 t70 -135.75 6.54 3.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.638 1.575 . . . . 0.0 111.501 -172.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -154.8 37.27 0.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.434 1.893 . . . . 0.0 109.05 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p -94.87 11.57 31.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.32 1.848 . . . . 0.0 115.751 -168.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.64 160.37 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.44 135.05 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -171.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 49.6 mt -115.89 127.03 73.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.73 134.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 mt -129.79 164.03 24.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.411 1.484 . . . . 0.0 108.209 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.01 157.3 44.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.867 0.867 . . . . 0.0 108.696 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.29 -178.05 4.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.18 97.35 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.896 1.236 . . . . 0.0 113.136 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 63.16 22.48 13.41 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.541 1.936 . . . . 0.0 115.282 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -147.2 161.94 39.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.79 1.632 . . . . 0.0 111.016 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.5 m -135.54 151.45 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 123.799 0.84 . . . . 0.0 110.396 -170.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.55 174.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.235 1.814 . . . . 0.0 106.673 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.45 176.55 40.33 Favored Glycine 0 N--CA 1.448 -0.541 0 O-C-N 120.201 -1.562 . . . . 0.0 110.28 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.46 149.4 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.827 0.851 . . . . 0.0 109.559 -169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 m -94.32 136.1 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.836 1.254 . . . . 0.0 108.86 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.02 166.02 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.608 1.563 . . . . 0.0 109.363 -169.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.52 -43.0 67.27 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.07 154.0 10.73 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.45 123.41 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -49.38 12.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.867 0.467 . . . . 0.0 110.79 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.56 179.73 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.67 1.188 . . . . 0.0 109.618 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.45 127.92 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 pp -156.17 177.68 11.16 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.837 1.255 . . . . 0.0 109.753 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -129.86 148.82 51.77 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.866 0.757 . . . . 0.0 112.179 -169.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 mp -139.96 145.89 38.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.175 1.39 . . . . 0.0 108.698 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -94.02 172.2 8.37 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 111.543 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.1 21.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.406 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.11 -39.36 12.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.704 1.202 . . . . 0.0 109.143 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -69.02 -41.6 77.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.821 0.848 . . . . 0.0 110.703 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -86.43 117.58 31.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -143.23 -64.32 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.562 0 CA-C-O 116.838 -1.554 . . . . 0.0 111.818 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.93 -175.1 1.97 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.243 1.962 . . . . 0.0 111.501 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.22 31.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.221 1.808 . . . . 0.0 107.978 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.69 149.63 61.3 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.203 1.935 . . . . 0.0 110.546 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.57 24.96 0.46 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.709 1.204 . . . . 0.0 110.549 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -76.82 34.67 0.15 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.191 1.796 . . . . 0.0 114.038 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.77 32.28 5.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.891 2.076 . . . . 0.0 113.608 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.67 -178.86 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.401 1.08 . . . . 0.0 109.755 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -8.63 8.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.483 1.513 . . . . 0.0 113.974 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.05 151.23 40.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.102 1.361 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -135.25 160.28 38.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.422 1.089 . . . . 0.0 108.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 p -62.07 -10.47 10.2 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -22.46 12.06 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.306 1.042 . . . . 0.0 111.365 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -84.8 -9.8 57.81 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.941 -0.475 . . . . 0.0 110.341 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.93 120.26 2.95 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.197 2.199 . . . . 0.0 112.327 -169.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 145' ' ' VAL . 41.1 p -75.91 -166.18 0.55 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.428 2.691 . . . . 0.0 111.431 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -132.74 175.18 20.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.48 143.59 39.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -152.32 170.14 31.56 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.7 154.49 29.45 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.22 1.008 . . . . 0.0 109.595 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.39 71.79 1.36 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.72 -38.64 1.27 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.894 2.188 . . . . 0.0 113.723 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.6 -34.92 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.99 2.116 . . . . 0.0 110.13 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -71.54 166.08 22.54 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -139.59 145.42 38.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -132.01 126.31 33.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.9 mt -79.7 110.88 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.07 105.64 11.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 132' ' ' THR . 58.0 t -60.15 120.89 6.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.52 60.33 2.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.305 0.574 . . . . 0.0 110.131 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 tp -53.17 -37.66 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.615 1.166 . . . . 0.0 111.018 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.35 -23.52 66.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.187 0.995 . . . . 0.0 112.312 -175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -110.56 -20.41 12.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 117.337 -1.316 . . . . 0.0 111.841 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.21 -61.67 2.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.782 1.173 . . . . 0.0 109.885 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.04 -48.37 63.05 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.82 -40.07 75.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.32 0.509 . . . . 0.0 111.83 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.2 m -80.89 -29.55 35.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.187 0.449 . . . . 0.0 111.568 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.01 -9.31 57.02 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.477 0.711 . . . . 0.0 111.125 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.99 -49.05 66.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.895 1.225 . . . . 0.0 112.089 -169.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.6 ptp -66.02 -31.41 72.28 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.868 -0.52 . . . . 0.0 112.056 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.2 59.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.339 1.056 . . . . 0.0 110.35 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.95 -49.24 78.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.089 1.356 . . . . 0.0 109.041 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.1 -24.61 63.09 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 123.796 0.839 . . . . 0.0 111.977 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.21 -22.06 64.42 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.281 0.946 . . . . 0.0 112.35 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.6 m -130.91 23.6 4.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 111.428 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.75 48.84 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.384 1.474 . . . . 0.0 108.476 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.71 14.74 1.22 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.172 1.389 . . . . 0.0 112.87 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.6 m 64.01 41.93 6.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.412 1.485 . . . . 0.0 108.882 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.08 -77.31 0.16 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.424 1.09 . . . . 0.0 109.117 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -65.66 -35.18 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 173.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.384 0 C-N-CA 129.59 3.156 . . . . 0.0 104.738 169.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 18.45 2.94 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.438 1.095 . . . . 0.0 110.297 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.54 -53.8 4.29 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 125.122 1.344 . . . . 0.0 111.2 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.7 mtm -58.11 -27.37 63.65 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.278 1.431 . . . . 0.0 111.42 174.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -70.94 -28.37 64.44 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.712 . . . . 0.0 112.443 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -87.62 16.05 6.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.853 1.261 . . . . 0.0 113.505 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.35 165.04 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 121.28 -0.887 . . . . 0.0 110.577 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.17 137.94 12.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.786 1.234 . . . . 0.0 109.661 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -122.68 109.32 14.12 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -169.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.26 -5.78 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.533 1.133 . . . . 0.0 112.667 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.17 20.7 2.79 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.628 1.571 . . . . 0.0 110.115 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 51.67 36.5 17.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.223 1.409 . . . . 0.0 111.669 -172.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.36 134.94 88.5 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 123.796 0.838 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.77 -42.07 5.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.563 2.175 . . . . 0.0 112.881 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.4 m -167.98 158.71 10.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 127.208 2.203 . . . . 0.0 106.951 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 88.48 0.29 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -75.52 170.17 16.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.737 0.815 . . . . 0.0 110.168 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.34 145.19 51.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.0 136.26 35.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.382 0.673 . . . . 0.0 110.136 -169.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.5 tp -78.44 133.94 37.42 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 167.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.28 148.14 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 119.324 0.965 . . . . 0.0 108.54 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -141.15 153.16 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.957 0.903 . . . . 0.0 110.125 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -93.55 145.92 24.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' CD1' HD21 ' A' ' 85' ' ' ASN . 56.4 tp -136.77 96.76 3.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.624 . . . . 0.0 107.5 173.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.48 -76.03 0.52 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.169 1.366 . . . . 0.0 111.907 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.08 30.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.285 1.434 . . . . 0.0 110.494 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.36 160.54 39.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 108.145 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -127.93 151.6 48.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.045 1.403 . . . . 0.0 110.824 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -137.33 156.84 47.76 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.878 2.071 . . . . 0.0 108.045 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.73 153.92 19.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.848 1.213 . . . . 0.0 110.419 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -136.63 130.99 47.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -48.65 120.36 3.71 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.94 -31.89 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.336 0.654 . . . . 0.0 111.595 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.99 -23.58 67.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.502 -0.749 . . . . 0.0 112.689 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -77.64 -22.91 49.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.928 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.94 140.2 20.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.637 1.108 . . . . 0.0 108.369 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 -40.67 2.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.522 1.129 . . . . 0.0 110.431 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -166.19 177.47 6.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.559 . . . . 0.0 107.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.86 135.6 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -120.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -170.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.85 164.07 32.77 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.732 1.634 . . . . 0.0 109.266 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -61.8 139.48 58.34 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -147.96 -65.31 0.25 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.465 0.306 . . . . 0.0 111.195 -174.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.48 72.84 0.55 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.491 1.116 . . . . 0.0 108.606 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.83 113.97 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 m -73.46 85.66 1.52 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -65.92 104.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 mm -69.82 148.04 11.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.85 -23.57 67.41 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -170.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.29 31.86 0.38 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -65.21 160.04 60.89 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.922 -1.111 . . . . 0.0 109.206 169.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -61.1 145.83 98.38 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.957 1.772 . . . . 0.0 108.176 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.72 -31.47 64.55 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -56.62 -41.91 77.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.227 0.467 . . . . 0.0 111.174 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.0 mt -92.23 89.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -51.7 -47.74 63.82 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.022 169.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.28 -177.04 28.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 119.977 1.262 . . . . 0.0 111.853 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 159.93 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 118.051 0.925 . . . . 0.0 109.788 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 t -141.24 158.56 43.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.519 1.054 . . . . 0.0 109.559 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -79.82 129.92 34.88 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.436 1.095 . . . . 0.0 110.233 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.19 84.42 2.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.902 1.281 . . . . 0.0 107.894 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 53.12 34.85 18.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.624 1.17 . . . . 0.0 113.425 169.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.1 -5.26 25.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.502 1.049 . . . . 0.0 112.974 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.72 177.49 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.153 1.781 . . . . 0.0 106.495 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -134.43 156.33 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 120.555 -1.341 . . . . 0.0 109.721 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -154.18 141.4 13.49 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.352 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.11 130.07 19.45 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.137 1.891 . . . . 0.0 108.747 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -106.85 135.88 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 108.422 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.61 139.35 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -96.26 104.49 16.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.312 1.045 . . . . 0.0 109.094 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -29.76 70.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.328 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -38.57 83.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.5 -36.82 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -71.72 -22.16 61.67 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.37 11.22 9.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.884 1.22 . . . . 0.0 112.842 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m 55.34 25.07 7.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.556 1.542 . . . . 0.0 113.023 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -68.77 161.62 28.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.878 0.871 . . . . 0.0 111.211 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.01 165.95 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 0.0 111.293 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.4 t70 45.05 68.14 0.61 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.106 2.962 . . . . 0.0 114.073 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.09 62.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.911 1.284 . . . . 0.0 109.5 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -143.54 164.67 29.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.61 1.164 . . . . 0.0 110.99 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -81.71 66.76 7.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 169.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.32 -60.16 0.27 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.076 1.351 . . . . 0.0 109.721 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.69 -38.86 73.73 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.014 0.825 . . . . 0.0 111.476 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.469 HD21 ' CD1' ' A' ' 24' ' ' LEU . 7.2 m120 -91.86 -79.31 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -169.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.7 p 60.67 -3.56 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.929 2.092 . . . . 0.0 116.073 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.68 144.97 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 120.468 1.485 . . . . 0.0 107.211 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -120.58 139.49 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.37 133.25 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.57 134.87 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.35 163.01 30.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.755 1.622 . . . . 0.0 108.839 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.28 145.03 35.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.006 1.723 . . . . 0.0 107.547 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -159.44 142.4 14.17 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.49 -85.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.567 1.556 . . . . 0.0 113.047 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -143.48 16.58 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.013 -170.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.2 177.98 9.41 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.153 -0.967 . . . . 0.0 112.089 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.97 157.41 38.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 110.027 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -160.39 169.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 126.205 1.802 . . . . 0.0 107.218 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.94 168.88 30.68 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.5 pt -140.72 147.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 123.966 0.906 . . . . 0.0 108.76 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.26 139.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.988 0.915 . . . . 0.0 109.16 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -142.86 156.68 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 108.736 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.26 -39.4 89.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.204 0.911 . . . . 0.0 110.578 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.96 162.56 20.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.62 117.97 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -49.26 42.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.194 0.597 . . . . 0.0 110.565 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -172.44 -174.82 1.26 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.292 1.437 . . . . 0.0 108.526 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.18 131.07 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.88 146.21 40.88 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.116 0.966 . . . . 0.0 109.604 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 p -84.8 144.43 28.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 109.568 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.08 138.48 29.92 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 p -77.57 153.86 32.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.19 -10.01 37.39 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.562 -0.711 . . . . 0.0 111.756 172.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.08 -30.78 70.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.687 1.195 . . . . 0.0 110.23 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -68.07 -41.45 81.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.908 0.776 . . . . 0.0 110.124 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.87 89.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.249 1.82 . . . . 0.0 109.315 -169.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -142.79 -60.24 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-O 116.809 -1.567 . . . . 0.0 112.846 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.13 176.8 4.24 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.944 1.762 . . . . 0.0 111.491 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.1 154.01 30.36 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.892 1.277 . . . . 0.0 109.38 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -80.6 50.04 3.42 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.417 3.411 . . . . 0.0 110.646 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.54 21.09 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.114 1.766 . . . . 0.0 114.621 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -142.81 146.96 34.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.973 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.32 6.95 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.08 2.152 . . . . 0.0 115.039 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 m -144.03 165.82 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.921 1.288 . . . . 0.0 109.457 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -0.38 13.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.739 1.216 . . . . 0.0 113.996 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.3 150.77 21.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.326 0.966 . . . . 0.0 110.59 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.6 m -136.67 147.71 46.98 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 p -57.13 -3.18 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.346 2.258 . . . . 0.0 116.015 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.91 -38.17 23.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.797 1.239 . . . . 0.0 110.575 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -132.16 1.74 3.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.71 1.604 . . . . 0.0 111.608 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.22 132.09 12.74 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.741 2.416 . . . . 0.0 109.963 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.1 p -80.93 -169.39 2.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.774 2.83 . . . . 0.0 111.875 -170.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.98 179.27 16.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.19 149.32 44.28 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 108.206 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.72 169.69 29.89 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 169.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.53 158.84 43.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.176 0.99 . . . . 0.0 110.644 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.5 mt -146.0 67.05 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.366 1.866 . . . . 0.0 107.483 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.34 2.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.168 1.842 . . . . 0.0 113.333 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.54 -32.82 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.695 1.998 . . . . 0.0 110.625 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -69.35 153.36 43.72 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 87.0 mtp -141.89 142.4 33.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -133.34 124.18 26.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.39 109.56 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -77.65 116.8 18.48 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -64.18 141.63 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.49 0.586 . . . . 0.0 109.92 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.43 57.25 3.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.805 0.812 . . . . 0.0 109.021 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.34 -38.69 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.428 1.491 . . . . 0.0 112.732 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -67.71 -7.06 23.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.807 0.843 . . . . 0.0 113.204 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -133.1 23.48 4.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.231 1.412 . . . . 0.0 110.232 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.41 -90.96 0.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -32.34 71.89 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -59.17 -20.55 54.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -117.63 4.21 12.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.064 0.945 . . . . 0.0 112.22 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -113.47 -9.65 13.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.651 1.18 . . . . 0.0 111.35 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.43 -39.28 83.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.117 1.326 . . . . 0.0 111.452 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.5 ptp -59.07 -23.73 62.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 112.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.43 -29.04 12.98 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.801 1.64 . . . . 0.0 111.484 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.9 -62.19 2.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.424 1.09 . . . . 0.0 109.438 170.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -18.26 60.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.09 -168.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -52.89 -22.1 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 169.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.3 m -124.82 -41.28 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.338 1.055 . . . . 0.0 111.415 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.93 -4.33 56.36 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.35 18.33 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.17 1.35 . . . . 0.0 111.833 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.5 m 69.9 16.3 7.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.768 2.027 . . . . 0.0 111.723 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.66 -32.54 71.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.726 0.81 . . . . 0.0 109.81 169.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -132.06 -41.33 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.651 1.58 . . . . 0.0 109.631 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.694 175.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.6 p -77.33 -34.11 55.38 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.59 -0.694 . . . . 0.0 110.307 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 119.15 -43.06 1.64 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.994 -2.043 . . . . 0.0 107.994 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.49 -28.85 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.065 -0.668 . . . . 0.0 110.445 170.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -54.13 -17.34 2.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.55 1.54 . . . . 0.0 114.012 171.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -66.95 -22.42 65.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.147 0.885 . . . . 0.0 113.219 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.1 167.86 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.207 0.912 . . . . 0.0 111.421 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.5 167.61 10.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 tt -141.64 81.46 1.77 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.69 -13.1 0.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.774 1.629 . . . . 0.0 112.141 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.02 27.95 1.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.196 2.198 . . . . 0.0 108.493 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -141.47 159.84 59.12 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.477 1.911 . . . . 0.0 109.033 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 132.59 31.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.723 2.282 . . . . 0.0 112.016 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 m -62.62 161.55 12.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.132 1.373 . . . . 0.0 111.591 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.67 111.56 4.01 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 106.618 -2.593 . . . . 0.0 106.618 169.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -134.95 165.81 24.47 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.635 1.974 . . . . 0.0 110.412 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -111.16 147.78 34.17 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.34 137.49 32.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.186 0.994 . . . . 0.0 108.927 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.7 tp -78.64 137.04 37.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.01 147.99 30.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 119.579 1.082 . . . . 0.0 108.824 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -143.12 156.48 44.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.313 1.045 . . . . 0.0 110.168 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.5 m -95.8 145.3 25.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -159.95 129.99 5.43 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 125.791 1.636 . . . . 0.0 106.904 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.69 39.78 87.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.323 0.963 . . . . 0.0 113.509 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.5 37.43 19.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.144 1.778 . . . . 0.0 111.751 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -144.46 162.1 37.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.716 2.006 . . . . 0.0 107.058 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -118.39 152.73 35.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.819 1.295 . . . . 0.0 110.496 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -138.99 161.65 36.85 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.016 2.126 . . . . 0.0 107.72 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.75 164.11 27.15 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.407 0.527 . . . . 0.0 112.398 169.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.2 mt -143.65 138.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -46.41 119.08 2.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.426 1.091 . . . . 0.0 109.261 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.44 -32.47 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.481 0.712 . . . . 0.0 111.865 -170.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.98 -21.11 66.79 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.468 -0.77 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -23.47 60.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.261 0.937 . . . . 0.0 111.786 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.43 143.02 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 119.021 0.828 . . . . 0.0 109.377 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -106.67 -59.53 1.79 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.563 1.145 . . . . 0.0 108.41 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.65 177.57 10.35 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 109.774 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.32 147.67 32.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -149.8 164.74 34.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.974 2.11 . . . . 0.0 106.805 -170.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.75 168.46 51.2 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.04 -1.037 . . . . 0.0 110.817 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -74.16 109.6 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -162.81 154.57 18.08 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.411 1.484 . . . . 0.0 107.783 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 26.99 56.75 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.066 2.546 . . . . 0.0 115.119 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.45 97.47 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 167.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -50.94 -41.07 58.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.522 1.129 . . . . 0.0 110.461 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 52.99 -179.81 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.402 1.881 . . . . 0.0 111.763 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 51' ' ' THR . 16.4 mm -132.7 159.48 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.16 68.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.12 36.0 0.43 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.869 0.868 . . . . 0.0 112.688 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' HB ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -55.51 145.31 49.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.312 -0.868 . . . . 0.0 111.219 173.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.22 161.69 29.51 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.563 2.842 . . . . 0.0 111.316 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.1 50.22 0.47 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.172 1.789 . . . . 0.0 113.352 -170.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -157.46 -46.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.228 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.3 mt -49.19 -42.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.275 1.03 . . . . 0.0 110.745 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.4 tttp 57.41 -81.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.888 2.075 . . . . 0.0 108.97 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.35 -160.11 10.07 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 120.705 1.593 . . . . 0.0 114.469 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.89 153.78 27.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.7 t -139.22 150.38 45.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.925 0.784 . . . . 0.0 110.48 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -79.21 89.86 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.869 1.668 . . . . 0.0 110.715 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.75 90.1 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.019 0.528 . . . . 0.0 110.107 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 49.62 29.36 3.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.691 1.196 . . . . 0.0 114.004 168.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.71 -3.67 14.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.683 1.135 . . . . 0.0 114.098 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.16 -174.39 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.839 1.656 . . . . 0.0 107.445 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 tp -130.62 151.39 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.535 -1.353 . . . . 0.0 110.587 -172.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.27 143.38 16.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.532 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.44 129.47 21.47 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.748 1.632 . . . . 0.0 108.323 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.62 114.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.93 172.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.402 2.281 . . . . 0.0 106.232 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -138.45 124.75 20.42 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.611 -1.306 . . . . 0.0 108.749 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -62.45 -27.97 69.48 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.376 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.92 -39.11 53.87 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.189 0.904 . . . . 0.0 111.032 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.12 -41.63 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -81.65 -7.65 59.62 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.448 -0.782 . . . . 0.0 112.874 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.85 -12.66 14.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.285 0.948 . . . . 0.0 113.13 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m 53.46 35.18 19.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.532 1.06 . . . . 0.0 111.82 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.46 162.53 15.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.524 -0.735 . . . . 0.0 110.578 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -37.82 -92.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 128.258 2.623 . . . . 0.0 115.865 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -163.87 84.01 0.45 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.789 1.236 . . . . 0.0 108.997 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -51.16 139.02 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.086 0.954 . . . . 0.0 110.523 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.27 167.95 26.4 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.688 1.595 . . . . 0.0 108.51 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -70.25 50.78 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.355 1.462 . . . . 0.0 111.92 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.406 ' H ' ' H ' ' A' ' 84' ' ' ASP . 48.8 t30 -159.58 -16.09 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.758 3.223 . . . . 0.0 110.557 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 83' ' ' ASN . 33.2 t70 -141.3 3.4 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.771 1.628 . . . . 0.0 111.692 -176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -150.21 37.13 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.434 -1.416 . . . . 0.0 109.662 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.8 p -96.14 0.14 50.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.662 1.585 . . . . 0.0 114.494 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.2 t -134.49 159.76 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.591 1.157 . . . . 0.0 108.153 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.84 131.1 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 107.051 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.63 137.62 28.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.08 135.41 53.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -136.32 166.8 22.61 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.659 1.183 . . . . 0.0 109.854 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -139.3 131.91 28.86 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 92' ' ' ASN . 5.3 mp -135.73 124.47 23.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -168.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.87 -81.91 0.12 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.909 0.766 . . . . 0.0 112.564 172.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -147.42 13.92 1.09 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.223 1.809 . . . . 0.0 110.669 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -143.5 174.43 10.77 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.466 1.106 . . . . 0.0 110.246 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.71 155.52 26.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.859 0.864 . . . . 0.0 109.592 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.18 175.27 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 126.189 1.796 . . . . 0.0 107.01 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.65 178.47 41.03 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.29 146.93 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.47 146.41 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -149.78 168.17 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 126.433 1.893 . . . . 0.0 108.893 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.79 -42.09 64.29 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.389 -0.819 . . . . 0.0 109.811 169.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.85 154.93 9.64 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.97 124.34 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 172.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -40.85 13.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.1 0.56 . . . . 0.0 111.056 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB2' HH22 ' A' ' 140' ' ' ARG . 5.8 t0 -168.04 -177.24 3.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.865 0.466 . . . . 0.0 110.882 -168.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.19 124.14 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.4 mt -140.91 171.8 13.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.703 1.201 . . . . 0.0 109.815 -168.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.4 m -126.45 134.31 50.99 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.682 0.674 . . . . 0.0 110.699 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.23 160.35 39.68 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.125 0.97 . . . . 0.0 110.194 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -145.18 161.32 39.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.23 1.412 . . . . 0.0 109.297 -168.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.22 -25.26 13.45 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.7 -38.15 86.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.073 -1.017 . . . . 0.0 109.669 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -83.07 -37.92 23.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 110.969 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.58 108.93 22.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -146.53 -58.67 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.075 -175.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 41.5 Cg_endo -67.67 173.29 9.21 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.11 1.873 . . . . 0.0 112.052 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.07 162.27 27.07 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.215 1.806 . . . . 0.0 108.335 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.46 -54.98 2.42 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.991 2.461 . . . . 0.0 112.723 -175.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 53.37 -21.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 130.392 3.477 . . . . 0.0 117.969 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -144.49 159.93 41.94 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.305 1.442 . . . . 0.0 109.582 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 50.6 36.07 13.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.523 1.529 . . . . 0.0 112.758 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.39 155.75 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 108.121 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -35.39 76.57 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.562 0.745 . . . . 0.0 111.304 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.4 170.44 4.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.981 1.713 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.9 m -140.83 178.98 6.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.368 2.267 . . . . 0.0 107.276 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 -27.87 2.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.571 2.349 . . . . 0.0 114.227 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.83 -18.94 62.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.422 1.489 . . . . 0.0 112.344 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.17 23.3 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.33 1.852 . . . . 0.0 109.762 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.92 115.05 27.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.482 1.513 . . . . 0.0 111.604 -169.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 145' ' ' VAL . 44.8 p -72.27 -179.1 2.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.048 2.539 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -121.84 172.93 15.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.943 -2.463 . . . . 0.0 106.943 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.25 157.64 43.52 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.329 1.565 . . . . 0.0 110.329 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.07 179.57 38.21 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.22 157.44 23.69 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.24 1.016 . . . . 0.0 111.071 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.18 81.3 1.67 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.59 -51.61 2.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.6 2.047 . . . . 0.0 113.012 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.01 -32.02 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 111.043 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 107' ' ' ASP . 62.1 mtp180 -69.49 162.56 27.22 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.7 mtp -139.49 145.96 39.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.9 mt -134.24 130.15 36.72 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.9 mt -84.07 100.94 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.45 118.03 20.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.414 ' HA ' HG22 ' A' ' 132' ' ' THR . 61.5 t -63.54 137.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -72.92 52.75 0.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.479 1.112 . . . . 0.0 110.077 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.83 -40.56 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.505 1.522 . . . . 0.0 114.784 -168.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.97 -20.91 51.79 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.669 -1.27 . . . . 0.0 111.432 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -41.96 21.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.7 tp -50.6 -45.0 57.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 110.184 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.29 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.714 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -75.93 -56.23 4.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 m -54.46 -46.24 73.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 110.425 -176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -74.33 -20.57 60.06 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.135 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.44 -47.02 80.65 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 122.122 2.237 . . . . 0.0 110.102 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.0 mtm -65.19 -45.95 82.72 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.85 96.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.279 -0.391 . . . . 0.0 111.074 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.3 -60.42 3.88 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.949 1.299 . . . . 0.0 109.548 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -27.98 68.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.992 -169.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.63 -23.15 26.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.317 0.647 . . . . 0.0 112.676 174.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.3 m -131.56 22.31 4.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.039 1.336 . . . . 0.0 111.705 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.07 46.3 0.68 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.447 1.499 . . . . 0.0 108.846 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.15 13.59 1.43 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.061 1.344 . . . . 0.0 112.983 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.6 m 63.3 41.49 7.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.328 1.451 . . . . 0.0 108.96 -169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -150.37 -77.55 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 108.694 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.41 -34.56 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.754 0.822 . . . . 0.0 110.568 173.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 C-N-CA 129.558 3.143 . . . . 0.0 104.692 169.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 m -143.91 148.12 34.95 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.56 -19.88 0.1 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.238 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.89 -32.02 60.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.996 1.898 . . . . 0.0 112.388 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 p -124.92 18.73 8.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.806 1.642 . . . . 0.0 110.391 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -151.83 46.6 0.78 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.825 2.05 . . . . 0.0 106.965 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -50.64 -31.11 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -168.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m 42.22 62.63 1.6 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.305 1.442 . . . . 0.0 110.765 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' A' ' 11' ' ' ALA . 50.4 tttp -58.25 144.25 41.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.469 -171.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -120.08 -7.62 9.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.78 1.632 . . . . 0.0 110.607 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 62.45 15.71 8.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.066 2.146 . . . . 0.0 111.854 -169.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -157.81 21.33 0.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.482 1.913 . . . . 0.0 110.416 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -67.0 142.37 97.29 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.511 0.725 . . . . 0.0 109.969 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.95 132.97 25.84 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.69 2.26 . . . . 0.0 111.485 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -66.41 163.11 19.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.722 1.209 . . . . 0.0 110.937 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.53 112.27 4.86 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -135.3 166.97 21.89 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.167 1.787 . . . . 0.0 110.655 -169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -117.79 148.52 41.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.78 135.45 29.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.918 0.887 . . . . 0.0 109.296 -169.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.9 tp -77.21 134.66 38.56 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 168.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.6 m -121.57 149.21 24.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.778 1.172 . . . . 0.0 109.127 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.65 150.86 44.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.477 1.111 . . . . 0.0 109.696 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.3 m -91.43 147.46 23.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 tp -140.73 101.41 4.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.37 -76.26 0.19 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.512 1.53 . . . . 0.0 112.026 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.17 31.13 0.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.428 1.491 . . . . 0.0 110.657 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.77 160.54 39.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.941 1.696 . . . . 0.0 107.952 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -119.89 153.57 35.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.191 1.472 . . . . 0.0 110.846 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -140.51 159.43 42.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.532 2.333 . . . . 0.0 107.274 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 21' ' ' VAL . . . -140.55 164.26 26.34 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 118.669 0.668 . . . . 0.0 111.989 170.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 mt -142.29 135.85 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -49.0 115.81 1.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.664 1.186 . . . . 0.0 108.983 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.37 -34.12 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.438 0.695 . . . . 0.0 111.697 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.63 -24.92 67.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.759 0.824 . . . . 0.0 112.668 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -84.83 -18.64 34.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.813 0.733 . . . . 0.0 112.061 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.87 136.8 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -100.44 -56.44 2.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 108.912 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -162.31 -179.18 6.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.526 1.13 . . . . 0.0 109.75 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -136.2 147.09 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -145.28 169.38 18.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.154 1.382 . . . . 0.0 108.297 -172.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.66 148.85 19.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -82.03 100.69 9.88 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.81 1.244 . . . . 0.0 107.922 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -160.3 165.99 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.6 1.96 . . . . 0.0 106.587 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . 0.299 1.0 OUTLIER 42.91 30.02 0.22 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.582 2.753 . . . . 0.0 117.498 171.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.01 127.92 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 112.691 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 45.34 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.67 2.388 . . . . 0.0 110.689 -169.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.0 mm -57.37 153.43 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -18.37 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.43 23.27 0.72 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.53 155.57 67.64 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.519 0.728 . . . . 0.0 110.079 169.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -61.98 161.17 26.83 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.387 2.058 . . . . 0.0 109.01 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.52 80.6 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.674 -172.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -59.89 -41.08 90.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.195 0.907 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 158' ' ' LEU . 37.8 mt -71.81 82.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -53.18 -30.61 38.39 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.629 1.172 . . . . 0.0 109.455 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.98 -151.5 22.45 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.85 154.92 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -136.01 145.96 46.64 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.99 92.89 5.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.45 175.62 1.31 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp-105 -69.54 59.49 0.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.87 1.668 . . . . 0.0 113.249 -169.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.86 -6.89 3.51 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.168 2.318 . . . . 0.0 113.389 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.6 OUTLIER -153.71 -165.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.375 1.588 . . . . 0.0 108.458 -169.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . 4.6 tp -121.1 158.75 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.094 1.758 . . . . 0.0 108.403 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.82 142.39 15.43 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.817 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.15 147.18 59.78 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.408 2.072 . . . . 0.0 110.745 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -131.32 148.16 32.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.721 0.808 . . . . 0.0 109.04 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.84 137.31 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -95.7 124.74 39.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.78 -18.83 64.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.361 0.664 . . . . 0.0 111.98 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -60.23 -31.44 70.19 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.839 -1.163 . . . . 0.0 109.624 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.64 -47.83 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -71.79 -33.08 68.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.859 -1.067 . . . . 0.0 113.581 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.432 ' CD1' HD22 ' A' ' 126' ' ' LEU . 16.0 m-30 -121.55 3.05 10.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.816 1.189 . . . . 0.0 112.552 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.3 m 58.67 29.59 18.78 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.986 0.812 . . . . 0.0 111.317 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -57.06 142.03 43.72 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.726 0.81 . . . . 0.0 110.41 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.22 140.47 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 122.092 0.949 . . . . 0.0 111.946 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 24.68 60.55 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 130.734 3.614 . . . . 0.0 115.557 168.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.5 146.92 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -160.33 162.27 33.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.678 0.791 . . . . 0.0 109.251 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.77 40.68 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.872 2.469 . . . . 0.0 111.562 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -155.28 -25.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.837 2.455 . . . . 0.0 110.978 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -135.32 9.32 3.45 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 111.491 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.12 36.71 0.43 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.602 1.961 . . . . 0.0 108.478 -177.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 p -73.41 4.88 4.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.81 165.23 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.986 1.721 . . . . 0.0 108.948 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -141.06 140.8 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.283 1.833 . . . . 0.0 106.236 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.0 134.87 56.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.62 134.13 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.46 161.62 34.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.469 1.508 . . . . 0.0 108.316 -169.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.56 148.65 39.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.38 127.34 29.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 52.35 -99.1 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 CA-C-N 118.609 0.641 . . . . 0.0 111.791 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -129.64 20.94 5.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.347 1.459 . . . . 0.0 111.863 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.72 166.32 22.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.479 1.112 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.89 153.03 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.525 1.13 . . . . 0.0 109.883 -171.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -160.28 176.51 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.819 1.648 . . . . 0.0 107.05 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 176.82 38.97 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 120.538 -1.351 . . . . 0.0 111.025 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.2 pt -141.79 154.1 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 124.396 1.078 . . . . 0.0 109.032 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.05 137.2 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.321 1.048 . . . . 0.0 108.304 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.25 168.09 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.15 1.38 . . . . 0.0 110.38 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.28 -40.99 64.14 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.856 -1.153 . . . . 0.0 110.619 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.31 154.53 9.52 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.83 128.23 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.47 -43.29 9.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.236 0.615 . . . . 0.0 111.321 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -168.36 -174.32 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.739 0.816 . . . . 0.0 109.874 -168.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.0 t -134.19 129.61 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -138.21 169.75 17.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.867 1.267 . . . . 0.0 109.309 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 m -129.24 134.93 48.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.446 0.566 . . . . 0.0 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.19 160.25 41.26 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.815 1.246 . . . . 0.0 109.579 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -144.06 172.7 12.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.81 2.044 . . . . 0.0 107.347 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.6 0.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -78.1 -45.42 23.46 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 120.182 1.355 . . . . 0.0 108.669 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -84.31 -32.68 24.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.111 1.364 . . . . 0.0 111.656 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.93 121.67 50.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 13.7 mmt180 -147.96 -54.86 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.604 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 52.0 Cg_endo -69.28 -178.78 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.114 1.876 . . . . 0.0 111.981 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.27 32.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.694 1.598 . . . . 0.0 109.36 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.01 58.09 6.78 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.052 3.168 . . . . 0.0 111.704 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 30.07 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.297 1.439 . . . . 0.0 112.456 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.91 30.26 0.11 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.236 2.215 . . . . 0.0 113.865 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.47 31.81 4.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.882 2.073 . . . . 0.0 113.456 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 m -78.33 175.88 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -57.05 -17.38 9.96 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 75' ' ' PHE . 15.7 tp -78.05 -29.34 49.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.564 0.746 . . . . 0.0 112.921 177.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.1 m -70.91 78.02 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.731 1.612 . . . . 0.0 111.003 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.2 p -140.21 -102.01 0.15 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.374 1.069 . . . . 0.0 112.279 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.31 -36.18 0.41 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 127.333 2.253 . . . . 0.0 109.895 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -78.92 15.49 1.08 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.8 137.6 20.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.806 2.042 . . . . 0.0 109.896 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 145' ' ' VAL . 51.8 p -81.91 -168.86 2.09 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.823 2.049 . . . . 0.0 109.877 -174.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.52 177.03 18.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 171.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -140.54 140.72 35.27 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.725 1.21 . . . . 0.0 107.783 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.73 173.97 30.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.84 155.11 50.83 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.69 0.796 . . . . 0.0 110.8 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.2 mt -142.31 78.11 1.61 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.002 1.721 . . . . 0.0 107.38 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.94 -51.48 3.15 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.43 1.967 . . . . 0.0 112.833 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.02 -30.56 0.22 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.278 1.831 . . . . 0.0 111.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -69.79 153.51 43.23 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 171.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.94 140.72 40.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.36 115.2 15.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.7 mt -75.61 107.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.67 111.44 21.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 t -65.17 126.28 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -76.43 56.89 1.13 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.674 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.66 -35.0 48.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.035 1.334 . . . . 0.0 111.51 -170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.77 -18.43 64.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.301 0.64 . . . . 0.0 112.348 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.99 -15.59 14.32 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 116.917 -1.516 . . . . 0.0 112.003 170.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.25 -63.91 1.03 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.932 1.696 . . . . 0.0 110.668 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.37 -39.55 81.72 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -60.1 -43.81 95.3 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.663 1.12 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -73.38 -16.22 61.35 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.902 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -115.58 -0.29 13.08 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.702 -1.142 . . . . 0.0 113.43 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -49.72 -53.1 26.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.022 1.737 . . . . 0.0 111.819 -173.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -28.63 68.44 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.62 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.551 1.069 . . . . 0.0 111.167 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 55' ' ' ILE . 23.4 tp -59.77 -53.04 62.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.727 1.211 . . . . 0.0 108.46 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.07 -11.88 61.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 118.127 -0.94 . . . . 0.0 112.389 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -54.27 -27.19 33.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.028 1.286 . . . . 0.0 110.965 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 m -115.33 -44.5 2.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.936 0.894 . . . . 0.0 110.827 169.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.89 5.33 4.25 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 13.6 0.31 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.356 0.98 . . . . 0.0 111.52 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.5 m 59.46 39.84 21.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.13 1.772 . . . . 0.0 110.326 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.39 -43.1 3.08 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.324 0.65 . . . . 0.0 111.377 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.64 -27.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.658 0.383 . . . . 0.0 110.193 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.51 1.524 . . . . 0.0 107.566 171.857 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 tpp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.28 149.68 33.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.77 56.58 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.44 161.9 18.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.999 0.919 . . . . 0.0 110.11 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -60.48 -20.1 58.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.781 1.232 . . . . 0.0 113.04 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -74.71 55.7 0.68 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 110.297 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -56.72 -26.93 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.918 1.287 . . . . 0.0 113.323 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m 47.4 51.98 12.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.808 1.243 . . . . 0.0 111.536 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 37.27 -139.07 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.977 2.111 . . . . 0.0 112.548 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.31 -66.33 0.56 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.65 -159.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.774 2.429 . . . . 0.0 105.783 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -70.44 32.53 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.355 1.462 . . . . 0.0 114.353 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.19 126.28 88.83 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.29 1.436 . . . . 0.0 108.488 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.82 134.82 24.5 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.268 1.312 . . . . 0.0 108.713 169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.2 m -61.71 158.32 15.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.065 0.936 . . . . 0.0 111.981 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.69 96.62 0.67 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.08 138.85 58.58 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.34 143.81 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.67 139.56 33.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.997 0.919 . . . . 0.0 109.346 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 tp -83.37 130.24 35.04 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.2 152.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 109.317 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.27 153.59 45.3 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.544 1.138 . . . . 0.0 109.596 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -93.4 144.78 25.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -133.03 88.28 2.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.695 1.598 . . . . 0.0 106.742 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.75 -70.15 0.4 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.935 1.731 . . . . 0.0 112.755 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -151.24 27.73 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.37 1.468 . . . . 0.0 111.223 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.75 161.71 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.579 1.552 . . . . 0.0 108.154 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.82 150.2 46.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.464 1.126 . . . . 0.0 109.663 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -141.16 155.19 46.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.409 1.884 . . . . 0.0 107.507 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.97 158.68 22.99 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.425 1.012 . . . . 0.0 110.584 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.58 140.62 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -49.89 117.26 2.2 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.83 0.852 . . . . 0.0 109.993 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.75 -30.56 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.457 0.703 . . . . 0.0 111.569 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 mt -66.43 -4.88 9.16 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -109.88 -13.52 14.43 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 112.878 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.51 142.17 17.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 119.548 1.067 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -103.68 -57.71 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 169.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.22 -179.37 6.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.7 1.2 . . . . 0.0 109.295 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.57 149.51 31.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -143.59 174.32 10.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.28 1.432 . . . . 0.0 107.743 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.0 161.59 26.9 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 169.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.19 129.19 39.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.78 -43.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.7 41.19 0.77 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.61 135.86 26.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -123.43 92.33 3.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.17 111.66 5.26 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.2 -45.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.207 -170.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 144.73 -62.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.461 3.504 . . . . 0.0 108.696 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.82 18.47 22.08 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.673 1.189 . . . . 0.0 112.544 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.53 155.77 2.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.74 1.616 . . . . 0.0 110.003 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.24 146.65 49.0 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.726 1.617 . . . . 0.0 108.641 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.52 -33.0 74.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.581 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -53.63 -42.5 67.84 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.976 0.807 . . . . 0.0 109.959 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.9 87.17 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -49.77 -32.09 13.04 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.317 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.62 -162.32 35.74 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -114.49 145.15 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -136.55 161.03 37.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 119.801 1.182 . . . . 0.0 109.178 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -80.31 108.94 14.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.759 0.823 . . . . 0.0 110.125 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.72 171.81 14.09 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.62 55.19 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.76 1.624 . . . . 0.0 112.831 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.01 -11.76 1.24 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.392 2.425 . . . . 0.0 113.743 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -151.56 -159.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 119.87 1.835 . . . . 0.0 108.828 -169.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.2 tp -121.36 155.35 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.839 1.655 . . . . 0.0 109.12 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.89 139.94 15.16 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.404 1.081 . . . . 0.0 109.314 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 141.26 47.22 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.228 1.952 . . . . 0.0 109.774 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 tp -126.09 138.03 55.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.491 1.117 . . . . 0.0 108.602 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.12 130.44 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.11 119.47 25.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.55 -18.98 64.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.135 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -33.99 70.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 121.007 1.73 . . . . 0.0 110.278 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.03 0.89 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.51 1.124 . . . . 0.0 109.065 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -116.29 -30.6 5.89 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.757 -1.214 . . . . 0.0 111.616 172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -136.78 0.06 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 m 54.06 50.53 16.43 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.137 1.335 . . . . 0.0 111.941 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -54.94 169.28 0.23 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.469 1.108 . . . . 0.0 112.85 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.48 -66.46 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.391 1.477 . . . . 0.0 112.108 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.24 98.14 0.35 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 0.0 109.255 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.21 139.95 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.6 137.11 15.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.964 0.905 . . . . 0.0 109.351 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -73.23 34.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.118 2.167 . . . . 0.0 113.049 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -13.37 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.182 2.193 . . . . 0.0 110.636 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.01 8.63 4.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.628 1.171 . . . . 0.0 111.827 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.59 35.97 0.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.048 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -100.31 16.77 23.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -168.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.15 157.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.009 1.277 . . . . 0.0 107.68 173.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.43 111.65 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 mt -84.05 143.08 12.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.02 131.7 72.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.8 mt -134.18 166.15 23.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.957 1.703 . . . . 0.0 108.272 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.63 156.05 49.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.499 0.72 . . . . 0.0 109.845 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.54 96.93 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.51 -73.22 0.77 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.511 0.596 . . . . 0.0 113.752 174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -143.31 7.14 1.54 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.951 2.1 . . . . 0.0 111.879 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -137.73 161.99 35.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.77 1.628 . . . . 0.0 108.288 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.79 151.18 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -157.07 170.93 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.988 1.715 . . . . 0.0 106.92 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.83 176.96 37.4 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 120.77 -1.206 . . . . 0.0 111.233 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.9 pt -145.68 144.97 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.106 0.962 . . . . 0.0 109.147 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.7 m -89.51 133.71 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.025 0.93 . . . . 0.0 109.119 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.08 169.59 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.34 1.456 . . . . 0.0 109.83 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.84 -43.85 67.67 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 170.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.05 156.15 11.3 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 m -71.93 123.84 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -53.97 6.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 109.857 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -174.48 177.31 2.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.015 1.726 . . . . 0.0 108.533 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.46 133.38 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.158 1.783 . . . . 0.0 107.481 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.87 178.26 10.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.936 1.294 . . . . 0.0 109.397 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 m -129.94 150.55 51.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.303 0.501 . . . . 0.0 111.91 -171.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -140.49 141.7 35.34 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.413 1.485 . . . . 0.0 107.227 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.8 p -76.95 162.71 27.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.356 0.598 . . . . 0.0 109.993 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.21 7.24 1.34 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.814 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -101.9 -37.32 8.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.719 2.008 . . . . 0.0 109.131 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.53 -41.26 98.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.559 1.544 . . . . 0.0 106.891 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -144.23 -70.99 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.463 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.41 -174.35 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.4 2.067 . . . . 0.0 111.314 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.91 55.6 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.657 1.583 . . . . 0.0 108.929 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -82.58 38.45 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 124.133 3.222 . . . . 0.0 111.053 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.18 21.0 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.381 1.472 . . . . 0.0 114.135 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -137.52 144.74 42.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.674 1.19 . . . . 0.0 110.314 -171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.11 35.94 14.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.506 1.922 . . . . 0.0 114.479 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.24 176.84 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.42 1.488 . . . . 0.0 109.074 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -9.9 50.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 113.495 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.42 153.38 43.03 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.845 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -144.97 165.86 26.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.59 1.156 . . . . 0.0 109.318 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.7 p -56.14 -28.72 59.04 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.169 1.388 . . . . 0.0 113.119 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.88 -29.09 67.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.572 0.749 . . . . 0.0 112.148 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -123.67 -1.12 8.51 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.226 1.011 . . . . 0.0 112.892 -168.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.27 0.9 OUTLIER -61.71 164.87 5.64 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.378 1.085 . . . . 0.0 112.937 -171.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 145' ' ' VAL . 39.8 p -122.05 -159.47 0.82 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.142 1.777 . . . . 0.0 109.346 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.83 23.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 168.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.53 153.62 40.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.363 1.582 . . . . 0.0 109.577 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.19 172.68 39.24 Favored Glycine 0 C--N 1.333 0.377 0 O-C-N 123.09 0.244 . . . . 0.0 113.55 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.61 153.15 17.86 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.942 0.897 . . . . 0.0 110.967 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.75 79.79 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.64 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.611 2.053 . . . . 0.0 113.31 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -156.71 -33.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.504 2.322 . . . . 0.0 110.582 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -68.92 166.41 17.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.64 0.776 . . . . 0.0 110.493 172.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.8 mmm -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 169.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.66 151.08 46.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.2 mt -110.09 120.27 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.88 104.19 16.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.432 ' HA ' HG22 ' A' ' 132' ' ' THR . 60.2 t -62.64 129.89 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 126.011 1.724 . . . . 0.0 108.133 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -62.96 -28.36 70.03 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . 0.315 8.2 tp 46.31 -48.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 131.421 3.888 . . . . 0.0 116.503 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -62.62 -17.26 59.94 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.278 1.854 . . . . 0.0 113.961 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -101.93 -10.34 19.89 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 116.575 -1.679 . . . . 0.0 112.502 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.55 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.533 1.515 . . . . 0.0 111.455 -169.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.24 -29.57 64.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.613 -0.68 . . . . 0.0 110.388 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -57.38 -36.16 70.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.682 0.674 . . . . 0.0 111.649 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 m -91.77 -27.7 17.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.081 0.553 . . . . 0.0 111.485 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.98 -15.37 38.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.133 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.4 -36.11 77.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.196 1.816 . . . . 0.0 112.498 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -63.62 -45.78 88.71 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.744 -0.597 . . . . 0.0 109.537 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.15 87.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.122 0.569 . . . . 0.0 111.089 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.23 -64.43 0.82 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.131 1.372 . . . . 0.0 108.311 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.62 -31.26 70.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -168.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.01 -20.91 42.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.4 m -136.0 7.86 3.2 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.028 0.931 . . . . 0.0 113.148 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -151.41 15.6 0.7 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -173.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.6 10.45 0.65 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.424 1.011 . . . . 0.0 112.788 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 73.1 -32.69 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.304 2.642 . . . . 0.0 112.785 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.94 -23.49 63.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.796 1.638 . . . . 0.0 111.539 169.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.02 19.11 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.196 1.798 . . . . 0.0 111.184 -169.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.523 178.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.8 p -70.0 -43.95 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.459 0.703 . . . . 0.0 110.353 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.69 179.06 31.38 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.329 1.442 . . . . 0.0 109.887 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.43 89.33 2.33 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -69.17 -18.25 63.91 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.119 0.967 . . . . 0.0 113.279 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -76.67 83.7 3.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.037 0.835 . . . . 0.0 109.731 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -62.0 -37.42 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.235 0.614 . . . . 0.0 111.887 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m 45.8 52.36 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.785 1.279 . . . . 0.0 110.29 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HG2' ' H ' ' A' ' 11' ' ' ALA . 66.2 tttt -59.88 139.89 57.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 109.762 -175.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.04 -4.52 57.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.071 0.949 . . . . 0.0 110.64 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.452 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 53.09 30.24 9.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.82 1.648 . . . . 0.0 110.785 -169.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -145.83 30.58 1.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.902 1.681 . . . . 0.0 109.046 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.44 151.46 95.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.806 0.842 . . . . 0.0 110.274 -169.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -69.26 163.07 39.29 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.771 2.314 . . . . 0.0 110.619 172.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -62.77 165.93 6.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 110.063 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.43 100.09 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.997 1.284 . . . . 0.0 110.673 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -67.8 138.06 55.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -106.02 144.16 33.14 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.96 140.21 32.67 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.03 0.932 . . . . 0.0 110.594 -169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.08 137.04 35.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 167.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.04 151.11 25.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 119.782 1.174 . . . . 0.0 109.066 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -139.45 150.04 44.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.466 1.106 . . . . 0.0 109.556 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -89.71 147.02 24.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.33 106.36 4.96 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.71 -80.37 0.24 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.653 1.121 . . . . 0.0 111.756 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -153.71 32.34 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.684 1.593 . . . . 0.0 110.158 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.58 162.06 36.86 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.462 1.905 . . . . 0.0 107.707 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.58 154.96 38.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.823 1.297 . . . . 0.0 111.042 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -140.86 156.28 46.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.182 2.193 . . . . 0.0 107.593 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.22 157.03 22.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.543 1.068 . . . . 0.0 111.31 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 136.34 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.97 123.56 13.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.22 -35.04 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.604 0.762 . . . . 0.0 112.822 -169.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.8 -18.71 60.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.984 1.266 . . . . 0.0 112.681 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.45 -23.32 50.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.731 0.696 . . . . 0.0 110.55 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.61 136.96 23.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -43.9 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.268 1.027 . . . . 0.0 110.26 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -159.81 170.99 20.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.201 1.0 . . . . 0.0 109.064 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.75 142.09 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -147.62 178.59 8.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.506 1.122 . . . . 0.0 108.252 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.21 165.43 15.07 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.94 128.75 38.76 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.59 -45.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -148.35 65.72 1.08 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.876 1.27 . . . . 0.0 108.907 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 37.4 t -85.07 112.13 21.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -75.88 81.98 2.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -60.77 133.7 56.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.16 151.83 8.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -30.38 66.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.81 28.34 0.85 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.96 156.83 9.25 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.458 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.52 132.93 32.65 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 107.46 -1.785 . . . . 0.0 107.46 175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 84.98 0.68 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 122.755 1.264 . . . . 0.0 111.076 -170.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -167.8 -46.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.012 4.525 . . . . 0.0 102.889 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -78.37 97.06 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.116 1.766 . . . . 0.0 108.775 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -58.68 -36.03 73.53 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.58 -147.37 9.79 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.88 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 m -122.38 165.41 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.0 t -145.34 159.83 42.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.347 -1.471 . . . . 0.0 109.124 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -81.26 96.01 7.14 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.114 0.966 . . . . 0.0 111.275 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.15 164.06 13.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -74.06 58.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.493 1.042 . . . . 0.0 113.18 -169.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.39 -15.78 0.57 Allowed Glycine 0 CA--C 1.536 1.384 0 C-N-CA 127.3 2.381 . . . . 0.0 112.945 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -151.21 -158.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 119.302 1.551 . . . . 0.0 108.653 -169.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.434 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.0 tp -125.19 153.6 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.269 1.828 . . . . 0.0 108.276 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.7 139.23 14.58 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.426 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.79 146.05 82.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.33 2.02 . . . . 0.0 111.368 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 tp -130.48 132.37 64.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 124.157 0.983 . . . . 0.0 108.965 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.72 153.46 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.4 1.88 . . . . 0.0 106.629 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -131.1 128.66 40.62 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.08 -19.09 62.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.674 1.59 . . . . 0.0 111.056 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -57.32 -27.52 62.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.635 1.107 . . . . 0.0 111.568 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.82 -46.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.64 -27.74 68.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.745 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.96 1.84 3.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.041 1.291 . . . . 0.0 112.317 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.9 m 55.08 44.51 27.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.177 0.991 . . . . 0.0 112.091 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . 0.289 0.0 OUTLIER -54.45 148.76 11.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.114 -0.366 . . . . 0.0 111.363 176.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 78' ' ' VAL . 6.5 t -37.91 -60.79 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 128.39 2.676 . . . . 0.0 114.337 -169.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -174.38 88.4 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.057 1.743 . . . . 0.0 108.968 -169.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.16 154.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.461 0.648 . . . . 0.0 110.882 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' ASN . 20.7 t0 -158.45 161.2 37.43 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.19 38.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.267 1.827 . . . . 0.0 111.375 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ASP . 69.3 m-80 -151.69 -7.98 0.22 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.948 2.899 . . . . 0.0 110.282 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -123.34 -23.09 4.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.749 1.22 . . . . 0.0 112.664 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 34.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.666 0.787 . . . . 0.0 109.436 -170.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 p -82.52 -13.37 56.76 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.94 153.02 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.752 1.614 . . . . 0.0 107.653 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.4 t -120.53 137.88 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 126.159 1.783 . . . . 0.0 106.326 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.77 134.66 58.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.42 136.27 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -133.38 153.56 51.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.905 1.682 . . . . 0.0 108.384 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.84 144.96 43.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.46 158.76 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 40.27 -98.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.158 1.361 . . . . 0.0 112.919 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -136.19 30.53 2.99 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.077 1.751 . . . . 0.0 110.52 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -149.51 178.55 8.72 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.965 -1.085 . . . . 0.0 112.256 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 p -136.82 146.32 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.473 1.509 . . . . 0.0 107.991 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.18 -178.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.636 1.574 . . . . 0.0 107.774 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.66 177.14 41.0 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 120.639 -1.288 . . . . 0.0 111.008 169.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 pt -140.22 163.21 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.11 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 m -106.82 142.1 20.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.131 0.972 . . . . 0.0 108.93 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.33 168.15 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.528 1.531 . . . . 0.0 110.019 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.42 -43.83 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.885 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.32 156.11 12.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.63 127.66 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.6 -41.88 9.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.901 0.48 . . . . 0.0 111.717 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -167.15 178.72 5.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.26 0.624 . . . . 0.0 110.576 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.4 t -136.3 125.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 pp -158.12 178.3 10.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.743 1.217 . . . . 0.0 109.677 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.2 m -129.78 150.08 51.24 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.444 0.565 . . . . 0.0 111.995 -171.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mp -143.32 169.31 17.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.782 1.633 . . . . 0.0 109.043 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -129.02 168.55 15.88 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.642 1.577 . . . . 0.0 109.566 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.32 -13.14 48.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.72 -33.83 75.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.603 1.092 . . . . 0.0 109.575 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -87.75 -39.6 14.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.585 1.154 . . . . 0.0 110.682 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.9 mt -91.58 101.86 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.913 0.885 . . . . 0.0 108.672 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 -143.3 -57.64 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 CA-C-O 116.624 -1.655 . . . . 0.0 113.372 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.98 175.87 3.48 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.951 1.767 . . . . 0.0 111.499 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.06 150.6 26.11 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.714 1.206 . . . . 0.0 109.227 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.89 44.25 1.68 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.93 3.753 . . . . 0.0 110.986 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.44 19.65 0.08 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.838 1.655 . . . . 0.0 114.053 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.5 155.85 42.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.335 1.454 . . . . 0.0 110.605 -169.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.66 33.29 10.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.525 1.93 . . . . 0.0 114.413 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.12 169.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.779 1.632 . . . . 0.0 108.858 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.98 -76.58 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.811 1.245 . . . . 0.0 109.534 172.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 127' ' ' SER . 8.1 tp 49.71 -167.23 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.626 2.371 . . . . 0.0 113.626 174.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.412 ' H ' ' HG ' ' A' ' 126' ' ' LEU . 1.6 p -155.51 145.54 21.58 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 120.976 -1.078 . . . . 0.0 110.401 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -64.41 -21.43 66.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.746 1.219 . . . . 0.0 113.91 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.69 -22.46 21.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.461 0.573 . . . . 0.0 110.464 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.31 7.82 11.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.169 0.988 . . . . 0.0 111.898 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -63.22 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 145' ' ' VAL . 22.9 p 62.51 -170.91 0.17 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.5 1.92 . . . . 0.0 113.834 168.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -143.66 176.08 23.25 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 169.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.11 143.22 38.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.44 161.97 32.07 Favored Glycine 0 CA--C 1.519 0.321 0 O-C-N 123.61 0.569 . . . . 0.0 112.442 170.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.16 153.85 17.46 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 110.313 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.75 85.05 1.87 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.41 -52.79 2.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.622 2.058 . . . . 0.0 112.804 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.52 -30.31 0.1 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.034 2.134 . . . . 0.0 111.215 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -67.67 161.67 25.35 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.809 0.844 . . . . 0.0 108.993 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 76.8 mmm -127.44 140.53 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.34 135.21 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.31 106.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.72 111.18 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 132' ' ' THR . 18.2 m -65.93 143.05 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.84 59.29 4.75 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.8 0.727 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -41.51 -52.62 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.68 2.392 . . . . 0.0 113.511 -168.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.08 11.44 1.82 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.696 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -135.76 20.51 3.3 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.579 1.552 . . . . 0.0 110.499 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.05 -98.33 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.86 -29.03 65.04 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.606 -1.309 . . . . 0.0 109.92 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -62.27 -15.72 49.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.4 m -124.93 5.54 8.01 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 112.029 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -122.79 2.58 9.46 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.016 0.927 . . . . 0.0 112.952 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.75 -38.99 90.02 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 119.796 -1.815 . . . . 0.0 112.312 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -62.43 -36.1 81.34 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.285 0.634 . . . . 0.0 110.566 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.21 -38.13 66.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.771 0.829 . . . . 0.0 111.08 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.27 -61.9 2.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.829 1.252 . . . . 0.0 109.126 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.64 -29.6 69.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.441 -168.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -54.81 -24.76 24.33 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.0 m -136.67 20.52 3.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.312 1.045 . . . . 0.0 112.098 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.79 12.77 0.79 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.41 11.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 113.281 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.9 m 74.0 -34.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.669 2.388 . . . . 0.0 113.028 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.94 -11.58 39.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.361 1.064 . . . . 0.0 111.266 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.89 9.17 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 127.291 2.236 . . . . 0.0 110.775 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.567 -1.206 . . . . 0.0 107.903 -178.267 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -59.95 117.72 5.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.93 -50.05 0.9 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.5 mtt -81.4 -43.74 18.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m 46.6 45.37 14.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.499 1.92 . . . . 0.0 111.833 173.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -59.83 -14.79 16.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.454 1.902 . . . . 0.0 114.425 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.4 m -64.4 -23.52 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.395 -0.816 . . . . 0.0 112.011 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -63.82 138.8 58.63 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.96 125.0 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.56 -37.82 65.41 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.342 0.519 . . . . 0.0 111.198 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.45 -145.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -85.17 -5.89 59.31 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 60.05 173.89 0.05 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.96 2.504 . . . . 0.0 113.169 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.74 124.83 17.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.808 2.339 . . . . 0.0 113.657 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -66.99 164.86 16.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.58 0.752 . . . . 0.0 109.233 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.19 111.12 3.55 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 169.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -136.89 164.0 29.35 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.531 1.932 . . . . 0.0 110.414 -169.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -110.87 149.84 30.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -141.97 134.62 28.36 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.065 0.946 . . . . 0.0 109.33 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.4 tp -74.94 139.05 42.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.82 146.54 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.691 1.132 . . . . 0.0 108.795 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -140.81 150.19 43.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.413 1.085 . . . . 0.0 110.261 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -91.02 142.6 27.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -133.24 90.92 2.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.14 -71.71 0.31 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.18 1.848 . . . . 0.0 112.222 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.62 28.66 0.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.215 1.406 . . . . 0.0 111.164 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -138.72 162.41 34.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.611 1.564 . . . . 0.0 108.053 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.58 150.76 45.58 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.598 1.189 . . . . 0.0 110.098 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -140.49 156.86 46.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.97 2.108 . . . . 0.0 107.506 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.9 158.1 22.72 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.589 1.09 . . . . 0.0 111.463 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 mt -144.89 133.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -48.12 115.88 1.34 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.896 1.278 . . . . 0.0 109.584 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -53.94 -39.27 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -168.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.63 -17.14 64.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.319 0.963 . . . . 0.0 112.784 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -74.2 -24.26 59.33 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.537 0.608 . . . . 0.0 110.588 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.29 138.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 119.463 1.028 . . . . 0.0 108.723 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -102.15 -57.44 2.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.858 0.863 . . . . 0.0 109.293 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -160.69 174.62 13.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.581 1.152 . . . . 0.0 108.768 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.47 139.01 46.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -141.76 179.31 6.92 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.742 1.617 . . . . 0.0 107.856 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.92 161.5 14.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -56.44 131.18 47.74 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -155.14 -46.96 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.61 81.5 1.29 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.048 0.939 . . . . 0.0 109.525 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 115.67 32.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 90.32 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 173.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 118.87 10.95 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mm -81.95 -38.46 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 51.7 13.66 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.851 2.06 . . . . 0.0 114.798 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.93 13.91 2.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.525 2.33 . . . . 0.0 110.233 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.66 170.79 7.35 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 130.024 3.33 . . . . 0.0 110.333 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.94 -38.53 37.6 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.968 1.779 . . . . 0.0 112.134 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 139.42 170.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.657 4.383 . . . . 0.0 106.885 -176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' H ' HG21 ' A' ' 73' ' ' ILE . 44.8 m-85 68.12 -53.72 0.52 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 128.137 2.575 . . . . 0.0 109.346 -169.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -72.75 82.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.326 2.25 . . . . 0.0 110.209 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -56.07 -36.59 68.28 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.061 -1.024 . . . . 0.0 109.725 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.48 -173.38 36.99 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.024 -1.56 . . . . 0.0 115.112 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.77 119.43 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -89.66 146.84 24.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.757 1.623 . . . . 0.0 110.033 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -62.02 101.58 0.22 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG 0.302 0.2 OUTLIER -78.79 64.89 3.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.161 1.384 . . . . 0.0 107.834 169.996 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 43.35 36.96 1.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.443 2.297 . . . . 0.0 112.72 170.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.44 -23.39 4.05 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.013 1.292 . . . . 0.0 112.981 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -160.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.327 1.851 . . . . 0.0 106.692 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.86 146.77 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.878 1.217 . . . . 0.0 112.398 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.12 132.5 13.64 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.049 0.94 . . . . 0.0 108.685 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.55 142.01 69.48 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 CA-C-N 121.249 1.482 . . . . 0.0 110.207 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -128.16 132.62 68.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 152.95 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.555 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -103.88 119.91 39.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.172 1.389 . . . . 0.0 107.945 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.93 -7.18 49.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.319 -0.848 . . . . 0.0 113.01 -170.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ttt85 -69.56 -38.15 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 121.338 1.881 . . . . 0.0 108.202 168.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.44 HG21 ' H ' ' A' ' 54' ' ' PHE . 12.3 mt -71.88 -17.73 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 0.0 110.497 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -122.46 -29.11 4.15 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.777 1.172 . . . . 0.0 113.698 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -131.72 15.32 4.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.787 1.176 . . . . 0.0 112.72 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 m 58.93 28.97 18.3 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.53 1.132 . . . . 0.0 113.113 171.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -48.51 140.92 7.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.383 0.673 . . . . 0.0 109.246 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.07 -54.15 27.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 125.301 1.44 . . . . 0.0 111.377 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -165.43 82.58 0.34 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.593 1.157 . . . . 0.0 108.423 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.3 114.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -153.21 148.98 27.51 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.368 1.067 . . . . 0.0 109.085 -175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.81 45.82 0.73 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.683 1.593 . . . . 0.0 111.944 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.82 -17.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.397 2.279 . . . . 0.0 111.284 169.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.93 -3.31 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.698 1.199 . . . . 0.0 112.178 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.58 38.03 0.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -85.3 -7.55 58.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.516 2.327 . . . . 0.0 117.177 -168.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.39 152.72 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 120.693 1.588 . . . . 0.0 107.911 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.17 111.99 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 61.4 mt -87.52 142.78 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.82 134.65 63.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.3 mt -134.32 160.23 38.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 108.817 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.48 152.16 46.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.491 1.517 . . . . 0.0 107.479 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.8 130.69 13.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.89 -83.2 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.211 1.386 . . . . 0.0 113.162 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -142.19 12.48 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.337 1.855 . . . . 0.0 111.704 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -143.98 166.8 23.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.403 1.081 . . . . 0.0 110.315 -169.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.62 151.88 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.737 1.215 . . . . 0.0 109.836 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.02 177.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.057 1.743 . . . . 0.0 106.939 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.31 173.93 39.52 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 120.494 -1.379 . . . . 0.0 110.628 170.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.3 pt -142.81 145.3 23.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 108.792 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.46 135.75 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.767 0.827 . . . . 0.0 109.047 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.84 169.79 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.872 1.269 . . . . 0.0 110.091 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 -42.04 65.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.81 160.36 19.11 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.34 135.83 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.61 -42.19 6.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.95 0.9 . . . . 0.0 111.161 -173.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -168.94 -177.37 2.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.72 125.91 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 169.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.5 mt -140.26 173.94 11.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.091 1.356 . . . . 0.0 109.382 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.2 m -129.18 138.71 51.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.153 0.888 . . . . 0.0 110.797 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 mp -145.86 163.53 34.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.9 1.28 . . . . 0.0 110.229 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 m -141.76 174.07 10.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.382 2.273 . . . . 0.0 107.133 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.04 1.59 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.72 -51.01 8.62 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 120.859 -1.151 . . . . 0.0 108.04 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -70.85 -43.12 69.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.613 1.165 . . . . 0.0 110.157 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.43 116.29 33.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -142.19 -66.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 116.395 -1.765 . . . . 0.0 110.8 -171.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.8 -175.69 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.105 1.87 . . . . 0.0 111.099 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.7 154.41 31.47 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.902 1.681 . . . . 0.0 107.715 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.51 42.21 1.29 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.839 3.026 . . . . 0.0 110.987 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.17 -19.7 3.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -140.74 34.6 1.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.936 0.894 . . . . 0.0 110.669 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.13 19.57 2.79 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 172.36 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.592 1.957 . . . . 0.0 108.788 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 2.82 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.368 1.867 . . . . 0.0 113.75 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.14 164.6 15.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.211 2.204 . . . . 0.0 112.685 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.4 m -137.12 159.28 42.36 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.554 1.542 . . . . 0.0 108.924 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 p -61.35 -20.45 63.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.535 . . . . 0.0 113.434 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -70.09 -36.18 74.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.3 13.12 19.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.431 1.092 . . . . 0.0 109.68 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 121.43 9.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.37 1.068 . . . . 0.0 110.862 -169.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 58.6 p -81.24 -162.22 0.48 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.991 2.517 . . . . 0.0 110.518 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -135.53 174.86 21.08 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.88 141.96 44.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.05 177.71 32.14 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.37 156.04 47.98 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.379 1.071 . . . . 0.0 109.711 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.5 mt -141.78 77.87 1.61 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.706 1.603 . . . . 0.0 107.272 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.31 -52.28 3.38 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.512 2.005 . . . . 0.0 112.624 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.64 -29.45 0.24 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.398 1.879 . . . . 0.0 111.637 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -69.38 157.13 37.65 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mtp -136.0 153.69 51.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.095 170.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -145.51 135.86 24.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 80.4 mt -97.67 118.43 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.83 105.53 17.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.68 120.37 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.626 1.17 . . . . 0.0 107.918 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -75.62 66.2 1.93 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.966 0.889 . . . . 0.0 109.902 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tp -57.6 -35.89 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.567 1.147 . . . . 0.0 110.801 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.62 -18.84 65.62 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -114.15 -2.74 13.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.971 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.74 -75.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.971 1.308 . . . . 0.0 109.652 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.02 -28.53 63.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.887 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.39 -34.42 61.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.056 0.942 . . . . 0.0 111.83 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -103.77 -19.62 14.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.78 0.832 . . . . 0.0 111.73 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.55 -18.8 32.33 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.421 -0.799 . . . . 0.0 111.796 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.5 -35.82 76.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.94 1.245 . . . . 0.0 111.968 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.7 mtm -63.82 -41.1 97.93 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 109.952 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.84 -43.16 72.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.916 0.487 . . . . 0.0 110.459 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.63 -58.93 5.21 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.718 1.207 . . . . 0.0 109.647 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -18.37 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.36 -22.87 66.85 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -135.52 -6.55 2.23 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.64 31.2 0.65 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.452 1.101 . . . . 0.0 112.173 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 13.5 0.32 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.094 0.958 . . . . 0.0 112.644 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.2 m 71.41 -29.98 0.2 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 128.288 2.635 . . . . 0.0 113.046 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.23 -27.0 68.76 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.04 1.336 . . . . 0.0 111.215 169.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.0 m -128.3 -1.49 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 125.064 1.346 . . . . 0.0 112.556 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.849 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 p -65.54 -12.76 55.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.038 1.335 . . . . 0.0 113.745 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.2 171.74 35.77 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.54 173.69 16.33 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.447 1.499 . . . . 0.0 108.749 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.8 p -124.57 -34.57 2.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.081 0.952 . . . . 0.0 110.734 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.3 t30 42.93 43.59 3.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.415 1.886 . . . . 0.0 112.845 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.3 -170.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.977 1.311 . . . . 0.0 110.381 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -60.5 -37.59 81.57 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.301 -0.874 . . . . 0.0 111.251 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -67.99 135.39 52.25 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.32 35.55 2.51 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.153 0.981 . . . . 0.0 110.61 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.72 -53.33 13.81 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.534 -0.729 . . . . 0.0 109.626 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -147.75 10.26 0.93 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.574 1.15 . . . . 0.0 112.875 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -65.66 -32.07 5.6 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.325 1.85 . . . . 0.0 114.845 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.77 -18.52 41.87 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.432 2.088 . . . . 0.0 112.621 169.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m 46.38 40.85 8.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.255 2.222 . . . . 0.0 114.599 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.25 72.29 1.27 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -56.97 135.28 56.16 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -110.44 144.91 38.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -140.6 139.95 35.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.692 0.797 . . . . 0.0 109.554 -169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.33 134.01 35.25 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 168.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.61 148.79 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 119.274 0.943 . . . . 0.0 109.164 -172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -144.21 150.1 37.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.54 1.136 . . . . 0.0 109.506 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -86.71 148.0 25.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -143.42 111.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.495 1.518 . . . . 0.0 106.92 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.48 -84.77 0.19 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.308 0.956 . . . . 0.0 111.398 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.21 32.17 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.114 1.366 . . . . 0.0 110.377 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -144.08 161.05 39.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.149 1.379 . . . . 0.0 108.236 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -118.58 150.4 39.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.648 1.213 . . . . 0.0 109.256 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -139.91 158.3 44.3 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.897 2.079 . . . . 0.0 107.142 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.28 24.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.856 0.741 . . . . 0.0 111.551 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mt -140.21 137.33 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.62 124.2 14.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.44 0.564 . . . . 0.0 109.708 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.99 -33.61 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.61 0.764 . . . . 0.0 112.5 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.3 mt -67.46 -23.6 65.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.965 0.802 . . . . 0.0 111.961 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.79 -21.95 40.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.626 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.92 137.75 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.53 -43.23 2.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.759 1.223 . . . . 0.0 109.246 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -160.98 172.94 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 108.289 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.4 138.45 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -145.81 168.38 20.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.195 1.398 . . . . 0.0 107.552 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.06 164.7 27.5 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -70.1 3.88 2.5 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.088 1.355 . . . . 0.0 114.37 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -22.18 3.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.148 1.779 . . . . 0.0 115.714 -169.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.31 49.11 1.44 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.546 1.067 . . . . 0.0 112.64 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.95 110.79 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 90.45 5.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -67.87 110.67 3.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 mm -71.24 156.39 7.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.79 -24.58 65.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.7 p30 -145.98 22.63 1.39 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.494 1.117 . . . . 0.0 113.927 -169.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.03 153.74 84.05 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.28 151.33 83.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.852 1.701 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.46 75.67 4.01 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 122.097 0.951 . . . . 0.0 109.977 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -163.88 -46.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 130.613 3.565 . . . . 0.0 103.919 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.92 90.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 108.027 174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -52.99 -27.83 21.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.158 0.983 . . . . 0.0 110.516 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.13 -168.69 40.54 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.905 1.229 . . . . 0.0 112.106 169.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.97 114.76 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -85.5 135.57 33.78 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.763 1.625 . . . . 0.0 109.049 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.39 91.48 3.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.46 174.04 2.38 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 169.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -68.86 52.59 0.08 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.417 2.287 . . . . 0.0 113.597 -169.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.34 -8.58 1.89 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.361 2.41 . . . . 0.0 113.512 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -151.96 -164.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 119.565 1.683 . . . . 0.0 108.848 -169.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.481 ' H ' HG12 ' A' ' 64' ' ' VAL . 5.5 tp -122.74 156.14 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.466 1.906 . . . . 0.0 108.073 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.98 135.42 9.44 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.437 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.82 140.01 59.55 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 121.274 1.491 . . . . 0.0 110.451 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.96 130.87 73.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.25 158.64 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -121.57 121.51 37.6 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.97 -22.37 66.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.29 -24.03 67.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.862 1.665 . . . . 0.0 111.785 170.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.34 -48.6 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -64.97 -18.25 65.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -132.13 -3.92 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.509 1.504 . . . . 0.0 112.636 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.5 m 50.08 37.41 14.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.29 1.036 . . . . 0.0 111.595 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -66.45 100.57 0.66 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.991 1.317 . . . . 0.0 109.439 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 t 39.15 -115.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 126.809 2.044 . . . . 0.0 108.733 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -158.0 100.07 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.25 1.42 . . . . 0.0 107.253 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 20.2 m -68.42 176.95 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 111.225 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -149.24 169.67 20.24 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.678 1.591 . . . . 0.0 108.917 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.36 43.3 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.638 1.975 . . . . 0.0 111.646 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -152.89 -6.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.649 3.179 . . . . 0.0 109.978 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.12 12.53 1.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.766 1.626 . . . . 0.0 111.3 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.72 25.47 0.57 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.108 2.563 . . . . 0.0 108.648 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.5 p -97.66 -2.43 41.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -167.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.4 t -110.67 160.45 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.6 t -138.29 132.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.0 mt -104.8 129.27 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.33 141.6 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.0 mt -134.24 160.52 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.604 1.562 . . . . 0.0 108.852 -169.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.76 146.74 38.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.515 1.126 . . . . 0.0 108.196 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -159.6 143.82 14.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.22 5.28 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 119.414 1.006 . . . . 0.0 114.581 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 56.86 35.25 26.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.3 1.44 . . . . 0.0 113.628 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.94 173.91 11.04 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.696 1.598 . . . . 0.0 109.151 169.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.21 152.47 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.705 0.802 . . . . 0.0 110.576 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 99' ' ' GLY . 11.0 p -157.89 -175.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 106.355 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 98' ' ' VAL . . . -172.04 -179.1 42.75 Favored Glycine 0 N--CA 1.448 -0.527 0 O-C-N 120.495 -1.378 . . . . 0.0 109.67 169.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 pt -141.94 144.49 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.844 0.457 . . . . 0.0 110.532 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.86 145.6 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 169.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.82 167.72 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.589 1.956 . . . . 0.0 108.547 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.02 -45.48 63.86 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.667 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.48 151.9 8.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.4 142.43 16.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 m -124.16 -26.96 3.91 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -168.71 178.74 4.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.653 1.115 . . . . 0.0 110.475 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.17 120.88 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.86 167.23 22.59 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.12 0.968 . . . . 0.0 110.291 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -128.07 138.15 52.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.77 0.428 . . . . 0.0 110.722 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.92 165.9 26.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 107.552 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.76 161.29 29.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -18.25 53.95 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.463 -0.773 . . . . 0.0 112.953 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.66 -36.74 83.27 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.986 -1.071 . . . . 0.0 110.45 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -76.69 -42.25 42.33 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.061 0.945 . . . . 0.0 109.848 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.78 88.91 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.203 1.001 . . . . 0.0 108.58 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 59.6 mtm180 -139.53 -55.32 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.981 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.1 Cg_endo -65.55 175.27 4.43 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.716 1.611 . . . . 0.0 111.315 175.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.93 157.3 30.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.848 1.259 . . . . 0.0 109.723 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.36 59.83 6.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.354 3.369 . . . . 0.0 110.048 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.39 1.4 11.79 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -148.16 160.35 43.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.369 0.986 . . . . 0.0 110.948 -172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 54.25 34.87 21.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.034 2.133 . . . . 0.0 114.24 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.0 161.98 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.135 1.374 . . . . 0.0 109.006 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -10.09 58.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.089 1.356 . . . . 0.0 113.426 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.2 tp -52.75 125.78 17.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.68 1.592 . . . . 0.0 113.806 -169.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -63.78 148.53 49.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 111.026 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.2 p -76.92 -16.07 59.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.982 0.913 . . . . 0.0 113.109 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -94.45 -43.07 8.53 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -80.59 7.3 10.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.76 1.224 . . . . 0.0 110.699 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.85 118.34 5.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p -69.96 -177.27 1.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.782 2.433 . . . . 0.0 110.838 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -123.39 179.17 16.21 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 mt -136.45 147.56 47.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.673 1.589 . . . . 0.0 106.878 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.35 171.26 34.62 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.17 154.19 31.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.118 0.967 . . . . 0.0 109.972 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.06 81.71 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.411 1.485 . . . . 0.0 107.052 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 -47.94 2.0 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.662 2.077 . . . . 0.0 113.672 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.53 -36.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.3 2.24 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -71.51 167.19 20.19 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.759 0.79 . . . . 0.0 110.056 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.0 mtp -135.13 154.79 51.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -136.75 138.22 40.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.7 mt -87.86 113.74 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.88 107.46 14.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.36 120.11 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.211 1.404 . . . . 0.0 107.909 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -76.72 63.89 2.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.705 0.764 . . . . 0.0 110.27 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.58 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.396 1.478 . . . . 0.0 111.321 -172.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.49 -4.19 14.16 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -126.94 22.97 6.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.558 1.143 . . . . 0.0 110.839 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 -95.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -65.57 -35.62 81.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.985 -1.072 . . . . 0.0 110.112 -173.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.16 -30.51 49.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.141 0.977 . . . . 0.0 113.051 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.5 m -114.7 -1.97 13.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.21 -9.14 11.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.771 -1.109 . . . . 0.0 113.195 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -52.66 -42.95 65.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.901 1.682 . . . . 0.0 112.168 -172.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.3 ptp -59.65 -27.56 66.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.02 1.328 . . . . 0.0 113.338 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.83 -33.48 12.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.093 1.357 . . . . 0.0 111.242 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.95 -60.12 4.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.488 1.115 . . . . 0.0 109.318 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -29.06 68.14 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.522 -169.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.47 -23.74 27.37 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.344 1.058 . . . . 0.0 112.725 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 40.0 m -136.05 15.93 3.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.487 1.115 . . . . 0.0 111.791 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -149.19 11.97 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.8 5.79 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.556 1.071 . . . . 0.0 113.369 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.1 m 73.04 -36.28 0.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.084 2.553 . . . . 0.0 113.6 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.2 -30.87 71.38 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -82.45 -6.96 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.708 1.603 . . . . 0.0 113.023 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-N 119.28 0.945 . . . . 0.0 109.289 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 m -140.05 151.62 45.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.93 179.37 48.81 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.16 152.45 31.26 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.553 1.141 . . . . 0.0 108.598 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -71.33 -18.07 62.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.629 0.772 . . . . 0.0 112.052 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -72.62 -5.44 37.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.682 1.193 . . . . 0.0 113.664 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.9 m -57.63 149.5 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.338 0.972 . . . . 0.0 110.574 174.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -58.98 128.55 37.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.966 0.906 . . . . 0.0 109.478 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -82.41 69.73 9.21 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.706 0.802 . . . . 0.0 109.579 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.72 10.89 6.64 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.641 1.176 . . . . 0.0 112.386 -177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.31 -52.71 0.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.493 0.717 . . . . 0.0 109.931 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -76.73 26.87 0.13 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 0.0 112.511 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.45 -26.78 2.64 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.33 -21.24 72.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.801 2.334 . . . . 0.0 114.105 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m 55.66 -162.99 0.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.739 1.216 . . . . 0.0 109.769 -169.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.11 78.0 0.81 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -65.22 151.0 47.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.252 1.421 . . . . 0.0 108.247 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.1 143.53 44.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -142.39 136.89 30.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.504 0.722 . . . . 0.0 110.272 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -79.74 135.87 36.62 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 167.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.16 149.49 31.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 109.098 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -146.11 151.97 38.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.255 1.022 . . . . 0.0 110.242 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.5 m -86.93 146.39 26.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.438 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -137.23 103.23 5.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.95 -86.86 0.17 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.958 0.789 . . . . 0.0 111.575 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.02 31.02 0.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.239 1.416 . . . . 0.0 110.376 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -139.66 159.2 42.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.711 1.605 . . . . 0.0 107.566 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -122.71 149.65 43.79 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.206 1.479 . . . . 0.0 110.785 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -137.92 161.56 36.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 107.621 -169.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.64 163.95 26.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.845 0.748 . . . . 0.0 112.145 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mt -142.75 138.04 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -48.04 114.59 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.169 . . . . 0.0 109.357 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -54.84 -34.12 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.968 0.907 . . . . 0.0 111.594 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.75 -23.87 67.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.717 0.807 . . . . 0.0 112.618 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -82.64 -19.0 39.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.948 0.794 . . . . 0.0 112.069 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.29 125.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -80.83 -57.58 3.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.02 -178.29 5.53 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.625 1.57 . . . . 0.0 108.537 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.34 141.71 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -143.4 -155.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.925 1.29 . . . . 0.0 108.186 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.15 161.84 26.41 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.33 136.09 57.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -160.3 -51.82 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.45 0.7 . . . . 0.0 110.27 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -157.63 73.06 0.69 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.173 1.389 . . . . 0.0 107.926 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.42 103.44 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 168.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.46 84.9 4.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -70.06 118.13 12.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.97 -24.06 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 118.222 0.464 . . . . 0.0 110.287 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 55.11 20.92 3.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.002 1.721 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -142.47 41.08 1.6 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.777 2.831 . . . . 0.0 105.127 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.88 151.18 34.42 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 109.096 -168.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.16 156.33 55.89 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.132 1.888 . . . . 0.0 108.846 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.64 -25.55 64.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -53.43 -50.33 65.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.427 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.7 mt -77.17 82.03 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -60.8 -27.39 67.99 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.562 -0.711 . . . . 0.0 110.069 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -166.45 34.81 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.903 0.774 . . . . 0.0 111.302 169.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.92 121.2 66.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -99.93 131.17 46.06 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.742 1.217 . . . . 0.0 110.739 -168.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -63.24 136.33 57.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.0 102.45 4.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 169.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.31 34.38 14.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.393 1.077 . . . . 0.0 113.139 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.28 9.39 55.56 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.035 0.826 . . . . 0.0 113.432 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 65' ' ' ILE . 1.6 t -131.8 -176.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 127.0 2.12 . . . . 0.0 106.816 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 64' ' ' VAL . 3.9 tp -136.82 159.07 37.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.831 1.253 . . . . 0.0 109.939 -173.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.18 140.47 13.75 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.09 132.21 23.9 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 N-CA-C 106.833 -2.026 . . . . 0.0 106.833 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 tp -111.87 140.14 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.54 172.21 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -132.51 117.8 18.46 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.93 -24.86 67.65 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.363 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -66.46 -25.53 66.77 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 120.075 1.307 . . . . 0.0 111.687 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.7 mm -71.43 -50.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 120.053 1.297 . . . . 0.0 107.545 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -64.91 -16.93 63.87 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.94 1.81 9.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.653 1.181 . . . . 0.0 112.542 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m 47.59 38.15 7.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.579 1.152 . . . . 0.0 111.505 -169.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.21 29.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.502 1.121 . . . . 0.0 110.681 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t 33.62 -109.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.6 2.36 . . . . 0.0 112.178 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -172.02 111.58 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.031 2.132 . . . . 0.0 105.888 -172.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -56.31 160.41 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.963 0.905 . . . . 0.0 111.462 172.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -153.28 149.88 28.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.219 1.008 . . . . 0.0 108.305 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.18 38.21 0.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.643 1.977 . . . . 0.0 113.163 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.14 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.099 2.16 . . . . 0.0 110.747 169.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.11 6.72 5.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.854 1.262 . . . . 0.0 111.658 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.458 HD22 ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -155.34 28.86 0.4 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.705 -1.247 . . . . 0.0 110.343 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.2 p -94.05 15.17 17.66 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -167.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.84 150.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.417 1.462 . . . . 0.0 107.144 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 m -119.61 135.1 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 119.691 1.132 . . . . 0.0 109.963 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -98.94 128.7 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.84 133.42 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -133.65 166.43 22.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.505 1.522 . . . . 0.0 109.617 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -139.93 154.83 47.33 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.89 0.876 . . . . 0.0 109.439 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -137.09 83.74 2.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.82 -68.66 1.9 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.057 0.837 . . . . 0.0 112.91 169.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.04 2.25 2.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.804 1.642 . . . . 0.0 112.42 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 166.27 21.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.631 1.105 . . . . 0.0 110.189 174.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.81 154.5 34.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.697 1.199 . . . . 0.0 108.842 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.33 169.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.86 175.41 30.63 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 120.82 -1.175 . . . . 0.0 110.164 169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 pt -135.48 140.85 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 85' ' ' ASN . 1.4 m -75.17 135.7 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.486 0.714 . . . . 0.0 109.084 170.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 m -141.65 166.17 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.039 1.735 . . . . 0.0 108.862 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.17 -43.97 69.72 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.233 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.23 10.63 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.18 127.6 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.2 -53.69 7.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.226 0.61 . . . . 0.0 109.673 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -175.26 -176.63 0.95 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.003 1.721 . . . . 0.0 108.166 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.9 132.35 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -134.63 175.96 9.06 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.787 1.635 . . . . 0.0 108.192 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 m -133.33 143.66 49.14 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.53 141.34 33.57 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 158.9 15.56 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.445 1.098 . . . . 0.0 108.308 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.08 -20.64 26.37 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.7 -31.13 63.26 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.937 1.295 . . . . 0.0 111.065 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.79 -39.65 30.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.375 1.47 . . . . 0.0 110.482 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.75 113.81 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.6 ttp-105 -155.2 -56.96 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 116.708 -1.615 . . . . 0.0 112.312 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.82 178.22 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.701 1.601 . . . . 0.0 111.567 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.81 156.01 29.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.43 1.492 . . . . 0.0 109.567 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.38 59.71 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.684 3.589 . . . . 0.0 111.574 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.66 31.29 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.149 1.779 . . . . 0.0 112.906 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.51 171.28 9.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.164 1.386 . . . . 0.0 110.418 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.22 30.74 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.767 1.627 . . . . 0.0 113.38 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.77 177.43 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.42 1.488 . . . . 0.0 110.119 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -9.13 15.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.425 1.49 . . . . 0.0 113.789 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.57 142.34 55.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.0 m -143.46 163.36 33.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 110.114 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -53.98 -31.54 51.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.884 1.673 . . . . 0.0 115.222 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -69.63 -26.07 64.24 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.455 1.025 . . . . 0.0 112.808 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.2 9.9 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.276 0.631 . . . . 0.0 112.597 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.11 154.73 12.35 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 118.382 0.537 . . . . 0.0 110.126 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.8 p -107.34 172.73 6.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.342 1.457 . . . . 0.0 109.335 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.39 -179.62 29.74 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.0 145.19 32.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 168.78 32.65 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.55 154.69 25.56 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.696 0.799 . . . . 0.0 109.517 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.31 80.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -174.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.42 -57.2 2.01 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.924 2.202 . . . . 0.0 112.115 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -148.96 -24.91 0.3 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.315 2.246 . . . . 0.0 111.939 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -71.72 165.8 23.29 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 84.9 mtp -141.46 142.2 33.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -133.77 123.54 25.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 mt -77.42 112.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 170.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.52 108.36 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.02 128.35 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.792 1.637 . . . . 0.0 108.098 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -79.17 60.0 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.687 1.195 . . . . 0.0 110.191 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.84 168.67 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.821 0.848 . . . . 0.0 108.866 170.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.67 -18.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.136 1.775 . . . . 0.0 113.009 -169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -109.67 -33.56 6.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.09 -1.433 . . . . 0.0 111.38 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -48.65 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.528 1.531 . . . . 0.0 112.205 -170.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 42.8 tp -71.36 -25.96 62.6 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.176 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -56.78 -29.4 62.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.253 0.933 . . . . 0.0 112.136 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -114.82 -3.34 12.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.234 1.414 . . . . 0.0 111.678 -173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.08 2.35 19.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.534 1.534 . . . . 0.0 111.739 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.54 -44.86 77.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.444 1.098 . . . . 0.0 111.343 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.11 -37.79 88.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.003 0.921 . . . . 0.0 111.082 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 -37.25 72.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.644 0.778 . . . . 0.0 111.273 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.77 -55.1 33.71 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.06 -28.84 69.36 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.645 0.778 . . . . 0.0 112.118 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.74 -24.03 54.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.675 0.79 . . . . 0.0 112.478 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.9 m -133.19 27.62 4.15 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.31 1.044 . . . . 0.0 111.035 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.41 46.76 1.13 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.701 1.6 . . . . 0.0 108.31 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.86 14.08 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 112.82 -170.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 m 64.79 38.75 6.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.677 1.591 . . . . 0.0 109.153 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -142.5 -79.69 0.23 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.025 1.33 . . . . 0.0 108.401 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.9 m -64.53 -35.17 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.391 0 C-N-CA 129.556 3.142 . . . . 0.0 104.822 169.862 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -61.35 -14.52 27.92 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.11 -0.87 84.23 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.174 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -17.56 19.2 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.094 1.947 . . . . 0.0 113.22 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.7 p -64.94 -10.32 28.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.948 1.699 . . . . 0.0 113.147 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -71.42 37.19 0.06 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.261 1.824 . . . . 0.0 113.73 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.14 74.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 m -138.3 139.8 39.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.811 1.244 . . . . 0.0 108.753 -168.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 174.66 6.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.284 0.564 . . . . 0.0 111.409 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 10' ' ' LEU . 1.2 pt? -69.11 51.27 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.393 2.277 . . . . 0.0 113.637 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.05 -29.29 12.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.175 1.79 . . . . 0.0 114.522 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 m -131.89 20.52 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.428 1.891 . . . . 0.0 111.14 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 22.84 73.23 0.27 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 129.567 3.147 . . . . 0.0 116.935 169.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.98 -170.41 0.62 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.652 2.234 . . . . 0.0 108.886 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.9 m -43.16 126.98 4.23 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.663 1.585 . . . . 0.0 111.681 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.74 94.64 1.05 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.788 1.661 . . . . 0.0 109.109 -174.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -80.76 153.1 27.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.512 1.525 . . . . 0.0 108.724 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.02 142.52 49.73 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -142.65 143.01 32.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.348 0.659 . . . . 0.0 111.608 -169.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -83.79 133.56 34.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 167.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.98 152.08 25.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 119.875 1.216 . . . . 0.0 109.514 -174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -146.55 153.76 40.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.379 1.072 . . . . 0.0 110.46 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.6 m -90.07 147.15 23.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.2 tp -144.97 105.59 4.12 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.512 1.525 . . . . 0.0 107.468 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.54 -77.68 0.61 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.146 1.355 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -153.45 22.97 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.061 1.344 . . . . 0.0 112.084 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -139.48 160.33 40.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.175 1.39 . . . . 0.0 108.555 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -120.17 150.35 40.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.911 1.339 . . . . 0.0 110.449 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -140.12 159.49 42.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.564 1.946 . . . . 0.0 108.029 -169.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.18 160.31 23.88 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.487 1.041 . . . . 0.0 111.092 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -140.62 139.2 35.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -50.07 115.51 1.44 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.946 0.899 . . . . 0.0 109.667 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -54.13 -33.99 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.373 1.069 . . . . 0.0 112.212 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.5 -24.97 68.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.805 0.842 . . . . 0.0 112.988 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -79.85 -18.53 50.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.024 0.829 . . . . 0.0 112.22 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.93 139.75 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.385 0.674 . . . . 0.0 109.235 -175.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -103.17 -57.96 1.95 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.451 1.1 . . . . 0.0 108.722 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.02 178.73 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.484 1.114 . . . . 0.0 109.556 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.43 144.15 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -147.66 168.71 21.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.472 1.909 . . . . 0.0 107.146 -169.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.46 -178.0 52.12 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.089 -1.007 . . . . 0.0 111.411 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -124.08 93.39 3.91 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.511 1.525 . . . . 0.0 106.942 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -159.49 -43.76 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.549 1.139 . . . . 0.0 109.678 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -74.07 29.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.456 1.902 . . . . 0.0 114.13 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.63 157.49 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.041 0.936 . . . . 0.0 110.878 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.7 m -141.93 148.72 39.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.381 2.672 . . . . 0.0 104.576 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -146.63 142.97 28.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.324 1.42 . . . . 0.0 109.642 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.76 140.53 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 169.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.11 -26.33 26.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -169.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -139.29 37.83 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.767 1.627 . . . . 0.0 112.422 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 48' ' ' ILE . 39.9 p -55.72 152.49 18.91 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 172.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.71 147.59 81.62 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 N-CA-C 106.163 -2.283 . . . . 0.0 106.163 167.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.35 32.48 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -61.24 -39.47 90.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.247 0.931 . . . . 0.0 110.806 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.37 80.93 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -60.73 -14.07 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.09 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.5 -141.25 9.12 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 120.579 1.536 . . . . 0.0 114.158 168.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' PRO . 18.2 m -134.07 166.19 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 128.374 2.669 . . . . 0.0 105.144 169.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 t -147.96 151.23 35.45 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.507 -1.371 . . . . 0.0 110.33 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.46 112.8 15.87 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.488 0.715 . . . . 0.0 110.78 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.38 91.74 8.27 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.59 21.67 0.93 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.089 1.756 . . . . 0.0 115.417 169.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.7 5.55 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.515 1.052 . . . . 0.0 114.079 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.81 -172.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.75 1.62 . . . . 0.0 107.55 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tp -129.41 152.59 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 120.132 1.333 . . . . 0.0 110.844 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.61 142.55 18.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.8 Cg_endo -64.32 151.74 84.22 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.691 1.594 . . . . 0.0 111.777 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tp -125.55 134.96 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.89 142.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -103.53 113.01 26.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.47 -170.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.52 -27.09 65.87 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.112 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -55.12 -46.22 75.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.019 0.827 . . . . 0.0 109.753 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.86 -38.78 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -64.73 -28.35 69.53 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.442 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.31 2.23 10.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.666 0.786 . . . . 0.0 112.725 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m 50.34 48.25 22.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.433 1.093 . . . . 0.0 111.551 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -174.99 0.3 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 111.148 175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.21 173.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.878 1.271 . . . . 0.0 110.949 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -80.78 65.61 5.99 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.589 2.356 . . . . 0.0 110.073 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 m -51.0 157.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.906 1.282 . . . . 0.0 112.744 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -151.53 176.11 11.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.9 1.68 . . . . 0.0 110.548 -171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -67.96 49.85 0.06 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.366 2.267 . . . . 0.0 110.686 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -149.72 -30.48 0.23 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.338 2.655 . . . . 0.0 109.986 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -141.9 19.22 2.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.127 1.371 . . . . 0.0 111.832 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -142.82 16.75 1.96 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.799 2.039 . . . . 0.0 110.484 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -73.56 3.29 6.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.631 2.772 . . . . 0.0 116.309 -168.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.04 157.45 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 119.781 1.173 . . . . 0.0 108.043 -175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.3 t -132.81 133.62 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 127.059 2.144 . . . . 0.0 107.632 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -99.99 134.14 40.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.293 -2.855 . . . . 0.0 103.293 168.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.91 134.64 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.5 mt -134.44 167.47 20.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.572 1.549 . . . . 0.0 108.703 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.04 153.4 42.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.08 141.95 20.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 170.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.36 0.02 OUTLIER Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.063 1.315 . . . . 0.0 112.148 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -146.29 9.12 1.08 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.832 1.653 . . . . 0.0 111.521 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 164.28 24.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.773 -1.204 . . . . 0.0 110.68 -173.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.46 149.73 26.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.195 1.398 . . . . 0.0 108.567 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.12 162.24 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.28 167.08 24.83 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.62 135.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.18 144.31 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.015 0.926 . . . . 0.0 110.291 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -148.13 165.83 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.547 1.939 . . . . 0.0 108.315 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.37 -42.78 74.73 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.248 -0.908 . . . . 0.0 110.03 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.93 157.97 11.59 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.26 122.19 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.79 -48.43 18.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.254 0.622 . . . . 0.0 111.039 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -170.94 -179.78 2.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.724 1.21 . . . . 0.0 109.692 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.3 t -127.48 126.86 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.88 178.07 10.68 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.892 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.1 m -130.44 148.73 52.28 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.166 0.587 . . . . 0.0 111.053 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -143.07 143.19 31.76 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.9 p -82.84 164.92 20.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.352 0.596 . . . . 0.0 111.37 174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 14.61 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.719 1.208 . . . . 0.0 113.376 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.25 -38.49 3.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.228 1.811 . . . . 0.0 109.512 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.66 -39.5 88.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.97 121.91 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.66 1.984 . . . . 0.0 106.988 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 118' ' ' PRO . 63.9 mtt85 -150.83 -56.33 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 117.088 -1.434 . . . . 0.0 110.61 169.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 36.5 Cg_endo -65.78 178.35 2.33 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.889 2.392 . . . . 0.0 112.704 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.05 33.48 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.254 1.421 . . . . 0.0 109.415 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -80.98 50.42 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.086 3.191 . . . . 0.0 110.441 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.5 21.21 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.521 1.529 . . . . 0.0 114.424 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -148.86 152.39 36.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.844 1.658 . . . . 0.0 109.377 -169.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 49.31 40.14 17.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.734 . . . . 0.0 114.008 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.2 157.94 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.861 1.265 . . . . 0.0 109.396 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -15.69 61.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.194 1.397 . . . . 0.0 112.376 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.524 HD13 ' H ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -50.52 155.85 1.0 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.378 2.271 . . . . 0.0 112.22 176.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' LEU . 5.5 m -130.38 156.21 45.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 110.261 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -60.05 -35.28 74.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -76.98 -15.56 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.123 1.329 . . . . 0.0 112.75 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -126.39 25.4 6.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.94 138.93 57.71 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.1 p -75.41 -174.45 2.43 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.32 1.848 . . . . 0.0 109.989 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.46 175.48 20.17 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.39 155.78 42.28 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.041 1.421 . . . . 0.0 109.506 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.38 179.82 29.43 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 123.696 0.665 . . . . 0.0 111.958 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.86 158.48 39.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -169.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.51 60.14 1.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.107 2.163 . . . . 0.0 107.463 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 -48.25 2.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.22 1.867 . . . . 0.0 113.199 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.87 -32.35 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.73 2.012 . . . . 0.0 110.39 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -68.92 154.56 41.82 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.7 mtp -143.77 143.71 31.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.895 1.678 . . . . 0.0 106.496 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -137.01 140.48 42.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 92.4 mt -96.34 112.42 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.49 110.22 19.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.52 130.43 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.511 1.124 . . . . 0.0 108.277 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -79.98 60.61 3.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.022 1.329 . . . . 0.0 109.408 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.99 -37.14 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.514 1.126 . . . . 0.0 111.78 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.15 -26.78 68.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.374 0.534 . . . . 0.0 112.409 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -106.54 -17.47 14.24 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.856 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -50.35 -73.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.495 1.498 . . . . 0.0 110.858 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.3 tp -74.37 -26.51 60.16 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.31 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -63.56 -31.12 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.849 1.204 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -84.1 -27.59 28.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.872 0.869 . . . . 0.0 111.559 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -111.31 6.42 20.48 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -51.21 -48.9 61.92 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.991 1.316 . . . . 0.0 111.074 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -28.27 69.97 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.512 0.725 . . . . 0.0 112.554 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.08 -42.67 23.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.666 0.786 . . . . 0.0 110.593 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.43 -46.05 91.44 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.997 0.817 . . . . 0.0 109.547 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.93 -12.96 61.18 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.143 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.98 -23.57 65.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.038 1.29 . . . . 0.0 111.507 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -124.38 -42.38 2.11 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.493 0.717 . . . . 0.0 111.977 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.09 30.69 1.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.634 0.774 . . . . 0.0 112.795 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.75 7.3 2.02 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.54 0.736 . . . . 0.0 112.283 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 15.9 m 54.79 43.21 30.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.036 1.335 . . . . 0.0 109.873 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.19 -46.89 0.84 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.329 1.051 . . . . 0.0 110.681 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.12 -21.13 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.016 0.527 . . . . 0.0 110.528 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 C-N-CA 126.088 1.755 . . . . 0.0 107.048 169.831 . . . . . . . . 0 0 . 1 stop_ save_